,text
0,"{'title': 'W12 cervical ectokeratinocytes, Series 1 passage 22 (p22) #2', 'description': 'W12 cervical ectokeratinocytes; a model that recapitulates features of neoplastic progression in vitro; originally described in Stanley et al 1989, PMID 2467886;\tW12 Series 1 passage 22 (p22) #2', 'type': 'RNA', 'source_name_ch1': 'W12 passage 22 replicate 2 of 3', 'characteristics_ch1': 'gender: Female;\tcell line: W12 cervical ectokeratinocytes;\tanatomical site: Cervix;\tpassage: 22 (p22)'}"
1,"{'title': 'newly diagnosed multiple myeloma 252', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: III'}"
2,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 17', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
3,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R27', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 83.89;\t%cd3cd8: 14.59;\t%cd8+cd28-: 1.42;\t%cd8+cd28+: 7.55;\t%cd4cd25cd62l: 5.67;\t%cd3delta1: 0.14;\t%cd3delta2: 0.79;\tratio delta1/delta2: 0.18;\t%cd3gammadelta: 1.08;\t%cd3alphabeta: 96.73;\t%cd4cd8-ab+(dn): 1.27;\t%cd4 cd62l+cd45+: 22.80;\t%cd4 cd62l-cd45+: 0.02;\t%cd4 cd62l - cd45-: 18.27;\t%cd4cd62l+cd45-: 58.91;\t%cd4 ccr7+ cd45 -: 45.83;\t%cd4 ccr7+ cd45+: 29.03;\t%cd4 ccr7 - cd45+: 0.37;\t%cd4 ccr7 – cd45-: 24.78;\t%cd8 cd62l+ cd45-: 29.84;\t%cd8cd62l+ cd45+: 30.57;\t%cd8cd62l- cd45+: 5.79;\t%cd8cd62l- cd45 -: 33.80;\t%cd8ccr7+ cd45-: 10.64;\t%cd8ccr7+ cd45+: 19.46;\t%cd8ccr7-cd45+: 21.81;\t%cd8ccr7-cd45 -: 48.09;\t%cd3-cd56+cd16+: 8.97;\t%nkts: 1.97;\t%cd19: 15.17;\t%cd4foxp3+: 6.66'}"
4,"{'title': 'colonic_mucosa_non_inflamed_721', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Control subject, biopsy taken from the colon, no macroscopic signs of inflammation.'}"
5,"{'title': 'COL2_538', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 49;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 438;\tsecond apc mutation: 0;\t5q loh: 0'}"
6,"{'title': 'B25', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 66;\tSex: M;\tcode: resection;\tclass: Unannotated;\ttp53 mutation: 0;\tctnnb1 mutation: 233A>AG,p.D32D/G;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
7,"{'title': 'normal colon 2', 'description': 'total RNA isolated from normal colon of stage D colorectal carcinoma patient 2', 'type': 'RNA', 'source_name_ch1': 'normal colon from stage D colorectal carcinoma patient 2', 'characteristics_ch1': 'tissue: colon;\ttumor stage of patient: stage D'}"
8,"{'title': 'RR670b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1467;\tdisease state: Uninfected;\tgender: Male;\tage: 26;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 326;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
9,"{'title': 'CLL_FISHnormal_rep1', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'female'}"
10,"{'title': 'Patient 18, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
11,"{'title': 'Glioblastoma_11', 'description': 'bh20061208u133v2_A_11-GBM12_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 69;\tgender: male;\ttumor grade: IV'}"
12,"{'title': 'Group B1-IVIG-Pre-3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: pre-treatment'}"
13,"{'title': 'Endometrium in control conditioned medium for 12 hours TCM-15', 'description': 'Control conditioned medium endometrium  12 hours TCM-15', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control conditioned medium endometrium  12 hours TCM-15'}"
14,"{'title': 'HBE_t0_code1', 'description': 'Gene expression data from human airway epithelium treated as described.', 'type': 'RNA', 'source_name_ch1': 'well-differentiated primary airway bronchial culture', 'characteristics_ch1': 'Genotype:normal'}"
15,"{'title': 'AML 7405', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 47 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: neg'}"
16,"{'title': 'M35', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 62;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 2.72;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
17,"{'title': 'untreated: m4: i3: d06', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 4; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 4;\tReplicate: 3;\tBatch: d06'}"
18,"{'title': 'X23026', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
19,"{'title': 'ALL without MLL - sample 10', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
20,"{'title': 'Replicate 2 for MB231inhibitor72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 2 for MB231inhibitor72h breast cell line'}"
21,"{'title': '10311', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 55;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 68;\tDonor Sex: M;\tCAN Banff Score =2;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
22,"{'title': 'Sputum from Stage II Moderate, biological replicate 24', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 66;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
23,"{'title': 'X424', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
24,"{'title': 'Sputum from Stage II Moderate, biological replicate 38', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 71;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
25,"{'title': 'MDS patient 60', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: other'}"
26,"{'title': '27006', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 2;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
27,"{'title': 'VCX control 4', 'description': 'arrayconsortium.tgen.org::biosample.435236;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 4;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 79 years'}"
28,"{'title': 'Lung Cancer 158T', 'description': 'Gene expression data from 158T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 72;\tstage: 2B'}"
29,"{'title': '2x9 PGC-1 mutant, repeat 1', 'description': 'HePG2 cells infected with adenovirus expressing the 2x9 mutant of PGC-1', 'type': 'RNA', 'source_name_ch1': 'HePG2', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
30,"{'title': 'X60048', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
31,"{'title': 'Hippocampus_female_87yrs_indiv109', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 87 years', 'characteristics_ch1': 'individual: 109, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 87'}"
32,"{'title': 'Insulin resistant patient 15 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
33,"{'title': '01_0052A_Day1_14', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Female;\tSurvivor;\torganism: None;\tupdate'}"
34,"{'title': 'B1-RR-Pat.9 [wf20071123u133v2_U_05_HT20_B1_F_50yr_No_151]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
35,"{'title': 'PTCL.BO.11', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
36,"{'title': 'shRB-A (senescent) E2', 'description': 'Senescent cells expressing shRNA targeting RB  replicate 1, experiment 2', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing shRNA targeting RB', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
37,"{'title': 'CD19_selected_B-cells_before_FC_rep9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before FC (control)'}"
38,"{'title': 'cin_NY20', 'description': 'cirrhotic liver tissue from patients without HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue from patients without HCC', 'characteristics_ch1': 'cirrhotic liver tissue from patients without HCC'}"
39,"{'title': 'MonoMac6 - unstimulated', 'description': 'Expression pattern of unstimulated MonoMac6 cells', 'type': 'RNA', 'source_name_ch1': 'human monocytic cell line MonoMac6', 'characteristics_ch1': 'cultured MonoMac6 cells, near confluent state, solvent (12 h incubated with appropriate volume of DMSO)'}"
40,"{'title': 'ALL without MLL - sample 11', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
41,"{'title': 'MCF-7 +scrambled siRNA + vehicle rep1 (MD39)', 'description': 'Gene expression data from MCF-7cells treated with vehicle and scrambled siRNA;\tMD39', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with vehicle and scrambled siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: control (scrambled siRNA);\tagent: control (vehicle);\tdose: n/a'}"
42,"{'title': 'AML with normal karyotype #177', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 44;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 86;\tdisease state: de novo AML'}"
43,"{'title': 'DM2_M54_VL_12', 'description': 'DM2 patient, age 54, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Vastus Lateralis'}"
44,"{'title': 'Epilepsy patient E5, 2 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E5 taken 2 hours after GC administration.;\t;\tE5-2h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E5, 2 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: dexamethasone;\ttreatment_time: 2 hrs;\tpatient: E5'}"
45,"{'title': '3.1.NDV.1', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 1 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 1'}"
46,"{'title': 'class S, rep33', 'description': 'VAN_00187.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 22;\tsex: f;\tdisease stage: 2;\talbumin level: 44;\themoglobin level: 106;\tlymphocyte percentage: 4;\twhite blood count: 12.8;\tinternational prognostic score (ips): 2'}"
47,"{'title': 'SG-91A_phenotype of EPC colony assay', 'description': 'EPC sampled from blood and cultured', 'type': 'RNA', 'source_name_ch1': 'cultured EPC, baseline', 'characteristics_ch1': 'baseline'}"
48,"{'title': 'Huh7 cells_JFH-1 Infected 48 hours_ rep3', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 48 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 48 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
49,"{'title': '10412', 'description': 'RNA from whole blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 63;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 45;\tDonor Sex: F;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
50,"{'title': 'AML 4336', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 30 years;\tscore: RAEB-t;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
51,"{'title': 'AML 2765', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 33 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
52,"{'title': 'group-1-pt-t16437161', 'description': 'group-1-pt-t16437161', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 51;\tgender: male;\tfinal disposition: 05: Home with services'}"
53,"{'title': 'newly diagnosed multiple myeloma 96', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
54,"{'title': 'M-56', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
55,"{'title': 'Thyroid_papillary carcinoma 14', 'description': 'sample name in manuscript: T-PTC2', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: tumor; Gender: male; Age:42  Tumor stage: T3NxMx'}"
56,"{'title': 'EPN_285, non-recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_285, non-recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
57,"{'title': 'class F, rep17', 'description': 'NEB_26.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 20;\tsex: M;\tdisease stage: 3;\talbumin level: 26;\themoglobin level: 75;\tlymphocyte percentage: 2;\twhite blood count: 23.6;\tinternational prognostic score (ips): 4'}"
58,"{'title': 'S126', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S126', 'characteristics_ch1': 'patient id: P073;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
59,"{'title': 'SS gland, moderate, patient 9, batch 1', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: moderate SS'}"
60,"{'title': 'K_STA5', 'description': 'K_STA5', 'type': 'RNA', 'source_name_ch1': 'STA5 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
61,"{'title': 'CD34+cells_normal_bone_marrow_3', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'CD34+ cells sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
62,"{'title': 'S096', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S096', 'characteristics_ch1': 'patient id: P120;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 34'}"
63,"{'title': 'whole blood_101467', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Male', 'characteristics_ch1': 'General population, Male'}"
64,"{'title': 'Myeloma tumor, sample 4', 'description': 'MM_TUMOR_04;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: female;\tdisease state: advanced multiple myeloma (MM)'}"
65,"{'title': 'class S, rep79', 'description': 'VAN_00507.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 28;\tsex: F;\tdisease stage: 2;\talbumin level: 45;\themoglobin level: 128;\tlymphocyte percentage: 17;\twhite blood count: 6.8;\tinternational prognostic score (ips): 1'}"
66,"{'title': 'H4_HC5d', 'description': 'gene expression data for H4 treated with HC for 5d', 'type': 'RNA', 'source_name_ch1': 'human fetal small intestinal epithelial cell, HC 5 day', 'characteristics_ch1': 'origin: fetal;\tcell line: H4;\ttreatment: hydrocortisone;\ttreatment: 5 d'}"
67,"{'title': 'N2-30', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
68,"{'title': 'group-1-pt-t27151221', 'description': 'group-1-pt-t27151221', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 46;\tgender: male;\tfinal disposition: 07: Another acute care facility'}"
69,"{'title': 'AML 7145', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 50 years;\tscore: FAB M2;\trisk: unknown;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
70,"{'title': 'siWT-1', 'description': 'PLC/PRF/5 were transfected in triplicate with WT1 specific siRNAs (siWT) and siRNAs control (siGL)', 'type': 'RNA', 'source_name_ch1': 'PLC/PRF/5 cells transfected with 2 duplexes of specific siRNA targeting exons 7 and 10 of WT1', 'characteristics_ch1': 'Human hepatoma cell line'}"
71,"{'title': 'Pt8 whole subcutaneous adipose tissue, biological rep1', 'description': 'Pt8_SQAT', 'type': 'RNA', 'source_name_ch1': 'Whole subcutaneous adipose tissue, patient 8', 'characteristics_ch1': 'tissue: whole subcutaneous adipose tissue;\tpatient: 8'}"
72,"{'title': 'Cord blood CD21hi transitional B cells, rep2', 'description': 'Sample pooled from 3 cord blood donors.', 'type': 'RNA', 'source_name_ch1': 'Cord blood CD21hi transitional B cells', 'characteristics_ch1': 'tissue: cord blood;\tb-cell subset: CD20+CD10+CD27-CD21hi'}"
73,"{'title': 'non-malignant FTEb_patient 6', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 46;\tCycle: Luteal;\tBRCA1/2 mutation: BRCA2 C5910G;\tFamily History: Yes'}"
74,"{'title': 'cord blood 24', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.74', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.74;\t'}"
75,"{'title': 'Gingival tissue sample 2 from patient 95, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 95 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
76,"{'title': 'muscle_preTZD_preClamp_IRd_s51', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 51'}"
77,"{'title': 'PBMCs_EB_after exercise_04', 'description': 'EB_Peak_112-JuT', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 9;\tafter-exercise'}"
78,"{'title': 'Gingival tissue sample 2 from patient 42, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 42 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
79,"{'title': 'CD16- 2', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'human CD16- monocytes', 'characteristics_ch1': 'monocyte subsets: CD16- monocytes'}"
80,"{'title': 'shp130-B (Senescent)', 'description': 'Senescent cells expressing shRNA targeting p130 replicate 2', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing shRNA targeting p130', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
81,"{'title': 'Spleen_control_S1', 'description': 'Spleen control S1', 'type': 'RNA', 'source_name_ch1': 'normal spleen sample', 'characteristics_ch1': 'tissue: normal spleen'}"
82,"{'title': 'B77', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.0'}"
83,"{'title': 'No29inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No29RVR;\ttime point: under therapy'}"
84,"{'title': 'AML sample #34', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00110;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
85,"{'title': 'DLBCL biopsy, sample 2184A', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
86,"{'title': 'class S, rep15', 'description': 'VAN_00072.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 31;\tsex: M;\tdisease stage: 2;\talbumin level: 46;\themoglobin level: 136;\tlymphocyte percentage: 25;\twhite blood count: 6.3;\tinternational prognostic score (ips): 2'}"
87,"{'title': 'B84', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 74;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 816;\ttp53 mutation: 0;\tctnnb1 mutation: 232G>GA | D32D/N;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
88,"{'title': 'Training_Site8_11', 'description': 'Performed by Operator 1 from Site8 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 8.2; Lot# = 035PO41658D'}"
89,"{'title': 'Liver_hyperglycima_no.2', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: type 2 diabetes'}"
90,"{'title': 'MERLION_X02K02220', 'description': 'MERLION_X02K02220', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=50, state=1', 'characteristics_ch1': 'pT2N0, male, age=50, state=1'}"
91,"{'title': '05-206_CaP', 'description': 'Prostate cancer whole tissue.', 'type': 'RNA', 'source_name_ch1': 'cancer prostate', 'characteristics_ch1': 'tissue: prostate;\tgleason: 3+3;\ttumor stage: T2cN0Mx;\ttumor volume: 4.7 cc'}"
92,"{'title': 'UCNR12_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
93,"{'title': 'Group B1-IVIG-Post-5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: post-treatment'}"
94,"{'title': 'AML 2762', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 23 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
95,"{'title': 'Blood_TD19902_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
96,"{'title': '22073', 'description': '11724', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24298;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
97,"{'title': 'U937_naive_untreated_18h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, untreated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
98,"{'title': 'MCF-10F, biological rep3', 'description': 'Gene expression data from nontumorigenic ER(-) human breast epithelial cells', 'type': 'RNA', 'source_name_ch1': 'breast epithelial cells derived from fibroadenoma', 'characteristics_ch1': 'Genotype: slightly aneuploid'}"
99,"{'title': 'MCF7 silenced Estrogen receptor, biological rep3', 'description': 'Gene expression data from MCF7 breast cancer cell line with silenced Estrogen receptor', 'type': 'RNA', 'source_name_ch1': 'MCF7 silenced Estrogen receptor alpha (PII)', 'characteristics_ch1': 'knockdown: estrogen receptor alpha KD;\tcell line: MCF7'}"
100,"{'title': 'Lung Normal 2N', 'description': 'Gene expression data from 2N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 55;\tstage: n/a'}"
101,"{'title': 'NY224', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: C;\tage: 42;\tSex: M;\tcode: resection;\tclass: Proliferation;\tafp: 13787;\ttp53 mutation: 195G>GT | E271E/X;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
102,"{'title': 'RTX11 T0', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).', 'characteristics_ch1': 'treatment: baseline;\tgender: F;\tage (y): 47;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Poor-responder;\ttissue: synovium'}"
103,"{'title': 'AML 5359', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: t(6;9);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
104,"{'title': 'ALL without MLL - sample 66', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
105,"{'title': 'GA_904', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
106,"{'title': 'AML sample #19', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00039;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
107,"{'title': 'SI9', 'description': 'Gene expression data from Standard Immunotherapy 9', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 9', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
108,"{'title': 'Proficiency_Site7_18', 'description': 'Performed by Operator 1 from Site7 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 69.5; Lot# = 035PO41658D'}"
109,"{'title': 'T152 U133p2', 'description': 'bulk breast tumor RNA from patient T152', 'type': 'RNA', 'source_name_ch1': 'T152', 'characteristics_ch1': 'breast tumor'}"
110,"{'title': 'AML 7125', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 48 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
111,"{'title': 'S025', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S025', 'characteristics_ch1': 'patient id: P085;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
112,"{'title': '41-2', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 41 treated 786-O cells, replicate 2'}"
113,"{'title': 'Patient 4415 AML85', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 85;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
114,"{'title': 'PCB77 treated HepG2 cells at T0.5, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines after 30 minutes of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 30 minutes of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
115,"{'title': 'lymphocytes_HD_M_62y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: male; Age: 62; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/47'}"
116,"{'title': 'pU62_B', 'description': 'Gene expression data from control cell line', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma cell line Hep3B cells, plasmid pU6, clone 2', 'characteristics_ch1': 'Hep3B cells stably transfected with short hairpin vectors (plasmid pU6 is the host vector);\tHep3B cells stably transfected with plasmid pU6, clone 2, replicate 2'}"
117,"{'title': '23030', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
118,"{'title': 'MERLION_X00K05435', 'description': 'MERLION_X00K05435', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:60, state:0', 'characteristics_ch1': 'pT2N0, male, age:60, state:0'}"
119,"{'title': '11-0049A_SIRS_day1_132', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
120,"{'title': 'NSCLC_SCC_412', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 412.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
121,"{'title': 'AML with normal karyotype #50', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: positive;\tage: 38;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 81;\tdisease state: de novo AML'}"
122,"{'title': 'X70056', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
123,"{'title': 'S119', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S119', 'characteristics_ch1': 'patient id: P003;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
124,"{'title': 'IFNβ_531', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
125,"{'title': 'BC13008', 'description': '080306.12.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 35;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: --;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: --;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: --;\terbb2p ihc status: --;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: --;\tfoxa1 ihc status: --;\tmfs: 0;\tmfsdel (month): 32.82'}"
126,"{'title': 'Endometrium-prog B (01B04871-3)', 'description': '01B04871-3.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group B', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2-3;\tpregnancy status: non-pregnant;\tprogesterone serum level: group B (1-1.5 ng/ml)'}"
127,"{'title': 'whole blood_100354', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Female', 'characteristics_ch1': 'General population, Female'}"
128,"{'title': 'Old sedentary subject, biological replicate (OS5)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old sedentary subject', 'characteristics_ch1': 'no additional information'}"
129,"{'title': '1-CD4-1-N', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Individual #1, CD4 T cell clone #1, resting', 'characteristics_ch1': 'cell type: CD4 T cell clone'}"
130,"{'title': 'MCF-7_Si-Wu-Tang_2.56mg/ml_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
131,"{'title': 'Training_Site9_19', 'description': 'Performed by Operator 1 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
132,"{'title': 'Patient 5047 AML186', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 186;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
133,"{'title': 'Scz-18', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tInt10', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: M;\tage: 38;\ttissue ph: 5.6;\tpmi (hrs): 40;\ttype of drug: Haloperidol;\tdrug dose (chlorpromazine equivalents): 160 mg'}"
134,"{'title': 'newly diagnosed multiple myeloma 126', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
135,"{'title': 'Gingival tissue sample 4 from patient 12, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 12 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
136,"{'title': 'MLD AML sample #18', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
137,"{'title': 'PC3', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'plasma cells donor 3', 'characteristics_ch1': 'plasma cells, isolated from tonsils by fluorescence-activated cell sorting'}"
138,"{'title': 'Patient_6558_diagnosis', 'description': '6558D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 33;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
139,"{'title': 'newly diagnosed multiple myeloma 75', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
140,"{'title': 'K_STA11', 'description': 'K_STA11', 'type': 'RNA', 'source_name_ch1': 'STA11 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
141,"{'title': 'sample 44, brca1 mutation positive, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: luteal;\tsample identifier: 44'}"
142,"{'title': 'IFNa treated donor 3', 'description': 'RNA from healthy donor', 'type': 'RNA', 'source_name_ch1': 'primary macrophages, IFNa-treated', 'characteristics_ch1': 'cell type: monocyte-derived macrophage;\tagent: IFNalpha'}"
143,"{'title': 'Gingival tissue sample 2 from patient 37, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 37 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
144,"{'title': 'class S, rep35', 'description': 'VAN_00270.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 33;\tsex: M;\tdisease stage: 2;\talbumin level: 45;\themoglobin level: 160;\tlymphocyte percentage: 23;\twhite blood count: 7.7;\tinternational prognostic score (ips): 2'}"
145,"{'title': 'T9740A3: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
146,"{'title': 'miR-124 transfection for 120 hours', 'description': 'miR-124 transfection for 120 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
147,"{'title': 'X60066', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
148,"{'title': 'HF1475_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
149,"{'title': 'newly diagnosed multiple myeloma 50', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
150,"{'title': 'PCB77 treated HepG2 cells at T6, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines after 6 hours of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 6 hours of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
151,"{'title': 'GC B cell_LMP1_rep1', 'description': 'Amplified total RNA from transfected and FACS sorted GC Bells', 'type': 'RNA', 'source_name_ch1': 'GC B cell transfected with LMP1 expression vector (pSG5-LMP1), rep1', 'characteristics_ch1': 'GC B cells sorted using CD10 MACS from reactive human tonsils'}"
152,"{'title': 'Blk-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': '786-O cells treated with medium only, replicate 3'}"
153,"{'title': 'Clone A cells cultured for 48 hours rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
154,"{'title': 'CLL cells  LN patient #9', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #9'}"
155,"{'title': 'control participant P318', 'description': 'Gene expression data from control participant TL', 'type': 'RNA', 'source_name_ch1': 'control participant P318 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
156,"{'title': 'Blood_TD23461_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
157,"{'title': 'Young trained subject, biological replicate (YT11)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
158,"{'title': 'C99558', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7230_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 55;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
159,"{'title': 'Replicate 2 for MB231control72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 2 for MB231control72h breast cell line'}"
160,"{'title': 'N51292', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51292;\tsample: normal'}"
161,"{'title': 'non-malignant FTEn_patient 11', 'description': 'Gene expression profile of non-malignant FTE from control patient during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 50;\tCycle: Follicular;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
162,"{'title': 'L+S I BEAS2b_ML04C', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - mechanical stretch plus LPS', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
163,"{'title': 'Septic Shock_biological rep87 15-0012A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0;\toutcome: Nonsurvivor;\tgroup: A'}"
164,"{'title': 'Training_Site8_15', 'description': 'Performed by Operator 1 from Site8 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
165,"{'title': 'Healthy donor, 2 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of a healthy donor taken 2 hours after GC administration.;\t;\tRPK-II-2h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, healthy donor, 2 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: healthy;\ttreatment: dexamethasone;\ttreatment_time: 2 hrs'}"
166,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 14', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
167,"{'title': 'Patient 4555 AML124', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 124;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
168,"{'title': 'CD19_selected_B-cells_after_R_rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after Rituximab'}"
169,"{'title': 'Training_Site2_07', 'description': 'Performed by Operator 1 from Site2 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
170,"{'title': 'mock-infected, asthmatic S12 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, asthmatic S12', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
171,"{'title': 'adenocarcinoma_26 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 81;\tlocalization: transverse'}"
172,"{'title': 'VAN_00633', 'description': '07-14026', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: COMPOSITE (>50% DLBCL, remaining FL);\ttissue: lymph node;\tage: 78;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP8-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.02;\tprogression-free_survival (years): 1.02'}"
173,"{'title': 'X2227', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : NA;\tConsolidated.Grade : NA'}"
174,"{'title': 'Healthy donor, untreated sample', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of a healthy donor before administration of GC.;\t;\tRPK-II-0h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, healthy donor, before administration of GC', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: healthy;\ttreatment: untreated;\ttreatment_time: 0 hrs'}"
175,"{'title': 'Bronchial epithelial cells, day 2, donor 3', 'description': 'Bronchial epithelial cells, day 2, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 2 of air-liquid interface culture'}"
176,"{'title': 'AML with normal karyotype #114', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 84;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 49.5;\tdisease state: de novo AML'}"
177,"{'title': 'Proficiency_Site9_31', 'description': 'Performed by Operator 2 from Site9 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 68.6; Lot# = 035PO41658D'}"
178,"{'title': 'adenocarcinoma_75 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 53;\tlocalization: caecum'}"
179,"{'title': 'C158', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 3.5'}"
180,"{'title': 'mucosa_carcinoma_7 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: carcinoma;\tsex: female'}"
181,"{'title': 'Patient_7304_relapse', 'description': '7304R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 38;\tconclusions ig/tcr: unstable;\tselected: no'}"
182,"{'title': 'NB87 U133p2 (breast epithelial study)', 'description': 'RNA from bulk normal breast or normal breast organoid', 'type': 'RNA', 'source_name_ch1': 'NB87', 'characteristics_ch1': 'bulk normal breast or normal breast organoid'}"
183,"{'title': 'mRNA of GBM-HGG077, Glioblastoma, 4 years, Diffuse pontine glioma', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 4 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 4 years; Other: Diffuse pontine glioma'}"
184,"{'title': 'HF0066_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
185,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 22', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
186,"{'title': 'S148', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S148', 'characteristics_ch1': 'patient id: P009;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
187,"{'title': 'THRBL_lymph_node_case6', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: female, Age: 75, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: IIIA, IPI prognostic score: low intermediate, follow-up: <1 year; status at last follow-up: death with disease'}"
188,"{'title': 'GA_805', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
189,"{'title': '07-0006A_Septic Shock_day1_99', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
190,"{'title': 'B12', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 2.2'}"
191,"{'title': 'Tumor Tum_Ph2_rep11', 'description': 'Tumor paired  14', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N2;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
192,"{'title': 'newly diagnosed multiple myeloma 25', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: III'}"
193,"{'title': 'AML 2252', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 27 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
194,"{'title': 'NY309', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: B;\tage: 66;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 23.2;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
195,"{'title': 'Training_Site10_04', 'description': 'Performed by Operator 1 from Site10 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 67.45; Lot# = 065PO36893A'}"
196,"{'title': 'Blood_TD24112_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
197,"{'title': 'ALL without MLL - sample 58', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
198,"{'title': 'colonic_crypt_epithelial_cells_carcinoma_22 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: carcinoma;\tsex: female'}"
199,"{'title': 'TC.CD8-2', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
200,"{'title': 'Adenocarcinoma, bone marrow negative AC 12', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'female pulmonary adenocarcinoma;\tbone marrow negative'}"
201,"{'title': 'Sepsis gram-negative V34', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
202,"{'title': 'Scz-22', 'description': 'ID# from Supplementary Table 3 of PMID 18778695: -', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: F;\tage: 65;\ttissue ph: 6.35;\tpmi (hrs): 50;\ttype of drug: Fluphenazine, Haloperidol;\tdrug dose (chlorpromazine equivalents): 550 mg'}"
203,"{'title': 'CDcR12_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
204,"{'title': 'Differentiated HepaRG, biological replicate 2', 'description': 'Diff2', 'type': 'RNA', 'source_name_ch1': 'Differentiated well-confluent HepaRG', 'characteristics_ch1': 'cell line: HepaRG;\tdifferentiation state: differentiated;\tgender: female'}"
205,"{'title': 'EC control 3', 'description': 'arrayconsortium.tgen.org::biosample.433915;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 3;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 80 years'}"
206,"{'title': 'class F, rep24', 'description': 'VAN_00084f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 12;\tsex: M;\tdisease stage: 2;\talbumin level: 37;\themoglobin level: 117;\tlymphocyte percentage: 13;\twhite blood count: 8.78;\tinternational prognostic score (ips): 3'}"
207,"{'title': 'B18', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 1.1'}"
208,"{'title': 'C020_Control_M_25', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 25;\tpost-mortem delay: 12h;\tph: 6.6'}"
209,"{'title': 'M106', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 80;\tSex: F;\tcode: resection;\tclass: Unannotated;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
210,"{'title': 'cord blood 19', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.5', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.5;\t'}"
211,"{'title': 'AML with normal karyotype #2', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 41;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 50.5;\tdisease state: de novo AML'}"
212,"{'title': '3485', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 66 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
213,"{'title': 'Subcutaneous adipose tissue, SAT12', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
214,"{'title': 'Subcutaneous adipose tissue, SAT27', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
215,"{'title': 'vad4', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: adenoma'}"
216,"{'title': 'MCF7 siRNA control', 'description': 'Gene expression data from MCF7 siRNA control', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7, siRNA control', 'characteristics_ch1': 'MCF7 siRNA control'}"
217,"{'title': 'GBM, radiotherapy (534)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 534;\tage: 41.7;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 0;\tsurvival time in months: 23.29;\tmgmt status: M'}"
218,"{'title': 'colon_adenoma_1832', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
219,"{'title': 'HIV+ Individual HIV-1a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-1a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
220,"{'title': 'adipose_postTZD_IRd_s9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 9'}"
221,"{'title': 'N11464B1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
222,"{'title': 'C007_Control_M_54', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 54;\tpost-mortem delay: 12h;\tph: 6.6'}"
223,"{'title': 'AML with normal karyotype #46', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 72.5;\tdisease state: de novo AML'}"
224,"{'title': 'Group B1-IVIG-Post-1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: post-treatment'}"
225,"{'title': 'group-1-pt-t18691395', 'description': 'group-1-pt-t18691395', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 26;\tgender: male;\tfinal disposition: 06: Home'}"
226,"{'title': 'G166-NS_A', 'description': 'U133Plus2_122906L_DK20.CEL', 'type': 'RNA', 'source_name_ch1': 'Glioblastoma derived cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: malignant;\tcell type: cell line;\tcell type: glioblastoma'}"
227,"{'title': 'LMP494', 'description': 'low-malignant tumors of the ovary', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: low-malignant tumors of the ovary'}"
228,"{'title': 'AML 7164', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 48 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
229,"{'title': 'Control 72', 'description': '08SE393', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
230,"{'title': 'class S, rep80', 'description': 'VAN_00508.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 34;\tsex: M;\tdisease stage: 1;\talbumin level: _;\themoglobin level: 149;\tlymphocyte percentage: 15;\twhite blood count: 7.1;\tinternational prognostic score (ips): 2.3'}"
231,"{'title': 'cord blood 2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.13', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.13;\t'}"
232,"{'title': 'Patient 5163 AML212', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 212;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
233,"{'title': 'MERLION_X02K04866', 'description': 'MERLION_X02K04866', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=48, state=0', 'characteristics_ch1': 'pT2N0, female, age=48, state=0'}"
234,"{'title': 'S072', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S072', 'characteristics_ch1': 'patient id: P061;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
235,"{'title': 'group-1-pt-t32734260', 'description': 'group-1-pt-t32734260', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 35;\tgender: male;\tfinal disposition: 06: Home'}"
236,"{'title': '51068', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade High;\tStage IA;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
237,"{'title': 'Gingival tissue sample 2 from patient 70, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 70 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
238,"{'title': 'PGA_PA-D_98', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
239,"{'title': 'AML without MLL - sample 91', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
240,"{'title': '22081', 'description': '11775', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: African American;\tGender: F;\tTSP_Patient# 24312;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
241,"{'title': 'HF0962_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
242,"{'title': 'DM2_M51_?_19', 'description': 'DM2 patient, age 51, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site:  unknown'}"
243,"{'title': 'Replicate 1 for BT474EI breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
244,"{'title': 'AML 7320', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 34 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
245,"{'title': 'newly diagnosed multiple myeloma 129', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
246,"{'title': 'DietSensitive _6 weeks_subject5', 'description': 'DietSensitive _6 weeks_subject5', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 5;\tgender: Female'}"
247,"{'title': 'Control_biological rep8', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 2;\toutcome: Survivor'}"
248,"{'title': 'MDS patient 92', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
249,"{'title': 'UCR6_beforeT', 'description': 'Colonic mucosal gene expression data from UC responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
250,"{'title': 'T41 U133p2', 'description': 'bulk breast tumor RNA from patient T41', 'type': 'RNA', 'source_name_ch1': 'T41', 'characteristics_ch1': 'breast tumor'}"
251,"{'title': 'IFNβ_887', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
252,"{'title': 'KS64b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 34;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 202;\tplasma hiv-1 rna levels (copies/ml): 122,000'}"
253,"{'title': 'B25', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.5'}"
254,"{'title': 'HUVEC_TNFa_3h00m', 'description': '3h00m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 3h00m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
255,"{'title': 'PGA-Hs_H-5', 'description': 'Human subjects with hypertrophic cardiomyopathy;\tKeywords = hypertrophic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
256,"{'title': 'MDS patient 38', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: del5q plus monosomy7/del7q plus other'}"
257,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 4', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
258,"{'title': 'PGA-Hs_S-13', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
259,"{'title': 'Sepsis V21', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis'}"
260,"{'title': 'SH-SY5Y(ECACC)_RA_1d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
261,"{'title': 'Proficiency_Site6_18', 'description': 'Performed by Operator 1 from Site6 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 68.54; Lot# = 035PO41658D'}"
262,"{'title': 'X22048', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 2'}"
263,"{'title': 'Lung Cancer 91T', 'description': 'Gene expression data from 91T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 76;\tstage: 1A'}"
264,"{'title': 'NY65', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 54;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 41573;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
265,"{'title': 'UNTREATED_938', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
266,"{'title': 'MDS patient 158', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: del5q plus monosomy7/del7q plus other'}"
267,"{'title': 'colonic_crypt_epithelial_cells_carcinoma_16 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: carcinoma;\tsex: female'}"
268,"{'title': 'Gingival tissue sample 1 from patient 11, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 11 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
269,"{'title': 'Control_biological rep7 04-0011', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 2.9;\toutcome: Survivor;\tgroup: n/a'}"
270,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 22', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
271,"{'title': 'DLBCL biopsy, sample 2138', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
272,"{'title': 'Patient_01', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 1;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.257749878348863;\tproliferation index: -3.2910462876416'}"
273,"{'title': 'Patient 17, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
274,"{'title': 'Patient_11', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 11;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.793842491002142;\tproliferation index: 3.73041611647222'}"
275,"{'title': 'PBMCs_EB_before exercise_04', 'description': 'EB_Pre_111-JuT', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 9;\tbefore-exercise'}"
276,"{'title': 'Blood - Axial Spondyloarthropathy - 066A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 68;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
277,"{'title': 'muscle_preTZD_preClamp_IRd-_s3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 3'}"
278,"{'title': 'T118 U133p2', 'description': 'bulk breast tumor RNA from patient T118', 'type': 'RNA', 'source_name_ch1': 'T118', 'characteristics_ch1': 'breast tumor'}"
279,"{'title': 'Blood sample from patient 163 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 163;\tday: Day 1;\tage (years): 64;\tsex: Female'}"
280,"{'title': 'B72', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 4.2'}"
281,"{'title': 'AML 6945', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 33 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: neg'}"
282,"{'title': 'Peripheral T-Cell lymphoma, unspecified 44_replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-04', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 76;\tgender: male'}"
283,"{'title': 'Cervical cancer-lymph node positive-24-09', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 60.6;\tfigo stage: 1b1'}"
284,"{'title': 'Hippocampus_male_84yrs_indiv108', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 84 years', 'characteristics_ch1': 'individual: 108, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 84'}"
285,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R1', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 58.23;\t%cd3cd8: 30.37;\t%cd8+cd28-: 20.67;\t%cd8+cd28+: 4.28;\t%cd4cd25cd62l: 3.71;\t%cd3delta1: 0.62;\t%cd3delta2: 0.18;\tratio delta1/delta2: 3.44;\t%cd3gammadelta: 1.46;\t%cd3alphabeta: 92.40;\t%cd4cd8-ab+(dn): 1.92;\t%cd4 cd62l+cd45+: 9.91;\t%cd4 cd62l-cd45+: 0.98;\t%cd4 cd62l - cd45-: 44.95;\t%cd4cd62l+cd45-: 44.16;\t%cd4 ccr7+ cd45 -: 8.04;\t%cd4 ccr7+ cd45+: 8.08;\t%cd4 ccr7 - cd45+: 2.16;\t%cd4 ccr7 – cd45-: 81.71;\t%cd8 cd62l+ cd45-: 70.20;\t%cd8cd62l+ cd45+: 3.84;\t%cd8cd62l- cd45+: 2.03;\t%cd8cd62l- cd45 -: 29.93;\t%cd8ccr7+ cd45-: 0.77;\t%cd8ccr7+ cd45+: 2.25;\t%cd8ccr7-cd45+: 3.64;\t%cd8ccr7-cd45 -: 93.34;\t%cd3-cd56+cd16+: 30.41;\t%nkts: 29.16;\t%cd19: 2.84;\t%cd4foxp3+: 2.78'}"
286,"{'title': 'Hippocampus_female_47yrs_indiv88', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 47 years', 'characteristics_ch1': 'individual: 88, AA;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 47'}"
287,"{'title': 'AML with normal karyotype #61', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 30;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 32;\tdisease state: de novo AML'}"
288,"{'title': 'EPN_319, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_319, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
289,"{'title': 'AML with normal karyotype #201', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 37;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 91;\tdisease state: de novo AML'}"
290,"{'title': 'HF0211_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
291,"{'title': 'c_B53', 'description': 'normal liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; normal liver tissue', 'characteristics_ch1': 'normal liver tissue'}"
292,"{'title': 'L2L3 mutant, repeat 3', 'description': 'HePG2 cells infected with adenovirus expressing the L2L3 mutant of PGC-1', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
293,"{'title': 'Septic Shock_biological rep68 10-0019', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 6.1;\toutcome: Survivor;\tgroup: B'}"
294,"{'title': 'AML sample #68', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
295,"{'title': 'Cervical cancer-lymph node positive-32-37', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 32.0;\tfigo stage: 1b1'}"
296,"{'title': '621 - mAdbID:66606', 'description': 'mAdb experiment ID: 66606', 'type': 'RNA', 'source_name_ch1': '621', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 621;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 8.14;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
297,"{'title': 'Pt17 whole subcutaneous adipose tissue, biological rep1', 'description': 'Pt17_SQAT', 'type': 'RNA', 'source_name_ch1': 'Whole subcutaneous adipose tissue, patient 17', 'characteristics_ch1': 'tissue: whole subcutaneous adipose tissue;\tpatient: 17'}"
298,"{'title': 'AML with normal karyotype #14', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 45;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 86.5;\tdisease state: de novo AML'}"
299,"{'title': 'AML 7318', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 60 years;\tscore: FAB unknown;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
300,"{'title': 'Cervical cancer-lymph node negative-09-33', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 42.3;\tfigo stage: 1b1'}"
301,"{'title': 'Patient 3434 AML22', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 22;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
302,"{'title': 'C016_Control_M_60', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 60;\tpost-mortem delay: 16h;\tph: 6.9'}"
303,"{'title': 'Replicate 1 for MDA468 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
304,"{'title': 'Tumor Tum_Ph1_rep7', 'description': 'Tumor paired  11', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N0;\thistology: cdi;\tgrade: I;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
305,"{'title': 'AML 2202', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 35 years;\tscore: FAB M4E;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
306,"{'title': 'B22', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.3'}"
307,"{'title': 'Sputum from Stage II Moderate, biological replicate 59', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 64;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
308,"{'title': 'S024', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S024', 'characteristics_ch1': 'patient id: P085;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 52.5'}"
309,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 19', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
310,"{'title': 'Bronchial epithelial cells, day 0, donor 3', 'description': 'Bronchial epithelial cells, day 0, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 0, the first day of air-liquid interface culture'}"
311,"{'title': 'C99556', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6712_Tumor;\tfab: M4;\tSex: F;\trace: AA;\tage on study: 59;\tcytogenetic change: del(12)(p12.3p13.3);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
312,"{'title': ""Wilms' FFPE B-1"", 'description': 'L744-A-HG-U133_Plus_2-01-1 (S99-2051N-FFPE)', 'type': 'RNA', 'source_name_ch1': 'Formalin-fixed paraffin-embedded tissue, kidney', 'characteristics_ch1': 'tissue: kidney;\tfixation: FFPE;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-1;\tdonor: A normal'}"
313,"{'title': 'Sputum from Stage IV Severe, biological replicate 6', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 68;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
314,"{'title': 'adipose_preTZD_IRd-_s36', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 36'}"
315,"{'title': 'TH49b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 30;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 333;\tplasma hiv-1 rna levels (copies/ml): 100,000'}"
316,"{'title': '11-0059A_SIRS_day1_185', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
317,"{'title': 'MDS patient 106', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: other'}"
318,"{'title': 'Kidney 2', 'description': 'Gene expression data from kidney mRNA sample', 'type': 'RNA', 'source_name_ch1': 'Kidney mRNA', 'characteristics_ch1': 'human male'}"
319,"{'title': 'AR-P12', 'description': 'AR-P12', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
320,"{'title': 'human BM MSC TGFb3 stimulated day 7 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 7', 'type': 'RNA', 'source_name_ch1': 'donor 6, stimulated with TGFb3 for 7 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 7 days'}"
321,"{'title': 'HepG2 cells at T18 Control, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines after 18 hours of growth without PCB treatment (Control).', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
322,"{'title': 'Insulin sensitive patient 11 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
323,"{'title': 'M79', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 69;\tSex: M;\tcode: resection;\tclass: Proliferation;\tafp: 7;\ttp53 mutation: 0;\tctnnb1 mutation: 271T>TG,p.S45S/A;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
324,"{'title': 'newly diagnosed multiple myeloma 95', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: nd'}"
325,"{'title': 'CD16+ 2', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'human CD16+ monocytes', 'characteristics_ch1': 'monocyte subsets: CD16+ monocytes'}"
326,"{'title': 'AML sample #94', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
327,"{'title': 'mRNA of GBM-HGG031, Glioblastoma, 1.2 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 1.2 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 1.2 years'}"
328,"{'title': 'UNTREATED_1086', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
329,"{'title': 'platelet_Ctrl_11', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
330,"{'title': 'C00266', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7223_Tumor;\tfab: M2;\tSex: M;\trace: H;\tage on study: 32;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
331,"{'title': 'L+S II BEAS 2b_ML05', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - mechanical stretch plus LPS', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
332,"{'title': 'AML with normal karyotype #182', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 50;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 42;\tdisease state: de novo AML'}"
333,"{'title': 'MDS patient 119', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: del5q plus monosomy7/del7q plus trisomy8 plus other'}"
334,"{'title': 'humanMDM_Healthy_Particles', 'description': 'see Affymetrix standard protocol', 'type': 'RNA', 'source_name_ch1': 'humanMDM_Healthy_Particles', 'characteristics_ch1': 'monocyte-derived macrophages of 13 male healthy subjects'}"
335,"{'title': 'Pax_C2', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene;\tmolecule: total RNA'}"
336,"{'title': 'Control 23', 'description': '07SE511', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
337,"{'title': 'hES_WIBR7_rep1_090811_3', 'description': 'Gene expression data from hES line WIBR7', 'type': 'RNA', 'source_name_ch1': 'hES line WIBR7', 'characteristics_ch1': 'cell line: hES line WIBR7'}"
338,"{'title': 'Adipose tissue_421_obese_rep4', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, obese, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: obese;\tgender: M;\tage: 9 years;\tz score bmi: 4.25'}"
339,"{'title': 'newly diagnosed multiple myeloma 34', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: None;\tiss: I'}"
340,"{'title': 'platelet_sickle_1', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
341,"{'title': 'H416 Triadimefon 100uM', 'description': 'H416 Triadimefon 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H416 Triadimefon 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
342,"{'title': 'C122', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.5'}"
343,"{'title': 'NY218', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: C;\tage: 52;\tSex: F;\tcode: resection;\tclass: Inflammation;\tafp: 413.9;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
344,"{'title': 'AML 2255', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 44 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: 11q23;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Pos;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
345,"{'title': 'HIP control 7', 'description': 'arrayconsortium.tgen.org::biosample.434589;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 7;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 76 years'}"
346,"{'title': 'K_AR12', 'description': 'K_AR12', 'type': 'RNA', 'source_name_ch1': 'AR12 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
347,"{'title': 'Healthy control 7', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
348,"{'title': 'Untreated replicate 3', 'description': ""Performed by UTMB microarray core per manufacturer's instructions"", 'type': 'RNA', 'source_name_ch1': 'THP-1 cells', 'characteristics_ch1': 'cell type: Human myelogenous leukemia (macrophage-like) cells;\tcell line: THP-1'}"
349,"{'title': 'Lung siScramble Replicate1', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 1'}"
350,"{'title': 'cMyb virus-infected replicate 2\t(monocytes)', 'description': 'Adenovirus-infected monocytes', 'type': 'RNA', 'source_name_ch1': 'Primary human monocytes', 'characteristics_ch1': 'Monocytes from buffy coat preparation'}"
351,"{'title': 'Angioimmunoblastic T-cell lymphoma 16', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-20', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 76;\tgender: male'}"
352,"{'title': 'MTX1', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincMTX2;\treplicate: 1'}"
353,"{'title': 'Insulin resistant patient 3 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
354,"{'title': 'S073', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S073', 'characteristics_ch1': 'patient id: P063;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 10'}"
355,"{'title': '6463', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 63 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
356,"{'title': 'HF0526_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
357,"{'title': 'Sputum from Stage III Severe, biological replicate 30', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 59;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
358,"{'title': 'ci_NY19', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
359,"{'title': 'Blood - Control - 112A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 24;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
360,"{'title': 'HepG2_HNF4a&HNF4g_knockdown1_rep2', 'description': 'HepG2_HNF4a&HNF4gknockdouwn1_try2', 'type': 'RNA', 'source_name_ch1': 'HNF4a&HNF4g_knockdown1', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocellular carcinoma'}"
361,"{'title': 'AML 7134', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 35 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
362,"{'title': 'Clone A cells cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
363,"{'title': 'ALL without MLL - sample 5', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
364,"{'title': '11-0044A_Sepsis_day1_174', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
365,"{'title': 'Patient 5164 AML213', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 213;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
366,"{'title': 'not used-treatment interrupted [wf20071123u133v2_U_04_SZ13_B2_M_46yr_alpha_151]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
367,"{'title': 'N11472B4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
368,"{'title': '3.1.NDV.14', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 14 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 14'}"
369,"{'title': 'Pilocytic astrocytoma chip 7759', 'description': 'Pilocytic astrocytoma.  Chip ID 7759', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
370,"{'title': 'Patient 5032 AML181', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 181;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
371,"{'title': 'AML with MLL - sample 140', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
372,"{'title': '13-0005B_Sepsis_day3_190', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
373,"{'title': 'Patient 4102 AML56', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 56;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
374,"{'title': 'UCNR11_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
375,"{'title': 'Mature IFN 6h biological replicate 3 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: IFN 6h;\tcell line: BE(2)-C'}"
376,"{'title': 'Treatment-1, cells cultured in DMEM plus 5 mM HisOH', 'description': 'none;\tnone', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
377,"{'title': 'UNTREATED_1701', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
378,"{'title': 'group-2-pt-t13427118', 'description': 'group-2-pt-t13427118', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 29;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
379,"{'title': 'IFNβ_1135', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
380,"{'title': 'Subcutaneous adipose tissue, SAT41', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
381,"{'title': 'vn2', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: normal'}"
382,"{'title': 'C98412', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7202_Tumor;\tfab: M0;\tSex: M;\trace: C;\tage on study: 38;\tcytogenetic change: t(11;19)(q23;p13); +X;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
383,"{'title': 'brain_neurons_rep6', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'neurons from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 34'}"
384,"{'title': 'ALL without MLL - sample 30', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
385,"{'title': 'AML 3313', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 49 years;\tscore: FAB M0;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
386,"{'title': 'Old sedentary subject, biological replicate (OS10)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old sedentary subject', 'characteristics_ch1': 'no additional information'}"
387,"{'title': 'Human Hepatocytes_Doxorubicin, Donor 5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: female; age: 57; reason for liver resection: Epitheloidal angiolipoma'}"
388,"{'title': 'B20', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 0.9'}"
389,"{'title': 'newly diagnosed multiple myeloma 221', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
390,"{'title': 'NSCLC EMC 2419N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
391,"{'title': 'KT0817_0_D_training', 'description': 'KT0817_0_D_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, training set', 'characteristics_ch1': 'baseline, deceased donor, training set'}"
392,"{'title': 'NSCLC EMC TB0017he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
393,"{'title': 'Patient 4444 AML96', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 96;\tcohort: Validation;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
394,"{'title': 'C025_Control_F_88', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 88;\tpost-mortem delay: 5h;\tph: 6.8'}"
395,"{'title': 'AML 3301', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 56 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
396,"{'title': 'ALL without MLL - sample 41', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
397,"{'title': 'Young rep6', 'description': 'Early passage BJ fibroblasts, grown in serum-free media for 72hrs at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Early passage human foreskin BJ fibroblasts'}"
398,"{'title': 'Lung Normal 115N', 'description': 'Gene expression data from 115N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 80;\tstage: n/a'}"
399,"{'title': '51024', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant KRAS;\tGrade High;\tStage IA;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
400,"{'title': 'Thyroid_ unaffected_paired with PTC50T', 'description': 'sample name in manuscript: N-PTC4', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: normal thyroid; Gender:male; Age:33'}"
401,"{'title': 'T50 U133p2', 'description': 'bulk breast tumor RNA from patient T50', 'type': 'RNA', 'source_name_ch1': 'T50', 'characteristics_ch1': 'breast tumor'}"
402,"{'title': 'Septic Shock_biological rep67', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 2.8;\toutcome: Survivor'}"
403,"{'title': 'Peripheral T-Cell lymphoma, unspecified 16_replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-18', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 80;\tgender: male'}"
404,"{'title': 'TBM3 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tmeningeal tuberculosis'}"
405,"{'title': 'AML 2550', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 55 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
406,"{'title': 'Control (dupl) sample 1a', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
407,"{'title': 'X70088', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
408,"{'title': 'CDcR4_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
409,"{'title': 'newly diagnosed multiple myeloma 316', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: II'}"
410,"{'title': 'H4_HC12h', 'description': 'gene expression data for H4 treated with HC for 12 h', 'type': 'RNA', 'source_name_ch1': 'human fetal small intestinal epithelial cell, HC 12h', 'characteristics_ch1': 'origin: fetal;\tcell line: H4;\ttreatment: hydrocortisone;\ttreatment: 12 h'}"
411,"{'title': 'Primary 2-1318(13.08.01)', 'description': 'Gene expression data  for primary', 'type': 'RNA', 'source_name_ch1': 'PrimaryHepatocellular Carcinoma', 'characteristics_ch1': 'Tissue: liver'}"
412,"{'title': 'newly diagnosed multiple myeloma 178', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
413,"{'title': 'MCF-7 +scrambled siRNA + vehicle rep2 (MD40)', 'description': 'Gene expression data from MCF-7cells treated with vehicle and scrambled siRNA;\tMD40', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with vehicle and scrambled siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: control (scrambled siRNA);\tagent: control (vehicle);\tdose: n/a'}"
414,"{'title': 'class S, rep3', 'description': 'NEB_1062.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 27;\tsex: F;\tdisease stage: 2;\talbumin level: 39;\themoglobin level: 114;\tlymphocyte percentage: 6;\twhite blood count: 10.8;\tinternational prognostic score (ips): 2'}"
415,"{'title': 'newly diagnosed multiple myeloma 93', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
416,"{'title': 'endothelial_rep2', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h'}"
417,"{'title': 'mRNA of OT-HGG155, Anaplastic Oligodendroglioma, 6.2 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 6.2 years', 'characteristics_ch1': 'disease: Anaplastic Oligodendroglioma;\tage: 6.2 years'}"
418,"{'title': 'MLD AML sample #30', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
419,"{'title': 'group-2-pt-t18932716', 'description': 'group-2-pt-t18932716', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 35;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
420,"{'title': 'ALL without MLL - sample 46', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
421,"{'title': 'CRCCD04', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CRC-CD'}"
422,"{'title': 'adenocarcinoma_100 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 42;\tlocalization: sigmoid'}"
423,"{'title': 'AML sample #94', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00726;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
424,"{'title': 'Lung Normal 145N', 'description': 'Gene expression data from 145N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 76;\tstage: n/a'}"
425,"{'title': 'DM2_F57_VL_08', 'description': 'DM2 patient, age 57, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Vastus Lateralis'}"
426,"{'title': 'VA49', 'description': '05-24561', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 66;\tgender: M;\tipi_stage: 3A;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 2.81;\tprogression-free_survival (years): 2.81'}"
427,"{'title': 'newly diagnosed multiple myeloma 8', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
428,"{'title': 'NS1-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: non-smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: non-smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: non-smoker;\tPack-years: 0;\tAge: 35;\tSex: M;\tEthnic group: black'}"
429,"{'title': 'adipose_preTZD_IRd_s34', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 34'}"
430,"{'title': 'hf289-NS', 'description': 'U133Plus2_122906L_DK15.CEL', 'type': 'RNA', 'source_name_ch1': 'human foetal cortex derived NS cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: non-malignant;\tcell type: cell line;\tcell type: neural stem'}"
431,"{'title': 'THRBL_lymph_node_case7', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: male, Age: 47, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: IVB, IPI prognostic score: high intermediate, follow-up: <1 year; status at last follow-up: death with disease'}"
432,"{'title': 'EPN_80, non-recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_80, non-recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
433,"{'title': 'vad3', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: adenoma'}"
434,"{'title': 'lg_NY24', 'description': 'low-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; low-grade dysplastic liver tissue', 'characteristics_ch1': 'low-grade dysplastic liver tissue'}"
435,"{'title': 'AML 7409', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 56 years;\tscore: FAB M0;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
436,"{'title': 'adipose_postTZD_IRd_s2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 2'}"
437,"{'title': 'colon_CRC_1556', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
438,"{'title': 'PBMCs vehicle treated for 2 hours,replicate 6', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 2 hours,replicate 6', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
439,"{'title': '3.2.NDV.18', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 18 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 18'}"
440,"{'title': 'Huh7 cells_Mock Infected 12 hours_ rep2', 'description': 'Gene expression data from Huh7 cells treated with mock media for 12 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 12 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
441,"{'title': 'X23043', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIC;\tConsolidated.Grade : 2'}"
442,"{'title': 'Patient 13, biopsy; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'Control'}"
443,"{'title': 'Blood Sample of subject 43 after inhalation; Group A: inhalation with 0.7 ppm FA 72 h before sampling', 'description': 'Bl_Group_A_AI_subject_43', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 72 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 72 h;\tsubject: 43;\tgroup: A'}"
444,"{'title': 'T137 U133p2', 'description': 'bulk breast tumor RNA from patient T137', 'type': 'RNA', 'source_name_ch1': 'T137', 'characteristics_ch1': 'breast tumor'}"
445,"{'title': 'S014_Scz_M_74', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 74;\tpost-mortem delay: 4.5h;\tph: 6'}"
446,"{'title': 'KT0581_24_L_test2_test3', 'description': 'KT0581_24_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set2 and test set3', 'characteristics_ch1': '24 months, living donor, test set2 and test set3'}"
447,"{'title': 'MLD AML sample #11', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
448,"{'title': 'HBEC3 High dose treatment group (1000 nM).', 'description': 'HBEC3 High dose treatment group (1000 nM).', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
449,"{'title': 'IFNβ_2536', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
450,"{'title': 'NLPHL_lymph_node_case9', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: male, Age: 25, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, An Arbor Stage: IA, follow-up: 11 years; status at last follow-up: alive without disease""}"
451,"{'title': 'Liver364T (mRNA expression)', 'description': 'liver cancer HCV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 364T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately differentiated;\tgender: M;\tage: 74;\tvirus: HCV'}"
452,"{'title': 'normal_colon_5 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: colonoscopy;\tage: 50;\tlocalization: sigmoid'}"
453,"{'title': '3487', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 72 years, RAEB-t, cytogenetic good risk, CEBPA wild type'}"
454,"{'title': 'Tumor 40', 'description': '07SE535', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
455,"{'title': 'CD34+CD45RA+Lin- HPCs transduced with A2M', 'description': 'CD45RA+M;\tGene expression data from cell transduced with nuclear-trapped AF1q/MLLT11 (A2M)', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA+Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tgenotype/variation: transduced with A2M;\tcell type: hematopoietic progenitors'}"
456,"{'title': 'class F, rep33', 'description': 'VAN_00082f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 30;\tsex: F;\tdisease stage: 2;\talbumin level: 42;\themoglobin level: 123;\tlymphocyte percentage: 12;\twhite blood count: 7.1;\tinternational prognostic score (ips): 1'}"
457,"{'title': 'S088', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S088', 'characteristics_ch1': 'patient id: P103;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 51'}"
458,"{'title': 'Endometrium-prog C (07B13462-3)', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group C', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d3;\tpregnancy status: biochemical pregnancy;\tprogesterone serum level: group C (> 1.5ng/ml)'}"
459,"{'title': 'human BM MSC BMP2 stimulated day 21 rep 1', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 21', 'type': 'RNA', 'source_name_ch1': 'donor 1, stimulated with BMP2 for 21 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 21 days'}"
460,"{'title': 'DLBCL biopsy, sample 2029', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
461,"{'title': 'newly diagnosed multiple myeloma 206', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: nd'}"
462,"{'title': 'DietResistant _3 weeks_subject2', 'description': 'DietResistant _3 weeks_subject2', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 3 weeks;\tsubject: 2;\tgender: Female'}"
463,"{'title': 'BC15120', 'description': '080214.11.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 33;\tmolecular subtype: Normal;\thistology: DUC;\tpt: --;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: neg;\tigf1r ihc status: pos;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: pos;\tmfs: --;\tmfsdel (month): --'}"
464,"{'title': 'UCNR7_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
465,"{'title': 'colon_normal_1357', 'description': 'total RNA extracted from cells obtained using biopsy of the colon in a healthy control', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
466,"{'title': 'ALL without MLL - sample 7', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
467,"{'title': 'Untreated PBMCs, replicate 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Untreated PBMCs, replicate 3', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
468,"{'title': 'Huh7 cells_JFH-1 Infected 18 hours_ rep1', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 18 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 18 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
469,"{'title': 'Training_Site10_03', 'description': 'Performed by Operator 1 from Site10 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 16.9; Lot# = 065PO36893A'}"
470,"{'title': 'Control V7', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
471,"{'title': '22055', 'description': '11690', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24278;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
472,"{'title': 'newly diagnosed multiple myeloma 184', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
473,"{'title': 'Adenocarcinoma, bone marrow negative AC 2', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'female pulmonary adenocarcinoma;\tbone marrow negative'}"
474,"{'title': 'D_MKne U133 Plus 2.0', 'description': 'Gene expression data from peripheral blood sample', 'type': 'RNA', 'source_name_ch1': 'Human peripheral blood sample', 'characteristics_ch1': 'tissue: blood;\tdisease state: Diverticulitis'}"
475,"{'title': '05-213_CaP', 'description': 'Prostate cancer whole tissue.', 'type': 'RNA', 'source_name_ch1': 'cancer prostate', 'characteristics_ch1': 'tissue: prostate;\tgleason: 3+4;\ttumor stage: T2c;\ttumor volume: 3.4 cc'}"
476,"{'title': 'S084', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S084', 'characteristics_ch1': 'patient id: P078;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 47'}"
477,"{'title': 'Patient_6557_relapse', 'description': '6557R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 19;\tconclusions ig/tcr: stable;\tselected: yes'}"
478,"{'title': 'Gingival tissue sample 2 from patient 23, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 23 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
479,"{'title': 'NLPHL_lymph_node_case4', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: male, Age: 43, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, An Arbor Stage: IA, follow-up: 6 years; status at last follow-up: alive without disease""}"
480,"{'title': 'GL38a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 49;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 147;\tplasma hiv-1 rna levels (copies/ml): 4,960'}"
481,"{'title': 'X23143', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : 2'}"
482,"{'title': 'Gingival tissue sample 2 from patient 52, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 52 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
483,"{'title': 'Lung Normal 132N', 'description': 'Gene expression data from 132N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 47;\tstage: n/a'}"
484,"{'title': 'DietSensitive _1 day_subject7', 'description': 'DietSensitive _1 day_subject7', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 7;\tgender: Male'}"
485,"{'title': '44110', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
486,"{'title': 'H4_HC48h', 'description': 'gene expression data for H4 treated with HC for 48 h', 'type': 'RNA', 'source_name_ch1': 'human fetal small intestinal epithelial cell, HC 48h', 'characteristics_ch1': 'origin: fetal;\tcell line: H4;\ttreatment: hydrocortisone;\ttreatment: 48 h'}"
487,"{'title': 'NSCLC EMC SCC2283N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
488,"{'title': 'Patient 4427 AML93', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 93;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
489,"{'title': '10556', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 52;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 39;\tDonor Sex: F;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
490,"{'title': 'X34085', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
491,"{'title': 'MLD AML sample #24', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
492,"{'title': 'AML without MLL - sample 99', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
493,"{'title': 'Group B2-IVIG+IVMP-Pre-2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, IVMP + IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: methylprednisolone (IVMP) + IVIG;\ttime: pre-treatment'}"
494,"{'title': 'adipose_preTZD_IRd_s12', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 12'}"
495,"{'title': 'muscle_preTZD_preClamp_NRd_s16', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 16'}"
496,"{'title': 'Tolerant PBMC_TOL_25', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from tolerant liver transplant recipient, virus hepatitis C negative'}"
497,"{'title': 'PBMCs_LB_before exercise_16', 'description': 'LB_Pre_103-CM', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 18;\tbefore-exercise'}"
498,"{'title': 'AML with normal karyotype #156', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 33;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 80;\tdisease state: de novo AML'}"
499,"{'title': 'AML 2183', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 52 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
500,"{'title': 'HF0300-3_U133P2', 'description': 'Brain tissue from  patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from  patient', 'characteristics_ch1': 'Histopathological diagnostic:'}"
501,"{'title': 'mRNA of AA-HGG045, Anaplastic Astrocytoma, 5 days old', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 5 days old', 'characteristics_ch1': 'disease: Anaplastic Astrocytoma;\tage: 5 days old'}"
502,"{'title': 'Normal_5', 'description': 'Normal mucosa', 'type': 'RNA', 'source_name_ch1': 'Normal tissue 5', 'characteristics_ch1': 'tissue: esophagus, normal;\tgender: male, Japanese;\tage: 52'}"
503,"{'title': 'class S, rep60', 'description': 'VAN_00450.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 38;\tsex: M;\tdisease stage: 4;\talbumin level: _;\themoglobin level: 92;\tlymphocyte percentage: 30;\twhite blood count: 3;\tinternational prognostic score (ips): 4.7'}"
504,"{'title': 'Insulin sensitive patient 6 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
505,"{'title': 'KT0652_3_L_test2_test3', 'description': 'KT0652_3_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set2 and test set3', 'characteristics_ch1': '3 months, living donor, test set2 and test set3'}"
506,"{'title': 'Gingival tissue sample 4 from patient 10, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 10 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
507,"{'title': 'S049', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S049', 'characteristics_ch1': 'patient id: P077;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 37'}"
508,"{'title': 'PNS033', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.42;\tdisease activity (das28_v3): 3.84;\tresponse to anti-tnf therapy: NORESPONSE'}"
509,"{'title': 'T11688A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
510,"{'title': 'whole blood_101584', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
511,"{'title': 'Muscle PCOS control 11', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
512,"{'title': 'Young trained subject, biological replicate (YT9)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
513,"{'title': 'VT_Epidi_norm_26ans_corps', 'description': 'biological rep 2', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus, 26 years-old, corpus segment', 'characteristics_ch1': 'Seminal vesicles'}"
514,"{'title': 'NSCLC EMC ADC2295N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
515,"{'title': 'MDS patient 112', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
516,"{'title': 'group-1-pt-t18794715', 'description': 'group-1-pt-t18794715', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 16;\tgender: male;\tfinal disposition: 06: Home'}"
517,"{'title': 'S164', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S164', 'characteristics_ch1': 'patient id: P034;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
518,"{'title': 'Patient_5775_diagnosis', 'description': '5775D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 7;\tconclusions ig/tcr: some clonal evolution;\tselected: yes'}"
519,"{'title': 'LPS_2', 'description': 'LPS treatment 2', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells treated with LPS', 'characteristics_ch1': 'lipopolysaccharide treated cells'}"
520,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 21', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
521,"{'title': 'Simvastatin treated 24h, sample 3, Simvastatin is anti-inflammatory in macrophages', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'human peripheral blood monocyte-derived macrophages', 'characteristics_ch1': 'from unknown healthy blood-donor volunteers (Finnish Red Cross)'}"
522,"{'title': 'Blood sample from patient 113 at Day 14', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 113;\tday: Day 14;\tage (years): 28;\tsex: Male'}"
523,"{'title': 'MCF-7_Estradiol_0.1μM_rep3', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Estradiol treated'}"
524,"{'title': 'OB06Nb', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1406;\tdisease state: AIDS;\tgender: Male;\tage: 45;\trace: African American;\tblood cd4+ t  cell count (cells/ml): 188;\tplasma hiv-1     rna level   (copies/ml): 10684;\ttissue: lymph node'}"
525,"{'title': 'MLD AML sample #38', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
526,"{'title': 'Gingival tissue sample 3 from patient 8, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 8 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
527,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_22_5)', 'description': 'Gene expression data from whole blood 30 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 64;\tSex: M'}"
528,"{'title': 'AML 6721', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 39 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
529,"{'title': 'Patient 5238 AML231', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 231;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
530,"{'title': 'Scz-29', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tL7', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - schizophrenia;\tSex: F;\tage: 81;\ttissue ph: 6.31;\tpmi (hrs): 25;\ttype of drug: Trifluphenazine;\tdrug dose (chlorpromazine equivalents): 100 mg'}"
531,"{'title': 'AML 2177', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 18 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
532,"{'title': 'Thyroid_ papillary carcinoma 69', 'description': 'sample name in manuscript: T-PTC6', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue:tumor; Gender:male; Age:56; Tumor stage:T4N0M1'}"
533,"{'title': 'UCNR4_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
534,"{'title': 'CDcR12_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
535,"{'title': 'whole blood_100309', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
536,"{'title': '22066', 'description': '11717', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24291;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
537,"{'title': 'T-cell prolymphocytic leukemia', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-93', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 66;\tgender: male'}"
538,"{'title': 'GPR54-suppressed Ishikawa treated with metastin-10, biological rep3', 'description': 'Gene expression data from Ishikawa cells that were introduced with GPR54 siRNA and treated with metastin-10.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells introduced with GPR54 siRNA and treated with metastin-10', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: GPR54-specific siRNA;\tpeptide treatment: metastin-10'}"
539,"{'title': 'MCF-7-14', 'description': 'Gene expression data from cultured MCF-7-14 cell line', 'type': 'RNA', 'source_name_ch1': 'Invasive MCF-7-14 breast cancer cell line established from non-aggressive MCF7', 'characteristics_ch1': 'tissue type: breast cancer;\tcell line: MCF-7-14'}"
540,"{'title': 'Glioblastoma_10', 'description': 'bh20061208u133v2_A_10-GBM10_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 69;\tgender: female;\ttumor grade: IV'}"
541,"{'title': 'adipose_preTZD_IRd-_s39', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 39'}"
542,"{'title': 'MERLION_X03K03296', 'description': 'MERLION_X03K03296', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=60, state=0', 'characteristics_ch1': 'pT2N0, male, age=60, state=0'}"
543,"{'title': 'PBMC-1-Non-RR-Pat.14 [wf20070510u133v2_U_07_SK15_M_LC1_None_107_1]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
544,"{'title': 'colon_IBD_1802', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
545,"{'title': 'adenocarcinoma_59 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 78;\tlocalization: sigmoid'}"
546,"{'title': 'HRV-infected, normal S15 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, normal S15', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
547,"{'title': 'PGA_PA-D_319', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
548,"{'title': 'AML sample #35', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00113;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
549,"{'title': 'Angioimmunoblastic T-cell lymphoma 3', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-138', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 77;\tgender: male'}"
550,"{'title': 'Sputum from Stage II Moderate, biological replicate 14', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 67;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
551,"{'title': 'No14LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No14;\tcell type: lymphocytes;\ttime point: before therapy'}"
552,"{'title': 'monocytes_Q10_3', 'description': '24h Q10 preincubation, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +Q10, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h Q10 preincubation, 4h LPS stimulation'}"
553,"{'title': ""Wilms' FFPE C-1"", 'description': 'L745-A-HG-U133_Plus_2-01-1 (S07-1035W-FFPE)', 'type': 'RNA', 'source_name_ch1': 'Formalin-fixed paraffin-embedded tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FFPE;\tblock age (at extraction in years): 0.5;\tbiological replicate: rep-1;\tdonor: C tumor""}"
554,"{'title': 'SK-N-SH_RA_6h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
555,"{'title': '76-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 76 treated 786-O cells, replicate 3'}"
556,"{'title': 'T40977', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40977;\tsample: tumor'}"
557,"{'title': 'Control_biological rep10', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 4.4;\toutcome: Survivor'}"
558,"{'title': 'DM1_F?_BB_01', 'description': 'DM1 patient, age unknown, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM1 patient;\tbiopsy site: Biceps Brachii'}"
559,"{'title': 'Subcutaneous adipose tissue, SAT39', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
560,"{'title': '01-0034B_Septic Shock_day3_2', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
561,"{'title': 'mRNA of GBM-HGG046, Glioblastoma, 1 month years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 1 month years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 1 month years'}"
562,"{'title': 'Quadriceps muscle at T0, control patient 3', 'description': 'Gene expression data from quadriceps muscle biopsy of control patient', 'type': 'RNA', 'source_name_ch1': 'Quadriceps muscle, control patient, T0', 'characteristics_ch1': 'tissue type: Quadriceps muscle;\tpatient group: total knee arthroplasty control patient;\ttime point: T0'}"
563,"{'title': 'AML 2696', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 46 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
564,"{'title': 'ALL without MLL - sample 60', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
565,"{'title': 'N11063A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
566,"{'title': 'X23102', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIB;\tConsolidated.Grade : 2'}"
567,"{'title': 'HIP control 13', 'description': 'arrayconsortium.tgen.org::biosample.434673;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 13;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 78 years'}"
568,"{'title': 'AML sample #21', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00051;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
569,"{'title': 'No15LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No15;\tcell type: hepatocytes;\ttime point: before therapy'}"
570,"{'title': 'ALL with MLL - sample 126', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
571,"{'title': 'ALL without MLL - sample 21', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
572,"{'title': '23172', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
573,"{'title': 'Peripheral T-Cell lymphoma, unspecified 45', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-05', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 58;\tgender: male'}"
574,"{'title': 'S111', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S111', 'characteristics_ch1': 'patient id: P103;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 1'}"
575,"{'title': 'Glioblastoma_8', 'description': 'bh20061208u133v2_A_08-GBM8_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 70;\tgender: male;\ttumor grade: IV'}"
576,"{'title': 'MERLION_X01K04994', 'description': 'MERLION_X01K04994', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=73, state=1', 'characteristics_ch1': 'pT2N0, male, age=73, state=1'}"
577,"{'title': 'Pax_S2', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene;\tmolecule: total RNA'}"
578,"{'title': '22059', 'description': '11694', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24283;\tSmoking_Status: Never;\tPathology: Adenocarcinoma'}"
579,"{'title': 'HUVEC_TNFa_1h00m', 'description': '1h00m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 1h00m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
580,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_71_4)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 69;\tSex: M'}"
581,"{'title': 'GA_1020', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
582,"{'title': 'Hepatosplenic T-cell lymphoma 2', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-141', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 33;\tgender: female'}"
583,"{'title': 'SK-N-SH_RA_1d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
584,"{'title': 'Cervical cancer-lymph node positive-29-25', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 48.5;\tfigo stage: 1b2'}"
585,"{'title': 'Glioblastoma_3', 'description': 'bh20061208u133v2_A_03-GBM3_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 47;\tgender: male;\ttumor grade: IV'}"
586,"{'title': 'AML sample #69', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
587,"{'title': 'Replicative Senescent rep3', 'description': 'BJ fibroblasts passaged in culture till they reached senescence (population doubling >85) as assessed by SA-Bgal. 72h starved in serum-free media and incubated at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Late passage BJ fibroblasts'}"
588,"{'title': 'X51125', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
589,"{'title': 'MLD AML sample #40', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
590,"{'title': 'MDS patient 125', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
591,"{'title': 'Patient_27', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 27;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.274440389816766;\tproliferation index: -1.47801713448523'}"
592,"{'title': 'N11732C4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
593,"{'title': 'MTX3', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincMTX2;\treplicate: 2'}"
594,"{'title': 'CLL cells  PB patient #4 replicate2', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #4'}"
595,"{'title': 'Proficiency_Site7_19', 'description': 'Performed by Operator 1 from Site7 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 71; Lot# = 035PO41658D'}"
596,"{'title': 'NY204', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 70;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 8.3;\ttp53 mutation: 0;\tctnnb1 mutation: 260C>CT | T41T/I;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
597,"{'title': 'Normal breast (B58)', 'description': 'no additional info;\tnone', 'type': 'RNA', 'source_name_ch1': 'B58', 'characteristics_ch1': 'NB'}"
598,"{'title': 'a_NY34', 'description': 'advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; advanced HCC', 'characteristics_ch1': 'advanced HCC'}"
599,"{'title': 'Gingival tissue sample 1 from patient 28, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 28 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
600,"{'title': 'Pt4 isolated pericardial adipocytes, biological rep2', 'description': 'Pt4_pcAds_2', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 4', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 4'}"
601,"{'title': 'mRNA of GBM-HGG023, Glioblastoma, 9.9 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 9.9 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 9.9 years'}"
602,"{'title': 'VAN_00700', 'description': '07-32561', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: COMPOSITE (>50% DLBCL, remaining FL);\ttissue: lymph node;\tage: 58;\tgender: M;\tipi_stage: 3B;\ttxprimary: CHOP6-RITU-RITUMAIN;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.79;\tprogression-free_survival (years): 0.79'}"
603,"{'title': 'Lung Normal 17N', 'description': 'Gene expression data from 17N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 55;\tstage: n/a'}"
604,"{'title': 'AML 7051', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
605,"{'title': 'Clone A  cells treated with 5uM CsA and cultured for 24 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
606,"{'title': 'SH-SY5Y(ATCC)_RA_3d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
607,"{'title': 'MERLION_X02K00554', 'description': 'MERLION_X02K00554', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=42, state=1', 'characteristics_ch1': 'pT2N0, female, age=42, state=1'}"
608,"{'title': 'Pilocytic astrocytoma chip 8022', 'description': 'Pilocytic astrocytoma.  Chip ID 8022', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
609,"{'title': 'UNTREATED_1754', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
610,"{'title': 'MCF-7_Ferulic acid_10μM_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Ferulic acid treated'}"
611,"{'title': 'vad2', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: adenoma'}"
612,"{'title': 'muscle_preTZD_preClamp_IRd_s37', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 37'}"
613,"{'title': 'IFNβ_1690', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
614,"{'title': 'Patient 4936 AML171', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 171;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
615,"{'title': 'S034', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S034', 'characteristics_ch1': 'patient id: P095;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 60'}"
616,"{'title': 'COL2_44', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 73;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1127;\tsecond apc mutation: 1474;\t5q loh: 0'}"
617,"{'title': 'UCNR3_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
618,"{'title': 'AML with normal karyotype #126', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 66;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 55.5;\tdisease state: de novo AML'}"
619,"{'title': 'X44219', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
620,"{'title': 'Sputum from Stage II Moderate, biological replicate 49', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 72;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
621,"{'title': 'Lean_1 day_subject14', 'description': 'Lean_1 day_subject14', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Lean;\ttime point: 1 day;\tsubject: 14;\tgender: Female'}"
622,"{'title': '11-0006_Sepsis_day1_192', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
623,"{'title': 'N10874A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
624,"{'title': 'NSCLC_AC_492', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 492.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
625,"{'title': 'miR-124 transfection for 8 hours', 'description': 'miR-124 transfection for 8 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
626,"{'title': 'AML 2187', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 50 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
627,"{'title': 'HS+LPS_1', 'description': 'HS+LPS treatment 1', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells with heat shock and LPS', 'characteristics_ch1': 'heat shock/lipopolysaccharide treated cells'}"
628,"{'title': 'AML 3318', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tgender: male;\tage: 53 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
629,"{'title': 'No5pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No5 nonRVR;\ttime point: before therapy'}"
630,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R25', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 80.23;\t%cd3cd8: 15.86;\t%cd8+cd28-: 2.17;\t%cd8+cd28+: 9.42;\t%cd4cd25cd62l: 4.00;\t%cd3delta1: 0.19;\t%cd3delta2: 3.63;\tratio delta1/delta2: 0.05;\t%cd3gammadelta: 3.93;\t%cd3alphabeta: 95.30;\t%cd4cd8-ab+(dn): 1.09;\t%cd4 cd62l+cd45+: 40.85;\t%cd4 cd62l-cd45+: 0.13;\t%cd4 cd62l - cd45-: 7.56;\t%cd4cd62l+cd45-: 51.46;\t%cd4 ccr7+ cd45 -: 38.64;\t%cd4 ccr7+ cd45+: 45.07;\t%cd4 ccr7 - cd45+: 1.33;\t%cd4 ccr7 – cd45-: 14.96;\t%cd8 cd62l+ cd45-: 21.92;\t%cd8cd62l+ cd45+: 48.12;\t%cd8cd62l- cd45+: 8.56;\t%cd8cd62l- cd45 -: 21.40;\t%cd8ccr7+ cd45-: 10.07;\t%cd8ccr7+ cd45+: 42.01;\t%cd8ccr7-cd45+: 16.18;\t%cd8ccr7-cd45 -: 31.74;\t%cd3-cd56+cd16+: 60.71;\t%nkts: 1.55;\t%cd19: 3.84;\t%cd4foxp3+: 3.01'}"
631,"{'title': 'GBM, TMZ/radiotherapy (269)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 269;\tage: 61;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 7.04;\tmgmt status: U'}"
632,"{'title': 'PBMCs treated at 3xIC90 for 24 hours,replicate 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at 3xIC90 for 24 hours,replicate 3', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
633,"{'title': 'Replicate 3 for MCF7untreated breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 untreated cell line to compare to older profiled MCF7 sample. See ATCC/DSMZ for cell line details.'}"
634,"{'title': 'control_16hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_16hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
635,"{'title': 'Cervical cancer-lymph node positive-25-10', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 49.9;\tfigo stage: 2a'}"
636,"{'title': 'Septic Shock_biological rep57 07-0004', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.7;\toutcome: Survivor;\tgroup: C'}"
637,"{'title': 'MCF-7_Ferulic acid_0.1μM_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Ferulic acid treated'}"
638,"{'title': 'M67', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 72;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 22036;\ttp53 mutation: 344A>AC | Q144Q/P;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
639,"{'title': 'SH-SY5Y(ATCC)_RA_5d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
640,"{'title': 'UNTREATED_810', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
641,"{'title': 'Hippocampus_male_85yrs_indiv46', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 85 years', 'characteristics_ch1': 'individual: 46, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 85'}"
642,"{'title': 'Clinically localized primary prostate cancer P3', 'description': 'clinically localized prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Primary, localized, prostate cancer'}"
643,"{'title': 'Gingival tissue sample 2 from patient 91, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 91 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
644,"{'title': 'HeLa_NT siRNA_rep3', 'description': 'Affymetrix HG U133+2 data', 'type': 'RNA', 'source_name_ch1': 'HeLa cells,control', 'characteristics_ch1': 'cell line: HeLa cancer cell line;\ttissue origin of cancer cell: cervix;\tprotocol: control siRNA'}"
645,"{'title': 'No10pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No10RVR;\ttime point: before therapy'}"
646,"{'title': 'Kidney 1', 'description': 'Gene expression data from kidney mRNA sample', 'type': 'RNA', 'source_name_ch1': 'Kidney mRNA', 'characteristics_ch1': 'human male'}"
647,"{'title': 'Sepsis gram-positive TP4', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
648,"{'title': 'CD34+cells_normal_bone_marrow_4', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'CD34+ cells sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
649,"{'title': 'N11003A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
650,"{'title': 'SI10', 'description': 'Gene expression data from Standard Immunotherapy 10', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 10', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
651,"{'title': 'S026', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S026', 'characteristics_ch1': 'patient id: P097;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 65'}"
652,"{'title': 'LTB3 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tLatent'}"
653,"{'title': 'T51783', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51783;\tsample: tumor'}"
654,"{'title': 'prostate tumor 3', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to prostate invasive tumor', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: tumor'}"
655,"{'title': 'SI8', 'description': 'Gene expression data from Standard Immunotherapy 8', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 8', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
656,"{'title': 'Huh7 cells treated with 1uM CsA and cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 1uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 1uM;\ttime: 48 hours'}"
657,"{'title': 'X23187', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
658,"{'title': 'hES_BG01_rep3_081006_13', 'description': 'Gene expression data from hES line BG01', 'type': 'RNA', 'source_name_ch1': 'hES line BG01', 'characteristics_ch1': 'cell line: hES line BG01'}"
659,"{'title': 'non-malignant FTEn_patient 1', 'description': 'Gene expression profile of non-malignant FTE from control patient during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 46;\tCycle: Luteal;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
660,"{'title': 'Huh7 cells treated with 1uM CsA and cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 1uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 1uM;\ttime: 48 hours'}"
661,"{'title': 'Blood_TD51281_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
662,"{'title': 'Patient_6190_relapse', 'description': '6190R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 104;\tconclusions ig/tcr: unstable;\tselected: yes'}"
663,"{'title': 'control participant P333', 'description': 'Gene expression data from control participant T4', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
664,"{'title': 'AML without MLL - sample 92', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
665,"{'title': 'PGA_PA-S_464', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
666,"{'title': 'newly diagnosed multiple myeloma 160', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: nd'}"
667,"{'title': 'NSCLC EMC ADC2231N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
668,"{'title': 'Sepsis gram-negative TN2', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
669,"{'title': 'Hyperplast06', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Hyperplastic polyp'}"
670,"{'title': 'AML with normal karyotype #146', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 78;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 50;\tdisease state: de novo AML'}"
671,"{'title': 'Tolerant PBMC_TOL_14', 'description': 'see M. Martinez-Llordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from a tolerant liver transplant recipient (no immunosuppressive drugs)'}"
672,"{'title': '2.1.NDV.4', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 4 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 4'}"
673,"{'title': 'HD1-STS-0h', 'description': 'biological source:;\thomo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation.', 'type': 'RNA', 'source_name_ch1': 'healthy donor HD1, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation.'}"
674,"{'title': 'T38 U133p2', 'description': 'bulk breast tumor RNA from patient T38', 'type': 'RNA', 'source_name_ch1': 'T38', 'characteristics_ch1': 'breast tumor'}"
675,"{'title': '10_0020_SepticShock_Day1_57', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '10_0020_Patient, Day1'}"
676,"{'title': 'VA48', 'description': '04-11156', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 68;\tgender: F;\tipi_stage: 3B;\ttxprimary: CHOP7-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 4.49;\tprogression-free_survival (years): 4.49'}"
677,"{'title': '2.2.NDV.10', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 10 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: NDV;\thours post infection: 10'}"
678,"{'title': 'Sputum from Stage II Moderate, biological replicate 7', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 62;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
679,"{'title': 'T92 U133p2', 'description': 'bulk breast tumor RNA from patient T92', 'type': 'RNA', 'source_name_ch1': 'T92', 'characteristics_ch1': 'breast tumor'}"
680,"{'title': 'KT0613_0_L_training', 'description': 'KT0613_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, training set'}"
681,"{'title': 'X502', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
682,"{'title': 'Transplanted-reperfused liver T2-10', 'description': 'Gene expression data from a frozen liver biopsy obtained during transplantation procedure, 2 hours after reperfusion', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from transplanted liver, 2 hours after reperfusion', 'characteristics_ch1': 'tissue: transplanted liver, 2 hours after reperfusion;\tgender: male;\tage: 34 years;\tprotocol: cold ischemia_8h 15min; Warm ischemia_60min'}"
683,"{'title': 'Lung Normal 102N', 'description': 'Gene expression data from 102N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 67;\tstage: n/a'}"
684,"{'title': 'human BM MSC BMP2 stimulated day 7 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 7', 'type': 'RNA', 'source_name_ch1': 'donor 3, stimulated with BMP2 for 7 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 7 days'}"
685,"{'title': 'PTB4 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
686,"{'title': 'X41325', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
687,"{'title': 'B84', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 4.5'}"
688,"{'title': 'IFNβ_698', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
689,"{'title': 'AML sample #101', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
690,"{'title': 'prostate tumor 4', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to prostate invasive tumor', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: tumor'}"
691,"{'title': 'neuron_rep16', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:49, gender:female, diagnostic group: control, PMI:45h'}"
692,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 10', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
693,"{'title': 'NB64 U133p2 (breast epithelial study)', 'description': 'RNA from bulk normal breast or normal breast organoid', 'type': 'RNA', 'source_name_ch1': 'NB64', 'characteristics_ch1': 'bulk normal breast or normal breast organoid'}"
694,"{'title': 'class S, rep19', 'description': 'VAN_00128.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 42;\tsex: M;\tdisease stage: 2;\talbumin level: 41;\themoglobin level: 107;\tlymphocyte percentage: 15;\twhite blood count: 8.3;\tinternational prognostic score (ips): 2'}"
695,"{'title': 'Control 43', 'description': '07SE541', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
696,"{'title': 'ALL without MLL - sample 12', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
697,"{'title': 'Muscle-FamilyHistoryPositive-10', 'description': 'Jos3712;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 44;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 25;\tfasting glucose (ogtt): 93.5;\t2 hour glucose (ogtt): 151;\themoglobin a1c: 4.8;\tfasting glucose (iv0gavg): 98;\tfasting insulin (iv0inavg): 10;\tsi: 1.77;\twaist hip ratio: 0.905'}"
698,"{'title': 'fetal normal kidney; FKmale_FKM', 'description': 'gene expression data for normal kidney', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'normal kidney'}"
699,"{'title': 'Muscle septic k64', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:female, Age:25yrs'}"
700,"{'title': '23052', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade High;\tStage IA;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
701,"{'title': 'NY6', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: Inflammation;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
702,"{'title': 'PGA_PA-N_249', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
703,"{'title': 'Control (dupl) sample 6b', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
704,"{'title': 'X95014', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
705,"{'title': 'Patient 4507 AML108', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 108;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
706,"{'title': 'MERLION_X02K00389', 'description': 'MERLION_X02K00389', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=50, state=0', 'characteristics_ch1': 'pT2N0, male, age=50, state=0'}"
707,"{'title': 'Stable-P6', 'description': 'Stable-P6', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Stable'}"
708,"{'title': 'normal Pre ECP, biological rep3', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Pre ECP', 'characteristics_ch1': 'disease state: normal;\tdose: pre ECP;\tperipheral blood: blood harvested with the Therakos machine'}"
709,"{'title': 'MERLION_X02K03250', 'description': 'MERLION_X02K03250', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=58, state=0', 'characteristics_ch1': 'pT2N0, male, age=58, state=0'}"
710,"{'title': 'newly diagnosed multiple myeloma 97', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: I'}"
711,"{'title': '08SE867HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
712,"{'title': 'Hyperplast11', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Hyperplastic polyp'}"
713,"{'title': 'Gingival tissue sample 4 from patient 1, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 1 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
714,"{'title': 'B19', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.5'}"
715,"{'title': 'whole blood_101007', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
716,"{'title': 'MDS patient 51', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
717,"{'title': '01-0007A_Septic Shock_day1_0', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
718,"{'title': 'CD19_selected_B-cells_after_FC_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
719,"{'title': 'papillary renal cell cancer; pRCCa_HD193A', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
720,"{'title': 'HIV+ Individual HIV-11a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-11a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
721,"{'title': 'C981202', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7228_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 57;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
722,"{'title': 'AML with normal karyotype #157', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 63;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 57.5;\tdisease state: de novo AML'}"
723,"{'title': 'Patient 2, IDC', 'description': '12738-1P 10-17-07', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 2'}"
724,"{'title': 'N11209A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
725,"{'title': 'PC control 1', 'description': 'arrayconsortium.tgen.org::biosample.434856;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior Cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 1;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior Cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: male\xa0;\tgenetic variation: None\xa0;\tage: 85 years'}"
726,"{'title': 'NSG519', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.87;\tdisease activity (das28_v3): 2.86;\tresponse to anti-tnf therapy: RESPONSE'}"
727,"{'title': 'human cultured bladder HB KM, subject 13', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 56;\tDisease status: HB (control (stress incontinence, no bladder pain));\tCulture medium: KM (proliferating medium)'}"
728,"{'title': '452', 'description': '02-22991', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 54;\tgender: F;\tipi_stage: 3A;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.62;\tprogression-free_survival (years): 5.62'}"
729,"{'title': 'No30inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No30RVR;\ttime point: under therapy'}"
730,"{'title': 'conventional renal cell cancer; cRCCb_HA312', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
731,"{'title': 'brain, unknown: C2B_e1_le1', 'description': 'control 2 weeks B;\tTreatment, type=time_course, measurement=2.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
732,"{'title': 'MDS patient 27', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
733,"{'title': 'N51315', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51315;\tsample: normal'}"
734,"{'title': 'C97779', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7201_Tumor;\tfab: M0;\tSex: M;\trace: C;\tage on study: 58;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
735,"{'title': 'GBM, TMZ/radiotherapy (104)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 104;\tage: 56.2;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 19.9;\tmgmt status: M'}"
736,"{'title': 'newly diagnosed multiple myeloma 202', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
737,"{'title': 'Activated CD4+ T-cells with anti-CD3, anti-CD28 and IL-12 and harvested after 2 hours incubation', 'description': 'Gene expression data from resting CD4+ T-cells.;\tCD4_T2', 'type': 'RNA', 'source_name_ch1': 'Normal CD4+ T-cell subset', 'characteristics_ch1': 'cell type: CD4+ T-cell'}"
738,"{'title': 'Replicate 1 for MCF10A breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
739,"{'title': 'Foot siScramble Replicate2', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 2'}"
740,"{'title': 'Pt4 whole pericardial adipose tissue, biological rep1', 'description': 'Pt4_PCAT', 'type': 'RNA', 'source_name_ch1': 'Whole pericardial adipose tissue, patient 4', 'characteristics_ch1': 'tissue: whole pericardial adipose tissue;\tpatient: 4'}"
741,"{'title': 'Liver_normoglycima_no.1', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: normal glucose tolerance'}"
742,"{'title': 'Blood Sample of subject 9 before inhalation; Group A', 'description': 'Bl_Group_A_BI_subject_9', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 9;\tgroup: A'}"
743,"{'title': '93C206', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6618_Tumor;\tfab: M3;\tSex: F;\trace: C;\tage on study: 29;\tcytogenetic change: t(15;17)(q22;q21); inv(12)(p12p13);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
744,"{'title': 'HF1585_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
745,"{'title': 'untreated-aza-1', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tDemethylation: aza;\tReplicate: 1'}"
746,"{'title': 'untreated-none-1', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Demethylation: none', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tDemethylation: none;\tReplicate: 1'}"
747,"{'title': '23077', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
748,"{'title': 'HepG2 APRIL 6h', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HepG2 cells, treated for 6 hours with 200ng/ml APRIL', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocyte derived cancer'}"
749,"{'title': 'hES_WIBR2_rep1_090811_8', 'description': 'Gene expression data from hES line WIBR2', 'type': 'RNA', 'source_name_ch1': 'hES line WIBR2', 'characteristics_ch1': 'cell line: hES line WIBR2'}"
750,"{'title': 'N2-50', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
751,"{'title': 'Patient 15, colonocytes; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'Control'}"
752,"{'title': 'Tumor 16', 'description': '07SE502', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
753,"{'title': 'wt PGC-1, repeat 1', 'description': 'HePG2 cells infected with adenovirus expressing wt PGC-1', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
754,"{'title': 'ALL without MLL - sample 54', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
755,"{'title': 'HF1316_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
756,"{'title': 'muscle_preTZD_preClamp_IRd-_s32', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 32'}"
757,"{'title': 'MDS patient 101', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
758,"{'title': 'HF1381_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
759,"{'title': 'control_08hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_08hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
760,"{'title': '6454', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 63 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
761,"{'title': 'MH58a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 51;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 400;\tplasma hiv-1 rna levels (copies/ml): 439,000'}"
762,"{'title': 'Subject 13, Family 5, Affected', 'description': 'microarray hybridization data 07/10/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Male;\tfamily: 5;\tage: 38;\tdisease status: Affected;\ttissue: Muscle: Biceps'}"
763,"{'title': 'Lean_1 day_subject12', 'description': 'Lean_1 day_subject12', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Lean;\ttime point: 1 day;\tsubject: 12;\tgender: Female'}"
764,"{'title': 'neuron_rep6', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:41, gender:female, diagnostic group: bipolar disorder, PMI:28h'}"
765,"{'title': 'Blood - Control - 138A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 47;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
766,"{'title': 'T cell donor 4, control', 'description': 'Cells treated with DMSO vehicle control', 'type': 'RNA', 'source_name_ch1': 'MACS purified T cells from healthy donor peripheral blood', 'characteristics_ch1': 'T cell donor 4, control'}"
767,"{'title': 'newly diagnosed multiple myeloma 308', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: II'}"
768,"{'title': 'AML 7423', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 40 years;\tscore: FAB M0;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
769,"{'title': 'Training_Site11_04', 'description': 'Performed by Operator 1 from Site11 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 60.07922; Lot# = 035PO41658D'}"
770,"{'title': '3.2.AF.0', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 0 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: AF;\thours post infection: 0'}"
771,"{'title': '10-0006_SIRS_day1_114', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
772,"{'title': 'AML 3309', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 32 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
773,"{'title': 'Lung Normal 158N', 'description': 'Gene expression data from 158N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 72;\tstage: n/a'}"
774,"{'title': 'Replicate 1 for HCC1806 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
775,"{'title': 'MS520a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1452;\tdisease state: Uninfected;\tgender: Male;\tage: 40;\trace: Hispanic;\tblood cd4+ t  cell count (cells/ml): 742;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
776,"{'title': 'Tumor 72', 'description': '08SE394', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
777,"{'title': 'homozygot FH P261', 'description': 'Gene expression data from the homozygous FH participant A', 'type': 'RNA', 'source_name_ch1': 'homozygot FH P261 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: homozygote FH'}"
778,"{'title': 'FHC - patient 18', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Patient 18', 'characteristics_ch1': 'Gender: male;\tAge: 22 years ;\tDisease: familial hypercholesterolemia;\tDrugs: Sortis (atorvastatin), 40 mg, Ezetrol (ezetimib);\tTissue: blood'}"
779,"{'title': 'COL2_187', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 77;\tgender: F;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 621;\tsecond apc mutation: 1407;\t5q loh: 0'}"
780,"{'title': 'BC7462', 'description': '080214.04.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 35;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT3;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: --;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: neg;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: neg;\terbb2p ihc status: neg;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: neg;\tmfs: 0;\tmfsdel (month): 11.14'}"
781,"{'title': 'Subcutaneous adipose tissue, SAT46', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
782,"{'title': 'SH-SY5Y(ECACC)_RA_5d_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
783,"{'title': 'Gingival tissue sample 1 from patient 14, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 14 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
784,"{'title': 'adipose_preTZD_IRd-_s11', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 11'}"
785,"{'title': 'Lung Normal 152N', 'description': 'Gene expression data from 152N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 62;\tstage: n/a'}"
786,"{'title': 'Patient 8, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
787,"{'title': 'carcinoma_78 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 66;\tlocalization: descending+sigmoid'}"
788,"{'title': 'C145', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 3.4'}"
789,"{'title': 'X41358', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
790,"{'title': 'Pt12 whole pericardial adipose tissue, biological rep1', 'description': 'Pt12_PCAT', 'type': 'RNA', 'source_name_ch1': 'Whole pericardial adipose tissue, patient 12', 'characteristics_ch1': 'tissue: whole pericardial adipose tissue;\tpatient: 12'}"
791,"{'title': 'Patient_31', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 31;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.236400802628529;\tproliferation index: 3.88220831880765'}"
792,"{'title': 'Young sedentary subject, biological replicate (YS4)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
793,"{'title': 'CLL cells  PB  patient #25', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #25'}"
794,"{'title': 'Gingival tissue sample 3 from patient 95, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 95 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
795,"{'title': 'Training_Site7_05', 'description': 'Performed by Operator 1 from Site7 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
796,"{'title': 'DP24a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 41;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 494;\tplasma hiv-1 rna levels (copies/ml): 14,696'}"
797,"{'title': 'Tumor 24', 'description': '07SE512', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
798,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Good Responder 3', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, good responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
799,"{'title': 'D_SZI U133 Plus 2.0', 'description': 'Gene expression data from peripheral blood sample', 'type': 'RNA', 'source_name_ch1': 'Human peripheral blood sample', 'characteristics_ch1': 'tissue: blood;\tdisease state: Diverticulitis'}"
800,"{'title': 'NSCLC_AC_400', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 400.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
801,"{'title': 'PTCL_AV_024', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
802,"{'title': 'S050', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S050', 'characteristics_ch1': 'patient id: P113;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 38.5'}"
803,"{'title': '3330', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 71 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type'}"
804,"{'title': 'X34049', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IA;\tConsolidated.Grade : 3'}"
805,"{'title': 'W12 cervical ectokeratinocytes, Series 1 passage 19 (p19) #2', 'description': 'W12 cervical ectokeratinocytes; a model that recapitulates features of neoplastic progression in vitro; originally described in Stanley et al 1989, PMID 2467886;\tW12 Series 1 passage 19  (p19) #2', 'type': 'RNA', 'source_name_ch1': 'W12 passage 19 replicate 2 of 3', 'characteristics_ch1': 'gender: Female;\tcell line: W12 cervical ectokeratinocytes;\tanatomical site: Cervix;\tpassage: 19 (p19)'}"
806,"{'title': 'Pax_S1', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene;\tmolecule: total RNA'}"
807,"{'title': 'colonic_mucosa_non_inflamed_76', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, no macroscopic signs of inflammation.'}"
808,"{'title': 'X93050', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
809,"{'title': 'X488', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : III;\tConsolidated.Grade : 3'}"
810,"{'title': 'KS640d', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1464;\tdisease state: Asympt;\tgender: Male;\tage: 34;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 202;\tplasma hiv-1     rna level   (copies/ml): 122000;\ttissue: lymph node'}"
811,"{'title': 'class S, rep51', 'description': 'VAN_00412.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 30;\tsex: F;\tdisease stage: 2;\talbumin level: 47;\themoglobin level: 124;\tlymphocyte percentage: 18;\twhite blood count: 7.6;\tinternational prognostic score (ips): 1'}"
812,"{'title': 'Patient 4501 AML106', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 106;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
813,"{'title': 'AML sample #50', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
814,"{'title': 'humanMDM_Healthy_LPS', 'description': 'see Affymetrix standard protocol', 'type': 'RNA', 'source_name_ch1': 'humanMDM_Healthy_LPS', 'characteristics_ch1': 'monocyte-derived macrophages of 13 male healthy subjects'}"
815,"{'title': 'PC control 12', 'description': 'arrayconsortium.tgen.org::biosample.435010;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 12;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: male\xa0;\tgenetic variation: None\xa0;\tage: 69 years'}"
816,"{'title': 'newly diagnosed multiple myeloma 136', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
817,"{'title': 'CLL_del13q_rep5', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with del13q', 'characteristics_ch1': 'male'}"
818,"{'title': 'C133', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 0.9'}"
819,"{'title': 'carcinoma_11 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 55;\tlocalization: rectum'}"
820,"{'title': 'H416 Myclobutanil 30uM', 'description': 'H416 Myclobutanil 30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H416 Myclobutanil 30uM', 'characteristics_ch1': 'primary hepatocytes'}"
821,"{'title': 'Sputum from Stage II Moderate, biological replicate 45', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 69;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
822,"{'title': 'blood, Blood: 10 nM nicotine_le1', 'description': '10nM nicotine treatment for 1 hour;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
823,"{'title': 'Donor 3 - control', 'description': 'Elutriated monocytes from donor 3 treated with vehicle control for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes exposed to vehicle control (EtOH)'}"
824,"{'title': 'Tumor 12', 'description': '07SE498', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
825,"{'title': 'class S, rep7', 'description': 'NEB_1069.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 41;\tsex: F;\tdisease stage: 2;\talbumin level: 39;\themoglobin level: 132;\tlymphocyte percentage: 17;\twhite blood count: 10;\tinternational prognostic score (ips): 1'}"
826,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 24 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 24 hours'}"
827,"{'title': 'MLD AML sample #1', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
828,"{'title': 'KT0877_6_L_test3', 'description': 'KT0877_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set3', 'characteristics_ch1': '6 months, living donor, test set3'}"
829,"{'title': 'UCNR10_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
830,"{'title': 'Bleomycin-treated rep3', 'description': 'BJ fibroblasts artificially-aged', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Human foreskin BJ fibroblasts;\t100ug/ml of bleomycin sulfate for 24hr, 72 serum-free incubation in 3% O2'}"
831,"{'title': 'class S, rep87', 'description': 'VAN_00519.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 47;\tsex: M;\tdisease stage: 3;\talbumin level: 0;\themoglobin level: 139;\tlymphocyte percentage: 10;\twhite blood count: 13.6;\tinternational prognostic score (ips): 4'}"
832,"{'title': 'X146', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : III;\tConsolidated.Grade : 3'}"
833,"{'title': 'Sputum from Stage II Moderate, biological replicate 29', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 57;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
834,"{'title': 'AML 7127', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 44 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
835,"{'title': 'CC1', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'centrocytes donor 1', 'characteristics_ch1': 'centrocytes, isolated from tonsils by fluorescence-activated cell sorting'}"
836,"{'title': 'X70148', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : 3'}"
837,"{'title': 'Patient 4701 AML135', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 135;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
838,"{'title': 'X44366', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
839,"{'title': 'cord blood 12', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 11.65', 'characteristics_ch1': 'Cord blood arsenic exposure level 11.65;\t'}"
840,"{'title': 'AML sample #91', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
841,"{'title': 'Patient 4098 AML55', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 55;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
842,"{'title': 'MCF-7_Ferulic acid_10μM_rep3', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Ferulic acid treated'}"
843,"{'title': 'TOL8', 'description': 'Gene expression data from Tolerant 8', 'type': 'RNA', 'source_name_ch1': 'Tolerant8', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Tolerant'}"
844,"{'title': 'COL2_225', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 55;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 876;\tsecond apc mutation: 0;\t5q loh: 0'}"
845,"{'title': 'Control_6', 'description': 'Control', 'type': 'RNA', 'source_name_ch1': 'Lung tissue sample from lung transplant patient', 'characteristics_ch1': 'diagnosis: Normal;\tfvc-group: Normal;\ttissue: lung'}"
846,"{'title': 'HepG2 APRIL 12h', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HepG2 cells, treated for 12 hours with 200ng/ml APRIL', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocyte derived cancer'}"
847,"{'title': 'AML with normal karyotype #87', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 65;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 63;\tdisease state: de novo AML'}"
848,"{'title': 'U937_ROS_curcumin_18h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 1uM curcumin treated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
849,"{'title': 'PBMC-1-Non-RR-Pat.15 [wf20061103u133v2_U_07-Lc1-Pat-3-HC]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
850,"{'title': 'NS3-7', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 7; Smoking status: non-smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 7; Smoking status: non-smoker', 'characteristics_ch1': 'Time: Day 7;\tSmoking status: non-smoker;\tPack-years: 0;\tAge: 40;\tSex: M;\tEthnic group: white'}"
851,"{'title': 'Blood - Control - 032A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 70;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
852,"{'title': 'conventional renal cell cancer; cRCCb_HD49B', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
853,"{'title': 'Septic Shock_biological rep39', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 4.4;\toutcome: Survivor'}"
854,"{'title': 'Blood_TD19902_Daytwo_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
855,"{'title': 'conventional renal cell cancer; cRCCa_HD63', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
856,"{'title': 'Scz-25', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tL3', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - schizophrenia;\tSex: M;\tage: 65;\ttissue ph: 6.29;\tpmi (hrs): 42;\ttype of drug: Trifluphenazine, Haloperidol;\tdrug dose (chlorpromazine equivalents): 460 mg'}"
857,"{'title': 'newly diagnosed multiple myeloma 226', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
858,"{'title': 'AML 7303', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: RAEB-t;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: MDS -Y;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
859,"{'title': 'AML 2541', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 56 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
860,"{'title': '487', 'description': '05-24666', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 57;\tgender: M;\tipi_stage: 3AE;\ttxprimary: CHOP8-RITU;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 0.63;\tprogression-free_survival (years): 0.59'}"
861,"{'title': 'Control-4', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tSc4', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness - control;\tSex: M;\tage: 22;\ttissue ph: 6.39;\tpmi (hrs): 62;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
862,"{'title': '22092', 'description': '11786', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24325;\tSmoking_Status: Never;\tPathology: Adenocarcinoma'}"
863,"{'title': 'Bronchial epithelial cells, day 10, donor 1', 'description': 'Bronchial epithelial cells, day 10, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 10 of air-liquid interface culture'}"
864,"{'title': 'Healthy volunteer HV1', 'description': 'Healthy volunteer', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: Healthy volunteer;\ttherapy: none;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
865,"{'title': 'X44428', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
866,"{'title': 'NSCLC EMC TB0011he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
867,"{'title': 'AML 1766', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 52 years;\tscore: FAB unknown;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
868,"{'title': 'GA_903', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
869,"{'title': 'K_STA2', 'description': 'K_STA2', 'type': 'RNA', 'source_name_ch1': 'STA2 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
870,"{'title': 'No9inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No9 nonRVR;\ttime point: under therapy'}"
871,"{'title': 'explanted liver Patient 2 (HBV-associated acute liver failure) - 3', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from explanted liver Patient 2', 'characteristics_ch1': 'tissue: liver;\torigin: HBV-associated acute liver failure'}"
872,"{'title': 'Muscle-FamilyHistoryNegative-3', 'description': 'Jos3664;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 42;\tfamily history: Family history negative;\tbody mass index (kg/m2): 21;\tfasting glucose (ogtt): 67;\t2 hour glucose (ogtt): 124;\themoglobin a1c: 4.6;\tfasting glucose (iv0gavg): 79;\tfasting insulin (iv0inavg): 6.1;\tsi: 1.59;\twaist hip ratio: 0.824'}"
873,"{'title': 'BC17253', 'description': '080311.08.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 34;\tmolecular subtype: NA;\thistology: other;\tpt: --;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: --;\tigf1r ihc status: pos;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: --;\tmfs: --;\tmfsdel (month): --'}"
874,"{'title': '60175', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
875,"{'title': 'Replicate 3 for MCF7siRNActr breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 siRNA against ESR1 control at 18h'}"
876,"{'title': 'WT8-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'VHL reconstituted 786-O cells (WT8), replicate 3'}"
877,"{'title': 'Septic Shock_biological rep17', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.8;\toutcome: Nonsurvivor'}"
878,"{'title': 'S143', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S143', 'characteristics_ch1': 'patient id: P007;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
879,"{'title': 'Tumor Tum_Ph1_rep4', 'description': 'Tumor paired  8', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N0;\thistology: cdi/cli;\tgrade: _;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
880,"{'title': 'Primary 2006(20.06.01)', 'description': 'Gene expression data  for primary', 'type': 'RNA', 'source_name_ch1': 'PrimaryHepatocellular Carcinoma', 'characteristics_ch1': 'Tissue: liver'}"
881,"{'title': 'acute GvHD', 'description': 'acute GvHD;\tMHH0893wdh', 'type': 'RNA', 'source_name_ch1': 'blood from allogeneic stem cell transplantation (SCT) patient', 'characteristics_ch1': 'disease state: acute GvHD;\tcell type: CD4+CD25highCD127low/- Tregs'}"
882,"{'title': 'Gingival tissue sample 2 from patient 85, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 85 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
883,"{'title': 'class F, rep34', 'description': 'VAN_00121f1.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 32;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: 129;\tlymphocyte percentage: 8;\twhite blood count: 9.8;\tinternational prognostic score (ips): 2.3'}"
884,"{'title': 'human BM MSC TGFb3 stimulated day 3 rep 2', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 3', 'type': 'RNA', 'source_name_ch1': 'donor 5, stimulated with TGFb3 for 3 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 3 days'}"
885,"{'title': '558395', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7505_Tumor;\tfab: M4;\tSex: M;\trace: W;\tage on study: 64;\tcytogenetic change: del(11)(p12);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
886,"{'title': 'HS_2', 'description': 'Heat shock treatment 2', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells treated with heat shock', 'characteristics_ch1': 'heat shock treated cells'}"
887,"{'title': 'PBMCs_LB_before exercise_14', 'description': 'LB_Pre_029-BD', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 19;\tbefore-exercise'}"
888,"{'title': 'liver donor 16', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from liver donor 16', 'characteristics_ch1': 'tissue: liver;\torigin: liver donor'}"
889,"{'title': 'PGA_PA-N_112', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
890,"{'title': 'Muscle septic k61', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:male, Age:77yrs'}"
891,"{'title': 'gd cell control time 0,donor 4', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated prior to activation;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: control;\ttime: 0;\tindividual: donor 4'}"
892,"{'title': 'HOSE2064', 'description': 'normal human ovarian surface epithelials cells', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: normal ovarian surface epithelials cells'}"
893,"{'title': 'DietResistant _1 day_subject9', 'description': 'DietResistant _1 day_subject9', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 9;\tgender: Male'}"
894,"{'title': 'Patient 4601 AML130', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 130;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
895,"{'title': 'EPN_388, non-recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_388, non-recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
896,"{'title': 'Gastric GIST 4', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 54;\tTumor size: 10;\tKIT mutation: Exon 11'}"
897,"{'title': 'TC.DR+-5', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
898,"{'title': 'Training_Site9_17', 'description': 'Performed by Operator 1 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
899,"{'title': 'X44288', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
900,"{'title': 'HD2-RPK-6h', 'description': 'biological source:;\thomo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation', 'type': 'RNA', 'source_name_ch1': 'healthy donor HD2, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation'}"
901,"{'title': 'Donor2_24h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 2 treated with Wy14643 for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 2;\tagent: Wy14643;\ttime: 24h;\tgender: Male;\tage: 44 years old'}"
902,"{'title': 'Patient 5035 AML183', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 183;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
903,"{'title': 'newly diagnosed multiple myeloma 1', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
904,"{'title': 'Donor6_6h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 6 treated with DMSO for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 6;\tagent: control;\ttime: 6h;\tgender: Male;\tage: 73 years old'}"
905,"{'title': 'group-1-pt-t16666198', 'description': 'group-1-pt-t16666198', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 27;\tgender: male;\tfinal disposition: 06: Home'}"
906,"{'title': 'DB720a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1472;\tdisease state: Uninfected;\tgender: Female;\tage: 52;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 837;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
907,"{'title': 'BC5520', 'description': '030205.06.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 64;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT1;\tpn: neg;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: neg;\terbb2.tab ihc status: neg;\terbb2p ihc status: neg;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: neg;\tmfs: 1;\tmfsdel (month): 14.52'}"
908,"{'title': 'Blood sample from patient 179 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 179;\tday: Day 90;\tage (years): 58;\tsex: Female'}"
909,"{'title': 'T161 U133p2', 'description': 'bulk breast tumor RNA from patient T161', 'type': 'RNA', 'source_name_ch1': 'T161', 'characteristics_ch1': 'breast tumor'}"
910,"{'title': 'platelet_Ctrl_4', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
911,"{'title': 'healthy breast 5, biological rep. 5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'healthy', 'characteristics_ch1': 'tissue: breast;\tdisease state: healthy'}"
912,"{'title': 'ALL without MLL - sample 71', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
913,"{'title': 'X23055', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
914,"{'title': 'MDA-MB-231_untreated', 'description': 'Untreated control cells in regular growth medium', 'type': 'RNA', 'source_name_ch1': 'MDA-MB-231', 'characteristics_ch1': 'cell line: MDA-MB-231 breast cancer cell line;\ttreatment: untreated (control)'}"
915,"{'title': 'SH-SY5Y(ECACC)_RA_3d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
916,"{'title': '10165', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 66;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 24;\tDonor Sex: M;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
917,"{'title': 'normal_colon_62 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 38;\tlocalization: sigmoid'}"
918,"{'title': 'Lung Normal 144N', 'description': 'Gene expression data from 144N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 57;\tstage: n/a'}"
919,"{'title': 'patient Pre ECP, biological rep5', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'GVHD patient Pre ECP', 'characteristics_ch1': 'disease state: graft-versus host disease;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
920,"{'title': '10-0023A_SIRS_day1_106', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
921,"{'title': 'PAF507', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.3;\tdisease activity (das28_v3): 6.44;\tresponse to anti-tnf therapy: NORESPONSE'}"
922,"{'title': 'Control-12', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc4', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: F;\tage: 29;\ttissue ph: 6.38;\tpmi (hrs): 34;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
923,"{'title': 'X44242', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
924,"{'title': 'GA_696', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
925,"{'title': '2.2.AF.10', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 10 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: AF;\thours post infection: 10'}"
926,"{'title': 'PBMC-2-RR-Pat.7 [wf20071123u133v2_U_18_LP21_Lc2_M_56yr_alpha_151]', 'description': 'Post-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Post-interferon blood sample', 'characteristics_ch1': 'treatment status: Post-interferon'}"
927,"{'title': 'ALL with MLL - sample 118', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
928,"{'title': 'X582', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
929,"{'title': 'ALL without MLL - sample 73', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
930,"{'title': 'HF1380_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
931,"{'title': 'dmso: m1: i3: d08', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 1; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 1;\tReplicate: 3;\tBatch: d08'}"
932,"{'title': 'MCF-7 +scrambled siRNA + 500 nM 4-hydroxytamoxifen rep1 (MD35)', 'description': 'Gene expression data from MCF-7cells treated with 500 nM 4-hydroxytamoxifen and scrambled siRNA;\tMD35', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with 500 nM 4-hydroxytamoxifen and scrambled siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: control (scrambled siRNA);\tagent: 4-hydroxytamoxifen;\tdose: 500 nM'}"
933,"{'title': 'Training_Site5_04', 'description': 'Performed by Operator 1 from Site5 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 59.478; Lot# = 035PO41658D'}"
934,"{'title': 'group-2-pt-t31980419', 'description': 'group-2-pt-t31980419', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 54;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
935,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 48 hours rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
936,"{'title': 'Globin_S4', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
937,"{'title': 'renal oncocytoma; RO_HD30', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
938,"{'title': 'adult normal kidney; NK1a_AK1', 'description': 'gene expression data for normal kidney', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'normal kidney'}"
939,"{'title': 'e_2m51', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
940,"{'title': 'Normal_6', 'description': 'Normal mucosa', 'type': 'RNA', 'source_name_ch1': 'Normal tissue 6', 'characteristics_ch1': 'tissue: esophagus, normal;\tgender: male, Japanese;\tage: 76'}"
941,"{'title': 'IFNβ_1820', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
942,"{'title': 'AML sample #16', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
943,"{'title': 'lymphocytes_HD_F_44y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: female; Age: 44; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/48'}"
944,"{'title': 'AML with normal karyotype #122', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 60;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 80.5;\tdisease state: de novo AML'}"
945,"{'title': 'Scz-21', 'description': 'ID# from Supplementary Table 3 of PMID 18778695: -', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: F;\tage: 33;\ttissue ph: 6.43;\tpmi (hrs): 20;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): NA'}"
946,"{'title': 'Cord blood naive B cells, rep2', 'description': 'Sample pooled from 3 cord blood donors.', 'type': 'RNA', 'source_name_ch1': 'Cord blood naive B cells', 'characteristics_ch1': 'tissue: cord blood;\tb-cell subset: CD20+CD10-CD27-'}"
947,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
948,"{'title': 'CLL_del13q_rep7', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with del13q', 'characteristics_ch1': 'male'}"
949,"{'title': 'AML 7052', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 34 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
950,"{'title': 'Lung Normal 130N', 'description': 'Gene expression data from 130N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 51;\tstage: n/a'}"
951,"{'title': 'Adult Blood 16, biological replicate 2', 'description': 'Gene expression data of reticulocytes from adult periperal blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from adult periperal blood', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: reticulocytes;\tdevelopmental stage: adult'}"
952,"{'title': 'T8936B1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
953,"{'title': 'class S, rep58', 'description': 'VAN_00445.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 54;\tsex: M;\tdisease stage: 4;\talbumin level: 36;\themoglobin level: 140;\tlymphocyte percentage: 26;\twhite blood count: 4.6;\tinternational prognostic score (ips): 5'}"
954,"{'title': 'UNTREATED_1691', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
955,"{'title': 'Blood Sample of subject 42 after inhalation; Group A: inhalation with 0.7 ppm FA 72 h before sampling', 'description': 'Bl_Group_A_AI_subject_42', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 72 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 72 h;\tsubject: 42;\tgroup: A'}"
956,"{'title': 'CLL cells  LN patient #5', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #5'}"
957,"{'title': 'Gingival tissue sample 2 from patient 10, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 10 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
958,"{'title': 'NZK25', 'description': 'early metastatic primary clear-cell renal cell carcinoma, batch 2', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: male;\ttumor stage (uicc 2002): pT3a;\tlymph node status: N1;\tinitial distant metastases: M0;\ttumor grade: G2;\tdfs/follow-up: DFS = 0 months;\tlocalisation of metastases: lymph node'}"
959,"{'title': 'Liver367N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HCV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 367N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: LC;\tgender: M;\tage: 72;\tvirus: HCV'}"
960,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Poor Responder 2', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, poor responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
961,"{'title': 'Gingival tissue sample 1 from patient 2, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 2 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
962,"{'title': 'MDS patient 121', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q'}"
963,"{'title': 'carcinoma_4 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 65;\tlocalization: sigmoid'}"
964,"{'title': 'Pilocytic astrocytoma chip 7750', 'description': 'Pilocytic astrocytoma.  Chip ID 7750', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
965,"{'title': '10_0004_SepticShock_Day1_73', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '10_0004_Patient, Day1'}"
966,"{'title': 'MCF-7_Si-Wu-Tang_0.0256mg/ml_rep1', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
967,"{'title': 'Patient 27, IDC', 'description': '17270-1P_exp', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 27'}"
968,"{'title': '2x9 PGC-1 mutant, repeat 2', 'description': 'HePG2 cells infected with adenovirus expressing the 2x9 mutant of PGC-1', 'type': 'RNA', 'source_name_ch1': 'HePG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
969,"{'title': 'Blood sample from patient 163 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 163;\tday: Day 28;\tage (years): 64;\tsex: Female'}"
970,"{'title': 'Patient 4559 AML126', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 126;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
971,"{'title': 'Sample 14: normal ovarian surface epithelium', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: Normal'}"
972,"{'title': 'Cell line HB4a_D_4', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line -DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
973,"{'title': 'MDS patient 107', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: other'}"
974,"{'title': 'newly diagnosed multiple myeloma 111', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: I'}"
975,"{'title': 'K_STA17', 'description': 'K_STA17', 'type': 'RNA', 'source_name_ch1': 'STA17 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
976,"{'title': 'T175 U133p2', 'description': 'bulk breast tumor RNA from patient T175', 'type': 'RNA', 'source_name_ch1': 'T175', 'characteristics_ch1': 'breast tumor'}"
977,"{'title': 'Replicate 1 for MCF7 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
978,"{'title': 'Adenocarcinoma, bone marrow negative AC 14', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'male pulmonary adenocarcinoma;\tbone marrow negative'}"
979,"{'title': 'Patient 5148 AML201', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 201;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
980,"{'title': 'control participant P331', 'description': 'Gene expression data from control participant T3', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
981,"{'title': 'S033_Scz_M_83', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 83;\tpost-mortem delay: 11.5h;\tph: 6.1'}"
982,"{'title': 'bladder_TaGL_pool-2', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, Ta low grade', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 5 individual samples.'}"
983,"{'title': 'Tumor 42', 'description': '07SE538', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
984,"{'title': 'AML 322', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
985,"{'title': 'C183', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 4.0'}"
986,"{'title': 'Lung Cancer 124T', 'description': 'Gene expression data from 124T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 62;\tstage: 1B'}"
987,"{'title': 'NZK 5', 'description': 'late metastatic primary clear-cell renal cell carcinoma, batch 4', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: female;\ttumor stage (uicc 2002): pT2;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G2;\tdfs/follow-up: DFS = 60 months;\tlocalisation of metastases: bone'}"
988,"{'title': 'colon_IBD_1606', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
989,"{'title': 'platelet_sickle_11', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
990,"{'title': 'AML 2285', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 17 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
991,"{'title': 'newly diagnosed multiple myeloma 314', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
992,"{'title': 'VAN_00567', 'description': '06-14634', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 61;\tgender: M;\tipi_stage: 4B;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 2.30;\tprogression-free_survival (years): 2.30'}"
993,"{'title': 'Sputum from Stage II Moderate, biological replicate 67', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 65;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
994,"{'title': 'hyperplastic polyp_sporadic_proximal, rep2', 'description': 'Gene expression data from samples of patients with HPPS.;\tA500PB', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic polyp located in proximal colon from a sporadic HPPS patient', 'characteristics_ch1': 'tissue: colon;\thistology: hyperplastic polyp;\tcolon location: proximal;\tdisease: hyperplastic polyposis syndrome (HPPS);\thereditary nature of hpps: sporadic'}"
995,"{'title': '10_0012_SepticShock_Day3_63', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '10_0012_Patient, Day3'}"
996,"{'title': 'Healthy control 16', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
997,"{'title': 'Blood Sample of subject 36 before inhalation; Group B', 'description': 'Bl_Group_B_BI_subject_36', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 36;\tgroup: B'}"
998,"{'title': 'Replicate 2 for MB231control breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 mir-221/222 inhibitor control at 18h'}"
999,"{'title': 'csc-none-2', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Demethylation: none', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tDemethylation: none;\tReplicate: 2'}"
1000,"{'title': 'cord blood 5', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.32', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.32;\t'}"
1001,"{'title': 'Normal breast (B83)', 'description': 'no additional info;\tnone', 'type': 'RNA', 'source_name_ch1': 'B83', 'characteristics_ch1': 'NB'}"
1002,"{'title': 'colonic_crypt_epithelial_cells_adenoma_36 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: adenoma;\tsex: female'}"
1003,"{'title': 'AML with normal karyotype #195', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 54;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 75;\tdisease state: de novo AML'}"
1004,"{'title': 'Control 42', 'description': '07SE539', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
1005,"{'title': 'PCB153 treated HepG2 cells at T0.5, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines after 30 minutes of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
1006,"{'title': ""HUVECs  treated with Hank's buffered salt solution for 4 hours rep 1"", 'description': 'Serum-deprived HUVECs', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells  treated with HBSS', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
1007,"{'title': 'Sputum from Stage II Moderate, biological replicate 39', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 71;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
1008,"{'title': 'pCR breast biopsy, sample 19 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 19 rep 2', 'characteristics_ch1': 'pathological complete response: yes;\ttissue: Breast tumor biopsy'}"
1009,"{'title': 'NSCLC EMC TB0068he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
1010,"{'title': ""Wilms' FF C-1"", 'description': 'L751-A-HG-U133_Plus_2-01-1 (S07-1035W-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FF;\tblock age (at extraction in years): 0.5;\tbiological replicate: rep-1;\tdonor: C tumor""}"
1011,"{'title': 'Liver376T (mRNA expression)', 'description': 'liver cancer HBV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 376T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately-poorly differentiated;\tgender: M;\tage: 57;\tvirus: HBV'}"
1012,"{'title': 'AML 7073', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 37 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1013,"{'title': 'dmso: m2: i1: d07', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 2; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 2;\tReplicate: 1;\tBatch: d07'}"
1014,"{'title': 'MDS patient 28', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
1015,"{'title': 'Lung Cancer 120T', 'description': 'Gene expression data from 120T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 61;\tstage: 1A'}"
1016,"{'title': 'No12pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No12 nonRVR;\ttime point: before therapy'}"
1017,"{'title': 'Endometrium - pregnant [08-10662-2]', 'description': '08-10662-2', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval,  pregnant', 'characteristics_ch1': 'tissue: endometrium on day of oocyte retrieval;\tstate: pregnant'}"
1018,"{'title': 'muscle_preTZD_preClamp_NRd_s15', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 15'}"
1019,"{'title': 'negative control transfection for 72 hours', 'description': 'negative control transfection for 72 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
1020,"{'title': 'newly diagnosed multiple myeloma 31', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: II'}"
1021,"{'title': 'FL1', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'follicular lymphoma case 1', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with follicular lymphoma (FL)'}"
1022,"{'title': 'AML 2230', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 37 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
1023,"{'title': 'T3-3 (HCC stage 3-3)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'Human Liver', 'characteristics_ch1': 'HCC stage 3'}"
1024,"{'title': 'MDS patient 140', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: other'}"
1025,"{'title': 'T cell donor 2, rolipram', 'description': 'Cells treated with 20 uM rolipram', 'type': 'RNA', 'source_name_ch1': 'MACS purified T cells from healthy donor peripheral blood', 'characteristics_ch1': 'T cell donor 2, rolipram'}"
1026,"{'title': 'X23128', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1027,"{'title': 'MCF-7_Estradiol_0.1μM_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Estradiol treated'}"
1028,"{'title': 'platelet_Ctrl_10', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
1029,"{'title': 'newly diagnosed multiple myeloma 273', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: I'}"
1030,"{'title': '22069', 'description': '11720', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24294;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
1031,"{'title': 'Tonsil epithelium 5', 'description': 'Laser Capture Microdissected Epithelium of Tonsil from healthy donors.', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic Tonsil of Sleap Apnea Adult Patient', 'characteristics_ch1': 'Tonsil Epithelium'}"
1032,"{'title': 'Insulin resistant patient 9 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
1033,"{'title': 'AML sample #30', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00075;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
1034,"{'title': 'Control Con_rep8', 'description': 'Control paired  21', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
1035,"{'title': 'X60258', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
1036,"{'title': 'Training_Site3_03', 'description': 'Performed by Operator 1 from Site3 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 17.2; Lot# = 035PO41658D'}"
1037,"{'title': 'Training_Site9_12', 'description': 'Performed by Operator 2 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 37.3; Lot# = 035PO41658D'}"
1038,"{'title': 'M92', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: 0;\tage: 75;\tSex: M;\tcode: resection;\tclass: Unannotated;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
1039,"{'title': 'newly diagnosed multiple myeloma 238', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
1040,"{'title': 'B73', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 3.0'}"
1041,"{'title': 'Angioimmunoblastic T-cell lymphoma 36_replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-99', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 65;\tgender: male'}"
1042,"{'title': 'No26pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No26RVR;\ttime point: before therapy'}"
1043,"{'title': 'X34125', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1044,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Moderate Responder 4', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, moderate responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
1045,"{'title': 'GA_1496', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
1046,"{'title': 'newly diagnosed multiple myeloma 44', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: nd'}"
1047,"{'title': 'Endometrium in trophoblast conditioned medium for 3 hours TCM-16', 'description': 'Trophoblast conditioned medium endometrium  3 hours TCM-16', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Trophoblast conditioned medium endometrium  3 hours TCM-16'}"
1048,"{'title': 'AML 5365', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 42 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1049,"{'title': 'cord blood 23', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.74', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.74;\t'}"
1050,"{'title': 'NLPHL_lymph_node_case1', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: male, Age: 49, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, An Arbor Stage: IA, follow-up: 10 years; status at last follow-up: died of squamous cell carcinoma of the larynx""}"
1051,"{'title': 'cord blood 16_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.13', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.13;\t'}"
1052,"{'title': 'B11', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.8'}"
1053,"{'title': 'Septic Shock_biological rep65', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 5.6;\toutcome: Survivor'}"
1054,"{'title': 'X60188', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1055,"{'title': 'X60228', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IA;\tConsolidated.Grade : 1'}"
1056,"{'title': 'PMNs_normal_bone_marrow_2', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'PMNs (neutrophils) sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
1057,"{'title': 'N40899', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40899;\tsample: normal'}"
1058,"{'title': 'N40843', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40843;\tsample: normal'}"
1059,"{'title': 'Control, rep 1', 'description': 'Gene expression data from control HUVEC', 'type': 'RNA', 'source_name_ch1': 'HUVEC control', 'characteristics_ch1': 'cell type: Endothelial cell;\tagent: ethanol;\tdose: 0.1%'}"
1060,"{'title': 'Sputum from Stage II Moderate, biological replicate 8', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 68;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
1061,"{'title': 'Clone A cells treated with 5uM CsA and cultured for 24 hours rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
1062,"{'title': 'NY99', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: C;\tage: 68;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 27646;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
1063,"{'title': 'Gastric GIST 13', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 63;\tTumor size: 13;\tKIT mutation: Exon 11'}"
1064,"{'title': 'Huh7 cells_JFH-1 Infected 12 hours_ rep1', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 12 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 12 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
1065,"{'title': 'Insulin sensitive patient 8 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
1066,"{'title': 'class F, rep37', 'description': 'VAN_00335f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 73;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: 124;\tlymphocyte percentage: 18;\twhite blood count: 9.5;\tinternational prognostic score (ips): 3.5'}"
1067,"{'title': 'Old trained subject, biological replicate (OT7)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old trained subject', 'characteristics_ch1': 'no additional information'}"
1068,"{'title': 'PGA-Hs_S-5', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
1069,"{'title': 'MDS patient 110', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: other'}"
1070,"{'title': 'newly diagnosed multiple myeloma 15', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: II'}"
1071,"{'title': 'GA_885', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1072,"{'title': '6461', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 65 years, RAEB-t, cytogenetic poor risk, CEBPA wild type'}"
1073,"{'title': 'Sputum from Stage III Severe, biological replicate 33', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 61;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
1074,"{'title': 'Blood - Axial Spondyloarthropathy - 083A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 51;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
1075,"{'title': 'HF1057_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1076,"{'title': 'Tumor Tum_Ph2_rep9', 'description': 'not paired', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N1;\thistology: cdi/cli;\tgrade: _;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
1077,"{'title': 'NY317', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: 0;\tage: 70;\tSex: M;\tcode: resection;\tclass: Inflammation;\tafp: 3.1;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
1078,"{'title': 'hES_BG01_rep1_081006_9', 'description': 'Gene expression data from hES line BG01', 'type': 'RNA', 'source_name_ch1': 'hES line BG01', 'characteristics_ch1': 'cell line: hES line BG01'}"
1079,"{'title': 'cord blood 3', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.14', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.14;\t'}"
1080,"{'title': 'carcinoma_3 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 63;\tlocalization: rectum'}"
1081,"{'title': 'vCRC3', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: colorectal cancer'}"
1082,"{'title': '25-070603_SIRS_day3_221', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1083,"{'title': 'B2-RR-Pat.7 [wf20071123u133v2_U_08_LP21_B2_M_56yr_alpha_151]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
1084,"{'title': 'S083', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S083', 'characteristics_ch1': 'patient id: P065;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 13.5'}"
1085,"{'title': 'N40728_rep', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40728;\tsample: normal'}"
1086,"{'title': 'Peripheral T-Cell lymphoma, unspecified 41', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-02', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 78;\tgender: male'}"
1087,"{'title': 'untreated: m3: i3: d06', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 3; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 3;\tReplicate: 3;\tBatch: d06'}"
1088,"{'title': 'Patient 5143 AML196', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 196;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1089,"{'title': '433325', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7501_Tumor;\tfab: M2;\tSex: F;\trace: W;\tage on study: 51;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
1090,"{'title': 'MERLION_X02K01914', 'description': 'MERLION_X02K01914', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=49, state=0', 'characteristics_ch1': 'pT2N0, male, age=49, state=0'}"
1091,"{'title': '195182', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9694_Tumor;\tfab: M2;\tSex: M;\trace: W;\tage on study: 63;\tcytogenetic change: t(9;22)(q34;q11.2)-7;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1092,"{'title': 'Adipose tissue_425_control_rep2', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, normal weight, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: normal weight;\tgender: M;\tage: 7 year;\tz score bmi: 0.49'}"
1093,"{'title': '93079', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade Low;\tStage IA;\tMicropapillary feature Negative;\t(LMP) implants Negative;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
1094,"{'title': 'N11472B3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1095,"{'title': '04-0004_Septic Shock_day3_220', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1096,"{'title': 'PTB2 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
1097,"{'title': 'CD02', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CD'}"
1098,"{'title': 'MCF7VP cell line, biological rep1', 'description': 'Gene expression data from etoposide resistant breast cancer cell line, MCF7VP', 'type': 'RNA', 'source_name_ch1': 'etoposide resistant MCF7 breast cancer cell line', 'characteristics_ch1': 'tissue: breast;\tcell line: MCF7VP (etoposide-resistant)'}"
1099,"{'title': 'N8706A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1100,"{'title': '06-0006_Septic Shock_day1_92', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1101,"{'title': 'HRV-infected, normal S9 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, normal S9', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
1102,"{'title': 'Angioimmunoblastic T-cell lymphoma 24', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-62', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 61;\tgender: female'}"
1103,"{'title': 'patient Post ECP, biological rep1', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'CTCL patient Post ECP', 'characteristics_ch1': 'disease state: cutaneous T cell lymphoma;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
1104,"{'title': 'EPN_459, non-recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_459, non-recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
1105,"{'title': 'Gingival tissue sample 1 from patient 17, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 17 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1106,"{'title': 'HF1490_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1107,"{'title': 'Normal Ovary, 2064', 'description': 'Gene expression data from normal ovary.;\tHOSE2064', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
1108,"{'title': 'AML 2497', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 20 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1109,"{'title': 'carcinoma_90 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 62;\tlocalization: descending'}"
1110,"{'title': 'Sputum from Stage III Severe, biological replicate 54', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 52;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39315'}"
1111,"{'title': 'human macrophages treated with PG-fimbriae, biological rep3', 'description': 'Gene expression data from human macrophages treated with PG-fimbriae for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis-fimbriae', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: P. gingivalis fimbriae;\ttreatment time: 2 hours;\tday: 9'}"
1112,"{'title': 'IFNa treated donor 1', 'description': 'RNA from healthy donor', 'type': 'RNA', 'source_name_ch1': 'primary macrophages, IFNa-treated', 'characteristics_ch1': 'cell type: monocyte-derived macrophage;\tagent: IFNalpha'}"
1113,"{'title': 'group-2-pt-t322025', 'description': 'group-2-pt-t322025', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 19;\tgender: male;\tfinal disposition: control'}"
1114,"{'title': 'No18LCMHinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No18;\tcell type: hepatocytes;\ttime point: under therapy'}"
1115,"{'title': 'GPR54-suppressed Ishikawa, biological rep2', 'description': 'Gene expression data from Ishikawa cells that were introduced with GPR54 siRNA.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells introduced with GPR54 siRNA', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: GPR54-specific siRNA;\tpeptide treatment: control peptide'}"
1116,"{'title': 'Endometrium in control conditioned medium for 3 hours TCM-5', 'description': 'Control conditioned medium endometrium  3 hours TCM-5', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control conditioned medium endometrium  3 hours TCM-5'}"
1117,"{'title': 'IFNβ_2125', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1118,"{'title': '3.1.AF.6', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 6 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: AF;\thours post infection: 6'}"
1119,"{'title': 'group-2-pt-t6495589', 'description': 'group-2-pt-t6495589', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 26;\tgender: female;\tfinal disposition: control'}"
1120,"{'title': 'N8735C2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1121,"{'title': 'AML 3334', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: RAEB-t;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1122,"{'title': 'X60135', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1123,"{'title': 'MDS patient 133', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
1124,"{'title': 'newly diagnosed multiple myeloma 190', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
1125,"{'title': 'Patient 4742 AML162', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 162;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1126,"{'title': 'NZK 8', 'description': 'non-metastatic primary clear-cell renal cell carcinoma, batch 4', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: female;\ttumor stage (uicc 2002): pT2;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G2;\tdfs/follow-up: Follow-up = 99 months;\tlocalisation of metastases: none'}"
1127,"{'title': 'T30068', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30068;\tsample: tumor'}"
1128,"{'title': 'TBM1 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tmeningeal tuberculosis'}"
1129,"{'title': 'SH-SY5Y(ECACC)_BDNF_1d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
1130,"{'title': 'colonic_mucosa_non_inflamed_125', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, no macroscopic signs of inflammation.'}"
1131,"{'title': 'adipose_preTZD_IRd-_s4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 4'}"
1132,"{'title': 'H439 DMSO 0.001', 'description': 'H439 DMSO 0.001.CEL', 'type': 'RNA', 'source_name_ch1': 'H439 DMSO 0.001', 'characteristics_ch1': 'primary hepatocytes'}"
1133,"{'title': 'AML sample #51', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00191;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
1134,"{'title': 'Tumor Tum_Ph2_rep6', 'description': 'Tumor paired  22', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N0;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
1135,"{'title': 'C011_Control_F_89', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 89;\tpost-mortem delay: 5h;\tph: 6.5'}"
1136,"{'title': 'Oestrogen-deprieved T47D Tamoxifen Resistant cells', 'description': 'ODT47DTR', 'type': 'RNA', 'source_name_ch1': 'Breast cancer cell line T47D grown in oestrogen deprieved and tamoxifen containing media.', 'characteristics_ch1': 'cell line: T47D;\tgrowth condition: grown in oestrogen deprieved and tamoxifen containing media;\tcell type: This is a hypotriploid human breast cell;\tbiomaterial provider: ATCC'}"
1137,"{'title': 'No1LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No1;\tcell type: hepatocytes;\ttime point: before therapy'}"
1138,"{'title': 'HF0510_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
1139,"{'title': 'Control_biological rep23 11-0077', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 1.9;\toutcome: n/a;\tgroup: n/a'}"
1140,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R22', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 61.36;\t%cd3cd8: 33.71;\t%cd8+cd28-: 11.44;\t%cd8+cd28+: 12.25;\t%cd4cd25cd62l: 2.74;\t%cd3delta1: 0.76;\t%cd3delta2: 3.6;\tratio delta1/delta2: 0.21;\t%cd3gammadelta: 4.69;\t%cd3alphabeta: 82.41;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: 12.04;\t%cd4 cd62l-cd45+: 0.01;\t%cd4 cd62l - cd45-: 34.88;\t%cd4cd62l+cd45-: 53.07;\t%cd4 ccr7+ cd45 -: 42.26;\t%cd4 ccr7+ cd45+: 12.44;\t%cd4 ccr7 - cd45+: 0.63;\t%cd4 ccr7 – cd45-: 44.67;\t%cd8 cd62l+ cd45-: 8.72;\t%cd8cd62l+ cd45+: 23.55;\t%cd8cd62l- cd45+: 22.36;\t%cd8cd62l- cd45 -: 45.37;\t%cd8ccr7+ cd45-: 3.56;\t%cd8ccr7+ cd45+: 18.28;\t%cd8ccr7-cd45+: 25.78;\t%cd8ccr7-cd45 -: 52.38;\t%cd3-cd56+cd16+: 10.84;\t%nkts: 10.24;\t%cd19: 6.11;\t%cd4foxp3+: 4.95'}"
1141,"{'title': 'EntorhinalCortex_male_45yrs_indiv12', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 45 years', 'characteristics_ch1': 'individual: 12, AA;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 45'}"
1142,"{'title': 'brain, unknown: R1B_e1_le1', 'description': 'rotenone 1 week B;\tTreatment, type=time_course, measurement=1.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
1143,"{'title': 'H133+_H416_Propi_100uM', 'description': 'H133+_H416_Propi_100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H416_Propi_100uM', 'characteristics_ch1': 'primary hepatocytes'}"
1144,"{'title': 'cHL1', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 1', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
1145,"{'title': 'adipose_postTZD_IRd_s31', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 31'}"
1146,"{'title': 'No18LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No18;\tcell type: lymphocytes;\ttime point: before therapy'}"
1147,"{'title': 'Lung Normal 189N', 'description': 'Gene expression data from 189N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 59;\tstage: n/a'}"
1148,"{'title': 'Lung Normal 127N', 'description': 'Gene expression data from 127N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 59;\tstage: n/a'}"
1149,"{'title': 'newly diagnosed multiple myeloma 217', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: None;\tiss: I'}"
1150,"{'title': '3.1.AF.10', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 10 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: AF;\thours post infection: 10'}"
1151,"{'title': 'AML with normal karyotype #5', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 21;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
1152,"{'title': 'N10559A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1153,"{'title': 'Patient 1, biopsy; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
1154,"{'title': 'mucosa_carcinoma_12 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: carcinoma;\tsex: female'}"
1155,"{'title': 'Cord Blood 20, biological replicate 6', 'description': 'Gene expression data of reticulocytes from umbilical cord blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from umbilical cord blood', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: reticulocytes'}"
1156,"{'title': 'blood_cd34pos_D2', 'description': '3 samples CD34+ and 2 samples CD34-', 'type': 'RNA', 'source_name_ch1': 'periphereal blood', 'characteristics_ch1': 'healty donors treated with GCSF isolated CD34+ cells and CD34+ after 10dd of differentiating medium.'}"
1157,"{'title': 'VT_Epidi_norm_47ans_tete', 'description': 'biological rep 1', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus,47 years-old, head segment', 'characteristics_ch1': 'Seminal vesicles'}"
1158,"{'title': 'breast normal 6', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal breast stroma', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: normal'}"
1159,"{'title': 'AML with normal karyotype #93', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 72;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 36.5;\tdisease state: de novo AML'}"
1160,"{'title': 'mesenchymal stem cells, lot#4F1127, 7th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F1127, passage number 7', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F1127, 7th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
1161,"{'title': 'muscle_preTZD_preClamp_IRd_s52', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 52'}"
1162,"{'title': 'B1-RR-Pat.4 [wf20070302u133v2_U_01_SC_B1_73]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
1163,"{'title': '22044', 'description': '11711', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24265;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
1164,"{'title': 'Sputum from Stage III Severe, biological replicate 59', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 69;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
1165,"{'title': 'dH1F_Fibro_2', 'description': 'Gene expression data obtained from fibroblasts', 'type': 'RNA', 'source_name_ch1': 'human fibroblast', 'characteristics_ch1': 'cell type: fibroblast;\tcell line: GM04981 from Coriell'}"
1166,"{'title': 'group-2-pt-t18509360', 'description': 'group-2-pt-t18509360', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 24;\tgender: female;\tfinal disposition: 05: Home with services'}"
1167,"{'title': 'N10475G1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1168,"{'title': 'AML 6977', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 33 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1169,"{'title': 'AML sample #63', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
1170,"{'title': 'JR310a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1431;\tdisease state: Asympt;\tgender: Male;\tage: 34;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 333;\tplasma hiv-1     rna level   (copies/ml): 71200;\ttissue: lymph node'}"
1171,"{'title': 'GBM, radiotherapy (94bis)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 94;\tage: 58.7;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 8.91;\tmgmt status: U'}"
1172,"{'title': 'newly diagnosed multiple myeloma 104', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
1173,"{'title': 'ALL without MLL - sample 38', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1174,"{'title': '94C046', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7199_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 41;\tcytogenetic change: del(9q);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
1175,"{'title': 'ALL without MLL - sample 65', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1176,"{'title': 'UCR4_beforeT', 'description': 'Colonic mucosal gene expression data from UC responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
1177,"{'title': 'Septic Shock_biological rep59', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1.2;\toutcome: Survivor'}"
1178,"{'title': 'Proficiency_Site1_19', 'description': 'Performed by Operator 1 from Site1 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 46.56; Lot# = 035PO41658D'}"
1179,"{'title': 'untreated: m1: i2: d01', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 1; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 1;\tReplicate: 2;\tBatch: d01'}"
1180,"{'title': 'AML 2174', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 45 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1181,"{'title': 'AML with normal karyotype #161', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 50;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 79;\tdisease state: de novo AML'}"
1182,"{'title': 'Pax_S6', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene;\tmolecule: total RNA'}"
1183,"{'title': 'B1-Non-RR-16 [wf20070130u133v2_U_01-B1-Pat.5-CE]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
1184,"{'title': 'No13pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No13 nonRVR;\ttime point: before therapy'}"
1185,"{'title': 'N11354D4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1186,"{'title': 'Patient 4370 AML63', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 63;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1187,"{'title': 'AML with normal karyotype #210', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 41;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: >30;\tdisease state: de novo AML'}"
1188,"{'title': 'Replicate 3 for BT474EI breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
1189,"{'title': 'NSCLC_AC_368', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 368.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
1190,"{'title': 'group-2-pt-t14755953', 'description': 'group-2-pt-t14755953', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 29;\tgender: female;\tfinal disposition: 06: Home'}"
1191,"{'title': 'explanted liver Patient 2 (HBV-associated acute liver failure) - 1', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from explanted liver Patient 2', 'characteristics_ch1': 'tissue: liver;\torigin: HBV-associated acute liver failure'}"
1192,"{'title': 'IPMA 1', 'description': 'Gene expression data from microdissected epithelial cells of IPMA', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMA 1', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous adenoma (IPMA)'}"
1193,"{'title': 'hTFC_1', 'description': 'BioConductor software package (Gentleman, R. C., Carey, V. J., Bates, D. M. et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 2004; 5: R80) (www.bioconductor.org).', 'type': 'RNA', 'source_name_ch1': 'Human testis biopsy sample', 'characteristics_ch1': 'tissue: testis;\tisolate: biopsy sample was obtained from patient (patient 16)'}"
1194,"{'title': 'Angioimmunoblastic T-cell lymphoma 35', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-96', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 72;\tgender: male'}"
1195,"{'title': 'SH-SY5Y(ECACC)_RA_0h_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
1196,"{'title': 'Sputum from Stage IV Severe, biological replicate 11', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 55;\tgender: F;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39315'}"
1197,"{'title': '15_0008_SepticShock_Day3_12', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '15_0008_Patient, Day3'}"
1198,"{'title': 'ALL without MLL - sample 84', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1199,"{'title': 'papillary renal cell cancer; pRCCa_HD21', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
1200,"{'title': 'HIV+ Individual HIV-3a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-3a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
1201,"{'title': 'GBM_stem_4 days_3', 'description': 'G63_SC.CEL', 'type': 'RNA', 'source_name_ch1': 'glioblastoma stem cells, stem, 4 days', 'characteristics_ch1': 'tissue: brain;\tdisease status: glioblastoma;\tcell type: stem cells G63'}"
1202,"{'title': '22045', 'description': '11712', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24266;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
1203,"{'title': 'Huh7 cells_Mock Infected 24 hours_ rep1', 'description': 'Gene expression data from Huh7 cells treated with mock media for 24 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 24 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
1204,"{'title': 'Globin_C1', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
1205,"{'title': 'UNTREATED_1786', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1206,"{'title': '11-0029_Septic Shock_day1_168', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1207,"{'title': 'AR-P5', 'description': 'AR-P5', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
1208,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_74_04)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 57;\tSex: M'}"
1209,"{'title': 'Insulin resistant patient 13 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
1210,"{'title': 'NSCLC EMC ADC2293N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
1211,"{'title': 'newly diagnosed multiple myeloma 16', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: I'}"
1212,"{'title': 'colon_CRC_1316', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
1213,"{'title': 'lymphocytes_HD_M_51y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: male; Age: 51; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/45'}"
1214,"{'title': 'class S, rep30', 'description': 'VAN_00182.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 20;\tsex: M;\tdisease stage: 1;\talbumin level: 44;\themoglobin level: 153;\tlymphocyte percentage: 23;\twhite blood count: 6.5;\tinternational prognostic score (ips): 2'}"
1215,"{'title': 'Small intestinal GIST 9', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human small intestinal GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 68;\tTumor size: 6;\tKIT mutation: Wild type'}"
1216,"{'title': '2704', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 69 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
1217,"{'title': 'cord blood 7', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.54', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.54;\t'}"
1218,"{'title': 'MCF7 silenced Estrogen receptor, biological rep2', 'description': 'Gene expression data from MCF7 breast cancer cell line with silenced Estrogen receptor', 'type': 'RNA', 'source_name_ch1': 'MCF7 silenced Estrogen receptor alpha (PII)', 'characteristics_ch1': 'knockdown: estrogen receptor alpha KD;\tcell line: MCF7'}"
1219,"{'title': 'Patient 5144 AML197', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 197;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1220,"{'title': '3.1.NDV.10', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 10 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 10'}"
1221,"{'title': 'AML 2241', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1222,"{'title': 'X44349', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 2'}"
1223,"{'title': 'No10inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No10RVR;\ttime point: under therapy'}"
1224,"{'title': 'NY325', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 52;\tSex: M;\tcode: resection;\tclass: Proliferation;\tafp: 12.1;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
1225,"{'title': 'Monocyte cell line, serum and inhibitor 1', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: Added serum and Erk-1/2 inhibitor U0126'}"
1226,"{'title': 'Patient 4092 AML52', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 52;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1227,"{'title': 'Cell line HB4a_DR4', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
1228,"{'title': '3.2.NDV.4', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 4 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 4'}"
1229,"{'title': 'PGA-Hs_D-1', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = Idiopathic Cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
1230,"{'title': 'X525', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
1231,"{'title': 'AML with normal karyotype #18', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 33;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 43;\tdisease state: de novo AML'}"
1232,"{'title': 'N2-35', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
1233,"{'title': 'Peripheral T-Cell lymphoma, unspecified 16', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-17', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 80;\tgender: male'}"
1234,"{'title': 'X474', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
1235,"{'title': 'AML 6734', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1236,"{'title': 'NLPHL_lymph_node_case3', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: male, Age: 63, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, An Arbor Stage: I, follow-up: lost for follow-up""}"
1237,"{'title': 've_M47', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
1238,"{'title': 'hES_BG01_rep2_081006_10', 'description': 'Gene expression data from hES line BG01', 'type': 'RNA', 'source_name_ch1': 'hES line BG01', 'characteristics_ch1': 'cell line: hES line BG01'}"
1239,"{'title': 'MDS patient 114', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
1240,"{'title': 'class S, rep88', 'description': 'VAN_00520.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 24;\tsex: F;\tdisease stage: 2;\talbumin level: 40;\themoglobin level: 130;\tlymphocyte percentage: 100;\twhite blood count: 1.5;\tinternational prognostic score (ips): 1'}"
1241,"{'title': 'SH-SY5Y(ECACC)_BDNF_3d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
1242,"{'title': 'Control Con_rep11', 'description': 'Control paired  10', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
1243,"{'title': 'Insulin resistant patient 5 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
1244,"{'title': 'Gingival tissue sample 1 from patient 54, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 54 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1245,"{'title': 'adipose_postTZD_IRd+_s21', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 21'}"
1246,"{'title': 'muscle_preTZD_preClamp_IRd+_s24', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 24'}"
1247,"{'title': 'T-ALL-25-6h-1ug-rep', 'description': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion.', 'type': 'RNA', 'source_name_ch1': 'T-ALL patient 25, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion.'}"
1248,"{'title': '10223', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 50;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 22;\tDonor Sex: M;\tCAN Banff Score =3;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
1249,"{'title': 'HIV+ Individual HIV-10a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-10a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
1250,"{'title': 'M-21', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
1251,"{'title': 'Gingival tissue sample 2 from patient 33, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 33 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1252,"{'title': 'group-2-pt-t13365750', 'description': 'group-2-pt-t13365750', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 34;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
1253,"{'title': 'ALL without MLL - sample 82', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1254,"{'title': 'Hyperplast02', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Hyperplastic polyp'}"
1255,"{'title': 'Lung Cancer 165T', 'description': 'Gene expression data from 165T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 64;\tstage: 3B'}"
1256,"{'title': 'NSG410', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.04;\tdisease activity (das28_v3): 3.87;\tresponse to anti-tnf therapy: MEDIUM'}"
1257,"{'title': 'Gingival tissue sample 2 from patient 1, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 1 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1258,"{'title': 'IFNβ_1117', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1259,"{'title': '7161', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 74 years, FAB M1, cytogenetic risk unknown, CEBPA wild type'}"
1260,"{'title': 'H439 Myclobutanil 10uM', 'description': 'H439 Myclobutanil 10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H439 Myclobutanil 10uM', 'characteristics_ch1': 'primary hepatocytes'}"
1261,"{'title': 'T8636A1.3: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
1262,"{'title': 'MDS patient 120', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
1263,"{'title': 'Patient_6558_relapse', 'description': '6558R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 33;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
1264,"{'title': 'ALL without MLL - sample 18', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1265,"{'title': 'class S, rep83', 'description': 'VAN_00515.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 48;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: 153;\tlymphocyte percentage: 24;\twhite blood count: 6.2;\tinternational prognostic score (ips): 3.5'}"
1266,"{'title': 'Gingival tissue sample 2 from patient 15, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 15 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1267,"{'title': 'DLBCL biopsy, sample 2112', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
1268,"{'title': 'Lung siScramble Replicate3', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 3'}"
1269,"{'title': 'NS2-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: non-smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: non-smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: non-smoker;\tPack-years: 0;\tAge: 36;\tSex: M;\tEthnic group: white'}"
1270,"{'title': 'e_B13', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
1271,"{'title': 'Tumor Tum_Ph1_rep10', 'description': 'Tumor paired  4', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N1;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
1272,"{'title': 'X51174', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IA;\tConsolidated.Grade : 1'}"
1273,"{'title': 'Hippocampus_male_97yrs_indiv34', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 97 years', 'characteristics_ch1': 'individual: 34, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 97'}"
1274,"{'title': 'FHC - patient 17', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Patient 17', 'characteristics_ch1': 'Gender: male;\tAge: 46 years ;\tDisease: familial hypercholesterolemia;\tDrugs: Silvacor (simvastatin), 20 mg;\tTissue: blood'}"
1275,"{'title': 'HOSE2237', 'description': 'normal human ovarian surface epithelials cells', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: normal ovarian surface epithelials cells'}"
1276,"{'title': 'Normal_colon_03_12April05', 'description': 'Normal_colon_03_12April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, sigmoid', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
1277,"{'title': 'Patient 3396 AML8', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 8;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1278,"{'title': '05_0007_SepticShock_Day1_3', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '05_0007_Patient, Day1'}"
1279,"{'title': 'HPB-ALL_SAHM1_03', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'HPB-ALL cells treated with SAHM1', 'characteristics_ch1': 'cell type: T-cell;\tcell line: HPB-ALL'}"
1280,"{'title': 'Globin_S1', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
1281,"{'title': 'HF0491_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
1282,"{'title': 'Lung Normal 94N', 'description': 'Gene expression data from 94N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 56;\tstage: n/a'}"
1283,"{'title': 'MERLION_X03K00525', 'description': 'MERLION_X03K00525', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=52, state=0', 'characteristics_ch1': 'pT2N0, male, age=52, state=0'}"
1284,"{'title': '01-0059A_Septic Shock_day1_12', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1285,"{'title': 'S053', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S053', 'characteristics_ch1': 'patient id: P075;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 50'}"
1286,"{'title': 'Huh7 cells treated with 1uM NIM811 and cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 1uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 1uM;\ttime: 48 hours'}"
1287,"{'title': 'cHL7', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 7', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
1288,"{'title': 'CD34+CD45RA+Lin- HPCs transduced with empty vector', 'description': 'CD45RA+P;\tGene expression data from cell transduced with empty vector', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA+Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tgenotype/variation: transduced with empty vector;\tcell type: hematopoietic progenitors'}"
1289,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 12 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 12 hours'}"
1290,"{'title': 'NF-7', 'description': 'Gene expression data from non-failing control hearts', 'type': 'RNA', 'source_name_ch1': 'Non-Failing Sample 3', 'characteristics_ch1': 'sample pairs: none;\ttissue: Myocard;\tvad status: unsupported;\tdisease status: none;\tvad: none;\tage: 5;\tgender: m'}"
1291,"{'title': 'AML sample #12', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00078;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
1292,"{'title': 'KT0975_6_D_test3', 'description': 'KT0975_6_D_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, deceased donor, test set3', 'characteristics_ch1': '6 months, deceased donor, test set3'}"
1293,"{'title': 'whole blood_100416', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism with regression, Female', 'characteristics_ch1': 'Autism with regression, Female'}"
1294,"{'title': 'not used-treatment interrupted [wf20071123u133v2_U_14_SZ13_Lc2_M_46yr_alpha_151]', 'description': 'Post-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Post-interferon blood sample', 'characteristics_ch1': 'treatment status: Post-interferon'}"
1295,"{'title': 'Control-27', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tLc5', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - control;\tSex: M;\tage: 60;\ttissue ph: 6.11;\tpmi (hrs): 27.5;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
1296,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_70_04)', 'description': 'Gene expression data from whole blood 7 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 65;\tSex: F'}"
1297,"{'title': 'Invasive cancer originating in IPMN 3', 'description': 'Gene expression data from microdissected epithelial cells of invasive cancer originating in IPMN', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from invasive cancer originating in IPMN 3', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous neoplasm (IPMN)'}"
1298,"{'title': 'Septic Shock_biological rep56 07-0006A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 6;\toutcome: Nonsurvivor;\tgroup: B'}"
1299,"{'title': 'Subcutaneous adipose tissue, SAT30', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
1300,"{'title': 'AML 2771', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 52 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1301,"{'title': 'CD34+CD45RA-Lin- HPCs transduced with empty vector', 'description': 'CD45RA-P;\tGene expression data from cell transduced with empty vector', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA-Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tgenotype/variation: transduced with empty vector;\tcell type: hematopoietic progenitors'}"
1302,"{'title': 'Patient 4384 AML70', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 70;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1303,"{'title': 'N11688A4: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
1304,"{'title': 'AML 2551', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 23 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
1305,"{'title': 'S030', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S030', 'characteristics_ch1': 'patient id: P082;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 50'}"
1306,"{'title': 'colon_CRC_1883', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
1307,"{'title': 'GBM, TMZ/radiotherapy (1360)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1360;\tage: 65;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 9.11;\tmgmt status: M'}"
1308,"{'title': 'class S, rep37', 'description': 'VAN_00364.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 70;\tsex: M;\tdisease stage: 3;\talbumin level: 31;\themoglobin level: 134;\tlymphocyte percentage: 5;\twhite blood count: 11.7;\tinternational prognostic score (ips): 5'}"
1309,"{'title': 'NZK 10', 'description': 'non-metastatic primary clear-cell renal cell carcinoma, batch 4', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: female;\ttumor stage (uicc 2002): pT1b;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G3;\tdfs/follow-up: Follow-up = 112 months;\tlocalisation of metastases: none'}"
1310,"{'title': '02-0002A_Septic Shock_day1_61', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1311,"{'title': 'CLL cells  PB  patient #5', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #5'}"
1312,"{'title': 'HBEC4 Control treatment group (DMSO).', 'description': 'HBEC4 Control treatment group (DMSO).', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
1313,"{'title': 'Cord Blood 16, biological replicate 2', 'description': 'Gene expression data of reticulocytes from umbilical cord blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from umbilical cord blood', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: reticulocytes'}"
1314,"{'title': 'Gingival tissue sample 1 from patient 40, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 40 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1315,"{'title': 'IFNβ_1059', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1316,"{'title': '10518', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 48;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 51;\tDonor Sex: M;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
1317,"{'title': 'platelet_sickle_18', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
1318,"{'title': 'Replicate 2 for MCF7control breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 mir-221/222 mimic control at 18h'}"
1319,"{'title': 'Septic Shock_biological rep66', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 9.8;\toutcome: Survivor'}"
1320,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_30_4)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 62;\tSex: F'}"
1321,"{'title': 'carcinoma_70 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 73;\tlocalization: rectum'}"
1322,"{'title': '3.1.AF.18', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 18 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: AF;\thours post infection: 18'}"
1323,"{'title': '22084', 'description': '11778', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24316;\tSmoking_Status: Current;\tPathology: Large cell Neuroendocrine carcinoma'}"
1324,"{'title': 'Sepsis gram-negative TN7', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
1325,"{'title': 'HF0460_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1326,"{'title': 'Muscle septic k63', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:female, Age:71yrs'}"
1327,"{'title': 'Ishikawa non-treated, biological rep3', 'description': 'Gene expression data from Ishikawa cells that were not treated with metastin-10 and not introduced with GPR54 siRNA.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells not introduced with GPR54 siRNA and not treated with metastin-10', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: negative control siRNA;\tpeptide treatment: control peptide'}"
1328,"{'title': 'mucosa_adenoma_6 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: adenoma;\tsex: female'}"
1329,"{'title': 'X60181', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : 3'}"
1330,"{'title': '849660', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '10567_Tumor;\tfab: M1;\tSex: M;\trace: C;\tage on study: 22;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1331,"{'title': 'MDS patient 4', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q'}"
1332,"{'title': 'IPMC 1', 'description': 'Gene expression data from microdissected epithelial cells of IPMC', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMC 1', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous carcinoma (IPMC)'}"
1333,"{'title': 'B61', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: II;\tnode status: pos;\tLVI: neg;\ttumor type: Mixed;\ttumor size: 2.9'}"
1334,"{'title': 'Old sedentary subject, biological replicate (OS2)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old sedentary subject', 'characteristics_ch1': 'no additional information'}"
1335,"{'title': 'Donor3_24h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 3 treated with Wy14643 for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 3;\tagent: Wy14643;\ttime: 24h;\tgender: Female;\tage: 70 years old'}"
1336,"{'title': 'U937_naive_untreated_18h_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, untreated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
1337,"{'title': 'AML 6953', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 55 years;\tscore: FAB M6;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1338,"{'title': 'PBMCs treated at the IC90 for 24 hours,replicate 6', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 24 hours,replicate 6', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
1339,"{'title': 'NSG401', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.25;\tdisease activity (das28_v3): 2.21;\tresponse to anti-tnf therapy: RESPONSE'}"
1340,"{'title': '11-0022_Sepsis_day1_164', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1341,"{'title': 'Replicative Senescent rep5', 'description': 'BJ fibroblasts passaged in culture till they reached senescence (population doubling >85) as assessed by SA-Bgal. 72h starved in serum-free media and incubated at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Late passage BJ fibroblasts'}"
1342,"{'title': 'Control 1, Simvastatin is anti-inflammatory in macrophages', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'human peripheral blood monocyte-derived macrophages', 'characteristics_ch1': 'from unknown healthy blood-donor volunteers (Finnish Red Cross)'}"
1343,"{'title': 'PBMC-2-Non-RR-Pat.13 [wf20071123u133v2_U_22_BJ23_Lc2_M_49yr_alpha_151]', 'description': 'Post-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Post-interferon blood sample', 'characteristics_ch1': 'treatment status: Post-interferon'}"
1344,"{'title': 'X70003', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : 3'}"
1345,"{'title': 'KOPT-K1_DMSO_02', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'KOPT-K1 cells treated with DMSO', 'characteristics_ch1': 'cell type: T-cell;\tcell line: KOPT-K1'}"
1346,"{'title': 'Clone A cells treated with 1uM NIM811 and cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 1uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 1uM;\ttime: 48 hours'}"
1347,"{'title': 'HeLa_SRA siRNA_rep1', 'description': 'Affymetrix HG U133+2 data', 'type': 'RNA', 'source_name_ch1': 'HeLa cells, SRA siRNA', 'characteristics_ch1': 'cell line: HeLa cancer cell line;\ttissue origin of cancer cell: cervix;\tprotocol: siRNA-mediated SRA depletion'}"
1348,"{'title': 'B67', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.2'}"
1349,"{'title': 'e_M75', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
1350,"{'title': 'adipose_preTZD_IRd+_s21', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 21'}"
1351,"{'title': '5289', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 67 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type'}"
1352,"{'title': 'newly diagnosed multiple myeloma 159', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
1353,"{'title': 'group-1-pt-t23306982', 'description': 'group-1-pt-t23306982', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 51;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
1354,"{'title': ""Wilms' FF A-1"", 'description': 'L749-A-HG-U133_Plus_2-01-1 (S99-2051W-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FF;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-1;\tdonor: A tumor""}"
1355,"{'title': 'MCF7VP cell line, biological rep3', 'description': 'Gene expression data from etoposide resistant breast cancer cell line, MCF7VP', 'type': 'RNA', 'source_name_ch1': 'etoposide resistant MCF7 breast cancer cell line', 'characteristics_ch1': 'tissue: breast;\tcell line: MCF7VP (etoposide-resistant)'}"
1356,"{'title': 'X374', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
1357,"{'title': 'ALL without MLL - sample 76', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1358,"{'title': 'CLL cells  LN patient #11', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #11'}"
1359,"{'title': 'EntorhinalCortex_female_70yrs_indiv47', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 70 years', 'characteristics_ch1': 'individual: 47, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 70'}"
1360,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R8', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 50.72;\t%cd3cd8: 44.51;\t%cd8+cd28-: 29.41;\t%cd8+cd28+: 8.69;\t%cd4cd25cd62l: 6.41;\t%cd3delta1: 4.48;\t%cd3delta2: 0.48;\tratio delta1/delta2: 9.33;\t%cd3gammadelta: 5.14;\t%cd3alphabeta: 94.30;\t%cd4cd8-ab+(dn): 1.63;\t%cd4 cd62l+cd45+: 26.46;\t%cd4 cd62l-cd45+: 3.30;\t%cd4 cd62l - cd45-: 35.51;\t%cd4cd62l+cd45-: 34.73;\t%cd4 ccr7+ cd45 -: 17.23;\t%cd4 ccr7+ cd45+: 26.88;\t%cd4 ccr7 - cd45+: 6.24;\t%cd4 ccr7 – cd45-: 49.65;\t%cd8 cd62l+ cd45-: 8.22;\t%cd8cd62l+ cd45+: 15.34;\t%cd8cd62l- cd45+: 40.33;\t%cd8cd62l- cd45 -: 36.10;\t%cd8ccr7+ cd45-: 0.65;\t%cd8ccr7+ cd45+: 4.53;\t%cd8ccr7-cd45+: 67.64;\t%cd8ccr7-cd45 -: 27.18;\t%cd3-cd56+cd16+: 37.94;\t%nkts: 8.87;\t%cd19: 1.22;\t%cd4foxp3+: 3.50'}"
1361,"{'title': 'Young sedentary subject, biological replicate (YS9)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
1362,"{'title': 'DLBCL biopsy, sample 2178', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
1363,"{'title': 'Oligodendrioglioma_7', 'description': 'bh20061208u133v2_A_28-Oligo10_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: oligodendrioglioma;\tage: 40;\tgender: male;\ttumor grade: OGII'}"
1364,"{'title': 'JS30a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 26;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 683;\tplasma hiv-1 rna levels (copies/ml): 3,610'}"
1365,"{'title': ""Wilms' FF A-2"", 'description': 'L749-A-HG-U133_Plus_2-02-1 (S99-2051W-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FF;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-2;\tdonor: A tumor""}"
1366,"{'title': 'MH58b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 51;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 400;\tplasma hiv-1 rna levels (copies/ml): 439,000'}"
1367,"{'title': 'Monocyte High PBM 12', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 12'}"
1368,"{'title': '15-0002_Control_day1_205', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Control_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1369,"{'title': 'CO6', 'description': 'Colonic mucosal gene expression data from control individual', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from control individual', 'characteristics_ch1': 'tissue: Colon;\tdisease: Control;\tresponse to infliximab: Not applicable;\tbefore or after first infliximab treatment: Not applicable'}"
1370,"{'title': 'Proficiency_Site6_17', 'description': 'Performed by Operator 1 from Site6 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 37.3; Lot# = 035PO41658D'}"
1371,"{'title': 'Young sedentary subject, biological replicate (YS2)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
1372,"{'title': 'OB06a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 45;\trace: African American;\tperipheral blood cd4+ t cells (cells/ml): 188;\tplasma hiv-1 rna levels (copies/ml): 10,684'}"
1373,"{'title': 'AML with normal karyotype #124', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 38;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 79.5;\tdisease state: de novo AML'}"
1374,"{'title': 'Tumor 2', 'description': '07SE486', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
1375,"{'title': 'N2-12', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
1376,"{'title': '633734', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9680_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 53;\tcytogenetic change: del(7)(q21q36);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1377,"{'title': 'Patient_8237_diagnosis', 'description': '8237D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: N/A;\tselected: no'}"
1378,"{'title': 'Control-13', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc5', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 36;\ttissue ph: 6.46;\tpmi (hrs): 42;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
1379,"{'title': 'IRX3', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincIRX5;\treplicate: 3'}"
1380,"{'title': 'Blood - Control - 021A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 59;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
1381,"{'title': 'DC_Unstimulated_Rep1', 'description': 'Circulating monocyte derived DCs were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure. At day four 10 million immature DCs were either left unstimulated or stimulated using plate bound anti-DC-SIGN antibody for 2 hr. Three replicates of non-stimulated or stimulated cells were taken and used to extract total RNA.', 'type': 'RNA', 'source_name_ch1': 'primary dendritic cells (DCs)', 'characteristics_ch1': 'Buffy coats were obtained from the National Blood Centre. Circulating myeloid DCs were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.'}"
1382,"{'title': 'CLL cells  PB  patient #8', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #8'}"
1383,"{'title': 'X92065', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
1384,"{'title': 'newly diagnosed multiple myeloma 293', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
1385,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 6', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
1386,"{'title': 'Muscle septic k50', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:male, Age:46yrs'}"
1387,"{'title': 'M43', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 74;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 245;\ttp53 mutation: 440G>GA | C176C/Y;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
1388,"{'title': '11-0050B_Sepsis_day3_181', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1389,"{'title': 'class S, rep89', 'description': 'VAN_00521.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 49;\tsex: F;\tdisease stage: 2;\talbumin level: 44;\themoglobin level: 125;\tlymphocyte percentage: 13;\twhite blood count: 7.6;\tinternational prognostic score (ips): 2'}"
1390,"{'title': 'C146', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.5'}"
1391,"{'title': 'Septic Shock_biological rep23 01-0078', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.8;\toutcome: Survivor;\tgroup: C'}"
1392,"{'title': 'Cell line C5.2_R_3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
1393,"{'title': 'HF0627_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1394,"{'title': 'Kidney 3', 'description': 'Gene expression data from kidney mRNA sample', 'type': 'RNA', 'source_name_ch1': 'Kidney mRNA', 'characteristics_ch1': 'human male'}"
1395,"{'title': 'EC control 7', 'description': 'arrayconsortium.tgen.org::biosample.433971;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 7;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 76 years'}"
1396,"{'title': 'X44303', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1397,"{'title': 'S127', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S127', 'characteristics_ch1': 'patient id: P005;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
1398,"{'title': 'mRNA of AA-HGG080, Anaplastic Astrocytoma, 12 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 12 years', 'characteristics_ch1': 'disease: Anaplastic Astrocytoma;\tage: 12 years'}"
1399,"{'title': 'IFNβ_1133', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1400,"{'title': 'mesenchymal stem cells, lot#5F0138, 7th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#5F0138, passage number 7', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#5F0138, 7th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
1401,"{'title': 'AML 2747', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 22 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
1402,"{'title': 'MCF-7 +scrambled siRNA + 100 nM 4-hydroxytamoxifen rep1 (MD33)', 'description': 'Gene expression data from MCF-7cells treated with 100 nM 4-hydroxytamoxifen and scrambled siRNA;\tMD33', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with 100 nM 4-hydroxytamoxifen and scrambled siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: control (scrambled siRNA);\tagent: 4-hydroxytamoxifen;\tdose: 100 nM'}"
1403,"{'title': 'ALL with MLL - sample 121', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1404,"{'title': 'Muscle control 18', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
1405,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 4', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
1406,"{'title': 'Cervical cancer-lymph node positive-27-21', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 32.7;\tfigo stage: 1b2'}"
1407,"{'title': 'blood-vehicle-control-1', 'description': 'Unstimulated control.;\t101-0-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, control', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: control'}"
1408,"{'title': 'No16inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No16RVR;\ttime point: under therapy'}"
1409,"{'title': 'AML sample #75', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00432;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
1410,"{'title': 'Normal_colon_40_20April05', 'description': 'Normal_colon_40_20April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, rectum', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
1411,"{'title': 'Donor6_6h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 6 treated with Wy14643 for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 6;\tagent: Wy14643;\ttime: 6h;\tgender: Male;\tage: 73 years old'}"
1412,"{'title': 'Patient 4416 AML86', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 86;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1413,"{'title': '399253', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6332_Tumor;\tfab: M4;\tSex: M;\trace: W;\tage on study: 77;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1414,"{'title': 'colon_CRC_1293', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
1415,"{'title': 'Fibroblast 6', 'description': 'Gene expression data obtained from fibroblasts', 'type': 'RNA', 'source_name_ch1': 'fibroblast', 'characteristics_ch1': 'cell line: 14 week old fetal lung fibroblast from ATCC'}"
1416,"{'title': 'DLBCL biopsy, sample 2091', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
1417,"{'title': 'Control_biological rep12', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 4.6;\toutcome: Survivor'}"
1418,"{'title': 'GA_895', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1419,"{'title': 'NF-10', 'description': 'Gene expression data from non-failing control hearts', 'type': 'RNA', 'source_name_ch1': 'Non-Failing Sample 6', 'characteristics_ch1': 'sample pairs: none;\ttissue: Myocard;\tvad status: unsupported;\tdisease status: none;\tvad: none;\tage: 31;\tgender: m'}"
1420,"{'title': 'PBMC_ectopic_validation_21', 'description': 'Blood collection: Samples collected by leukapheresis and stored in liquid nitrogen.;\tPBMC isolation:', 'type': 'RNA', 'source_name_ch1': 'PBMCs from patients with other cancer types (e.g., gastrointestinal and brain cancers)', 'characteristics_ch1': 'phenotype: Ectopic;\ttissue: peripheral blood leukocytes;\tdata set: validation'}"
1421,"{'title': 'T149 U133p2', 'description': 'bulk breast tumor RNA from patient T149', 'type': 'RNA', 'source_name_ch1': 'T149', 'characteristics_ch1': 'breast tumor'}"
1422,"{'title': 'PBMC_ectopic_validation_16', 'description': 'Blood collection: Samples collected by leukapheresis and stored in liquid nitrogen.;\tPBMC isolation:', 'type': 'RNA', 'source_name_ch1': 'PBMCs from patients with other cancer types (e.g., gastrointestinal and brain cancers)', 'characteristics_ch1': 'phenotype: Ectopic;\ttissue: peripheral blood leukocytes;\tdata set: validation'}"
1423,"{'title': 'S019', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S019', 'characteristics_ch1': 'patient id: P081;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
1424,"{'title': 'mock-infected, asthmatic S10 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, asthmatic S10', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
1425,"{'title': 'AML sample #61', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
1426,"{'title': 'Proficiency_Site3_17', 'description': 'Performed by Operator 1 from Site3 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 53.75; Lot# = 035PO41658D'}"
1427,"{'title': 'Germinal Center Centroblasts, sample 3', 'description': 'CD77-positive B-cells from human tonsil, purified by magnetic cell separation.;\tGene expression data from purified germinal center centroblasts', 'type': 'RNA', 'source_name_ch1': 'Germinal Center Centroblasts from human tonsil', 'characteristics_ch1': 'cell type: CD77-positive B-cells from human tonsil'}"
1428,"{'title': 'Hippocampus_female_96yrs_indiv105', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 96 years', 'characteristics_ch1': 'individual: 105, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 96'}"
1429,"{'title': 'HF1502_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
1430,"{'title': 'mRNA of GBM-HGG153, Glioblastoma, 13.1 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 13.1 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 13.1 years'}"
1431,"{'title': 'VAN_00568', 'description': '06-17315', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: NC;\tpathology: DLBC;\ttissue: lymph node;\tage: 65;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP7-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.88;\tprogression-free_survival (years): 1.88'}"
1432,"{'title': 'W12 cervical ectokeratinocytes, Series 1 passage 22 (p22) #3', 'description': 'W12 cervical ectokeratinocytes; a model that recapitulates features of neoplastic progression in vitro; originally described in Stanley et al 1989, PMID 2467886;\tW12 Series 1 passage 22 (p22) #3', 'type': 'RNA', 'source_name_ch1': 'W12 passage 22 replicate 3 of 3', 'characteristics_ch1': 'gender: Female;\tcell line: W12 cervical ectokeratinocytes;\tanatomical site: Cervix;\tpassage: 22 (p22)'}"
1433,"{'title': 'platelet_sickle_9', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
1434,"{'title': 'SI1', 'description': 'Gene expression data from Standard Immunotherapy 1', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 1', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
1435,"{'title': 'bladder_T1GH_pool-1', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, T1 high grade', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 5 individual samples.'}"
1436,"{'title': 'No29pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No29RVR;\ttime point: before therapy'}"
1437,"{'title': 'H133+_H439_Tri_30uM', 'description': 'H133+_H439_Tri_30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H439_Tri_30uM', 'characteristics_ch1': 'primary hepatocytes'}"
1438,"{'title': 'GA_862', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1439,"{'title': 'Replicate 1 for MCF7untreated72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 1 for MCF7untreated72h breast cell line'}"
1440,"{'title': 'Liver363T (mRNA expression)', 'description': 'liver cancer HBV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 363T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: poorly differentiated;\tgender: M;\tage: 64;\tvirus: HBV'}"
1441,"{'title': 'DM2_F43_VL_09', 'description': 'DM2 patient, age 43, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Vastus Lateralis'}"
1442,"{'title': 'Septic Shock_biological rep8 01-0030', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.6;\toutcome: Survivor;\tgroup: C'}"
1443,"{'title': 'siGL-1', 'description': 'PLC/PRF/5 were transfected in triplicate with WT1 specific siRNAs (siWT) and siRNAs control (siGL)', 'type': 'RNA', 'source_name_ch1': 'PLC/PRF/5 cells transfected with the siRNA control duplex siGL', 'characteristics_ch1': 'Human hepatoma cell line'}"
1444,"{'title': 'DietSensitive _6 weeks_subject10', 'description': 'DietSensitive _6 weeks_subject10', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 10;\tgender: Male'}"
1445,"{'title': 'GA_925', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
1446,"{'title': 'S107', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S107', 'characteristics_ch1': 'patient id: P054;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 5'}"
1447,"{'title': 'mRNA of GBV-HGG083, Glioblastoma variant, 8 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 8 years', 'characteristics_ch1': 'disease: Glioblastoma variant;\tage: 8 years'}"
1448,"{'title': 'AML 2688', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 40 years;\tscore: FAB unknown;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1449,"{'title': 'Control_biological rep14', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 2.3;\toutcome: Survivor'}"
1450,"{'title': 'Bronchial epithelial cells, day 0, donor 2', 'description': 'Bronchial epithelial cells, day 0, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 0, the first day of air-liquid interface culture'}"
1451,"{'title': 'class S, rep68', 'description': 'VAN_00482.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 28;\tsex: M;\tdisease stage: 2;\talbumin level: 48;\themoglobin level: 148;\tlymphocyte percentage: 15;\twhite blood count: 7.7;\tinternational prognostic score (ips): 2'}"
1452,"{'title': 'bladder_control_pool-1', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Normal bladder tissue', 'characteristics_ch1': 'Tissue extracted resecting a bladder area using scissors.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 4 individual samples.'}"
1453,"{'title': 'NSCLC_SCC_55', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 55.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
1454,"{'title': 'PCSC-2 parental biol repl 1', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-2 parental cultures in PCSCs medium', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-2;\tculture type: adherent'}"
1455,"{'title': 'GBM, TMZ/radiotherapy (57)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 57;\tage: 52.8;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 36.45;\tmgmt status: M'}"
1456,"{'title': 'C98395', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6610_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 55;\tcytogenetic change: inv(16)(p13q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1457,"{'title': 'PB34_iPS2_2', 'description': 'Gene expression data obtained from PB CD34+ blood iPS', 'type': 'RNA', 'source_name_ch1': 'iPS', 'characteristics_ch1': 'cell type: iPS cells;\tiPS derived from: PB CD34+ blood'}"
1458,"{'title': 'MDS patient 177', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: other'}"
1459,"{'title': 'Blood Sample of subject 42 before inhalation; Group A', 'description': 'Bl_Group_A_BI_subject_42', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 42;\tgroup: A'}"
1460,"{'title': 'T183 U133p2', 'description': 'bulk breast tumor RNA from patient T183', 'type': 'RNA', 'source_name_ch1': 'T183', 'characteristics_ch1': 'breast tumor'}"
1461,"{'title': 'Blood sample from patient 123 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 123;\tday: Day 1;\tage (years): 57;\tsex: Male'}"
1462,"{'title': 'Pilocytic astrocytoma chip 7756', 'description': 'Pilocytic astrocytoma.  Chip ID 7756', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
1463,"{'title': 'Gingival tissue sample 4 from patient 42, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 42 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1464,"{'title': 'hf240-NS-C', 'description': 'U133Plus2_122906L_DK13.CEL', 'type': 'RNA', 'source_name_ch1': 'human foetal cortex derived NS cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: non-malignant;\tcell type: cell line;\tcell type: neural stem'}"
1465,"{'title': '01-0053A_Septic Shock_day1_55', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1466,"{'title': 'HF0813_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
1467,"{'title': 'Gingival tissue sample 2 from patient 43, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 43 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1468,"{'title': '5352', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 70 years, FAB M2, cytogenetic intermediate risk, CEBPA double mutant'}"
1469,"{'title': 'GBM, TMZ/radiotherapy (1357)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1357;\tage: 35.9;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 28.22;\tmgmt status: M'}"
1470,"{'title': 'Replicate 2 for MCF7mimic breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 mir-221/222 mimic at 18h'}"
1471,"{'title': 'Replicate 1 for BT5491 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
1472,"{'title': 'Control (dupl) sample 4a', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
1473,"{'title': 'CD34+CD45RA+Lin- HPCs overexpressing A2M cultured onto 5 µg of Delta1ext-IgG', 'description': 'BCE_06;\tGene expression data from Notch-activated (5 µg) cells transduced with A2M lentiviral vector', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA-Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: hematopoietic progenitors;\tgenotype/variation: transduced with A2M;\ttreatment group: Notch-activated (5 µg)'}"
1474,"{'title': 'AML 6359', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 53 years;\tscore: RAEB-t;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: MDS complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1475,"{'title': '22093', 'description': '11855', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24326;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
1476,"{'title': 'HF1348_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
1477,"{'title': 'pU62_C', 'description': 'Gene expression data from control cell line', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma cell line Hep3B cells, plasmid pU6, clone 2', 'characteristics_ch1': 'Hep3B cells stably transfected with short hairpin vectors (plasmid pU6 is the host vector);\tHep3B cells stably transfected with plasmid pU6, clone 2, replicate 3'}"
1478,"{'title': 'human BM MSC BMP2 stimulated day 7 rep 2', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 7', 'type': 'RNA', 'source_name_ch1': 'donor 2, stimulated with BMP2 for 7 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 7 days'}"
1479,"{'title': 'Blood sample from patient 135 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 135;\tday: Day 180;\tage (years): 58;\tsex: Male'}"
1480,"{'title': 'C128', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 1.8'}"
1481,"{'title': 'patient Post ECP, biological rep4', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'GVHD patient Post ECP', 'characteristics_ch1': 'disease state: graft-versus host disease;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
1482,"{'title': 'NSCLC_SCC_215', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 215.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
1483,"{'title': 'IFNβ_835', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
1484,"{'title': 'RTX11 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: F;\tage (y): 47;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Poor-responder;\ttissue: synovium'}"
1485,"{'title': 'ALCL_006', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
1486,"{'title': 'ci_NY30', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
1487,"{'title': 'Blood - Axial Spondyloarthropathy - 152A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 63;\tset: 2;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
1488,"{'title': 'Mature WEEV infected biological replicate 2 (WEEV)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: WEEV 6h;\tcell line: BE(2)-C'}"
1489,"{'title': 'DLBCL biopsy, sample 2073', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
1490,"{'title': 'B66', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: B;\tage: 55;\tSex: M;\tcode: resection;\tclass: Proliferation;\tafp: 332;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
1491,"{'title': 'Cell line HB4a_DRC_1', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
1492,"{'title': '3491', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 72 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type'}"
1493,"{'title': 'C98520', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6611_Tumor;\tfab: M4;\tSex: F;\trace: C;\tage on study: 39;\tcytogenetic change: trisomy 21; + 22;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1494,"{'title': 'DietResistant _1 day_subject10', 'description': 'DietResistant _1 day_subject10', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 10;\tgender: Male'}"
1495,"{'title': 'SG-91B_phenotype of EPC colony assay', 'description': 'EPC sampled from blood and cultured', 'type': 'RNA', 'source_name_ch1': 'cultured EPC, after 3 months of exercise', 'characteristics_ch1': 'after 3 months of exercise'}"
1496,"{'title': 'AML 2751', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 31 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Pos;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1497,"{'title': 'X94099', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 3'}"
1498,"{'title': 'HF1409_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1499,"{'title': 'GBM, TMZ/radiotherapy (356bis)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 356;\tage: 32.4;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 6.94;\tmgmt status: U'}"
1500,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 16', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
1501,"{'title': 'S056', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S056', 'characteristics_ch1': 'patient id: P080;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 80'}"
1502,"{'title': 'Gingival tissue sample 3 from patient 13, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 13 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
1503,"{'title': 'AML sample #58', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
1504,"{'title': 'Thyroid_ unaffected_paired with PTC67T', 'description': 'sample name in manuscript: N-PTC5', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: normal thyroid; Gender:female; Age:43'}"
1505,"{'title': 'Angioimmunoblastic T-cell lymphoma 19', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-31', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 74;\tgender: male'}"
1506,"{'title': 'AML 7174', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 26 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1507,"{'title': 'platelet_Ctrl_6', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
1508,"{'title': 'Muscle-FamilyHistoryNegative-14', 'description': 'Jos3782;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 50;\tfamily history: Family history negative;\tbody mass index (kg/m2): 25;\tfasting glucose (ogtt): 84;\t2 hour glucose (ogtt): 65;\themoglobin a1c: 5.4;\tfasting glucose (iv0gavg): 93;\tfasting insulin (iv0inavg): 5.3;\tsi: 4.67;\twaist hip ratio: 0.929'}"
1509,"{'title': 'Training_Site4_07', 'description': 'Performed by Operator 1 from Site4 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
1510,"{'title': 'Cervical cancer-lymph node negative-17-52', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 31.5;\tfigo stage: 1b1'}"
1511,"{'title': 'N8514B4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1512,"{'title': 'T41027_rep', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 41027;\tsample: tumor'}"
1513,"{'title': 'X23162', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1514,"{'title': 'class S, rep50', 'description': 'VAN_00411.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 27;\tsex: M;\tdisease stage: 2;\talbumin level: 38;\themoglobin level: 130;\tlymphocyte percentage: 12;\twhite blood count: 13;\tinternational prognostic score (ips): 3'}"
1515,"{'title': 'Gingival tissue sample 2 from patient 77, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 77 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1516,"{'title': 'N8706L4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1517,"{'title': 'S141', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S141', 'characteristics_ch1': 'patient id: P021;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
1518,"{'title': 'ALL without MLL - sample 68', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1519,"{'title': 'JS42Nb', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1442;\tdisease state: Uninfected;\tgender: Female;\tage: 45;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 485;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
1520,"{'title': 'Cell line HepG2(b)', 'description': 'Gene expression data  for cell line', 'type': 'RNA', 'source_name_ch1': 'cell line', 'characteristics_ch1': 'Tissue: liver'}"
1521,"{'title': 'breast tumor 3', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to breast invasive tumor', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: tumor'}"
1522,"{'title': 'AML 7315', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 45 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1523,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R19', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 55.60;\t%cd3cd8: 39.31;\t%cd8+cd28-: 12.78;\t%cd8+cd28+: 12.73;\t%cd4cd25cd62l: 4.15;\t%cd3delta1: 4.93;\t%cd3delta2: 1.68;\tratio delta1/delta2: 2.93;\t%cd3gammadelta: 6.75;\t%cd3alphabeta: 76.41;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: 45.82;\t%cd4 cd62l-cd45+: 1.09;\t%cd4 cd62l - cd45-: 16.34;\t%cd4cd62l+cd45-: 36.75;\t%cd4 ccr7+ cd45 -: 28.90;\t%cd4 ccr7+ cd45+: 46.24;\t%cd4 ccr7 - cd45+: 1.84;\t%cd4 ccr7 – cd45-: 23.02;\t%cd8 cd62l+ cd45-: 16.53;\t%cd8cd62l+ cd45+: 19.34;\t%cd8cd62l- cd45+: 35.99;\t%cd8cd62l- cd45 -: 28.14;\t%cd8ccr7+ cd45-: 3.90;\t%cd8ccr7+ cd45+: 11.45;\t%cd8ccr7-cd45+: 44.86;\t%cd8ccr7-cd45 -: 39.79;\t%cd3-cd56+cd16+: 0.94;\t%nkts: 4.06;\t%cd19: 6.02;\t%cd4foxp3+: 3.50'}"
1524,"{'title': 'colonic_mucosa_inflamation_93', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible'}"
1525,"{'title': 'Proficiency_Site2_19', 'description': 'Performed by Operator 1 from Site2 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 42.66; Lot# = 035PO41658D'}"
1526,"{'title': 'mRNA of GBV-HGG048, Glioblastoma variant, 3.6 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 3.6 years', 'characteristics_ch1': 'disease: Glioblastoma variant;\tage: 3.6 years'}"
1527,"{'title': 'Gingival tissue sample 1 from patient 62, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 62 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1528,"{'title': 'newly diagnosed multiple myeloma 243', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
1529,"{'title': 'normal_colon_101 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: male;\tprotocol: surgery;\tage: 77;\tlocalization: caecum'}"
1530,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 9', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
1531,"{'title': '22036', 'description': '11703', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24251;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
1532,"{'title': 'AML with normal karyotype #160', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 65;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 85.5;\tdisease state: de novo AML'}"
1533,"{'title': 'HF0232_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
1534,"{'title': 'Patient 3446 AML31', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 31;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1535,"{'title': 'S137', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S137', 'characteristics_ch1': 'patient id: P122;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
1536,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
1537,"{'title': 'Monocyte High PBM 13', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 13'}"
1538,"{'title': 'Transfection Reagent Only Technical Replicate 2', 'description': 'transfection reagent only', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: Transfection Reagent;\tcell line: MCF7'}"
1539,"{'title': 'Tumor Tum_Ph2_rep1', 'description': 'not paired', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N0;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
1540,"{'title': 'AML 5285', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 59 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1541,"{'title': 'B31', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: B;\tage: 52;\tSex: M;\tcode: resection;\tclass: Unannotated;\tafp: 175;\ttp53 mutation: 0;\tctnnb1 mutation: 239G>GT,p.G34G/V;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
1542,"{'title': '95014', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
1543,"{'title': 'N30162_rep', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30162;\tsample: normal'}"
1544,"{'title': 'AML with normal karyotype #215', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 59;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 18;\tdisease state: de novo AML'}"
1545,"{'title': 'HF0434_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
1546,"{'title': 'EC control 2', 'description': 'arrayconsortium.tgen.org::biosample.433901;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 2;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 85 years'}"
1547,"{'title': 'IFNβ_1093', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
1548,"{'title': 'carcinoma_99 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 69;\tlocalization: ascending'}"
1549,"{'title': 'Group B1-IVIG-Post-2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: post-treatment'}"
1550,"{'title': 'mRNA of IBT-HGG081, Anaplastic PXA, 19 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 19 years', 'characteristics_ch1': 'disease: Anaplastic PXA;\tage: 19 years'}"
1551,"{'title': 'Patient_5978_diagnosis', 'description': '5978D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pro-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 8;\tconclusions ig/tcr: unstable;\tselected: yes'}"
1552,"{'title': 'SH-SY5Y(ECACC)_BDNF_2d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
1553,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
1554,"{'title': 'X34172', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1555,"{'title': 'CLL cells  LN patient #26', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #26'}"
1556,"{'title': 'N10608K2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1557,"{'title': 'e_M45B', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
1558,"{'title': 'B81', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.5'}"
1559,"{'title': 'AML 2480', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 34 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1560,"{'title': 'UCR7_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
1561,"{'title': 'Liver360N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HCV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 360N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: Chronic hepatitis;\tgender: M;\tage: 66;\tvirus: HCV'}"
1562,"{'title': 'KT0636_0_L_training', 'description': 'KT0636_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, training set'}"
1563,"{'title': 'B68', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Lobular;\ttumor size: 3.5'}"
1564,"{'title': 'AML sample #88', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
1565,"{'title': 'P_CD4_6', 'description': 'PS6 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Positive Selection', 'characteristics_ch1': 'age: 44;\tgender: Female;\tt_cell_purity: 96.30%'}"
1566,"{'title': 'CD19_selected_B-cells_after_R_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after Rituximab'}"
1567,"{'title': 'Donor 1 - LTD4 stimulated', 'description': 'Elutriated monocytes from donor 1 treated with LTD4 for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes stimulated with LTD4 (100nM) for 30 min.'}"
1568,"{'title': 'HF0244_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1569,"{'title': 'Sputum from Stage II Moderate, biological replicate 37', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 54;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
1570,"{'title': 'newly diagnosed multiple myeloma 302', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: None;\tiss: I'}"
1571,"{'title': 'hg_NY58', 'description': 'high-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; high-grade dysplastic liver tissue', 'characteristics_ch1': 'high-grade dysplastic liver tissue'}"
1572,"{'title': 'Blood Sample of subject 45 before inhalation; Group A', 'description': 'Bl_Group_A_BI_subject_45', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 45;\tgroup: A'}"
1573,"{'title': 'C98110', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6617_Tumor;\tfab: M4;\tSex: F;\trace: C;\tage on study: 43;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
1574,"{'title': 'whole blood_101062', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism with regression, Male', 'characteristics_ch1': 'Autism with regression, Male'}"
1575,"{'title': 'High TCF activity Huh7_S33Y#2', 'description': 'Replicates were done by using the same total RNA preparation', 'type': 'RNA', 'source_name_ch1': 'Huh7 stably expressing S33Y beta-catenin', 'characteristics_ch1': 'Huh7 stably expressing S33Y beta-catenin'}"
1576,"{'title': 'AML 6881', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 37 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1577,"{'title': 'papillary renal cell cancer; pRCCb_HD38a', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
1578,"{'title': 'NSG010', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.2;\tdisease activity (das28_v3): 1.73;\tresponse to anti-tnf therapy: RESPONSE'}"
1579,"{'title': 'whole blood_101644', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Male', 'characteristics_ch1': 'General population, Male'}"
1580,"{'title': 'GA_513', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1581,"{'title': 'N8671B4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1582,"{'title': 'B55', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.5'}"
1583,"{'title': 'SK-N-SH_BDNF_3d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
1584,"{'title': 'Pt20 whole pericardial adipose tissue, biological rep1', 'description': 'Pt20_PCAT', 'type': 'RNA', 'source_name_ch1': 'Whole pericardial adipose tissue, patient 20', 'characteristics_ch1': 'tissue: whole pericardial adipose tissue;\tpatient: 20'}"
1585,"{'title': 'Monocyte Low PBM 2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 2'}"
1586,"{'title': 'S108', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S108', 'characteristics_ch1': 'patient id: P102;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 65'}"
1587,"{'title': 'B cell donor 1, control', 'description': 'Cells treated with DMSO vehicle control', 'type': 'RNA', 'source_name_ch1': 'MACS purified resting B cells from healthy donor peripheral blood', 'characteristics_ch1': 'B cell donor 1, control'}"
1588,"{'title': 'MCF10A cells cocultured with normal breast fibroblasts that extracted from normal breast tissue sample No 16', 'description': 'gene expression data from MCF10A cells cocultured with breast fibroblasts', 'type': 'RNA', 'source_name_ch1': 'MCF10A cells', 'characteristics_ch1': 'cell line, normal mammary epithelium, immortalized'}"
1589,"{'title': 'csc-aza-2', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tDemethylation: aza;\tReplicate: 2'}"
1590,"{'title': 'siGL-2', 'description': 'PLC/PRF/5 were transfected in triplicate with WT1 specific siRNAs (siWT) and siRNAs control (siGL)', 'type': 'RNA', 'source_name_ch1': 'PLC/PRF/5 cells transfected with the siRNA control siGL', 'characteristics_ch1': 'Human hepatoma cell line'}"
1591,"{'title': 'Bleomycin-treated rep2', 'description': 'BJ fibroblasts artificially-aged', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Human foreskin BJ fibroblasts;\t100ug/ml of bleomycin sulfate for 24hr, 72 serum-free incubation in 3% O2'}"
1592,"{'title': 'K_STA7', 'description': 'K_STA7', 'type': 'RNA', 'source_name_ch1': 'STA7 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
1593,"{'title': 'normal liver 1', 'description': 'total RNA isolated from normal liver of stage D colorectal carcinoma patient 1', 'type': 'RNA', 'source_name_ch1': 'normal liver from stage D colorectal carcinoma patient 1', 'characteristics_ch1': 'tissue: liver;\ttumor stage of patient: stage D'}"
1594,"{'title': 'CD31+ rep3 (endothelial study)', 'description': 'endothelial cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD31+ MACS sorted cells'}"
1595,"{'title': '01-0055B_Septic Shock_day3_58', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1596,"{'title': 'MLD AML sample #9', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
1597,"{'title': 'GBM, radiotherapy (218)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 218;\tage: 48.3;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 16.25;\tmgmt status: M'}"
1598,"{'title': 'Ultrafine particle exposure 2 -baseline', 'description': 'Gene expression data from circulating mononuclear cells before exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells before exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: UFP;\ttime: 0 hour'}"
1599,"{'title': 'Muscle-FamilyHistoryPositive-1', 'description': 'Jos3690;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 45;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 36;\tfasting glucose (ogtt): 91.5;\t2 hour glucose (ogtt): 106;\themoglobin a1c: 5;\tfasting glucose (iv0gavg): 96;\tfasting insulin (iv0inavg): 4.6;\tsi: 9.64;\twaist hip ratio: 0.836'}"
1600,"{'title': 'Pt7 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt7_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 7', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 7'}"
1601,"{'title': 'AML 6717', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 58 years;\tscore: FAB M5;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1602,"{'title': 'C95318', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6703_Tumor;\tfab: M2;\tSex: F;\trace: C;\tage on study: 49;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1603,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 15', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
1604,"{'title': 'Monocyte Low PBM 8', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 8'}"
1605,"{'title': 'B5', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 2.6'}"
1606,"{'title': 'HF0184_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1607,"{'title': 'group-1-pt-t11706353', 'description': 'group-1-pt-t11706353', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 21;\tgender: male;\tfinal disposition: 06: Home'}"
1608,"{'title': 'AML 7410', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 57 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1609,"{'title': 'THP-1 control, biological rep1', 'description': 'Gene expression data from THP-1 cells after incubated with PBS for 3 hours', 'type': 'RNA', 'source_name_ch1': 'THP-1 cells with PBS,3 hours', 'characteristics_ch1': 'cell type: monocyte;\tcell line: THP-1;\tgrowth properties: suspension;\tinfected with bacterial strain: Streptcoccus suis 2 strain SC19'}"
1610,"{'title': 'adipose_postTZD_IRd-_s6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 6'}"
1611,"{'title': 'PTCL.BO.03', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
1612,"{'title': 'Lung Cancer 143T', 'description': 'Gene expression data from 143T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 59;\tstage: 1B'}"
1613,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R4', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 51.52;\t%cd3cd8: 44.58;\t%cd8+cd28-: 22.20;\t%cd8+cd28+: 6.07;\t%cd4cd25cd62l: 4.16;\t%cd3delta1: 1.53;\t%cd3delta2: 1.27;\tratio delta1/delta2: 1.2;\t%cd3gammadelta: 3.09;\t%cd3alphabeta: 94.14;\t%cd4cd8-ab+(dn): 1.69;\t%cd4 cd62l+cd45+: 16.38;\t%cd4 cd62l-cd45+: 8.03;\t%cd4 cd62l - cd45-: 40.28;\t%cd4cd62l+cd45-: 35.31;\t%cd4 ccr7+ cd45 -: 17.06;\t%cd4 ccr7+ cd45+: 13.42;\t%cd4 ccr7 - cd45+: 10.65;\t%cd4 ccr7 – cd45-: 58.86;\t%cd8 cd62l+ cd45-: 13.07;\t%cd8cd62l+ cd45+: 18.75;\t%cd8cd62l- cd45+: 47.27;\t%cd8cd62l- cd45 -: 20.89;\t%cd8ccr7+ cd45-: 1.77;\t%cd8ccr7+ cd45+: 5.71;\t%cd8ccr7-cd45+: 59.28;\t%cd8ccr7-cd45 -: 33.24;\t%cd3-cd56+cd16+: 69.63;\t%nkts: 5.42;\t%cd19: 2.22;\t%cd4foxp3+: 5.60'}"
1614,"{'title': 'MDS patient 56', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
1615,"{'title': 'group-2-pt-t2113833', 'description': 'group-2-pt-t2113833', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 33;\tgender: male;\tfinal disposition: 06: Home'}"
1616,"{'title': 'Patient C04, control kidney from nephrectomy', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C04, Sex: male, Age of patient: 28, Serum creatinine: 75 microMol/L, Control kidney sample  from nephrectomy'}"
1617,"{'title': 'HF1511_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 2'}"
1618,"{'title': '2 Monocyte', 'description': 'Gene expression data from freshly isolated monocytes', 'type': 'RNA', 'source_name_ch1': 'Freshly isolated monocytes', 'characteristics_ch1': 'donor: 2;\ttissue: monocyte;\tactivation: None;\ttreatment: None;\ttime: 0h'}"
1619,"{'title': 'newly diagnosed multiple myeloma 141', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: II'}"
1620,"{'title': 'Control TC3', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
1621,"{'title': 'Huh7 cells treated with Normal HDL, biological rep 1', 'description': 'Gene expression data from Huh7 cells treated with HDL from Normal or FH subjects in lipoprotein-depleted serum.', 'type': 'RNA', 'source_name_ch1': 'Human Huh7 cells, in culture', 'characteristics_ch1': 'cell line: Huh7;\ttreatment: normal HDL'}"
1622,"{'title': 'adenocarcinoma_46 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 55;\tlocalization: rectum'}"
1623,"{'title': 'AML with normal karyotype #168', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 59;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 89;\tdisease state: de novo AML'}"
1624,"{'title': 'Lung Cancer 17T', 'description': 'Gene expression data from 17T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 55;\tstage: 2B'}"
1625,"{'title': 'Treg THU d3', 'description': 'Treg THU d3', 'type': 'RNA', 'source_name_ch1': 'Treg THU d3', 'characteristics_ch1': 'genetic modification:;\ttissue: T-cells'}"
1626,"{'title': 'Adrenocortical adenoma with CTNNB1 mutation_(S37C)', 'description': 'Gene expression profile of an adrenocortical adenoma  with a T41A CTNNB1 mutation', 'type': 'RNA', 'source_name_ch1': 'M AA S37C', 'characteristics_ch1': 'tissue: Adrenocortical adenoma;\ttumor secretion profile: Cortisol;\tgenotype: CTNNB1 mutation (S37C)'}"
1627,"{'title': 'Sputum from Stage IV Severe, biological replicate 3', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 72;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
1628,"{'title': 'group-1-pt-t17649932', 'description': 'group-1-pt-t17649932', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 41;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
1629,"{'title': 'Pilocytic astrocytoma chip 8033', 'description': 'Pilocytic astrocytoma.  Chip ID 8033', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
1630,"{'title': 'NZK23', 'description': 'early metastatic primary clear-cell renal cell carcinoma, batch 2', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: female;\ttumor stage (uicc 2002): pT2;\tlymph node status: N0;\tinitial distant metastases: M1;\ttumor grade: G2;\tdfs/follow-up: DFS = 0 months;\tlocalisation of metastases: skin'}"
1631,"{'title': 'DM1_??_?_09', 'description': 'DM1 patient, age unknown, gender Unknown', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM1 patient;\tbiopsy site:  unknown'}"
1632,"{'title': '01_0025_SepticShock_Day3_115', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0025_Patient, Day3'}"
1633,"{'title': 'Healthy control 8', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
1634,"{'title': 'NB1', 'description': '171104-10.CEL', 'type': 'RNA', 'source_name_ch1': 'Normal Breast', 'characteristics_ch1': 'center: IPC;\ttype: --;\tage of diagnosis (year): --;\tmolecular subtype: --;\thistology: --;\tpt: --;\tpn: --;\tgrade sbr: --;\terbb2 ihc status: --;\ter ihc status: --;\tpr ihc status: --;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: --;\terbb2.tab ihc status: --;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: --;\ttop2a ihc status: --;\tfoxa1 ihc status: --;\tmfs: --;\tmfsdel (month): --'}"
1635,"{'title': 'Patient 5063 AML192', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 192;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
1636,"{'title': 'Subcutaneous adipose tissue, SAT26', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
1637,"{'title': 'Lung siTUG1 Replicate1', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siTUG1;\treplicate: 1'}"
1638,"{'title': 'AML without MLL - sample 95', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1639,"{'title': '501944', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7509_Tumor;\tfab: M3;\tSex: F;\trace: W;\tage on study: 40;\tcytogenetic change: t(15;17)(q22;q21); trisomy 8;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1640,"{'title': 'Gingival tissue sample 1 from patient 38, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 38 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1641,"{'title': 'Liver359N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HCV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 359N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: LC;\tgender: M;\tage: 51;\tvirus: HCV'}"
1642,"{'title': 'CRCB02', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CRC-B'}"
1643,"{'title': 'newly diagnosed multiple myeloma 130', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
1644,"{'title': 'mRNA of GBM-HGG027, Glioblastoma, 9.7 years, Post-ALL', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 9.7 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 9.7 years; Other: Post-ALL'}"
1645,"{'title': 'AML with normal karyotype #164', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 44;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 23;\tdisease state: t-AML'}"
1646,"{'title': 'non-pCR breast biopsy, sample 13 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 13 rep 2', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
1647,"{'title': 'MDS patient 175', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
1648,"{'title': 'HF0899_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
1649,"{'title': 'cord blood 21_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.66', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.66;\t'}"
1650,"{'title': 'GA_2153', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1651,"{'title': 'AML 2687', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1652,"{'title': 'C182', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 3.5'}"
1653,"{'title': 'neuron_rep5', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:44, gender:female, diagnostic group: schizophrenia, PMI:26h'}"
1654,"{'title': 'Invasive cancer originating in IPMN 2', 'description': 'Gene expression data from microdissected epithelial cells of invasive cancer originating in IPMN', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from invasive cancer originating in IPMN 2', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous neoplasm (IPMN)'}"
1655,"{'title': 'Patient 4401 AML78', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 78;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1656,"{'title': 'Gingival tissue sample 4 from patient 56, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 56 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
1657,"{'title': 'Tumor 43', 'description': '07SE540', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
1658,"{'title': 'UNTREATED_779', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1659,"{'title': 'BC9934', 'description': '080306.24.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 68;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: --;\tpn: --;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: pos;\tigf1r ihc status: neg;\tegfr ihc status: pos;\ttop2a ihc status: pos;\tfoxa1 ihc status: pos;\tmfs: 0;\tmfsdel (month): 1.74'}"
1660,"{'title': 'endothelial_rep16', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:34, gender:male, diagnostic group: control, PMI:22h'}"
1661,"{'title': 'class F, rep26', 'description': 'VAN_00266f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 25;\tsex: M;\tdisease stage: 4;\talbumin level: _;\themoglobin level: 118;\tlymphocyte percentage: 13;\twhite blood count: 10.1;\tinternational prognostic score (ips): 3.5'}"
1662,"{'title': '1924 - mAdbID:68951', 'description': 'mAdb experiment ID: 68951', 'type': 'RNA', 'source_name_ch1': '1924', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1924;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 6.11;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
1663,"{'title': 'VA137', 'description': '03-20981', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 80;\tgender: F;\tipi_stage: 1A;\ttxprimary: CHOP(CEOP)1-RITU;\tstatus: death unrelated;\tcode_os: dead;\tcode_pfs: alive;\toverall_survival (years): 3.20;\tprogression-free_survival (years): 3.20'}"
1664,"{'title': 'LPS II BEAS 2b_ML02', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - LPS', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
1665,"{'title': 'PGA_PA-D_85', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
1666,"{'title': 'Patient 4527 AML112', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 112;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1667,"{'title': 'Undifferentiated HepaRG, biological replicate 1', 'description': 'Undif1', 'type': 'RNA', 'source_name_ch1': 'Undifferentiated elongate HepaRG', 'characteristics_ch1': 'cell line: HepaRG;\tdifferentiation state: undifferentiated;\tgender: female'}"
1668,"{'title': 'K_STA3', 'description': 'K_STA3', 'type': 'RNA', 'source_name_ch1': 'STA3 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
1669,"{'title': 'cord blood 4', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.17', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.17;\t'}"
1670,"{'title': 'IFNβ_1481', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1671,"{'title': 'Lung Normal 97N', 'description': 'Gene expression data from 97N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 69;\tstage: n/a'}"
1672,"{'title': 'CLL_FISHnormal_rep10', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'male'}"
1673,"{'title': '11-0050A_Sepsis_day1_180', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1674,"{'title': 'Patient 3435 AML23', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 23;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1675,"{'title': 'Spleen_control_S5', 'description': 'Spleen control S5', 'type': 'RNA', 'source_name_ch1': 'normal spleen sample', 'characteristics_ch1': 'tissue: normal spleen'}"
1676,"{'title': 'BC12851', 'description': '080115.11.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 34;\tmolecular subtype: ERBB2;\thistology: other;\tpt: pT1;\tpn: neg;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: pos;\tigf1r ihc status: --;\tegfr ihc status: pos;\ttop2a ihc status: pos;\tfoxa1 ihc status: neg;\tmfs: 0;\tmfsdel (month): 40.94'}"
1677,"{'title': 'conventional renal cell cancer; cRCCa_HD34', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
1678,"{'title': 'SH-SY5Y(ECACC)_RA_2d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
1679,"{'title': 'PGA_PA-D_132', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
1680,"{'title': 'AML 2188', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 51 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1681,"{'title': 'Sepsis gram-negative V16', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
1682,"{'title': 'X70049', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1683,"{'title': 'AML 7067', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 42 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1684,"{'title': 'mRNA of GBM-HGG084, Glioblastoma, 1 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 1 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 1 years'}"
1685,"{'title': '994 - mAdbID:68950', 'description': 'mAdb experiment ID: 68950', 'type': 'RNA', 'source_name_ch1': '994', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 994;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 4.78;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
1686,"{'title': 'GBM, TMZ/radiotherapy (1284)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1284;\tage: 48.2;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 46.55;\tmgmt status: M'}"
1687,"{'title': 'B91', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.1'}"
1688,"{'title': 'ADLGD03', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Adenoma with low-grade dysplasia'}"
1689,"{'title': 'N7619A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1690,"{'title': 'Normal Control C-3a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Control C-3a', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
1691,"{'title': 'X51068', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IA;\tConsolidated.Grade : 1'}"
1692,"{'title': 'siGL-3', 'description': 'PLC/PRF/5 were transfected in triplicate with WT1 specific siRNAs (siWT) and siRNAs control (siGL)', 'type': 'RNA', 'source_name_ch1': 'PLC/PRF/5 cells transfected with the siRNA control siGL', 'characteristics_ch1': 'Human hepatoma cell line'}"
1693,"{'title': 'Control_biological rep32 15-0005', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0;\toutcome: Survivor;\tgroup: n/a'}"
1694,"{'title': 'MERLION_X02K00985', 'description': 'MERLION_X02K00985', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=42, state=0', 'characteristics_ch1': 'pT2N0, male, age=42, state=0'}"
1695,"{'title': 'Cell line C5.2_DR_3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
1696,"{'title': 'Donor liver T0-10', 'description': 'Gene expression data from a frozen liver biopsy obtained from a brain dead donor during explantation', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from donor liver', 'characteristics_ch1': 'tissue: donor liver;\tdonor: brain dead donor;\tage: 83 years;\tgender: female'}"
1697,"{'title': 'class S, rep25', 'description': 'VAN_00164.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 13;\tsex: M;\tdisease stage: 1;\talbumin level: _;\themoglobin level: 142;\tlymphocyte percentage: 50;\twhite blood count: 6.8;\tinternational prognostic score (ips): 2.3'}"
1698,"{'title': 'Donor5_24h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 5 treated with Wy14643 for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 5;\tagent: Wy14643;\ttime: 24h;\tgender: Male;\tage: 73 years old'}"
1699,"{'title': 'COL2_711', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 71;\tgender: M;\tlocalisation: Right;\tmetastasis: LIVER;\tfirst apc mutation: 1554;\tsecond apc mutation: 0;\t5q loh: 0'}"
1700,"{'title': 'CD04', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CD'}"
1701,"{'title': 'AP760a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1476;\tdisease state: Uninfected;\tgender: Female;\tage: 28;\trace: Hispanic;\tblood cd4+ t  cell count (cells/ml): 704;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
1702,"{'title': 'Sample 8: epithelial ovarian cancer', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'epithelial ovarian cancer', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: Cancer'}"
1703,"{'title': 'T37 U133p2', 'description': 'bulk breast tumor RNA from patient T37', 'type': 'RNA', 'source_name_ch1': 'T37', 'characteristics_ch1': 'breast tumor'}"
1704,"{'title': 'Sputum from Stage II Moderate, biological replicate 30', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 64;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
1705,"{'title': 'AML 2235', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1706,"{'title': 'PTCL.BO.02', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
1707,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R36', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 53.90;\t%cd3cd8: 31.61;\t%cd8+cd28-: 4.98;\t%cd8+cd28+: 18.36;\t%cd4cd25cd62l: 1.88;\t%cd3delta1: 0.92;\t%cd3delta2: 6.3;\tratio delta1/delta2: 0.15;\t%cd3gammadelta: 6.96;\t%cd3alphabeta: 78.38;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: 32.26;\t%cd4 cd62l-cd45+: 0.14;\t%cd4 cd62l - cd45-: 17.47;\t%cd4cd62l+cd45-: 50.13;\t%cd4 ccr7+ cd45 -: 35.70;\t%cd4 ccr7+ cd45+: 32.51;\t%cd4 ccr7 - cd45+: 0.67;\t%cd4 ccr7 – cd45-: 31.12;\t%cd8 cd62l+ cd45-: 30.22;\t%cd8cd62l+ cd45+: 34.03;\t%cd8cd62l- cd45+: 3.81;\t%cd8cd62l- cd45 -: 31.94;\t%cd8ccr7+ cd45-: 4.83;\t%cd8ccr7+ cd45+: 31.92;\t%cd8ccr7-cd45+: 6.34;\t%cd8ccr7-cd45 -: 56.91;\t%cd3-cd56+cd16+: 41.65;\t%nkts: 5.01;\t%cd19: 6.20;\t%cd4foxp3+: 6.14'}"
1708,"{'title': 'untreated: m2: i1: d07', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 2; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 2;\tReplicate: 1;\tBatch: d07'}"
1709,"{'title': 'HF0212_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1710,"{'title': 'TS35a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 42;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 663;\tplasma hiv-1 rna levels (copies/ml): 100,000'}"
1711,"{'title': 'Gingival tissue sample 3 from patient 55, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 55 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
1712,"{'title': '11-0001_SIRS resolved_day3_143', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1713,"{'title': 'HF1334_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
1714,"{'title': 'newly diagnosed multiple myeloma 168', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
1715,"{'title': 'AML 6724', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 26 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1716,"{'title': 'AML 2186', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 39 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
1717,"{'title': 'Adrenocortical adenoma with CTNNB1 mutation (T41A)', 'description': 'Gene expression profile of  an adrenocortical adenoma  with a  S37C  CTNNB1 mutation', 'type': 'RNA', 'source_name_ch1': 'M AA T41A', 'characteristics_ch1': 'tissue: Adrenocortical adenoma;\ttumor secretion profile: Aldosterone;\tgenotype: CTNNB1 mutation (T41A)'}"
1718,"{'title': 'AML sample #84', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
1719,"{'title': 'AML sample #96', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
1720,"{'title': 'Normal Control C-7a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Normal Control C-7a', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
1721,"{'title': 'HF1494_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1722,"{'title': 'NLPHL_lymph_node_case2', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: female, Age: 71, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, An Arbor Stage: IIIB, follow-up: 5 years; status at last follow-up: alive with disease""}"
1723,"{'title': '01_0019_SepticShock_Day1_120', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0019_Patient, Day1'}"
1724,"{'title': 'untreated: m2: i2: d07', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 2; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 2;\tReplicate: 2;\tBatch: d07'}"
1725,"{'title': 'AML 2665', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 45 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: t(6;9);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1726,"{'title': 'Scz-1', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tS1', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness-schizophrenia;\tSex: M;\tage: 38;\ttissue ph: 6.02;\tpmi (hrs): 50;\ttype of drug: Haloperidol, Chlorpromazine, Clozapine;\tdrug dose (chlorpromazine equivalents): 50 mg'}"
1727,"{'title': 'AML with normal karyotype #231', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 28;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 85;\tdisease state: de novo AML'}"
1728,"{'title': '974749', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6338_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 63;\tcytogenetic change: trisomy 8;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
1729,"{'title': 'Lung Normal 148N', 'description': 'Gene expression data from 148N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 56;\tstage: n/a'}"
1730,"{'title': 'Patient_6633_diagnosis', 'description': '6633D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pro-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 68;\tconclusions ig/tcr: stable;\tselected: yes'}"
1731,"{'title': 'AML with normal karyotype #192', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 45;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 95;\tdisease state: de novo AML'}"
1732,"{'title': '22068', 'description': '11719', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24293;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
1733,"{'title': 'X70055', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IA;\tConsolidated.Grade : 3'}"
1734,"{'title': 'Blood_TD51281_Daytwo_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
1735,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_55_4)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 53;\tSex: M'}"
1736,"{'title': 'Thyroid_ unaffected_paired with PTC77T', 'description': 'sample name in manuscript: N-PTC8', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: normal thyroid; Gender:female; Age:65'}"
1737,"{'title': 'normal fetal kidney, biological rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': '8 weeks normal', 'characteristics_ch1': 'age: 8 weeks gestation;\ttissue: kidney;\tkidney status: normal'}"
1738,"{'title': 'Control-16', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc8', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 34;\ttissue ph: 6.46;\tpmi (hrs): 15.5;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
1739,"{'title': 'AML 3312', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 19 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1740,"{'title': 'Patient 3411 AML14', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 14;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
1741,"{'title': 'Patient 3363 AML7', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 7;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1742,"{'title': '108135', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6322_Tumor;\tfab: M2;\tSex: F;\trace: W;\tage on study: 48;\tcytogenetic change: + 21(q22); del(7)(p11.2);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1743,"{'title': 'Gingival tissue sample 4 from patient 23, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 23 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
1744,"{'title': 'muscle_preTZD_preClamp_IRd_s2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 2'}"
1745,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Good Responder 2', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, good responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
1746,"{'title': 'Blood - Axial Spondyloarthropathy - 058A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 35;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
1747,"{'title': 'Blood - Control - 067A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 23;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
1748,"{'title': 'HRV-infected, normal S8 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, normal S8', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
1749,"{'title': 'Blood - Control - 051A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 32;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
1750,"{'title': 'Oestrogen-deprieved ZR75-1 Tamoxifen Resistant cells', 'description': 'ODZRTR', 'type': 'RNA', 'source_name_ch1': 'Breast cancer cell line ZR75-1 grown in oestrogen deprieved and tamoxifen containing media.', 'characteristics_ch1': 'cell line: ZR75-1;\tgrowth condition: grown in oestrogen deprieved and tamoxifen containing media;\tcell type: This is a hypotriploid human breast cell;\tbiomaterial provider: ATCC'}"
1751,"{'title': 'csc: m3: i2: d04', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 3; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 3;\tReplicate: 2;\tBatch: d04'}"
1752,"{'title': 'SK-N-SH_BDNF_2d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
1753,"{'title': 'Normal Ovary, 2085', 'description': 'Gene expression data from normal ovary.;\tHOSE2085', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
1754,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 11', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
1755,"{'title': 'MDS patient 126', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: del5q plus other'}"
1756,"{'title': 'Liver_normoglycima_no.2', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: normal glucose tolerance'}"
1757,"{'title': 'cord blood 6_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.38', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.38;\t'}"
1758,"{'title': 'MDS patient 53', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
1759,"{'title': 'BL41 60 min p-RNA Rep.1', 'description': 'unbound, preexisting RNA (p-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
1760,"{'title': 'UCNR13_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
1761,"{'title': 'AML 1188', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 33 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1762,"{'title': 'M-16', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
1763,"{'title': 'Patient 5023 AML178', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 178;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1764,"{'title': 'CD19_selected_B-cells_after_R_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after Rituximab'}"
1765,"{'title': 'Gingival tissue sample 1 from patient 12, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 12 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1766,"{'title': 'B88', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 69;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 16;\ttp53 mutation: 0;\tctnnb1 mutation: 272C>T | S45F;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
1767,"{'title': 'Monocyte Low PBM 10', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 10'}"
1768,"{'title': 'ALL without MLL - sample 72', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1769,"{'title': 'AML sample #52', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00199;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
1770,"{'title': 'UCNR10_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
1771,"{'title': '631879', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7660_Tumor;\tfab: M2;\tSex: M;\trace: W;\tage on study: 76;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1772,"{'title': 'CDcR11_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
1773,"{'title': 'Cervical cancer-lymph node positive-28-23', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 40.4;\tfigo stage: 1b1'}"
1774,"{'title': 'Muscle septic k59', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:male, Age:74yrs'}"
1775,"{'title': 'normal renal cortical tissue_1', 'description': 'normal control tissue', 'type': 'RNA', 'source_name_ch1': 'Non-cancerous renal cortical tissue from nephrectomized kidney with isolated renal cell carcinoma of patient 1', 'characteristics_ch1': 'PKD1 patient'}"
1776,"{'title': 'class S, rep32', 'description': 'VAN_00184.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 21;\tsex: F;\tdisease stage: 2;\talbumin level: 15;\themoglobin level: 85;\tlymphocyte percentage: 17;\twhite blood count: 12;\tinternational prognostic score (ips): 3'}"
1777,"{'title': 'Gingival tissue sample 2 from patient 12, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 12 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1778,"{'title': 'Blood - Control - 052A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 22;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
1779,"{'title': 'Myeloma tumor, sample 1', 'description': 'MM_TUMOR_01;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: male;\tdisease state: advanced multiple myeloma (MM)'}"
1780,"{'title': 'non-pCR breast biopsy, sample 3 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 3 rep 2', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
1781,"{'title': 'csc-aza-1', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tDemethylation: aza;\tReplicate: 1'}"
1782,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_0h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
1783,"{'title': 'NY41', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: Inflammation;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
1784,"{'title': 'AML 2278', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 45 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1785,"{'title': 'PGA-Hs_V-4', 'description': 'Human subjects with viral cardiomyopathy;\tKeywords = viral cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
1786,"{'title': 'class S, rep9', 'description': 'NEB_1072.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 52;\tsex: F;\tdisease stage: 4;\talbumin level: 32;\themoglobin level: 103;\tlymphocyte percentage: 17;\twhite blood count: 12.2;\tinternational prognostic score (ips): 4'}"
1787,"{'title': 'Muscle-FamilyHistoryNegative-15', 'description': 'Jos3792;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 52;\tfamily history: Family history negative;\tbody mass index (kg/m2): 27;\tfasting glucose (ogtt): 91.5;\t2 hour glucose (ogtt): 117;\themoglobin a1c: 4.9;\tfasting glucose (iv0gavg): 94;\tfasting insulin (iv0inavg): 4.2;\tsi: 6.28;\twaist hip ratio: 0.828'}"
1788,"{'title': 'UNTREATED_1716', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1789,"{'title': 'colonic_crypt_epithelial_cells_adenoma_15 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: adenoma;\tsex: female'}"
1790,"{'title': 'K_STA16', 'description': 'K_STA16', 'type': 'RNA', 'source_name_ch1': 'STA16 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
1791,"{'title': 'Gingival tissue sample 2 from patient 78, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 78 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1792,"{'title': 'Replicate 1 for SKBR31 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
1793,"{'title': 'MonoMac6 - lipoxin B4', 'description': 'Expression pattern of MonoMac6 cells stimulated for 12 h with lipoxin B4', 'type': 'RNA', 'source_name_ch1': 'human monocytic cell line MonoMac6 stimulated for 12 h with lipoxin B4', 'characteristics_ch1': 'cultured MonoMac6 cells, near confluent state, were stimulated for 12 h in the presence of 100 nM lipoxin B4 dissolved in DMSO'}"
1794,"{'title': 'SI13', 'description': 'Gene expression data from Standard Immunotherapy 13', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 13', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
1795,"{'title': 'Pt3 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt3_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 3', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 3'}"
1796,"{'title': 'DM1_F29_BB_08', 'description': 'DM1 patient, age 29, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM1 patient;\tbiopsy site: Biceps Brachii'}"
1797,"{'title': 'Peripheral T-Cell lymphoma, unspecified 13_replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-155', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 18;\tgender: male'}"
1798,"{'title': 'ALL without MLL - sample 15', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1799,"{'title': 'SH-SY5Y(ATCC)_RA_3d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
1800,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_2d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
1801,"{'title': 'HF1077_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1802,"{'title': 'SS gland, moderate, patient 22, batch 2', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: moderate SS'}"
1803,"{'title': 'IFNβ_929', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1804,"{'title': 'LTB2 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tLatent'}"
1805,"{'title': 'test experiment not for use [wf20061103u133v2_U_05-Lc1-Pat-2-EM]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
1806,"{'title': 'high grade serous carcinoma_patient 2_sample 1', 'description': 'Gene expression profile of high grade serous carcinoma of fallopian tube', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected high grade serous carcinoma', 'characteristics_ch1': 'Age: 57;\tCycle: NA;\tBRCA1/2 mutation: Unknown;\tFamily History: Yes'}"
1807,"{'title': 'N11580C3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1808,"{'title': 'class S, rep38', 'description': 'VAN_00366.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 47;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: 155;\tlymphocyte percentage: 11;\twhite blood count: 10.8;\tinternational prognostic score (ips): 3.5'}"
1809,"{'title': 'TK620b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1462;\tdisease state: AIDS;\tgender: Male;\tage: 43;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 81;\tplasma hiv-1     rna level   (copies/ml): 35000;\ttissue: lymph node'}"
1810,"{'title': 'PGA-Hs_D-4', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
1811,"{'title': 'blood_cd34pos_D3', 'description': '3 samples CD34+ and 2 samples CD34-', 'type': 'RNA', 'source_name_ch1': 'periphereal blood', 'characteristics_ch1': 'healty donors treated with GCSF isolated CD34+ cells and CD34+ after 10dd of differentiating medium.'}"
1812,"{'title': 'Control V23', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
1813,"{'title': 'ADHGD01', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Adenoma with high-grade dysplasia'}"
1814,"{'title': 'HF1534_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1815,"{'title': 'AML 2262', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 39 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1816,"{'title': '3.1.NDV.12', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 12 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 12'}"
1817,"{'title': 'Blood sample from patient 165 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 165;\tday: Day 1;\tage (years): 58;\tsex: Female'}"
1818,"{'title': 'S110', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S110', 'characteristics_ch1': 'patient id: P002;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
1819,"{'title': 'Blood sample from patient 138 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 138;\tday: Day 90;\tage (years): 62;\tsex: Male'}"
1820,"{'title': 'No13inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No13 nonRVR;\ttime point: under therapy'}"
1821,"{'title': 'AML 6364', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 49 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1822,"{'title': 'MDS patient 61', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
1823,"{'title': 'Sputum from Stage II Moderate, biological replicate 65', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 53;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
1824,"{'title': 'PTB3 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
1825,"{'title': 'Tumor 47', 'description': '08SE358', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
1826,"{'title': 'VAN_00615', 'description': '06-31353', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 76;\tgender: M;\tipi_stage: 1A;\ttxprimary: CHOP4-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.99;\tprogression-free_survival (years): 0.99'}"
1827,"{'title': 'B1-Non-RR-11 [wf20070130u133v2_U_13-B1-Pat.8-WE]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
1828,"{'title': 'ALL without MLL - sample 69', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1829,"{'title': 'Subject 1, Family 1, Affected', 'description': 'microarray hybridization data 07/10/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Male;\tfamily: 1;\tage: 49;\tdisease status: Affected;\ttissue: Muscle: Biceps'}"
1830,"{'title': '25_70603_SepticShock_Day3_8', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '25_70603_Patient, Day3'}"
1831,"{'title': 'Lung Cancer 37T', 'description': 'Gene expression data from 37T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 57;\tstage: 3A'}"
1832,"{'title': 'vCRC6', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: colorectal cancer'}"
1833,"{'title': 'S090', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S090', 'characteristics_ch1': 'patient id: P105;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 62.5'}"
1834,"{'title': 'HF1628_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1835,"{'title': 'NSCLC EMC SCC2267N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
1836,"{'title': 'mesenchymal stem cells, lot#4F0312, 7th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0312, passage number 7', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0312, 7th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
1837,"{'title': 'Gingival tissue sample 1 from patient 61, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 61 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
1838,"{'title': 'No17LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No17;\tcell type: hepatocytes;\ttime point: before therapy'}"
1839,"{'title': 'hES_WIBR1_rep1_090811_7', 'description': 'Gene expression data from hES line WIBR1', 'type': 'RNA', 'source_name_ch1': 'hES line WIBR1', 'characteristics_ch1': 'cell line: hES line WIBR1'}"
1840,"{'title': 'ALL without MLL - sample 47', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1841,"{'title': 'adenocarcinoma_40 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 83;\tlocalization: caecum'}"
1842,"{'title': 'Tumor Tum_Ph2_rep12', 'description': 'Tumor paired  7', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N0;\thistology: cdi;\tgrade: I;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
1843,"{'title': 'NZK18', 'description': 'non-metastatic primary clear-cell renal cell carcinoma, batch 1', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: female;\ttumor stage (uicc 2002): pT1b;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G3;\tdfs/follow-up: Follow-up = 130 months;\tlocalisation of metastases: none'}"
1844,"{'title': 'HF0017_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
1845,"{'title': 'Gingival tissue sample 3 from patient 54, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 54 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
1846,"{'title': 'mucosa_normal_colon_33 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: normal colon;\tsex: female'}"
1847,"{'title': 'hf240-NS-A', 'description': 'U133Plus2_122906L_DK11.CEL', 'type': 'RNA', 'source_name_ch1': 'human foetal cortex derived NS cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: non-malignant;\tcell type: cell line;\tcell type: neural stem'}"
1848,"{'title': 'AML 6246', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 25 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1849,"{'title': 'Sample 28 perihematomal area', 'description': 'Gene expression data from human brain samples 5h after intracerebral hemorrhage.', 'type': 'RNA', 'source_name_ch1': 'Human brain sample of intracerebral hemorrhage perihematomal area', 'characteristics_ch1': 'tissue: brain;\tage: 95;\tgender: female'}"
1850,"{'title': 'T8862B1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
1851,"{'title': '7084', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 64 years, FAB M2, cytogenetic risk unknown, CEBPA wild type'}"
1852,"{'title': 'BC17609', 'description': '080414-07.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 34;\tmolecular subtype: LuminalA;\thistology: DUC;\tpt: pT2;\tpn: pos;\tgrade sbr: 1;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: --;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: --;\ttop2a ihc status: --;\tfoxa1 ihc status: --;\tmfs: --;\tmfsdel (month): --'}"
1853,"{'title': 'Proficiency_Site4_13', 'description': 'Performed by Operator 1 from Site4 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 10.21; Lot# = 035PO41658D'}"
1854,"{'title': 'S5-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: smoker;\tPack-years: 23;\tAge: 46;\tSex: F;\tEthnic group: black'}"
1855,"{'title': 'adipose_postTZD_IRd_s12', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 12'}"
1856,"{'title': 'Patient 25, IDC', 'description': '17220-1P_exp', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 25'}"
1857,"{'title': 'U937_naive_untreated_4h_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, untreated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
1858,"{'title': ""Wilms' FF D-1"", 'description': 'L752-A-HG-U133_Plus_2-01-1 (S07-1035N-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney', 'characteristics_ch1': 'tissue: kidney;\tfixation: FF;\tblock age (at extraction in years): 0.5;\tbiological replicate: rep-1;\tdonor: C normal'}"
1859,"{'title': 'No29LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No29;\tcell type: hepatocytes;\ttime point: before therapy'}"
1860,"{'title': 'AML sample #31', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
1861,"{'title': 'newly diagnosed multiple myeloma 78', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: nd'}"
1862,"{'title': 'Donor3_6h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 3 treated with Wy14643 for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 3;\tagent: Wy14643;\ttime: 6h;\tgender: Female;\tage: 70 years old'}"
1863,"{'title': 'NLPHL1', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'nodular lymphocte-predominant Hodgkin lymphoma case 1', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)'}"
1864,"{'title': 'NSCLC_SCC_65', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 65.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
1865,"{'title': 'cHL8', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 8', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
1866,"{'title': 'H9_ES_2', 'description': 'Gene expression data obtained from human ES', 'type': 'RNA', 'source_name_ch1': 'human ES', 'characteristics_ch1': 'cell type: ES;\tcell line: H9 Human embryonic stem cells'}"
1867,"{'title': 'T51292', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51292;\tsample: tumor'}"
1868,"{'title': 'Pilocytic astrocytoma chip 7743', 'description': 'Pilocytic astrocytoma.  Chip ID 7743', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
1869,"{'title': 'PBMCs treated at 3xIC90 for 24 hours,replicate 1', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at 3xIC90 for 24 hours,replicate 1', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
1870,"{'title': 'Hippocampus_male_45yrs_indiv12', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 45 years', 'characteristics_ch1': 'individual: 12, AA;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 45'}"
1871,"{'title': 'lymphocytes_HD_M_59y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: male; Age: 59; Tissue: lymphocytes (blood); IT15 CAG repeats: 21/45'}"
1872,"{'title': 'AML without MLL - sample 93', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1873,"{'title': 'AML 7185', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 39 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
1874,"{'title': 'IFNβ_1753', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1875,"{'title': '06-0009A_Septic Shock_day1_83', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1876,"{'title': 'MDS patient 40', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
1877,"{'title': 'UCNR16_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
1878,"{'title': 'T147 U133p2', 'description': 'bulk breast tumor RNA from patient T147', 'type': 'RNA', 'source_name_ch1': 'T147', 'characteristics_ch1': 'breast tumor'}"
1879,"{'title': 'S015', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S015', 'characteristics_ch1': 'patient id: P069;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
1880,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 13', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
1881,"{'title': 'non-malignant FTEn_patient 6', 'description': 'Gene expression profile of non-malignant FTE from control patient during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 47;\tCycle: Luteal;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
1882,"{'title': 'Septic Shock_biological rep15', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.1;\toutcome: Survivor'}"
1883,"{'title': 'PNS004', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.06;\tdisease activity (das28_v3): 4.45;\tresponse to anti-tnf therapy: NORESPONSE'}"
1884,"{'title': 'Blood_TD51281_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
1885,"{'title': 'IFNβ_1729', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1886,"{'title': 'blood, Blood: control-3_e1_le1', 'description': 'no nicotine treatment;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
1887,"{'title': 'PTB1 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
1888,"{'title': 'DM2_F50_?_16', 'description': 'DM2 patient, age 50, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site:  unknown'}"
1889,"{'title': 'AML 7166', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 44 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
1890,"{'title': 'Sputum from Stage III Severe, biological replicate 26', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 65;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
1891,"{'title': 'AML with normal karyotype #180', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 35;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 88;\tdisease state: de novo AML'}"
1892,"{'title': 'group-1-pt-t32950994', 'description': 'group-1-pt-t32950994', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 22;\tgender: female;\tfinal disposition: 09: Death'}"
1893,"{'title': 'high grade serous carcinoma_patient 1', 'description': 'Gene expression profile of high grade serous carcinoma of fallopian tube', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected high grade serous carcinoma', 'characteristics_ch1': 'Age: 41;\tCycle: NA;\tBRCA1/2 mutation: Negative;\tFamily History: No'}"
1894,"{'title': 'si Control MCF7-repeat 2 - mAdbID:83292', 'description': 'mAdb experiment ID: 83292', 'type': 'RNA', 'source_name_ch1': 'si Control MCF7', 'characteristics_ch1': 'Tissue: breast;\tCell line: Breast Cancer Cell Line MCF7;\tCell type: epithelial cells;\tDisease state: Adenocarcinoma'}"
1895,"{'title': 'Donor 2 - control', 'description': 'Elutriated monocytes from donor 2 treated with vehicle control for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes exposed to vehicle control (EtOH)'}"
1896,"{'title': 'Adenocarcinoma, bone marrow negative AC 16', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'male pulmonary adenocarcinoma;\tbone marrow negative'}"
1897,"{'title': 'healthy breast 3, biological rep. 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'healthy', 'characteristics_ch1': 'tissue: breast;\tdisease state: healthy'}"
1898,"{'title': 'PC control 4', 'description': 'arrayconsortium.tgen.org::biosample.434898;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior Cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 4;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior Cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: male\xa0;\tgenetic variation: None\xa0;\tage: 63 years'}"
1899,"{'title': 'HF0920_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
1900,"{'title': 'group-2-pt-t31016255', 'description': 'group-2-pt-t31016255', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 31;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
1901,"{'title': 'Sputum from Stage III Severe, biological replicate 7', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 58;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
1902,"{'title': 'Muscle control k65', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:male, Age:70yrs'}"
1903,"{'title': 'mucosa_adenoma_10 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: adenoma;\tsex: female'}"
1904,"{'title': 'no GvHD d150', 'description': 'no GvHD d150;\tMHH0891', 'type': 'RNA', 'source_name_ch1': 'blood from allogeneic stem cell transplantation (SCT) patient', 'characteristics_ch1': 'disease state: no GvHD;\tcell type: CD4+CD25highCD127low/- Tregs;\ttime: 150 days'}"
1905,"{'title': 'class S, rep84', 'description': 'VAN_00516.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 24;\tsex: M;\tdisease stage: 3;\talbumin level: 27;\themoglobin level: 101;\tlymphocyte percentage: 6;\twhite blood count: 8.8;\tinternational prognostic score (ips): 5'}"
1906,"{'title': '10238', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 65;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: no information;\tDonor Sex: M;\tCAN Banff Score =2;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
1907,"{'title': 'THRBL_lymph_node_case1', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: female, Age: 50, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: IVB, IPI prognostic score: low intermediate, follow-up: 3 years; status at last follow-up: death with disease'}"
1908,"{'title': 'heterozygot FH P279', 'description': 'Gene expression data from the heterozygous FH participant F', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: heterozygote FH'}"
1909,"{'title': 'Blood - Sarcoidosis - 013A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Female;\tage: 41;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
1910,"{'title': 'N1-02', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
1911,"{'title': 'control participant P328wh', 'description': 'Gene expression data from control participant T1', 'type': 'RNA', 'source_name_ch1': 'control participant P328wh (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
1912,"{'title': '15-0008_Septic Shock_day1_212', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
1913,"{'title': 'AML 2194', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 20 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
1914,"{'title': 'PGA-Hs_S-20', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
1915,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Moderate Responder 2', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, moderate responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
1916,"{'title': 'HF1357_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
1917,"{'title': 'Bronchial epithelial cells, day 14, donor 3', 'description': 'Bronchial epithelial cells, day 14, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 14 of air-liquid interface culture'}"
1918,"{'title': 'KT0664_12_L_test3', 'description': 'KT0664_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
1919,"{'title': 'MERLION_X00K05009', 'description': 'MERLION_X00K05009', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:78, state:1', 'characteristics_ch1': 'pT2N0, male, age:78, state:1'}"
1920,"{'title': 'MERLION_X03K00095', 'description': 'MERLION_X03K00095', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=51, state=0', 'characteristics_ch1': 'pT2N0, female, age=51, state=0'}"
1921,"{'title': 'FAKsiRNA, rep1', 'description': 'Gene expression data from FAKsiRNA', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7, FAKsiRNA', 'characteristics_ch1': 'FAKsiRNA#1'}"
1922,"{'title': 'Lung Normal 177N', 'description': 'Gene expression data from 177N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 50;\tstage: n/a'}"
1923,"{'title': 'Endometrium - not pregnant [08-10334-3]', 'description': '08-10334-3', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, not pregnant', 'characteristics_ch1': 'tissue: endometrium on day of oocyte retrieval;\tstate: non-pregnant'}"
1924,"{'title': 'S068', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S068', 'characteristics_ch1': 'patient id: P044;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
1925,"{'title': 'S5-14', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 14; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 14; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 14;\tSmoking status: smoker;\tPack-years: 23;\tAge: 46;\tSex: F;\tEthnic group: black'}"
1926,"{'title': 'Subcutaneous adipose tissue, SAT6', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
1927,"{'title': 'B10', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: II;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.2'}"
1928,"{'title': 'Donor4_6h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 4 treated with DMSO for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 4;\tagent: control;\ttime: 6h;\tgender: Female;\tage: 54 years old'}"
1929,"{'title': 'N2-34', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
1930,"{'title': 'T84', 'description': 'gene expression data for T84', 'type': 'RNA', 'source_name_ch1': 'human colonic epithelial cell', 'characteristics_ch1': 'origin: adult;\tcell line: T84'}"
1931,"{'title': 'MDS patient 102', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
1932,"{'title': 'HOTAIR1', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siHOTAIR;\treplicate: 1'}"
1933,"{'title': '10_0017_SepticShock_Day3_59', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '10_0017_Patient, Day3'}"
1934,"{'title': 'Liver_hyperglycima_no.6', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: female;\tdisease status: type 2 diabetes'}"
1935,"{'title': 'C99474', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6706_Tumor;\tfab: M2;\tSex: M;\trace: C;\tage on study: 25;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1936,"{'title': '51062', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tAdjacent LMP/MPSC;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
1937,"{'title': 'MDS patient 161', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: del5q plus other'}"
1938,"{'title': 'KT0452_12_L_test3', 'description': 'KT0452_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
1939,"{'title': 'IFNβ_1666', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
1940,"{'title': 'newly diagnosed multiple myeloma 256', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
1941,"{'title': 'Septic Shock_biological rep3 01-0019', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.1;\toutcome: Survivor;\tgroup: C'}"
1942,"{'title': 'Patient 5062 AML191', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 191;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1943,"{'title': 'Gingival tissue sample 3 from patient 39, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 39 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
1944,"{'title': 'HOSE2230', 'description': 'normal human ovarian surface epithelials cells', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: normal ovarian surface epithelials cells'}"
1945,"{'title': 'Peripheral T-Cell lymphoma, unspecified 9', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-114', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 57;\tgender: male'}"
1946,"{'title': 'endothelial_rep1', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h'}"
1947,"{'title': 'Angioimmunoblastic T-cell lymphoma 27', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-70', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 63;\tgender: female'}"
1948,"{'title': 'X70119', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
1949,"{'title': 'PBMCs vehicle treated for 24 hours,replicate 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 24 hours,replicate 2', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
1950,"{'title': 'Patient 3495 AML42', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 42;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1951,"{'title': '454', 'description': '02-20170', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 77;\tgender: M;\tipi_stage: 3BE;\ttxprimary: CVPP1-DOXO-CYCL5-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.96;\tprogression-free_survival (years): 5.96'}"
1952,"{'title': 'S029', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S029', 'characteristics_ch1': 'patient id: P075;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
1953,"{'title': 'Training_Site9_03', 'description': 'Performed by Operator 1 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 22.1; Lot# = 035PO41658D'}"
1954,"{'title': 'AML with normal karyotype #208', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 28;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 100;\tdisease state: de novo AML'}"
1955,"{'title': 'Blood Sample of subject 34 before inhalation; Group C', 'description': 'Bl_Group_C_BI_subject_34', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 34;\tgroup: C'}"
1956,"{'title': 'newly diagnosed multiple myeloma 235', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: III'}"
1957,"{'title': 'Patient 5183 AML227', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 227;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
1958,"{'title': 'MERLION_X02K05529', 'description': 'MERLION_X02K05529', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=54, state=1', 'characteristics_ch1': 'pT2N0, male, age=54, state=1'}"
1959,"{'title': 'AML 2509', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 35 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1960,"{'title': 'ALL without MLL - sample 37', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1961,"{'title': 'Sc3_1', 'description': 'Human testis Score 3 Replicate 1', 'type': 'RNA', 'source_name_ch1': 'Spermatogonial presence in tubuli', 'characteristics_ch1': 'tissue type: testicular biopsy;\tspermatogenic stage (johnsen score): Score 3'}"
1962,"{'title': 'MDS patient 174', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
1963,"{'title': 'newly diagnosed multiple myeloma 241', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: I'}"
1964,"{'title': 'EntorhinalCortex_female_48yrs_indiv81', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 48 years', 'characteristics_ch1': 'individual: 81, AA;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 48'}"
1965,"{'title': 'AML without MLL - sample 98', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
1966,"{'title': 'HepG2 cells, control, rep2', 'description': 'Expression profiling from HepG2 cells', 'type': 'RNA', 'source_name_ch1': 'Cultured HepG2 cells,  ATCC# HB-8065', 'characteristics_ch1': 'cell line: HepG2;\tgenotype/variation: control'}"
1967,"{'title': 'Cell line C5.2_DRC_2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
1968,"{'title': 'T10143A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
1969,"{'title': 'X51062', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
1970,"{'title': 'Patient 4096 AML54', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 54;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
1971,"{'title': 'vn1', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: normal'}"
1972,"{'title': 'N10176F4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
1973,"{'title': 'AML 2205', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 33 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: t(6;9);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
1974,"{'title': 'Muscle-FamilyHistoryNegative-7', 'description': 'Jos3672;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 46;\tfamily history: Family history negative;\tbody mass index (kg/m2): 26;\tfasting glucose (ogtt): 85.5;\t2 hour glucose (ogtt): 77;\themoglobin a1c: 5.4;\tfasting glucose (iv0gavg): 88;\tfasting insulin (iv0inavg): 4.4;\tsi: 10.39;\twaist hip ratio: 0.845'}"
1975,"{'title': '291696', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '11415_Tumor;\tfab: M3;\tSex: F;\trace: W;\tage on study: 61;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
1976,"{'title': 'vn3', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: normal'}"
1977,"{'title': 'KT0921_12_L_paired_test3', 'description': 'KT0921_12_L_paired_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, paired set and test set3', 'characteristics_ch1': '12 months, living donor, paired set and test set3'}"
1978,"{'title': 'KT0727_24_L_test3', 'description': 'KT0727_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
1979,"{'title': 'Donor 2 - LTD4 stimulated', 'description': 'Elutriated monocytes from donor 2 treated with LTD4 for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes stimulated with LTD4 (100nM) for 30 min.'}"
1980,"{'title': 'hyperplastic polyp_sporadic_proximal, rep1', 'description': 'Gene expression data from samples of patients with HPPS.;\tA500PA', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic polyp located in proximal colon from a sporadic HPPS patient', 'characteristics_ch1': 'tissue: colon;\thistology: hyperplastic polyp;\tcolon location: proximal;\tdisease: hyperplastic polyposis syndrome (HPPS);\thereditary nature of hpps: sporadic'}"
1981,"{'title': 'brain, unknown: R2C_e1_le1', 'description': 'rotenone 2 weeks C;\tTreatment, type=time_course, measurement=2.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
1982,"{'title': 'MLD AML sample #32', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
1983,"{'title': 'GA_1081', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
1984,"{'title': 'AILD_AV_005', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
1985,"{'title': '06-14-05_Miller_U133Plus2_0_A5P5d07EPO', 'description': 'Pool of 3 samples:;\t20-30 age;\tM/F;\tDay 7: proerythroblast', 'type': 'RNA', 'source_name_ch1': 'CD34+ progenitor cells subjected to EPO and harvested at day 7', 'characteristics_ch1': 'cell type: CD34+ hematopoietic progenitor cells;\tdevelopmental stage: proerythroblast;\ttissue type: primary cells from donated blood'}"
1986,"{'title': 'Insulin sensitive patient 7 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
1987,"{'title': 'hg_NY61', 'description': 'high-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; high-grade dysplastic liver tissue', 'characteristics_ch1': 'high-grade dysplastic liver tissue'}"
1988,"{'title': 'DietSensitive _6 weeks_subject4', 'description': 'DietSensitive _6 weeks_subject4', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 4;\tgender: Female'}"
1989,"{'title': 'AML sample #22', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
1990,"{'title': 'group-2-pt-t17169324', 'description': 'group-2-pt-t17169324', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 43;\tgender: male;\tfinal disposition: 06: Home'}"
1991,"{'title': 'PBMCs_LB_after exercise_13', 'description': 'LB_Peak_022-KC', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 19;\tafter-exercise'}"
1992,"{'title': 'Blood_TD24111_Daytw0_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
1993,"{'title': 'Blood_TD24111_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
1994,"{'title': 'PA192', 'description': 'PA192', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
1995,"{'title': '12 hours post-infection, biological rep1', 'description': 'Gene expression data from cells 12 hours after HCMV infection', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
1996,"{'title': 'non-pCR breast biopsy, sample 10 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 10 rep 2', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
1997,"{'title': 'Donor2_6h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 2 treated with Wy14643 for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 2;\tagent: Wy14643;\ttime: 6h;\tgender: Male;\tage: 44 years old'}"
1998,"{'title': 'whole blood_100961', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - mental retardation or developmental delay, Female', 'characteristics_ch1': 'mental retardation or developmental delay, Female'}"
1999,"{'title': 'AML sample #42', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00164;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2000,"{'title': '3.2.NDV.2', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 2 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 2'}"
2001,"{'title': '5355', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 71 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type'}"
2002,"{'title': 'AML sample #96', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00732;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2003,"{'title': 'IFNβ_723', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2004,"{'title': 'AML 2240', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 48 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
2005,"{'title': 'Muscle control k70', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:male, Age:76yrs'}"
2006,"{'title': 'AML with normal karyotype #154', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
2007,"{'title': 'Lean_1 day_subject17', 'description': 'Lean_1 day_subject17', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Lean;\ttime point: 1 day;\tsubject: 17;\tgender: Male'}"
2008,"{'title': 'S004_Scz_F_88', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 88;\tpost-mortem delay: 7h;\tph: 5.7'}"
2009,"{'title': 'class F, rep2', 'description': 'NEB_8.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 44;\tsex: M;\tdisease stage: 1;\talbumin level: 36;\themoglobin level: 141;\tlymphocyte percentage: _;\twhite blood count: 5.9;\tinternational prognostic score (ips): 2.3'}"
2010,"{'title': 'Control Huh7_Vec#2', 'description': 'Replicates were done by using the same total RNA preparation', 'type': 'RNA', 'source_name_ch1': 'Huh7 Cells with PCI-Neo stable integration into genome', 'characteristics_ch1': 'Huh7 Cells with PCI-Neo stable integration into genome'}"
2011,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_58_04)', 'description': 'Gene expression data from whole blood 7 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 48;\tSex: M'}"
2012,"{'title': 'Sepsis mixed infection V10', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
2013,"{'title': 'AML with normal karyotype #45', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 66;\tdisease state: de novo AML'}"
2014,"{'title': 'aa_NY224', 'description': 'very advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very advanced HCC', 'characteristics_ch1': 'very advanced HCC'}"
2015,"{'title': 'whole blood_100476', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
2016,"{'title': 'HF1487_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
2017,"{'title': '11-0031_SIRS_day1_170', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2018,"{'title': 'GC B cell_pSG5_rep1', 'description': 'Amplified total RNA from transfected and FACS sorted GC Bells', 'type': 'RNA', 'source_name_ch1': 'GC B cell transfected with empty vector (pSG5), rep1', 'characteristics_ch1': 'GC B cells sorted using CD10 MACS from reactive human tonsils'}"
2019,"{'title': 'Control 48', 'description': '08SE359', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
2020,"{'title': 'group-2-pt-t34198779', 'description': 'group-2-pt-t34198779', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 36;\tgender: male;\tfinal disposition: 05: Home with services'}"
2021,"{'title': 'PGA-Hs_D-6', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
2022,"{'title': 'C148', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.8'}"
2023,"{'title': 'Control_biological rep19 11-0037', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0.3;\toutcome: Survivor;\tgroup: n/a'}"
2024,"{'title': 'newly diagnosed multiple myeloma 311', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: III'}"
2025,"{'title': '606061', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6334_Tumor;\tfab: M2;\tSex: F;\trace: W;\tage on study: 37;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2026,"{'title': 'PTB3 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
2027,"{'title': 'DM2_M?_BB_04', 'description': 'DM2 patient, age unknown, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Biceps Brachii'}"
2028,"{'title': 'PC control 10', 'description': 'arrayconsortium.tgen.org::biosample.434982;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 10;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: female\xa0;\tgenetic variation: None\xa0;\tage: 82 years'}"
2029,"{'title': 'No7LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No7;\tcell type: lymphocytes;\ttime point: before therapy'}"
2030,"{'title': 'HUVECs  treated with Actinomycin D (5 µg/ml) and IL1-beta (10 ng/ml) in EGM2 media', 'description': 'Test that HUVEC activation by the inflammatory factor occurs via de novo RNA synthesis', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells  treated with IL1-beta and Actinomycin D', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
2031,"{'title': 'B40', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.1'}"
2032,"{'title': 'Pt11 isolated pericardial adipocytes, biological rep1', 'description': 'Pt11_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 11', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 11'}"
2033,"{'title': 'Septic Shock_biological rep70 11-0001', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.8;\toutcome: Survivor;\tgroup: A'}"
2034,"{'title': 'X60211', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
2035,"{'title': 'FHC - control 21', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Control 21', 'characteristics_ch1': 'Gender: male;\tAge: 37 years ;\tDisease: none;\tDrugs: none;\tTissue: blood'}"
2036,"{'title': 'NSCLC EMC TB0028tu', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
2037,"{'title': '7327', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 62 years, RAEB-t, cytogenetic poor risk, CEBPA wild type'}"
2038,"{'title': '02-0002B_Septic Shock_day3_62', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2039,"{'title': 'ALL without MLL - sample 86', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2040,"{'title': 'Patient C03, control kidney from nephrectomy', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C03, Sex: male, Age of patient: 71, Serum creatinine: 61 microMol/L, Control kidney sample  from nephrectomy'}"
2041,"{'title': 'Monocyte_patient50_time3', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:Caucasian,Age:59,VAP day:7'}"
2042,"{'title': 'AML 2246', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 33 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2043,"{'title': 'AML 7071', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 50 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2044,"{'title': 'platelet_Ctrl_8', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
2045,"{'title': 'H133+_H448_Propi_10uM', 'description': 'H133+_H448_Propi_10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H448_Propi_10uM', 'characteristics_ch1': 'primary hepatocytes'}"
2046,"{'title': 'brain_endothelial_cells_rep6', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'endothelial cells from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 55'}"
2047,"{'title': 'Patient 7, biopsy; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
2048,"{'title': 'Adult T-cell leukemia/lymphoma-7', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-65', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 56;\tgender: male'}"
2049,"{'title': 'AML sample #54', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00232;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2050,"{'title': 'MDS patient 14', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q'}"
2051,"{'title': 'MDS patient 150', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
2052,"{'title': 'IPMA 2', 'description': 'Gene expression data from microdissected epithelial cells of IPMA', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMA 2', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous adenoma (IPMA)'}"
2053,"{'title': 'B2-Non-RR-12 [wf20070302u133v2_U_12_HW_B2_73]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
2054,"{'title': 'HF0931_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
2055,"{'title': 'Liver358N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HBV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 358N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: Chronic hepatitis;\tgender: M;\tage: 52;\tvirus: HBV'}"
2056,"{'title': 'Patient 7, colonocytes; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
2057,"{'title': 'newly diagnosed multiple myeloma 161', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
2058,"{'title': 'Gingival tissue sample 1 from patient 36, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 36 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2059,"{'title': 'Subcutaneous adipose tissue, SAT34', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
2060,"{'title': 'AML 2266', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 58 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2061,"{'title': 'No29LCMHinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No29;\tcell type: hepatocytes;\ttime point: under therapy'}"
2062,"{'title': 'newly diagnosed multiple myeloma 100', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: nd'}"
2063,"{'title': 'Insulin sensitive patient 3 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
2064,"{'title': 'MDS patient 129', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
2065,"{'title': 'S026_Scz_M_72', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 72;\tpost-mortem delay: 20h;\tph: 6.6'}"
2066,"{'title': 'MDS patient 153', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
2067,"{'title': 'SH-SY5Y(ECACC)_BDNF_6h_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
2068,"{'title': 'Septic Shock_biological rep60 10-0001', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 5.3;\toutcome: Survivor;\tgroup: B'}"
2069,"{'title': 'Control, rep 2', 'description': 'Gene expression data from control HUVEC', 'type': 'RNA', 'source_name_ch1': 'HUVEC control', 'characteristics_ch1': 'cell type: Endothelial cell;\tagent: ethanol;\tdose: 0.1%'}"
2070,"{'title': 'AML sample #11', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00074;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2071,"{'title': 'KT0730_0_L_training', 'description': 'KT0730_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, trainingset'}"
2072,"{'title': '22082', 'description': '11776', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24313;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
2073,"{'title': 'Sputum from Stage II Moderate, biological replicate 47', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 64;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
2074,"{'title': 'Sputum from Stage III Severe, biological replicate 10', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 60;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
2075,"{'title': '11_0008C_Day1_21', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Male'}"
2076,"{'title': 'colon_IBD_1017', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
2077,"{'title': 'UNTREATED_2159', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
2078,"{'title': 'S061', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S061', 'characteristics_ch1': 'patient id: P094;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
2079,"{'title': 'MERLION_X02K02285', 'description': 'MERLION_X02K02285', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=76, state=1', 'characteristics_ch1': 'pT2N0, male, age=76, state=1'}"
2080,"{'title': 'N30277', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30277;\tsample: normal'}"
2081,"{'title': 'S048', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S048', 'characteristics_ch1': 'patient id: P072;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 75.5'}"
2082,"{'title': 'SCRA', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 2'}"
2083,"{'title': 'Tumor Tum_Ph3_rep4', 'description': 'Tumor paired  1', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T3;\tn: N0;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
2084,"{'title': 'X387', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2085,"{'title': 'Lung Normal 149N', 'description': 'Gene expression data from 149N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 42;\tstage: n/a'}"
2086,"{'title': 'CDcNR6_afterT', 'description': 'Colonic mucosal gene expression data from CDc non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
2087,"{'title': 'Lung Normal 117N', 'description': 'Gene expression data from 117N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 70;\tstage: n/a'}"
2088,"{'title': 'Patient 4414 AML84', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 84;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2089,"{'title': 'Replicate 1 for CAL148 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2090,"{'title': 'Liver358T (mRNA expression)', 'description': 'liver cancer HBV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 358T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately differentiated;\tgender: M;\tage: 52;\tvirus: HBV'}"
2091,"{'title': 'Gingival tissue sample 2 from patient 66, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 66 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2092,"{'title': 'Replicate 1 for MFM223 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2093,"{'title': 'AML with normal karyotype #227', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 34;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
2094,"{'title': 'AML with normal karyotype #33', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 74.5;\tdisease state: de novo AML'}"
2095,"{'title': 'DS350a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1335;\tdisease state: Asympt;\tgender: Male;\tage: 32;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 400;\tplasma hiv-1     rna level   (copies/ml): 15284;\ttissue: lymph node'}"
2096,"{'title': 'Sample 5: normal ovarian surface epithelium', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: Normal'}"
2097,"{'title': 'newly diagnosed multiple myeloma 185', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
2098,"{'title': '2.2.NDV.2', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 2 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: NDV;\thours post infection: 2'}"
2099,"{'title': 'AML 7147', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 59 years;\tscore: FAB M1;\trisk: unknown;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2100,"{'title': 'PNS012', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.08;\tdisease activity (das28_v3): 3.65;\tresponse to anti-tnf therapy: MEDIUM'}"
2101,"{'title': 'No28LCMHinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No28;\tcell type: hepatocytes;\ttime point: under therapy'}"
2102,"{'title': 'No27inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No27RVR;\ttime point: under therapy'}"
2103,"{'title': 'ISC_GG U133 Plus 2.0', 'description': 'Gene expression data from peripheral blood sample', 'type': 'RNA', 'source_name_ch1': 'Human peripheral blood sample', 'characteristics_ch1': 'tissue: blood;\tdisease state: Infective colitis'}"
2104,"{'title': 'TC.CD8-3', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
2105,"{'title': 'S123', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S123', 'characteristics_ch1': 'patient id: P052;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 27.5'}"
2106,"{'title': 'CRCCD01', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CRC-CD'}"
2107,"{'title': 'csc-none-1', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Demethylation: none', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tDemethylation: none;\tReplicate: 1'}"
2108,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 24 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 24 hours'}"
2109,"{'title': 'UNTREATED_845', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2110,"{'title': 'centroblast, tonsil#8', 'description': 'centroblast, tonsil#8', 'type': 'RNA', 'source_name_ch1': 'Inflamed non tumoral human tonsil#8', 'characteristics_ch1': 'cell suspension: Flow sorted cells;\tcell type: centroblast, tonsil'}"
2111,"{'title': 'B23', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.5'}"
2112,"{'title': 'Blk-1', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': '786-O cells treated with medium only, replicate 1'}"
2113,"{'title': 'C98804', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6609_Tumor;\tfab: M2;\tSex: M;\trace: C;\tage on study: 24;\tcytogenetic change: t(8;21)(q22;q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2114,"{'title': 'Myeloma tumor, sample 7', 'description': 'MM_TUMOR_07;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: male;\tdisease state: advanced multiple myeloma (MM)'}"
2115,"{'title': 'Patient_8711_diagnosis', 'description': '8711D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 7;\tconclusions ig/tcr: stable;\tselected: yes'}"
2116,"{'title': 'MERLION_X02K02911', 'description': 'MERLION_X02K02911', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=77, state=1', 'characteristics_ch1': 'pT2N0, male, age=77, state=1'}"
2117,"{'title': 'Replicate 1 for HCC2218 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2118,"{'title': 'ALL without MLL - sample 63', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2119,"{'title': 'Blood - Control - 140A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 32;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
2120,"{'title': 'PGA_PA-S_342', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
2121,"{'title': 'Bronchial epithelial cells, day 21, donor 1', 'description': 'Bronchial epithelial cells, day 21, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 21 of air-liquid interface culture'}"
2122,"{'title': 'cHL4', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 4', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
2123,"{'title': 'No25inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No25RVR;\ttime point: under therapy'}"
2124,"{'title': 'Replicate 1 for BT549 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2125,"{'title': 'blood-vehicle-DHA-2', 'description': 'Unstimulated cells, DHA supplementation.;\t202-91-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, DHA', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: DHA'}"
2126,"{'title': 'Transplanted-reperfused liver T2-16', 'description': 'Gene expression data from a frozen liver biopsy obtained during transplantation procedure, 2 hours after reperfusion', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from transplanted liver, 2 hours after reperfusion', 'characteristics_ch1': 'tissue: transplanted liver, 2 hours after reperfusion;\tgender: female;\tage: 48 years;\tprotocol: cold ischemia_7h 30min; Warm ischemia_40min'}"
2127,"{'title': 'N11063A5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2128,"{'title': 'AML 5356', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 40 years;\tscore: FAB unknown;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: t(6;9);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2129,"{'title': 'BT474_untreated', 'description': 'Untreated control cells in regular growth medium', 'type': 'RNA', 'source_name_ch1': 'BT474', 'characteristics_ch1': 'cell line: BT474 breast cancer cell line;\ttreatment: untreated (control)'}"
2130,"{'title': 'Healthy volunteer HV3', 'description': 'Healthy volunteer', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: Healthy volunteer;\ttherapy: none;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
2131,"{'title': 'HF0963_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2132,"{'title': 'carcinoma_69 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 78;\tlocalization: rectum'}"
2133,"{'title': 'Patient 28, normal', 'description': '13080 2br 1-11-08', 'type': 'RNA', 'source_name_ch1': 'Breast, normal', 'characteristics_ch1': 'tissue: breast;\ttissue type: normal;\tpatient: 28'}"
2134,"{'title': 'Pilocytic astrocytoma chip 8035', 'description': 'Pilocytic astrocytoma.  Chip ID 8035', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
2135,"{'title': 'ADLGD01', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Adenoma with low-grade dysplasia'}"
2136,"{'title': 'Patient 3398 AML10', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 10;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2137,"{'title': 'colonic_crypt_epithelial_cells_carcinoma_21 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: carcinoma;\tsex: female'}"
2138,"{'title': 'ALL without MLL - sample 48', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2139,"{'title': 'Gingival tissue sample 1 from patient 26, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 26 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2140,"{'title': 'lg_NY10', 'description': 'low-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; low-grade dysplastic liver tissue', 'characteristics_ch1': 'low-grade dysplastic liver tissue'}"
2141,"{'title': 'X2219', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : NA;\tConsolidated.Grade : 3'}"
2142,"{'title': 'Replicate 3 for MCF7siRNAESR1_72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 3 for MCF7siRNAESR1_72h breast cell line'}"
2143,"{'title': 'X60318', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2144,"{'title': 'PAF509', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.89;\tdisease activity (das28_v3): 3.81;\tresponse to anti-tnf therapy: MEDIUM'}"
2145,"{'title': 'Patient 5175 AML221', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 221;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2146,"{'title': 'neuron_rep3', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:47, gender:male, diagnostic group: control, PMI:11h'}"
2147,"{'title': 'AML 7061', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 31 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: nd'}"
2148,"{'title': 'MLD AML sample #39', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
2149,"{'title': 'Blood sample from patient 121 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 121;\tday: Day 180;\tage (years): 62;\tsex: Male'}"
2150,"{'title': 'Sepsis gram-positive V30', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
2151,"{'title': 'Tumor 9', 'description': '07SE492', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
2152,"{'title': 'N8380A5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2153,"{'title': 'T1-1 (HCC stage 1-1)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'Human Liver', 'characteristics_ch1': 'Human'}"
2154,"{'title': 'carcinoma_44 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 62;\tlocalization: sigmoid'}"
2155,"{'title': 'Normal breast (B42)', 'description': 'no additional info;\tnone', 'type': 'RNA', 'source_name_ch1': 'B42', 'characteristics_ch1': 'NB'}"
2156,"{'title': 'heterozygot FH P278', 'description': 'Gene expression data from the heterozygous FH participant F', 'type': 'RNA', 'source_name_ch1': 'heterozygot FH P278 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: heterozygote FH'}"
2157,"{'title': 'N30617', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30617;\tsample: normal'}"
2158,"{'title': 'IFNβ_1809', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2159,"{'title': 'Lung Normal 40N', 'description': 'Gene expression data from 40N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 61;\tstage: n/a'}"
2160,"{'title': 'VT_Epidi_norm_50ans_queue', 'description': 'biological rep 3', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus,50 years-old, tail segment', 'characteristics_ch1': 'Seminal vesicles'}"
2161,"{'title': 'B32', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 1.1'}"
2162,"{'title': 'HIV+ Individual HIV-7a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-7a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
2163,"{'title': 'dmso: m3: i3: d05', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 3; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 3;\tReplicate: 3;\tBatch: d05'}"
2164,"{'title': 'high grade serous carcinoma_patient 3_sample 1', 'description': 'Gene expression profile of high grade serous carcinoma of fallopian tube', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected high grade serous carcinoma', 'characteristics_ch1': 'Age: 57;\tCycle: NA;\tBRCA1/2 mutation: Unknown;\tFamily History: No'}"
2165,"{'title': 'S092', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S092', 'characteristics_ch1': 'patient id: P118;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 13.5'}"
2166,"{'title': 'PBMCs_EB_before exercise_01', 'description': 'EB_Pre_063-AG', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 8;\tbefore-exercise'}"
2167,"{'title': 'newly diagnosed multiple myeloma 65', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: I'}"
2168,"{'title': 'AML sample #95', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
2169,"{'title': 'HF0291_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
2170,"{'title': 'DLBCL biopsy, sample 2096', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
2171,"{'title': 'VA155', 'description': '06-18547', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 52;\tgender: F;\tipi_stage: 4A;\ttxprimary: CHOP6-RITU-RITUMAIN;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.84;\tprogression-free_survival (years): 1.84'}"
2172,"{'title': 'NY313', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 46;\tSex: F;\tcode: resection;\tclass: Inflammation;\tafp: 43;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
2173,"{'title': 'Invasive cancer originating in IPMN 1', 'description': 'Gene expression data from microdissected epithelial cells of invasive cancer originating in IPMN', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from invasive cancer originating in IPMN 1', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous neoplasm (IPMN)'}"
2174,"{'title': 'X23030', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2175,"{'title': 'prostate tumor 2', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to prostate invasive tumor', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: tumor'}"
2176,"{'title': 'newly diagnosed multiple myeloma 236', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: I'}"
2177,"{'title': 've_2m57', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
2178,"{'title': 'B47', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 3.5'}"
2179,"{'title': 'B1-RR-Pat.3 [wf20070130u133v2_U_17-B1-Pat.9-WV]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
2180,"{'title': 'N_CD4_4', 'description': 'NS4 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Negative Selection', 'characteristics_ch1': 'age: 33;\tgender: Female;\tt_cell_purity: 94%'}"
2181,"{'title': 'VAN_00694', 'description': '07-30109', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: COMPOSITE (>50% DLBCL, remaining FL);\ttissue: lymph node;\tage: 67;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP6-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.56;\tprogression-free_survival (years): 0.56'}"
2182,"{'title': 'newly diagnosed multiple myeloma 266', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
2183,"{'title': 'UCNR11_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
2184,"{'title': 'NSCLC_AC_202', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 202.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
2185,"{'title': 'Huh7 cells cultured for 48 hours rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
2186,"{'title': 'class S, rep45', 'description': 'VAN_00403.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 37;\tsex: M;\tdisease stage: 2;\talbumin level: 0;\themoglobin level: 0;\tlymphocyte percentage: _;\twhite blood count: 0;\tinternational prognostic score (ips): 4.7'}"
2187,"{'title': 'Donor5_24h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 5 treated with DMSO for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 5;\tagent: control;\ttime: 24h;\tgender: Male;\tage: 73 years old'}"
2188,"{'title': 'mesenchymal stem cells, lot#4F1560, 28th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F1560, passage number 28', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F1560, 28th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
2189,"{'title': 'SS gland, early, patient 20, batch 2', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: early SS'}"
2190,"{'title': 'IRX1', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincIRX5;\treplicate: 1'}"
2191,"{'title': 'Replicate 2 for MCF10A breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2192,"{'title': 'class S, rep24', 'description': 'VAN_00162.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 8;\tsex: F;\tdisease stage: 2;\talbumin level: _;\themoglobin level: _;\tlymphocyte percentage: 100;\twhite blood count: _;\tinternational prognostic score (ips): 0'}"
2193,"{'title': 'Patient_12', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 12;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.564534395214908;\tproliferation index: -4.84416000472863'}"
2194,"{'title': 'adipose_postTZD_IRd_s30', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 30'}"
2195,"{'title': 'AML with normal karyotype #194', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 50;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 69;\tdisease state: de novo AML'}"
2196,"{'title': 'CD49a+ rep2 (stromal cell study)', 'description': 'Prostate stromal fibromuscular cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD49a+ MACS sorted cells'}"
2197,"{'title': 'adipose_postTZD_IRd+_s35', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 35'}"
2198,"{'title': 'adipose_preTZD_NRd_s16', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 16'}"
2199,"{'title': '08SE865HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
2200,"{'title': 'Lung Cancer 97T', 'description': 'Gene expression data from 97T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 69;\tstage: 1A'}"
2201,"{'title': 'control participant P335', 'description': 'Gene expression data from control participant T5', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
2202,"{'title': 'UNTREATED_806', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
2203,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 5', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
2204,"{'title': 'CDcR9_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
2205,"{'title': 'AML sample #55', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00241;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
2206,"{'title': '6459', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 61 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
2207,"{'title': 'brain, unknown: R2A_e1_le2', 'description': 'rotenone 2 weeks A;\tTreatment, type=time_course, measurement=2.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
2208,"{'title': 'HNL-1 (normal liver)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'human liver', 'characteristics_ch1': 'human liver'}"
2209,"{'title': 'MDS patient 141', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
2210,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 24 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 24 hours'}"
2211,"{'title': 'MCF-7_Si-Wu-Tang_0.256mg/ml_rep1', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
2212,"{'title': 'M-10', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
2213,"{'title': 'PCB77 treated HepG2 cells at T24, biological replicate 3', 'description': 'Gene expression data from HepG2 cell lines after 24 hours of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 24 hours of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
2214,"{'title': '3332', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 65 years, FAB M2, cytogenetic good risk, CEBPA wild type'}"
2215,"{'title': 'lg_NY23', 'description': 'low-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; low-grade dysplastic liver tissue', 'characteristics_ch1': 'low-grade dysplastic liver tissue'}"
2216,"{'title': 'MDS patient 154', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
2217,"{'title': 'CHM_FB_27', 'description': 'Strunnikova_27_111308', 'type': 'RNA', 'source_name_ch1': 'primary FB cultures from CHM patients', 'characteristics_ch1': 'cell type: primary fibroblasts cultures;\tdisease: choroideremia'}"
2218,"{'title': 'Patient 4375 AML66', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 66;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: MLL-PTD'}"
2219,"{'title': 'T8642A1.3: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
2220,"{'title': 'AML 7142', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 49 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: double mutant;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
2221,"{'title': 'B28', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: neg;\ttumor type: Mixed;\ttumor size: 5.5'}"
2222,"{'title': 'AML 7319', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 60 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2223,"{'title': 'class F, rep16', 'description': 'NEB_25.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 39;\tsex: M;\tdisease stage: 4;\talbumin level: _;\themoglobin level: 95;\tlymphocyte percentage: 7;\twhite blood count: 20;\tinternational prognostic score (ips): 4.7'}"
2224,"{'title': 'Mature IFN 12h biological replicate 1 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: IFN 12h;\tcell line: BE(2)-C'}"
2225,"{'title': '1006 - mAdbID:70395', 'description': 'mAdb experiment ID: 70395', 'type': 'RNA', 'source_name_ch1': '1006', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1006;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 7.11;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
2226,"{'title': 'UCNR14_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
2227,"{'title': 'Lung Normal 154N', 'description': 'Gene expression data from 154N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 73;\tstage: n/a'}"
2228,"{'title': 'Sepsis gram-positive TP10', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
2229,"{'title': 'UNTREATED_856', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2230,"{'title': 'UCR1_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
2231,"{'title': 'Replicate 1 for CAL51 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2232,"{'title': 'AML 2326', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 30 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: t(9;22);\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
2233,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 48 hours rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
2234,"{'title': 'X23177', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : 2'}"
2235,"{'title': 'mesenchymal stem cells, lot#4F0312, 28th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0312, passage number 28', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0312, 28th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
2236,"{'title': 'heterozygot FH P250', 'description': 'Gene expression data from the heterozygous FH participant V', 'type': 'RNA', 'source_name_ch1': 'heterozygot FH P250 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: heterozygote FH'}"
2237,"{'title': 'Peripheral T-Cell lymphoma, unspecified 28', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-120', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 87;\tgender: male'}"
2238,"{'title': '301733', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7495_Tumor;\tfab: M0;\tSex: M;\trace: W;\tage on study: 76;\tcytogenetic change: ND;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2239,"{'title': 'c_NY104', 'description': 'normal liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; normal liver tissue', 'characteristics_ch1': 'normal liver tissue'}"
2240,"{'title': 'N1-32', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
2241,"{'title': '208027', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7491_Tumor;\tfab: M2;\tSex: F;\trace: Asian;\tage on study: 62;\tcytogenetic change: add(7)(p22);\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 1'}"
2242,"{'title': 'Insulin sensitive patient 9 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: male;\tmetabolic status: insulin sensitive'}"
2243,"{'title': 'Epilepsy patient E3, 6 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E3 taken 6 hours after GC administration.;\t;\tE3-6h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E3, 6 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: dexamethasone;\ttreatment_time: 6 hrs;\tpatient: E3'}"
2244,"{'title': 'Patient 15, normal', 'description': '13201-4br 1-11-08', 'type': 'RNA', 'source_name_ch1': 'Breast, normal', 'characteristics_ch1': 'tissue: breast;\ttissue type: normal;\tpatient: 15'}"
2245,"{'title': 'Healthy control 1', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
2246,"{'title': 'X70039', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2247,"{'title': 'AML with normal karyotype #206', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 53;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
2248,"{'title': 'cord blood 27_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 3.24', 'characteristics_ch1': 'Cord blood arsenic exposure level 3.24;\t'}"
2249,"{'title': 'VAN_00605', 'description': '06-28900', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 69;\tgender: F;\tipi_stage: 2AE;\ttxprimary: CHOP4-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.99;\tprogression-free_survival (years): 0.99'}"
2250,"{'title': 'GA_883', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2251,"{'title': 'dmso: m2: i3: d03', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 2; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 2;\tReplicate: 3;\tBatch: d03'}"
2252,"{'title': 'AML with normal karyotype #104', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 75;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 94;\tdisease state: de novo AML'}"
2253,"{'title': 'Gingival tissue sample 2 from patient 81, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 81 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2254,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_7_4)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 50;\tSex: M'}"
2255,"{'title': 'Thyroid_ unaffected_paired with PTC26T', 'description': 'sample name in manuscript: N-PTC3', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: normal thyroid; Gender:male; Age:43'}"
2256,"{'title': 'Muscle-FamilyHistoryPositive-11', 'description': 'Jos3714;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 21;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 27;\tfasting glucose (ogtt): 84.5;\t2 hour glucose (ogtt): 114;\themoglobin a1c: 4.5;\tfasting glucose (iv0gavg): 83;\tfasting insulin (iv0inavg): 14.3;\tsi: 1.34;\twaist hip ratio: 0.948'}"
2257,"{'title': 'AML 2305', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 27 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2258,"{'title': 'newly diagnosed multiple myeloma 249', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
2259,"{'title': 'Hippocampus_female_74yrs_indiv38', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 74 years', 'characteristics_ch1': 'individual: 38, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 74'}"
2260,"{'title': 'Adipose tissue_428_control_rep5', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, normal weight, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: normal weight;\tgender: M;\tage: 7 year;\tz score bmi: -0.64'}"
2261,"{'title': 'group-2-pt-t16934338', 'description': 'group-2-pt-t16934338', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 33;\tgender: female;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
2262,"{'title': 'PBMCs treated at the IC90 for 2 hours,replicate 5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 2 hours,replicate 5', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
2263,"{'title': 'MDS patient 11', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
2264,"{'title': 'ISC Control heart, technical replicate B RMA', 'description': 'Gene expression data from left ventricle of human heart with no LMNA mutation', 'type': 'RNA', 'source_name_ch1': 'left ventricle patient with ischemic cardiomyopathy', 'characteristics_ch1': 'gender: male;\tdevelopmental stage: adult;\torgan: heart;\ttissue: left ventricle;\tgenotype: LMNA wt;\tdata analysis algorithm: RMA'}"
2265,"{'title': 'mesenchymal stem cells, lot#4F0591, 7th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0591, passage number 7', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0591, 7th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
2266,"{'title': 'Lung Cancer 148T', 'description': 'Gene expression data from 148T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 56;\tstage: 1A'}"
2267,"{'title': 'FL2', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'follicular lymphoma case 2', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with follicular lymphoma (FL)'}"
2268,"{'title': 'mRNA of IBT-HGG072, Anaplastic PXA, 7 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 7 years', 'characteristics_ch1': 'disease: Anaplastic PXA;\tage: 7 years'}"
2269,"{'title': 'VA134', 'description': '02-30519', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: NC;\tpathology: DLBC;\ttissue: tonsil;\tage: 23;\tgender: M;\tipi_stage: 2AE;\ttxprimary: CHOP3-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.07;\tprogression-free_survival (years): 5.07'}"
2270,"{'title': 'MCSF_B', 'description': 'MCSF_B', 'type': 'RNA', 'source_name_ch1': 'primary human monocyte-derived macrophages', 'characteristics_ch1': 'cell type: primary human monocyte-derived macrophages;\tdifferentiation factor: MCSF'}"
2271,"{'title': 'Lung Cancer 152T', 'description': 'Gene expression data from 152T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 62;\tstage: 1A'}"
2272,"{'title': 'Control 32', 'description': '07SE524', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
2273,"{'title': 'MCF10A cells cocultured with normal breast fibroblasts that extracted from normal breast tissue sample No 23', 'description': 'gene expression data from MCF10A cells cocultured with breast fibroblasts', 'type': 'RNA', 'source_name_ch1': 'MCF10A cells', 'characteristics_ch1': 'cell line, normal mammary epithelium, immortalized'}"
2274,"{'title': '2.2.AF.18', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 18 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: AF;\thours post infection: 18'}"
2275,"{'title': 'Patient 4451 AML102', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 102;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
2276,"{'title': 'class F, rep12', 'description': 'NEB_19.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 37;\tsex: F;\tdisease stage: 2;\talbumin level: 34;\themoglobin level: 105;\tlymphocyte percentage: 20;\twhite blood count: 10.4;\tinternational prognostic score (ips): 2'}"
2277,"{'title': 'MLD AML sample #10', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
2278,"{'title': 'Promyelocytes_normal_bone_marrow_5', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'Promyelocytes sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
2279,"{'title': 'PCB153 treated HepG2 cells at T18, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines after 18 hours of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
2280,"{'title': 'Activated CD8+ T-cells with anti-CD3, anti-CD28 and IL-12 and harvested after 24 hours incubation', 'description': 'Gene expression data from resting CD8+ T-cells.;\tCD8-T24', 'type': 'RNA', 'source_name_ch1': 'Normal CD8+ T-cell subset', 'characteristics_ch1': 'cell type: CD8+ T-cell'}"
2281,"{'title': 'T51681', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51681;\tsample: tumor'}"
2282,"{'title': 'VT_Epidi_norm_26ans_queue', 'description': 'biological rep 3', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus,26 years-old, tail segment', 'characteristics_ch1': 'Seminal vesicles'}"
2283,"{'title': 'AML 6892', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 21 years;\tscore: FAB M1;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2284,"{'title': 'Control Con_rep13', 'description': 'Control paired  20', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
2285,"{'title': 'AML 2296', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2286,"{'title': 'prostate normal 2', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal prostate stroma', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: normal'}"
2287,"{'title': 'H438 Myclobutanil 100uM', 'description': 'H438 Myclobutanil 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 Myclobutanil 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
2288,"{'title': 'C008_Control_F_94', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 94;\tpost-mortem delay: 9.5h;\tph: 6.3'}"
2289,"{'title': 'UNTREATED_1672', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2290,"{'title': 'Sample 6: normal ovarian surface epithelium', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: Normal'}"
2291,"{'title': 'mock-infected, normal S13 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, normal S13', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
2292,"{'title': 'AML 6369', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2293,"{'title': 'VT_Epidi_norm_26ans_tete', 'description': 'biological rep 1', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus,26 years-old, head segment', 'characteristics_ch1': 'Seminal vesicles'}"
2294,"{'title': 'Peripheral T-Cell lymphoma, unspecified 4', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-100', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 79;\tgender: female'}"
2295,"{'title': 'class S, rep31', 'description': 'VAN_00183.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 20;\tsex: F;\tdisease stage: 2;\talbumin level: 45;\themoglobin level: 113;\tlymphocyte percentage: 16;\twhite blood count: 13.5;\tinternational prognostic score (ips): 1'}"
2296,"{'title': 'MDS patient 105', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
2297,"{'title': 'endothelial_rep3', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:37h'}"
2298,"{'title': 'DietResistant _1 day_subject3', 'description': 'DietResistant _1 day_subject3', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 3;\tgender: Female'}"
2299,"{'title': 'C98358', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7220_Tumor;\tfab: M2;\tSex: F;\trace: C;\tage on study: 22;\tcytogenetic change: t(8;21)(q22;q22);\tflt3 d835: 1;\tflt3 itd: 1;\tnpm1 ins: 0'}"
2300,"{'title': 'Septic Shock_biological rep66 10-0009', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.9;\toutcome: Survivor;\tgroup: C'}"
2301,"{'title': 'MDS patient 145', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
2302,"{'title': 'csc: m1: i3: d08', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 1; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 1;\tReplicate: 3;\tBatch: d08'}"
2303,"{'title': 'NSCLC EMC ADC2277N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
2304,"{'title': '476', 'description': '00-26427', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 72;\tgender: M;\tipi_stage: 4B;\ttxprimary: CHOP6-RITU-RAD;\tstatus: free of disease after treatment for first relapse;\tcode_os: alive;\tcode_pfs: dead;\toverall_survival (years): 7.32;\tprogression-free_survival (years): 3.46'}"
2305,"{'title': 'Adipose tissue_422_obese_rep5', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, obese, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: obese;\tgender: M;\tage: 10 years;\tz score bmi: 2.72'}"
2306,"{'title': 'AML without MLL - sample 110', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2307,"{'title': 'Gingival tissue sample 1 from patient 33, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 33 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2308,"{'title': 'IFNβ_1215', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2309,"{'title': '22075', 'description': '11726', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24300;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
2310,"{'title': '295', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9833_Tumor;\tfab: M2;\tSex: F;\trace: AA;\tage on study: 76;\tcytogenetic change: ND;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
2311,"{'title': 'AML with normal karyotype #225', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: >30;\tdisease state: de novo AML'}"
2312,"{'title': 'Patient 4706 AML139', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 139;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2313,"{'title': 'colon_adenoma_983', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
2314,"{'title': 'adipose_preTZD_IRd+_s43', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 43'}"
2315,"{'title': 'MERLION_X04K00321', 'description': 'MERLION_X04K00321', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=68, state=0', 'characteristics_ch1': 'pT2N0, male, age=68, state=0'}"
2316,"{'title': 'Patient_45', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 45;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.181427505355961;\tproliferation index: -12.4602631319388'}"
2317,"{'title': 'HUVECs  treated with 10 ng/ml IL1-beta for 4 hours in EGM2 media', 'description': 'Test for HUVEC activation by the inflammatory factor', 'type': 'RNA', 'source_name_ch1': 'Human umbilical vein endothelial cells  treated with IL1-beta', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
2318,"{'title': '263578', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6327_Tumor;\tfab: M2;\tSex: F;\trace: W;\tage on study: 52;\tcytogenetic change: t(8;21)(q22;q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2319,"{'title': 'S021_Scz_M_71', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 71;\tpost-mortem delay: 6.5h;\tph: 6'}"
2320,"{'title': 'Primary hepatocyte, biological replicate 1', 'description': 'PH_1', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocyte', 'characteristics_ch1': 'cell type: primary hepatocyte;\tgender: female'}"
2321,"{'title': 'AML 2256', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 51 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2322,"{'title': 'a_NY70', 'description': 'advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; advanced HCC', 'characteristics_ch1': 'advanced HCC'}"
2323,"{'title': 've_NY6', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
2324,"{'title': 'Lung Cancer 131T', 'description': 'Gene expression data from 131T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 71;\tstage: 1B'}"
2325,"{'title': 'Patient 3418 AML18', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 18;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
2326,"{'title': 'HUVEC_TNFa_1h45m', 'description': '1h45m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 1h45m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
2327,"{'title': 'Hippocampus_female_44yrs_indiv80', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 44 years', 'characteristics_ch1': 'individual: 80, AA;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 44'}"
2328,"{'title': 'AML sample #86', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
2329,"{'title': 'cord blood 11', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.62', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.62;\t'}"
2330,"{'title': 'AML with normal karyotype #204', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 30;\tdisease state: t-AML'}"
2331,"{'title': 'negative control transfection for 8 hours', 'description': 'negative control transfection for 8 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
2332,"{'title': 'hf240-NS-B', 'description': 'U133Plus2_122906L_DK12.CEL', 'type': 'RNA', 'source_name_ch1': 'human foetal cortex derived NS cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: non-malignant;\tcell type: cell line;\tcell type: neural stem'}"
2333,"{'title': 'pCR breast biopsy, sample 16 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 16 rep 1', 'characteristics_ch1': 'pathological complete response: yes;\ttissue: Breast tumor biopsy'}"
2334,"{'title': 'newly diagnosed multiple myeloma 208', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
2335,"{'title': 'Pilocytic astrocytoma chip 7745', 'description': 'Pilocytic astrocytoma.  Chip ID 7745', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
2336,"{'title': 'non-malignant FTEb_patient 2', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 45;\tCycle: Luteal;\tBRCA1/2 mutation: BRCA1 185delAG;\tFamily History: Yes'}"
2337,"{'title': 'SI4', 'description': 'Gene expression data from Standard Immunotherapy 4', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 4', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
2338,"{'title': 'ESCC_6', 'description': 'ESCC, TNM stage III, moderately differentiated', 'type': 'RNA', 'source_name_ch1': 'ESCC tumor tissue 6', 'characteristics_ch1': 'tissue: esophagus, tumor;\tgender: male, Japanese;\tage: 76'}"
2339,"{'title': 'Insulin resistant patient 12 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
2340,"{'title': 'AML 6239', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 42 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2341,"{'title': 'AML 3484', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 60 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2342,"{'title': 'AML 2749', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2343,"{'title': 'Normal N3', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary lung', 'characteristics_ch1': 'male pulmonary lung;\tnormal tissue'}"
2344,"{'title': 'HF0835_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
2345,"{'title': 'newly diagnosed multiple myeloma 303', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: I'}"
2346,"{'title': 'group-2-pt-t15733320', 'description': 'group-2-pt-t15733320', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 40;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
2347,"{'title': 'NY16', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: CTNNB1;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pAkt : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
2348,"{'title': 'FHC - control 2', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Control 2', 'characteristics_ch1': 'Gender: male;\tAge: 33 years ;\tDisease: none;\tDrugs: none;\tTissue: blood'}"
2349,"{'title': '01-0058B_Septic Shock_day3_11', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2350,"{'title': 'AML 7074', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 45 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2351,"{'title': 'Promyelocytes_normal_bone_marrow_3', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'Promyelocytes sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
2352,"{'title': 'X536', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
2353,"{'title': 'AML 2279', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2354,"{'title': 'group-2-pt-t7061623', 'description': 'group-2-pt-t7061623', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 28;\tgender: female;\tfinal disposition: control'}"
2355,"{'title': 'Sputum from Stage III Severe, biological replicate 4', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 60;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
2356,"{'title': 'Foot siTUG1 Replicate 1', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siTUG1;\treplicate: 1'}"
2357,"{'title': '7148', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 75 years, FAB M1, cytogenetic intermediate risk, CEBPA double mutant'}"
2358,"{'title': 'DLBCL biopsy, sample 2065', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
2359,"{'title': '447649', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6333_Tumor;\tfab: M3;\tSex: M;\trace: W;\tage on study: 74;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
2360,"{'title': 'T133 U133p2', 'description': 'bulk breast tumor RNA from patient T133', 'type': 'RNA', 'source_name_ch1': 'T133', 'characteristics_ch1': 'breast tumor'}"
2361,"{'title': 'newly diagnosed multiple myeloma 6', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
2362,"{'title': 'Lung Normal 33N', 'description': 'Gene expression data from 33N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 69;\tstage: n/a'}"
2363,"{'title': 'adipose_postTZD_IRd+_s40', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 40'}"
2364,"{'title': 'TonsilPool-CD3-1', 'description': 'Project: Cell-Specific Gene Expression in Langerhans Cell Histiocytosis.', 'type': 'RNA', 'source_name_ch1': 'Sorted CD3+ Cells from 5 pooled tonsils (presumably normal).', 'characteristics_ch1': 'tissue: tonsils;\tcell type: CD3+'}"
2365,"{'title': 'sample 4, brca1 mutation positive, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: luteal;\tsample identifier: 4'}"
2366,"{'title': 'BL41 60 min tc-RNA Rep.3', 'description': 'total cellular RNA (tc-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
2367,"{'title': 'Patient 6, biopsy; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
2368,"{'title': 'non-pCR breast biopsy, sample 4 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 4 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
2369,"{'title': 'MDA-MB-231_emetine_10h', 'description': 'Cells treated with emetine for 10 hours.', 'type': 'RNA', 'source_name_ch1': 'MDA-MB-231', 'characteristics_ch1': 'cell line: MDA-MB-231 breast cancer cell line;\ttreatment: emetine;\ttime: 10h'}"
2370,"{'title': 'Proficiency_Site10_06', 'description': 'Performed by Operator 1 from Site10 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
2371,"{'title': 'S043', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S043', 'characteristics_ch1': 'patient id: P038;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 40'}"
2372,"{'title': '23062', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant KRAS;\tGrade Low;\tStage IIIC;\tMicropapillary feature Negative;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
2373,"{'title': 'Patient_5978_relapse', 'description': '5978R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pro-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 8;\tconclusions ig/tcr: unstable;\tselected: yes'}"
2374,"{'title': 'EntorhinalCortex_female_47yrs_indiv88', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 47 years', 'characteristics_ch1': 'individual: 88, AA;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 47'}"
2375,"{'title': 'class S, rep52', 'description': 'VAN_00413.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 74;\tsex: F;\tdisease stage: 1;\talbumin level: 48;\themoglobin level: 133;\tlymphocyte percentage: 21;\twhite blood count: 9.5;\tinternational prognostic score (ips): 2'}"
2376,"{'title': 'Tumor 46', 'description': '08SE356', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
2377,"{'title': 'DLBCL biopsy, sample 2067', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
2378,"{'title': 'AML sample #52', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
2379,"{'title': 'NLPHL_lymph_node_case5', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: male, Age: 67, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, An Arbor Stage: IIA, follow-up: 8 years; status at last follow-up: died of squamous cell carcinoma of the lung""}"
2380,"{'title': 'Pilocytic astrocytoma chip 7755', 'description': 'Pilocytic astrocytoma.  Chip ID 7755', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
2381,"{'title': 'adipose_postTZD_NRd_s18', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 18'}"
2382,"{'title': 'C981301', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7380_Tumor;\tfab: M1;\tSex: M;\trace: C;\tage on study: 22;\tcytogenetic change: del(7)(p13p15);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2383,"{'title': 'AML 7171', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 22 years;\tscore: FAB unknown;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: 11q23;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2384,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R17', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 32.89;\t%cd3cd8: 61.26;\t%cd8+cd28-: 46.02;\t%cd8+cd28+: 7.90;\t%cd4cd25cd62l: 2.30;\t%cd3delta1: 1.18;\t%cd3delta2: 1.86;\tratio delta1/delta2: 0.63;\t%cd3gammadelta: 3.16;\t%cd3alphabeta: 95.43;\t%cd4cd8-ab+(dn): 1.34;\t%cd4 cd62l+cd45+: 58.36;\t%cd4 cd62l-cd45+: 5.20;\t%cd4 cd62l - cd45-: 10.40;\t%cd4cd62l+cd45-: 26.04;\t%cd4 ccr7+ cd45 -: 15.27;\t%cd4 ccr7+ cd45+: 22.71;\t%cd4 ccr7 - cd45+: 39.50;\t%cd4 ccr7 – cd45-: 22.52;\t%cd8 cd62l+ cd45-: 5.48;\t%cd8cd62l+ cd45+: 74.07;\t%cd8cd62l- cd45+: 17.99;\t%cd8cd62l- cd45 -: 2.45;\t%cd8ccr7+ cd45-: 0.30;\t%cd8ccr7+ cd45+: 2.69;\t%cd8ccr7-cd45+: 90.13;\t%cd8ccr7-cd45 -: 6.88;\t%cd3-cd56+cd16+: 2.39;\t%nkts: 5.06;\t%cd19: 2.42;\t%cd4foxp3+: 3.97'}"
2385,"{'title': 'Monocyte High PBM 9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 9'}"
2386,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 20', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
2387,"{'title': 'Replicate 1 for AU565 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2388,"{'title': '22023', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 2;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
2389,"{'title': 'T8642A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
2390,"{'title': 'Subcutaneous adipose tissue, SAT8', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
2391,"{'title': 'IFNβ_1682', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
2392,"{'title': 'DLBCL biopsy, sample 2017', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
2393,"{'title': 'Lung-sarcoidosis-rep6', 'description': 'frozen sarcoidosis lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen sarcoidosis lung tissue', 'characteristics_ch1': 'disease state: sarcoidosis;\tbiopsy type: surgical;\ttissue: lung'}"
2394,"{'title': 'X351', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2395,"{'title': 'Lung Normal 116N', 'description': 'Gene expression data from 116N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 61;\tstage: n/a'}"
2396,"{'title': 'Liver_hyperglycima_no.5', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: type 2 diabetes'}"
2397,"{'title': 'Lung-sarcoidosis-rep4', 'description': 'frozen sarcoidosis lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen sarcoidosis lung tissue', 'characteristics_ch1': 'disease state: sarcoidosis;\tbiopsy type: surgical;\ttissue: lung'}"
2398,"{'title': 'Lung Normal 159N', 'description': 'Gene expression data from 159N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 59;\tstage: n/a'}"
2399,"{'title': 'Stable-P8', 'description': 'Stable-P8', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Stable'}"
2400,"{'title': 'S149', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S149', 'characteristics_ch1': 'patient id: P010;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
2401,"{'title': 'newly diagnosed multiple myeloma 228', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
2402,"{'title': 'human left atrial_control_1', 'description': 'K4_control', 'type': 'RNA', 'source_name_ch1': 'human left atrial appendage - control', 'characteristics_ch1': 'tissue: left atrial appendage'}"
2403,"{'title': 'Sepsis gram-negative V22', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
2404,"{'title': 'Blood - Sarcoidosis - 034A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Female;\tage: 59;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
2405,"{'title': 'AML sample #31', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00077;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2406,"{'title': 'NOB1228', 'description': 'Brain tissue from glioblastopma patient NOB1228', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from patient NOB1228', 'characteristics_ch1': 'primary GBM'}"
2407,"{'title': 'AML 6360', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 30 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2408,"{'title': 'Insulin resistant patient 1 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
2409,"{'title': 'NSCLC EMC SCC2235N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
2410,"{'title': 'AML 2245', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 47 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2411,"{'title': 'Blood sample from patient 174 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 174;\tday: Day 90;\tage (years): 56;\tsex: Female'}"
2412,"{'title': 'Blood_TD32681_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Male;\tage: 12;\ttissue: whole blood'}"
2413,"{'title': 'STXBP3', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincSTXBP5;\treplicate: 3'}"
2414,"{'title': 'GBM, radiotherapy (284)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 284;\tage: 51.5;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 26.74;\tmgmt status: M'}"
2415,"{'title': 'NSG508', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.25;\tdisease activity (das28_v3): 3.77;\tresponse to anti-tnf therapy: NORESPONSE'}"
2416,"{'title': 'negative control transfection for 120 hours', 'description': 'negative control transfection for 120 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
2417,"{'title': 'Gingival tissue sample 1 from patient 78, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 78 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2418,"{'title': 'Muscle-FamilyHistoryPositive-20', 'description': 'Jos3732;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 43;\tfamily history: Family history positive - 2 parents;\tbody mass index (kg/m2): 25;\tfasting glucose (ogtt): 83.5;\t2 hour glucose (ogtt): 90;\themoglobin a1c: 4.6;\tfasting glucose (iv0gavg): 77;\tfasting insulin (iv0inavg): 1.5;\tsi: 8.43;\twaist hip ratio: 0.784'}"
2419,"{'title': 'Huh7 cells_Mock Infected 48 hours_ rep2', 'description': 'Gene expression data from Huh7 cells treated with mock media for 48 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 48 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
2420,"{'title': 'Angioimmunoblastic T-cell lymphoma 12', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-148', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 51;\tgender: male'}"
2421,"{'title': 'T119 U133p2', 'description': 'bulk breast tumor RNA from patient T119', 'type': 'RNA', 'source_name_ch1': 'T119', 'characteristics_ch1': 'breast tumor'}"
2422,"{'title': 'AML 2261', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 37 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2423,"{'title': 'T10781D2: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
2424,"{'title': 'newly diagnosed multiple myeloma 13', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: I'}"
2425,"{'title': 'Mature IFN 6h biological replicate 2 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: IFN 6h;\tcell line: BE(2)-C'}"
2426,"{'title': 'AML with normal karyotype #220', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 35;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Peripheral Blood;\tblast cell percentage: 93;\tdisease state: de novo AML'}"
2427,"{'title': 'C126', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 3.0'}"
2428,"{'title': 'GBM, TMZ/radiotherapy (30)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 30;\tage: 61;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 6.94;\tmgmt status: M'}"
2429,"{'title': 'T51722', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51722;\tsample: tumor'}"
2430,"{'title': 'colon_adenoma_1830', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
2431,"{'title': 'Young trained subject, biological replicate (YT5)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
2432,"{'title': 'ALL without MLL - sample 44', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2433,"{'title': 'AML sample #79', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
2434,"{'title': 'PC4', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'plasma cells donor 4', 'characteristics_ch1': 'plasma cells, isolated from tonsils by fluorescence-activated cell sorting'}"
2435,"{'title': 'Replicate 2 for MCF7control72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 2 for MCF7control72h breast cell line'}"
2436,"{'title': 'Seminal vesicle, biological replicate 4', 'description': 'Gene expression from adult Human seminal vesicle', 'type': 'RNA', 'source_name_ch1': 'Normal seminal vesicle from adult man', 'characteristics_ch1': 'tissue: Seminal vesicle;\tage: adult'}"
2437,"{'title': 'H448 Myclobutanil 100uM', 'description': 'H448 Myclobutanil 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H448 Myclobutanil 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
2438,"{'title': 'non-pCR breast biopsy, sample 5 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 5 rep 2', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
2439,"{'title': 'PGA-Hs_S-2', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
2440,"{'title': 'AML 7081', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 43 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2441,"{'title': 'Adenocarcinoma, bone marrow positive AC 30', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'male pulmonary adenocarcinoma;\tbone marrow positive'}"
2442,"{'title': 'Training_Site11_08', 'description': 'Performed by Operator 2 from Site11 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 77.54588; Lot# = 035PO41658D'}"
2443,"{'title': 'HF1318_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2444,"{'title': 'Insulin sensitive patient 4 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
2445,"{'title': 'Young rep3', 'description': 'Early passage BJ fibroblasts, grown in serum-free media for 72hrs at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Early passage human foreskin BJ fibroblasts'}"
2446,"{'title': 'AML 6365', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 56 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2447,"{'title': 'colon_IBD_1665', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
2448,"{'title': 'adipose_preTZD_IRd+_s35', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 35'}"
2449,"{'title': 'MDS patient 73', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
2450,"{'title': 'Group A-IVIG-Pre-1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-responsive patient, pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-responsive patient;\ttreatment: IVIG;\ttime: pre-treatment'}"
2451,"{'title': 'AML sample #102', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
2452,"{'title': 'X70144', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IA;\tConsolidated.Grade : 3'}"
2453,"{'title': 'C010_Control_F_90', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 90;\tpost-mortem delay: 12.5h;\tph: 5.7'}"
2454,"{'title': 'Sputum from Stage III Severe, biological replicate 46', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 55;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
2455,"{'title': 'HC5', 'description': 'Gene expression data from Healthy Control 5', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 5', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
2456,"{'title': 'Blood sample from patient 154 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 154;\tday: Day 90;\tage (years): 37;\tsex: Female'}"
2457,"{'title': 'WI38, biological replicate 3', 'description': 'gene expression from WI38, biological replicate 3', 'type': 'RNA', 'source_name_ch1': 'WI38 cells from ATCC', 'characteristics_ch1': 'cell type: fibroblast;\tcell line: WI38'}"
2458,"{'title': 'DietSensitive _6 weeks_subject9', 'description': 'DietSensitive _6 weeks_subject9', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 9;\tgender: Male'}"
2459,"{'title': 'KT0325_6_L_test3', 'description': 'KT0325_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set3', 'characteristics_ch1': '6 months, living donor, test set3'}"
2460,"{'title': 'MDS patient 80', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: del5q plus other'}"
2461,"{'title': 'Training_Site1_08', 'description': 'Performed by Operator 1 from Site1 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
2462,"{'title': 'PNS038', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.18;\tdisease activity (das28_v3): 3.92;\tresponse to anti-tnf therapy: MEDIUM'}"
2463,"{'title': 'brain, unknown: R2A_e1_le1', 'description': 'rotenone 2 weeks A;\tTreatment, type=time_course, measurement=2.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
2464,"{'title': 'csc: m3: i1: d04', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 3; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 3;\tReplicate: 1;\tBatch: d04'}"
2465,"{'title': 'AML sample #41', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
2466,"{'title': 'CDcNR3_afterT', 'description': 'Colonic mucosal gene expression data from CDc non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
2467,"{'title': '1383 (HIV+)', 'description': 'Gene expression data from frozen ARL tumor specimen', 'type': 'RNA', 'source_name_ch1': 'Frozen Tumor Biopsy_Colon', 'characteristics_ch1': 'specimen: frozen ARL tumor biopsy;\ttumor biopsy origin: Colon;\tage at diagnosis: 35;\tgender: Male;\tpathology diagnosis: DLBCL;\tmolecular diagnosis: GCB DLBCL;\tebv status: positive'}"
2468,"{'title': 'CDcNR3_beforeT', 'description': 'Colonic mucosal gene expression data from CDc non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
2469,"{'title': 'Blood Sample of subject 25 after inhalation; Group B: inhalation with 0.7 ppm FA 24 h before sampling', 'description': 'Bl_Group_B_AI_subject_25', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 24 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 24 h;\tsubject: 25;\tgroup: B'}"
2470,"{'title': 'N8653E4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2471,"{'title': 'B82', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 60;\tSex: F;\tcode: resection;\tclass: Unannotated;\tafp: 2;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
2472,"{'title': 'GBM, radiotherapy (283)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 283;\tage: 56.9;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 7.5;\tmgmt status: M'}"
2473,"{'title': 'IFNβ_567', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2474,"{'title': 'AML sample #30', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
2475,"{'title': 'AML sample #59', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00258;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
2476,"{'title': 'AML 7076', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 40 years;\tscore: FAB M0;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2477,"{'title': 'Gingival tissue sample 2 from patient 76, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 76 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2478,"{'title': 'PBMCs_LB_before exercise_11', 'description': 'LB_Pre_009-GR', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 17;\tbefore-exercise'}"
2479,"{'title': 'MLD AML sample #14', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
2480,"{'title': 'cin_NY42B', 'description': 'cirrhotic liver tissue from patients without HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue from patients without HCC', 'characteristics_ch1': 'cirrhotic liver tissue from patients without HCC'}"
2481,"{'title': 'ALL without MLL - sample 16', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2482,"{'title': 'No27LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No27;\tcell type: lymphocytes;\ttime point: before therapy'}"
2483,"{'title': 'TC.CD8-4', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
2484,"{'title': 'Monocyte_patient45_time1', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:African-american,Age:32,VAP day:3'}"
2485,"{'title': 'newly diagnosed multiple myeloma 26', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: I'}"
2486,"{'title': 'Recurrent GBM, TMZ/radiotherapy (1622R)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: recurrent GBM;\tpatient: 1621;\tage: 61.8;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 25.13;\tmgmt status: M'}"
2487,"{'title': 'SCRB', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 3'}"
2488,"{'title': 'muscle_preTZD_preClamp_IRd+_s43', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 43'}"
2489,"{'title': 'Lung Normal 37N', 'description': 'Gene expression data from 37N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 57;\tstage: n/a'}"
2490,"{'title': 'Seminal vesicle, biological replicate 2', 'description': 'Gene expression from adult Human seminal vesicle', 'type': 'RNA', 'source_name_ch1': 'Normal seminal vesicle from adult man', 'characteristics_ch1': 'tissue: Seminal vesicle;\tage: adult'}"
2491,"{'title': 'AML 2290', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 41 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2492,"{'title': 'Ultrafine particle exposure 1 -24 hours post-exposure', 'description': 'Gene expression data from circulating mononuclear cells after ultrafine carbon particle exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells after exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: UFP;\ttime: 24 hours'}"
2493,"{'title': 'Metastatic prostate cancer W1', 'description': 'metastatic prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'metastatic, prostate cancer'}"
2494,"{'title': 'IFNβ_868', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2495,"{'title': 'PTCL_026', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
2496,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_3d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
2497,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 8', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
2498,"{'title': 'Sputum from Stage II Moderate, biological replicate 16', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 60;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
2499,"{'title': 'Healthy donor, 24 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of a healthy donor taken 24 hours after GC administration.;\t;\tRPK-II-24h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, healthy donor, 24 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: healthy;\ttreatment: dexamethasone;\ttreatment_time: 24 hrs'}"
2500,"{'title': 'GA_934', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2501,"{'title': 'C154', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.1'}"
2502,"{'title': 'AML with normal karyotype #79', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 71;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 60;\tdisease state: de novo AML'}"
2503,"{'title': 'ALL without MLL - sample 77', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2504,"{'title': 'Capan-1 V1 mock', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Capan-1 cells mock-transfected', 'characteristics_ch1': 'cell line: Capan-1;\tcell type: pancreatic carcinoma cells;\tp16 restoration: no'}"
2505,"{'title': 'UNTREATED_837', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
2506,"{'title': 'MDS patient 164', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
2507,"{'title': 'D_KJne div U133 Plus 2.0', 'description': 'Gene expression data from peripheral blood sample', 'type': 'RNA', 'source_name_ch1': 'Human peripheral blood sample', 'characteristics_ch1': 'tissue: blood;\tdisease state: Diverticulitis'}"
2508,"{'title': 'AML 7178', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 28 years;\tscore: FAB M5;\trisk: unknown;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2509,"{'title': 'Quadriceps muscle at T1, control patient 4', 'description': 'Gene expression data from quadriceps muscle biopsy of control patient', 'type': 'RNA', 'source_name_ch1': 'Quadriceps muscle, control patient, T1', 'characteristics_ch1': 'tissue type: Quadriceps muscle;\tpatient group: total knee arthroplasty control patient;\ttime point: T1'}"
2510,"{'title': 'colonic_mucosa_inflamation_94', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible'}"
2511,"{'title': 'HBE_t0_code3', 'description': 'Gene expression data from human airway epithelium treated as described.', 'type': 'RNA', 'source_name_ch1': 'well-differentiated primary airway bronchial culture', 'characteristics_ch1': 'Genotype:normal'}"
2512,"{'title': '7323', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 67 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
2513,"{'title': '3.2.NDV.8', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 8 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 8'}"
2514,"{'title': 'ALL without MLL - sample 20', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2515,"{'title': 'Gingival tissue sample 1 from patient 34, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 34 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2516,"{'title': 'SH-SY5Y(ECACC)_RA_5d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
2517,"{'title': '488', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage III;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
2518,"{'title': 'Healthy control 2', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
2519,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_7_5)', 'description': 'Gene expression data from whole blood 30 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 50;\tSex: M'}"
2520,"{'title': 'newly diagnosed multiple myeloma 212', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
2521,"{'title': 'Angioimmunoblastic T-cell lymphoma 11', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-146', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 78;\tgender: male'}"
2522,"{'title': 'DM2_F55_?_20', 'description': 'DM2 patient, age 55, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site:  unknown'}"
2523,"{'title': 'ALCL_AV_001', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
2524,"{'title': 'Sputum from Stage II Moderate, biological replicate 23', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 64;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
2525,"{'title': 'MDA-MB-468_untreated', 'description': 'Untreated control cells in regular growth medium', 'type': 'RNA', 'source_name_ch1': 'MDA-MB-468', 'characteristics_ch1': 'cell line: MDA-MB-468 breast cancer cell line;\ttreatment: untreated (control)'}"
2526,"{'title': 'C97408', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7226_Tumor;\tfab: M4;\tSex: F;\trace: C;\tage on study: 33;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
2527,"{'title': '15-0008_Septic Shock_day3_213', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2528,"{'title': 'Healthy volunteer HV7', 'description': 'Healthy volunteer', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: Healthy volunteer;\ttherapy: none;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
2529,"{'title': 'Muscle-FamilyHistoryPositive-23', 'description': 'Jos3738;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 40;\tfamily history: Family history positive - 2 parents;\tbody mass index (kg/m2): 35;\tfasting glucose (ogtt): 98;\t2 hour glucose (ogtt): 155;\themoglobin a1c: 5.4;\tfasting glucose (iv0gavg): 101;\tfasting insulin (iv0inavg): 13.8;\tsi: 2.2;\twaist hip ratio: 0.958'}"
2530,"{'title': 'PCSC-2 sphere biol repl 1', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-2 spheres 7 days in SCM-1% KO', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-2;\tculture type: sphere'}"
2531,"{'title': 'Lung-normal-rep2', 'description': 'frozen normal lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen disease-free lung tissue', 'characteristics_ch1': 'disease state: normal;\tbiopsy type: surgical;\ttissue: lung'}"
2532,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 24 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 24 hours'}"
2533,"{'title': 'Insulin resistant patient 8 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
2534,"{'title': 'B2-Non-RR-11 [wf20070130u133v2_U_14-B2-Pat.8-WE]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
2535,"{'title': '12 hours post-infection, biological rep2', 'description': 'Gene expression data from cells 12 hours after HCMV infection', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
2536,"{'title': 'Pt4 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt4_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 4', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 4'}"
2537,"{'title': 'PGA-Hs_S-6', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
2538,"{'title': 'newly diagnosed multiple myeloma 91', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
2539,"{'title': '957664', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9848_Tumor;\tfab: M5;\tSex: M;\trace: W;\tage on study: 76;\tcytogenetic change: trisomy 8;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
2540,"{'title': 'AML with normal karyotype #226', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 91;\tdisease state: de novo AML'}"
2541,"{'title': 'Young trained subject, biological replicate (YT10)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
2542,"{'title': 'MLD AML sample #25', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
2543,"{'title': 'cord blood 13_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 13.76', 'characteristics_ch1': 'Cord blood arsenic exposure level 13.76;\t'}"
2544,"{'title': 'group-1-pt-t16744186', 'description': 'group-1-pt-t16744186', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 28;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
2545,"{'title': '22105', 'description': '11866', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: African American;\tGender: F;\tTSP_Patient# 24340;\tSmoking_Status: Never;\tPathology: Adenocarcinoma'}"
2546,"{'title': 'AML 6368', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 49 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2547,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 21', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
2548,"{'title': 'K_STA10', 'description': 'K_STA10', 'type': 'RNA', 'source_name_ch1': 'STA10 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
2549,"{'title': 'BL1', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'Burkitt lymphoma case 1', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with Burkitt lymphoma (BL)'}"
2550,"{'title': 'Control Huh7_Vec#3', 'description': 'Replicates were done by using the same total RNA preparation', 'type': 'RNA', 'source_name_ch1': 'Huh7 Cells with PCI-Neo stable integration into genome', 'characteristics_ch1': 'Huh7 Cells with PCI-Neo stable integration into genome'}"
2551,"{'title': 'group-2-pt-t13213595', 'description': 'group-2-pt-t13213595', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 24;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
2552,"{'title': 'Senescent cells, rep2', 'description': 'gene expression data from senescent cells', 'type': 'RNA', 'source_name_ch1': 'Senescent activated hepatic stellate cells', 'characteristics_ch1': 'fibrogenic cells of the liver'}"
2553,"{'title': 'C026_Control_M_58', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 58;\tpost-mortem delay: 15h;\tph: 6.5'}"
2554,"{'title': 'Normal breast (B69)', 'description': 'no additional info;\tnone', 'type': 'RNA', 'source_name_ch1': 'B69', 'characteristics_ch1': 'NB'}"
2555,"{'title': 'N11640A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2556,"{'title': 'Cell line C5.2_R_6', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
2557,"{'title': 'Replicative Senescent rep1', 'description': 'BJ fibroblasts passaged in culture till they reached senescence (population doubling >85) as assessed by SA-Bgal. 72h starved in serum-free media and incubated at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Late passage BJ fibroblasts'}"
2558,"{'title': 'PNS030', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.31;\tdisease activity (das28_v3): 2.39;\tresponse to anti-tnf therapy: RESPONSE'}"
2559,"{'title': 'MDS patient 78', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
2560,"{'title': 'COL2_14604', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 34;\tgender: F;\tlocalisation: Left;\tmetastasis: LIVER;\tfirst apc mutation: 1368;\tsecond apc mutation: 0;\t5q loh: 0'}"
2561,"{'title': 'TH490b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1449;\tdisease state: Acute;\tgender: Male;\tage: 30;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 333;\tplasma hiv-1     rna level   (copies/ml): > 100,000;\ttissue: lymph node'}"
2562,"{'title': 'TC.CD4-3', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
2563,"{'title': 'AML with normal karyotype #8', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 56;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 58;\tdisease state: de novo AML'}"
2564,"{'title': 'S159', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S159', 'characteristics_ch1': 'patient id: P029;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
2565,"{'title': 'AML sample #85', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00588;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2566,"{'title': 'Sputum from Stage II Moderate, biological replicate 66', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 73;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
2567,"{'title': 'normal_colon_88 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: male;\tprotocol: colonoscopy;\tage: 57;\tlocalization: transverse'}"
2568,"{'title': 'group-2-pt-t33640716', 'description': 'group-2-pt-t33640716', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 34;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
2569,"{'title': '23162', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
2570,"{'title': 'adipose_postTZD_IRd+_s33', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 33'}"
2571,"{'title': 'Stable-P4', 'description': 'Stable-P4', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Stable'}"
2572,"{'title': 'AML 6373', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 56 years;\tscore: RAEB-t;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: MDS complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2573,"{'title': 'X60174', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2574,"{'title': 'Training_Site6_08', 'description': 'Performed by Operator 1 from Site6 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
2575,"{'title': 'GBM, TMZ/radiotherapy (129)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 129;\tage: 48.9;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 3.75;\tmgmt status: U'}"
2576,"{'title': 'Peripheral T-Cell lymphoma, unspecified 8', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-110', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 52;\tgender: male'}"
2577,"{'title': 'No15LCMHinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No15;\tcell type: hepatocytes;\ttime point: under therapy'}"
2578,"{'title': 'Globin_S6', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
2579,"{'title': 'MDS patient 67', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
2580,"{'title': 'N10473B5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2581,"{'title': '1943 - mAdbID:66611', 'description': 'mAdb experiment ID: 66611', 'type': 'RNA', 'source_name_ch1': '1943', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1943;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 8.96;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
2582,"{'title': 'Septic Shock_biological rep8', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1.1;\toutcome: Survivor'}"
2583,"{'title': 'GBM_differentiation_4 days_1', 'description': 'G48_DF_4d.CEL', 'type': 'RNA', 'source_name_ch1': 'glioblastoma stem cells, differentiation, 4 days', 'characteristics_ch1': 'tissue: brain;\tdisease status: glioblastoma;\tcell type: stem cells G48'}"
2584,"{'title': 'Peripheral T-Cell lymphoma, unspecified 11', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-115', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 56;\tgender: male'}"
2585,"{'title': 'EPN_135, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_135, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
2586,"{'title': 'newly diagnosed multiple myeloma 167', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: nd'}"
2587,"{'title': '01-0026_SIRS resolved_day3_34', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2588,"{'title': 'N11689D4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2589,"{'title': 'ALL without MLL - sample 4', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2590,"{'title': ""Wilms' FF E-1"", 'description': 'L753-A-HG-U133_Plus_2-01-1 (S06-965W-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FF;\tblock age (at extraction in years): 1.5;\tbiological replicate: rep-1;\tdonor: B tumor""}"
2591,"{'title': 'Blood sample from patient 114 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 114;\tday: Day 28;\tage (years): 39;\tsex: Male'}"
2592,"{'title': 'N8463I3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2593,"{'title': 'Muscle-FamilyHistoryNegative-8', 'description': 'Jos3674;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 28;\tfamily history: Family history negative;\tbody mass index (kg/m2): 24;\tfasting glucose (ogtt): 78.5;\t2 hour glucose (ogtt): 58;\themoglobin a1c: 4.7;\tfasting glucose (iv0gavg): 83;\tfasting insulin (iv0inavg): 1.7;\tsi: 14.28;\twaist hip ratio: 0.865'}"
2594,"{'title': 'brain, unknown: C2A_e1_le1', 'description': 'control 2 weeks A;\tTreatment, type=time_course, measurement=2.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
2595,"{'title': 'AML 2286', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 35 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2596,"{'title': 'CDcNR1_afterT', 'description': 'Colonic mucosal gene expression data from CDc non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
2597,"{'title': 'Patient 4396 AML75', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 75;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
2598,"{'title': 'AML 6361', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 60 years;\tscore: RAEB-t;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2599,"{'title': 'UCR5_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
2600,"{'title': 'NY307', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 71;\tSex: F;\tcode: resection;\tclass: Inflammation;\tafp: 20.7;\ttp53 mutation: 249_250het_insGAATC;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
2601,"{'title': 'Scz-7', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tS7', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness-schizophrenia;\tSex: F;\tage: 21;\ttissue ph: 6.24;\tpmi (hrs): 56;\ttype of drug: Haloperidol;\tdrug dose (chlorpromazine equivalents): NA'}"
2602,"{'title': 'S071', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S071', 'characteristics_ch1': 'patient id: P056;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
2603,"{'title': 'a_NY18', 'description': 'advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; advanced HCC', 'characteristics_ch1': 'advanced HCC'}"
2604,"{'title': 'Insulin resistant patient 2 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
2605,"{'title': 'U937_ROS_untreated_18h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
2606,"{'title': '11_0009C_Day1_22', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Female'}"
2607,"{'title': 'AML without MLL - sample 101', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2608,"{'title': 'Lung Cancer 129T', 'description': 'Gene expression data from 129T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 71;\tstage: 1A'}"
2609,"{'title': 'AML with normal karyotype #106', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 46;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 50.5;\tdisease state: de novo AML'}"
2610,"{'title': 'NSCLC_SCC_248', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 248.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
2611,"{'title': 'T11365A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
2612,"{'title': 'Human lymphatic endothelial cells Control_Rep 3', 'description': 'Here we have addressed important question of inflammation-induced mechanism for leukocyte transmigration of lymphatic vessel endothelium by comparing global gene expression profile of normal dermal lymphatic endothelial cells with/without TNFa added to the culture.', 'type': 'RNA', 'source_name_ch1': 'Skin samples obtained from healthy human donors during elective surgery at the Radcliffe Infirmary Hospital_Oxford (with full ethical approval)', 'characteristics_ch1': 'Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).'}"
2613,"{'title': 'monocytes_-LPS_3', 'description': '28h medium', 'type': 'RNA', 'source_name_ch1': 'blood, -LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 28h medium'}"
2614,"{'title': 'mRNA of GBM-HGG008, Glioblastoma, 16.5 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 16.5 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 16.5 years'}"
2615,"{'title': 'carcinoma_64 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 60;\tlocalization: rectum'}"
2616,"{'title': 'HOSE2234', 'description': 'Gene expression data from ovarian surface epithelial cells', 'type': 'RNA', 'source_name_ch1': 'Normal', 'characteristics_ch1': 'tissue: ovary;\tcell type: Normal ovarian surface epithelium'}"
2617,"{'title': 'RJ560b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1456;\tdisease state: Asympt;\tgender: Male;\tage: 49;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 478;\tplasma hiv-1     rna level   (copies/ml): 174000;\ttissue: lymph node'}"
2618,"{'title': 'HF1345_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
2619,"{'title': 'muscle_preTZD_preClamp_IRd-_s4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 4'}"
2620,"{'title': 'Control Con_rep10', 'description': 'Control paired  13', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
2621,"{'title': 'cord blood 20_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.63', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.63;\t'}"
2622,"{'title': 'Differentiated HepaRG, biological replicate 3', 'description': 'Diff3', 'type': 'RNA', 'source_name_ch1': 'Differentiated well-confluent HepaRG', 'characteristics_ch1': 'cell line: HepaRG;\tdifferentiation state: differentiated;\tgender: female'}"
2623,"{'title': 'Sample R179', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: R179;\ttissue: blood;\tage: 76;\tgender: Male;\trs7956957 genotype: CG'}"
2624,"{'title': 'CLL_FISHnormal_rep3', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'male'}"
2625,"{'title': 'X41307', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : 2'}"
2626,"{'title': 'AML 7065', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 45 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2627,"{'title': 'C006_Control_F_71', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 71;\tpost-mortem delay: 13h;\tph: 6.3'}"
2628,"{'title': 'Blood sample from patient 179 at Day 14', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 179;\tday: Day 14;\tage (years): 58;\tsex: Female'}"
2629,"{'title': 'Insulin sensitive patient 5 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
2630,"{'title': 'normal_colon_33 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: male;\tprotocol: colonoscopy;\tage: 62;\tlocalization: transverse'}"
2631,"{'title': 'Lung Cancer 123T', 'description': 'Gene expression data from 123T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 53;\tstage: 1B'}"
2632,"{'title': 'HF1493_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
2633,"{'title': 'CF630b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1463;\tdisease state: Asympt;\tgender: Male;\tage: 23;\trace: African American;\tblood cd4+ t  cell count (cells/ml): 259;\tplasma hiv-1     rna level   (copies/ml): 27200;\ttissue: lymph node'}"
2634,"{'title': 'Gingival tissue sample 2 from patient 16, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 16 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2635,"{'title': 'Sepsis gram-positive TP2', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
2636,"{'title': 'Insulin sensitive patient 11 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
2637,"{'title': 'KT0412_0_L_training', 'description': 'KT0412_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, training set'}"
2638,"{'title': 'S155', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S155', 'characteristics_ch1': 'patient id: P016;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
2639,"{'title': 'BJ-fib_2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'BJ fibroblast replicate 2', 'characteristics_ch1': 'cell line: bj-fib_2: BJ (CRL-2522) fibroblasts were purchased from ATCC.'}"
2640,"{'title': 'Gastric GIST 10', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 50;\tTumor size: 21;\tKIT mutation: Wild type'}"
2641,"{'title': 'PA281', 'description': 'PA281', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
2642,"{'title': 'IFNβ_515', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2643,"{'title': '11_0012C_Day1_24', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Male'}"
2644,"{'title': 'S121', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S121', 'characteristics_ch1': 'patient id: P036;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
2645,"{'title': 'Sepsis gram-negative V29', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
2646,"{'title': 'group-1-pt-t16644640', 'description': 'group-1-pt-t16644640', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 41;\tgender: male;\tfinal disposition: 05: Home with services'}"
2647,"{'title': 'AML with normal karyotype #72', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 50;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 86;\tdisease state: de novo AML'}"
2648,"{'title': 'GBM, TMZ/radiotherapy (157)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 157;\tage: 48.7;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 8.06;\tmgmt status: U'}"
2649,"{'title': 'Patient_6051_diagnosis', 'description': '6051D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 7;\tconclusions ig/tcr: stable;\tselected: yes'}"
2650,"{'title': '3.2.AF.10', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 10 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: AF;\thours post infection: 10'}"
2651,"{'title': 'IPMA 4', 'description': 'Gene expression data from microdissected epithelial cells of IPMA', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMA 4', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous adenoma (IPMA)'}"
2652,"{'title': 'heterozygot FH P266', 'description': 'Gene expression data from the heterozygous FH participant B', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: heterozygote FH'}"
2653,"{'title': 'Gingival tissue sample 2 from patient 36, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 36 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2654,"{'title': 'AML with normal karyotype #224', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 40;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
2655,"{'title': 'NSCLC EMC 2344T', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
2656,"{'title': 'heterozygot FH P276', 'description': 'Gene expression data from the heterozygous FH participant E', 'type': 'RNA', 'source_name_ch1': 'heterozygot FH P276 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: heterozygote FH'}"
2657,"{'title': 'FL3', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'follicular lymphoma case 3', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with follicular lymphoma (FL)'}"
2658,"{'title': 'HF1325_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
2659,"{'title': 'newly diagnosed multiple myeloma 312', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
2660,"{'title': 'PC control 5', 'description': 'arrayconsortium.tgen.org::biosample.434912;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior Cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 5;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior Cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: male\xa0;\tgenetic variation: None\xa0;\tage: 79 years'}"
2661,"{'title': 'Control Con_rep19', 'description': 'Control paired  12', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
2662,"{'title': 'MERLION_X01K01501', 'description': 'MERLION_X01K01501', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=53, state=0', 'characteristics_ch1': 'pT2N0, male, age=53, state=0'}"
2663,"{'title': 'IPMA 5', 'description': 'Gene expression data from microdissected epithelial cells of IPMA', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMA 5', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous adenoma (IPMA)'}"
2664,"{'title': '464', 'description': '01-19969', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 73;\tgender: F;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.48;\tprogression-free_survival (years): 5.48'}"
2665,"{'title': 'HF1326_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2666,"{'title': 'Control-18', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc10', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 37;\ttissue ph: 6.4;\tpmi (hrs): 47;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
2667,"{'title': 'PRC3-2', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Vector only 786-O cells (PRC3), replicate 2'}"
2668,"{'title': 'Endometrium group A rFSH not pregnant 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group A, not pregnant', 'characteristics_ch1': 'treatment: rFSH;\ttissue: endometrium'}"
2669,"{'title': 'H439 Triadimefon 10uM', 'description': 'H439 Triadimefon 10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H439 Triadimefon 10uM', 'characteristics_ch1': 'primary hepatocytes'}"
2670,"{'title': 'AML 7312', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 33 years;\tscore: RAEB;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: MDS complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2671,"{'title': 'MLD AML sample #20', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
2672,"{'title': 'e_NY16', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
2673,"{'title': 'No29LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No29;\tcell type: lymphocytes;\ttime point: before therapy'}"
2674,"{'title': 'Group B2-IVIG+IVMP-Pre-3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, IVMP + IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: methylprednisolone (IVMP) + IVIG;\ttime: pre-treatment'}"
2675,"{'title': 'Patient_6584_relapse', 'description': '6584R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 14;\tconclusions ig/tcr: stable;\tselected: no'}"
2676,"{'title': 'DietSensitive _1 day_subject10', 'description': 'DietSensitive _1 day_subject10', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 10;\tgender: Male'}"
2677,"{'title': 'M69', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 69;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 2568;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
2678,"{'title': '570 - mAdbID:66605', 'description': 'mAdb experiment ID: 66605', 'type': 'RNA', 'source_name_ch1': '570', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 570;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 14.39;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
2679,"{'title': 'S062', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S062', 'characteristics_ch1': 'patient id: P037;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
2680,"{'title': 'HS_3', 'description': 'Heat shock treatment 3', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells treated with heat shock', 'characteristics_ch1': 'heat shock treated cells'}"
2681,"{'title': 'HF1122_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2682,"{'title': 'DLBCL biopsy, sample 2135', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
2683,"{'title': 'No27LCMHinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No27;\tcell type: hepatocytes;\ttime point: under therapy'}"
2684,"{'title': 'UNTREATED_561', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
2685,"{'title': 'SK-N-SH_RA_5d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
2686,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R26', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 40.08;\t%cd3cd8: 55.69;\t%cd8+cd28-: 22.24;\t%cd8+cd28+: 17.43;\t%cd4cd25cd62l: 15.31;\t%cd3delta1: 0.33;\t%cd3delta2: 1.33;\tratio delta1/delta2: 0.25;\t%cd3gammadelta: 1.97;\t%cd3alphabeta: 93.73;\t%cd4cd8-ab+(dn): 2.24;\t%cd4 cd62l+cd45+: 2.84;\t%cd4 cd62l-cd45+: 0.42;\t%cd4 cd62l - cd45-: 64.76;\t%cd4cd62l+cd45-: 31.98;\t%cd4 ccr7+ cd45 -: 15.54;\t%cd4 ccr7+ cd45+: 3.03;\t%cd4 ccr7 - cd45+: 0.83;\t%cd4 ccr7 – cd45-: 80.60;\t%cd8 cd62l+ cd45-: 10.36;\t%cd8cd62l+ cd45+: 6.03;\t%cd8cd62l- cd45+: 36.70;\t%cd8cd62l- cd45 -: 46.92;\t%cd8ccr7+ cd45-: 0.68;\t%cd8ccr7+ cd45+: 3.15;\t%cd8ccr7-cd45+: 35.59;\t%cd8ccr7-cd45 -: 60.59;\t%cd3-cd56+cd16+: 5.83;\t%nkts: 5.71;\t%cd19: 9.32;\t%cd4foxp3+: 4.94'}"
2687,"{'title': 'Replicate 1 for MDAMB361.1 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2688,"{'title': 'KT0986_0_D_training', 'description': 'KT0986_0_D_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, training set', 'characteristics_ch1': 'baseline, deceased donor, training set'}"
2689,"{'title': 'MDS patient 43', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
2690,"{'title': 'Patient 5012 AML175', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 175;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2691,"{'title': 'class F, rep6', 'description': 'NEB_12.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 80;\tsex: F;\tdisease stage: 4;\talbumin level: 24;\themoglobin level: 95;\tlymphocyte percentage: 13;\twhite blood count: 3.1;\tinternational prognostic score (ips): 4'}"
2692,"{'title': 'SK-N-SH_RA_1d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
2693,"{'title': 'MDS patient 50', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
2694,"{'title': 'AML sample #65', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00345;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2695,"{'title': 'PGA_PA-N_322', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
2696,"{'title': 'PCB153 treated HepG2 cells at T6, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines after 6 hours of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
2697,"{'title': 'PGA_PA-D_216', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
2698,"{'title': 'Adult Blood 18, biological replicate 4', 'description': 'Gene expression data of reticulocytes from adult periperal blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from adult periperal blood', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: reticulocytes;\tdevelopmental stage: adult'}"
2699,"{'title': 'Patient 4, IDC', 'description': '12838-1P 10-23-07', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 4'}"
2700,"{'title': 'ci_NY3', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
2701,"{'title': 'pCR breast biopsy, sample 15 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 15 rep 2', 'characteristics_ch1': 'pathological complete response: yes;\ttissue: Breast tumor biopsy'}"
2702,"{'title': '40-2', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 40 treated 786-O cells, replicate 2'}"
2703,"{'title': 'MDS patient 96', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
2704,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 48 hours rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
2705,"{'title': 'K_AR17', 'description': 'K_AR17', 'type': 'RNA', 'source_name_ch1': 'AR17 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1A'}"
2706,"{'title': 'Septic Shock_biological rep54 06-0009A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 5.1;\toutcome: Survivor;\tgroup: B'}"
2707,"{'title': '10-0002_SIRS resolved_day3_225', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2708,"{'title': 'Lung Cancer 43T', 'description': 'Gene expression data from 43T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 44;\tstage: 1B'}"
2709,"{'title': 'newly diagnosed multiple myeloma 274', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: I'}"
2710,"{'title': 'Bronchial epithelial cells, day 14, donor 2', 'description': 'Bronchial epithelial cells, day 14, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 14 of air-liquid interface culture'}"
2711,"{'title': 'AML with normal karyotype #246', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 59;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 87;\tdisease state: de novo AML'}"
2712,"{'title': 'normal_colon_49 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 65;\tlocalization: ascending'}"
2713,"{'title': 'newly diagnosed multiple myeloma 103', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
2714,"{'title': 'CLL cells  PB  patient #21', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #21'}"
2715,"{'title': 'AML with normal karyotype #109', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 81;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 75.5;\tdisease state: de novo AML'}"
2716,"{'title': 'heterozygot FH P249', 'description': 'Gene expression data from the heterozygous FH participant V', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: heterozygote FH'}"
2717,"{'title': 'MERLION_X03K05471', 'description': 'MERLION_X03K05471', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=79, state=1', 'characteristics_ch1': 'pT2N0, male, age=79, state=1'}"
2718,"{'title': 'MCF-10F, biological rep2', 'description': 'Gene expression data from nontumorigenic ER(-) human breast epithelial cells', 'type': 'RNA', 'source_name_ch1': 'breast epithelial cells derived from fibroadenoma', 'characteristics_ch1': 'Genotype: slightly aneuploid'}"
2719,"{'title': 'e_NY44', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
2720,"{'title': 'CDcR2_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
2721,"{'title': 'AML with normal karyotype #217', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 88;\tdisease state: S-AML'}"
2722,"{'title': 'Control Con_rep17', 'description': 'Control paired  15', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
2723,"{'title': 'Septic Shock_biological rep16', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 6.6;\toutcome: Survivor'}"
2724,"{'title': '23202', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
2725,"{'title': 'newly diagnosed multiple myeloma 294', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
2726,"{'title': 'PC control 7', 'description': 'arrayconsortium.tgen.org::biosample.434940;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 7;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: male\xa0;\tgenetic variation: None\xa0;\tage: 83 years'}"
2727,"{'title': '22050', 'description': '11685', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24271;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
2728,"{'title': 'human macrophages treated with PG-LPS, biological rep2', 'description': 'Gene expression data from human macrophages treated with PG-LPS for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis-LPS', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: P. gingivalis lipopolysaccharide (LPS);\ttreatment time: 2 hours;\tday: 9'}"
2729,"{'title': 'Sputum from Stage II Moderate, biological replicate 18', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 70;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
2730,"{'title': '22077', 'description': '11870', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24302;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
2731,"{'title': 'PGA-Hs_F-1', 'description': 'Human subjects with familial cardiomyopathy;\tKeywords = Familial Cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
2732,"{'title': 'AML with normal karyotype #47', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 84;\tdisease state: de novo AML'}"
2733,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_5d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
2734,"{'title': 'X23066', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 1'}"
2735,"{'title': 'newly diagnosed multiple myeloma 77', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
2736,"{'title': 'KT0876_12_L_paired', 'description': 'KT0876_12_L_paired', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, paired set', 'characteristics_ch1': '12 months, living donor, paired set'}"
2737,"{'title': 'MERLION_X00K06157', 'description': 'MERLION_X00K06157', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:72, state:0', 'characteristics_ch1': 'pT2N0, male, age:72, state:0'}"
2738,"{'title': 'Gene expression: HCC1008', 'description': 'Breast cancer cell line, ATCC# CRL-2320', 'type': 'RNA', 'source_name_ch1': 'RNA from cell line', 'characteristics_ch1': 'cell line: HCC1008;\tcatalog number: ATCC# CRL-2320'}"
2739,"{'title': 'whole blood_100676', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
2740,"{'title': 'class S, rep54', 'description': 'VAN_00416.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 49;\tsex: M;\tdisease stage: 4;\talbumin level: 39;\themoglobin level: 74;\tlymphocyte percentage: 3;\twhite blood count: 27.3;\tinternational prognostic score (ips): 6'}"
2741,"{'title': 'GBM, TMZ/radiotherapy (1308)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1308;\tage: 45;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 17.07;\tmgmt status: M'}"
2742,"{'title': 'c_B51', 'description': 'normal liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; normal liver tissue', 'characteristics_ch1': 'normal liver tissue'}"
2743,"{'title': '15-0010B_SIRS_day3_200', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2744,"{'title': 'Non-tumoral,  (1780)', 'description': 'MGMT status:', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: non-tumoral;\tpatient: 1780;\tage: NA;\tgender: NA;\ttreatment: NA;\tsurvival status: NA;\tsurvival time in months: NA;\tmgmt status: '}"
2745,"{'title': 'X507', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2746,"{'title': 'AML 1299', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 32 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2747,"{'title': '2.2.NDV.12', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 12 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: NDV;\thours post infection: 12'}"
2748,"{'title': 'DLBCL biopsy, sample 2105', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
2749,"{'title': 'AML sample #23', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
2750,"{'title': 'Cervical cancer-lymph node negative-07-27', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 34.9;\tfigo stage: 1b1'}"
2751,"{'title': 'CHM_FB_19', 'description': 'Strunnikova_19_111308', 'type': 'RNA', 'source_name_ch1': 'primary FB cultures from CHM patients', 'characteristics_ch1': 'cell type: primary fibroblasts cultures;\tdisease: choroideremia'}"
2752,"{'title': 'CLL cells  LN patient #6', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #6'}"
2753,"{'title': 'Insulin resistant patient 11 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
2754,"{'title': 'Clone A cells treated with 1uM CsA and cultured for 24 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 1uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 1uM;\ttime: 24 hours'}"
2755,"{'title': 'Pilocytic astrocytoma chip 7765', 'description': 'Pilocytic astrocytoma.  Chip ID 7765', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
2756,"{'title': 'PCB153 treated HepG2 cells at T0, biological replicate 3', 'description': 'Gene expression data from HepG2 cell lines before PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
2757,"{'title': 'AML 7402', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 22 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2758,"{'title': 'SH-SY5Y(ECACC)_RA_6h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
2759,"{'title': 'MCF-7_Ferulic acid_0.1μM_rep1', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Ferulic acid treated'}"
2760,"{'title': 'NB58 U133p2', 'description': 'RNA from bulk normal breast or normal bresat organoid', 'type': 'RNA', 'source_name_ch1': 'NB58', 'characteristics_ch1': 'bulk normal breast or normal bresat organoid'}"
2761,"{'title': 'AML 2185', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 50 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2762,"{'title': 'Pilocytic astrocytoma chip 8028', 'description': 'Pilocytic astrocytoma.  Chip ID 8028', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
2763,"{'title': 'Astrocytoma_6', 'description': 'bh20061208u133v2_A_19-Astro9_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: astrocytoma;\tage: 39;\tgender: male;\ttumor grade: AII'}"
2764,"{'title': 'HF1397_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2765,"{'title': 'THRBL_lymph_node_case2', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: male, Age: 67, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: IVB, IPI prognostic score: high intermediate, follow-up: 2 years; status at last follow-up: death with disease'}"
2766,"{'title': 'homozygot FH P269', 'description': 'Gene expression data from the homozygous FH participant C', 'type': 'RNA', 'source_name_ch1': 'homozygot FH P269 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: homozygote FH'}"
2767,"{'title': 'Patient 5501 AML234', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 234;\tcohort: Discovery;\tkaryotype: t(7;12);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2768,"{'title': 'Septic Shock_biological rep47 05-0008', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 9;\toutcome: Survivor;\tgroup: B'}"
2769,"{'title': 'DLBCL6', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 6', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
2770,"{'title': 'group-1-pt-t4253298', 'description': 'group-1-pt-t4253298', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 21;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
2771,"{'title': 'Patient 5169 AML217', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 217;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
2772,"{'title': 'BL41 60 min tc-RNA Rep.1', 'description': 'total cellular RNA (tc-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
2773,"{'title': 'brain_endothelial_cells_rep3', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'endothelial cells from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 44'}"
2774,"{'title': 'Patient_52', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 52;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 1.47235447087446;\tproliferation index: 9.09020446018991'}"
2775,"{'title': 'NY96', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tage: 54;\tSex: M;\tcode: resection;\tclass: Proliferation;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
2776,"{'title': 'Replicate 3 for MCF7control72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 3 for MCF7control72h breast cell line'}"
2777,"{'title': 'EntorhinalCortex_male_28yrs_indiv29', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 28 years', 'characteristics_ch1': 'individual: 29, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 28'}"
2778,"{'title': 'NSCLC_AC_40', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 40.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
2779,"{'title': 'Healthy control 10', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
2780,"{'title': 'HF1178_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2781,"{'title': 'N8608A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2782,"{'title': 'Patient_02', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 2;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.426605884261942;\tproliferation index: 6.47945020327462'}"
2783,"{'title': 'T10143A2: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
2784,"{'title': 'Normal Control C-1a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Normal Control', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
2785,"{'title': 'newly diagnosed multiple myeloma 263', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: II'}"
2786,"{'title': 'CD49a_03-04-04', 'description': 'Prostate stromal fibromuscular cells.', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'tissue: prostate;\tcell type: CD49a+ MACS sorted cells'}"
2787,"{'title': 'AML 3286', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 55 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2788,"{'title': 'carcinoma_63 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 38;\tlocalization: sigmoid'}"
2789,"{'title': 'N10608K5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2790,"{'title': 'EC control 12', 'description': 'arrayconsortium.tgen.org::biosample.434041;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 12;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 69 years'}"
2791,"{'title': 'Patient_7300_relapse', 'description': '7300R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: stable;\tselected: no'}"
2792,"{'title': 'NSCLC EMC LCC2327N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
2793,"{'title': 'PGA_PA-N_325', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
2794,"{'title': 'Young trained subject, biological replicate (YT3)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
2795,"{'title': 'control participant P310', 'description': 'Gene expression data from control participant LF', 'type': 'RNA', 'source_name_ch1': 'control participant P310 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
2796,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 7', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
2797,"{'title': 'MDS patient 76', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q plus other'}"
2798,"{'title': 'NB69 U133p2 (breast epithelial study)', 'description': 'RNA from bulk normal breast or normal breast organoid', 'type': 'RNA', 'source_name_ch1': 'NB69', 'characteristics_ch1': 'bulk normal breast or normal breast organoid'}"
2799,"{'title': 'newly diagnosed multiple myeloma 7', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: I'}"
2800,"{'title': 'X60065', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
2801,"{'title': 'Sputum from Stage II Moderate, biological replicate 71', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 57;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39315'}"
2802,"{'title': 'AML 1174', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2803,"{'title': 'CD49a-4_06-02-04', 'description': 'Prostate stromal fibromuscular cells.', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'tissue: prostate;\tcell type: CD49a+ MACS sorted cells'}"
2804,"{'title': 'Adult T-cell leukemia/lymphoma-9', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-68', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 47;\tgender: female'}"
2805,"{'title': 'Pt10 whole pericardial adipose tissue, biological rep1', 'description': 'Pt10_PCAT', 'type': 'RNA', 'source_name_ch1': 'Whole pericardial adipose tissue, patient 10', 'characteristics_ch1': 'tissue: whole pericardial adipose tissue;\tpatient: 10'}"
2806,"{'title': 'HF1540_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2807,"{'title': 'MDS patient 2', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
2808,"{'title': 'GBM, radiotherapy (328)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 328;\tage: 62.7;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 11.35;\tmgmt status: U'}"
2809,"{'title': 'Patient 22, biopsy; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'Control'}"
2810,"{'title': 'AML with normal karyotype #52', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 43;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 72.5;\tdisease state: de novo AML'}"
2811,"{'title': 'Gingival tissue sample 2 from patient 30, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 30 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2812,"{'title': 'N40977', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40977;\tsample: normal'}"
2813,"{'title': 'HF0652-4_U133P2', 'description': 'Brain tissue from  patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from  patient', 'characteristics_ch1': 'Histopathological diagnostic:'}"
2814,"{'title': 'Patient 16, biopsy; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'Control'}"
2815,"{'title': 'Patient 4708 AML140', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 140;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2816,"{'title': 'Clone A  cells treated with 5uM CsA and cultured for 12 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 12 hours'}"
2817,"{'title': 'CD19_selected_B-cells_after_FC_rep9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
2818,"{'title': 'CCD-18Co TREATED (digested orange extract, 60 μM total flavanones)_24h_biological rep1', 'description': 'Gene expression data from normal colon CCD-18Co cells exposed for 24h to a pre-digested orange extract containing a mixture of flavanones.', 'type': 'RNA', 'source_name_ch1': 'CCD-18Co fibroblasts, pre-digested orange extract rich in flavanones', 'characteristics_ch1': 'cell line: CCD-18Co;\tcell type: Normal human colon fibroblasts cells;\tconfluency: ~90% confluent monolayer;\ttreatment: pre-digested orange extract containing a mixture of flavanones;\ttreatment time: 24h'}"
2819,"{'title': 'Replicate 1 for HCC1500 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2820,"{'title': '06-0003_Septic Shock_day3_89', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2821,"{'title': 'IFNβ_1814', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
2822,"{'title': 'Metastatic prostate cancer W2', 'description': 'hormone-refractory metastatic prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Metastatic, prostate cancer'}"
2823,"{'title': 'C022_Control_F_68', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 68;\tpost-mortem delay: 6h;\tph: 6.4'}"
2824,"{'title': 'Blood - Control - 155A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 45;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
2825,"{'title': '10-0029A_Day1_20', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Male;\tSurvivor;\torganism: None'}"
2826,"{'title': 'PGA_PA-D_82', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
2827,"{'title': 'RM08b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 39;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 685;\tplasma hiv-1 rna levels (copies/ml): 20,014'}"
2828,"{'title': 'Angioimmunoblastic T-cell lymphoma 26', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-67', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 65;\tgender: male'}"
2829,"{'title': 'ALL without MLL - sample 14', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2830,"{'title': 'Control-14', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc6', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 48;\ttissue ph: 6;\tpmi (hrs): 52;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
2831,"{'title': 'adipose_postTZD_IRd_s42', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 42'}"
2832,"{'title': 'Control 50', 'description': '08SE363', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
2833,"{'title': 'newly diagnosed multiple myeloma 125', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: None;\tiss: I'}"
2834,"{'title': '619751', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9687_Tumor;\tfab: M4;\tSex: F;\trace: W;\tage on study: 57;\tcytogenetic change: inv(16)(p13q22);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
2835,"{'title': 'S004', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S004', 'characteristics_ch1': 'patient id: P079;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
2836,"{'title': 'Young trained subject, biological replicate (YT4)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
2837,"{'title': 'AML 6888', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: abn(3q);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2838,"{'title': 'HF1382_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
2839,"{'title': 'WB550a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1455;\tdisease state: Acute;\tgender: Male;\tage: 23;\trace: African American;\tblood cd4+ t  cell count (cells/ml): 209;\tplasma hiv-1     rna level   (copies/ml): 19400;\ttissue: lymph node'}"
2840,"{'title': '93C270', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7197_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 40;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
2841,"{'title': 'Blood Sample of subject 4 after inhalation; Group C: inhalation with 0.7 ppm FA 0h before sampling', 'description': 'Bl_Group_C_AI_subject_4', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 0 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 0 h;\tsubject: 4;\tgroup: C'}"
2842,"{'title': 'ALL without MLL - sample 89', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2843,"{'title': 'Blood sample from patient 163 at Day 14', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 163;\tday: Day 14;\tage (years): 64;\tsex: Female'}"
2844,"{'title': 'Bronchial epithelial cells, day 4, donor 3', 'description': 'Bronchial epithelial cells, day 4, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 4 of air-liquid interface culture'}"
2845,"{'title': 'Control 55', 'description': '08SE367', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
2846,"{'title': 'Patient 2, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
2847,"{'title': 'NY26', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: Inflammation;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
2848,"{'title': 'PC control 9', 'description': 'arrayconsortium.tgen.org::biosample.434968;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 9;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: female\xa0;\tgenetic variation: None\xa0;\tage: 88 years'}"
2849,"{'title': 'Control_biological rep5 04-0010', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0;\toutcome: Survivor;\tgroup: n/a'}"
2850,"{'title': 'Patient_10', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 10;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.423514679440933;\tproliferation index: 8.03331517358988'}"
2851,"{'title': 'Sputum from Stage III Severe, biological replicate 28', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 67;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
2852,"{'title': 'FIBROBLAST_GM_rep1_081006_7', 'description': 'Gene expression data from human fibroblast line GM', 'type': 'RNA', 'source_name_ch1': 'human fibroblast line GM', 'characteristics_ch1': 'cell line: human fibroblast line GM'}"
2853,"{'title': 'OB06b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 45;\trace: African American;\tperipheral blood cd4+ t cells (cells/ml): 188;\tplasma hiv-1 rna levels (copies/ml): 10,684'}"
2854,"{'title': 'NSCLC_AC_10', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 10.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
2855,"{'title': '938150', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9836_Tumor;\tfab: M7;\tSex: F;\trace: W;\tage on study: 60;\tcytogenetic change: >3;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2856,"{'title': '15_0008_SepticShock_Day1_13', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '15_0008_Patient, Day1'}"
2857,"{'title': '992966', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9686_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 67;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2858,"{'title': 'Adipose tissue_427_control_rep4', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, normal weight, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: normal weight;\tgender: M;\tage: 10 year;\tz score bmi: -1.81'}"
2859,"{'title': 'No14LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No14;\tcell type: hepatocytes;\ttime point: before therapy'}"
2860,"{'title': 'Patient C01, control kidney from nephrectomy', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C01, Sex: female, Age of patient: 61, Serum creatinine: 65 microMol/L, Control kidney sample  from nephrectomy'}"
2861,"{'title': 'AML 7412', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 17 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2862,"{'title': '11-0016_SIRS resolved_day3_156', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2863,"{'title': 'MLD AML sample #8', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
2864,"{'title': 'Patient_6051_relapse', 'description': '6051R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 7;\tconclusions ig/tcr: stable;\tselected: yes'}"
2865,"{'title': '104', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7492_Tumor;\tfab: M4;\tSex: M;\trace: W;\tage on study: 51;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
2866,"{'title': 'Patient 4731 AML153', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 153;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2867,"{'title': 'CO1', 'description': 'Colonic mucosal gene expression data from control individual', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from control individual', 'characteristics_ch1': 'tissue: Colon;\tdisease: Control;\tresponse to infliximab: Not applicable;\tbefore or after first infliximab treatment: Not applicable'}"
2868,"{'title': 'Scz-3', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tS3', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness-schizophrenia;\tSex: M;\tage: 19;\ttissue ph: 6.22;\tpmi (hrs): 43;\ttype of drug: Haloperidol, Risperidone, Chlorpromazine;\tdrug dose (chlorpromazine equivalents): 750 mg'}"
2869,"{'title': '7321', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 61 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
2870,"{'title': 'human BM MSC TGFb3 stimulated day 3 rep 1', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 3', 'type': 'RNA', 'source_name_ch1': 'donor 4, stimulated with TGFb3 for 3 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 3 days'}"
2871,"{'title': 'ALL without MLL - sample 28', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2872,"{'title': 'Gingival tissue sample 1 from patient 56, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 56 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2873,"{'title': 'No2inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No2RVR;\ttime point: under therapy'}"
2874,"{'title': 'NSCLC EMC ADC2325N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
2875,"{'title': 'COL2_11196', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 58;\tgender: M;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 1506;\tsecond apc mutation: 0;\t5q loh: 1'}"
2876,"{'title': '01-0007A_Day1_0', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Male;\tNon survivor;\torganism: Neisseria'}"
2877,"{'title': 'human BM MSC unstimulated rep 1', 'description': 'gene expression data of unstimulated human bone marrow mesenchymal stem cells', 'type': 'RNA', 'source_name_ch1': 'donor 1, unstimulated', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3'}"
2878,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 18', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
2879,"{'title': 'mRNA of AA-HGG063, Anaplastic Astrocytoma, 2 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 2 years', 'characteristics_ch1': 'disease: Anaplastic Astrocytoma;\tage: 2 years'}"
2880,"{'title': 'AML with MLL - sample 136', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
2881,"{'title': 'Promyelocytes_normal_bone_marrow_2', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'Promyelocytes sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
2882,"{'title': 'Sputum from Stage II Moderate, biological replicate 11', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 63;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
2883,"{'title': 'group-1-pt-t10999876', 'description': 'group-1-pt-t10999876', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 50;\tgender: male;\tfinal disposition: 09: Death'}"
2884,"{'title': ""Wilms' tumor; WT_RK34"", 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
2885,"{'title': 'X94093', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
2886,"{'title': 'S006', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S006', 'characteristics_ch1': 'patient id: P089;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 77.5'}"
2887,"{'title': 'Gingival tissue sample 3 from patient 45, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 45 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
2888,"{'title': 'colon_IBD_939', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
2889,"{'title': '22012', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
2890,"{'title': 'GBM, radiotherapy (254)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 254;\tage: 63.6;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 7.5;\tmgmt status: U'}"
2891,"{'title': 'IFNβ_822', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
2892,"{'title': 'vn6', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: normal'}"
2893,"{'title': 'Sputum from Stage III Severe, biological replicate 51', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 69;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
2894,"{'title': 'AML sample #3', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00031;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
2895,"{'title': 'Control TC6', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
2896,"{'title': 'Blood sample from patient 159 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 159;\tday: Day 90;\tage (years): 23;\tsex: Female'}"
2897,"{'title': 'No7inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No7RVR;\ttime point: under therapy'}"
2898,"{'title': 'newly diagnosed multiple myeloma 42', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: I'}"
2899,"{'title': 'AML 7059', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 43 years;\tscore: FAB M0;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
2900,"{'title': 'Gingival tissue sample 1 from patient 60, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 60 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2901,"{'title': 'MLD AML sample #17', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
2902,"{'title': '1379 (HIV+)', 'description': 'Gene expression data from frozen ARL tumor specimen', 'type': 'RNA', 'source_name_ch1': 'Frozen Tumor Biopsy_Hilar/Lung', 'characteristics_ch1': 'specimen: frozen ARL tumor biopsy;\ttumor biopsy origin: Hilar/Lung;\tage at diagnosis: 57;\tgender: Male;\tpathology diagnosis: DLBCL;\tmolecular diagnosis: DLBCL_NC;\tebv status: positive'}"
2903,"{'title': 'Cell line Hep3B(a)', 'description': 'Gene expression data  for cell line', 'type': 'RNA', 'source_name_ch1': 'cell line', 'characteristics_ch1': 'Tissue: liver'}"
2904,"{'title': 'COL2_625', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 75;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 499;\tsecond apc mutation: 0;\t5q loh: 1'}"
2905,"{'title': 'SH-SY5Y(ECACC)_BDNF_1d_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
2906,"{'title': 'VAN_00608', 'description': '06-30145', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 49;\tgender: F;\tipi_stage: 3A;\ttxprimary: CHOP4-RITU;\tstatus: With disease, after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.54;\tprogression-free_survival (years): 1.54'}"
2907,"{'title': 'prostate normal 3', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal prostate stroma', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: normal'}"
2908,"{'title': 'newly diagnosed multiple myeloma 239', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: I'}"
2909,"{'title': 'Training_Site10_07', 'description': 'Performed by Operator 1 from Site10 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
2910,"{'title': 'newly diagnosed multiple myeloma 54', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
2911,"{'title': 'normal_colon_16 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: male;\tprotocol: surgery;\tage: 69;\tlocalization: sigmoid'}"
2912,"{'title': 'Liver367T (mRNA expression)', 'description': 'liver cancer HCV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 367T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately differentiated;\tgender: M;\tage: 72;\tvirus: HCV'}"
2913,"{'title': 'newly diagnosed multiple myeloma 19', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
2914,"{'title': '2.1.NDV.1', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 1 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 1'}"
2915,"{'title': 'Healthy control 5', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
2916,"{'title': 'MLD AML sample #35', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
2917,"{'title': 'whole blood_101339', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Male', 'characteristics_ch1': 'General population, Male'}"
2918,"{'title': 'newly diagnosed multiple myeloma 210', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
2919,"{'title': 'FHC - patient 14', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Patient 14', 'characteristics_ch1': 'Gender: male;\tAge: 33 years ;\tDisease: familial hypercholesterolemia;\tDrugs: Altrain (lovastatin), 20 mg;\tTissue: blood'}"
2920,"{'title': 'Healthy control 15', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
2921,"{'title': 'Patient 3439 AML26', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 26;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
2922,"{'title': 'Liver360T (mRNA expression)', 'description': 'liver cancer HCV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 360T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately differentiated;\tgender: M;\tage: 66;\tvirus: HCV'}"
2923,"{'title': 'Blood sample from patient 180 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 180;\tday: Day 90;\tage (years): 63;\tsex: Female'}"
2924,"{'title': 'CXCL4_A', 'description': 'CXCL4_A', 'type': 'RNA', 'source_name_ch1': 'primary human monocyte-derived macrophages', 'characteristics_ch1': 'cell type: primary human monocyte-derived macrophages;\tdifferentiation factor: CXCL4'}"
2925,"{'title': 'newly diagnosed multiple myeloma 30', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: III'}"
2926,"{'title': 'CD49a+ rep1 (stromal cell study)', 'description': 'Prostate stromal fibromuscular cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD49a+ MACS sorted cells'}"
2927,"{'title': 'AML 3304', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 58 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2928,"{'title': 'GBM, TMZ/radiotherapy (1297)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1297;\tage: 36.4;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 59.7;\tmgmt status: M'}"
2929,"{'title': 'IV-B-ALL-40-24h-EtOH', 'description': 'biological source:;\thomo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of ethanol 0,1% for 24h', 'type': 'RNA', 'source_name_ch1': 'B-ALL patient 40, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of ethanol 0,1% for 24h'}"
2930,"{'title': 'Endometrium group A rFSH not pregnant 4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group A, not pregnant', 'characteristics_ch1': 'treatment: rFSH;\ttissue: endometrium'}"
2931,"{'title': 'C119', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.5'}"
2932,"{'title': 'newly diagnosed multiple myeloma 153', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
2933,"{'title': 'GBM, radiotherapy (211)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 211;\tage: 44.4;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 8.75;\tmgmt status: M'}"
2934,"{'title': 'adipose_postTZD_IRd+_s24', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 24'}"
2935,"{'title': 'blood, Blood: control-2_e1_le1', 'description': 'no nicotine treatment;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
2936,"{'title': 'ci_NY33', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
2937,"{'title': 'VA47', 'description': '02-30647', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 60;\tgender: M;\tipi_stage: 2B;\ttxprimary: CHOP8-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.11;\tprogression-free_survival (years): 5.11'}"
2938,"{'title': '11_0011C_Day1_23', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Male'}"
2939,"{'title': 'Monocyte_patient51_time7', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:African-american,Age:46,VAP day:3'}"
2940,"{'title': 'Blood_TD19902_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
2941,"{'title': 'CLL cells  LN patient #8', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #8'}"
2942,"{'title': 'N10481A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2943,"{'title': '11_0029_SepticShock_Day3_29', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0029_Patient, Day3'}"
2944,"{'title': 'Gingival tissue sample 2 from patient 75, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 75 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
2945,"{'title': 'Patient 4432 AML95', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 95;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2946,"{'title': 'class S, rep65', 'description': 'VAN_00477.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 23;\tsex: F;\tdisease stage: 2;\talbumin level: 36;\themoglobin level: 120;\tlymphocyte percentage: 4;\twhite blood count: 12.1;\tinternational prognostic score (ips): 3'}"
2947,"{'title': 'Patient 5066 AML195', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 195;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2948,"{'title': 'N51308', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51308;\tsample: normal'}"
2949,"{'title': 'Septic Shock_biological rep83 15-0007', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.3;\toutcome: Survivor;\tgroup: A'}"
2950,"{'title': '10-0006_SIRS_day3_115', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
2951,"{'title': 'DietSensitive _1 day_subject2', 'description': 'DietSensitive _1 day_subject2', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 2;\tgender: Female'}"
2952,"{'title': 'human left atrial_control_2', 'description': 'K5_control', 'type': 'RNA', 'source_name_ch1': 'human left atrial appendage - control', 'characteristics_ch1': 'tissue: left atrial appendage'}"
2953,"{'title': 'N9112A5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
2954,"{'title': 'Blood sample from patient 160 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 160;\tday: Day 28;\tage (years): 35;\tsex: Female'}"
2955,"{'title': 'MLD AML sample #44', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-wild type;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
2956,"{'title': 'Replicate 1 for T47D1 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
2957,"{'title': 'AML 2196', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 19 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
2958,"{'title': 'AML sample #20', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
2959,"{'title': 'DietSensitive _3 weeks_subject7', 'description': 'DietSensitive _3 weeks_subject7', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 3 weeks;\tsubject: 7;\tgender: Male'}"
2960,"{'title': 'PA206', 'description': 'PA206', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: extended;\tcell type: Synovial fluid mononuclear cells'}"
2961,"{'title': 'Patient 4373 AML65', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 65;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2962,"{'title': 'Sepsis V6', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis'}"
2963,"{'title': 'AML 2242', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: -9q;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
2964,"{'title': 'cord blood 30', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 10.02', 'characteristics_ch1': 'Cord blood arsenic exposure level 10.02;\t'}"
2965,"{'title': 'AML 3285', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 26 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
2966,"{'title': 'Control 33', 'description': '08SE354', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
2967,"{'title': 'NY39', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: Proliferation;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
2968,"{'title': 'SH-SY5Y(ECACC)_RA_0h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
2969,"{'title': 'HF0026_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
2970,"{'title': '3488', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 61 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type'}"
2971,"{'title': 'GBM, TMZ/radiotherapy (547)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 547;\tage: 43.1;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 16.97;\tmgmt status: U'}"
2972,"{'title': 'Patient 3421 AML20', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 20;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
2973,"{'title': 'class S, rep27', 'description': 'VAN_00178.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 18;\tsex: F;\tdisease stage: 1;\talbumin level: _;\themoglobin level: 141;\tlymphocyte percentage: 34;\twhite blood count: 7.8;\tinternational prognostic score (ips): 1.2'}"
2974,"{'title': 'newly diagnosed multiple myeloma 118', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
2975,"{'title': 'HUVECs  maintained in EGM2 media, the control rep 1', 'description': 'HUVECs in the basal state', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
2976,"{'title': 'NSCLC EMC SCC2279N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
2977,"{'title': 'normal fetal kidney, biological rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': '18 weeks normal', 'characteristics_ch1': 'age: 18 weeks gestation;\ttissue: kidney;\tkidney status: normal'}"
2978,"{'title': 'mucosa_distant_normal_colon_29 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: mucosa;\tmalignacy: distant normal colon;\tsex: female'}"
2979,"{'title': 'EntorhinalCortex_male_97yrs_indiv34', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 97 years', 'characteristics_ch1': 'individual: 34, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 97'}"
2980,"{'title': 'DLBCL biopsy, sample 2026', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
2981,"{'title': 'Sputum from Stage II Moderate, biological replicate 31', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 63;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: F;\thyb date: 39324'}"
2982,"{'title': 'lg_NY57', 'description': 'low-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; low-grade dysplastic liver tissue', 'characteristics_ch1': 'low-grade dysplastic liver tissue'}"
2983,"{'title': 'Liver_normoglycima_no.5', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: normal glucose tolerance'}"
2984,"{'title': 'human BM MSC TGFb3 stimulated day 1 rep 2', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 1', 'type': 'RNA', 'source_name_ch1': 'donor 5, stimulated with TGFb3 for 1 day', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 1 day'}"
2985,"{'title': 'AML sample #100', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
2986,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 8', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
2987,"{'title': 'X41264', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
2988,"{'title': 'Patient_38', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 38;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.471016500029659;\tproliferation index: -5.39373719688763'}"
2989,"{'title': 'PBMCs_EB_before exercise_05', 'description': 'EB_Pre_119-MJ', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 11;\tbefore-exercise'}"
2990,"{'title': 'Monocyte cell line, control 5', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: serum starved'}"
2991,"{'title': 'Patient 6, colonocytes; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
2992,"{'title': 'B7', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 0.9'}"
2993,"{'title': 'Glioblastoma_6', 'description': 'bh20061208u133v2_A_06-GBM6_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 52;\tgender: male;\ttumor grade: IV'}"
2994,"{'title': 'Septic Shock_biological rep5 01-0024', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.8;\toutcome: Survivor;\tgroup: B'}"
2995,"{'title': 'B1', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 3.5'}"
2996,"{'title': '444', 'description': '01-29174', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 55;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.13;\tprogression-free_survival (years): 5.13'}"
2997,"{'title': 'PGA_PA-D_206', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
2998,"{'title': 'Chlamydia pneumoniae infected (12)', 'description': 'Chlamydia pneumoniae infected (12)', 'type': 'RNA', 'source_name_ch1': 'Chlamydia pneumoniae infected', 'characteristics_ch1': 'infection: Chlamydia pneumoniae;\ttissue: Dendritic cells derived from human monocytes'}"
2999,"{'title': 'Patient 5168 AML216', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 216;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3000,"{'title': 'Lung Cancer 145T', 'description': 'Gene expression data from 145T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 76;\tstage: 1B'}"
3001,"{'title': 'Cell line HB4a_D_6', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line -DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
3002,"{'title': 'Replicate 1 for MCF7siRNAESR1 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 siRNA against ESR1 at 18h'}"
3003,"{'title': 'Cervical cancer-lymph node positive-23-07', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 32.2;\tfigo stage: 2a'}"
3004,"{'title': 'AML sample #95', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00728;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
3005,"{'title': 'AML with normal karyotype #113', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 68;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
3006,"{'title': 'AR-P13', 'description': 'AR-P13', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
3007,"{'title': 'KT0331_12_L_test3', 'description': 'KT0331_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
3008,"{'title': 'Blood_TD19901_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
3009,"{'title': '22089', 'description': '11783', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: African American;\tGender: M;\tTSP_Patient# 24321;\tSmoking_Status: Former;\tPathology: Large cell Neuroendocrine carcinoma'}"
3010,"{'title': 'control participant P316', 'description': 'Gene expression data from control participant MO', 'type': 'RNA', 'source_name_ch1': 'control participant P316 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
3011,"{'title': 'cord blood 7_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.54', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.54;\t'}"
3012,"{'title': 'C98319', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7214_Tumor;\tfab: M0;\tSex: M;\trace: C;\tage on study: 43;\tcytogenetic change: t(3;3)(q21;q26); +6;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3013,"{'title': 'No8pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No8 nonRVR;\ttime point: before therapy'}"
3014,"{'title': 'cord blood 24_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.74', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.74;\t'}"
3015,"{'title': '10-0029B_SIRS_day3_109', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3016,"{'title': 'M31', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: 0;\tage: 66;\tSex: M;\tcode: resection;\tclass: Unannotated;\tafp: 5;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
3017,"{'title': 'Lung Normal 79N', 'description': 'Gene expression data from 79N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 37;\tstage: n/a'}"
3018,"{'title': 'Endometrium in control conditioned medium for 3 hours TCM-14', 'description': 'Control conditioned medium endometrium  3 hours TCM-14', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control conditioned medium endometrium  3 hours TCM-14'}"
3019,"{'title': 'AML 2288', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 31 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
3020,"{'title': 'newly diagnosed multiple myeloma 86', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: nd'}"
3021,"{'title': 'LTB2 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tLatent'}"
3022,"{'title': 'HD1-STS-24h', 'description': 'biological source:;\thomo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 24h after first GC-administration, total GC-administration 33% of 60mg/m2 prednisolon + 1/3 of 66% of 60mg/m2', 'type': 'RNA', 'source_name_ch1': 'healthy donor HD1, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 24h after first GC-administration, total GC-administration 33% of 60mg/m2 prednisolon + 1/3 of 66% of 60mg/m2'}"
3023,"{'title': 'Gingival tissue sample 1 from patient 73, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 73 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3024,"{'title': 'human cultured bladder IC DM, subject 3', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 37;\tDisease status: IC (interstitial cystitis);\tCulture medium: DM (differentiating medium)'}"
3025,"{'title': 'class S, rep86', 'description': 'VAN_00518.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 34;\tsex: F;\tdisease stage: 1;\talbumin level: 43;\themoglobin level: 128;\tlymphocyte percentage: 35;\twhite blood count: 5.9;\tinternational prognostic score (ips): 1'}"
3026,"{'title': 'S008_Scz_F_81', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 81;\tpost-mortem delay: 22h'}"
3027,"{'title': 'Sputum from Stage III Severe, biological replicate 48', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 72;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
3028,"{'title': 'GA_824', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3029,"{'title': 'AML with normal karyotype #35', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 55;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 70;\tdisease state: de novo AML'}"
3030,"{'title': 'Angioimmunoblastic T-cell lymphoma 30', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-82', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 49;\tgender: male'}"
3031,"{'title': 'COL2_10411', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 81;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 516;\tsecond apc mutation: 0;\t5q loh: 1'}"
3032,"{'title': 'X51005Str', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
3033,"{'title': 'breast normal 4', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal breast stroma', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: normal'}"
3034,"{'title': 'IFNβ_737', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
3035,"{'title': 'NY327', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: C;\tage: 73;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 612.1;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3036,"{'title': 'CLL cells  LN patient #10', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #10'}"
3037,"{'title': 'MLD AML sample #22', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
3038,"{'title': 'group-2-pt-t13513185', 'description': 'group-2-pt-t13513185', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 19;\tgender: female;\tfinal disposition: control'}"
3039,"{'title': 'BC9296', 'description': '080306.15.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 70;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: --;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: neg;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: --;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: --;\tmfs: 0;\tmfsdel (month): 31.67'}"
3040,"{'title': 'UNTREATED_893', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
3041,"{'title': 'Gingival tissue sample 3 from patient 91, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 91 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
3042,"{'title': 'Control-20', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc12', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 35;\ttissue ph: 6.4;\tpmi (hrs): 27;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
3043,"{'title': 'Control 6', 'description': '08SE350', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3044,"{'title': 'AML sample #91', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00659;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
3045,"{'title': 'Normal Control C-2a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Normal Control C-2a', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
3046,"{'title': 'Control Con_rep7', 'description': 'Control paired  8', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
3047,"{'title': '321258', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '10572_Tumor;\tfab: M3;\tSex: F;\trace: C;\tage on study: 31;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3048,"{'title': 'non-malignant FTEb_patient 9', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 47;\tCycle: Follicular;\tBRCA1/2 mutation: BRCA2 6174delT;\tFamily History: Yes'}"
3049,"{'title': 'AML 6887', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 41 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3050,"{'title': 'Patient 14, IDC', 'description': '13153-1P 10-23-07', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 14'}"
3051,"{'title': 'FHC - control 13', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Control 13', 'characteristics_ch1': 'Gender: male;\tAge: 35 years ;\tDisease: none;\tDrugs: none;\tTissue: blood'}"
3052,"{'title': 'Sepsis V20', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis'}"
3053,"{'title': 'Huh7 cells treated with 1uM NIM811 and cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 1uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 1uM;\ttime: 48 hours'}"
3054,"{'title': 'Patient_8148_relapse', 'description': '8148R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: stable;\tselected: no'}"
3055,"{'title': 'MDS patient 155', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
3056,"{'title': 'non-malignant FTEb_patient 3', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 38;\tCycle: Luteal;\tBRCA1/2 mutation: BRCA1 A1959T;\tFamily History: Yes'}"
3057,"{'title': 'AML sample #73', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
3058,"{'title': 'Patient_7300_diagnosis', 'description': '7300D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: stable;\tselected: no'}"
3059,"{'title': 'GBM, radiotherapy (84)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 84;\tage: 53.8;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 1.41;\tmgmt status: M'}"
3060,"{'title': 'N10180C3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3061,"{'title': '77-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 77 treated 786-O cells, replicate 3'}"
3062,"{'title': 'Patient_5864_relapse', 'description': '5864R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 9;\tconclusions ig/tcr: stable;\tselected: yes'}"
3063,"{'title': 'adipose_preTZD_IRd+_s38', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 38'}"
3064,"{'title': 'B30', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Lobular;\ttumor size: 2.3'}"
3065,"{'title': 'M-43', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
3066,"{'title': 'X70057', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 3'}"
3067,"{'title': 'Lung Normal 136N', 'description': 'Gene expression data from 136N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 65;\tstage: n/a'}"
3068,"{'title': 'COL2_244', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 72;\tgender: M;\tlocalisation: Left;\tmetastasis: LUNG;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 0'}"
3069,"{'title': 'Sepsis mixed infection TM5', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
3070,"{'title': 'UNTREATED_736', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3071,"{'title': 'Control-26', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tLc4', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - control;\tSex: M;\tage: 50;\ttissue ph: 6.43;\tpmi (hrs): 69;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
3072,"{'title': 'GA_730', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3073,"{'title': 'Control 60', 'description': '08SE375', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3074,"{'title': 'HUVEC_K13_ER_4OHT', 'description': '06_0397.CEL', 'type': 'RNA', 'source_name_ch1': 'Human Umbilical Vein Endothelial Cells', 'characteristics_ch1': 'cell type: Human Umbilical Vein Endothelial Cells;\tcell type: primary cells'}"
3075,"{'title': 'Proficiency_Site11_35', 'description': 'Performed by Operator 3 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 75.60905; Lot# = 125PO54621A'}"
3076,"{'title': 'Insulin resistant patient 9 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
3077,"{'title': 'Blood_TD19901_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
3078,"{'title': 'Control I BEAS2b_ML01C', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - control', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
3079,"{'title': 'AML 6955', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 31 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3080,"{'title': 'B31', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.0'}"
3081,"{'title': 'Cervical cancer-lymph node negative-18-53', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 72.7;\tfigo stage: 2a'}"
3082,"{'title': '23066', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tWild Type (BRAF/KRAS/ERBB2);\tGrade Low;\tStage IIIA;\tMicropapillary feature Negative;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
3083,"{'title': 'Insulin sensitive patient 10 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
3084,"{'title': 'EPN_483, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_483, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
3085,"{'title': 'DLBCL biopsy, sample 2141', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3086,"{'title': 'Tumor 41', 'description': '07SE537', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
3087,"{'title': '2020 - mAdbID:69960', 'description': 'mAdb experiment ID: 69960', 'type': 'RNA', 'source_name_ch1': '2020', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 2020;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 2.07;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
3088,"{'title': 'ALL without MLL - sample 33', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3089,"{'title': 'Gingival tissue sample 1 from patient 84, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 84 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3090,"{'title': 'Gingival tissue sample 2 from patient 35, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 35 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3091,"{'title': 'N8721A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3092,"{'title': 'Glioblastoma_2', 'description': 'bh20061208u133v2_A_02-GBM2_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 40;\tgender: male;\ttumor grade: IV'}"
3093,"{'title': 'adipose_postTZD_NRd_s20', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 20'}"
3094,"{'title': 'DLBCL biopsy, sample 2126', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3095,"{'title': 'N51628', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51628;\tsample: normal'}"
3096,"{'title': 'cord blood 25', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.76', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.76;\t'}"
3097,"{'title': 'Cervical cancer-lymph node positive-22-05', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 29.1;\tfigo stage: 1b1'}"
3098,"{'title': 'Replicate 1 for KPL1 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
3099,"{'title': 'N1-07', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
3100,"{'title': 'B2-RR-Pat.9 [wf20071123u133v2_U_06_HT20_B2_F_50yr_alpha_151]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
3101,"{'title': 'Subcutaneous adipose tissue, SAT23', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
3102,"{'title': 'Blood - Control - 154A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 33;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
3103,"{'title': '08SE859HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
3104,"{'title': 'AML with normal karyotype #92', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 38;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 86.5;\tdisease state: de novo AML'}"
3105,"{'title': '2.2.NDV.18', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 18 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: NDV;\thours post infection: 18'}"
3106,"{'title': 'N40726', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40726;\tsample: normal'}"
3107,"{'title': 'PBMCs_EB_after exercise_07', 'description': 'EB_Peak_144-SA', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 11;\tafter-exercise'}"
3108,"{'title': 'newly diagnosed multiple myeloma 282', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
3109,"{'title': 'KT0545_6_L_test3', 'description': 'KT0545_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set3', 'characteristics_ch1': '6 months, living donor, test set3'}"
3110,"{'title': 'Sample A, replicate 1', 'description': 'Following patient consent, samples were obtained from breast cancer excisions as part of a Duke University Health System (DUHS) institutional review board–approved tissue banking and research protocol for the Duke University Medical Center (DUMC) Breast Cancer Specialized Program of Research Excellence (SPORE). Immediately after surgical excision, lumpectomy specimens were sampled by 14-gauge needle core biopsy using an imaging device, as previously described.  The core biopsies were embedded in ornithine carbamoyltransferase and frozen in liquid nitrogen. One 5-um frozen section was prepared from each sample, stained with hematoxylin and eosin, and evaluated by an expert breast pathologist. Routine pathologic evaluation of the corresponding clinical specimens by the DUHS laboratories included determination of ER and PR status by IHC. Samples with an Allred score of 0 or 2 were classified as negative. HER2 status was determined by IHC and fluorescent in situ hybridization. This study included only HER2-negative patients with at least two frozen core biopsies containing neoplastic cells.;\tA1', 'type': 'RNA', 'source_name_ch1': 'Breast tumor core needle biopsy', 'characteristics_ch1': 'patient: A;\tdisease state: Breast tumor;\ttumor grade: 3;\ter status: ER Positive;\tpr status: PR Positive'}"
3111,"{'title': 'HBEC2 Control group treatment', 'description': 'HBEC2 Control group treatment. DMSO qod for 6 days.', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
3112,"{'title': 'Patient 4713 AML143', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 143;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3113,"{'title': 'Myeloma tumor, sample 11', 'description': 'MM_TUMOR_11;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: male;\tdisease state: advanced multiple myeloma (MM)'}"
3114,"{'title': 'colon_IBD_923', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
3115,"{'title': 'brain, unknown: C4B_e1_le1', 'description': 'control 4 weeks B;\tTreatment, type=time_course, measurement=4.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
3116,"{'title': 'csc: m3: i3: d05', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 3; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 3;\tReplicate: 3;\tBatch: d05'}"
3117,"{'title': 'X493', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
3118,"{'title': 'B13', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 64;\tSex: M;\tcode: resection;\tclass: Inflammation;\tafp: 5;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3119,"{'title': 'AML 6732', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3120,"{'title': 'class S, rep62', 'description': 'VAN_00469.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 34;\tsex: M;\tdisease stage: 2;\talbumin level: 46;\themoglobin level: 152;\tlymphocyte percentage: 14;\twhite blood count: 8.9;\tinternational prognostic score (ips): 2'}"
3121,"{'title': 'N_M85_?_02', 'description': 'Normal Adult patient, age 85, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'Normal Adult patient;\tbiopsy site:  unknown'}"
3122,"{'title': 'DM2_M39_BB_02', 'description': 'DM2 patient, age 39, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Biceps Brachii'}"
3123,"{'title': 'UCNR8_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
3124,"{'title': 'AML with normal karyotype #143', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 65;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
3125,"{'title': 'X23197', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
3126,"{'title': '06-0009B_Septic Shock_day3_84', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3127,"{'title': 'IPMC 6', 'description': 'Gene expression data from microdissected epithelial cells of IPMC', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMC 6', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous carcinoma (IPMC)'}"
3128,"{'title': 'AML sample #82', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
3129,"{'title': 'UCR4_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
3130,"{'title': 'mock-infected, biological rep2', 'description': 'Gene expression data from mock-infected cells', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
3131,"{'title': 'Subcutaneous adipose tissue, SAT21', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
3132,"{'title': 'newly diagnosed multiple myeloma 20', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
3133,"{'title': 'TK07Na', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1407;\tdisease state: Asympt;\tgender: Male;\tage: 35;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 372;\tplasma hiv-1     rna level   (copies/ml): 31922;\ttissue: lymph node'}"
3134,"{'title': 'ST-treated_6h replicate 2', 'description': ""Performed by UTMB microarray core per manufacturer's instructions"", 'type': 'RNA', 'source_name_ch1': 'THP-1 cells', 'characteristics_ch1': 'cell type: Human myelogenous leukemia (macrophage-like) cells;\tcell line: THP-1'}"
3135,"{'title': 'CLL cells  PB  patient #3', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #3'}"
3136,"{'title': 'papillary renal cell cancer; pRCCa_HD101', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
3137,"{'title': 'Blood sample from patient 173 at Day 14', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 173;\tday: Day 14;\tage (years): 56;\tsex: Female'}"
3138,"{'title': 'PGA-Hs_S-10', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
3139,"{'title': 'NSG029', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.63;\tdisease activity (das28_v3): 4.88;\tresponse to anti-tnf therapy: MEDIUM'}"
3140,"{'title': 'muscle_preTZD_preClamp_IRd_s7', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 7'}"
3141,"{'title': 'X94056', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
3142,"{'title': 'GA_1524', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3143,"{'title': 'group-1-pt-t19228402', 'description': 'group-1-pt-t19228402', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 32;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
3144,"{'title': 'X428', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 1'}"
3145,"{'title': 'Adult Blood 15, biological replicate 1', 'description': 'Gene expression data of reticulocytes from adult periperal blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from adult periperal blood', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: reticulocytes;\tdevelopmental stage: adult'}"
3146,"{'title': 'Normal liver N15_E-AFMX-11-448274667', 'description': 'Gene expression data from a frozen liver biopsy obtained from a healthy adult subject who suffered sudden death', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from normal liver', 'characteristics_ch1': 'tissue: normal liver;\tarrayexpress repository sample id: data retrieved from arrayexpress database, E-AFMX-11-448274667;\tage: not available;\tgender: male'}"
3147,"{'title': 'AML with normal karyotype #193', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 40;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 80;\tdisease state: de novo AML'}"
3148,"{'title': 'X94025', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
3149,"{'title': 'S094', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S094', 'characteristics_ch1': 'patient id: P108;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0.5'}"
3150,"{'title': 'vCRC5', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: colorectal cancer'}"
3151,"{'title': 'MERLION_X00K06227', 'description': 'MERLION_X00K06227', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:49, state:0', 'characteristics_ch1': 'pT2N0, male, age:49, state:0'}"
3152,"{'title': 'Monocyte High PBM 4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 4'}"
3153,"{'title': 'NZK 12', 'description': 'non-metastatic primary clear-cell renal cell carcinoma, batch 4', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: female;\ttumor stage (uicc 2002): pT3b;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G2;\tdfs/follow-up: Follow-up = 143 months;\tlocalisation of metastases: none'}"
3154,"{'title': 'Gingival tissue sample 3 from patient 86, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 86 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
3155,"{'title': 'HOSE2085', 'description': 'normal human ovarian surface epithelials cells', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: normal ovarian surface epithelials cells'}"
3156,"{'title': '22060', 'description': '11695', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24284;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
3157,"{'title': 'Patient 3438 AML25', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 25;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
3158,"{'title': 'IPMC 3', 'description': 'Gene expression data from microdissected epithelial cells of IPMC', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMC 3', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous carcinoma (IPMC)'}"
3159,"{'title': 'S023_Scz_F_97', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 97;\tpost-mortem delay: 3.5h;\tph: 6.2'}"
3160,"{'title': 'newly diagnosed multiple myeloma 48', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
3161,"{'title': 'Healthy volunteer HV4', 'description': 'Healthy volunteer', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: Healthy volunteer;\ttherapy: none;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
3162,"{'title': 'NORM#12', 'description': 'U133Plus2_122906L_DK06.CEL', 'type': 'RNA', 'source_name_ch1': 'Non-malignant human cortex sample', 'characteristics_ch1': 'tissue: brain;\tcondition: Primary biopsy;\tcell type: non-malignant;\tcell type: primary tissue;\tcell type: normal cortex'}"
3163,"{'title': 'Pt5 whole subcutaneous adipose tissue, biological rep1', 'description': 'Pt5_SQAT', 'type': 'RNA', 'source_name_ch1': 'Whole subcutaneous adipose tissue, patient 5', 'characteristics_ch1': 'tissue: whole subcutaneous adipose tissue;\tpatient: 5'}"
3164,"{'title': 'AML with normal karyotype #53', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 30;\tdisease state: de novo AML'}"
3165,"{'title': 'colon_CRC_1377', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
3166,"{'title': 'Bronchial epithelial cells, day 12, donor 3', 'description': 'Bronchial epithelial cells, day 12, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 12 of air-liquid interface culture'}"
3167,"{'title': 'HF0855_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
3168,"{'title': 'Healthy volunteer HV8', 'description': 'Healthy volunteer', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: Healthy volunteer;\ttherapy: none;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
3169,"{'title': 'B1-Non-RR-Pat.15 [wf20060926u133v2_U_05_B1-Pat.3-HC]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
3170,"{'title': 'H448 Propiconazole 100uM', 'description': 'H448 Propiconazole 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H448 Propiconazole 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
3171,"{'title': 'NSCLC EMC TB0067he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
3172,"{'title': 'UNTREATED_685', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
3173,"{'title': 'EntorhinalCortex_female_45yrs_indiv17', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 45 years', 'characteristics_ch1': 'individual: 17, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 45'}"
3174,"{'title': 'Estradiol, rep 1', 'description': 'Gene expression data from estradiol-treated HUVEC', 'type': 'RNA', 'source_name_ch1': 'HUVEC treated with 1 nM for 24 h', 'characteristics_ch1': 'cell type: Endothelial cell;\tagent: estradiol;\tdose: 1 nM;\ttime: 24 h'}"
3175,"{'title': 'PA124', 'description': 'PA124', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
3176,"{'title': 'newly diagnosed multiple myeloma 195', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: II'}"
3177,"{'title': 'Patient_4785_relapse', 'description': '4785R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: N/A;\tselected: no'}"
3178,"{'title': 'Gingival tissue sample 3 from patient 18, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 18 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3179,"{'title': 'Patient_4785_diagnosis', 'description': '4785D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: N/A;\tselected: no'}"
3180,"{'title': 'CO4', 'description': 'Colonic mucosal gene expression data from control individual', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from control individual', 'characteristics_ch1': 'tissue: Colon;\tdisease: Control;\tresponse to infliximab: Not applicable;\tbefore or after first infliximab treatment: Not applicable'}"
3181,"{'title': 'S116', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S116', 'characteristics_ch1': 'patient id: P003;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
3182,"{'title': '5349', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 61 years, RAEB-t, cytogenetic intermediate risk, CEBPA wild type'}"
3183,"{'title': 'colonic_crypt_epithelial_cells_distant_normal_colon_38 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: distant normal colon;\tsex: female'}"
3184,"{'title': 'Gingival tissue sample 3 from patient 29, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 29 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
3185,"{'title': 'PGA-Hs_F-3', 'description': 'Human subjects with familial cardiomyopathy;\tKeywords = familial cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
3186,"{'title': 'DLBCL biopsy, sample 2019', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3187,"{'title': 'class S, rep4', 'description': 'NEB_1064.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 38;\tsex: F;\tdisease stage: 2;\talbumin level: 41;\themoglobin level: 125;\tlymphocyte percentage: 1;\twhite blood count: 5.6;\tinternational prognostic score (ips): 2'}"
3188,"{'title': 'SS gland, early, patient 21, batch 2', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: early SS'}"
3189,"{'title': 'HF1458_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
3190,"{'title': 'AML 2664', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 33 years;\tscore: FAB M0;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
3191,"{'title': 'UNTREATED_582', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3192,"{'title': 'platelet_sickle_15', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
3193,"{'title': 'hg_NY53', 'description': 'high-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; high-grade dysplastic liver tissue', 'characteristics_ch1': 'high-grade dysplastic liver tissue'}"
3194,"{'title': '22104', 'description': '11865', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24339;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
3195,"{'title': 'HUVEC_TNFa_6h30m', 'description': '6h30m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 6h30m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
3196,"{'title': 'blood-vehicle-control-4', 'description': 'Unstimulated control.;\t418-0-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, control', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: control'}"
3197,"{'title': 'DietResistant _3 weeks_subject10', 'description': 'DietResistant _3 weeks_subject10', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 3 weeks;\tsubject: 10;\tgender: Male'}"
3198,"{'title': '22046', 'description': '11713', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24267;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
3199,"{'title': 'N8628A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3200,"{'title': 'COL2_706', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 66;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 1'}"
3201,"{'title': 'PCB153 treated HepG2 cells at T18, biological replicate 3', 'description': 'Gene expression data from HepG2 cell lines after 18 hours of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
3202,"{'title': '1949 - mAdbID:69359', 'description': 'mAdb experiment ID: 69359', 'type': 'RNA', 'source_name_ch1': '1949', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1949;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 4.27;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
3203,"{'title': 'mesenchymal stem cells, lot#4F0760, 28th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0760, passage number 28', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0760, 28th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
3204,"{'title': 'control participant P300', 'description': 'Gene expression data from control participant DB', 'type': 'RNA', 'source_name_ch1': 'control participant P300 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
3205,"{'title': 'AML 2753', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 34 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: -9q;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
3206,"{'title': 'control_00hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_00hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
3207,"{'title': 'AML 3277', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 28 years;\tscore: FAB M1;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3208,"{'title': 'NSCLC EMC TB0053he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
3209,"{'title': 'muscle_preTZD_preClamp_IRd_s41', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 41'}"
3210,"{'title': 'AML sample #37', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00133;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
3211,"{'title': 'PBMCs_LB_after exercise_15', 'description': 'LB_Peak_040-BT', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 17;\tafter-exercise'}"
3212,"{'title': 'centrocyte, tonsil#11', 'description': 'centrocyte, tonsil#11', 'type': 'RNA', 'source_name_ch1': 'Inflamed non tumoral human tonsil#11', 'characteristics_ch1': 'cell suspension: Flow sorted cells;\tcell type: centrocyte, tonsil'}"
3213,"{'title': '70148', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIB;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
3214,"{'title': 'Gingival tissue sample 2 from patient 60, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 60 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3215,"{'title': 'MERLION_X01K04841', 'description': 'MERLION_X01K04841', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=55, state=1', 'characteristics_ch1': 'pT2N0, male, age=55, state=1'}"
3216,"{'title': 'MLD AML sample #4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-wild type;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
3217,"{'title': 'No4pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No4 nonRVR;\ttime point: before therapy'}"
3218,"{'title': 'carcinoma_37 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 74;\tlocalization: caecum'}"
3219,"{'title': 'Liver359T (mRNA expression)', 'description': 'liver cancer HCV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 359T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately-poorly differentiated;\tgender: M;\tage: 51;\tvirus: HCV'}"
3220,"{'title': 'CD19_selected_B-cells_before_FC_rep8', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before FC (control)'}"
3221,"{'title': 'AML 7304', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 60 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3222,"{'title': 'human cultured bladder IC DM, subject 10', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 39;\tDisease status: IC (interstitial cystitis);\tCulture medium: DM (differentiating medium)'}"
3223,"{'title': 'e_B7', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
3224,"{'title': '60214', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tmutant KRAS;\tGrade 2;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
3225,"{'title': 'NSCLC EMC SCC2287N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
3226,"{'title': 'newly diagnosed multiple myeloma 225', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: I'}"
3227,"{'title': '01-0051A_Septic Shock_day1_52', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3228,"{'title': '1994 - mAdbID:74493', 'description': 'mAdb experiment ID: 74493', 'type': 'RNA', 'source_name_ch1': '1994', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1994;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: ABC DLBCL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 1.20;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
3229,"{'title': 'human BM MSC TGFb3 stimulated day 7 rep 1', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 7', 'type': 'RNA', 'source_name_ch1': 'donor 4, stimulated with TGFb3 for 7 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 7 days'}"
3230,"{'title': 'newly diagnosed multiple myeloma 119', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: III'}"
3231,"{'title': 'Metastatic prostate cancer tissue pool WX1', 'description': 'hormone-refractory metastatic prostate cancer tissue pool extraced from sample W1, W2, W3 and W4', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'metastatic, pooled, prostate cancer'}"
3232,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 24 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
3233,"{'title': 'WT8-2', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'VHL reconstituted 786-O cells (WT8), replicate 2'}"
3234,"{'title': 'X32054', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
3235,"{'title': 'MDS patient 52', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
3236,"{'title': 'HBEC4 Low dose treatment group (100 nM).', 'description': 'HBEC4 Low dose treatment group (100 nM).', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
3237,"{'title': 'AML without MLL - sample 116', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3238,"{'title': 'Lung Normal 122N', 'description': 'Gene expression data from 122N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 59;\tstage: n/a'}"
3239,"{'title': 'colonic_mucosa_non_inflamed_728', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Control subject, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.'}"
3240,"{'title': 'Peripheral T-Cell lymphoma, unspecified 12 replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-14', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 73;\tgender: male'}"
3241,"{'title': 'NF-9', 'description': 'Gene expression data from non-failing control hearts', 'type': 'RNA', 'source_name_ch1': 'Non-Failing Sample 5', 'characteristics_ch1': 'sample pairs: none;\ttissue: Myocard;\tvad status: unsupported;\tdisease status: none;\tvad: none;\tage: 64;\tgender: m'}"
3242,"{'title': 'T130 U133p2', 'description': 'bulk breast tumor RNA from patient T130', 'type': 'RNA', 'source_name_ch1': 'T130', 'characteristics_ch1': 'breast tumor'}"
3243,"{'title': 'DM2_M47_VL_11', 'description': 'DM2 patient, age 47, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Vastus Lateralis'}"
3244,"{'title': 'COL2_684', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 86;\tgender: M;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 0'}"
3245,"{'title': 'S007_Scz_F_67', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 67;\tpost-mortem delay: 3.5h;\tph: 6.1'}"
3246,"{'title': 'Training_Site9_20', 'description': 'Performed by Operator 1 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
3247,"{'title': 'CDcR4_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
3248,"{'title': 'Lung Cancer 40T', 'description': 'Gene expression data from 40T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 61;\tstage: 1B'}"
3249,"{'title': 've_B5', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
3250,"{'title': 'Sputum from Stage II Moderate, biological replicate 3', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 71;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
3251,"{'title': 'adenocarcinoma_55 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 61;\tlocalization: rectum'}"
3252,"{'title': 'DLBCL biopsy, sample 2033', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3253,"{'title': 'Tumor 31', 'description': '07SE523', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
3254,"{'title': 'cord blood 31', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 14.74', 'characteristics_ch1': 'Cord blood arsenic exposure level 14.74;\t'}"
3255,"{'title': 'Patient_6309_diagnosis', 'description': '6309D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 32;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
3256,"{'title': 'AML without MLL - sample 107', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3257,"{'title': 'AML with normal karyotype #223', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 36;\tdisease state: de novo AML'}"
3258,"{'title': 'bladder_control_pool-3', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Normal bladder tissue', 'characteristics_ch1': 'Tissue extracted resecting a bladder area using scissors.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 4 individual samples.'}"
3259,"{'title': 'Patient_5449_relapse', 'description': '5449R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 24;\tconclusions ig/tcr: stable;\tselected: yes'}"
3260,"{'title': 'Control Con_rep14', 'description': 'Control paired  18', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
3261,"{'title': 'B90', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.4'}"
3262,"{'title': '10420', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 57;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 13;\tDonor Sex: M;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
3263,"{'title': 'AML 7317', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 37 years;\tscore: RAEB-t;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3264,"{'title': 'Lung Cancer 116T', 'description': 'Gene expression data from 116T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 61;\tstage: 3A'}"
3265,"{'title': 'AML 6362', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 29 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: nd'}"
3266,"{'title': 'mRNA of GBM-HGG085, Glioblastoma, 10 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 10 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 10 years'}"
3267,"{'title': '537782', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6340_Tumor;\tfab: M3;\tSex: F;\trace: W;\tage on study: 51;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3268,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R21', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 62.51;\t%cd3cd8: 30.98;\t%cd8+cd28-: 18.14;\t%cd8+cd28+: 6.63;\t%cd4cd25cd62l: 7.81;\t%cd3delta1: 1.19;\t%cd3delta2: 2.41;\tratio delta1/delta2: 0.49;\t%cd3gammadelta: 3.45;\t%cd3alphabeta: 95.78;\t%cd4cd8-ab+(dn): 0.83;\t%cd4 cd62l+cd45+: 21.68;\t%cd4 cd62l-cd45+: 0.33;\t%cd4 cd62l - cd45-: 59.73;\t%cd4cd62l+cd45-: 18.26;\t%cd4 ccr7+ cd45 -: 11.43;\t%cd4 ccr7+ cd45+: 20.48;\t%cd4 ccr7 - cd45+: 1.21;\t%cd4 ccr7 – cd45-: 66.88;\t%cd8 cd62l+ cd45-: 10.07;\t%cd8cd62l+ cd45+: 15.35;\t%cd8cd62l- cd45+: 12.70;\t%cd8cd62l- cd45 -: 61.38;\t%cd8ccr7+ cd45-: 1.44;\t%cd8ccr7+ cd45+: 10.91;\t%cd8ccr7-cd45+: 24.97;\t%cd8ccr7-cd45 -: 62.67;\t%cd3-cd56+cd16+: 56.96;\t%nkts: 38.18;\t%cd19: 3.09;\t%cd4foxp3+: 2.03'}"
3269,"{'title': 'gd cell activation+7day,donor 2', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 7 days after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 7 days;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 7 d;\tindividual: donor 2'}"
3270,"{'title': 'Gingival tissue sample 3 from patient 48, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 48 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
3271,"{'title': 'AML 7122', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 18 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3272,"{'title': 'AML with normal karyotype #236', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 40;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: >30;\tdisease state: de novo AML'}"
3273,"{'title': 'collecting duct carcinoma; CDC_HD85', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
3274,"{'title': 'lymphocytes_HD_F_36y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: female; Age: 36; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/51'}"
3275,"{'title': 'RTX10 T0', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).', 'characteristics_ch1': 'treatment: baseline;\tgender: M;\tage (y): 64;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Poor-responder;\ttissue: synovium'}"
3276,"{'title': 'Insulin sensitive patient 15 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
3277,"{'title': 'HepG2 cells_GW7647_6h_rep3', 'description': 'A125_06_GW6', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells treated with PPARα agonist GW7647 at 100 nM for 6h', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatoma;\ttreatment: PPARα agonist GW7647;\ttreatment duration: 6 hr'}"
3278,"{'title': 'CO5', 'description': 'Colonic mucosal gene expression data from control individual', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from control individual', 'characteristics_ch1': 'tissue: Colon;\tdisease: Control;\tresponse to infliximab: Not applicable;\tbefore or after first infliximab treatment: Not applicable'}"
3279,"{'title': 'newly diagnosed multiple myeloma 300', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
3280,"{'title': 'HF0505_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
3281,"{'title': 'FHC - control 22', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Control 22', 'characteristics_ch1': 'Gender: male;\tAge: 22 years ;\tDisease: none;\tDrugs: none;\tTissue: blood'}"
3282,"{'title': 'secondary glioblastoma_3', 'description': 'bh20061208u133v2_A_31-2ary-GBM4_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: secondary brain tumor;\tcell type: glioblastoma;\tage: 40;\tgender: female;\ttumor grade: IV'}"
3283,"{'title': 'Lung Normal 156N', 'description': 'Gene expression data from 156N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 68;\tstage: n/a'}"
3284,"{'title': 'Gingival tissue sample 3 from patient 20, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 20 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3285,"{'title': 'AML with normal karyotype #239', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: >30;\tdisease state: de novo AML'}"
3286,"{'title': 'Patient 4380 AML67', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 67;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3287,"{'title': 'GBM, TMZ/radiotherapy (506)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 506;\tage: 57.3;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 5.95;\tmgmt status: U'}"
3288,"{'title': 'X34066', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
3289,"{'title': 'Sample 16: high risk ovarian epithelium', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'high risk ovarian epithelium', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: High Risk'}"
3290,"{'title': '5348', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 68 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type'}"
3291,"{'title': '22076', 'description': '11727', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24301;\tSmoking_Status: Never;\tPathology: Adenocarcinoma'}"
3292,"{'title': 'gd cell activation+6h,donor 3', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 6 hours after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 6 hrs;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 6 h;\tindividual: donor 3'}"
3293,"{'title': 'Normal_colon_22_13April05', 'description': 'Normal_colon_22_13April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, cecum', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
3294,"{'title': 'SH-SY5Y(ECACC)_RA_1d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
3295,"{'title': 'S161', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S161', 'characteristics_ch1': 'patient id: P031;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
3296,"{'title': 'C001895', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7212_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 33;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3297,"{'title': 'N51084', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51084;\tsample: normal'}"
3298,"{'title': 'HepG2 cells_control_rep2', 'description': 'A125_02A_ctr', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells treated with vehicle (DMSO)', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatoma;\ttreatment: DMSO vehicle'}"
3299,"{'title': '11-0045B_SIRS resolved_day3_177', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3300,"{'title': 'AML with normal karyotype #150', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 72;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
3301,"{'title': 'group-1-pt-t19176208', 'description': 'group-1-pt-t19176208', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 50;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
3302,"{'title': 'Gingival tissue sample 2 from patient 17, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 17 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3303,"{'title': 'Normal Ovary, 2008', 'description': 'Gene expression data from normal ovary.;\tHOSE2008', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
3304,"{'title': 'EntorhinalCortex_male_69yrs_indiv93', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 69 years', 'characteristics_ch1': 'individual: 93, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 69'}"
3305,"{'title': 'AML 2525', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: NULL;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3306,"{'title': 'Cell line C5.2_R_1', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
3307,"{'title': 'Non-tolerant PBMCs_NoTOL_VHC_1', 'description': 'see M. Martinez-Llordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood obtained from non-tolerant liver transplant recipient with hepatitis C virus infection'}"
3308,"{'title': 'Capan-1 V1 p16', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Capan-1 cells p16-transfected', 'characteristics_ch1': 'cell line: Capan-1;\tcell type: pancreatic carcinoma cells;\tp16 restoration: yes'}"
3309,"{'title': 'mock-infected, biological rep1', 'description': 'Gene expression data from mock-infected cells', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
3310,"{'title': '08SE868HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
3311,"{'title': 'PCSC-1 sphere biol repl 2', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-1 spheres 7 days in SCM-1% KO', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-1;\tculture type: sphere'}"
3312,"{'title': 'muscle_preTZD_preClamp_IRd+_s33', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 33'}"
3313,"{'title': 'UCNR6_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
3314,"{'title': 'Control 30', 'description': '07SE521', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3315,"{'title': 'human BM MSC BMP2 stimulated day 21 rep 2', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 21', 'type': 'RNA', 'source_name_ch1': 'donor 2, stimulated with BMP2 for 21 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 21 days'}"
3316,"{'title': 'carcinoma_42 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 74;\tlocalization: rectosigmoid'}"
3317,"{'title': 'JR31b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 34;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 333;\tplasma hiv-1 rna levels (copies/ml): 71,200'}"
3318,"{'title': 'HF0163_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
3319,"{'title': 'MERLION_X02K01675', 'description': 'MERLION_X02K01675', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=57, state=1', 'characteristics_ch1': 'pT2N0, male, age=57, state=1'}"
3320,"{'title': 'Monocyte High PBM 11', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 11'}"
3321,"{'title': 'Subcutaneous adipose tissue, SAT29', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
3322,"{'title': 'Normal N1', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary lung', 'characteristics_ch1': 'female pulmonary adenocarcinoma;\tnormal tissue'}"
3323,"{'title': 'Patient 4450 AML101', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 101;\tcohort: Validation;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3324,"{'title': 'MDS patient 71', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: trisomy8'}"
3325,"{'title': 'AML 6891', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tgender: male;\tage: 56 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3326,"{'title': 'Sputum from Stage IV Severe, biological replicate 12', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 66;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
3327,"{'title': 'Colonic_mucosa_inflammation_26', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible'}"
3328,"{'title': 'M98', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 64;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\ttp53 mutation: 366A>AG,Y205Y/C;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3329,"{'title': '3490', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 70 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
3330,"{'title': 'Gene expression: HCC1599', 'description': 'Breast cancer cell line, ATCC# CRL-2331', 'type': 'RNA', 'source_name_ch1': 'RNA from cell line', 'characteristics_ch1': 'cell line: HCC1599;\tcatalog number: ATCC# CRL-2331'}"
3331,"{'title': 'N10475G2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3332,"{'title': 'HS_1', 'description': 'Heat shock treatment 1', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells treated with heat shock', 'characteristics_ch1': 'heat shock treated cells'}"
3333,"{'title': 'Patient 19, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
3334,"{'title': 'T4 U133p2', 'description': 'bulk breast tumor RNA from patient T4', 'type': 'RNA', 'source_name_ch1': 'T4', 'characteristics_ch1': 'breast tumor'}"
3335,"{'title': 'T cell donor 1, rolipram', 'description': 'Cells treated with 20 uM rolipram', 'type': 'RNA', 'source_name_ch1': 'MACS purified T cells from healthy donor peripheral blood', 'characteristics_ch1': 'T cell donor 1, rolipram'}"
3336,"{'title': 'Donor3_24h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 3 treated with DMSO for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 3;\tagent: control;\ttime: 24h;\tgender: Female;\tage: 70 years old'}"
3337,"{'title': 'Patient_6190_diagnosis', 'description': '6190D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 104;\tconclusions ig/tcr: unstable;\tselected: yes'}"
3338,"{'title': 'Control 11', 'description': '07SE497', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3339,"{'title': 'PBMCs_LB_after exercise_12', 'description': 'LB_Peak_020-TP', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 18;\tafter-exercise'}"
3340,"{'title': 'Cell line HK-Hep1(b)', 'description': 'Gene expression data  for cell line', 'type': 'RNA', 'source_name_ch1': 'cell line', 'characteristics_ch1': 'Tissue: liver'}"
3341,"{'title': 'Group B1-IVIG-Post-6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: post-treatment'}"
3342,"{'title': 'HepG2 cells_control_rep1', 'description': 'A125_01_ctr', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells treated with vehicle (DMSO)', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatoma;\ttreatment: DMSO vehicle'}"
3343,"{'title': 'K_STA6', 'description': 'K_STA6', 'type': 'RNA', 'source_name_ch1': 'STA6 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
3344,"{'title': 'S114', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S114', 'characteristics_ch1': 'patient id: P028;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
3345,"{'title': 'LPS I BEAS2b_ML03C', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - LPS', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
3346,"{'title': 'T9097C1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
3347,"{'title': 'Group A-IVIG-Post-6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-responsive patient, post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-responsive patient;\ttreatment: IVIG;\ttime: post-treatment'}"
3348,"{'title': 'AML with normal karyotype #85', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 75;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 47.5;\tdisease state: de novo AML'}"
3349,"{'title': 'Sepsis gram-positive TP7', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
3350,"{'title': 'IFNβ_1509', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
3351,"{'title': 'C142', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.4'}"
3352,"{'title': 'Patient 5057 AML189', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 189;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3353,"{'title': 'Gingival tissue sample 3 from patient 53, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 53 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3354,"{'title': 'AML sample #57', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
3355,"{'title': 'Huh7 cells cultured for 24 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 24 hours'}"
3356,"{'title': 'C175', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 4.0'}"
3357,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 5', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
3358,"{'title': 'TH490a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1449;\tdisease state: Acute;\tgender: Male;\tage: 30;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 333;\tplasma hiv-1     rna level   (copies/ml): > 100,000;\ttissue: lymph node'}"
3359,"{'title': 'adipose_preTZD_IRd+_s27', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 27'}"
3360,"{'title': 'Septic Shock_biological rep45', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.8;\toutcome: Survivor'}"
3361,"{'title': '7116', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 66 years, FAB unknown, cytogenetic intermediate risk, CEBPA wild type'}"
3362,"{'title': 'Pilocytic astrocytoma chip 7753', 'description': 'Pilocytic astrocytoma.  Chip ID 7753', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
3363,"{'title': 'Blood sample from patient 117 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 117;\tday: Day 90;\tage (years): 33;\tsex: Male'}"
3364,"{'title': 'GBM, radiotherapy (323)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 323;\tage: 53.3;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 16.38;\tmgmt status: M'}"
3365,"{'title': 'Septic Shock_biological rep79 13-0002A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 7;\toutcome: Survivor;\tgroup: A'}"
3366,"{'title': 'Muscle control k71', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:male, Age:71yrs'}"
3367,"{'title': 'Control Con_rep23', 'description': 'Control paired  5', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
3368,"{'title': '08SE863HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
3369,"{'title': 'AML 3115', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 57 years;\tscore: FAB M5;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3370,"{'title': 'M-25', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
3371,"{'title': 'Normal_colon_35_13April05', 'description': 'Normal_colon_35_13April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, rectum', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
3372,"{'title': '2019 - mAdbID:66613', 'description': 'mAdb experiment ID: 66613', 'type': 'RNA', 'source_name_ch1': '2019', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 2019;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 0.99;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
3373,"{'title': 'NSCLC_AC_378', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 378.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
3374,"{'title': 'AML sample #70', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
3375,"{'title': 'L2L3 mutant, repeat 2', 'description': 'HePG2 cells infected with adenovirus expressing the L2L3 mutant of PGC-1', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
3376,"{'title': 'humanMDM_COPD_untreated', 'description': 'see Affymetrix standard protocol', 'type': 'RNA', 'source_name_ch1': 'humanMDM_COPD_untreated', 'characteristics_ch1': 'monocyte-derived macrophages of 13 male COPD patients'}"
3377,"{'title': 'C95058', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7224_Tumor;\tfab: M4;\tSex: F;\trace: Other;\tage on study: 54;\tcytogenetic change: trisomy 21;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
3378,"{'title': 'Pt15 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt15_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 15', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 15'}"
3379,"{'title': 'B2-RR-Pat.1 [wf20061103u133v2_U_02-B2-Pat-4-SA]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
3380,"{'title': 'TC.DR-1', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
3381,"{'title': 'No4LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No4;\tcell type: lymphocytes;\ttime point: under therapy'}"
3382,"{'title': 'platelet_Ctrl_5', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
3383,"{'title': 'NZK 14', 'description': 'non-metastatic primary clear-cell renal cell carcinoma, batch 4', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: male;\ttumor stage (uicc 2002): pT1a;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G2;\tdfs/follow-up: Follow-up = 148 months;\tlocalisation of metastases: none'}"
3384,"{'title': 'NSCLC EMC SCC2213N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
3385,"{'title': 've_2m41', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
3386,"{'title': 'UNTREATED_708', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
3387,"{'title': 'DLBCL biopsy, sample 2094', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3388,"{'title': 'UNTREATED_897', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3389,"{'title': 'Control_biological rep21', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 0.5;\toutcome: Survivor'}"
3390,"{'title': 'Patient_23', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 23;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.191644697156534;\tproliferation index: 3.97701074492705'}"
3391,"{'title': 'a_NY7', 'description': 'advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; advanced HCC', 'characteristics_ch1': 'advanced HCC'}"
3392,"{'title': 'B13', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 4.2'}"
3393,"{'title': 'Monocyte Low PBM 6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 6'}"
3394,"{'title': 'S070', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S070', 'characteristics_ch1': 'patient id: P051;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
3395,"{'title': 'No18inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No18 nonRVR;\ttime point: under therapy'}"
3396,"{'title': 'cord blood 11_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.62', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.62;\t'}"
3397,"{'title': 'secondary glioblastoma_1', 'description': 'bh20061208u133v2_A_29-2ary-GBM2_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: secondary brain tumor;\tcell type: glioblastoma;\tage: 64;\tgender: female;\ttumor grade: IV'}"
3398,"{'title': 'H133+_H439_Propi_100uM', 'description': 'H133+_H439_Propi_100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H439_Propi_100uM', 'characteristics_ch1': 'primary hepatocytes'}"
3399,"{'title': 'HepG2_HNF4a&HNF4g_knockdown1_rep1', 'description': 'HepG2_HNF4a&HNF4gknockdouwn1_try1', 'type': 'RNA', 'source_name_ch1': 'HNF4a&HNF4g_knockdown1', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocellular carcinoma'}"
3400,"{'title': 'Cell line HB4a_DR1', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
3401,"{'title': '1990 - mAdbID:74491', 'description': 'mAdb experiment ID: 74491', 'type': 'RNA', 'source_name_ch1': '1990', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1990;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: GCB DLBCL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 0.06;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
3402,"{'title': 'newly diagnosed multiple myeloma 21', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: II'}"
3403,"{'title': 'Patient 4508 AML109', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 109;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3404,"{'title': 'newly diagnosed multiple myeloma 279', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
3405,"{'title': 'AML 2229', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 43 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3406,"{'title': 'X22023', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
3407,"{'title': 'FHC - patient 19', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Patient 19', 'characteristics_ch1': 'Gender: male;\tAge: 35 years ;\tDisease: familial hypercholesterolemia;\tDrugs: none;\tTissue: blood'}"
3408,"{'title': 'NSCLC EMC LCC2311N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
3409,"{'title': 'Tumor Tum_Ph2_rep3', 'description': 'Tumor paired  26', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N2;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
3410,"{'title': 'Gingival tissue sample 1 from patient 64, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 64 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3411,"{'title': 'sample 19, brca1 mutation negative, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation negative, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: no;\tovarian cycle status: luteal;\tsample identifier: 19'}"
3412,"{'title': 'SI19', 'description': 'Gene expression data from Standard Immunotherapy 19', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 19', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
3413,"{'title': 'platelet_Ctrl_1', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
3414,"{'title': '15-0003_Control_day1_206', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Control_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3415,"{'title': 'class F, rep5', 'description': 'NEB_11.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 71;\tsex: M;\tdisease stage: 4;\talbumin level: 37;\themoglobin level: 106;\tlymphocyte percentage: 10;\twhite blood count: 9.8;\tinternational prognostic score (ips): 3'}"
3416,"{'title': 'PGA_PA-S_267', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
3417,"{'title': 'Blood_TD24112_Daytwo_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
3418,"{'title': 'N1-40', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
3419,"{'title': 'MDS patient 180', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: other'}"
3420,"{'title': ""Wilms' FFPE B-2"", 'description': 'L744-A-HG-U133_Plus_2-02-1 (S99-2051N-FFPE)', 'type': 'RNA', 'source_name_ch1': 'Formalin-fixed paraffin-embedded tissue, kidney', 'characteristics_ch1': 'tissue: kidney;\tfixation: FFPE;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-2;\tdonor: A normal'}"
3421,"{'title': 'AML 7131', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 55 years;\tscore: FAB M1;\trisk: unknown;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3422,"{'title': 'BRCA1 carrier sample 8', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from BCRA1 mutation carrier', 'characteristics_ch1': 'Breast epithelial cells'}"
3423,"{'title': 'Mature unstimulated biological replicate 1 (WEEV)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: none;\tcell line: BE(2)-C'}"
3424,"{'title': 'carcinoma_22 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 55;\tlocalization: descending'}"
3425,"{'title': 'AML with normal karyotype #71', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 68;\tdisease state: de novo AML'}"
3426,"{'title': 'Patient_5864_diagnosis', 'description': '5864D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 9;\tconclusions ig/tcr: stable;\tselected: yes'}"
3427,"{'title': 'mRNA of GBM-HGG151, Glioblastoma, 8.9 years, Post-Ependymoma', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 8.9 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 8.9 years; Other: Post-Ependymoma'}"
3428,"{'title': 'Ctrl_1', 'description': 'Control 1', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells', 'characteristics_ch1': 'control cells'}"
3429,"{'title': 'Foot siScramble Replicate1', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 1'}"
3430,"{'title': '22040', 'description': '11707', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24258;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
3431,"{'title': 'ALL without MLL - sample 75', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3432,"{'title': 'DLBCL1', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 1', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
3433,"{'title': 'VAN_00593', 'description': '06-24915', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 60;\tgender: M;\tipi_stage: 3A;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.63;\tprogression-free_survival (years): 1.63'}"
3434,"{'title': 'IFNβ_1137', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
3435,"{'title': 'Patient 20, IDC', 'description': '17045-1P_exp', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 20'}"
3436,"{'title': 'AML sample #44', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00173;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
3437,"{'title': 'MERLION_X02K01226', 'description': 'MERLION_X02K01226', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=66, state=1', 'characteristics_ch1': 'pT2N0, male, age=66, state=1'}"
3438,"{'title': 'IFNβ_1122', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3439,"{'title': 'Patient 9, colonocytes; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'Control'}"
3440,"{'title': 'Sample T35', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: T35;\ttissue: blood;\tage: 79;\tgender: Male;\trs7956957 genotype: CG'}"
3441,"{'title': 'JS30b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 26;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 683;\tplasma hiv-1 rna levels (copies/ml): 3,610'}"
3442,"{'title': 'chromophobe renal cell cancer; chRCC_HA417', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
3443,"{'title': 'Patient_6449_diagnosis', 'description': '6449D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 8;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
3444,"{'title': 'S115', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S115', 'characteristics_ch1': 'patient id: P001;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
3445,"{'title': 'S2-7', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 7; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 7; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 7;\tSmoking status: smoker;\tPack-years: 21;\tAge: 46;\tSex: M;\tEthnic group: white'}"
3446,"{'title': 'Gingival tissue sample 1 from patient 91, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 91 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3447,"{'title': '575512', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9850_Tumor;\tfab: M3;\tSex: F;\trace: AA;\tage on study: 60;\tcytogenetic change: >3;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3448,"{'title': 'Muscle-FamilyHistoryNegative-4', 'description': 'Jos3666;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 40;\tfamily history: Family history negative;\tbody mass index (kg/m2): 27;\tfasting glucose (ogtt): 103;\t2 hour glucose (ogtt): 150;\themoglobin a1c: 5.1;\tfasting glucose (iv0gavg): 91;\tfasting insulin (iv0inavg): 5.6;\tsi: 8.38;\twaist hip ratio: 0.981'}"
3449,"{'title': 'B96', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.5'}"
3450,"{'title': '22088', 'description': '11782', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24320;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
3451,"{'title': 'Sputum from Stage II Moderate, biological replicate 36', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 60;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
3452,"{'title': 'TC.DR+-1', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
3453,"{'title': 'colonic_mucosa_non_inflamed_123', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, no macroscopic signs of inflammation.'}"
3454,"{'title': 'Control 36', 'description': '07SE528', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3455,"{'title': 'Endometrium group B hCG not pregnant 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group B, not pregnant', 'characteristics_ch1': 'treatment: hCG;\ttissue: endometrium'}"
3456,"{'title': 'Gingival tissue sample 1 from patient 81, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 81 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3457,"{'title': 'COL2_10228', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 65;\tgender: M;\tlocalisation: Left;\tmetastasis: LIVER;\tfirst apc mutation: 1386;\tsecond apc mutation: 0;\t5q loh: 0'}"
3458,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_0h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
3459,"{'title': 'Blood - Sarcoidosis - 064A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 59;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
3460,"{'title': 'N_CD8_4', 'description': 'NS4 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Negative Selection', 'characteristics_ch1': 'age: 33;\tgender: Female;\tt_cell_purity: 87%'}"
3461,"{'title': 'Normal breast (B60)', 'description': 'no additional info;\tnone', 'type': 'RNA', 'source_name_ch1': 'B60', 'characteristics_ch1': 'NB'}"
3462,"{'title': 'Septic Shock_biological rep43 04-0003', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.9;\toutcome: Nonsurvivor;\tgroup: A'}"
3463,"{'title': 'control participant P302', 'description': 'Gene expression data from control participant BL', 'type': 'RNA', 'source_name_ch1': 'control participant P302 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
3464,"{'title': 'K_AR3', 'description': 'K_AR3', 'type': 'RNA', 'source_name_ch1': 'AR3 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
3465,"{'title': 'Donor1_24h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 1 treated with Wy14643 for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 1;\tagent: Wy14643;\ttime: 24h;\tgender: Male;\tage: 63 years old'}"
3466,"{'title': 'Sepsis gram-negative TN4', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
3467,"{'title': 'mucosa_normal_colon_1 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: normal colon;\tsex: female'}"
3468,"{'title': 'NHDF at passage 6, from neonatal donor, biological rep 2', 'description': 'Gene expression data from NHDF in culture', 'type': 'RNA', 'source_name_ch1': 'NHDF in culture', 'characteristics_ch1': 'Fibroblast cells'}"
3469,"{'title': 'colon_adenoma_1312', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
3470,"{'title': '05-0006_Septic Shock_day1_75', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3471,"{'title': 'Patient 5056 AML188', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 188;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3472,"{'title': 'EPN_419, non-recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_419, non-recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
3473,"{'title': '2x9 PGC-1 mutant, repeat 3', 'description': 'HePG2 cells infected with adenovirus expressing the 2x9 mutant of PGC-1', 'type': 'RNA', 'source_name_ch1': 'HePG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
3474,"{'title': 'cHL5', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 5', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
3475,"{'title': 'MDS patient 19', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: other'}"
3476,"{'title': 'Sputum from Stage II Moderate, biological replicate 50', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 74;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
3477,"{'title': '91077', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tWild Type (BRAF/KRAS/ERBB2);\tGrade Low;\tStage IIIC;\tMicropapillary feature Positive;\t(LMP) implants Negative;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
3478,"{'title': 'No23pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No23 nonRVR;\ttime point: before therapy'}"
3479,"{'title': '2.2.NDV.14', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 14 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: NDV;\thours post infection: 14'}"
3480,"{'title': 'MDS patient 157', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
3481,"{'title': 'Patient_39', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 39;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.536378814446085;\tproliferation index: -5.17670239245308'}"
3482,"{'title': 'Lung Cancer 109T', 'description': 'Gene expression data from 109T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 74;\tstage: 3B'}"
3483,"{'title': 'H438 Myclobutanil 30uM', 'description': 'H438 Myclobutanil 30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 Myclobutanil 30uM', 'characteristics_ch1': 'primary hepatocytes'}"
3484,"{'title': 'Endometrium-d4-not pregnant rep 2', 'description': ""Gene expression of morphological more advanced endometria, assessed buy Noyes' criteria, (n=3) was compared with matched less advanced endometria (n=4)."", 'type': 'RNA', 'source_name_ch1': ""Endometrium on day of oocyte retrieval, dated as d4 of the luteal phase by Noyes' criteria, not pregnant"", 'characteristics_ch1': 'Endometrial dating d4, non-pregnant'}"
3485,"{'title': 'AML sample #15', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
3486,"{'title': 'Subject 15, Family 5, Control', 'description': 'microarray hybridization data 07/11/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Male;\tfamily: 5;\tage: 39;\tdisease status: Control;\ttissue: Muscle: Biceps'}"
3487,"{'title': 'W12 cervical ectokeratinocytes, Series 1 passage 22 (p22) #1', 'description': 'W12 cervical ectokeratinocytes; a model that recapitulates features of neoplastic progression in vitro; originally described in Stanley et al 1989, PMID 2467886;\tW12 Series 1 passage 22 (p22) #1', 'type': 'RNA', 'source_name_ch1': 'W12 passage 22 replicate 1 of 3', 'characteristics_ch1': 'gender: Female;\tcell line: W12 cervical ectokeratinocytes;\tanatomical site: Cervix;\tpassage: 22 (p22)'}"
3488,"{'title': 'Patient_8198_relapse', 'description': '8198R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 19;\tconclusions ig/tcr: stable;\tselected: yes'}"
3489,"{'title': 'HRV-infected, normal S7 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, normal S7', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
3490,"{'title': 'N_CD4_2', 'description': 'NS2 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Negative Selection', 'characteristics_ch1': 'age: 44;\tgender: Female;\tt_cell_purity: 95.50%'}"
3491,"{'title': 'Patient 5, IDC', 'description': '12866-1P 10-17-07', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 5'}"
3492,"{'title': 'AML 3278', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 52 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3493,"{'title': 'ALL without MLL - sample 83', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3494,"{'title': 'HIP control 11', 'description': 'arrayconsortium.tgen.org::biosample.434645;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 11;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: female\xa0;\tGenetic Variation: None\xa0;\tAge: 73 years'}"
3495,"{'title': 'adipose_preTZD_IRd_s10', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 10'}"
3496,"{'title': 'class F, rep28', 'description': 'VAN_00410.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 52;\tsex: F;\tdisease stage: 3;\talbumin level: 32;\themoglobin level: 96;\tlymphocyte percentage: 16;\twhite blood count: 5.5;\tinternational prognostic score (ips): 4'}"
3497,"{'title': 'group-1-pt-t30534587', 'description': 'group-1-pt-t30534587', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 35;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
3498,"{'title': 'class S, rep43', 'description': 'VAN_00401.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 42;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: _;\tlymphocyte percentage: 0;\twhite blood count: _;\tinternational prognostic score (ips): 3.5'}"
3499,"{'title': 'BC5117cc', 'description': '010606.05.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 58;\tmolecular subtype: LuminalA;\thistology: --;\tpt: --;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: --;\terbb2.tab ihc status: --;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: --;\ttop2a ihc status: --;\tfoxa1 ihc status: --;\tmfs: 1;\tmfsdel (month): 9.99'}"
3500,"{'title': 'Replicate 1 for UACC812 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
3501,"{'title': 'Patient 3400 AML12', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 12;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3502,"{'title': 'UNTREATED_2156', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3503,"{'title': '05-0008_Septic Shock_day1_77', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3504,"{'title': 'Insulin sensitive patient 3 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
3505,"{'title': 'Patient_6417_diagnosis', 'description': '6417D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 63;\tconclusions ig/tcr: unstable;\tselected: yes'}"
3506,"{'title': 'Gene expression: HCC1937', 'description': 'Breast cancer cell line, ATCC# CRL-2336', 'type': 'RNA', 'source_name_ch1': 'RNA from cell line', 'characteristics_ch1': 'cell line: HCC1937;\tcatalog number: ATCC# CRL-2336'}"
3507,"{'title': 'Blood - Axial Spondyloarthropathy - 083B', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 51;\tset: 2;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
3508,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 10', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
3509,"{'title': 'Old trained subject, biological replicate (OT1)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old trained subject', 'characteristics_ch1': 'no additional information'}"
3510,"{'title': 'IV-B-ALL-40-24h-GC', 'description': 'biological source:;\thomo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of dexamethasone 10e-7M  for 24h', 'type': 'RNA', 'source_name_ch1': 'B-ALL patient 40, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of dexamethasone 10e-7M  for 24h'}"
3511,"{'title': 'breast tumor 5', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to breast invasive tumor', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: tumor'}"
3512,"{'title': 'AML with normal karyotype #209', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 53;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 75;\tdisease state: de novo AML'}"
3513,"{'title': 'newly diagnosed multiple myeloma 189', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
3514,"{'title': 'Tumor 65', 'description': '08SE384', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
3515,"{'title': 'Young sedentary subject, biological replicate (YS6)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
3516,"{'title': 'papillary renal cell cancer; pRCCb_HD183', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
3517,"{'title': 'BT474_emetine_10h', 'description': 'Cells treated with emetine for 10 hours.', 'type': 'RNA', 'source_name_ch1': 'BT474', 'characteristics_ch1': 'cell line: BT474 breast cancer cell line;\ttreatment: emetine;\ttime: 10h'}"
3518,"{'title': 'AML without MLL - sample 115', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3519,"{'title': 'FIBROBLAST_PDB_rep1_120208_3', 'description': 'Gene expression data from human fibroblast line PDB', 'type': 'RNA', 'source_name_ch1': 'human fibroblast line PDB', 'characteristics_ch1': 'cell line: human fibroblast line PDB'}"
3520,"{'title': 'Primary 30-1004(30.08.01)', 'description': 'Gene expression data  for primary', 'type': 'RNA', 'source_name_ch1': 'PrimaryHepatocellular Carcinoma', 'characteristics_ch1': 'Tissue: liver'}"
3521,"{'title': 'csc: m2: i2: d03', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 2; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 2;\tReplicate: 2;\tBatch: d03'}"
3522,"{'title': 'No24pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No24RVR;\ttime point: before therapy'}"
3523,"{'title': 'Pilocytic astrocytoma chip 8021', 'description': 'Pilocytic astrocytoma.  Chip ID 8021', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
3524,"{'title': 'U937_naive_untreated_4h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, untreated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
3525,"{'title': 'cadmium_16hr_rep2', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'cadmium_16hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
3526,"{'title': 'Sepsis gram-negative V18', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
3527,"{'title': 'Cervical cancer-lymph node negative-19-54', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 39.9;\tfigo stage: 1b1'}"
3528,"{'title': 'Replicate 2 for BT474EI breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
3529,"{'title': 'newly diagnosed multiple myeloma 278', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
3530,"{'title': 'PBMCs treated at 3xIC90 for 24 hours,replicate 6', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at 3xIC90 for 24 hours,replicate 6', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
3531,"{'title': 'B4', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.4'}"
3532,"{'title': 'blood-vehicle-control-2', 'description': 'Unstimulated control.;\t202-0-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, control', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: control'}"
3533,"{'title': 'UCNR12_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
3534,"{'title': '3.2.NDV.14', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 14 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 14'}"
3535,"{'title': 'Sputum from Stage II Moderate, biological replicate 9', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 65;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
3536,"{'title': 'S131', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S131', 'characteristics_ch1': 'patient id: P076;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 12.5'}"
3537,"{'title': 'ZR75-1 Tamoxifen resistant', 'description': 'ZRTR', 'type': 'RNA', 'source_name_ch1': 'Breast cancer cell line ZR75-1 grown in tamoxifen containing media.', 'characteristics_ch1': 'cell line: ZR75-1;\tgrowth condition: grown in tamoxifen containing media;\tcell type: This is a hypotriploid human breast cell;\tbiomaterial provider: ATCC'}"
3538,"{'title': 'Control Con_rep2', 'description': 'Control paired  25', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
3539,"{'title': 'c_NY101', 'description': 'normal liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; normal liver tissue', 'characteristics_ch1': 'normal liver tissue'}"
3540,"{'title': 'Blood sample from patient 135 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 135;\tday: Day 28;\tage (years): 58;\tsex: Male'}"
3541,"{'title': 'mucosa_carcinoma_34 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: carcinoma;\tsex: female'}"
3542,"{'title': 'Control 26', 'description': '07SE515', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3543,"{'title': 'Cell line HB4a_DRC_2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
3544,"{'title': 'dmso: m1: i2: d01', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 1; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 1;\tReplicate: 2;\tBatch: d01'}"
3545,"{'title': 'Septic Shock_biological rep9', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.7;\toutcome: Survivor'}"
3546,"{'title': 'AML sample #18', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
3547,"{'title': 'AML with normal karyotype #22', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 60;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 64;\tdisease state: de novo AML'}"
3548,"{'title': 'csc-none-3', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Demethylation: none', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tDemethylation: none;\tReplicate: 3'}"
3549,"{'title': 'S059', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S059', 'characteristics_ch1': 'patient id: P092;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
3550,"{'title': 'Blood Sample of subject 34 after inhalation; Group C: inhalation with 0.7 ppm FA 0h before sampling', 'description': 'Bl_Group_C_AI_subject_34', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 0 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 0 h;\tsubject: 34;\tgroup: C'}"
3551,"{'title': 'THRBL_lymph_node_case8', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: male, Age: 45, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: IVB, IPI prognostic score: high, follow-up: 1 year; status at last follow-up: death with disease'}"
3552,"{'title': 'newly diagnosed multiple myeloma 188', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
3553,"{'title': 'colonic_crypt_epithelial_cells_adenoma_18 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: adenoma;\tsex: female'}"
3554,"{'title': 'KT0702_6_L_test3', 'description': 'KT0702_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set3', 'characteristics_ch1': '6 months, living donor, test set3'}"
3555,"{'title': 'normal_colon_1 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 64;\tlocalization: sigmoid'}"
3556,"{'title': 'AML sample #90', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
3557,"{'title': 'Filtered air exposure 1 -baseline', 'description': 'Gene expression data from circulating mononuclear cells before exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells before exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: FA;\ttime: 0 hour'}"
3558,"{'title': 'class F, rep8', 'description': 'NEB_14.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 63;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: _;\tlymphocyte percentage: _;\twhite blood count: _;\tinternational prognostic score (ips): 2.3'}"
3559,"{'title': 'B2-RR-Pat.3 [wf20070130u133v2_U_18-B2-Pat.9-WV]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
3560,"{'title': 'Huh7 cells treated with FH HDL, biological rep 3', 'description': 'Gene expression data from Huh7 cells treated with HDL from Normal or FH subjects in lipoprotein-depleted serum.', 'type': 'RNA', 'source_name_ch1': 'Human Huh7 cells, in culture', 'characteristics_ch1': 'cell line: Huh7;\ttreatment: familial hypercholesterolemia HDL'}"
3561,"{'title': 'dmso: m3: i1: d04', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 3; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 3;\tReplicate: 1;\tBatch: d04'}"
3562,"{'title': 'AML 6883', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 42 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3563,"{'title': 'MERLION_X03K02235', 'description': 'MERLION_X03K02235', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=72, state=1', 'characteristics_ch1': 'pT2N0, male, age=72, state=1'}"
3564,"{'title': 'S105', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S105', 'characteristics_ch1': 'patient id: P092;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 6'}"
3565,"{'title': 'Gingival tissue sample 1 from patient 88, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 88 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3566,"{'title': 'DM2_F51_?_17', 'description': 'DM2 patient, age 51, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site:  unknown'}"
3567,"{'title': 'adenocarcinoma_21 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 79;\tlocalization: sigmoid'}"
3568,"{'title': 'AML 7128', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3569,"{'title': 'mesenchymal stem cells, lot#4F0312, 9th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0312, passage number 9', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0312, 9th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
3570,"{'title': 'COL2_714', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 48;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 213;\tsecond apc mutation: 1319;\t5q loh: 0'}"
3571,"{'title': 'HF1618_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
3572,"{'title': 'Human Hepatocytes_Trovafloxacin, Donor_3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: female; age: 43; reason for liver resection: liver adenoma'}"
3573,"{'title': 'Patient_03', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 3;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.616236507855708;\tproliferation index: -5.68945328494326'}"
3574,"{'title': '22099', 'description': '11860', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: N/A;\tGender: F;\tTSP_Patient# 24333;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
3575,"{'title': 'Cord Blood 15, biological replicate 1', 'description': 'Gene expression data of reticulocytes from umbilical cord blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from umbilical cord blood', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: reticulocytes'}"
3576,"{'title': 'AML with normal karyotype #100', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 62;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 25;\tdisease state: de novo AML'}"
3577,"{'title': 'Group B1-IVIG-Pre-6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: pre-treatment'}"
3578,"{'title': 'CD19_selected_B-cells_before_R_rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before Rituximab (control)'}"
3579,"{'title': 'Normal Brain #4', 'description': 'U133Plus2_122906L_DK05.CEL', 'type': 'RNA', 'source_name_ch1': 'Non-malignant human cortex sample', 'characteristics_ch1': 'tissue: brain;\tcondition: Primary biopsy;\tcell type: non-malignant;\tcell type: primary tissue;\tcell type: normal cortex'}"
3580,"{'title': '01-0043A_Sepsis_day1_7', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3581,"{'title': '22049', 'description': '11684', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: African American;\tGender: F;\tTSP_Patient# 24270;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
3582,"{'title': 'Patient 3496 AML43', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 43;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3583,"{'title': 'Gingival tissue sample 3 from patient 74, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 74 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
3584,"{'title': 'Gingival tissue sample 1 from patient 22, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 22 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3585,"{'title': 'AML 7153', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 22 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3586,"{'title': 'brain, unknown: UTA_e1_le1', 'description': 'untreated A;\tTreatment, type=time_course, measurement=1.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
3587,"{'title': 'adipose_postTZD_IRd+_s1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 1'}"
3588,"{'title': 'Gingival tissue sample 1 from patient 72, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 72 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3589,"{'title': 'Septic Shock_biological rep35', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1.4;\toutcome: Survivor'}"
3590,"{'title': 'AML with normal karyotype #233', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 35;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 100;\tdisease state: de novo AML'}"
3591,"{'title': 'HF0616_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
3592,"{'title': 'No27LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No27;\tcell type: lymphocytes;\ttime point: under therapy'}"
3593,"{'title': 'AML with normal karyotype #51', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 48;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 66.5;\tdisease state: de novo AML'}"
3594,"{'title': 'Undifferentiated HepaRG, biological replicate 3', 'description': 'Undif3', 'type': 'RNA', 'source_name_ch1': 'Undifferentiated elongate HepaRG', 'characteristics_ch1': 'cell line: HepaRG;\tdifferentiation state: undifferentiated;\tgender: female'}"
3595,"{'title': 'AML 2682', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 56 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
3596,"{'title': 'PTCL_025', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
3597,"{'title': 'AML 2257', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 40 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3598,"{'title': 'N8717B2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3599,"{'title': 'VCX control 1', 'description': 'arrayconsortium.tgen.org::biosample.435194;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 1;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 85 years'}"
3600,"{'title': 'ZR751_emetine_10h', 'description': 'Cells treated with emetine for 10 hours.', 'type': 'RNA', 'source_name_ch1': 'ZR751', 'characteristics_ch1': 'cell line: ZR751 breast cancer cell line;\ttreatment: emetine;\ttime: 10h'}"
3601,"{'title': 'AML with normal karyotype #228', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 80;\tdisease state: de novo AML'}"
3602,"{'title': 'Hippocampus_male_69yrs_indiv8', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 69 years', 'characteristics_ch1': 'individual: 8, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 69'}"
3603,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 2', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
3604,"{'title': 'Bronchial epithelial cells, day 0, donor 1', 'description': 'Bronchial epithelial cells, day 0, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 0, the first day of air-liquid interface culture'}"
3605,"{'title': 'Gingival tissue sample 1 from patient 10, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 10 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3606,"{'title': 'CB4', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'centroblasts donor 4', 'characteristics_ch1': 'centroblasts, isolated from tonsils by fluorescence-activated cell sorting'}"
3607,"{'title': 'Endometrium-d4-not pregnant rep 1', 'description': ""Gene expression of morphological more advanced endometria, assessed buy Noyes' criteria, (n=3) was compared with matched less advanced endometria (n=4)."", 'type': 'RNA', 'source_name_ch1': ""Endometrium on day of oocyte retrieval, dated as d4 of the luteal phase by Noyes' criteria, not pregnant"", 'characteristics_ch1': 'Endometrial dating d4, non-pregnant'}"
3608,"{'title': 'Liver_hyperglycima_no.8', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: female;\tdisease status: type 2 diabetes'}"
3609,"{'title': 'cord blood 23_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.74', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.74;\t'}"
3610,"{'title': 'AML sample #61', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00264;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
3611,"{'title': 'C113', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.3'}"
3612,"{'title': 'non-SS control gland, patient 19, batch 2', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: non-SS control'}"
3613,"{'title': 'PCSC-1 parental biol repl 2', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-1 parental cultures in PCSCs medium', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-1;\tculture type: adherent'}"
3614,"{'title': 'T30057', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30057;\tsample: tumor'}"
3615,"{'title': 'Peripheral T-Cell lymphoma, unspecified 5', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-103', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 33;\tgender: male'}"
3616,"{'title': 'CCD-18Co CONTROL (contains only the mixture of enzymes + salts)_24h_biological rep2', 'description': 'Gene expression data from normal colon CCD-18Co cells exposed for 24h to a control mixture containing only the equivalent quantities of digestive enzymes and salts as those used in the in vitro gastro-duodenal digestion of the orange extract.', 'type': 'RNA', 'source_name_ch1': 'CCD-18Co fibroblasts, control mixture', 'characteristics_ch1': 'cell line: CCD-18Co;\tcell type: Normal human colon fibroblasts cells;\tconfluency: ~90% confluent monolayer;\ttreatment: control mixture;\ttreatment time: 24h'}"
3617,"{'title': 'X496', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
3618,"{'title': 'Pilocytic astrocytoma chip 8034', 'description': 'Pilocytic astrocytoma.  Chip ID 8034', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
3619,"{'title': '6357', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 61 years, FAB M1, cytogenetic poor risk, CEBPA wild type'}"
3620,"{'title': 'VA65', 'description': '03-33266', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 50;\tgender: M;\tipi_stage: 1A;\ttxprimary: CHOP3-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 3.67;\tprogression-free_survival (years): 3.67'}"
3621,"{'title': 'mRNA of OT-HGG069, Anaplastic Oligodendroglioma, 1.6 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 1.6 years', 'characteristics_ch1': 'disease: Anaplastic Oligodendroglioma;\tage: 1.6 years'}"
3622,"{'title': 'Control Con_rep18', 'description': 'Control paired  14', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
3623,"{'title': 'MDS patient 36', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
3624,"{'title': 'newly diagnosed multiple myeloma 66', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
3625,"{'title': 'No17LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No17;\tcell type: lymphocytes;\ttime point: before therapy'}"
3626,"{'title': 'Blood sample from patient 159 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 159;\tday: Day 1;\tage (years): 23;\tsex: Female'}"
3627,"{'title': 'Blood Sample of subject 3 before inhalation; Group C', 'description': 'Bl_Group_C_BI_subject_3', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 3;\tgroup: C'}"
3628,"{'title': 'Control-1', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tSc1', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness - control;\tSex: M;\tage: 38;\ttissue ph: 6.42;\tpmi (hrs): 46;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
3629,"{'title': 'Sputum from Stage III Severe, biological replicate 16', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 70;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
3630,"{'title': 'colon_CRC_1739', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
3631,"{'title': 'No2pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No2RVR;\ttime point: before therapy'}"
3632,"{'title': 'X500', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
3633,"{'title': '22056', 'description': '11691', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24279;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
3634,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_28_4)', 'description': 'Gene expression data from whole blood 7 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 56;\tSex: F'}"
3635,"{'title': 'pCR breast biopsy, sample 18 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 18 rep 2', 'characteristics_ch1': 'pathological complete response: yes;\ttissue: Breast tumor biopsy'}"
3636,"{'title': 'control participant P336', 'description': 'Gene expression data from control participant T5', 'type': 'RNA', 'source_name_ch1': 'control participant P336 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
3637,"{'title': 'Human Hepatocytes_Control, Donor_1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 63; reason for liver resection: liver metastasis, kidney carcinoma'}"
3638,"{'title': 'newly diagnosed multiple myeloma 58', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
3639,"{'title': 'N51294', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51294;\tsample: normal'}"
3640,"{'title': 'PC control 6', 'description': 'arrayconsortium.tgen.org::biosample.434926;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior Cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 6;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior Singulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: male\xa0;\tgenetic variation: None\xa0;\tage: 76 years'}"
3641,"{'title': 'Pt2 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt2_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 2', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 2'}"
3642,"{'title': 'T3-6 (HCC stage 3-6)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'Human Liver', 'characteristics_ch1': 'HCC stage 3'}"
3643,"{'title': 'Huh7 cells cultured for 12 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 12 hours'}"
3644,"{'title': 'Tumor Tum_Ph2_rep4', 'description': 'Tumor paired  25', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N0;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
3645,"{'title': 'MERLION_X03K05904', 'description': 'MERLION_X03K05904', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=74, state=1', 'characteristics_ch1': 'pT2N0, male, age=74, state=1'}"
3646,"{'title': 'endothelial_rep8', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:44, gender:female, diagnostic group: control, PMI:10h'}"
3647,"{'title': 'MDS patient 89', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: trisomy8'}"
3648,"{'title': 'AML with normal karyotype #41', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 59;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 66;\tdisease state: de novo AML'}"
3649,"{'title': 'AML with normal karyotype #59', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 31;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
3650,"{'title': 'CD19_selected_B-cells_after_RFC_rep7', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after RFC'}"
3651,"{'title': 'U937_ROS_untreated_4h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
3652,"{'title': 'Lung Cancer 139T', 'description': 'Gene expression data from 139T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 68;\tstage: 1B'}"
3653,"{'title': 'AML sample #90', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00622;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
3654,"{'title': 'AML with normal karyotype #243', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 41;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 52;\tdisease state: de novo AML'}"
3655,"{'title': 'AML without MLL - sample 97', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3656,"{'title': 'Control 3', 'description': '07SE489', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3657,"{'title': 'GBM, TMZ/radiotherapy (461)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 461;\tage: 63.8;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 14.74;\tmgmt status: U'}"
3658,"{'title': 'Patient_17', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 17;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.586696129601375;\tproliferation index: 6.6119374910063'}"
3659,"{'title': 'N10475G3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3660,"{'title': 'HF0303_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
3661,"{'title': 'N8880I4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3662,"{'title': 'PGA_PA-N_300', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
3663,"{'title': 'colon_adenoma_1115', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
3664,"{'title': 'Cell line HB4a_R2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
3665,"{'title': '7167', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 67 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
3666,"{'title': 'newly diagnosed multiple myeloma 39', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
3667,"{'title': 'N11545D4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3668,"{'title': 'CD19_selected_B-cells_after_R_rep9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after Rituximab'}"
3669,"{'title': 'whole blood_100315', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - mental retardation or developmental delay, Female', 'characteristics_ch1': 'mental retardation or developmental delay, Female'}"
3670,"{'title': 'AML 2243', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 26 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3671,"{'title': 'AML with normal karyotype #66', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 95;\tdisease state: de novo AML'}"
3672,"{'title': 'N8463I2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3673,"{'title': 'Sample 18: normal ovarian surface epithelium', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: Normal'}"
3674,"{'title': 'AML 2248', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3675,"{'title': 'Control-28', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tLc6', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - control;\tSex: M;\tage: 72;\ttissue ph: 6.21;\tpmi (hrs): 39;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
3676,"{'title': 'M-29', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
3677,"{'title': 'AML 2301', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 24 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3678,"{'title': 'Gingival tissue sample 1 from patient 82, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 82 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3679,"{'title': 'MDS patient 151', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: monosomy7/del(7q)'}"
3680,"{'title': 'AML 7078', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 55 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3681,"{'title': 'IFNβ_866', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3682,"{'title': 'DM1_F?_BB_02', 'description': 'DM1 patient, age unknown, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM1 patient;\tbiopsy site: Biceps Brachii'}"
3683,"{'title': 'muscle_preTZD_preClamp_NRd_s18', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 18'}"
3684,"{'title': 'Patient_6584_diagnosis', 'description': '6584D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 14;\tconclusions ig/tcr: stable;\tselected: no'}"
3685,"{'title': 'Control TC8', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
3686,"{'title': 'B57', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.7'}"
3687,"{'title': 'SH-SY5Y(ECACC)_RA_3d_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
3688,"{'title': 'AML 7316', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3689,"{'title': 'Insulin sensitive patient 15 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
3690,"{'title': 'newly diagnosed multiple myeloma 301', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
3691,"{'title': 'X94044', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
3692,"{'title': 'PGA-Hs_D-12', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
3693,"{'title': 'endothelial_rep11', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:54, gender:female, diagnostic group: schizophrenia, PMI:42h'}"
3694,"{'title': 'Subcutaneous adipose tissue, SAT32', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
3695,"{'title': 'GA_754', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3696,"{'title': 'VAN_00598', 'description': '06-23792', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 76;\tgender: M;\tipi_stage: 3A;\ttxprimary: CHOP5-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.25;\tprogression-free_survival (years): 1.25'}"
3697,"{'title': 'C021_Control_M_25', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 25;\tpost-mortem delay: 17h;\tph: 6.9'}"
3698,"{'title': 'Sample 12: epithelial ovarian cancer', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'epithelial ovarian cancer', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: Cancer'}"
3699,"{'title': 'Human Hepatocytes_Trovafloxacin, Donor_2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: female; age: 60; reason for liver resection: liver metastasis, mamma carcinoma'}"
3700,"{'title': 'X44090', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
3701,"{'title': 'Pilocytic astrocytoma chip 8036', 'description': 'Pilocytic astrocytoma.  Chip ID 8036', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
3702,"{'title': 'SS gland, early, patient 5, batch 1', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: early SS'}"
3703,"{'title': 'renal lipoma ; LP_HD1847', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
3704,"{'title': 'control participant P306wdh', 'description': 'Gene expression data from control participant KP', 'type': 'RNA', 'source_name_ch1': 'control participant P306wdh (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
3705,"{'title': 'MDS patient 10', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: del5q'}"
3706,"{'title': 'Tonsil epithelium 4-batch 2', 'description': 'Laser Capture Microdissected Epithelium of Tonsil from healthy donors.', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic Tonsil of Sleap Apnea Adult Patient', 'characteristics_ch1': 'Tonsil Epithelium'}"
3707,"{'title': 'MDS patient 55', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
3708,"{'title': 'AML with normal karyotype #232', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 38;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 62;\tdisease state: de novo AML'}"
3709,"{'title': '10424', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 65;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 41;\tDonor Sex: F;\tCAN Banff Score =2;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
3710,"{'title': 'Muscle-FamilyHistoryPositive-25', 'description': 'Jos3793;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 49;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 36;\tfasting glucose (ogtt): 88.5;\t2 hour glucose (ogtt): 99;\themoglobin a1c: 5.3;\tfasting glucose (iv0gavg): 94;\tfasting insulin (iv0inavg): 4.5;\tsi: 6.76;\twaist hip ratio: 0.853'}"
3711,"{'title': 'AML with normal karyotype #170', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 67;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 74;\tdisease state: S-AML'}"
3712,"{'title': 'NSCLC EMC ADC2263N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
3713,"{'title': '3.2.NDV.12', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 12 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 12'}"
3714,"{'title': 'Muscle septic k53', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:male, Age:77yrs'}"
3715,"{'title': 'AML sample #37', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
3716,"{'title': 'HF1492_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
3717,"{'title': 'Control 28', 'description': '07SE517', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3718,"{'title': 'AML 2680', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 32 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3719,"{'title': 'Insulin resistant patient 7 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
3720,"{'title': 'Huh7 cells_JFH-1 Infected 18 hours_ rep2', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 18 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 18 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
3721,"{'title': 'AML 7314', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 41 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3722,"{'title': 'ALL without MLL - sample 90', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3723,"{'title': 'X34117', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
3724,"{'title': 'N10443A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3725,"{'title': 'Patient_41', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 41;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.386719773707478;\tproliferation index: 5.59879455330861'}"
3726,"{'title': 'PGA_PA-N_294', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
3727,"{'title': 'Insulin sensitive patient 14 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
3728,"{'title': 'sample 2, brca1 mutation positive, follicular phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, follicular phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: follicular;\tsample identifier: 2'}"
3729,"{'title': '22072', 'description': '11723', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24297;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
3730,"{'title': '275382', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6328_Tumor;\tfab: M0;\tSex: M;\trace: W;\tage on study: 65;\tcytogenetic change: trisomy 8;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3731,"{'title': 'Gastric GIST 17', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 52;\tTumor size: 5;\tKIT mutation: Wild type'}"
3732,"{'title': 'PCB153 treated HepG2 cells at T0.5, biological replicate 3', 'description': 'Gene expression data from HepG2 cell lines after 30 minutes of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
3733,"{'title': 'Monocyte Low PBM 11', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 11'}"
3734,"{'title': 'class F, rep15', 'description': 'NEB_22.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 55;\tsex: M;\tdisease stage: 4;\talbumin level: _;\themoglobin level: 100;\tlymphocyte percentage: 18;\twhite blood count: 10.8;\tinternational prognostic score (ips): 4.7'}"
3735,"{'title': 'C165', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Lobular;\ttumor size: 7.0'}"
3736,"{'title': 'dmso: m4: i2: d05', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 4; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 4;\tReplicate: 2;\tBatch: d05'}"
3737,"{'title': 'cadmium_32hr_rep2', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'cadmium_32hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
3738,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R28', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 68.69;\t%cd3cd8: 24.80;\t%cd8+cd28-: 4.92;\t%cd8+cd28+: 10.86;\t%cd4cd25cd62l: 5.32;\t%cd3delta1: 0.99;\t%cd3delta2: 2.92;\tratio delta1/delta2: 0.34;\t%cd3gammadelta: 4.49;\t%cd3alphabeta: 94.26;\t%cd4cd8-ab+(dn): 1.42;\t%cd4 cd62l+cd45+: 32.90;\t%cd4 cd62l-cd45+: 0.09;\t%cd4 cd62l - cd45-: 21.60;\t%cd4cd62l+cd45-: 45.41;\t%cd4 ccr7+ cd45 -: 27.49;\t%cd4 ccr7+ cd45+: 32.67;\t%cd4 ccr7 - cd45+: 0.71;\t%cd4 ccr7 – cd45-: 39.13;\t%cd8 cd62l+ cd45-: 22.41;\t%cd8cd62l+ cd45+: 42.75;\t%cd8cd62l- cd45+: 6.36;\t%cd8cd62l- cd45 -: 28.48;\t%cd8ccr7+ cd45-: 4.82;\t%cd8ccr7+ cd45+: 32.28;\t%cd8ccr7-cd45+: 12.78;\t%cd8ccr7-cd45 -: 50.11;\t%cd3-cd56+cd16+: 32.00;\t%nkts: 2.51;\t%cd19: 11.05;\t%cd4foxp3+: 8.38'}"
3739,"{'title': 'KT1084_6_L_test3', 'description': 'KT1084_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set3', 'characteristics_ch1': '6 months, living donor, test set3'}"
3740,"{'title': 'B94', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 47;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 6;\ttp53 mutation: 0;\tctnnb1 mutation: 248C>CG | S37S/C;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3741,"{'title': 'AML with normal karyotype #21', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 92.5;\tdisease state: de novo AML'}"
3742,"{'title': 'T11478C3: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
3743,"{'title': 'Control Con_rep22', 'description': 'Control paired  6', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
3744,"{'title': 'blood, Blood: 10uM nicotine treatment_le1', 'description': '10uM nicotine treatment for 1 hour;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
3745,"{'title': 'AILD-01', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
3746,"{'title': 'Young sedentary subject, biological replicate (YS12)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
3747,"{'title': 'RTX12 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: F;\tage (y): 59;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Poor-responder;\ttissue: synovium'}"
3748,"{'title': 'Patient 3864 AML44', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 44;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3749,"{'title': 'Pilocytic astrocytoma chip 7746', 'description': 'Pilocytic astrocytoma.  Chip ID 7746', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
3750,"{'title': 'Endometrium - pregnant [08-10335-1]', 'description': '08-10335-1', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval,  pregnant', 'characteristics_ch1': 'tissue: endometrium on day of oocyte retrieval;\tstate: pregnant'}"
3751,"{'title': 'SU360a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1436;\tdisease state: Asympt;\tgender: Male;\tage: 63;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 248;\tplasma hiv-1     rna level   (copies/ml): 46400;\ttissue: lymph node'}"
3752,"{'title': 'Pt11 whole subcutaneous adipose tissue, biological rep1', 'description': 'Pt11_SQAT', 'type': 'RNA', 'source_name_ch1': 'Whole subcutaneous adipose tissue, patient 11', 'characteristics_ch1': 'tissue: whole subcutaneous adipose tissue;\tpatient: 11'}"
3753,"{'title': 'C99550', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7210_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 38;\tcytogenetic change: inv(16)(p13q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3754,"{'title': 'DP24b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 41;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 494;\tplasma hiv-1 rna levels (copies/ml): 14,696'}"
3755,"{'title': 'IFNβ_578', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3756,"{'title': '01-0066A_Septic Shock_day1_21', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3757,"{'title': 'NSCLC EMC LCC2249N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
3758,"{'title': 'ALL without MLL - sample 80', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3759,"{'title': '23098', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
3760,"{'title': 'T51315', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51315;\tsample: tumor'}"
3761,"{'title': 'class F, rep20', 'description': 'NEB_1073.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 34;\tsex: F;\tdisease stage: 3;\talbumin level: 27;\themoglobin level: 85;\tlymphocyte percentage: 16;\twhite blood count: 23.5;\tinternational prognostic score (ips): 2'}"
3762,"{'title': 'DLBCL biopsy, sample 2163', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3763,"{'title': 'gd cell control time 0,donor 2', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated prior to activation;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: control;\ttime: 0;\tindividual: donor 2'}"
3764,"{'title': 'Cell line HB4a_R4', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
3765,"{'title': 'Patient 4740 AML160', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 160;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3766,"{'title': 'AML 3327', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
3767,"{'title': 'MDS patient 103', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
3768,"{'title': 'newly diagnosed multiple myeloma 262', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: I'}"
3769,"{'title': 'NSG006', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 6;\tdisease activity (das28_v3): 6.13;\tresponse to anti-tnf therapy: NORESPONSE'}"
3770,"{'title': 'AML without MLL - sample 106', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3771,"{'title': 'Training_Site2_06', 'description': 'Performed by Operator 1 from Site2 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
3772,"{'title': 'AML sample #14', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00082;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
3773,"{'title': 'IFNβ_2058', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3774,"{'title': 'Septic Shock_biological rep64', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 2.4;\toutcome: Survivor'}"
3775,"{'title': 'cord blood 16', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.13', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.13;\t'}"
3776,"{'title': 'LTB4 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tLatent'}"
3777,"{'title': 'AML sample #53', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
3778,"{'title': 'Patient_6285_relapse', 'description': '6285R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 35;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
3779,"{'title': 'D20_A', 'description': 'Gene expression data from cell line knocked-down for SDHB gene', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma cell line Hep3B cells, plasmid siSDHB, clone D20', 'characteristics_ch1': 'Hep3B cells stably transfected with short hairpin vectors containing an siRNA directed to SDHB;\tHep3B cells stably transfected with plasmid siSDHB, clone D20, replicate 1'}"
3780,"{'title': 'N1-03', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
3781,"{'title': 'AML 2683', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3782,"{'title': 'AML without MLL - sample 105', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3783,"{'title': 'Control 53', 'description': '08SE365', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3784,"{'title': 'Sputum from Stage III Severe, biological replicate 27', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 57;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
3785,"{'title': 'NSG510', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.24;\tdisease activity (das28_v3): 4.26;\tresponse to anti-tnf therapy: MEDIUM'}"
3786,"{'title': 'AML 6889', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 36 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3787,"{'title': 'MERLION_X02K05993', 'description': 'MERLION_X02K05993', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=70, state=0', 'characteristics_ch1': 'pT2N0, male, age=70, state=0'}"
3788,"{'title': 'N10584A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3789,"{'title': 'normal brain_2', 'description': 'bh20061208u133v2_A_36-Brain2_1', 'type': 'RNA', 'source_name_ch1': 'normal brain tissue', 'characteristics_ch1': 'tissue: brain'}"
3790,"{'title': 'VCX control 9', 'description': 'arrayconsortium.tgen.org::biosample.435310;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 9;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: female\xa0;\tGenetic Variation: None\xa0;\tAge: 82 years'}"
3791,"{'title': 'endothelial_rep15', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:55, gender:male, diagnostic group: control, PMI:31h'}"
3792,"{'title': 'PR89a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 32;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 824;\tplasma hiv-1 rna levels (copies/ml): 32,173'}"
3793,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 17', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
3794,"{'title': 'colonic_crypt_epithelial_cells_normal_colon_35 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: normal colon;\tsex: female'}"
3795,"{'title': 'UNTREATED_1794', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3796,"{'title': 'mucosa_normal_colon_2 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: normal colon;\tsex: female'}"
3797,"{'title': 'JS300b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1430;\tdisease state: Acute;\tgender: Male;\tage: 26;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 683;\tplasma hiv-1     rna level   (copies/ml): 3610;\ttissue: lymph node'}"
3798,"{'title': 'Monocyte_patient50_time5', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:Caucasian,Age:59,VAP day:7'}"
3799,"{'title': 'MDS patient 68', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
3800,"{'title': 'Healthy control 17', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
3801,"{'title': 'RTX7 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: F;\tage (y): 77;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
3802,"{'title': 'AML 4340', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 39 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3803,"{'title': 'untreated-none-3', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Demethylation: none', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tDemethylation: none;\tReplicate: 3'}"
3804,"{'title': 'primary colorectal carcinoma 2', 'description': 'total RNA isolated from primary colorectal carcinoma of stage D colorectal carcinoma patient 2', 'type': 'RNA', 'source_name_ch1': 'primary colorectal carcinoma from stage D colorectal carcinoma 2', 'characteristics_ch1': 'tissue: colon;\ttumor stage of patient: stage D;\tprimary site: colon'}"
3805,"{'title': 'Hippocampus_male_42yrs_indiv86', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 42 years', 'characteristics_ch1': 'individual: 86, AA;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 42'}"
3806,"{'title': 'Liver365N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HCV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 365N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: LC;\tgender: F;\tage: 71;\tvirus: HCV'}"
3807,"{'title': 'Capan-1 V1 control', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Capan-I cells allStar-transfected', 'characteristics_ch1': 'cell line: Capan-1;\tcell type: pancreatic carcinoma cells;\tgne mrna: unchanged'}"
3808,"{'title': 'HF1000_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
3809,"{'title': 'Adenocarcinoma, bone marrow negative AC 8', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'female pulmonary adenocarcinoma;\tbone marrow negative'}"
3810,"{'title': 'AML sample #46', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
3811,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 3', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
3812,"{'title': 'DLBCL biopsy, sample 2134', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3813,"{'title': 'PBMC_ectopic_validation_18', 'description': 'Blood collection: Samples collected by leukapheresis and stored in liquid nitrogen.;\tPBMC isolation:', 'type': 'RNA', 'source_name_ch1': 'PBMCs from patients with other cancer types (e.g., gastrointestinal and brain cancers)', 'characteristics_ch1': 'phenotype: Ectopic;\ttissue: peripheral blood leukocytes;\tdata set: validation'}"
3814,"{'title': 'Gingival tissue sample 4 from patient 43, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 43 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
3815,"{'title': 'class F, rep35', 'description': 'VAN_00159f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 68;\tsex: M;\tdisease stage: 3;\talbumin level: 33;\themoglobin level: 113;\tlymphocyte percentage: 9;\twhite blood count: 24.6;\tinternational prognostic score (ips): 3'}"
3816,"{'title': 'COL2_208', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 78;\tgender: M;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 1495;\tsecond apc mutation: 0;\t5q loh: 0'}"
3817,"{'title': 'Patient 4127 AML57', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 57;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: MLL-PTD'}"
3818,"{'title': 'Tumor 32', 'description': '07SE525', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
3819,"{'title': 'DLBCL biopsy, sample 2032', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
3820,"{'title': 'N10910A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3821,"{'title': 'Quadriceps muscle at T0, control patient 2', 'description': 'Gene expression data from quadriceps muscle biopsy of control patient', 'type': 'RNA', 'source_name_ch1': 'Quadriceps muscle, control patient, T0', 'characteristics_ch1': 'tissue type: Quadriceps muscle;\tpatient group: total knee arthroplasty control patient;\ttime point: T0'}"
3822,"{'title': 'csc: m2: i1: d07', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 2; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 2;\tReplicate: 1;\tBatch: d07'}"
3823,"{'title': 'MERLION_X00K01639', 'description': 'MERLION_X00K01639', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:52, state:0', 'characteristics_ch1': 'pT2N0, male, age:52, state:0'}"
3824,"{'title': 'B71', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.2'}"
3825,"{'title': 'NSG509', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.93;\tdisease activity (das28_v3): 1.68;\tresponse to anti-tnf therapy: RESPONSE'}"
3826,"{'title': 'Sepsis gram-negative TN9', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
3827,"{'title': 'Tumor Tum_Ph1_rep5', 'description': 'Tumor paired  18', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N0;\thistology: cli;\tgrade: _;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
3828,"{'title': '5290', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 63 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
3829,"{'title': 'D551, biological replicate 3', 'description': 'gene expression from D551, biological replicate 3', 'type': 'RNA', 'source_name_ch1': 'D551 cells from ATCC', 'characteristics_ch1': 'cell type: fibroblast;\tcell line: D551'}"
3830,"{'title': 'Gingival tissue sample 2 from patient 83, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 83 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3831,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_5d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
3832,"{'title': 'HOSE2008', 'description': 'Gene expression data from ovarian surface epithelial cells', 'type': 'RNA', 'source_name_ch1': 'Normal', 'characteristics_ch1': 'tissue: ovary;\tcell type: Normal ovarian surface epithelium'}"
3833,"{'title': 'AML 2327', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
3834,"{'title': 'X70118', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
3835,"{'title': 'Blood_TD24112_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
3836,"{'title': 'E161K heart, technical replicate A Mas5', 'description': 'Gene expression data from left ventricle of human heart with E161K LMNA mutation', 'type': 'RNA', 'source_name_ch1': 'left ventricle patient with E161K LMNA mutation', 'characteristics_ch1': 'gender: male;\tdevelopmental stage: adult;\torgan: heart;\ttissue: left ventricle;\tgenotype: LMNA E161K;\tdata analysis algorithm: Mas5'}"
3837,"{'title': 'control-4, cells cultured in regular DMEM', 'description': 'none;\tnone', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
3838,"{'title': 'MCF-7_Si-Wu-Tang_0.0256mg/ml_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
3839,"{'title': 'ALL without MLL - sample 78', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3840,"{'title': 'PCB77 treated HepG2 cells at T0, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines before PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation before PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
3841,"{'title': 'AML 7479', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 56 years;\tscore: FAB M0;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3842,"{'title': 'Training_Site3_04', 'description': 'Performed by Operator 1 from Site3 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 80.14; Lot# = 035PO41658D'}"
3843,"{'title': 'AML with normal karyotype #238', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: positive;\tage: 35;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 91;\tdisease state: de novo AML'}"
3844,"{'title': 'X469', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : 2'}"
3845,"{'title': 'HC6', 'description': 'Gene expression data from Healthy Control 6', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 6', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
3846,"{'title': 'C120', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.2'}"
3847,"{'title': 'newly diagnosed multiple myeloma 112', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: III'}"
3848,"{'title': 'CLL cells  PB  patient #23', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #23'}"
3849,"{'title': 'group-1-pt-t32042281', 'description': 'group-1-pt-t32042281', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 18;\tgender: male;\tfinal disposition: 06: Home'}"
3850,"{'title': 'Sputum from Stage III Severe, biological replicate 34', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 64;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
3851,"{'title': 'Gingival tissue sample 1 from patient 49, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 49 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3852,"{'title': 'Insulin sensitive patient 8 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
3853,"{'title': 'AML with normal karyotype #3', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 22;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Peripheral Blood;\tblast cell percentage: 20;\tdisease state: de novo AML'}"
3854,"{'title': 'Patient 4394 AML73', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 73;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
3855,"{'title': 'AML 2299', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 39 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3856,"{'title': 'IFNβ_1841', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
3857,"{'title': 'Patient_28', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 28;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 1.13E-05;\tproliferation index: -1.12423228082112'}"
3858,"{'title': 'HF1517_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
3859,"{'title': 'Enteropathy-associated T-cell lymphoma 2', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-156', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 55;\tgender: female'}"
3860,"{'title': 'hg_NY28', 'description': 'high-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; high-grade dysplastic liver tissue', 'characteristics_ch1': 'high-grade dysplastic liver tissue'}"
3861,"{'title': 'class S, rep44', 'description': 'VAN_00402.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 39;\tsex: F;\tdisease stage: 1;\talbumin level: 41;\themoglobin level: 137;\tlymphocyte percentage: 14;\twhite blood count: 10.8;\tinternational prognostic score (ips): 1'}"
3862,"{'title': 'group-1-pt-t3896185', 'description': 'group-1-pt-t3896185', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 30;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
3863,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_6h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
3864,"{'title': 'NY206', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 54;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\tafp: 6.7;\ttp53 mutation: 0;\tctnnb1 mutation: 232G>GA,p.D32D/N;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3865,"{'title': 'PR890a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1389;\tdisease state: Acute;\tgender: Male;\tage: 32;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 824;\tplasma hiv-1     rna level   (copies/ml): 32173;\ttissue: lymph node'}"
3866,"{'title': 'AML 5363', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 55 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3867,"{'title': 'Patient_6411_diagnosis', 'description': '6411D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 31;\tconclusions ig/tcr: stable;\tselected: no'}"
3868,"{'title': 'CB3', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'centroblasts donor 3', 'characteristics_ch1': 'centroblasts, isolated from tonsils by fluorescence-activated cell sorting'}"
3869,"{'title': 'S021', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S021', 'characteristics_ch1': 'patient id: P091;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
3870,"{'title': 'AML 5362', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 53 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
3871,"{'title': 'C024_Control_F_78', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 78;\tpost-mortem delay: 8h;\tph: 6.7'}"
3872,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 4', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
3873,"{'title': 'DietSensitive _6 weeks_subject8', 'description': 'DietSensitive _6 weeks_subject8', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 8;\tgender: Male'}"
3874,"{'title': 'KT1125_24_L_test3', 'description': 'KT1125_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
3875,"{'title': '807970', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '11416_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 38;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
3876,"{'title': 'Blood - Axial Spondyloarthropathy - 062A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 67;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
3877,"{'title': 'MCSF_A', 'description': 'MCSF_A', 'type': 'RNA', 'source_name_ch1': 'primary human monocyte-derived macrophages', 'characteristics_ch1': 'cell type: primary human monocyte-derived macrophages;\tdifferentiation factor: MCSF'}"
3878,"{'title': 'Cord blood CD21lo transitional B cells', 'description': 'Sample pooled from 2 cord blood donors.', 'type': 'RNA', 'source_name_ch1': 'Cord blood CD21lo transitional B cells', 'characteristics_ch1': 'tissue: cord blood;\tb-cell subset: CD20+CD10+CD27-CD21lo'}"
3879,"{'title': 'VAN_00648', 'description': '07-17613', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: testis;\tage: 67;\tgender: M;\tipi_stage: 2AE;\ttxprimary: CHOP6-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.14;\tprogression-free_survival (years): 1.14'}"
3880,"{'title': 'AML sample #24', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
3881,"{'title': 'TC.CD4-5', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
3882,"{'title': 'Lung Cancer 126T', 'description': 'Gene expression data from 126T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 62;\tstage: 2B'}"
3883,"{'title': 'Replicate 1 for T47D breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
3884,"{'title': 'Huh7 cells_Mock Infected 12 hours_ rep1', 'description': 'Gene expression data from Huh7 cells treated with mock media for 12 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 12 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
3885,"{'title': 'N8513C2: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
3886,"{'title': '34019', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tmutant KRAS;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
3887,"{'title': 'X22002', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : 3'}"
3888,"{'title': '2.1.NDV.2', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 2 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 2'}"
3889,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 24 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
3890,"{'title': 'UNTREATED_1790', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3891,"{'title': 'S032_Scz_M_77', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 77;\tpost-mortem delay: 3h;\tph: 6.2'}"
3892,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 9', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
3893,"{'title': '22053', 'description': '11688', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24275;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
3894,"{'title': 'control participant P332wh', 'description': 'Gene expression data from control participant T3', 'type': 'RNA', 'source_name_ch1': 'control participant P332wh (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
3895,"{'title': 'Gingival tissue sample 2 from patient 21, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 21 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3896,"{'title': 'not used- treatment interrupted [wf20071123u133v2_U_03_SZ13_B1_M_46yr_No_151]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
3897,"{'title': 'Simvastatin treated 12h, sample 3, Simvastatin is anti-inflammatory in macrophages', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'human peripheral blood monocyte-derived macrophages', 'characteristics_ch1': 'from unknown healthy blood-donor volunteers (Finnish Red Cross)'}"
3898,"{'title': 'Muscle-FamilyHistoryPositive-3', 'description': 'Jos3694;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 37;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 25;\tfasting glucose (ogtt): 102.5;\t2 hour glucose (ogtt): 141;\themoglobin a1c: 5.4;\tfasting glucose (iv0gavg): 95;\tfasting insulin (iv0inavg): 3.7;\tsi: 2.56;\twaist hip ratio: 0.805'}"
3899,"{'title': 'AML with normal karyotype #62', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 51.5;\tdisease state: de novo AML'}"
3900,"{'title': 'AML 2234', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 37 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
3901,"{'title': 'HIP control 4', 'description': 'arrayconsortium.tgen.org::biosample.434547;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 4;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: female\xa0;\tGenetic Variation: None\xa0;\tAge: 102 years'}"
3902,"{'title': 'control_B3, empty vector', 'description': 'None', 'type': 'RNA', 'source_name_ch1': 'Cervical carcinoma', 'characteristics_ch1': 'Age: 66 yrs Gender: Female  Ethnicity: Caucasian'}"
3903,"{'title': 'PRC3-1', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Vector only 786-O cells (PRC3), replicate 1'}"
3904,"{'title': 'Sputum from Stage III Severe, biological replicate 6', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 67;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
3905,"{'title': 'X41310', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
3906,"{'title': 'Pilocytic astrocytoma chip 7761', 'description': 'Pilocytic astrocytoma.  Chip ID 7761', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
3907,"{'title': 'AML with normal karyotype #89', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 67;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 84.5;\tdisease state: de novo AML'}"
3908,"{'title': '767545', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7507_Tumor;\tfab: M2;\tSex: M;\trace: W;\tage on study: 72;\tcytogenetic change: trisomy 11;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
3909,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_25_5)', 'description': 'Gene expression data from whole blood 30 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 74;\tSex: M'}"
3910,"{'title': 'Muscle control 15', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
3911,"{'title': '11-0021_Sepsis_day3_163', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3912,"{'title': 'group-2-pt-t3217508', 'description': 'group-2-pt-t3217508', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 39;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
3913,"{'title': 'C017_Control_M_72', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 72;\tpost-mortem delay: 12h;\tph: 6.8'}"
3914,"{'title': 'newly diagnosed multiple myeloma 254', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: III'}"
3915,"{'title': 'Blood sample from patient 135 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 135;\tday: Day 90;\tage (years): 58;\tsex: Male'}"
3916,"{'title': 'non-malignant FTEn_patient 12', 'description': 'Gene expression profile of non-malignant FTE from control patient during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 48;\tCycle: Follicular;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
3917,"{'title': 'M81', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 78;\tSex: F;\tcode: resection;\tclass: CTNNB1;\tafp: 23;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3918,"{'title': 'lymphocytes_HD_F_43y_1', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 26/47'}"
3919,"{'title': 'negative control transfection for 32 hours', 'description': 'negative control transfection for 32 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
3920,"{'title': 'GA_816', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3921,"{'title': 'Replicate 1 for HCC1428 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
3922,"{'title': 'AML 2306', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 35 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3923,"{'title': 'VCX control 2', 'description': 'arrayconsortium.tgen.org::biosample.435208;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 2;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 80 years'}"
3924,"{'title': 'K_AR13', 'description': 'K_AR13', 'type': 'RNA', 'source_name_ch1': 'AR13 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
3925,"{'title': 'AML 4338', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 50 years;\tscore: FAB M0;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3926,"{'title': 'Blood_TD23462_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
3927,"{'title': 'NSG400', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.77;\tdisease activity (das28_v3): 3.26;\tresponse to anti-tnf therapy: MEDIUM'}"
3928,"{'title': 'MDA MB231 YAP knock down cell pmig-YAP/pRS-IRES-GFP-YAP rep2', 'description': 'gene expression data from MDA MB231 pmig-YAP/pRS-IRES-GFP-YAP', 'type': 'RNA', 'source_name_ch1': 'breast cancer cell line MDA MB231', 'characteristics_ch1': 'stable breast cancer cell line MDA MB231with YAP gene knock down'}"
3929,"{'title': 'No18LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No18;\tcell type: lymphocytes;\ttime point: under therapy'}"
3930,"{'title': 'Septic Shock_biological rep61', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.7;\toutcome: Survivor'}"
3931,"{'title': 'HF1219_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
3932,"{'title': 'carcinoma_98 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 76;\tlocalization: caecum'}"
3933,"{'title': '789 - mAdbID:66370', 'description': 'mAdb experiment ID: 66370', 'type': 'RNA', 'source_name_ch1': '789', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 789;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: ABC DLBCL;\tClinical info: Follow up status: NA;\tClinical info: Follow up years: NA;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
3934,"{'title': 'N11320G3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3935,"{'title': 'Replicate 1 for HCC1954 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
3936,"{'title': 'ALL without MLL - sample 19', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3937,"{'title': 'M-24', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
3938,"{'title': 'MCF10A cells cocultured with breast cancer associated fibroblasts that extracted from breast cancer sample No 4', 'description': 'gene expression data from MCF10A cells cocultured with breast fibroblasts', 'type': 'RNA', 'source_name_ch1': 'MCF10A cells', 'characteristics_ch1': 'cell line, normal mammary epithelium, immortalized'}"
3939,"{'title': 'HC2', 'description': 'Gene expression data from Healthy Control 2', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 2', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
3940,"{'title': 'B35', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 67;\tSex: M;\tcode: resection;\tclass: Inflammation;\tafp: 104;\ttp53 mutation: 0;\tctnnb1 mutation: 259A>AG,p.T41T/A;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3941,"{'title': 'AML 2671', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3942,"{'title': 'IFNβ_1687', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
3943,"{'title': 'AML without MLL - sample 96', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
3944,"{'title': '2.1.NDV.16', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 16 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 16'}"
3945,"{'title': 'AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 3', 'description': 'AP-2 gamma silenced', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: AP-2 gamma targetting siRNA 1;\tcell line: MCF7'}"
3946,"{'title': 'whole blood_100190', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Female', 'characteristics_ch1': 'General population, Female'}"
3947,"{'title': 'adenocarcinoma_6 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 57;\tlocalization: sigmoid'}"
3948,"{'title': 'Pt1 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt1_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 1', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 1'}"
3949,"{'title': 'No7pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No7RVR;\ttime point: before therapy'}"
3950,"{'title': 'HIP control 10', 'description': 'arrayconsortium.tgen.org::biosample.434631;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 10;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: female\xa0;\tGenetic Variation: None\xa0;\tAge: 88 years'}"
3951,"{'title': 'CDcNR2_afterT', 'description': 'Colonic mucosal gene expression data from CDc non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
3952,"{'title': 'Blood - Control - 020A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 69;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
3953,"{'title': 'Sputum from Stage III Severe, biological replicate 19', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 62;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
3954,"{'title': 'PHI-CTR-5UP-S2', 'description': 'We examined the effects of 48h of knee immobilization on alterations in mRNA and protein in human skeletal muscle.  Biopsies were taken from the vastus lateralis muscle of five men (20.4 + 0.5 years) before and after 48h immobilization.', 'type': 'RNA', 'source_name_ch1': 'Human skeletal muscle', 'characteristics_ch1': 'treatment:control;'}"
3955,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_60_5)', 'description': 'Gene expression data from whole blood 30 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 71;\tSex: M'}"
3956,"{'title': 'SGBS control, biological rep2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'human SGBS mature adipocytes, control', 'characteristics_ch1': 'tissue: adipose;\tcell type: mature adipocytes;\tdisease state: Simpson-Golabi-Behmel syndrome (SGBS);\tcondition: normoxia'}"
3957,"{'title': '15-0011A_Septic Shock_day1_201', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
3958,"{'title': 'H9 ESC - replicate 2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'H9-ESC_2', 'characteristics_ch1': 'cell line: h9-esc_2: H9 hESCs (WiCell Research)'}"
3959,"{'title': 'HF1255_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
3960,"{'title': 'T8672A1.1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
3961,"{'title': 'X479', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 2'}"
3962,"{'title': 'DietSensitive _6 weeks_subject6', 'description': 'DietSensitive _6 weeks_subject6', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 6;\tgender: Female'}"
3963,"{'title': 'M53', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: B;\tage: 68;\tSex: F;\tcode: resection;\tclass: Unannotated;\tafp: 2653;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
3964,"{'title': 'Tonsil epithelium 2-batch 2', 'description': 'Laser Capture Microdissected Epithelium of Tonsil from healthy donors.', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic Tonsil of Sleap Apnea Adult Patient', 'characteristics_ch1': 'Tonsil Epithelium'}"
3965,"{'title': 'U937_ROS_curcumin_4h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 1uM curcumin treated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
3966,"{'title': 'vMyb virus-infected replicate 2\t(monocytes)', 'description': 'Adenovirus-infected monocytes', 'type': 'RNA', 'source_name_ch1': 'Primary human monocytes', 'characteristics_ch1': 'Monocytes from buffy coat preparation'}"
3967,"{'title': 'colonic_mucosa_non_inflamed_743', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Control subject, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.'}"
3968,"{'title': 'MDS patient 74', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
3969,"{'title': 'Patient 5236 AML229', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 229;\tcohort: Validation;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
3970,"{'title': 'AML sample #17', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
3971,"{'title': 'Control 12', 'description': '07SE499', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
3972,"{'title': 'B53', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.0'}"
3973,"{'title': 'ISC Control heart, technical replicate A Mas5', 'description': 'Gene expression data from left ventricle of human heart with no LMNA mutation', 'type': 'RNA', 'source_name_ch1': 'left ventricle patient with ischemic cardiomyopathy', 'characteristics_ch1': 'gender: male;\tdevelopmental stage: adult;\torgan: heart;\ttissue: left ventricle;\tgenotype: LMNA wt;\tdata analysis algorithm: Mas5'}"
3974,"{'title': 'Blood sample from patient 113 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 113;\tday: Day 28;\tage (years): 28;\tsex: Male'}"
3975,"{'title': 'HF0822_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
3976,"{'title': 'N11123D3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
3977,"{'title': 'No30pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No30RVR;\ttime point: before therapy'}"
3978,"{'title': 'muscle_preTZD_preClamp_NRd_s17', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 17'}"
3979,"{'title': 'Patient_5370_relapse', 'description': '5370R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 10;\tconclusions ig/tcr: stable;\tselected: yes'}"
3980,"{'title': 'Clone A cells treated with 5uM CsA and cultured for 48 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
3981,"{'title': 'Gingival tissue sample 2 from patient 69, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 69 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
3982,"{'title': 'Adult T-cell leukemia/lymphoma-1', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-07', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 48;\tgender: male'}"
3983,"{'title': 'Sepsis mixed infection  V12', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
3984,"{'title': 'KT0646_12_L_test3', 'description': 'KT0646_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
3985,"{'title': 'AML 7420', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 56 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
3986,"{'title': 'CLL cells  PB  patient #16', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #16'}"
3987,"{'title': 'Replicate 1 for CAL1201 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
3988,"{'title': 'newly diagnosed multiple myeloma 255', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
3989,"{'title': 'newly diagnosed multiple myeloma 145', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
3990,"{'title': 'DP240b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1324;\tdisease state: Acute;\tgender: Male;\tage: 41;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 494;\tplasma hiv-1     rna level   (copies/ml): 14696;\ttissue: lymph node'}"
3991,"{'title': 'Septic Shock_biological rep2', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.5;\toutcome: Survivor'}"
3992,"{'title': 'MDS patient 17', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
3993,"{'title': 'PBMCs_LB_after exercise_20', 'description': 'LB_Peak_188-EB', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 17;\tafter-exercise'}"
3994,"{'title': 'mesenchymal stem cells, lot#4F1560, 7th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F1560, passage number 7', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F1560, 7th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
3995,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 1', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
3996,"{'title': 'Patient_5370_diagnosis', 'description': '5370D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 10;\tconclusions ig/tcr: stable;\tselected: yes'}"
3997,"{'title': 'AML 2263', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 31 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
3998,"{'title': 'Training_Site6_07', 'description': 'Performed by Operator 1 from Site6 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
3999,"{'title': 'Septic Shock_biological rep51 06-0003', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.5;\toutcome: Survivor;\tgroup: B'}"
4000,"{'title': 'TNS1C', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siLincTNS1;\treplicate: 3'}"
4001,"{'title': 'PC5', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'plasma cells donor 5', 'characteristics_ch1': 'plasma cells, isolated from tonsils by fluorescence-activated cell sorting'}"
4002,"{'title': 'AML 6735', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 55 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
4003,"{'title': '70107', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4004,"{'title': 'Control 2, Simvastatin is anti-inflammatory in macrophages', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'human peripheral blood monocyte-derived macrophages', 'characteristics_ch1': 'from unknown healthy blood-donor volunteers (Finnish Red Cross)'}"
4005,"{'title': 'Gingival tissue sample 3 from patient 21, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 21 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
4006,"{'title': 'mRNA of GBM-HGG159, Glioblastoma, 13.1 years, Post-medulloblastoma', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 13.1 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 13.1 years; Other: Post-medulloblastoma'}"
4007,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_2d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
4008,"{'title': 'RR670a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1467;\tdisease state: Uninfected;\tgender: Male;\tage: 26;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 326;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
4009,"{'title': '06-0002_SIRS_day1_87', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4010,"{'title': 'PTB1 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
4011,"{'title': 'AML with normal karyotype #172', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 75;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 77;\tdisease state: de novo AML'}"
4012,"{'title': 'DLBCL biopsy, sample 2034', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
4013,"{'title': '1935 - mAdbID:66609', 'description': 'mAdb experiment ID: 66609', 'type': 'RNA', 'source_name_ch1': '1935', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1935;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 12.41;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
4014,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_54_5)', 'description': 'Gene expression data from whole blood 30 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 39;\tSex: M'}"
4015,"{'title': 'T-ALL-25-6h-5ug-rep', 'description': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion.', 'type': 'RNA', 'source_name_ch1': 'T-ALL patient 25, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion.'}"
4016,"{'title': '22100', 'description': '11861', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: African American;\tGender: M;\tTSP_Patient# 11974;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
4017,"{'title': 'No28pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No28RVR;\ttime point: before therapy'}"
4018,"{'title': 'MDS patient 115', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q plus other'}"
4019,"{'title': 'GC B cell_LMP1_rep2', 'description': 'Amplified total RNA from transfected and FACS sorted GC Bells', 'type': 'RNA', 'source_name_ch1': 'GC B cell transfected with LMP1 expression vector (pSG5-LMP1), rep2', 'characteristics_ch1': 'GC B cells sorted using CD10 MACS from reactive human tonsils'}"
4020,"{'title': 'HRV-infected, asthmatic S12 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, asthmatic S12', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
4021,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_6h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
4022,"{'title': 'carcinoma_32 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 71;\tlocalization: rectosigmoid'}"
4023,"{'title': '936028', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '10568_Tumor;\tfab: M2;\tSex: M;\trace: AA;\tage on study: 40;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
4024,"{'title': 'mesenchymal stem cells, lot#5F0138, 4th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#5F0138, passage number 4', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#5F0138, 4th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
4025,"{'title': 'Huh7 cells_JFH-1 Infected 24 hours_ rep1', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 24 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 24 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
4026,"{'title': 'muscle_preTZD_preClamp_IRd-_s13', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 13'}"
4027,"{'title': 'Young rep2', 'description': 'Early passage BJ fibroblasts, grown in serum-free media for 72hrs at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Early passage human foreskin BJ fibroblasts'}"
4028,"{'title': 'Proficiency_Site5_20', 'description': 'Performed by Operator 1 from Site5 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 8ug; cRNA yield (ug) = 67.896; Lot# = 035PO41658D'}"
4029,"{'title': 'MDS patient 70', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q'}"
4030,"{'title': 'NSCLC_AC_342', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 342.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
4031,"{'title': 'Muscle-FamilyHistoryNegative-5', 'description': 'Jos3668;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 57;\tfamily history: Family history negative;\tbody mass index (kg/m2): 22;\tfasting glucose (ogtt): 81.5;\t2 hour glucose (ogtt): 95;\themoglobin a1c: 5.5;\tfasting glucose (iv0gavg): 94;\tfasting insulin (iv0inavg): 5;\tsi: 4.06;\twaist hip ratio: 0'}"
4032,"{'title': 'Gingival tissue sample 2 from patient 49, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 49 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4033,"{'title': 'MDS patient 1', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
4034,"{'title': 'class S, rep20', 'description': 'VAN_00129.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 16;\tsex: M;\tdisease stage: 2;\talbumin level: 36;\themoglobin level: 124;\tlymphocyte percentage: 7;\twhite blood count: 15.2;\tinternational prognostic score (ips): 3'}"
4035,"{'title': 'N10535A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4036,"{'title': 'G179-NS_A', 'description': 'U133Plus2_122906L_DK03.CEL', 'type': 'RNA', 'source_name_ch1': 'Oligoastrocytoma derived cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: malignant;\tcell type: cell line;\tcell type: oligoastrocytoma'}"
4037,"{'title': 'NSCLC EMC TB0036he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
4038,"{'title': '2001 - mAdbID:75130', 'description': 'mAdb experiment ID: 75130', 'type': 'RNA', 'source_name_ch1': '2001', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 2001;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: ABC DLBCL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 1.31;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
4039,"{'title': 'MDS patient 86', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
4040,"{'title': 'Mature IFN 12h biological replicate 3 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: IFN 12h;\tcell line: BE(2)-C'}"
4041,"{'title': 'AML with normal karyotype #118', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 0.5;\tdisease state: de novo AML'}"
4042,"{'title': 'X32048', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 3'}"
4043,"{'title': 'Blood sample from patient 159 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 159;\tday: Day 28;\tage (years): 23;\tsex: Female'}"
4044,"{'title': 'class S, rep61', 'description': 'VAN_00468.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 58;\tsex: F;\tdisease stage: 1;\talbumin level: 43;\themoglobin level: 122;\tlymphocyte percentage: 30;\twhite blood count: 5.6;\tinternational prognostic score (ips): 2'}"
4045,"{'title': 'Angioimmunoblastic T-cell lymphoma 36', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-98', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 65;\tgender: male'}"
4046,"{'title': 'Peripheral T-Cell lymphoma, unspecified 12', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-13', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 73;\tgender: male'}"
4047,"{'title': 'COL2_211', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 70;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 0'}"
4048,"{'title': 'AML sample #38', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
4049,"{'title': '10241', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 41;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: no information;\tDonor Sex: M;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
4050,"{'title': 'PNS057', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.68;\tdisease activity (das28_v3): 3.37;\tresponse to anti-tnf therapy: MEDIUM'}"
4051,"{'title': 'Patient_6557_diagnosis', 'description': '6557D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 19;\tconclusions ig/tcr: stable;\tselected: yes'}"
4052,"{'title': 'DLBCL biopsy, sample 2125', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
4053,"{'title': 'S080', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S080', 'characteristics_ch1': 'patient id: P048;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 20'}"
4054,"{'title': 'HOSE2228', 'description': 'Gene expression data from ovarian surface epithelial cells', 'type': 'RNA', 'source_name_ch1': 'Normal', 'characteristics_ch1': 'tissue: ovary;\tcell type: Normal ovarian surface epithelium'}"
4055,"{'title': 'NY2', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: 0;\tage: 65;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 12.6;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
4056,"{'title': 'PTCL_AV_020', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
4057,"{'title': 'shp107-B (Senescent)', 'description': 'Senescent cells expressing shRNA targeting p107 replicate 2', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing shRNA targeting p107', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
4058,"{'title': 'platelet_sickle_14', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
4059,"{'title': 'AML without MLL - sample 109', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4060,"{'title': 'NSCLC_AC_148', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 148.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
4061,"{'title': 'Proficiency_Site11_34', 'description': 'Performed by Operator 3 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 72.00403; Lot# = 125PO54621A'}"
4062,"{'title': 'PBMCs treated at the IC90 for 2 hours,replicate 4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 2 hours,replicate 4', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
4063,"{'title': '04-0007A_Sepsis_day1_65', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4064,"{'title': 'PBMCs treated at the IC90 for 24 hours,replicate 5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 24 hours,replicate 5', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
4065,"{'title': 'Monocyte Low PBM 1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 1'}"
4066,"{'title': '32100', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade Low;\tStage IA;\tMicropapillary feature Negative;\t(LMP) implants Negative;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4067,"{'title': 'AML sample #80', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4068,"{'title': 'newly diagnosed multiple myeloma 276', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
4069,"{'title': 'Patient_22', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 22;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.129098987668566;\tproliferation index: 4.30937436036589'}"
4070,"{'title': 'N8803D3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4071,"{'title': 'normal_colon_23 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: male;\tprotocol: surgery;\tage: 59;\tlocalization: rectum'}"
4072,"{'title': 'T30582', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30582;\tsample: tumor'}"
4073,"{'title': 'UNTREATED_1681', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4074,"{'title': 'Blood Sample of subject 26 after inhalation; Group C: inhalation with 0.7 ppm FA 0h before sampling', 'description': 'Bl_Group_C_AI_subject_26', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 0 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 0 h;\tsubject: 26;\tgroup: C'}"
4075,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 17', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
4076,"{'title': 'T10473B1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4077,"{'title': 'Primary hepatocyte, biological replicate 2', 'description': 'PH_2', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocyte', 'characteristics_ch1': 'cell type: primary hepatocyte;\tgender: female'}"
4078,"{'title': 'VA46', 'description': '05-28122', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 57;\tgender: M;\tipi_stage: 4B;\ttxprimary: CHOP6-RITU;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 0.90;\tprogression-free_survival (years): 0.46'}"
4079,"{'title': 'Cervical cancer-lymph node negative-02-02', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 45.8;\tfigo stage: 1b1'}"
4080,"{'title': 'MS520b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1452;\tdisease state: Uninfected;\tgender: Male;\tage: 40;\trace: Hispanic;\tblood cd4+ t  cell count (cells/ml): 742;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
4081,"{'title': 'Peripheral T-Cell lymphoma, unspecified 43', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-147', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: not available;\tgender: not available'}"
4082,"{'title': 'Gingival tissue sample 1 from patient 43, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 43 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4083,"{'title': 'C011729', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7213_Tumor;\tfab: M3;\tSex: F;\trace: C;\tage on study: 26;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
4084,"{'title': 'class S, rep13', 'description': 'VAN_00069.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 15;\tsex: F;\tdisease stage: 3;\talbumin level: 38;\themoglobin level: 118;\tlymphocyte percentage: 19;\twhite blood count: 9.1;\tinternational prognostic score (ips): 2'}"
4085,"{'title': '11_0008_Control_Day1_52', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0008_Normal, Day1'}"
4086,"{'title': 'N11103G2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4087,"{'title': 'Gingival tissue sample 2 from patient 48, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 48 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4088,"{'title': 'AML sample #87', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4089,"{'title': 'neuron_rep11', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:32, gender:male, diagnostic group: control, PMI:13h'}"
4090,"{'title': 'Scz-27', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tL5', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - schizophrenia;\tSex: M;\tage: 61;\ttissue ph: 6.46;\tpmi (hrs): 37.5;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): 745 mg'}"
4091,"{'title': 'newly diagnosed multiple myeloma 201', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
4092,"{'title': 'T11286A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4093,"{'title': 'ALL without MLL - sample 56', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4094,"{'title': 'blood-vehicle-DHA-1', 'description': 'Unstimulated cells, DHA supplementation.;\t101-91-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, DHA', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: DHA'}"
4095,"{'title': 'hES_WIBR1_rep2_090811_11', 'description': 'Gene expression data from hES line WIBR1', 'type': 'RNA', 'source_name_ch1': 'hES line WIBR1', 'characteristics_ch1': 'cell line: hES line WIBR1'}"
4096,"{'title': 'HepG2 cells_GW7647_24h_rep2', 'description': 'A125_08_GW24', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells treated with PPARα agonist GW7647 at 100 nM for 24h', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatoma;\ttreatment: PPARα agonist GW7647;\ttreatment duration: 24 hr'}"
4097,"{'title': 'hES_BG01_rep5_120208_1', 'description': 'Gene expression data from hES line BG01', 'type': 'RNA', 'source_name_ch1': 'hES line BG01', 'characteristics_ch1': 'cell line: hES line BG01'}"
4098,"{'title': 'C011211', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6614_Tumor;\tfab: M3;\tSex: M;\trace: Asian;\tage on study: 28;\tcytogenetic change: t(15;17)(q22;q21); + 8;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4099,"{'title': 'Scz-14', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tInt6', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: M;\tage: 46;\ttissue ph: 5.83;\tpmi (hrs): 42;\ttype of drug: Haloperidol;\tdrug dose (chlorpromazine equivalents): 160 mg'}"
4100,"{'title': 'CLL_FISHnormal_rep6', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'female'}"
4101,"{'title': 'class S, rep69', 'description': 'VAN_00483.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 55;\tsex: M;\tdisease stage: 2;\talbumin level: 37;\themoglobin level: 156;\tlymphocyte percentage: 18;\twhite blood count: 7.6;\tinternational prognostic score (ips): 4'}"
4102,"{'title': 'S031_Scz_M_79', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 79;\tpost-mortem delay: 4.5h;\tph: 6.1'}"
4103,"{'title': 'T-cell acute lymphoblastic leukemia, MOLT3', 'description': 'Gene expression data from T-ALL cell line.;\tMOLT3', 'type': 'RNA', 'source_name_ch1': 'T-ALL cell line', 'characteristics_ch1': 'cell type: T-ALL;\tage: 19;\tgender: male'}"
4104,"{'title': 'Endometrium group A rFSH not pregnant 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group A, not pregnant', 'characteristics_ch1': 'treatment: rFSH;\ttissue: endometrium'}"
4105,"{'title': 'AML 7180', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4106,"{'title': 'Patient_29', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 29;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.281856034822844;\tproliferation index: -4.59679049874046'}"
4107,"{'title': 'EPN_242, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_242, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
4108,"{'title': '07-0002_Septic Shock_day1_95', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4109,"{'title': 'HF1139_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
4110,"{'title': 'Tumor 30', 'description': '07SE520', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
4111,"{'title': 'MDS patient 142', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
4112,"{'title': 'Control-22', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc14', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: F;\tage: 66;\ttissue ph: 6.37;\tpmi (hrs): 43;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
4113,"{'title': 'Patient 24, biopsy; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
4114,"{'title': 'Donor2_24h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 2 treated with DMSO for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 2;\tagent: control;\ttime: 24h;\tgender: Male;\tage: 44 years old'}"
4115,"{'title': 'S112', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S112', 'characteristics_ch1': 'patient id: P117;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 2'}"
4116,"{'title': 'colon_IBD_1110', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
4117,"{'title': 'AML 7419', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 58 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4118,"{'title': 'SH-SY5Y(ECACC)_RA_6h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
4119,"{'title': 'SK-N-SH_RA_2d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
4120,"{'title': 'Gingival tissue sample 3 from patient 46, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 46 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
4121,"{'title': 'GvHD d150', 'description': 'GvHD d150;\tMHH0897', 'type': 'RNA', 'source_name_ch1': 'blood from allogeneic stem cell transplantation (SCT) patient', 'characteristics_ch1': 'disease state: GvHD;\tcell type: CD4+CD25highCD127low/- Tregs;\ttime: 150 days'}"
4122,"{'title': 'Replicate 1 for MCF7mimic72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 1 for MCF7mimic72h breast cell line'}"
4123,"{'title': 'CB1', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'centroblasts donor 1', 'characteristics_ch1': 'centroblasts, isolated from tonsils by fluorescence-activated cell sorting'}"
4124,"{'title': 'normal fetal kidney, biological rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': '8 weeks normal', 'characteristics_ch1': 'age: 8 weeks gestation;\ttissue: kidney;\tkidney status: normal'}"
4125,"{'title': 'Patient 4425 AML92', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 92;\tcohort: Discovery;\tkaryotype: t(7;12);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4126,"{'title': 'K_AR4', 'description': 'K_AR4', 'type': 'RNA', 'source_name_ch1': 'AR4 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
4127,"{'title': 'C156', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 5.5'}"
4128,"{'title': 'Human lymphatic endothelial cells Control_Rep 1', 'description': 'Here we have addressed important question of inflammation-induced mechanism for leukocyte transmigration of lymphatic vessel endothelium by comparing global gene expression profile of normal dermal lymphatic endothelial cells with/without TNFa added to the culture.', 'type': 'RNA', 'source_name_ch1': 'skin samples obtained healthy human donars during elective surgery at the Radcliffe Infirmary Hospital_Oxford (with full ethical approval)', 'characteristics_ch1': 'Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).'}"
4129,"{'title': 'Replicate 1 for MB231control breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 mir-221/222 inhibitor control at 18h'}"
4130,"{'title': 'B76', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 70;\tSex: F;\tcode: resection;\tclass: CTNNB1;\tafp: 12;\ttp53 mutation: 256G>GT | R249R/S;\tctnnb1 mutation: 236C>CT | S33S/F;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4131,"{'title': '22034', 'description': '11701', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24249;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
4132,"{'title': 'Gingival tissue sample 1 from patient 13, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 13 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4133,"{'title': '869586', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '10571_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 23;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4134,"{'title': 'cord blood 9_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.6', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.6;\t'}"
4135,"{'title': 'B1-RR-Pat.8 [wf20071123u133v2_U_09_CH22_B1_M_38yr_No_151]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
4136,"{'title': 'Pt11 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt11_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 11', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 11'}"
4137,"{'title': 'newly diagnosed multiple myeloma 237', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
4138,"{'title': '44078', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIB;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4139,"{'title': 'UNTREATED_1066', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4140,"{'title': 'non-pCR breast biopsy, sample 6 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 6 rep 2', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
4141,"{'title': 'AML with normal karyotype #216', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 49;\tdisease state: de novo AML'}"
4142,"{'title': 'KT0477_3_L_test3', 'description': 'KT0477_3_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set3', 'characteristics_ch1': '3 months, living donor, test set3'}"
4143,"{'title': 'Proficiency_Site2_18', 'description': 'Performed by Operator 1 from Site2 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 48.82; Lot# = 035PO41658D'}"
4144,"{'title': '1-Va24-4-N', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Individual #1, CD1d-aGC+ Va24- T cell clone #4, resting', 'characteristics_ch1': 'cell type: CD1d-aGC+ Va24- T cell clone'}"
4145,"{'title': '1374 (HIV+)', 'description': 'Gene expression data from frozen ARL tumor specimen', 'type': 'RNA', 'source_name_ch1': 'Frozen Tumor Biopsy_Lung', 'characteristics_ch1': 'specimen: frozen ARL tumor biopsy;\ttumor biopsy origin: Lung;\tage at diagnosis: 33;\tgender: Male;\tpathology diagnosis: DLBCL;\tmolecular diagnosis: GCB DLBCL;\tebv status: negative'}"
4146,"{'title': 'Sputum from Stage II Moderate, biological replicate 44', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 65;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
4147,"{'title': 'CD34+CD45RA+Lin- HPCs transduced with empty vector cultured onto BSA', 'description': 'BCE_01;\tGene expression data from control cells transduced with empty vector', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA-Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: hematopoietic progenitors;\tgenotype/variation: transduced with empty vector;\ttreatment group: control'}"
4148,"{'title': 'NF-8', 'description': 'Gene expression data from non-failing control hearts', 'type': 'RNA', 'source_name_ch1': 'Non-Failing Sample 4', 'characteristics_ch1': 'sample pairs: none;\ttissue: Myocard;\tvad status: unsupported;\tdisease status: none;\tvad: none;\tage: 28;\tgender: m'}"
4149,"{'title': 'NSCLC_AC_445', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 445.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
4150,"{'title': 'IFNβ_1165', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4151,"{'title': 'UCR6_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
4152,"{'title': 'TC.CD8-5', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
4153,"{'title': 'Proficiency_Site2_17', 'description': 'Performed by Operator 1 from Site2 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 17.87; Lot# = 035PO41658D'}"
4154,"{'title': 'NY311', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: C;\tage: 68;\tSex: M;\tcode: resection;\tclass: Proliferation;\tafp: 13625;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4155,"{'title': 'CD19_selected_B-cells_after_RFC_rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after RFC'}"
4156,"{'title': 'C134', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.2'}"
4157,"{'title': 'T162 U133p2', 'description': 'bulk breast tumor RNA from patient T162', 'type': 'RNA', 'source_name_ch1': 'T162', 'characteristics_ch1': 'breast tumor'}"
4158,"{'title': 'Septic Shock_biological rep21 01-0074', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 7.3;\toutcome: Survivor;\tgroup: B'}"
4159,"{'title': 'AML 3292', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 41 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4160,"{'title': 'C98840', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6619_Tumor;\tfab: M4;\tSex: F;\trace: C;\tage on study: 37;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
4161,"{'title': 'No27pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No27RVR;\ttime point: before therapy'}"
4162,"{'title': 'AML with normal karyotype #101', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 36;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 35;\tdisease state: de novo AML'}"
4163,"{'title': 'KOPT-K1_SAHM1_01', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'KOPT-K1 cells treated with SAHM1', 'characteristics_ch1': 'cell type: T-cell;\tcell line: KOPT-K1'}"
4164,"{'title': 'C98974', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7215_Tumor;\tfab: M0;\tSex: M;\trace: C;\tage on study: 23;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4165,"{'title': 'group-2-pt-t4965319', 'description': 'group-2-pt-t4965319', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 35;\tgender: male;\tfinal disposition: control'}"
4166,"{'title': 'VCX control 8', 'description': 'arrayconsortium.tgen.org::biosample.435296;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 8;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: female\xa0;\tGenetic Variation: None\xa0;\tAge: 88 years'}"
4167,"{'title': 'MDS patient 168', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
4168,"{'title': 'AML 5360', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 29 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4169,"{'title': 'AML with normal karyotype #58', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 41;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 15;\tdisease state: advanced MDS/AML'}"
4170,"{'title': 'aa_NY216', 'description': 'very advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very advanced HCC', 'characteristics_ch1': 'very advanced HCC'}"
4171,"{'title': 'COL2_426', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 71;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1114;\tsecond apc mutation: 1415;\t5q loh: 0'}"
4172,"{'title': 'Gene expression: HCC1395', 'description': 'Breast cancer cell line, ATCC# CRL-2324', 'type': 'RNA', 'source_name_ch1': 'RNA from cell line', 'characteristics_ch1': 'cell line: HCC1395;\tcatalog number: ATCC# CRL-2324'}"
4173,"{'title': 'AML without MLL - sample 100', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4174,"{'title': 'WU590a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1459;\tdisease state: Asympt;\tgender: Male;\tage: 36;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 286;\tplasma hiv-1     rna level   (copies/ml): > 100,000;\ttissue: lymph node'}"
4175,"{'title': 'AML sample #9', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
4176,"{'title': 'AML 7115', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 39 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4177,"{'title': 'Non-tumoral,  (148)', 'description': 'MGMT status:', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: non-tumoral;\tpatient: 148;\tage: NA;\tgender: NA;\ttreatment: NA;\tsurvival status: NA;\tsurvival time in months: NA'}"
4178,"{'title': 'H448 Rif 30uM', 'description': 'H448 Rif 30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H448 Rif 30uM', 'characteristics_ch1': 'primary hepatocytes'}"
4179,"{'title': 'C98154', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6698_Tumor;\tfab: M2;\tSex: F;\trace: C;\tage on study: 20;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
4180,"{'title': 'AML with normal karyotype #247', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 50;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 70;\tdisease state: de novo AML'}"
4181,"{'title': 'EPN_246, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_246, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
4182,"{'title': 'Subject 6, Family 2, Control', 'description': 'microarray hybridization data 07/10/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Female;\tfamily: 2;\tage: 38;\tdisease status: Control;\ttissue: Muscle: Deltoid'}"
4183,"{'title': 'group-1-pt-t5928763', 'description': 'group-1-pt-t5928763', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 18;\tgender: female;\tfinal disposition: 88: Other (specify)'}"
4184,"{'title': 'NSCLC_AC_88', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 88.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
4185,"{'title': 'PCB153 treated HepG2 cells at T0, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines before PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
4186,"{'title': 'adenocarcinoma_82 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 48;\tlocalization: rectum'}"
4187,"{'title': 'S5-7', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 7; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 7; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 7;\tSmoking status: smoker;\tPack-years: 23;\tAge: 46;\tSex: F;\tEthnic group: black'}"
4188,"{'title': '01-0037A_SIRS_day1_41', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4189,"{'title': 'newly diagnosed multiple myeloma 59', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
4190,"{'title': 'Mature IFN 6h biological replicate 1 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: IFN 6h;\tcell line: BE(2)-C'}"
4191,"{'title': 'Sepsis gram-positive V17', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
4192,"{'title': 'Pilocytic astrocytoma chip 8461', 'description': 'Pilocytic astrocytoma.  Chip ID 8461', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
4193,"{'title': 'S018', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S018', 'characteristics_ch1': 'patient id: P081;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 55'}"
4194,"{'title': 'normal_colon_96 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 65;\tlocalization: rectum'}"
4195,"{'title': '11_0029_SepticShock_Day1_30', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0029_Patient, Day1'}"
4196,"{'title': 'KT0481_12_D_test2', 'description': 'KT0481_12_D_test2', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, deceased donor, test set2', 'characteristics_ch1': '12 months, deceased donor, test set2'}"
4197,"{'title': 'Hippocampus_male_52yrs_indiv71', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 52 years', 'characteristics_ch1': 'individual: 71, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 52'}"
4198,"{'title': 'colon_adenoma_1154', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
4199,"{'title': 'Gingival tissue sample 1 from patient 31, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 31 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4200,"{'title': 'bladder_T1GH_pool-3', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, T1 high grade', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 4 individual samples.'}"
4201,"{'title': 'SU36b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 63;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 248;\tplasma hiv-1 rna levels (copies/ml): 46,400'}"
4202,"{'title': 'Patient_6285_diagnosis', 'description': '6285D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 35;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
4203,"{'title': '287', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7499_Tumor;\tfab: M3;\tSex: F;\trace: W;\tage on study: 64;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
4204,"{'title': 'PBMCs treated at the IC90 for 24 hours,replicate 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 24 hours,replicate 2', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
4205,"{'title': 'AML sample #83', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00584;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
4206,"{'title': 'AML sample #4', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00032;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
4207,"{'title': 'N_F61_?_01', 'description': 'Normal Adult patient, age 61, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'Normal Adult patient;\tbiopsy site:  unknown'}"
4208,"{'title': 'platelet_Ctrl_2', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
4209,"{'title': 'T10180C1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4210,"{'title': 'class S, rep56', 'description': 'VAN_00441.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 38;\tsex: M;\tdisease stage: 1;\talbumin level: _;\themoglobin level: 139;\tlymphocyte percentage: 29;\twhite blood count: 6.4;\tinternational prognostic score (ips): 2.3'}"
4211,"{'title': 'Lung Cancer 149T', 'description': 'Gene expression data from 149T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 42;\tstage: 2A'}"
4212,"{'title': 'MERLION_X01K01544', 'description': 'MERLION_X01K01544', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age 48, state 0', 'characteristics_ch1': 'pT2N0, male, age 48, state 0'}"
4213,"{'title': 'X44377', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
4214,"{'title': 'MCF7, biological rep1', 'description': 'Gene expression data from MCF7 breast cancer cell line expressing Estrogen receptor', 'type': 'RNA', 'source_name_ch1': 'MCF7 expressing Estrogen receptor alpha', 'characteristics_ch1': 'knockdown: control;\tcell line: MCF7'}"
4215,"{'title': 'CDcNR5_beforeT', 'description': 'Colonic mucosal gene expression data from CDc non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
4216,"{'title': 'Young trained subject, biological replicate (YT7)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
4217,"{'title': '22067', 'description': '11718', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24292;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
4218,"{'title': 'vCRC2', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: colorectal cancer'}"
4219,"{'title': '11_0018C_Day1_27', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Female'}"
4220,"{'title': 'Gingival tissue sample 4 from patient 61, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 61 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
4221,"{'title': 'control_08hr_rep2', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_08hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
4222,"{'title': 'PGA_PA-N_148', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
4223,"{'title': 'mRNA of AA-HGG073, Anaplastic Astrocytoma, 6 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 6 years', 'characteristics_ch1': 'disease: Anaplastic Astrocytoma;\tage: 6 years'}"
4224,"{'title': '22051', 'description': '11686', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24272;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
4225,"{'title': '93C57', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6715_Tumor;\tfab: M3;\tSex: M;\trace: H;\tage on study: 50;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4226,"{'title': 'AML 6982', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 47 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: neg'}"
4227,"{'title': 'Gastric GIST 19', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 68;\tTumor size: 17;\tKIT mutation: Exon 11'}"
4228,"{'title': 'BC2163cc', 'description': '060406.05.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 47;\tmolecular subtype: NA;\thistology: --;\tpt: --;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: --;\terbb2.tab ihc status: --;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: --;\ttop2a ihc status: --;\tfoxa1 ihc status: --;\tmfs: 1;\tmfsdel (month): 16.3'}"
4229,"{'title': 'PTCL_AV_022', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
4230,"{'title': 'newly diagnosed multiple myeloma 11', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
4231,"{'title': 'KT1111_12_L_test3', 'description': 'KT1111_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
4232,"{'title': 'group-2-pt-t17044501', 'description': 'group-2-pt-t17044501', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 17;\tgender: female;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
4233,"{'title': 'AML 7309', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 60 years;\tscore: RAEB-t;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4234,"{'title': 'PBMCs_EB_after exercise_03', 'description': 'EB_Peak_096-RB', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 10;\tafter-exercise'}"
4235,"{'title': 'Replicate 1 for MB231inhibitor breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 mir-221/222 inhibitor at 18h'}"
4236,"{'title': 'Donor4_24h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 4 treated with DMSO for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 4;\tagent: control;\ttime: 24h;\tgender: Female;\tage: 54 years old'}"
4237,"{'title': 'PGA_PA-D_93', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
4238,"{'title': 'neuron_rep1', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h'}"
4239,"{'title': 'Muscle-FamilyHistoryPositive-7', 'description': 'Jos3706;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 31;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 26;\tfasting glucose (ogtt): 85.5;\t2 hour glucose (ogtt): 115;\themoglobin a1c: 4.9;\tfasting glucose (iv0gavg): 85;\tfasting insulin (iv0inavg): 1.9;\tsi: 6.02;\twaist hip ratio: 0.824'}"
4240,"{'title': 'Training_Site3_06', 'description': 'Performed by Operator 1 from Site3 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
4241,"{'title': 'T10781D1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4242,"{'title': 'X41079', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
4243,"{'title': 'Sputum from Stage II Moderate, biological replicate 17', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 66;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
4244,"{'title': 'PNS027', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.59;\tdisease activity (das28_v3): 3.18;\tresponse to anti-tnf therapy: RESPONSE'}"
4245,"{'title': '32089', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4246,"{'title': 'MERLION_X00K03912', 'description': 'MERLION_X00K03912', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:70, state:1', 'characteristics_ch1': 'pT2N0, male, age:70, state:1'}"
4247,"{'title': 'Thyroid_ unaffected_paired with PTC11T', 'description': 'sample name in manuscript: N-PTC1', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: normal thyroid; Gender:female; Age:48'}"
4248,"{'title': 'Tumor 23', 'description': '07SE510', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
4249,"{'title': 'AML 2302', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 34 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4250,"{'title': 'Patient 24, colonocytes; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
4251,"{'title': 'Control 9', 'description': '07SE493', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
4252,"{'title': 'ci_NY37', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
4253,"{'title': 'MDS patient 178', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
4254,"{'title': '10-0004_Sepsis_day1_111', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4255,"{'title': 'platelet_sickle_13', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
4256,"{'title': 'papillary renal cell cancer; pRCCa_HD1562T1', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
4257,"{'title': 'C97509', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7376_Tumor;\tfab: M1;\tSex: M;\trace: AA;\tage on study: 37;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
4258,"{'title': 'dmso-aza-2', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tDemethylation: aza;\tReplicate: 2'}"
4259,"{'title': 'AML 2275', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 46 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4260,"{'title': 'Sputum from Stage II Moderate, biological replicate 19', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 67;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
4261,"{'title': 'human BM MSC BMP2 stimulated day 3 rep 1', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 3', 'type': 'RNA', 'source_name_ch1': 'donor 1, stimulated with BMP2 for 3 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 3 days'}"
4262,"{'title': 'Septic Shock_biological rep88 17-0001A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 8.2;\toutcome: Survivor;\tgroup: B'}"
4263,"{'title': 'CC4', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'centrocytes donor 4', 'characteristics_ch1': 'centrocytes, isolated from tonsils by fluorescence-activated cell sorting'}"
4264,"{'title': 'PGA-Hs_D-10', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
4265,"{'title': '407992', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7504_Tumor;\tfab: M4;\tSex: M;\trace: W;\tage on study: 33;\tcytogenetic change: t(11;19)(q23;p13.1); inv(12)(p12p13);\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4266,"{'title': 'brain, unknown: R4B_e1_le1', 'description': 'rotenone 4 weeks C;\tTreatment, type=time_course, measurement=4.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
4267,"{'title': 'obstructed fetal kidney, biological rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': '18 weeks obstructed', 'characteristics_ch1': 'age: 18 weeks gestation;\ttissue: kidney;\tkidney status: obstructed'}"
4268,"{'title': 'aa_NY31', 'description': 'very advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very advanced HCC', 'characteristics_ch1': 'very advanced HCC'}"
4269,"{'title': 'HF1702_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4270,"{'title': 'hg_NY29', 'description': 'high-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; high-grade dysplastic liver tissue', 'characteristics_ch1': 'high-grade dysplastic liver tissue'}"
4271,"{'title': 'B cell donor 4, rolipram', 'description': 'Cells treated with 20 uM rolipram', 'type': 'RNA', 'source_name_ch1': 'MACS purified resting B cells from healthy donor peripheral blood', 'characteristics_ch1': 'B cell donor 4, rolipram'}"
4272,"{'title': '01-0052A_Septic Shock_day1_54', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4273,"{'title': 'Blood - Control - 111A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 25;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
4274,"{'title': 'Control 2', 'description': '07SE487', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
4275,"{'title': 'UNTREATED_2146', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4276,"{'title': '22027', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant KRAS;\tGrade Low;\tStage IIA;\tMicropapillary feature Negative;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4277,"{'title': 'Proficiency_Site9_21', 'description': 'Performed by Operator 1 from Site9 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 28.814; Lot# = 035PO41658D'}"
4278,"{'title': 'PBMCs treated at the IC90 for 2 hours,replicate 6', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 2 hours,replicate 6', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
4279,"{'title': 'AML sample #35', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
4280,"{'title': 'Blood_TD24111_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
4281,"{'title': 'SK-N-SH_BDNF_3d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
4282,"{'title': 'muscle_preTZD_preClamp_NRd_s23', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 23'}"
4283,"{'title': 'MCF10A cells cocultured without any breast fibroblasts and this sample is served as experimental control', 'description': 'gene expression data from MCF10A cells cocultured with breast fibroblasts', 'type': 'RNA', 'source_name_ch1': 'MCF10A cells', 'characteristics_ch1': 'cell line, normal mammary epithelium, immortalized'}"
4284,"{'title': '344551', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9684_Tumor;\tfab: M3;\tSex: M;\trace: H;\tage on study: 48;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4285,"{'title': 'Replicate 1 for BT474 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
4286,"{'title': 'normal renal cortical tissue_2', 'description': 'normal control tissue', 'type': 'RNA', 'source_name_ch1': 'Non-cancerous renal cortical tissue from nephrectomized kidney with isolated renal cell carcinoma of patient 2', 'characteristics_ch1': 'PKD1 patient'}"
4287,"{'title': 'Hippocampus_female_82yrs_indiv98', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 82 years', 'characteristics_ch1': 'individual: 98, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 82'}"
4288,"{'title': 'S091', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S091', 'characteristics_ch1': 'patient id: P109;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 8.5'}"
4289,"{'title': 'Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 2', 'description': 'non silencing control', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: Non-silencing control siRNA;\tcell line: MCF7'}"
4290,"{'title': 'Monocyte Low PBM 9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 9'}"
4291,"{'title': 'Normal_2', 'description': 'Normal mucosa', 'type': 'RNA', 'source_name_ch1': 'Normal tissue 2', 'characteristics_ch1': 'tissue: esophagus, normal;\tgender: male, Japanese;\tage: 51'}"
4292,"{'title': '905179', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9679_Tumor;\tfab: M2;\tSex: F;\trace: W;\tage on study: 75;\tcytogenetic change: t(8;21)(q22;q22); del(9)(q12q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4293,"{'title': 'MTX2', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincMTX2;\treplicate: 3'}"
4294,"{'title': 'AML sample #9', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00072;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
4295,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_5_5)', 'description': 'Gene expression data from whole blood 30 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 62;\tSex: M'}"
4296,"{'title': '04-0005_Septic Shock_day1_70', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4297,"{'title': 'Sputum from Stage II Moderate, biological replicate 43', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 73;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
4298,"{'title': 'AML 2179', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4299,"{'title': 'brain_endothelial_cells_rep1', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'endothelial cells from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 45; this individual had a medical history of schizophrenia'}"
4300,"{'title': 'No18LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No18;\tcell type: hepatocytes;\ttime point: before therapy'}"
4301,"{'title': 'NY82', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: Proliferation;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4302,"{'title': 'colon_adenoma_1419', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
4303,"{'title': 'PBMCs vehicle treated for 2 hours,replicate 4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 2 hours,replicate 4', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
4304,"{'title': 'Patient 4699 AML133', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 133;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4305,"{'title': '22097', 'description': '11859', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24331;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
4306,"{'title': 'HF0450_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
4307,"{'title': 'BL41 60 min nt-RNA Rep.2', 'description': 'newly transcribed RNA (nt-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
4308,"{'title': 'Gastric GIST 1', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 64;\tTumor size: 4;\tKIT mutation: Wild type'}"
4309,"{'title': 'No11inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No11RVR;\ttime point: under therapy'}"
4310,"{'title': 'ALL with MLL - sample 117', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4311,"{'title': 'blood-vehicle-DHA-3', 'description': 'Unstimulated cells, DHA supplementation.;\t203-91-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, DHA', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: DHA'}"
4312,"{'title': 'AML sample #7', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00038;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
4313,"{'title': '11-0046A_SIRS_day1_178', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4314,"{'title': 'X44192', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IC;\tConsolidated.Grade : 2'}"
4315,"{'title': 'CD19_selected_B-cells_after_R_rep8', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after Rituximab'}"
4316,"{'title': 'AML with normal karyotype #26', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 20;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: ;\tdisease state: de novo AML'}"
4317,"{'title': 'Liver, biological replicate 2', 'description': 'Liver2', 'type': 'RNA', 'source_name_ch1': 'Liver', 'characteristics_ch1': 'tissue: liver;\tgender: female'}"
4318,"{'title': 'humanMDM_COPD_LPS', 'description': 'see Affymetrix standard protocol', 'type': 'RNA', 'source_name_ch1': 'humanMDM_COPD_LPS', 'characteristics_ch1': 'monocyte-derived macrophages of 13 male COPD patients'}"
4319,"{'title': 'Hippocampus_male_83yrs_indiv28', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 83 years', 'characteristics_ch1': 'individual: 28, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 83'}"
4320,"{'title': 'Normal Control C-10a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Normal Control C-10a', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
4321,"{'title': 'Muscle-FamilyHistoryPositive-13', 'description': 'Jos3718;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 27;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 24;\tfasting glucose (ogtt): 87;\t2 hour glucose (ogtt): 148;\themoglobin a1c: 4.7;\tfasting glucose (iv0gavg): 86;\tfasting insulin (iv0inavg): 4.2;\tsi: 5.65;\twaist hip ratio: 0.865'}"
4322,"{'title': 'PCSC-3 parental biol repl 2', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-3 parental cultures in PCSCs medium', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-3;\tculture type: adherent'}"
4323,"{'title': 'AML with normal karyotype #112', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 50.5;\tdisease state: de novo AML'}"
4324,"{'title': 'LSD2 knockdown, replicate 1', 'description': 'Gene expression data from HeLa cells infected with shLSD2 retrovirus', 'type': 'RNA', 'source_name_ch1': 'HeLa cells infected with shLSD2 retrovirus', 'characteristics_ch1': 'cell line: HeLa cervical carcinoma'}"
4325,"{'title': 'muscle_preTZD_preClamp_IRd_s31', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 31'}"
4326,"{'title': 'AML with normal karyotype #42', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: positive;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 74.5;\tdisease state: de novo AML'}"
4327,"{'title': '24 hours post-infection, biological rep2', 'description': 'Gene expression data from cells 24 hours after HCMV infection', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
4328,"{'title': 'Sputum from Stage III Severe, biological replicate 11', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 60;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
4329,"{'title': 'HF0089_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4330,"{'title': 'DietSensitive _1 day_subject8', 'description': 'DietSensitive _1 day_subject8', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 8;\tgender: Male'}"
4331,"{'title': 'Gingival tissue sample 1 from patient 75, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 75 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4332,"{'title': 'GBM, TMZ/radiotherapy (300)', 'description': 'MGMT status: ?', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 300;\tage: 47.1;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 8.68;\tmgmt status: ?'}"
4333,"{'title': 'Septic Shock_biological rep9 01-0033A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.6;\toutcome: Survivor;\tgroup: B'}"
4334,"{'title': 'KT0785_3_L_paired', 'description': 'KT0785_3_L_paired', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, paired set', 'characteristics_ch1': '3 months, living donor, paired set'}"
4335,"{'title': 'Patient 4372 AML64', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 64;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4336,"{'title': '1024 - mAdbID:70397', 'description': 'mAdb experiment ID: 70397', 'type': 'RNA', 'source_name_ch1': '1024', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1024;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 19.83;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
4337,"{'title': 'AML 2686', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 31 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4338,"{'title': 'newly diagnosed multiple myeloma 90', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: II'}"
4339,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
4340,"{'title': 'Muscle-FamilyHistoryNegative-1', 'description': 'Jos3660;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 39;\tfamily history: Family history negative;\tbody mass index (kg/m2): 20;\tfasting glucose (ogtt): 85;\t2 hour glucose (ogtt): 125;\themoglobin a1c: 5.6;\tfasting glucose (iv0gavg): 90;\tfasting insulin (iv0inavg): 2.7;\tsi: 11.91;\twaist hip ratio: 1.364'}"
4341,"{'title': '06-0001_Septic Shock_day1_85', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4342,"{'title': 'HF1489_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
4343,"{'title': 'GA_1505', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4344,"{'title': 'AML with normal karyotype #153', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 47;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 83;\tdisease state: de novo AML'}"
4345,"{'title': 'newly diagnosed multiple myeloma 231', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
4346,"{'title': 'T10957A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4347,"{'title': 'Patient 4741 AML161', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 161;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4348,"{'title': 'HepG2, biological replicate 2', 'description': 'HepG2_2', 'type': 'RNA', 'source_name_ch1': 'HepG2', 'characteristics_ch1': 'cell line: HepG2;\tgender: female'}"
4349,"{'title': 'UNTREATED_717', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
4350,"{'title': 'Replicate 2 for MCF7untreated breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 untreated cell line to compare to older profiled MCF7 sample. See ATCC/DSMZ for cell line details.'}"
4351,"{'title': 'T51308', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51308;\tsample: tumor'}"
4352,"{'title': 'X23053', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
4353,"{'title': 'K_AR6', 'description': 'K_AR6', 'type': 'RNA', 'source_name_ch1': 'AR6 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection'}"
4354,"{'title': 'Blood sample from patient 180 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 180;\tday: Day 28;\tage (years): 63;\tsex: Female'}"
4355,"{'title': 'gd cell activation+6h,donor 2', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 6 hours after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 6 hrs;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 6 h;\tindividual: donor 2'}"
4356,"{'title': 'NY319', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 54;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\tafp: 3.4;\ttp53 mutation: 364C>CA | P151P/T;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4357,"{'title': 'Control (dupl) sample 5b', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
4358,"{'title': 'Normal Ovary, 2225', 'description': 'Gene expression data from normal ovary.;\tHOSE2225', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
4359,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 10', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
4360,"{'title': 'Thyroid_papillary carcinoma 71', 'description': 'sample name in manuscript: T-PTC7', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue:tumor; Gender:male; Age:36; Tumor stage:T4aN1aM1'}"
4361,"{'title': 'K_AR7', 'description': 'K_AR7', 'type': 'RNA', 'source_name_ch1': 'AR7 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection'}"
4362,"{'title': 'Human lymphatic endothelial cells Control_Rep 2', 'description': 'Here we have addressed important question of inflammation-induced mechanism for leukocyte transmigration of lymphatic vessel endothelium by comparing global gene expression profile of normal dermal lymphatic endothelial cells with/without TNFa added to the culture.', 'type': 'RNA', 'source_name_ch1': 'Skin samples obtained from healthy human donors during elective surgery at the Radcliffe Infirmary Hospital_Oxford (with full ethical approval)', 'characteristics_ch1': 'Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).'}"
4363,"{'title': 'AML sample #97', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4364,"{'title': 'X60170', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IIB;\tConsolidated.Grade : 1'}"
4365,"{'title': '11-0037_Control_day1_173', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Control_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4366,"{'title': 'Undifferentiated HepaRG, biological replicate 2', 'description': 'Undif2', 'type': 'RNA', 'source_name_ch1': 'Undifferentiated elongate HepaRG', 'characteristics_ch1': 'cell line: HepaRG;\tdifferentiation state: undifferentiated;\tgender: female'}"
4367,"{'title': 'LPS_1', 'description': 'LPS treatment 1', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells treated with LPS', 'characteristics_ch1': 'lipopolysaccharide treated cells'}"
4368,"{'title': 'N40656', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40656;\tsample: normal'}"
4369,"{'title': 'test experiment not for use [wf20060926u133v2_U_01_B1-Pat.1-GD]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
4370,"{'title': 'GBM, TMZ/radiotherapy (1621)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1621;\tage: 61.8;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 25.13;\tmgmt status: M'}"
4371,"{'title': 'C123', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 3.3'}"
4372,"{'title': 'HUVEC_TNFa_2h00m', 'description': '2h00m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 2h00m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
4373,"{'title': 'HF0543_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4374,"{'title': 'Estradiol, rep 2', 'description': 'Gene expression data from estradiol-treated HUVEC', 'type': 'RNA', 'source_name_ch1': 'HUVEC treated with 1 nM for 24 h', 'characteristics_ch1': 'cell type: Endothelial cell;\tagent: estradiol;\tdose: 1 nM;\ttime: 24 h'}"
4375,"{'title': 'CCD-18Co CONTROL (contains only the mixture of enzymes + salts)_24h_biological rep1', 'description': 'Gene expression data from normal colon CCD-18Co cells exposed for 24h to a control mixture containing only the equivalent quantities of digestive enzymes and salts as those used in the in vitro gastro-duodenal digestion of the orange extract.', 'type': 'RNA', 'source_name_ch1': 'CCD-18Co fibroblasts, control mixture', 'characteristics_ch1': 'cell line: CCD-18Co;\tcell type: Normal human colon fibroblasts cells;\tconfluency: ~90% confluent monolayer;\ttreatment: control mixture;\ttreatment time: 24h'}"
4376,"{'title': 'Lung Normal 121N', 'description': 'Gene expression data from 121N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 60;\tstage: n/a'}"
4377,"{'title': 'Muscle-FamilyHistoryNegative-9', 'description': 'Jos3676;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 38;\tfamily history: Family history negative;\tbody mass index (kg/m2): 25;\tfasting glucose (ogtt): 91.5;\t2 hour glucose (ogtt): 38;\themoglobin a1c: 5.1;\tfasting glucose (iv0gavg): 88;\tfasting insulin (iv0inavg): 4.6;\tsi: 10.29;\twaist hip ratio: 0.902'}"
4378,"{'title': 'PH29b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 59;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 370;\tplasma hiv-1 rna levels (copies/ml): 484,694'}"
4379,"{'title': 'Septic Shock_biological rep36', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.1;\toutcome: Nonsurvivor'}"
4380,"{'title': 'HF0936_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4381,"{'title': 'blood, Blood: 10 nm nic - 2_e1_le1', 'description': '10nM nicotine treatment for 1 hour;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
4382,"{'title': 'N2-33', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
4383,"{'title': 'Control Con_rep9', 'description': 'Control paired  19', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
4384,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R16', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 39.27;\t%cd3cd8: 53.21;\t%cd8+cd28-: 34.15;\t%cd8+cd28+: 8.45;\t%cd4cd25cd62l: 3.48;\t%cd3delta1: 3.06;\t%cd3delta2: 1.41;\tratio delta1/delta2: 2.17;\t%cd3gammadelta: 4.66;\t%cd3alphabeta: 94.51;\t%cd4cd8-ab+(dn): 1.87;\t%cd4 cd62l+cd45+: 11.60;\t%cd4 cd62l-cd45+: 0.51;\t%cd4 cd62l - cd45-: 52.63;\t%cd4cd62l+cd45-: 35.26;\t%cd4 ccr7+ cd45 -: 25.67;\t%cd4 ccr7+ cd45+: 11.57;\t%cd4 ccr7 - cd45+: 1.31;\t%cd4 ccr7 – cd45-: 61.46;\t%cd8 cd62l+ cd45-: 7.67;\t%cd8cd62l+ cd45+: 2.61;\t%cd8cd62l- cd45+: 26.45;\t%cd8cd62l- cd45 -: 63.27;\t%cd8ccr7+ cd45-: 0.63;\t%cd8ccr7+ cd45+: 0.62;\t%cd8ccr7-cd45+: 25.13;\t%cd8ccr7-cd45 -: 73.62;\t%cd3-cd56+cd16+: 5.67;\t%nkts: 12.48;\t%cd19: 2.43;\t%cd4foxp3+: 2.06'}"
4385,"{'title': 'Angioimmunoblastic T-cell lymphoma 14', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-152', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 74;\tgender: male'}"
4386,"{'title': 'Replicate 2 for MCF7mimic72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 2 for MCF7mimic72h breast cell line'}"
4387,"{'title': 'Blood_TD51281_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
4388,"{'title': 'class F, rep7', 'description': 'NEB_13.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 67;\tsex: M;\tdisease stage: 3;\talbumin level: 29;\themoglobin level: 95;\tlymphocyte percentage: 11;\twhite blood count: 9.2;\tinternational prognostic score (ips): 4'}"
4389,"{'title': 'BRCA1 carrier (dupl) sample 3b', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from BCRA1 mutation carrier', 'characteristics_ch1': 'Breast epithelial cells'}"
4390,"{'title': 'Liver_normoglycima_no.4', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: female;\tdisease status: normal glucose tolerance'}"
4391,"{'title': 'newly diagnosed multiple myeloma 82', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
4392,"{'title': '06-14-05_Miller_U133Plus2_0_A1P1d07EPO', 'description': 'Pool of 3 samples:;\t21-50 age;\tM/F;\tDay 7: proerythroblast', 'type': 'RNA', 'source_name_ch1': 'CD34+ progenitor cells subjected to EPO and harvested at day 7', 'characteristics_ch1': 'cell type: CD34+ hematopoietic progenitor cells;\tdevelopmental stage: proerythroblast;\ttissue type: primary cells from donated blood'}"
4393,"{'title': 'MDS patient 117', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q plus other'}"
4394,"{'title': 'High TCF activity Huh7_S33Y#1', 'description': 'Replicates were done by using the same total RNA preparation', 'type': 'RNA', 'source_name_ch1': 'Huh7 stably expressing S33Y beta-catenin', 'characteristics_ch1': 'Huh7 stably expressing S33Y beta-catenin'}"
4395,"{'title': 'ci_NY78', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
4396,"{'title': 'HC9', 'description': 'Gene expression data from Healthy Control 9', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 9', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
4397,"{'title': 'cord blood 26', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 2.29', 'characteristics_ch1': 'Cord blood arsenic exposure level 2.29;\t'}"
4398,"{'title': 'AML 2535', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 38 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4399,"{'title': 'Scz-12', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tInt4', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: F;\tage: 26;\ttissue ph: 6.11;\tpmi (hrs): 41;\ttype of drug: Remoxipride;\tdrug dose (chlorpromazine equivalents): 750 mg'}"
4400,"{'title': '94044', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4401,"{'title': 'Blood - Control - 017A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 68;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
4402,"{'title': '10240', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 65;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: no information;\tDonor Sex: M;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
4403,"{'title': 'AML 7407', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4404,"{'title': 'HUVEC_TNFa_0h00m', 'description': '0h00m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 0h00m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
4405,"{'title': 'BC9725', 'description': '090205.12.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 46;\tmolecular subtype: Normal;\thistology: DUC;\tpt: pT3;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: neg;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: neg;\terbb2p ihc status: pos;\tigf1r ihc status: neg;\tegfr ihc status: pos;\ttop2a ihc status: pos;\tfoxa1 ihc status: neg;\tmfs: 1;\tmfsdel (month): 62.88'}"
4406,"{'title': 'STXBP1', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincSTXBP5;\treplicate: 2'}"
4407,"{'title': 'H133+_H439_Rif_30uM', 'description': 'H133+_H439_Rif_30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H439_Rif_30uM', 'characteristics_ch1': 'primary hepatocytes'}"
4408,"{'title': 'PCB77 treated HepG2 cells at T0.5, biological replicate 3', 'description': 'Gene expression data from HepG2 cell lines after 30 minutes of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 30 minutes of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
4409,"{'title': 'whole blood_100374', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Male', 'characteristics_ch1': 'General population, Male'}"
4410,"{'title': 'Group B2-IVIG+IVMP-Pre-4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, IVMP + IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: methylprednisolone (IVMP) + IVIG;\ttime: pre-treatment'}"
4411,"{'title': 'High TCF activity Huh7_S33Y#3', 'description': 'Replicates were done by using the same total RNA preparation', 'type': 'RNA', 'source_name_ch1': 'Huh7 stably expressing S33Y beta-catenin', 'characteristics_ch1': 'Huh7 stably expressing S33Y beta-catenin'}"
4412,"{'title': 'Young trained subject, biological replicate (YT1)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
4413,"{'title': 'No19inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No19RVR;\ttime point: under therapy'}"
4414,"{'title': 'Sputum from Stage II Moderate, biological replicate 54', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 65;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
4415,"{'title': 'newly diagnosed multiple myeloma 246', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
4416,"{'title': 'chromophobe renal cell cancer; chRCC_HD29', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
4417,"{'title': 'Patient 4730 AML152', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 152;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4418,"{'title': 'AML sample #81', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4419,"{'title': 'muscle_preTZD_preClamp_IRd-_s11', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 11'}"
4420,"{'title': 'human left atrial_control_4', 'description': 'K8_control', 'type': 'RNA', 'source_name_ch1': 'human left atrial appendage - control', 'characteristics_ch1': 'tissue: left atrial appendage'}"
4421,"{'title': 'Gingival tissue sample 2 from patient 45, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 45 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4422,"{'title': 'B78', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 45;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 4;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4423,"{'title': 'Primary 5-1318-3(13.08.01)', 'description': 'Gene expression data  for primary', 'type': 'RNA', 'source_name_ch1': 'PrimaryHepatocellular Carcinoma', 'characteristics_ch1': 'Tissue: liver'}"
4424,"{'title': 'AML with normal karyotype #98', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 66;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 92;\tdisease state: de novo AML'}"
4425,"{'title': 'LMP459', 'description': 'low-malignant tumors of the ovary', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: low-malignant tumors of the ovary'}"
4426,"{'title': 'Endometrium-d2-3-not pregnant rep 3', 'description': ""Gene expression of morphological more advanced endometria, assessed buy Noyes' criteria, (n=3) was compared with matched less advanced endometria (n=4)."", 'type': 'RNA', 'source_name_ch1': ""Endometrium on day of oocyte retrieval, dated as d2 or d3 of the luteal phase by Noyes' criteria, not pregnant"", 'characteristics_ch1': 'Endometrial dating d2-3, non-pregnant'}"
4427,"{'title': 'neuron_rep12', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:42, gender:male, diagnostic group: bipolar disorder, PMI:32h'}"
4428,"{'title': 'AML 6245', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 55 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4429,"{'title': 'AML with normal karyotype #10', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 78;\tdisease state: de novo AML'}"
4430,"{'title': 'Myeloma tumor, sample 2', 'description': 'MM_TUMOR_02;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: female;\tdisease state: advanced multiple myeloma (MM)'}"
4431,"{'title': 'Patient 26, IDC', 'description': '17225-1P_exp', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 26'}"
4432,"{'title': 'group-2-pt-t32627779', 'description': 'group-2-pt-t32627779', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 52;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
4433,"{'title': 'HepG2_HNF4a&HNF4g_knockdown_control_rep3', 'description': 'HepG2_HNF4a&HNF4gknockdouwncontrol_try3', 'type': 'RNA', 'source_name_ch1': 'HNF4a&HNF4g_knockdown_control', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocellular carcinoma'}"
4434,"{'title': 'AML 2524', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 51 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4435,"{'title': 'Quadriceps muscle at T1, control patient 3', 'description': 'Gene expression data from quadriceps muscle biopsy of control patient', 'type': 'RNA', 'source_name_ch1': 'Quadriceps muscle, control patient, T1', 'characteristics_ch1': 'tissue type: Quadriceps muscle;\tpatient group: total knee arthroplasty control patient;\ttime point: T1'}"
4436,"{'title': 'Control-21', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc13', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: F;\tage: 38;\ttissue ph: 6.28;\tpmi (hrs): 52;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
4437,"{'title': 'B35', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 3.0'}"
4438,"{'title': 'Gingival tissue sample 3 from patient 72, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 72 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4439,"{'title': 'IFNβ_712', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4440,"{'title': '11_0012_Control_Day1_48', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0012_Normal, Day1'}"
4441,"{'title': 'EntorhinalCortex_female_44yrs_indiv80', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 44 years', 'characteristics_ch1': 'individual: 80, AA;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 44'}"
4442,"{'title': 'Donor1_6h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 1 treated with DMSO for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 1;\tagent: control;\ttime: 6h;\tgender: Male;\tage: 63 years old'}"
4443,"{'title': 'DLBCL biopsy, sample 2165', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
4444,"{'title': 'cord blood 30_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 10.02', 'characteristics_ch1': 'Cord blood arsenic exposure level 10.02;\t'}"
4445,"{'title': 'newly diagnosed multiple myeloma 57', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
4446,"{'title': 'COL2_510', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 88;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 0'}"
4447,"{'title': 'CLL_del13q_rep2', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with del13q', 'characteristics_ch1': 'male'}"
4448,"{'title': 'Human Hepatocytes_Trovafloxacin, Donor_4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 65; reason for liver resection: colorectal liver metastasis'}"
4449,"{'title': 'TBM3 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tmeningeal tuberculosis'}"
4450,"{'title': '824 - mAdbID:68986', 'description': 'mAdb experiment ID: 68986', 'type': 'RNA', 'source_name_ch1': '824', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 824;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 12.23;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
4451,"{'title': 'Non-tolerant PBMCs_NoTOL_VHC_21', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from non-tolerant liver transplant recipient with hepatitis C infection and under treatment with cyclosporine A.'}"
4452,"{'title': 'siTOP1 MCF7-repeat 2 - mAdbID:83287', 'description': 'mAdb experiment ID: 83287', 'type': 'RNA', 'source_name_ch1': 'siTOP1 MCF7', 'characteristics_ch1': 'Tissue: breast;\tCell line: Breast Cancer Cell Line MCF7;\tCell type: epithelial cells;\tDisease state: Adenocarcinoma;\tgenotype/variation gene knock out'}"
4453,"{'title': 'N11472B1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4454,"{'title': 'Insulin resistant patient 4 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
4455,"{'title': 'Peripheral T-Cell lymphoma, unspecified 25', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-86', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 77;\tgender: female'}"
4456,"{'title': 'bladder_control_pool-2', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Normal bladder tissue', 'characteristics_ch1': 'Tissue extracted resecting a bladder area using scissors.;\tImmediately frozen and store at -80ºC until processed.;\tPool of 4 individual samples.'}"
4457,"{'title': 'DLBCL biopsy, sample 2012', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
4458,"{'title': 'Control_biological rep18', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 4.2;\toutcome: Survivor'}"
4459,"{'title': 'Control-5', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tSc5', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness - control;\tSex: M;\tage: 25;\ttissue ph: 6.48;\tpmi (hrs): 50;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
4460,"{'title': 'SK-N-SH_RA_5d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
4461,"{'title': 'Control Con_rep15', 'description': 'Control paired  17', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
4462,"{'title': 'UNTREATED_858', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
4463,"{'title': 'NOB0308_1', 'description': 'Brain tissue from glioblastopma patient NOB0308', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from patient NOB0308', 'characteristics_ch1': 'primary GBM'}"
4464,"{'title': '22042', 'description': '11709', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24261;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
4465,"{'title': 'colon_normal_1081', 'description': 'total RNA extracted from cells obtained using biopsy of the colon in a healthy control', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
4466,"{'title': 'EntorhinalCortex_male_21yrs_indiv66', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 21 years', 'characteristics_ch1': 'individual: 66, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 21'}"
4467,"{'title': 'ALL without MLL - sample 67', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4468,"{'title': 'muscle_preTZD_preClamp_IRd_s8', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 8'}"
4469,"{'title': 'NSCLC_AC_53', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 53.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
4470,"{'title': 'Cell line HB4a_D_2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line -DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
4471,"{'title': 'newly diagnosed multiple myeloma 99', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
4472,"{'title': 'EntorhinalCortex_male_22yrs_indiv85', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 22 years', 'characteristics_ch1': 'individual: 85, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 22'}"
4473,"{'title': '2.2.NDV.6', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 6 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: NDV;\thours post infection: 6'}"
4474,"{'title': 'T11063A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4475,"{'title': 'HBEC3-Rep2 High dose treatment group (1000 nM).', 'description': 'HBEC3-Rep2 High dose treatment group (1000 nM).', 'type': 'RNA', 'source_name_ch1': 'Immortalzied human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
4476,"{'title': 'hTFC_2', 'description': 'BioConductor software package (Gentleman, R. C., Carey, V. J., Bates, D. M. et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 2004; 5: R80) (www.bioconductor.org).', 'type': 'RNA', 'source_name_ch1': 'Human testis biopsy sample', 'characteristics_ch1': 'tissue: testis;\tisolate: biopsy sample was obtained from patient (patient 16)'}"
4477,"{'title': 'MDS patient 69', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
4478,"{'title': 'MERLION_X03K05402', 'description': 'MERLION_X03K05402', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=70, state=0', 'characteristics_ch1': 'pT2N0, female, age=70, state=0'}"
4479,"{'title': 'Scz-6', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tS6', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness-schizophrenia;\tSex: M;\tage: 25;\ttissue ph: 6.38;\tpmi (hrs): 49;\ttype of drug: Trifluoperazine;\tdrug dose (chlorpromazine equivalents): 200 mg'}"
4480,"{'title': '22048', 'description': '11715', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24269;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
4481,"{'title': 'Septic Shock_biological rep24 01-0079', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.3;\toutcome: Survivor;\tgroup: C'}"
4482,"{'title': 'Proficiency_Site9_23', 'description': 'Performed by Operator 1 from Site9 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 62.98; Lot# = 035PO41658D'}"
4483,"{'title': 'B97', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Mixed;\ttumor size: 1.3'}"
4484,"{'title': 'Gastric GIST 5', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 56;\tTumor size: 38;\tKIT mutation: Exon 11'}"
4485,"{'title': 'group-2-pt-t32091878', 'description': 'group-2-pt-t32091878', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 43;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
4486,"{'title': 'Non-tumoral,  (1553)', 'description': 'MGMT status:', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: non-tumoral;\tpatient: 1553;\tage: NA;\tgender: NA;\ttreatment: NA;\tsurvival status: NA;\tsurvival time in months: NA;\tmgmt status: '}"
4487,"{'title': 'Control-8', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tSc8', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness - control;\tSex: F;\tage: 38;\ttissue ph: 6.14;\tpmi (hrs): 50;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
4488,"{'title': 'AML 2268', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 56 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4489,"{'title': 'newly diagnosed multiple myeloma 205', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
4490,"{'title': 'AML 2689', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 53 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4491,"{'title': 'Donor liver T0-15', 'description': 'Gene expression data from a frozen liver biopsy obtained from a brain dead donor during explantation', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from donor liver', 'characteristics_ch1': 'tissue: donor liver;\tdonor: brain dead donor;\tage: 40 years;\tgender: male'}"
4492,"{'title': 'KT0367_3_L_test2_test3', 'description': 'KT0367_3_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set2 and test set 3', 'characteristics_ch1': '3 months, living donor, test set2 and test set 3'}"
4493,"{'title': 'ESCC_7', 'description': 'ESCC, TNM stage III, well differentiated', 'type': 'RNA', 'source_name_ch1': 'ESCC tumor tissue 7', 'characteristics_ch1': 'tissue: esophagus, tumor;\tgender: male, Japanese;\tage: 73'}"
4494,"{'title': 'MonoMac6 - lipoxin A4', 'description': 'Stimulation of MonoMac6 cells with lipoxin A4', 'type': 'RNA', 'source_name_ch1': 'human monocytic cell line MonoMac6 stimulated for 12 h with lipoxin A4', 'characteristics_ch1': 'cultured MonoMac6 cells, near confluent state, incubated for 12 h in the presence of 100 nM lipoxin A4'}"
4495,"{'title': 'Transfection Reagent Only Technical Replicate 3', 'description': 'transfection reagent only', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: Transfection Reagent;\tcell line: MCF7'}"
4496,"{'title': 'AML 2247', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 47 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4497,"{'title': 'HF1356_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4498,"{'title': 'HF0654_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4499,"{'title': 'Subject 12, Family 4, Control', 'description': 'microarray hybridization data 07/10/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Male;\tfamily: 4;\tage: 16;\tdisease status: Control;\ttissue: Muscle: Biceps'}"
4500,"{'title': 'Gastric GIST 22', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 47;\tTumor size: 4;\tKIT mutation: Exon 11'}"
4501,"{'title': 'DLBCL biopsy, sample 2110', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
4502,"{'title': 'Lung Normal 126N', 'description': 'Gene expression data from 126N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 62;\tstage: n/a'}"
4503,"{'title': 'GA_1065', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4504,"{'title': 'AILD-03', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
4505,"{'title': 'Patient 4423 AML91', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 91;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4506,"{'title': 'TH49a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 30;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 333;\tplasma hiv-1 rna levels (copies/ml): 100,000'}"
4507,"{'title': 'Sputum from Stage II Moderate, biological replicate 51', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 70;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
4508,"{'title': 'N11354D3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4509,"{'title': 'B1-RR-Pat.6 [wf20070510u133v2_U_01_BC14_F_B1_None_107_1]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
4510,"{'title': 'HUVEC_TNFa_1h15m', 'description': '1h15m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 1h15m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
4511,"{'title': 'C011931', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6613_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 53;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4512,"{'title': 'Fibroblast 1', 'description': 'Gene expression data obtained from fibroblasts', 'type': 'RNA', 'source_name_ch1': 'fibroblast', 'characteristics_ch1': 'cell line: GM04981 from Coriell'}"
4513,"{'title': 'M59', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 67;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 306;\ttp53 mutation: 0;\tctnnb1 mutation: 248C>CT | S37S/F;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: No;\tuhrf1 study: Not used'}"
4514,"{'title': 'Control Con_rep20', 'description': 'Control paired  11', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
4515,"{'title': 'COL2_031424', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 94;\tgender: F;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 876;\tsecond apc mutation: 0;\t5q loh: 1'}"
4516,"{'title': 'AML with normal karyotype #211', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 44;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 50;\tdisease state: S-AML'}"
4517,"{'title': 'B24', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 4.0'}"
4518,"{'title': 'SI3', 'description': 'Gene expression data from Standard Immunotherapy 3', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 3', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
4519,"{'title': 'Hyperplast07', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Hyperplastic polyp'}"
4520,"{'title': 'DLBCL9', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 9', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
4521,"{'title': 'ALL without MLL - sample 27', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4522,"{'title': 'newly diagnosed multiple myeloma 203', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
4523,"{'title': 'AML 6949', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 33 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4524,"{'title': 'humanMDM_COPD_Particles', 'description': 'see Affymetrix standard protocol', 'type': 'RNA', 'source_name_ch1': 'humanMDM_COPD_Particles', 'characteristics_ch1': 'monocyte-derived macrophages of 13 male COPD patients'}"
4525,"{'title': 'Gingival tissue sample 1 from patient 25, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 25 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4526,"{'title': 'Endometrium in control conditioned medium for 12 hours TCM-9', 'description': 'Control conditioned medium endometrium  12 hours TCM-9', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control conditioned medium endometrium  12 hours TCM-9'}"
4527,"{'title': 'Patient 3410 AML13', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 13;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: PTPN11;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4528,"{'title': 'explanted liver Patient 1 (HBV-associated acute liver failure) - 1', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from explanted liver Patient 1', 'characteristics_ch1': 'tissue: liver;\torigin: HBV-associated acute liver failure'}"
4529,"{'title': 'AML with normal karyotype #142', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 37;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 54;\tdisease state: de novo AML'}"
4530,"{'title': 'whole blood_100240', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - mental retardation or developmental delay, Male', 'characteristics_ch1': 'mental retardation or developmental delay, Male'}"
4531,"{'title': 'LMP1102', 'description': 'low-malignant tumors of the ovary', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: low-malignant tumors of the ovary'}"
4532,"{'title': 'N7369B5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4533,"{'title': 'N8463I4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4534,"{'title': 'PGA-Hs_S-12', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
4535,"{'title': 'newly diagnosed multiple myeloma 158', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
4536,"{'title': 'MDS patient 176', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
4537,"{'title': 'NSCLC_SCC_30', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 30.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
4538,"{'title': 'AML 7173', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 46 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4539,"{'title': '3.1.AF.1', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 1 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: AF;\thours post infection: 1'}"
4540,"{'title': 'Pax_C4', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene;\tmolecule: total RNA'}"
4541,"{'title': 'Gingival tissue sample 3 from patient 64, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 64 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
4542,"{'title': 'Sepsis gram-negative TN1', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
4543,"{'title': 'Simvastatin treated 12h, sample 2, Simvastatin is anti-inflammatory in macrophages', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'human peripheral blood monocyte-derived macrophages', 'characteristics_ch1': 'from unknown healthy blood-donor volunteers (Finnish Red Cross)'}"
4544,"{'title': 'Replicate 1 for MCF7mimic breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 mir-221/222 mimic at 18h'}"
4545,"{'title': 'S3L-14', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 14; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 14; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 14;\tSmoking status: smoker;\tPack-years: 30;\tAge: 44;\tSex: F;\tEthnic group: white'}"
4546,"{'title': 'cord blood 15_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.12', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.12;\t'}"
4547,"{'title': '08-032_CP_strom_CD90posi', 'description': 'Prostate tumor-associated stromal cells.', 'type': 'RNA', 'source_name_ch1': 'cancer prostate', 'characteristics_ch1': 'tissue: prostate;\tcell type: CD90+ MACS sorted cells;\tgleason: 4+4;\ttumor stage: T3b;\ttumor volume: 2.7 cc'}"
4548,"{'title': 'N_M26_?_05', 'description': 'Normal Adult patient, age 26, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'Normal Adult patient;\tbiopsy site:  unknown'}"
4549,"{'title': 'B cell donor 2, control', 'description': 'Cells treated with DMSO vehicle control', 'type': 'RNA', 'source_name_ch1': 'MACS purified resting B cells from healthy donor peripheral blood', 'characteristics_ch1': 'B cell donor 2, control'}"
4550,"{'title': 'group-2-pt-t18368456', 'description': 'group-2-pt-t18368456', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 48;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
4551,"{'title': 'MERLION_X03K04174', 'description': 'MERLION_X03K04174', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=57, state=0', 'characteristics_ch1': 'pT2N0, male, age=57, state=0'}"
4552,"{'title': 'Replicate 1 for SKBR3 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
4553,"{'title': 'newly diagnosed multiple myeloma 222', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
4554,"{'title': '01-0049A_Septic Shock_day1_48', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4555,"{'title': 'newly diagnosed multiple myeloma 35', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: nd'}"
4556,"{'title': 'newly diagnosed multiple myeloma 122', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
4557,"{'title': 'IFNβ_1013', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
4558,"{'title': 'brain, unknown: R4A_e1_le1', 'description': 'rotenone 4 weeks A;\tTreatment, type=time_course, measurement=4.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
4559,"{'title': '94C149', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7198_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 47;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4560,"{'title': 'RVI037', 'description': 'RVI037', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
4561,"{'title': 'No19pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No19RVR;\ttime point: before therapy'}"
4562,"{'title': 'Patient 9, biopsy; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'Control'}"
4563,"{'title': 'H1 embryoid bodies - GFP (breast epithelial study)', 'description': 'H1-EB', 'type': 'RNA', 'source_name_ch1': 'H1 day3.5 embryoid bodies - GFP', 'characteristics_ch1': 'derived from H1-GFP labeled'}"
4564,"{'title': 'X60020', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 2'}"
4565,"{'title': 'X70103', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
4566,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R15', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 39.03;\t%cd3cd8: 58.22;\t%cd8+cd28-: 26.66;\t%cd8+cd28+: 12.57;\t%cd4cd25cd62l: 10.80;\t%cd3delta1: 1.93;\t%cd3delta2: 0.79;\tratio delta1/delta2: 2.44;\t%cd3gammadelta: 3.69;\t%cd3alphabeta: 94.08;\t%cd4cd8-ab+(dn): 1.21;\t%cd4 cd62l+cd45+: 14.67;\t%cd4 cd62l-cd45+: 4.67;\t%cd4 cd62l - cd45-: 36.46;\t%cd4cd62l+cd45-: 44.20;\t%cd4 ccr7+ cd45 -: 26.64;\t%cd4 ccr7+ cd45+: 11.39;\t%cd4 ccr7 - cd45+: 8.28;\t%cd4 ccr7 – cd45-: 55.69;\t%cd8 cd62l+ cd45-: 4.62;\t%cd8cd62l+ cd45+: 5.76;\t%cd8cd62l- cd45+: 52.99;\t%cd8cd62l- cd45 -: 36.63;\t%cd8ccr7+ cd45-: 0.77;\t%cd8ccr7+ cd45+: 2.31;\t%cd8ccr7-cd45+: 59.05;\t%cd8ccr7-cd45 -: 37.87;\t%cd3-cd56+cd16+: 48.07;\t%nkts: 8.07;\t%cd19: 4.64;\t%cd4foxp3+: 1.23'}"
4567,"{'title': 'TC.CD4-1', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
4568,"{'title': 'Muscle PCOS control 15', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
4569,"{'title': 'GA_1105', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4570,"{'title': 'IFNβ_1725', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4571,"{'title': 'Subcutaneous adipose tissue, SAT17', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
4572,"{'title': 'pCR breast biopsy, sample 16 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 16 rep 2', 'characteristics_ch1': 'pathological complete response: yes;\ttissue: Breast tumor biopsy'}"
4573,"{'title': 'Blood_TD23461_Daytwo_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
4574,"{'title': 'EntorhinalCortex_male_20yrs_indiv77', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 20 years', 'characteristics_ch1': 'individual: 77, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 20'}"
4575,"{'title': 'Patient 4088 AML49', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 49;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4576,"{'title': 'Replicate 3 for MB231control72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 3 for MB231control72h breast cell line'}"
4577,"{'title': 'CLL_FISHnormal_rep4', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'male'}"
4578,"{'title': 'Control Con_rep21', 'description': 'Control paired  7', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
4579,"{'title': 'Control_biological rep24 11-0078', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0.7;\toutcome: n/a;\tgroup: n/a'}"
4580,"{'title': 'AML with normal karyotype #36', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 53;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 60.5;\tdisease state: de novo AML'}"
4581,"{'title': 'IFNβ_1696', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4582,"{'title': 'Patient 4446 AML98', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 98;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4583,"{'title': 'NHDF at passage 13, from adult donor, biological rep 3', 'description': 'Gene expression data from NHDF in culture', 'type': 'RNA', 'source_name_ch1': 'NHDF in culture', 'characteristics_ch1': 'Fibroblast cells'}"
4584,"{'title': 'colonic_crypt_epithelial_cells_distant_normal_colon_24 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: distant normal colon;\tsex: female'}"
4585,"{'title': 'HF1366_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 2'}"
4586,"{'title': 'PC2', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'plasma cells donor 2', 'characteristics_ch1': 'plasma cells, isolated from tonsils by fluorescence-activated cell sorting'}"
4587,"{'title': 'NSCLC_SCC_347', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 347.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
4588,"{'title': 'KT0548_12_L_paired', 'description': 'KT0548_12_L_paired', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, paired set', 'characteristics_ch1': '12 months, living donor, paired set'}"
4589,"{'title': 'AML with normal karyotype #86', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 86;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 71.5;\tdisease state: de novo AML'}"
4590,"{'title': 'adult normal kidney; NK1b_AK1', 'description': 'gene expression data for normal kidney', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'normal kidney'}"
4591,"{'title': 'Muscle septic k62', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:male, Age:48yrs'}"
4592,"{'title': 'SH-SY5Y(ATCC)_RA_0h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
4593,"{'title': 'VA140', 'description': '99-25549', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 71;\tgender: F;\tipi_stage: 2AE;\ttxprimary: CHOP-RITU;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 0.03;\tprogression-free_survival (years): 0.02'}"
4594,"{'title': 'AML 2516', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 51 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4595,"{'title': 'AML sample #4', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
4596,"{'title': 'AR-P3', 'description': 'AR-P3', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
4597,"{'title': 'Monocyte cell line, serum only 2', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: Added serum only'}"
4598,"{'title': 'Cervical cancer-lymph node positive-38-57', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 34.2;\tfigo stage: 1b2'}"
4599,"{'title': 'Clinically localized primary prostate cancer P2', 'description': 'clinically localized prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Primary, localized, prostate cancer'}"
4600,"{'title': '10425', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 61;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 51;\tDonor Sex: M;\tCAN Banff Score =3;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
4601,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R18', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 36.80;\t%cd3cd8: 56.37;\t%cd8+cd28-: 28.92;\t%cd8+cd28+: 16.16;\t%cd4cd25cd62l: 2.82;\t%cd3delta1: 4.51;\t%cd3delta2: 1.98;\tratio delta1/delta2: 2.28;\t%cd3gammadelta: 7.51;\t%cd3alphabeta: 92.41;\t%cd4cd8-ab+(dn): 1.76;\t%cd4 cd62l+cd45+: 17.54;\t%cd4 cd62l-cd45+: 0.09;\t%cd4 cd62l - cd45-: 16.42;\t%cd4cd62l+cd45-: 65.95;\t%cd4 ccr7+ cd45 -: 17.16;\t%cd4 ccr7+ cd45+: 9.48;\t%cd4 ccr7 - cd45+: 1.41;\t%cd4 ccr7 – cd45-: 71.96;\t%cd8 cd62l+ cd45-: 29.07;\t%cd8cd62l+ cd45+: 20.27;\t%cd8cd62l- cd45+: 9.76;\t%cd8cd62l- cd45 -: 40.91;\t%cd8ccr7+ cd45-: 0.36;\t%cd8ccr7+ cd45+: 1.09;\t%cd8ccr7-cd45+: 16.26;\t%cd8ccr7-cd45 -: 82.29;\t%cd3-cd56+cd16+: 48.67;\t%nkts: 10.16;\t%cd19: 0.65;\t%cd4foxp3+: 6.96'}"
4602,"{'title': 'Bronchial epithelial cells, day 4, donor 2', 'description': 'Bronchial epithelial cells, day 4, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 4 of air-liquid interface culture'}"
4603,"{'title': 'MERLION_X03K00615', 'description': 'MERLION_X03K00615', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=75, state=0', 'characteristics_ch1': 'pT2N0, male, age=75, state=0'}"
4604,"{'title': 'COL2_712', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 70;\tgender: F;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 1465;\tsecond apc mutation: 1556;\t5q loh: 0'}"
4605,"{'title': 'UNTREATED_1529', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
4606,"{'title': 'CLL_FISHnormal_rep8', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'female'}"
4607,"{'title': 'AML with normal karyotype #165', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 66;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 24;\tdisease state: de novo AML'}"
4608,"{'title': 'AML 7144', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 51 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4609,"{'title': 'KT0922_0_D_training', 'description': 'KT0922_0_D_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, training set', 'characteristics_ch1': 'baseline, deceased donor, training set'}"
4610,"{'title': 'Tumor 66', 'description': '08SE386', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
4611,"{'title': 'Patient 15, IDC', 'description': '13201-1P 10-23-07', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 15'}"
4612,"{'title': 'AML 2217', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 53 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4613,"{'title': 'X60180', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
4614,"{'title': 'SH-SY5Y(ATCC)_RA_1d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
4615,"{'title': 'TBM1 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tmeningeal tuberculosis'}"
4616,"{'title': 'Liver_hyperglycima_no.4', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: female;\tdisease status: type 2 diabetes'}"
4617,"{'title': 'cord blood 2_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.13', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.13;\t'}"
4618,"{'title': 'Control Con_rep24', 'description': 'Control paired  4', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
4619,"{'title': '14-0004A_Septic Shock_day1_197', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4620,"{'title': 'M102', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 72;\tSex: M;\tcode: resection;\tclass: Proliferation;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4621,"{'title': '15_0004_SepticShock_Day3_17', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '15_0004_Patient, Day3'}"
4622,"{'title': 'Globin_C5', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
4623,"{'title': 'Pilocytic astrocytoma chip 8030', 'description': 'Pilocytic astrocytoma.  Chip ID 8030', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
4624,"{'title': '11_0017_SepticShock_Day1_41', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0017_Patient, Day1'}"
4625,"{'title': 'Lung Normal 137N', 'description': 'Gene expression data from 137N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 79;\tstage: n/a'}"
4626,"{'title': 'blood_cd34neg_D1', 'description': '3 samples CD34+ and 2 samples CD34-', 'type': 'RNA', 'source_name_ch1': 'periphereal blood', 'characteristics_ch1': 'healty donor treated with GCSF isolated CD34+ cells and CD34+ after 10dd of differentiating medium.'}"
4627,"{'title': 'PTCL_AV_023', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
4628,"{'title': 'cord blood 1_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.1', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.1;\t'}"
4629,"{'title': 'Peripheral T-Cell lymphoma, unspecified 36', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-133', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 97;\tgender: male'}"
4630,"{'title': 'PGA-Hs_D-7', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
4631,"{'title': 'Hippocampus_female_70yrs_indiv47', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 70 years', 'characteristics_ch1': 'individual: 47, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 70'}"
4632,"{'title': 'muscle_preTZD_preClamp_IRd+_s21', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 21'}"
4633,"{'title': 'Patient 2, biopsy; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
4634,"{'title': 'N10910A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4635,"{'title': 'Patient 27, biopsy; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'Control'}"
4636,"{'title': 'Patient 28, biopsy; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
4637,"{'title': 'Subject 10, Family 4, Affected', 'description': 'microarray hybridization data 07/10/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Male;\tfamily: 4;\tage: 12;\tdisease status: Affected;\ttissue: Muscle: Biceps'}"
4638,"{'title': '01-0027_Sepsis_day1_35', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4639,"{'title': 'Hippocampus_male_45yrs_indiv87', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 45 years', 'characteristics_ch1': 'individual: 87, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 45'}"
4640,"{'title': 'GBM, radiotherapy (574)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 574;\tage: 44.5;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 5.3;\tmgmt status: U'}"
4641,"{'title': 'group-2-pt-t21347674', 'description': 'group-2-pt-t21347674', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 21;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
4642,"{'title': 'Ultrafine particle exposure 3 -24 hours post-exposure', 'description': 'Gene expression data from circulating mononuclear cells after ultrafine carbon particle exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells after exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: UFP;\ttime: 24 hours'}"
4643,"{'title': 'HF0593_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
4644,"{'title': '01-0058A_Septic Shock_day1_10', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4645,"{'title': 'mRNA of GBM-HGG028, Glioblastoma, 19.8 years, Post-Germinoma', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 19.8 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 19.8 years; Other: Post-Germinoma'}"
4646,"{'title': 'Insulin sensitive patient 6 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
4647,"{'title': 'No8inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No8 nonRVR;\ttime point: under therapy'}"
4648,"{'title': 'colonic_mucosa_non_inflamed_877', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.'}"
4649,"{'title': 'Septic Shock_biological rep33', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.1;\toutcome: Survivor'}"
4650,"{'title': 'mRNA of AA-HGG079, Anaplastic Astrocytoma, 23 years, Post-ALL', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 23 years', 'characteristics_ch1': 'disease: Anaplastic Astrocytoma;\tage: 23 years; Other: Post-ALL'}"
4651,"{'title': 'AML sample #62', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4652,"{'title': '11_0009_Control_Day1_51', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0009_Normal, Day1'}"
4653,"{'title': 'AML with normal karyotype #235', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 34;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 52;\tdisease state: de novo AML'}"
4654,"{'title': 'Adult T-cell leukemia/lymphoma-3', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-43', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 49;\tgender: male'}"
4655,"{'title': 'Subcutaneous adipose tissue, SAT31', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
4656,"{'title': 'AML with normal karyotype #11', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 53;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: ;\tdisease state: de novo AML'}"
4657,"{'title': 'SH-SY5Y(ATCC)_RA_5d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
4658,"{'title': 'Training_Site4_05', 'description': 'Performed by Operator 1 from Site4 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
4659,"{'title': 'Blood Sample of subject 45 after inhalation; Group A: inhalation with 0.7 ppm FA 72 h before sampling', 'description': 'Bl_Group_A_AI_subject_45', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 72 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 72 h;\tsubject: 45;\tgroup: A'}"
4660,"{'title': 'high grade serous carcinoma_patient 6', 'description': 'Gene expression profile of high grade serous carcinoma of fallopian tube', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected high grade serous carcinoma', 'characteristics_ch1': 'Age: 58;\tCycle: NA;\tBRCA1/2 mutation: BRCA1;\tFamily History: Yes'}"
4661,"{'title': 'newly diagnosed multiple myeloma 219', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
4662,"{'title': 'GBM, radiotherapy (15)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 15;\tage: 45.4;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 5.62;\tmgmt status: U'}"
4663,"{'title': 'AML sample #74', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00427;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
4664,"{'title': 'heterozygot FH P387', 'description': 'Gene expression data from control participant LW', 'type': 'RNA', 'source_name_ch1': 'heterozygot FH P387 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: heterozygote FH'}"
4665,"{'title': '7117', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 67 years, FAB unknown, cytogenetic intermediate risk, CEBPA wild type'}"
4666,"{'title': 'C118', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: n;\ttumor type: Ductal;\ttumor size: 2.1'}"
4667,"{'title': 'H438 Propiconazole 100uM', 'description': 'H438 Propiconazole 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 Propiconazole 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
4668,"{'title': 'GA_721', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4669,"{'title': 'K_STA1', 'description': 'K_STA1', 'type': 'RNA', 'source_name_ch1': 'STA1 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
4670,"{'title': 'S052', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S052', 'characteristics_ch1': 'patient id: P112;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 80'}"
4671,"{'title': 'CDcNR6_beforeT', 'description': 'Colonic mucosal gene expression data from CDc non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
4672,"{'title': 'H1_ES_1', 'description': 'Gene expression data obtained from human ES', 'type': 'RNA', 'source_name_ch1': 'human ES', 'characteristics_ch1': 'cell type: ES;\tcell line: H1 Human embryonic stem cells'}"
4673,"{'title': '3492', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 67 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
4674,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 13', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
4675,"{'title': 'AML 2237', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 57 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: single mutant;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
4676,"{'title': 'Lung Cancer 33T', 'description': 'Gene expression data from 33T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 69;\tstage: 1A'}"
4677,"{'title': 'T8636A1.2: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4678,"{'title': 'C99901', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6714_Tumor;\tfab: M4;\tSex: F;\trace: AA;\tage on study: 38;\tcytogenetic change: t(16;16)(p13;q22); +22;\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4679,"{'title': 'IFNβ_821', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4680,"{'title': 'HF0088_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
4681,"{'title': 've_NY26', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
4682,"{'title': 'neuron_rep2', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h'}"
4683,"{'title': 'C144', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.3'}"
4684,"{'title': 'patient Post ECP, biological rep3', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'CTCL patient Post ECP', 'characteristics_ch1': 'disease state: cutaneous T cell lymphoma;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
4685,"{'title': 'Clinically localized primary prostate cancer P5', 'description': 'clinically localized prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Primary, localized, prostate cancer'}"
4686,"{'title': 'adult normal kidney; NK2b_AK2', 'description': 'gene expression data for normal kidney', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'normal kidney'}"
4687,"{'title': 'cord blood 12_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 11.65', 'characteristics_ch1': 'Cord blood arsenic exposure level 11.65;\t'}"
4688,"{'title': 'SS gland, advanced, patient 10, batch 1', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: advanced SS'}"
4689,"{'title': 'papillary renal cell cancer; pRCCb_HD11', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
4690,"{'title': 'PTCL.BO-13', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
4691,"{'title': 'Lung Normal 167N', 'description': 'Gene expression data from 167N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 53;\tstage: n/a'}"
4692,"{'title': 'class S, rep40', 'description': 'VAN_00372.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 61;\tsex: M;\tdisease stage: 2;\talbumin level: 42;\themoglobin level: 145;\tlymphocyte percentage: 27;\twhite blood count: 8;\tinternational prognostic score (ips): 3'}"
4693,"{'title': 'Insulin resistant patient 3 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
4694,"{'title': 'mesenchymal stem cells, lot#4F0591, 28th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0591, passage number 28', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0591, 28th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
4695,"{'title': 'DP240a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1324;\tdisease state: Acute;\tgender: Male;\tage: 41;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 494;\tplasma hiv-1     rna level   (copies/ml): 14696;\ttissue: lymph node'}"
4696,"{'title': 'Monocyte High PBM 5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 5'}"
4697,"{'title': 'S140', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S140', 'characteristics_ch1': 'patient id: P020;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
4698,"{'title': 'TC.CD4-6', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
4699,"{'title': 'HF0120_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
4700,"{'title': 'CD34+cells_normal_bone_marrow_1', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'CD34+ cells sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
4701,"{'title': 'S025_Scz_M_41', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 41;\tpost-mortem delay: 8h;\tph: 6.3'}"
4702,"{'title': 'Sputum from Stage II Moderate, biological replicate 68', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 66;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
4703,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 20', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
4704,"{'title': '10-0022A_SIRS_day1_105', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4705,"{'title': 'No14LCMHinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No14;\tcell type: hepatocytes;\ttime point: under therapy'}"
4706,"{'title': 'conventional renal cell cancer; cRCCa_HD18', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
4707,"{'title': 'Muscle-FamilyHistoryPositive-8', 'description': 'Jos3708;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 47;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 23;\tfasting glucose (ogtt): 91;\t2 hour glucose (ogtt): 123;\themoglobin a1c: 4.7;\tfasting glucose (iv0gavg): 86;\tfasting insulin (iv0inavg): 5.6;\tsi: 3.18;\twaist hip ratio: 0.805'}"
4708,"{'title': 'SK-N-SH_BDNF_6h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
4709,"{'title': 'Clone A cells treated with 5uM CsA and cultured for 24 hours rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
4710,"{'title': 'M-22', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
4711,"{'title': 'BL41 60 min tc-RNA Rep.2', 'description': 'total cellular RNA (tc-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
4712,"{'title': 'platelet_sickle_4', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
4713,"{'title': 'non-pCR breast biopsy, sample 10 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 10 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
4714,"{'title': 'HepG2 cells_GW7647_24h_rep1', 'description': 'A125_07_GW24', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells treated with PPARα agonist GW7647 at 100 nM for 24h', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatoma;\ttreatment: PPARα agonist GW7647;\ttreatment duration: 24 hr'}"
4715,"{'title': 'Clone A cells treated with 1uM NIM811 and cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 1uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 1uM;\ttime: 48 hours'}"
4716,"{'title': 'PA195', 'description': 'PA195', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
4717,"{'title': 'IFNβ_1164', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4718,"{'title': 'N10176F2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4719,"{'title': 'No4inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No4 nonRVR;\ttime point: under therapy'}"
4720,"{'title': 'Sepsis gram-positive V32', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
4721,"{'title': '327929', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9862_Tumor;\tfab: M6;\tSex: M;\trace: AA;\tage on study: 50;\tcytogenetic change: ND;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4722,"{'title': 'group-1-pt-t32750360', 'description': 'group-1-pt-t32750360', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 20;\tgender: male;\tfinal disposition: 06: Home'}"
4723,"{'title': 'CCD-18Co TREATED (digested orange extract, 60 μM total flavanones)_24h_biological rep3', 'description': 'Gene expression data from normal colon CCD-18Co cells exposed for 24h to a pre-digested orange extract containing a mixture of flavanones.', 'type': 'RNA', 'source_name_ch1': 'CCD-18Co fibroblasts, pre-digested orange extract rich in flavanones', 'characteristics_ch1': 'cell line: CCD-18Co;\tcell type: Normal human colon fibroblasts cells;\tconfluency: ~90% confluent monolayer;\ttreatment: pre-digested orange extract containing a mixture of flavanones;\ttreatment time: 24h'}"
4724,"{'title': 'AML 6375', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 58 years;\tscore: FAB unknown;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4725,"{'title': 'T47D_untreated', 'description': 'Untreated control cells in regular growth medium', 'type': 'RNA', 'source_name_ch1': 'T47D', 'characteristics_ch1': 'cell line: T47D breast cancer cell line;\ttreatment: untreated (control)'}"
4726,"{'title': 'TC.CD4-2', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
4727,"{'title': 'AML with normal karyotype #178', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 36;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 35;\tdisease state: de novo AML'}"
4728,"{'title': ""Wilms' FFPE A-2"", 'description': 'L743-A-HG-U133_Plus_2-02-1 (S99-2051W-FFPE)', 'type': 'RNA', 'source_name_ch1': 'Formalin-fixed paraffin-embedded tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FFPE;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-2;\tdonor: A tumor""}"
4729,"{'title': 'T144 U133p2', 'description': 'bulk breast tumor RNA from patient T144', 'type': 'RNA', 'source_name_ch1': 'T144', 'characteristics_ch1': 'breast tumor'}"
4730,"{'title': 'MDS patient 98', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
4731,"{'title': 'Tumor Tum_Ph1_rep2', 'description': 'not paired', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N0;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
4732,"{'title': 'PBMCs_LB_after exercise_19', 'description': 'LB_Peak_136-GA', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 15;\tafter-exercise'}"
4733,"{'title': 'Lung Normal 114N', 'description': 'Gene expression data from 114N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 74;\tstage: n/a'}"
4734,"{'title': 'Huh7 cells_JFH-1 Infected 48 hours_ rep1', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 48 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 48 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
4735,"{'title': 'Gingival tissue sample 4 from patient 26, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 26 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
4736,"{'title': '3.2.NDV.1', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 1 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 1'}"
4737,"{'title': 'S057', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S057', 'characteristics_ch1': 'patient id: P083;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
4738,"{'title': 'test experiment not for use [wf20060926u133v2_U_03_B1-Pat.2-EM]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
4739,"{'title': 'Quadriceps muscle at T1, control patient 1', 'description': 'Gene expression data from quadriceps muscle biopsy of control patient', 'type': 'RNA', 'source_name_ch1': 'Quadriceps muscle, control patient, T1', 'characteristics_ch1': 'tissue type: Quadriceps muscle;\tpatient group: total knee arthroplasty control patient;\ttime point: T1'}"
4740,"{'title': 'S163', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S163', 'characteristics_ch1': 'patient id: P033;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
4741,"{'title': 'Sputum from Stage III Severe, biological replicate 9', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 74;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
4742,"{'title': 'normal_colon_77 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 66;\tlocalization: descending'}"
4743,"{'title': 'Replicate 1 for MB231untreated breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 untreated cell line to compare to older profiled MB231 sample. See ATCC/DSMZ for cell line details.'}"
4744,"{'title': 'Peripheral T-Cell lymphoma, unspecified 24', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-85', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 44;\tgender: female'}"
4745,"{'title': 'X95002', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : NA'}"
4746,"{'title': 'colon_normal_1456', 'description': 'total RNA extracted from cells obtained using biopsy of the colon in a healthy control', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
4747,"{'title': 'COL2_704', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 75;\tgender: F;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 1'}"
4748,"{'title': 'Hippocampus_male_20yrs_indiv78', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 20 years', 'characteristics_ch1': 'individual: 78, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 20'}"
4749,"{'title': 'Gingival tissue sample 1 from patient 94, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 94 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4750,"{'title': 'Patient 3476 AML39', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 39;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: PTPN11;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4751,"{'title': 'PBMC-1-RR-Pat.8 [wf20071123u133v2_U_19_CH22_Lc1_M_38yr_No_151]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
4752,"{'title': '08SE864HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
4753,"{'title': 'AML sample #24', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00058;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
4754,"{'title': 'DLBCL10', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 10', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
4755,"{'title': 'FAKsiRNA, rep4', 'description': 'Gene expression data from FAKsiRNA', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7, FAKsiRNA', 'characteristics_ch1': 'FAKsiRNA#2'}"
4756,"{'title': 'MLD AML sample #7', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
4757,"{'title': 'UNTREATED_2089', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4758,"{'title': 'newly diagnosed multiple myeloma 251', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: III'}"
4759,"{'title': 'Liver biopsy-Control-B1 [wf20070302u133v2_U_10_OR_B1_73]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
4760,"{'title': 'BC13681', 'description': '010806-16.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: Tunis;\ttype: IBC;\tage of diagnosis (year): 38;\tmolecular subtype: ERBB2;\thistology: --;\tpt: pT3;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: --;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: --;\terbb2.tab ihc status: --;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: --;\ttop2a ihc status: --;\tfoxa1 ihc status: --;\tmfs: --;\tmfsdel (month): --'}"
4761,"{'title': 'MDS patient 124', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
4762,"{'title': 'PHI-CTR-4UP-S2', 'description': 'We examined the effects of 48h of knee immobilization on alterations in mRNA and protein in human skeletal muscle.  Biopsies were taken from the vastus lateralis muscle of five men (20.4 + 0.5 years) before and after 48h immobilization.', 'type': 'RNA', 'source_name_ch1': 'Human skeletal muscle', 'characteristics_ch1': 'treatment:control;'}"
4763,"{'title': 'control-1, cells cultured in regular DMEM', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
4764,"{'title': 'HOTAIR5', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siHOTAIR;\treplicate: 3'}"
4765,"{'title': 'Subcutaneous adipose tissue, SAT37', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
4766,"{'title': '2.2.AF.1', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 1 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: AF;\thours post infection: 1'}"
4767,"{'title': 'NS4-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: non-smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: non-smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: non-smoker;\tPack-years: 0;\tAge: 35;\tSex: M;\tEthnic group: black'}"
4768,"{'title': 'Patient_26', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 26;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.797996560779891;\tproliferation index: 11.7976930565281'}"
4769,"{'title': 'Patient 5180 AML225', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 225;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
4770,"{'title': 'NSCLC EMC 2407N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
4771,"{'title': 'Hippocampus_male_22yrs_indiv85', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 22 years', 'characteristics_ch1': 'individual: 85, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 22'}"
4772,"{'title': '17-0001B_Septic Shock_day3_217', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4773,"{'title': '01-0043B_SIRS resolved_day3_8', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4774,"{'title': 'Primary 5-1318(13.08.01)', 'description': 'Gene expression data  for primary', 'type': 'RNA', 'source_name_ch1': 'PrimaryHepatocellular Carcinoma', 'characteristics_ch1': 'Tissue: liver'}"
4775,"{'title': '22144', 'description': '11869', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24330;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
4776,"{'title': 'MDS patient 87', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: trisomy8'}"
4777,"{'title': 'Tumor 33', 'description': '07SE527', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
4778,"{'title': '724606', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7496_Tumor;\tfab: M2;\tSex: F;\trace: AA;\tage on study: 71;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4779,"{'title': 'Normal_colon_27_13April05', 'description': 'Normal_colon_27_13April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, transverse', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
4780,"{'title': 'Patient 4403 AML79', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 79;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4781,"{'title': 'AML sample #93', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4782,"{'title': 'endothelial_rep12', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:47, gender:female, diagnostic group: schizophrenia, PMI:30h'}"
4783,"{'title': 'Gingival tissue sample 1 from patient 80, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 80 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4784,"{'title': 'Patient_34', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 34;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.62145362477056;\tproliferation index: 0.832584271552268'}"
4785,"{'title': 'Cell line PLC-PRL(b)', 'description': 'Gene expression data  for cell line', 'type': 'RNA', 'source_name_ch1': 'cell line', 'characteristics_ch1': 'Tissue: liver'}"
4786,"{'title': 'PBMCs_Oligo', 'description': 'Gene expression data from PBMCs treated with Oligofectamine without oligonucleotide', 'type': 'RNA', 'source_name_ch1': 'PBMCs', 'characteristics_ch1': 'cell type: PBMCs;\ttreatment group: treated with Oligofectamine without oligonucleotide'}"
4787,"{'title': 'non-malignant FTEb_patient 5', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 39;\tCycle: Luteal;\tBRCA1/2 mutation: BRCA1 185delAG;\tFamily History: Yes'}"
4788,"{'title': 'Gingival tissue sample 1 from patient 87, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 87 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4789,"{'title': 'Normal_colon_01_20April05', 'description': 'Normal_colon_01_20April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, sigmoid', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
4790,"{'title': 'control_00hr_rep2', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_00hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
4791,"{'title': 'Angioimmunoblastic T-cell lymphoma 15', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-19', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: not available;\tgender: not available'}"
4792,"{'title': 'adipose_postTZD_IRd+_s43', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 43'}"
4793,"{'title': 'T134 U133p2', 'description': 'bulk breast tumor RNA from patient T134', 'type': 'RNA', 'source_name_ch1': 'T134', 'characteristics_ch1': 'breast tumor'}"
4794,"{'title': 'Control_biological rep27 11-0082', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 1.2;\toutcome: n/a;\tgroup: n/a'}"
4795,"{'title': 'UC02', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: UC'}"
4796,"{'title': 'human cultured bladder HB KM, subject 12', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 57;\tDisease status: HB (control (stress incontinence, no bladder pain));\tCulture medium: KM (proliferating medium)'}"
4797,"{'title': 'aa_NY79', 'description': 'very advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very advanced HCC', 'characteristics_ch1': 'very advanced HCC'}"
4798,"{'title': 'Septic Shock_biological rep6 01-0025', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.3;\toutcome: Survivor;\tgroup: A'}"
4799,"{'title': 'ALL with MLL - sample 130', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4800,"{'title': '7326', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 61 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type'}"
4801,"{'title': 'NHDF at passage 6, from neonatal donor, biological rep 1', 'description': 'Gene expression data from NHDF in culture', 'type': 'RNA', 'source_name_ch1': 'NHDF in culture', 'characteristics_ch1': 'Fibroblast cells'}"
4802,"{'title': 'newly diagnosed multiple myeloma 74', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: II'}"
4803,"{'title': 'Patient 5, colonocytes; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
4804,"{'title': 'cord blood 17', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.17', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.17;\t'}"
4805,"{'title': '15-0009A_Sepsis_day1_214', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4806,"{'title': 'breast tumor 2', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to breast invasive tumor', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: tumor'}"
4807,"{'title': 'SI21', 'description': 'Gene expression data from Standard Immunotherapy 21', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 21', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
4808,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 14', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
4809,"{'title': 'class S, rep76', 'description': 'VAN_00496.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 23;\tsex: F;\tdisease stage: 3;\talbumin level: _;\themoglobin level: 126;\tlymphocyte percentage: 9;\twhite blood count: 13.1;\tinternational prognostic score (ips): 1.2'}"
4810,"{'title': 'Sputum from Stage III Severe, biological replicate 35', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 69;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: B;\thyb date: 39321'}"
4811,"{'title': 'THP-1 control, biological rep2', 'description': 'Gene expression data from THP-1 cells after incubated with PBS for 3 hours', 'type': 'RNA', 'source_name_ch1': 'THP-1 cells with PBS,3 hours', 'characteristics_ch1': 'cell type: monocyte;\tcell line: THP-1;\tgrowth properties: suspension;\tinfected with bacterial strain: Streptcoccus suis 2 strain SC19'}"
4812,"{'title': 'pCR breast biopsy, sample 15 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 15 rep 1', 'characteristics_ch1': 'pathological complete response: yes;\ttissue: Breast tumor biopsy'}"
4813,"{'title': 'Promyelocytes_normal_bone_marrow_4', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'Promyelocytes sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
4814,"{'title': 'X23210', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Adeno;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
4815,"{'title': 'cord blood 8_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.44', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.44;\t'}"
4816,"{'title': 'S010', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S010', 'characteristics_ch1': 'patient id: P093;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 47.5'}"
4817,"{'title': 'MCF-7_Si-Wu-Tang_2.56mg/ml_rep3', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
4818,"{'title': '2.1.AF.10', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 10 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: AF;\thours post infection: 10'}"
4819,"{'title': 'CD19_selected_B-cells_after_RFC_rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after RFC'}"
4820,"{'title': '3.1.NDV.18', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 18 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 18'}"
4821,"{'title': 'X60091', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
4822,"{'title': 'Control-29', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tLc7', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - control;\tSex: F;\tage: 80;\ttissue ph: 6.28;\tpmi (hrs): 55;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
4823,"{'title': 'S146', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S146', 'characteristics_ch1': 'patient id: P008;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
4824,"{'title': 'Muscle control k68', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:female, Age:72yrs'}"
4825,"{'title': 'S011', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S011', 'characteristics_ch1': 'patient id: P093;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
4826,"{'title': 'Tumor Tum_Ph2_rep2', 'description': 'not paired', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N0;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
4827,"{'title': 'RTX6 T0', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: baseline;\tgender: M;\tage (y): 59;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
4828,"{'title': 'HOSE2085', 'description': 'Gene expression data from ovarian surface epithelial cells', 'type': 'RNA', 'source_name_ch1': 'Normal', 'characteristics_ch1': 'tissue: ovary;\tcell type: Normal ovarian surface epithelium'}"
4829,"{'title': 'mesenchymal stem cells, lot#4F1127, 22nd passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F1127, passage number 22', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F1127, 22nd passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
4830,"{'title': 'CDcR6_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
4831,"{'title': 'Blood - Control - 056A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 41;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
4832,"{'title': 'UCR3_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
4833,"{'title': 'carcinoma_35 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 55;\tlocalization: descending'}"
4834,"{'title': 'B85', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 1.2'}"
4835,"{'title': '11-0044B_Sepsis_day3_175', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
4836,"{'title': 'X44262', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : NA'}"
4837,"{'title': 'K_STA14', 'description': 'K_STA14', 'type': 'RNA', 'source_name_ch1': 'STA14 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
4838,"{'title': 'non-pCR breast biopsy, sample 4 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 4 rep 2', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
4839,"{'title': 'Subcutaneous adipose tissue, SAT20', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
4840,"{'title': 'T8703A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4841,"{'title': 'AML 2223', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4842,"{'title': 'Blood - Sarcoidosis - 086A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 60;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
4843,"{'title': 'AML sample #55', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4844,"{'title': 'miR-124 transfection for 24 hours', 'description': 'miR-124 transfection for 24 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
4845,"{'title': 'S055', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S055', 'characteristics_ch1': 'patient id: P074;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 50'}"
4846,"{'title': 'cord blood 5_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.32', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.32;\t'}"
4847,"{'title': 'T115 U133p2', 'description': 'bulk breast tumor RNA from patient T115', 'type': 'RNA', 'source_name_ch1': 'T115', 'characteristics_ch1': 'breast tumor'}"
4848,"{'title': 'Control V2', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
4849,"{'title': 'obstructed fetal kidney, biological rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': '18 weeks obstructed', 'characteristics_ch1': 'age: 18 weeks gestation;\ttissue: kidney;\tkidney status: obstructed'}"
4850,"{'title': 'CD19_selected_B-cells_after_FC_rep8', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
4851,"{'title': 'Tumor 55', 'description': '08SE368', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
4852,"{'title': 'Sample 14140', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: 14140;\ttissue: blood;\tage: 64;\tgender: Male;\trs7956957 genotype: CG'}"
4853,"{'title': 'Blood sample from patient 174 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 174;\tday: Day 28;\tage (years): 56;\tsex: Female'}"
4854,"{'title': 'Subcutaneous adipose tissue, SAT18', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
4855,"{'title': 'adenocarcinoma_95 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 66;\tlocalization: ascending'}"
4856,"{'title': 'newly diagnosed multiple myeloma 257', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: II'}"
4857,"{'title': 'Subcutaneous adipose tissue, SAT11', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
4858,"{'title': 'S156', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S156', 'characteristics_ch1': 'patient id: P014;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
4859,"{'title': 'Sputum from Stage II Moderate, biological replicate 64', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 64;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: C;\thyb date: 39322'}"
4860,"{'title': 'newly diagnosed multiple myeloma 138', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: II'}"
4861,"{'title': 'M-20', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
4862,"{'title': 'T51721', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51721;\tsample: tumor'}"
4863,"{'title': 'SH-SY5Y(ECACC)_RA_3d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
4864,"{'title': 'HF1220_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4865,"{'title': 'Group B1-IVIG-Pre-1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: pre-treatment'}"
4866,"{'title': 'K_AR18', 'description': 'K_AR18', 'type': 'RNA', 'source_name_ch1': 'AR18 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection'}"
4867,"{'title': 'Blood sample from patient 179 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 179;\tday: Day 180;\tage (years): 58;\tsex: Female'}"
4868,"{'title': 'HF0142_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
4869,"{'title': 'RTX7 T0', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: baseline;\tgender: F;\tage (y): 77;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
4870,"{'title': 'Sputum from Stage III Severe, biological replicate 47', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 68;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
4871,"{'title': 'Tumor 70', 'description': '08SE392', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
4872,"{'title': 'Scz-26', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tL4', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - schizophrenia;\tSex: M;\tage: 55;\ttissue ph: 6.1;\tpmi (hrs): 25;\ttype of drug: Thioridazine;\tdrug dose (chlorpromazine equivalents): 400 mg'}"
4873,"{'title': 'S017_Scz_F_85', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 85;\tpost-mortem delay: 3.5h;\tph: 5.9'}"
4874,"{'title': '94C022', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6696_Tumor;\tfab: M2;\tSex: F;\trace: Asian;\tage on study: 28;\tcytogenetic change: t(8;21)(q22;q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4875,"{'title': 'C028_Control_F_54', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 54;\tpost-mortem delay: 4h;\tph: 6.5'}"
4876,"{'title': 'COL2_26', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 49;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1319;\tsecond apc mutation: 0;\t5q loh: 1'}"
4877,"{'title': 'KT0763_3_L_test3', 'description': 'KT0763_3_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set3', 'characteristics_ch1': '3 months, living donor, test set3'}"
4878,"{'title': 'B17', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: 0;\tage: 68;\tSex: F;\tcode: resection;\tclass: Unannotated;\tafp: 3;\ttp53 mutation: 256G>GT | R249R/S;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4879,"{'title': 'AML with normal karyotype #163', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 69;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
4880,"{'title': 'Thyroid_papillary carcinoma 77', 'description': 'sample name in manuscript: T-PTC8', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue:tumor; Gender:female; Age:65  Tumor stage:T2NxMx'}"
4881,"{'title': 'Gene expression: HCC2218', 'description': 'Breast cancer cell line, ATCC# CRL-2343', 'type': 'RNA', 'source_name_ch1': 'RNA from cell line', 'characteristics_ch1': 'cell line: HCC2218;\tcatalog number: ATCC# CRL-2343'}"
4882,"{'title': 'Peripheral T-Cell lymphoma, unspecified 2', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-159', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: not available;\tgender: not available'}"
4883,"{'title': 'BL41 60 min p-RNA Rep.2', 'description': 'unbound, preexisting RNA (p-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
4884,"{'title': 'MERLION_X01K05045', 'description': 'MERLION_X01K05045', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=44, state=0', 'characteristics_ch1': 'pT2N0, female, age=44, state=0'}"
4885,"{'title': 'S147', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S147', 'characteristics_ch1': 'patient id: P009;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
4886,"{'title': 'B95', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.1'}"
4887,"{'title': 'Gingival tissue sample 2 from patient 28, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 28 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
4888,"{'title': 'non-malignant FTEn_patient 10', 'description': 'Gene expression profile of non-malignant FTE from control patient during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 47;\tCycle: Follicular;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
4889,"{'title': 'No28inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No28RVR;\ttime point: under therapy'}"
4890,"{'title': '70118', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tAdjacent intraepithelial carcinoma;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4891,"{'title': 'Muscle control 13', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
4892,"{'title': 'T8642B1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
4893,"{'title': 'No17inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No17RVR;\ttime point: under therapy'}"
4894,"{'title': 'Huh7 cells_JFH-1 Infected 12 hours_ rep2', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 12 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 12 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
4895,"{'title': 'adipose_postTZD_IRd_s29', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 29'}"
4896,"{'title': 'COL2_315', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 71;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 1'}"
4897,"{'title': 'DLBCL biopsy, sample 2106', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
4898,"{'title': 'X51104', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 2'}"
4899,"{'title': 'mock-infected, normal S14 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, normal S14', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
4900,"{'title': 'Pilocytic astrocytoma chip 7767', 'description': 'Pilocytic astrocytoma.  Chip ID 7767', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
4901,"{'title': 'IFNβ_937', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4902,"{'title': '51174', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade High;\tStage IA;\tMicropapillary feature Positive;\t(LMP) implants Negative;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4903,"{'title': '22035', 'description': '11702', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24250;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
4904,"{'title': 'Group B2-IVIG+IVMP-Pre-1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, IVMP + IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: methylprednisolone (IVMP) + IVIG;\ttime: pre-treatment'}"
4905,"{'title': 'UNTREATED_1692', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
4906,"{'title': 'hES_H9_rep2_120208_15', 'description': 'Gene expression data from hES line H9', 'type': 'RNA', 'source_name_ch1': 'hES line H9', 'characteristics_ch1': 'cell line: hES line H9'}"
4907,"{'title': 'Fibroblast 5', 'description': 'Gene expression data obtained from fibroblasts', 'type': 'RNA', 'source_name_ch1': 'fibroblast', 'characteristics_ch1': 'cell line: DF250'}"
4908,"{'title': 'AML 7079', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 28 years;\tscore: FAB M5;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
4909,"{'title': 'GA_2143', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
4910,"{'title': 'N40975', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40975;\tsample: normal'}"
4911,"{'title': 'Training_Site8_12', 'description': 'Performed by Operator 1 from Site8 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 49.5; Lot# = 035PO41658D'}"
4912,"{'title': 'S093', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S093', 'characteristics_ch1': 'patient id: P107;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 39'}"
4913,"{'title': 'whole blood_101094', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
4914,"{'title': 'siWT-2', 'description': 'PLC/PRF/5 were transfected in triplicate with WT1 specific siRNAs (siWT) and siRNAs control (siGL)', 'type': 'RNA', 'source_name_ch1': 'PLC/PRF/5 cells transfected with 2 duplexes of specific siRNA targeting exons 7 and 10 of WT1', 'characteristics_ch1': 'Human hepatoma cell line'}"
4915,"{'title': 'AML sample #34', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
4916,"{'title': 'T1-3 (HCC stage 1-3)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'Human Liver', 'characteristics_ch1': 'HCC stage 1'}"
4917,"{'title': 'DC_Stimulated_Rep2', 'description': 'Circulating monocyte derived DCs were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure. At day four 10 million immature DCs were either left unstimulated or stimulated using plate bound anti-DC-SIGN antibody for 2 hr. Three replicates of non-stimulated or stimulated cells were taken and used to extract total RNA.', 'type': 'RNA', 'source_name_ch1': 'primary dendritic cells (DCs)', 'characteristics_ch1': 'Buffy coats were obtained from the National Blood Centre. Circulating myeloid dendritic cells (DCs) were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.'}"
4918,"{'title': 'IFNa treated donor 2', 'description': 'RNA from healthy donor', 'type': 'RNA', 'source_name_ch1': 'primary macrophages, IFNa-treated', 'characteristics_ch1': 'cell type: monocyte-derived macrophage;\tagent: IFNalpha'}"
4919,"{'title': 'platelet_sickle_5', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
4920,"{'title': '730817', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9840_Tumor;\tfab: M5;\tSex: F;\trace: W;\tage on study: 66;\tcytogenetic change: Normal;\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 0'}"
4921,"{'title': ""Wilms' FFPE A-1"", 'description': 'L743-A-HG-U133_Plus_2-01-1 (S99-2051W-FFPE)', 'type': 'RNA', 'source_name_ch1': 'Formalin-fixed paraffin-embedded tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FFPE;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-1;\tdonor: A tumor""}"
4922,"{'title': 'HBEC2-Rep2 High dose treatment group (1000 nM).', 'description': 'HBEC2-Rep2 High dose treatment group (1000 nM).', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
4923,"{'title': 'newly diagnosed multiple myeloma 306', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
4924,"{'title': 'UCR8_beforeT', 'description': 'Colonic mucosal gene expression data from UC responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
4925,"{'title': 'HF1136_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
4926,"{'title': 'BC9077', 'description': '090205.10.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 39;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT3;\tpn: neg;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: neg;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: --;\tigf1r ihc status: neg;\tegfr ihc status: pos;\ttop2a ihc status: pos;\tfoxa1 ihc status: --;\tmfs: 0;\tmfsdel (month): 51.32'}"
4927,"{'title': 'Tumor Tum_Ph4_rep2', 'description': 'Tumor paired  16', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T4;\tn: N1;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
4928,"{'title': 'S076', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S076', 'characteristics_ch1': 'patient id: P070;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 1'}"
4929,"{'title': 'non-pCR breast biopsy, sample 3 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 3 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
4930,"{'title': 'BC9948', 'description': '080306.06.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 80;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT1;\tpn: --;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: pos;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: pos;\tmfs: 1;\tmfsdel (month): 25.59'}"
4931,"{'title': 'X152', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
4932,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 3', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
4933,"{'title': 'bladder_T2-4_pool-2', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, T2, T3 or T4 (high grade)', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 5 individual samples.'}"
4934,"{'title': 'Myeloma tumor, sample 10', 'description': 'MM_TUMOR_10;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: female;\tdisease state: advanced multiple myeloma (MM)'}"
4935,"{'title': 'NY232', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 54;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 506.5;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
4936,"{'title': 'Sepsis mixed infection TM1', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
4937,"{'title': 'SH-SY5Y(ECACC)_BDNF_6h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
4938,"{'title': 'Thyroid_ unaffected_paired with PTC86T', 'description': 'sample name in manuscript: N-PTC9', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: normal thyroid; Gender: female; Age:31'}"
4939,"{'title': 'Young sedentary subject, biological replicate (YS10)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
4940,"{'title': 'AML with normal karyotype #88', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 60;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 40;\tdisease state: t-AML'}"
4941,"{'title': 'adenocarcinoma_104 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 46;\tlocalization: rectum'}"
4942,"{'title': 'ALL with MLL - sample 125', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
4943,"{'title': 'EntorhinalCortex_female_30yrs_indiv82', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 30 years', 'characteristics_ch1': 'individual: 82, AA;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 30'}"
4944,"{'title': 'SI23', 'description': 'Gene expression data from Standard Immunotherapy 23', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 23', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
4945,"{'title': 'Patient C11, control kidney from nephrectomy, cortex', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C11, Sex: male, Age of patient: 82, Serum creatinine: 113 microMol/L, Control kidney sample (cortex)  from nephrectomy'}"
4946,"{'title': 'Proficiency_Site5_19', 'description': 'Performed by Operator 1 from Site5 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 132.59; Lot# = 035PO41658D'}"
4947,"{'title': 'NSCLC EMC ADC2307N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
4948,"{'title': 'B75', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.3'}"
4949,"{'title': 'Adenocarcinoma, bone marrow positive AC 34', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'male pulmonary adenocarcinoma;\tbone marrow positive'}"
4950,"{'title': 'mesenchymal stem cells, lot#4F1560, 5th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F1560, passage number 5', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F1560, 5th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
4951,"{'title': 'Patient 5065 AML194', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 194;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4952,"{'title': 'Tumor 11', 'description': '07SE496', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
4953,"{'title': 'Tolerant PBMC_TOL_17', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from a tolerant liver transplant recipient, virus hepatitis C negative'}"
4954,"{'title': 'U937_naive_curcumin_18h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, 1uM curcumin treated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
4955,"{'title': 'N10180C2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4956,"{'title': 'LTB3 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tLatent'}"
4957,"{'title': 'adipose_preTZD_IRd_s37', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 37'}"
4958,"{'title': 'AML sample #33', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00097;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
4959,"{'title': 'AML sample #65', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
4960,"{'title': 'VM270a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1327;\tdisease state: AIDS;\tgender: Female;\tage: 40;\trace: African American;\tblood cd4+ t  cell count (cells/ml): 112;\tplasma hiv-1     rna level   (copies/ml): 12046;\ttissue: lymph node'}"
4961,"{'title': 'Re-recurrent GBM, TMZ/radiotherapy (1869RR)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: re-recurrent GBM;\tpatient: 1795;\tage: 43.4;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 72.04;\tmgmt status: M'}"
4962,"{'title': 'X93031', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
4963,"{'title': 'Sputum from Stage II Moderate, biological replicate 52', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 70;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
4964,"{'title': 'N40875', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40875;\tsample: normal'}"
4965,"{'title': 'KT0650_0_L_training', 'description': 'KT0650_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, training set'}"
4966,"{'title': 'untreated-aza-2', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tDemethylation: aza;\tReplicate: 2'}"
4967,"{'title': 'Control_biological rep28 11-0083', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 5.1;\toutcome: n/a;\tgroup: n/a'}"
4968,"{'title': 'class S, rep14', 'description': 'VAN_00071.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 36;\tsex: F;\tdisease stage: 3;\talbumin level: 0;\themoglobin level: 118;\tlymphocyte percentage: 9;\twhite blood count: 8.5;\tinternational prognostic score (ips): 2'}"
4969,"{'title': 'CDcR10_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
4970,"{'title': 'AML sample #32', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00095;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
4971,"{'title': 'N11693B2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
4972,"{'title': 'S017', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S017', 'characteristics_ch1': 'patient id: P067;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
4973,"{'title': '07-0006A_Day1_18', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Female;\tNon survivor;\torganism: Strep pneumo'}"
4974,"{'title': 'Sc3_2', 'description': 'Human testis Score 3 Replicate 2', 'type': 'RNA', 'source_name_ch1': 'Spermatogonial presence in tubuli', 'characteristics_ch1': 'tissue type: testicular biopsy;\tspermatogenic stage (johnsen score): Score 3'}"
4975,"{'title': 'Patient 4738 AML159', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 159;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: PTPN11;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
4976,"{'title': 'newly diagnosed multiple myeloma 109', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
4977,"{'title': 'Donor liver T0-16', 'description': 'Gene expression data from a frozen liver biopsy obtained from a brain dead donor during explantation', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from donor liver', 'characteristics_ch1': 'tissue: donor liver;\tdonor: brain dead donor;\tage: 38 years;\tgender: male'}"
4978,"{'title': 'AML 3326', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 60 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
4979,"{'title': 'AML with normal karyotype #145', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 68.5;\tdisease state: de novo AML'}"
4980,"{'title': 'Liver375T (mRNA expression)', 'description': 'liver cancer HBV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 375T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately differentiated;\tgender: M;\tage: 68;\tvirus: HBV'}"
4981,"{'title': 'S038', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S038', 'characteristics_ch1': 'patient id: P104;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
4982,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 12 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 12 hours'}"
4983,"{'title': 'Cell line HB4a_DRC_3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
4984,"{'title': 'PBMCs vehicle treated for 24 hours,replicate 1', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 24 hours,replicate 1', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
4985,"{'title': 'Monocyte cell line, control 1', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: serum starved'}"
4986,"{'title': 'adenocarcinoma_20 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 62;\tlocalization: transverse'}"
4987,"{'title': 'KT0796_0_D_training', 'description': 'KT0796_0_D_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, training set', 'characteristics_ch1': 'baseline, deceased donor, training set'}"
4988,"{'title': 'WB55a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 23;\trace: African American;\tperipheral blood cd4+ t cells (cells/ml): 209;\tplasma hiv-1 rna levels (copies/ml): 19,400'}"
4989,"{'title': 'Blood - Axial Spondyloarthropathy - 015A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 39;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
4990,"{'title': 'RVI085', 'description': 'RVI085', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
4991,"{'title': 'Blood sample from patient 160 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 160;\tday: Day 180;\tage (years): 35;\tsex: Female'}"
4992,"{'title': 'CRCCD02', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CRC-CD'}"
4993,"{'title': 'Muscle control k69', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:male, Age:60yrs'}"
4994,"{'title': '32103', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIA;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
4995,"{'title': 'EntorhinalCortex_female_74yrs_indiv21', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 74 years', 'characteristics_ch1': 'individual: 21, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 74'}"
4996,"{'title': 'control participant P317', 'description': 'Gene expression data from control participant MO', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
4997,"{'title': '22054', 'description': '11689', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24276;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
4998,"{'title': 'PGA-Hs_F-2', 'description': 'Human subjects with familial cardiomyopathy;\tKeywords = Familial Cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
4999,"{'title': 'Blood_TD23462_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
5000,"{'title': 'non infected MOCK control (2)', 'description': 'non infected MOCK control (2)', 'type': 'RNA', 'source_name_ch1': 'non infected MOCK control', 'characteristics_ch1': 'infection: control;\ttissue: Dendritic cells derived from human monocytes'}"
5001,"{'title': 'Normal Ovary, 2061', 'description': 'Gene expression data from normal ovary.;\tHOSE2061', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
5002,"{'title': 'explanted liver Patient 2 (HBV-associated acute liver failure) - 4', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from explanted liver Patient 2', 'characteristics_ch1': 'tissue: liver;\torigin: HBV-associated acute liver failure'}"
5003,"{'title': 'HUVEC_TNFa_5h00m', 'description': '5h00m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 5h00m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
5004,"{'title': 'KT0352_24_L_test3', 'description': 'KT0352_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
5005,"{'title': 'MCF7VP cell line, RUNX2 knockdown', 'description': 'Gene expression data from etoposide resistant breast cancer cell line', 'type': 'RNA', 'source_name_ch1': 'MCF7VP_siRUNX2', 'characteristics_ch1': 'cell line: MCF7VP;\ttissue: breast'}"
5006,"{'title': 'KT0998_12_L_test3', 'description': 'KT0998_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
5007,"{'title': 'KT0627_3_L_test3', 'description': 'KT0627_3_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set3', 'characteristics_ch1': '3 months, living donor, test set3'}"
5008,"{'title': 'N_CD4_5', 'description': 'NS5 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Negative Selection', 'characteristics_ch1': 'age: 44;\tgender: Male;\tt_cell_purity: 94%'}"
5009,"{'title': 'Patient 3445 AML30', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 30;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5010,"{'title': 'prostate tumor 5', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to prostate invasive tumor', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: tumor'}"
5011,"{'title': 'No1LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No1;\tcell type: lymphocytes;\ttime point: before therapy'}"
5012,"{'title': 'newly diagnosed multiple myeloma 101', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
5013,"{'title': 'Gingival tissue sample 2 from patient 55, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 55 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5014,"{'title': 'CD19_selected_B-cells_before_FC_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before FC (control)'}"
5015,"{'title': 'HUVEC_Vector_4OHT', 'description': '06_0395.CEL', 'type': 'RNA', 'source_name_ch1': 'Human Umbilical Vein Endothelial Cells', 'characteristics_ch1': 'cell type: Human Umbilical Vein Endothelial Cells;\tcell type: primary cells'}"
5016,"{'title': 'HUVEC_TNFa_7h00m', 'description': '7h00m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 7h00m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
5017,"{'title': 'Lung Normal 139N', 'description': 'Gene expression data from 139N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 68;\tstage: n/a'}"
5018,"{'title': 'Ultrafine particle exposure 3 -baseline', 'description': 'Gene expression data from circulating mononuclear cells before exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells before exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: UFP;\ttime: 0 hour'}"
5019,"{'title': 'mRNA of GBM-HGG020, Glioblastoma, 13.8 years, Post-ALL', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 13.8 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 13.8 years; Other: Post-ALL'}"
5020,"{'title': 'whole blood_100346', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - mental retardation or developmental delay, Male', 'characteristics_ch1': 'mental retardation or developmental delay, Male'}"
5021,"{'title': 'HBEC4-Rep2 Control treatment group (DMSO)', 'description': 'HBEC4-Rep2 Control treatment group (DMSO)', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
5022,"{'title': 'normal_colon_43 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 62;\tlocalization: sigmoid'}"
5023,"{'title': 'Estradiol, rep 3', 'description': 'Gene expression data from estradiol-treated HUVEC', 'type': 'RNA', 'source_name_ch1': 'HUVEC treated with 1 nM for 24 h', 'characteristics_ch1': 'cell type: Endothelial cell;\tagent: estradiol;\tdose: 1 nM;\ttime: 24 h'}"
5024,"{'title': 'BGAL, repeat 3', 'description': 'HePG2 cells infected with adenovirus expressing the BGAL control', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
5025,"{'title': 'platelet_sickle_16', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
5026,"{'title': 'DS35a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 32;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 400;\tplasma hiv-1 rna levels (copies/ml): 15,284'}"
5027,"{'title': 'human macrophages treated with P. gingivalis, biological rep2', 'description': 'Gene expression data from human macrophages treated with P. gingivalis for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis 381', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: live P. gingivalis 381;\ttreatment time: 2 hours;\tday: 9'}"
5028,"{'title': 'AML sample #103', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
5029,"{'title': 'class F, rep10', 'description': 'NEB_16.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 73;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: _;\tlymphocyte percentage: _;\twhite blood count: _;\tinternational prognostic score (ips): 2.3'}"
5030,"{'title': 'Blood - Control - 141A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 27;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
5031,"{'title': 'PBMC_ectopic_validation_22', 'description': 'Blood collection: Samples collected by leukapheresis and stored in liquid nitrogen.;\tPBMC isolation:', 'type': 'RNA', 'source_name_ch1': 'PBMCs from patients with other cancer types (e.g., gastrointestinal and brain cancers)', 'characteristics_ch1': 'phenotype: Ectopic;\ttissue: peripheral blood leukocytes;\tdata set: validation'}"
5032,"{'title': 'N11103G4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5033,"{'title': 'newly diagnosed multiple myeloma 32', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: III'}"
5034,"{'title': 'SI18', 'description': 'Gene expression data from Standard Immunotherapy 18', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 18', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
5035,"{'title': 'X386', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5036,"{'title': 'HUVEC_TNFa_2h15m', 'description': '2h15m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 2h15m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
5037,"{'title': 'S040', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S040', 'characteristics_ch1': 'patient id: P111;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 15'}"
5038,"{'title': 'PBMCs_LB_before exercise_18', 'description': 'LB_Pre_131-TK', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 16;\tbefore-exercise'}"
5039,"{'title': 'Liver_hyperglycima_no.9', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: type 2 diabetes'}"
5040,"{'title': 'colonic_mucosa_inflamation_125', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible'}"
5041,"{'title': 'Cell line C5.2_DRC_3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
5042,"{'title': 'MDS patient 64', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
5043,"{'title': 'Lung-normal-rep5', 'description': 'frozen normal lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen disease-free lung tissue', 'characteristics_ch1': 'disease state: normal;\tbiopsy type: surgical;\ttissue: lung'}"
5044,"{'title': 'T30162_rep', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30162;\tsample: tumor'}"
5045,"{'title': 'Cadmium_00hr_rep2', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'Cadmium_00hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
5046,"{'title': 'Endometrium-d4-not pregnant rep 3', 'description': ""Gene expression of morphological more advanced endometria, assessed buy Noyes' criteria, (n=3) was compared with matched less advanced endometria (n=4)."", 'type': 'RNA', 'source_name_ch1': ""Endometrium on day of oocyte retrieval, dated as d4 of the luteal phase by Noyes' criteria, not pregnant"", 'characteristics_ch1': 'Endometrial dating d4, non-pregnant'}"
5047,"{'title': 'MCF-10F, biological rep1', 'description': 'Gene expression data from nontumorigenic ER(-) human breast epithelial cells', 'type': 'RNA', 'source_name_ch1': 'breast epithelial cells derived from fibroadenoma', 'characteristics_ch1': 'Genotype: slightly aneuploid'}"
5048,"{'title': 'MDS patient 44', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
5049,"{'title': 'KT0690_0_L_training', 'description': 'KT0690_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, training set'}"
5050,"{'title': 'HOTAIR4', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siHOTAIR;\treplicate: 2'}"
5051,"{'title': 'Sputum from Stage III Severe, biological replicate 20', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 60;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
5052,"{'title': 'adenocarcinoma_86 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 59;\tlocalization: sigmoid'}"
5053,"{'title': 'KT0563_24_L_test2_test3', 'description': 'KT0563_24_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set2 and test set3', 'characteristics_ch1': '24 months, living donor, test set2 and test set3'}"
5054,"{'title': 'newly diagnosed multiple myeloma 56', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: I'}"
5055,"{'title': 'AR-P7', 'description': 'AR-P7', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
5056,"{'title': 'Healthy control 6', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
5057,"{'title': 'C991255', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6695_Tumor;\tfab: M1;\tSex: M;\trace: C;\tage on study: 22;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5058,"{'title': 'Patient 4452 AML103', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 103;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5059,"{'title': 'Gastric GIST 8', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 55;\tTumor size: 6;\tKIT mutation: Wild type'}"
5060,"{'title': 'group-1-pt-t29753308', 'description': 'group-1-pt-t29753308', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 45;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
5061,"{'title': 'Sepsis gram-positive V33', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
5062,"{'title': 'Control Con_rep27', 'description': 'Control paired  1', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
5063,"{'title': 'MCF-7_Estradiol_0.1μM_rep1', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Estradiol treated'}"
5064,"{'title': 'newly diagnosed multiple myeloma 150', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: nd'}"
5065,"{'title': '22103', 'description': '11864', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24338;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
5066,"{'title': 'Replicate 1 for HCC38 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
5067,"{'title': 'Patient 5146 AML199', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 199;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5068,"{'title': 'KT0691_3_L_paired_test3', 'description': 'KT0691_3_L_paired_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, paired set and test set3', 'characteristics_ch1': '3 months, living donor, paired set and test set3'}"
5069,"{'title': '1989 - mAdbID:66616', 'description': 'mAdb experiment ID: 66616', 'type': 'RNA', 'source_name_ch1': '1989', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1989;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: NA;\tClinical info: Follow up years: NA;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
5070,"{'title': 'Tumor Tum_Ph2_rep10', 'description': 'Tumor paired  17', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N0;\thistology: cdi;\tgrade: II;\treceptor: NEG;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
5071,"{'title': 'UCNR4_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
5072,"{'title': '10-0028B_Sepsis_day3_128', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5073,"{'title': 'ALL without MLL - sample 43', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5074,"{'title': 'Training_Site9_04', 'description': 'Performed by Operator 1 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 56.2; Lot# = 035PO41658D'}"
5075,"{'title': 'newly diagnosed multiple myeloma 172', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: nd'}"
5076,"{'title': '439 - mAdbID:69959', 'description': 'mAdb experiment ID: 69959', 'type': 'RNA', 'source_name_ch1': '439', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 439;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: GCB DLBCL;\tClinical info: Follow up status: NA;\tClinical info: Follow up years: NA;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
5077,"{'title': 'Pt17 isolated pericardial adipocytes, biological rep1', 'description': 'Pt17_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 17', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 17'}"
5078,"{'title': '15_0004_SepticShock_Day1_18', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '15_0004_Patient, Day1'}"
5079,"{'title': 'AML 2231', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5080,"{'title': 'platelet_Ctrl_3', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
5081,"{'title': 'PBMCs_EB_after exercise_02', 'description': 'EB_Peak_088-JoT', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 11;\tafter-exercise'}"
5082,"{'title': 'KOPT-K1_DMSO_03', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'KOPT-K1 cells treated with DMSO', 'characteristics_ch1': 'cell type: T-cell;\tcell line: KOPT-K1'}"
5083,"{'title': 'N11196A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5084,"{'title': 'gd cell activation+7day,donor 1', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 7 days after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 7 days;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 7 d;\tindividual: donor 1'}"
5085,"{'title': 'Hippocampus_female_64yrs_indiv52', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 64 years', 'characteristics_ch1': 'individual: 52, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 64'}"
5086,"{'title': '6453', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 73 years, FAB M0, cytogenetic intermediate risk, CEBPA wild type'}"
5087,"{'title': 'SI5', 'description': 'Gene expression data from Standard Immunotherapy 5', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 5', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
5088,"{'title': 'AML with normal karyotype #199', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 40;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Peripheral Blood;\tblast cell percentage: 77;\tdisease state: de novo AML'}"
5089,"{'title': 'AML 2490', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 56 years;\tscore: FAB M6;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5090,"{'title': 'CLL cells  PB  patient #20', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #20'}"
5091,"{'title': 'AML with normal karyotype #6', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 35;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 72;\tdisease state: de novo AML'}"
5092,"{'title': 'non-malignant FTEb_patient 10', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 39;\tCycle: Follicular;\tBRCA1/2 mutation: BRCA1 1293del40;\tFamily History: Yes'}"
5093,"{'title': 'NY333', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 72;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 32.5;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
5094,"{'title': '22033', 'description': '11700', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24248;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
5095,"{'title': 'HF0332_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
5096,"{'title': 'papillary renal cell cancer; pRCCb_HA393B', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
5097,"{'title': '585686', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '10569_Tumor;\tfab: M1;\tSex: M;\trace: C;\tage on study: 26;\tcytogenetic change: t(12;22)(p13;q12);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5098,"{'title': 'Control_biological rep19', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 2.2;\toutcome: Survivor'}"
5099,"{'title': 'platelet_Ctrl_7', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
5100,"{'title': 'MCF-7 +scrambled siRNA + 500 nM 4-hydroxytamoxifen rep2 (MD36)', 'description': 'Gene expression data from MCF-7cells treated with 500 nM 4-hydroxytamoxifen and scrambled siRNA;\tMD36', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with 500 nM 4-hydroxytamoxifen and scrambled siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: control (scrambled siRNA);\tagent: 4-hydroxytamoxifen;\tdose: 500 nM'}"
5101,"{'title': 'UNTREATED_1815', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5102,"{'title': 'brain_endothelial_cells_rep4', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'endothelial cells from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 37'}"
5103,"{'title': '731274', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7498_Tumor;\tfab: M3;\tSex: M;\trace: AA;\tage on study: 18;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
5104,"{'title': 'group-1-pt-t17826449', 'description': 'group-1-pt-t17826449', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 33;\tgender: male;\tfinal disposition: 06: Home'}"
5105,"{'title': 'ZR751_untreated', 'description': 'Untreated control cells in regular growth medium', 'type': 'RNA', 'source_name_ch1': 'ZR751', 'characteristics_ch1': 'cell line: ZR751 breast cancer cell line;\ttreatment: untreated (control)'}"
5106,"{'title': 'newly diagnosed multiple myeloma 79', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
5107,"{'title': 'K_STA12', 'description': 'K_STA12', 'type': 'RNA', 'source_name_ch1': 'STA12 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
5108,"{'title': 'vMyb virus-infected replicate 1\t(monocytes)', 'description': 'Adenovirus-infected monocytes', 'type': 'RNA', 'source_name_ch1': 'Primary human monocytes', 'characteristics_ch1': 'Monocytes from buffy coat preparation'}"
5109,"{'title': 'HF0131_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
5110,"{'title': 'Tolerant PBMC_TOL_28', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from a tolerant liver transplant recipient, hepatitis C virus negative'}"
5111,"{'title': 'CD19_selected_B-cells_after_FC_rep7', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
5112,"{'title': 'LPS-treated_6h replicate 1', 'description': ""Performed by UTMB microarray core per manufacturer's instructions"", 'type': 'RNA', 'source_name_ch1': 'THP-1 cells', 'characteristics_ch1': 'cell type: Human myelogenous leukemia (macrophage-like) cells;\tcell line: THP-1'}"
5113,"{'title': 'GBM, TMZ/radiotherapy (444)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 444;\tage: 63.2;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 6.45;\tmgmt status: M'}"
5114,"{'title': 'Peripheral T-Cell lymphoma, unspecified 3_replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-10', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 53;\tgender: male'}"
5115,"{'title': 'Pilocytic astrocytoma chip 7752', 'description': 'Pilocytic astrocytoma.  Chip ID 7752', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
5116,"{'title': 'p63shRNA_B2, p63-depleted', 'description': 'None', 'type': 'RNA', 'source_name_ch1': 'Cervical carcinoma', 'characteristics_ch1': 'Age: 66 yrs Gender: Female  Ethnicity: Caucasian'}"
5117,"{'title': 'S023', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S023', 'characteristics_ch1': 'patient id: P084;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
5118,"{'title': 'HF1191_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5119,"{'title': 'Insulin sensitive patient 1 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
5120,"{'title': 'AML sample #104', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
5121,"{'title': 'AML 7124', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5122,"{'title': 'Donor5_6h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 5 treated with Wy14643 for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 5;\tagent: Wy14643;\ttime: 6h;\tgender: Male;\tage: 73 years old'}"
5123,"{'title': 'AML with normal karyotype #147', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 71;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 82.5;\tdisease state: de novo AML'}"
5124,"{'title': 'PBMC-1-RR-Pat.5 [wf20070302u133v2_U_07_GP_LC1_73]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
5125,"{'title': 'class S, rep29', 'description': 'VAN_00181.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 20;\tsex: F;\tdisease stage: 2;\talbumin level: 48;\themoglobin level: 129;\tlymphocyte percentage: 21;\twhite blood count: 9.8;\tinternational prognostic score (ips): 1'}"
5126,"{'title': 'PRC3-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Vector only 786-O cells (PRC3), replicate 3'}"
5127,"{'title': 'Sepsis gram-positive V25', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
5128,"{'title': 'C172', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 5.5'}"
5129,"{'title': 'Group B1-IVIG-Pre-5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: pre-treatment'}"
5130,"{'title': 'NSCLC_AC_51', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 51.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
5131,"{'title': 'AML 6715', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 39 years;\tscore: FAB M4E;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5132,"{'title': 'ALL without MLL - sample 61', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5133,"{'title': 'AML sample #38', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00140;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
5134,"{'title': 'N_CD8_3', 'description': 'NS3 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Negative Selection', 'characteristics_ch1': 'age: 37;\tgender: Male;\tt_cell_purity: 83%'}"
5135,"{'title': 'Endometrium-prog C (08B9935)', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group C', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2;\tpregnancy status: non-pregnant;\tprogesterone serum level: group C (> 1.5ng/ml)'}"
5136,"{'title': 'AML with normal karyotype #32', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 59;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 83;\tdisease state: de novo AML'}"
5137,"{'title': '11-0015_SIRS_day1_153', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5138,"{'title': 'Monocyte cell line, serum and inhibitor 5', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: Added serum and Erk-1/2 inhibitor U0126'}"
5139,"{'title': '01_0026_SepticShock_Day3_113', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0026_Patient, Day3'}"
5140,"{'title': 'HepG2 cells_control_rep3', 'description': 'A125_03_ctr', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells treated with vehicle (DMSO)', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatoma;\ttreatment: DMSO vehicle'}"
5141,"{'title': 'group-2-pt-t15501307', 'description': 'group-2-pt-t15501307', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 36;\tgender: female;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
5142,"{'title': 'S007', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S007', 'characteristics_ch1': 'patient id: P087;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
5143,"{'title': 'AML sample #47', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
5144,"{'title': 'HF0050_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5145,"{'title': '5350', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 63 years, FAB M1, cytogenetic poor risk, CEBPA wild type'}"
5146,"{'title': 'Training_Site9_18', 'description': 'Performed by Operator 1 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
5147,"{'title': 'S3R-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: smoker;\tPack-years: 30;\tAge: 44;\tSex: F;\tEthnic group: white'}"
5148,"{'title': 'Training_Site3_07', 'description': 'Performed by Operator 1 from Site3 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
5149,"{'title': 'Cord Blood 18, biological replicate 4', 'description': 'Gene expression data of reticulocytes from umbilical cord blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from umbilical cord blood', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: reticulocytes'}"
5150,"{'title': 'H439 PB 1000uM', 'description': 'H439 PB 1000uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H439 PB 1000uM', 'characteristics_ch1': 'primary hepatocytes'}"
5151,"{'title': 'negative control transfection for 16 hours', 'description': 'negative control transfection for 16 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
5152,"{'title': 'X44102', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5153,"{'title': 'colonic_crypt_epithelial_cells_normal_colon_4 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: normal colon;\tsex: female'}"
5154,"{'title': 'MERLION_X03K00958', 'description': 'MERLION_X03K00958', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=79, state=0', 'characteristics_ch1': 'pT2N0, male, age=79, state=0'}"
5155,"{'title': 'NSCLC EMC 2387N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
5156,"{'title': 'N1-12', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
5157,"{'title': '3.2.NDV.16', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 16 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 16'}"
5158,"{'title': 'Scz-4', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tS4', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness-schizophrenia;\tSex: M;\tage: 22;\ttissue ph: 6.17;\tpmi (hrs): 37;\ttype of drug: Pimozide;\tdrug dose (chlorpromazine equivalents): 200 mg'}"
5159,"{'title': '2002 - mAdbID:66617', 'description': 'mAdb experiment ID: 66617', 'type': 'RNA', 'source_name_ch1': '2002', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 2002;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 6.62;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
5160,"{'title': 'Hippocampus_male_28yrs_indiv29', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 28 years', 'characteristics_ch1': 'individual: 29, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 28'}"
5161,"{'title': 'S019_Scz_M_79', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 79;\tpost-mortem delay: 4.5h;\tph: 6.3'}"
5162,"{'title': 'Lung Cancer 125T', 'description': 'Gene expression data from 125T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 64;\tstage: 2A'}"
5163,"{'title': 'MDS patient 57', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
5164,"{'title': 'HIV+ Individual HIV-8a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-8a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
5165,"{'title': 'N_MF43-46_?_06', 'description': 'Normal Adult patients pool, age 43-46, gender Male/Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'Normal Adult patient;\tbiopsy site:  unknown'}"
5166,"{'title': 'patient Post ECP, biological rep5', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'GVHD patient Post ECP', 'characteristics_ch1': 'disease state: graft-versus host disease;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
5167,"{'title': 'Senescent A  E2', 'description': 'Senescent cells expressing a vector control replicate 1, experiment 2', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing a vector control', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
5168,"{'title': 'Gingival tissue sample 2 from patient 73, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 73 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5169,"{'title': 'GBM, TMZ/radiotherapy (1317)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1317;\tage: 26.4;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 16.61;\tmgmt status: U'}"
5170,"{'title': 'UNTREATED_2077', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
5171,"{'title': 'human cultured bladder HB DM, subject 13', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 56;\tDisease status: HB (control (stress incontinence, no bladder pain));\tCulture medium: DM (differentiating medium)'}"
5172,"{'title': '17-0003B_Septic Shock_day3_215', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5173,"{'title': 'brain, unknown: C4C_e1_le1', 'description': 'control 4 weeks C;\tTreatment, type=time_course, measurement=4.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
5174,"{'title': 'sample 34, brca1 mutation positive, follicular phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, follicular phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: follicular;\tsample identifier: 34'}"
5175,"{'title': 'NSCLC_AC_489', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 489.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
5176,"{'title': 'Gene expression: MCF7', 'description': 'Data obtained from caBIG (https://cabig.nci.nih.gov);\tBreast cancer cell line, ATCC# HTB-22', 'type': 'RNA', 'source_name_ch1': 'RNA from breast cancer cell line', 'characteristics_ch1': 'cell line: MCF7;\tcatalog number: ATCC# HTB-22'}"
5177,"{'title': 'SU36a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 63;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 248;\tplasma hiv-1 rna levels (copies/ml): 46,400'}"
5178,"{'title': 'CD19_selected_B-cells_before_R_rep10', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before Rituximab (control)'}"
5179,"{'title': 'Patient 5007 AML174', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 174;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5180,"{'title': 'human BM MSC BMP2 stimulated day 1 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 1', 'type': 'RNA', 'source_name_ch1': 'donor 3, stimulated with BMP2 for 1 day', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 1 day'}"
5181,"{'title': 'Control 21', 'description': '07SE507', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
5182,"{'title': 'CDcR9_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
5183,"{'title': 'CD34+CD45RA-Lin- HPCs transduced with A2M', 'description': 'CD45RA-M;\tGene expression data from cell transduced with nuclear-trapped AF1q/MLLT11 (A2M)', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA-Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tgenotype/variation: transduced with A2M;\tcell type: hematopoietic progenitors'}"
5184,"{'title': '05-0007_Septic Shock_day1_226', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5185,"{'title': 'C981243', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7221_Tumor;\tfab: M2;\tSex: F;\trace: C;\tage on study: 51;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5186,"{'title': 'PBMC-2-RR-Pat.9 [wf20071123u133v2_U_16_HT20_Lc2_F_50yr_alpha_151]', 'description': 'Post-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Post-interferon blood sample', 'characteristics_ch1': 'treatment status: Post-interferon'}"
5187,"{'title': 'N8696B1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5188,"{'title': 'AML with normal karyotype #91', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 69;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 93.5;\tdisease state: de novo AML'}"
5189,"{'title': 'Patient 4806 AML168', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 168;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: PTPN11;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5190,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Moderate Responder 3', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, moderate responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
5191,"{'title': '10358', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 31;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 52;\tDonor Sex: M;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
5192,"{'title': 'X23084', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : 3'}"
5193,"{'title': 'MDS patient 82', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
5194,"{'title': 'PCB77 treated HepG2 cells at T6, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines after 6 hours of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 6 hours of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
5195,"{'title': 'Monocyte Low PBM 4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in high-PBM phase', 'characteristics_ch1': 'Monocyte-Low-PBM 4'}"
5196,"{'title': 'HF1581_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
5197,"{'title': 'HF1150_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
5198,"{'title': 'Blk-2', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': '786-O cells treated with medium only, replicate 2'}"
5199,"{'title': 'AML with normal karyotype #77', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 54;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 88;\tdisease state: de novo AML'}"
5200,"{'title': 'class S, rep46', 'description': 'VAN_00404.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 23;\tsex: M;\tdisease stage: 3;\talbumin level: 42;\themoglobin level: 140;\tlymphocyte percentage: 18;\twhite blood count: 6;\tinternational prognostic score (ips): 2'}"
5201,"{'title': 'N30068', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30068;\tsample: normal'}"
5202,"{'title': 'Cervical cancer-lymph node negative-15-48', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 68.9;\tfigo stage: 2a'}"
5203,"{'title': 'AML sample #75', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
5204,"{'title': 'class S, rep71', 'description': 'VAN_00487.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 31;\tsex: M;\tdisease stage: 2;\talbumin level: 34;\themoglobin level: 105;\tlymphocyte percentage: 7;\twhite blood count: 14;\tinternational prognostic score (ips): 4'}"
5205,"{'title': 'Sepsis V27', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis'}"
5206,"{'title': 'HF0954-2_U133P2', 'description': 'Brain tissue from  patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from  patient', 'characteristics_ch1': 'Histopathological diagnostic:'}"
5207,"{'title': 'SG-92A_phenotype of EPC colony assay', 'description': 'EPC sampled from blood and cultured', 'type': 'RNA', 'source_name_ch1': 'cultured EPC, baseline', 'characteristics_ch1': 'baseline'}"
5208,"{'title': 'Peripheral T-Cell lymphoma, unspecified 3', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-09', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 53;\tgender: male'}"
5209,"{'title': 'HC8', 'description': 'Gene expression data from Healthy Control 8', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 8', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
5210,"{'title': 'PBMCs_AuNP_24hr_2', 'description': 'Gene expression data from PBMCs treated with AuNP EGFP oligonucleotide complex for 24 hours', 'type': 'RNA', 'source_name_ch1': 'PBMCs', 'characteristics_ch1': 'cell type: PBMCs;\ttreatment group: treated with AuNP EGFP oligonucleotide complex for 24 hours'}"
5211,"{'title': 'Hyperplast08', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Hyperplastic polyp'}"
5212,"{'title': 'Pt3 isolated pericardial adipocytes, biological rep1', 'description': 'Pt3_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 3', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 3'}"
5213,"{'title': 'Normal Ovary, 2234', 'description': 'Gene expression data from normal ovary.;\tHOSE2234', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
5214,"{'title': 'blood, Blood: 10uM nic - 2_e1_le1', 'description': '10uM nicotine treatment for 1 hour;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
5215,"{'title': 'GBM_differentiation_4 days_2', 'description': 'G52_DF_4d.CEL', 'type': 'RNA', 'source_name_ch1': 'glioblastoma stem cells, differentiation, 4 days', 'characteristics_ch1': 'tissue: brain;\tdisease status: glioblastoma;\tcell type: stem cells G52'}"
5216,"{'title': 'Patient_08', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 8;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.118802274469692;\tproliferation index: 3.87350706442681'}"
5217,"{'title': 'PCB77 treated HepG2 cells at T24, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines after 24 hours of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 24 hours of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
5218,"{'title': 'CD19_selected_B-cells_before_R_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before Rituximab (control)'}"
5219,"{'title': 'PTB4 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
5220,"{'title': 'Adenocarcinoma, bone marrow positive AC 25', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'male pulmonary adenocarcinoma;\tbone marrow positive'}"
5221,"{'title': 'Insulin resistant patient 1 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
5222,"{'title': 'PB34_iPS1_2', 'description': 'Gene expression data obtained from PB CD34+ blood iPS', 'type': 'RNA', 'source_name_ch1': 'iPS', 'characteristics_ch1': 'cell type: iPS cells;\tiPS derived from: PB CD34+ blood'}"
5223,"{'title': 'Replicate 1 for HCC70 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
5224,"{'title': 'Gingival tissue sample 1 from patient 90, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 90 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5225,"{'title': 'CLL cells  LN patient #2', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #2'}"
5226,"{'title': 'KT0607_24_D_test3', 'description': 'KT0607_24_D_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, deceased donor, test set3', 'characteristics_ch1': '24 months, deceased donor, test set3'}"
5227,"{'title': 'Insulin sensitive patient 13 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin sensitive'}"
5228,"{'title': 'Monocyte_patient45_time5', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:African-american,Age:32,VAP day:3'}"
5229,"{'title': 'B2-Non-RR-2 [wf20070130u133v2_U_06-B2-Pat.6-PS]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
5230,"{'title': 'Pt13 whole subcutaneous adipose tissue, biological rep1', 'description': 'Pt13_SQAT', 'type': 'RNA', 'source_name_ch1': 'Whole subcutaneous adipose tissue, patient 13', 'characteristics_ch1': 'tissue: whole subcutaneous adipose tissue;\tpatient: 13'}"
5231,"{'title': 'NY36', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 54;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 7.3;\ttp53 mutation: 0;\tctnnb1 mutation: 248C>CG | S37S/C;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
5232,"{'title': 'human macrophages treated with saline, biological rep2', 'description': 'Gene expression data from human macrophages treated with saline (control) for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with saline', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: saline;\ttreatment time: 2 hours;\tday: 9'}"
5233,"{'title': 'Control (dupl) sample 6a', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
5234,"{'title': 'Monocyte High PBM 7', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 7'}"
5235,"{'title': 'NSCLC EMC ADC2245N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
5236,"{'title': 'NSG202', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 2.72;\tdisease activity (das28_v3): 4.63;\tresponse to anti-tnf therapy: NORESPONSE'}"
5237,"{'title': 'HF0914_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
5238,"{'title': 'AML 2219', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 31 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5239,"{'title': 'DM2_F43_?_13', 'description': 'DM2 patient, age 43, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site:  unknown'}"
5240,"{'title': 'H133+_H439_Propi_10uM', 'description': 'H133+_H439_Propi_10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H439_Propi_10uM', 'characteristics_ch1': 'primary hepatocytes'}"
5241,"{'title': 'Patient_5500_relapse', 'description': '5500R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 18;\tconclusions ig/tcr: some clonal evolution;\tselected: yes'}"
5242,"{'title': '94C207', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7392_Tumor;\tfab: M4;\tSex: M;\trace: Other;\tage on study: 45;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
5243,"{'title': '4 hours post-infection, biological rep2', 'description': 'Gene expression data from cells 4 hours after HCMV infection', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
5244,"{'title': 'Huh7 cells treated with FH HDL, biological rep 2', 'description': 'Gene expression data from Huh7 cells treated with HDL from Normal or FH subjects in lipoprotein-depleted serum.', 'type': 'RNA', 'source_name_ch1': 'Human Huh7 cells, in culture', 'characteristics_ch1': 'cell line: Huh7;\ttreatment: familial hypercholesterolemia HDL'}"
5245,"{'title': 'PBMC-1-RR-Pat.3 [wf20070130u133v2_U_19-Lc1-Pat.9-WV]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
5246,"{'title': 'class F, rep30', 'description': 'VAN_00499f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 74;\tsex: F;\tdisease stage: 4;\talbumin level: 20;\themoglobin level: 110;\tlymphocyte percentage: 7;\twhite blood count: 15.3;\tinternational prognostic score (ips): 4'}"
5247,"{'title': 'UCR7_beforeT', 'description': 'Colonic mucosal gene expression data from UC responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
5248,"{'title': 'PTCL.BG.18', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5249,"{'title': 'S144', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S144', 'characteristics_ch1': 'patient id: P007;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
5250,"{'title': 'G144-NS_B', 'description': 'U133Plus2_122906L_DK19.CEL', 'type': 'RNA', 'source_name_ch1': 'Glioblastoma derived cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: malignant;\tcell type: cell line;\tcell type: glioblastoma'}"
5251,"{'title': 'Mature unstimulated biological replicate 3 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: none;\tcell line: BE(2)-C'}"
5252,"{'title': 'mucosa_normal_colon_32 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: normal colon;\tsex: female'}"
5253,"{'title': 'class S, rep66', 'description': 'VAN_00479.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 27;\tsex: F;\tdisease stage: 2;\talbumin level: 48;\themoglobin level: 121;\tlymphocyte percentage: 20;\twhite blood count: 6.9;\tinternational prognostic score (ips): 1'}"
5254,"{'title': 'U937_ROS_untreated_18h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
5255,"{'title': 'human cultured bladder IC KM, subject 3', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 37;\tDisease status: IC (interstitial cystitis);\tCulture medium: KM (proliferating medium)'}"
5256,"{'title': 'AML 2545', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 24 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
5257,"{'title': 'Sputum from Stage II Moderate, biological replicate 21', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 73;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: F;\thyb date: 39324'}"
5258,"{'title': 'HUVEC_TNFa_3h45m', 'description': '3h45m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 3h45m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
5259,"{'title': 'U937_naive_curcumin_4h_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, 1uM curcumin treated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
5260,"{'title': 'Lung Cancer 117T', 'description': 'Gene expression data from 117T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 70;\tstage: 3A'}"
5261,"{'title': '23177', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tWild Type (BRAF/KRAS/ERBB2);\tGrade High;\tStage IC;\tMicropapillary feature Positive;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
5262,"{'title': 'newly diagnosed multiple myeloma 105', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: II'}"
5263,"{'title': 'Huh7 cells_JFH-1 Infected 6 hours_ rep2', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 6 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 6 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
5264,"{'title': 'CLL_FISHnormal_rep2', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'male'}"
5265,"{'title': '22048', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 2;\tStage IIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
5266,"{'title': 'NY329', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 80;\tSex: M;\tcode: resection;\tclass: Proliferation;\tafp: 12.4;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
5267,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_0h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
5268,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_29_04)', 'description': 'Gene expression data from whole blood 7 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 62;\tSex: M'}"
5269,"{'title': 'Scz-11', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tInt3', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: M;\tage: 41;\ttissue ph: 6.2;\tpmi (hrs): 31;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): 500 mg'}"
5270,"{'title': 'non-pCR breast biopsy, sample 5 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 5 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
5271,"{'title': 'DLBCL biopsy, sample 2089', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
5272,"{'title': 'newly diagnosed multiple myeloma 155', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
5273,"{'title': 'newly diagnosed multiple myeloma 270', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
5274,"{'title': 'Endometrium-d2-3-not pregnant rep 2', 'description': ""Gene expression of morphological more advanced endometria, assessed buy Noyes' criteria, (n=3) was compared with matched less advanced endometria (n=4)."", 'type': 'RNA', 'source_name_ch1': ""Endometrium on day of oocyte retrieval, dated as d2 or d3 of the luteal phase by Noyes' criteria, not pregnant"", 'characteristics_ch1': 'Endometrial dating d2-3, non-pregnant'}"
5275,"{'title': 'Patient 5154 AML207', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 207;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5276,"{'title': 'Endometrium-prog B (01B06037)', 'description': '01B06037.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group B', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2-3;\tpregnancy status: pregnant;\tprogesterone serum level: group B (1-1.5 ng/ml)'}"
5277,"{'title': 'Transplanted-reperfused liver T2-08', 'description': 'Gene expression data from a frozen liver biopsy obtained during transplantation procedure, 2 hours after reperfusion', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from transplanted liver, 2 hours after reperfusion', 'characteristics_ch1': 'tissue: transplanted liver, 2 hours after reperfusion;\tgender: female;\tage: 48 years;\tprotocol: cold ischemia_8h 15min; Warm ischemia_60min'}"
5278,"{'title': 'AML 2211', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 28 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5279,"{'title': 'EntorhinalCortex_female_85yrs_indiv54', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 85 years', 'characteristics_ch1': 'individual: 54, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 85'}"
5280,"{'title': 'AML 7072', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 60 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: 11q23;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5281,"{'title': 'K_AR2', 'description': 'K_AR2', 'type': 'RNA', 'source_name_ch1': 'AR2 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
5282,"{'title': 'Septic Shock_biological rep62 10-0017', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 7.5;\toutcome: Nonsurvivor;\tgroup: B'}"
5283,"{'title': 'Blood sample from patient 138 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 138;\tday: Day 1;\tage (years): 62;\tsex: Male'}"
5284,"{'title': 'Muscle septic k49', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:male, Age:60yrs'}"
5285,"{'title': 'AML with normal karyotype #95', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 65;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 62;\tdisease state: de novo AML'}"
5286,"{'title': 'Lung Normal 135N', 'description': 'Gene expression data from 135N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 39;\tstage: n/a'}"
5287,"{'title': 'FHC - patient 15', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Patient 15', 'characteristics_ch1': 'Gender: male;\tAge: 33 years ;\tDisease: familial hypercholesterolemia;\tDrugs: none;\tTissue: blood'}"
5288,"{'title': 'MDS patient 7', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
5289,"{'title': 'Replicate 2 for MB231untreated breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 untreated cell line to compare to older profiled MB231 sample. See ATCC/DSMZ for cell line details.'}"
5290,"{'title': 'PGA_PA-S_224', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
5291,"{'title': 'PTCL.BO.05', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5292,"{'title': 'Control (dupl) sample 4b', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
5293,"{'title': 'PNS045', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.07;\tdisease activity (das28_v3): 3.69;\tresponse to anti-tnf therapy: MEDIUM'}"
5294,"{'title': 'CD03', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CD'}"
5295,"{'title': 'TC.DR+-3', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
5296,"{'title': 'newly diagnosed multiple myeloma 259', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
5297,"{'title': 'IFNβ_888', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5298,"{'title': 'X60067', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 2'}"
5299,"{'title': 'Patient_09', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 9;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 1.61902655822565;\tproliferation index: 13.7996428698926'}"
5300,"{'title': '05-0010_Septic Shock_day1_79', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5301,"{'title': 'Muscle PCOS control 2', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
5302,"{'title': '1 Monocyte', 'description': 'Gene expression data from freshly isolated monocytes', 'type': 'RNA', 'source_name_ch1': 'Freshly isolated monocytes', 'characteristics_ch1': 'donor: 1;\ttissue: monocyte;\tactivation: None;\ttreatment: None;\ttime: 0h'}"
5303,"{'title': 'Control 22', 'description': '07SE509', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
5304,"{'title': 'COL2_7094', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 87;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1309;\tsecond apc mutation: 0;\t5q loh: 1'}"
5305,"{'title': '11-0006_SIRS resolved_day3_198', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5306,"{'title': 'Control_biological rep8 04-0015', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0;\toutcome: n/a;\tgroup: n/a'}"
5307,"{'title': 'Training_Site8_16', 'description': 'Performed by Operator 1 from Site8 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
5308,"{'title': 'lg_NY49', 'description': 'low-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; low-grade dysplastic liver tissue', 'characteristics_ch1': 'low-grade dysplastic liver tissue'}"
5309,"{'title': 'HUVEC_TNFa_2h30m', 'description': '2h30m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 2h30m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
5310,"{'title': 'muscle_preTZD_preClamp_IRd_s12', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 12'}"
5311,"{'title': 'newly diagnosed multiple myeloma 68', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
5312,"{'title': 'AML 4341', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 53 years;\tscore: RAEB-t;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
5313,"{'title': 'GPR54-suppressed Ishikawa, biological rep1', 'description': 'Gene expression data from Ishikawa cells that were introduced with GPR54 siRNA.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells introduced with GPR54 siRNA', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: GPR54-specific siRNA;\tpeptide treatment: control peptide'}"
5314,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_6h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
5315,"{'title': 'MCF7VP cell line, biological rep2', 'description': 'Gene expression data from etoposide resistant breast cancer cell line, MCF7VP', 'type': 'RNA', 'source_name_ch1': 'etoposide resistant MCF7 breast cancer cell line', 'characteristics_ch1': 'tissue: breast;\tcell line: MCF7VP (etoposide-resistant)'}"
5316,"{'title': 'ALL without MLL - sample 1', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5317,"{'title': 'class S, rep18', 'description': 'VAN_00086.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 36;\tsex: M;\tdisease stage: 1;\talbumin level: 45;\themoglobin level: 149;\tlymphocyte percentage: 21;\twhite blood count: 9;\tinternational prognostic score (ips): 2'}"
5318,"{'title': 'H9 embryoid bodies (breast epithelial study)', 'description': 'H9-EB', 'type': 'RNA', 'source_name_ch1': 'H9 day3.5 embryoid bodies', 'characteristics_ch1': 'derived from H10'}"
5319,"{'title': 'Adenocarcinoma, bone marrow negative AC 11', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'male pulmonary adenocarcinoma;\tbone marrow negative'}"
5320,"{'title': 'papillary renal cell cancer; pRCCb_FR503', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
5321,"{'title': 've_NY41', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
5322,"{'title': 'Cervical cancer-lymph node positive-39-59', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 50.5;\tfigo stage: 2a'}"
5323,"{'title': 'X23070', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 2'}"
5324,"{'title': 'MLD AML sample #23', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
5325,"{'title': 'X23139', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
5326,"{'title': 'Patient_36', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 36;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.540766356333837;\tproliferation index: -0.347454606578821'}"
5327,"{'title': 'MonoMac6 - leukotriene B4', 'description': 'Expression pattern of MonoMac6 cells after stimulation with leukotriene B4', 'type': 'RNA', 'source_name_ch1': 'human monocytic cell line MonoMac6 stimulated for 12 h with leukotriene B4', 'characteristics_ch1': 'cultured MonoMac6 cells, near confluent state, incubated for 12 h in the presence of 100 nM leukotriene B4 dissolved in DMSO'}"
5328,"{'title': 'Normal02', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Normal'}"
5329,"{'title': 'DLBCL biopsy, sample 2041', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
5330,"{'title': 'mRNA of GBV-HGG050, Glioblastoma variant, 9.2 years, Post-ALL', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 9.2 years', 'characteristics_ch1': 'disease: Glioblastoma variant;\tage: 9.2 years; Other: Post-ALL'}"
5331,"{'title': 'group-2-pt-t34814188', 'description': 'group-2-pt-t34814188', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 34;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
5332,"{'title': 'DLBCL biopsy, sample 2148', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
5333,"{'title': 'AML sample #92', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
5334,"{'title': 'newly diagnosed multiple myeloma 10', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
5335,"{'title': 'Germinal Center Centroblasts, sample 2', 'description': 'CD77-positive B-cells from human tonsil, purified by magnetic cell separation.;\tGene expression data from purified germinal center centroblasts', 'type': 'RNA', 'source_name_ch1': 'Germinal Center Centroblasts from human tonsil', 'characteristics_ch1': 'cell type: CD77-positive B-cells from human tonsil'}"
5336,"{'title': 'endothelial_rep4', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:32, gender:male, diagnostic group: control, PMI:13h'}"
5337,"{'title': 'Gingival tissue sample 3 from patient 36, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 36 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
5338,"{'title': 'AML 7273', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 22 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5339,"{'title': 'Hippocampus_male_20yrs_indiv77', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 20 years', 'characteristics_ch1': 'individual: 77, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 20'}"
5340,"{'title': 'Control_biological rep29 15-0001', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 2;\toutcome: Survivor;\tgroup: n/a'}"
5341,"{'title': 'control_32hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_32hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
5342,"{'title': 'prostate normal 4', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal prostate stroma', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: normal'}"
5343,"{'title': 'AML with normal karyotype #144', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 75;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 75.5;\tdisease state: de novo AML'}"
5344,"{'title': 'HS+LPS_2', 'description': 'HS+LPS treatment 2', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells with heat shock and LPS', 'characteristics_ch1': 'heat shock/lipopolysaccharide treated cells'}"
5345,"{'title': 'EntorhinalCortex_female_74yrs_indiv18', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 74 years', 'characteristics_ch1': 'individual: 18, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 74'}"
5346,"{'title': 'IFNβ_2098', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
5347,"{'title': 'PBMC-2-RR-Pat.6 [wf20070510u133v2_U_04_BC14_F_LC2_IFNa_107_1]', 'description': 'Post-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Post-interferon blood sample', 'characteristics_ch1': 'treatment status: Post-interferon'}"
5348,"{'title': 'RTX5 T0', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patient with severe rheumatoid arthritis', 'characteristics_ch1': 'treatment: baseline;\tgender: F;\tage (y): 33;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
5349,"{'title': 'colon_normal_1114', 'description': 'total RNA extracted from cells obtained using biopsy of the colon in a healthy control', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
5350,"{'title': 'NSCLC_AC_426', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 426.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
5351,"{'title': 'BC9983', 'description': '090905.7.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 47;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT2;\tpn: neg;\tgrade sbr: 2;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: neg;\terbb2p ihc status: pos;\tigf1r ihc status: neg;\tegfr ihc status: pos;\ttop2a ihc status: pos;\tfoxa1 ihc status: neg;\tmfs: 0;\tmfsdel (month): 89.69'}"
5352,"{'title': 'VAN_00579', 'description': '06-16716', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 54;\tgender: M;\tipi_stage: 3A;\ttxprimary: CYCL1-CHOP6-RITU;\tstatus: With disease, after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.65;\tprogression-free_survival (years): 1.65'}"
5353,"{'title': 'Sepsis gram-negative TN6', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
5354,"{'title': 'X41192', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 2'}"
5355,"{'title': 'conventional renal cell cancer; cRCCa_HA343', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
5356,"{'title': 'AML with normal karyotype #68', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 80;\tdisease state: de novo AML'}"
5357,"{'title': 'U937_naive_curcumin_4h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, 1uM curcumin treated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
5358,"{'title': 'NY18', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 55;\tSex: M;\tcode: resection;\tclass: Inflammation;\tafp: 158.9;\ttp53 mutation: 366A>AG,Y205Y/C;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
5359,"{'title': 'Primary 26-1004(26.10.04)', 'description': 'Gene expression data  for primary', 'type': 'RNA', 'source_name_ch1': 'PrimaryHepatocellular Carcinoma', 'characteristics_ch1': 'Tissue: liver'}"
5360,"{'title': 'Blood - Sarcoidosis - 059A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 57;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
5361,"{'title': 'Lung Normal 3N', 'description': 'Gene expression data from 3N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 76;\tstage: n/a'}"
5362,"{'title': '94C271', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7378_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 25;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5363,"{'title': 'Patient_05', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 5;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.313554125952036;\tproliferation index: 4.21059592508044'}"
5364,"{'title': 'secondary glioblastoma_2', 'description': 'bh20061208u133v2_A_30-2ary-GBM3_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: secondary brain tumor;\tcell type: glioblastoma;\tage: 13;\tgender: male;\ttumor grade: IV'}"
5365,"{'title': 'Patient 5237 AML230', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 230;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5366,"{'title': 'Lung Normal 118N', 'description': 'Gene expression data from 118N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 63;\tstage: n/a'}"
5367,"{'title': 'Bronchial epithelial cells, day 2, donor 2', 'description': 'title = Bronchial epithelial cells, day 2, donor 2 source_name_ch1 = Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 2 of air-liquid interface culture'}"
5368,"{'title': 'C991142', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6699_Tumor;\tfab: M1;\tSex: F;\trace: Other;\tage on study: 51;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
5369,"{'title': 'B78', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Mixed;\ttumor size: 1.1'}"
5370,"{'title': 'brain, unknown: C4A_e1_le1', 'description': 'control 4 weeks;\tTreatment, type=time_course, measurement=4.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
5371,"{'title': 'carcinoma_58 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: -;\tlocalization: rectum'}"
5372,"{'title': 'Tumor 50', 'description': '08SE364', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
5373,"{'title': 'Insulin sensitive patient 13 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: male;\tmetabolic status: insulin sensitive'}"
5374,"{'title': 'B2-Non-RR-Pat.14 [wf20070510u133v2_U_06_SK15_M_B2_IFNa_107_1]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
5375,"{'title': 'N11147J1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5376,"{'title': 'PTCL_027', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5377,"{'title': 'platelet_sickle_3', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
5378,"{'title': 'COL2_533', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 79;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1309;\tsecond apc mutation: 0;\t5q loh: 0'}"
5379,"{'title': 'AML with normal karyotype #29', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 52;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 86;\tdisease state: de novo AML'}"
5380,"{'title': 'GBM, radiotherapy (246)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 246;\tage: 54.1;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 23.03;\tmgmt status: M'}"
5381,"{'title': 'Cervical cancer-lymph node negative-03-11', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 49.5;\tfigo stage: 1b1'}"
5382,"{'title': 'DietResistant _1 day_subject2', 'description': 'DietResistant _1 day_subject2', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 2;\tgender: Female'}"
5383,"{'title': 'PTCL.BO.09', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5384,"{'title': 'MH580a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1458;\tdisease state: Acute;\tgender: Male;\tage: 51;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 400;\tplasma hiv-1     rna level   (copies/ml): 439000;\ttissue: lymph node'}"
5385,"{'title': 'colon_adenoma_956', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
5386,"{'title': 'Liver363N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HBV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 363N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: Chronic hepatitis;\tgender: M;\tage: 64;\tvirus: HBV'}"
5387,"{'title': '76-1', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 76 treated 786-O cells, replicate 1'}"
5388,"{'title': '11-0060A_SIRS_day1_187', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5389,"{'title': 'No15pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No15 nonRVR;\ttime point: before therapy'}"
5390,"{'title': 'MDS patient 138', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: other'}"
5391,"{'title': 'N7619A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5392,"{'title': '60120', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tWild Type (BRAF/KRAS/ERBB2);\tGrade Low;\tStage IIC;\tMicropapillary feature Negative;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
5393,"{'title': 'whole blood_101621', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - mental retardation or developmental delay, Male', 'characteristics_ch1': 'mental retardation or developmental delay, Male'}"
5394,"{'title': 'Pt16 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt16_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 16', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 16'}"
5395,"{'title': 'N10964A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5396,"{'title': 'Scz-9', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tInt1', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: M;\tage: 53;\ttissue ph: 6.23;\tpmi (hrs): 25;\ttype of drug: Cholorpromazine;\tdrug dose (chlorpromazine equivalents): 200 mg'}"
5397,"{'title': 'PGA-Hs_S-1', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
5398,"{'title': 'AML with normal karyotype #218', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 54;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 100;\tdisease state: de novo AML'}"
5399,"{'title': 'Training_Site10_08', 'description': 'Performed by Operator 1 from Site10 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
5400,"{'title': 'Group B2-IVIG+IVMP-Post-1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, IVMP + IVIG post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: methylprednisolone (IVMP) + IVIG;\ttime: post-treatment'}"
5401,"{'title': 'newly diagnosed multiple myeloma 45', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: nd'}"
5402,"{'title': 'Sputum from Stage III Severe, biological replicate 15', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 68;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
5403,"{'title': 'Blood sample from patient 180 at Day 14', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 180;\tday: Day 14;\tage (years): 63;\tsex: Female'}"
5404,"{'title': 'B2-RR-Pat.6 [wf20070510u133v2_U_02_BC14_F_B2_IFNa_107_1]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
5405,"{'title': 'HF0031_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5406,"{'title': 'HOSE2225', 'description': 'Gene expression data from ovarian surface epithelial cells', 'type': 'RNA', 'source_name_ch1': 'Normal', 'characteristics_ch1': 'tissue: ovary;\tcell type: Normal ovarian surface epithelium'}"
5407,"{'title': '645137', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6335_Tumor;\tfab: M2;\tSex: F;\trace: W;\tage on study: 40;\tcytogenetic change: t(8;21)(q22;q22); del(9)(q22q34);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5408,"{'title': 'Adrenocortical adenoma with wild-type CTNNB1-3', 'description': 'Gene expression profile of an adrenocortical adenoma  with wild-type CTNNB1 gene', 'type': 'RNA', 'source_name_ch1': 'WT AA 3', 'characteristics_ch1': 'tissue: Adrenocortical adenoma;\ttumor secretion profile: Cortisol;\tgenotype: WT CTNNB1'}"
5409,"{'title': 'Tolerant PBMC_TOL_18', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from tolerant liver transplant recipient, virus hepatitis C negative'}"
5410,"{'title': '41-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 41 treated 786-O cells, replicate 3'}"
5411,"{'title': 'MLD AML sample #42', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
5412,"{'title': 'BC12710', 'description': '080306.08.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 49;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: --;\tpn: neg;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: pos;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: pos;\tmfs: 1;\tmfsdel (month): 8.41'}"
5413,"{'title': 'Lung Cancer 146T', 'description': 'Gene expression data from 146T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 48;\tstage: 3A'}"
5414,"{'title': 'papillary renal cell cancer; pRCCa_HD100', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
5415,"{'title': 'ALL with MLL - sample 124', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5416,"{'title': 'human BM MSC TGFb3 stimulated day 1 rep 1', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 1', 'type': 'RNA', 'source_name_ch1': 'donor 4, stimulated with TGFb3 for 1 day', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 1 day'}"
5417,"{'title': 'AML 6885', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 42 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5418,"{'title': 'Endometrium group B hCG not pregnant 4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group B, not pregnant', 'characteristics_ch1': 'treatment: hCG;\ttissue: endometrium'}"
5419,"{'title': 'S006_Scz_M_79', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 79;\tpost-mortem delay: 4h;\tph: 6.2'}"
5420,"{'title': 'IFNβ_1124', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
5421,"{'title': '10444', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 41;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 41;\tDonor Sex: F;\tCAN Banff Score =2;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
5422,"{'title': 'X23213', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 1'}"
5423,"{'title': 'CD31+ rep1 (endothelial study)', 'description': 'endothelial cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD31+ MACS sorted cells'}"
5424,"{'title': 'PA92', 'description': 'PA92', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: extended;\tcell type: Synovial fluid mononuclear cells'}"
5425,"{'title': 'normal Pre ECP, biological rep4', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Pre ECP', 'characteristics_ch1': 'disease state: normal;\tdose: pre ECP;\tperipheral blood: blood harvested with the Therakos machine'}"
5426,"{'title': '04_0004_SepticShock_Day1_10', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '04_0004_Patient, Day1'}"
5427,"{'title': 'Sputum from Stage III Severe, biological replicate 17', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 67;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
5428,"{'title': 'group-2-pt-t1129691', 'description': 'group-2-pt-t1129691', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 23;\tgender: male;\tfinal disposition: 09: Death'}"
5429,"{'title': 'N11478C4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5430,"{'title': 'SI17', 'description': 'Gene expression data from Standard Immunotherapy 17', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 17', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
5431,"{'title': 'SI2', 'description': 'Gene expression data from Standard Immunotherapy 2', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 2', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
5432,"{'title': 'Septic Shock_biological rep62', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.8;\toutcome: Survivor'}"
5433,"{'title': 'Gingival tissue sample 1 from patient 42, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 42 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5434,"{'title': 'Patient 5048 AML187', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 187;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
5435,"{'title': 'PTCL.BO.10', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5436,"{'title': 'ALL without MLL - sample 42', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5437,"{'title': 'GBM, TMZ/radiotherapy (236)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 236;\tage: 56.7;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 10.59;\tmgmt status: U'}"
5438,"{'title': '01-0024_SIRS resolved_day3_30', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5439,"{'title': 'HF1078_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5440,"{'title': '03-0001B_Sepsis_day3_63', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5441,"{'title': 'Sepsis V28', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis'}"
5442,"{'title': 'Blood_TD24112_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
5443,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 21', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
5444,"{'title': '807615', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6336_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 51;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
5445,"{'title': 'Sepsis mixed infection TM4', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
5446,"{'title': 'human BM MSC TGFb3 stimulated day 21 rep 1', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 21', 'type': 'RNA', 'source_name_ch1': 'donor 4, stimulated with TGFb3 for 21 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 21 days'}"
5447,"{'title': 'No27LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No27;\tcell type: hepatocytes;\ttime point: before therapy'}"
5448,"{'title': 'H133+_H416_Tri_10uM', 'description': 'H133+_H416_Tri_10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H416_Tri_10uM', 'characteristics_ch1': 'primary hepatocytes'}"
5449,"{'title': 'Septic Shock_biological rep7 01-0026', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 9.1;\toutcome: Survivor;\tgroup: A'}"
5450,"{'title': 'Patient 4703 AML137', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 137;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5451,"{'title': 'brain, unknown: C2C_e1_le1', 'description': 'control 2 weeks C;\tTreatment, type=time_course, measurement=2.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
5452,"{'title': 'PBMCs_LB_after exercise_18', 'description': 'LB_Peak_132-TK', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 16;\tafter-exercise'}"
5453,"{'title': 'AML 2216', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 58 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5454,"{'title': 'VM270b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1327;\tdisease state: AIDS;\tgender: Female;\tage: 40;\trace: African American;\tblood cd4+ t  cell count (cells/ml): 112;\tplasma hiv-1     rna level   (copies/ml): 12046;\ttissue: lymph node'}"
5455,"{'title': 'P_CD8_11', 'description': 'PS11 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Positive Selection', 'characteristics_ch1': 'age: 31;\tgender: Male;\tt_cell_purity: 87%'}"
5456,"{'title': 'RJ56a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 49;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 478;\tplasma hiv-1 rna levels (copies/ml): 174,000'}"
5457,"{'title': 'newly diagnosed multiple myeloma 18', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
5458,"{'title': 'N_CD4_1', 'description': 'NS1 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Negative Selection', 'characteristics_ch1': 'age: 30;\tgender: Male;\tt_cell_purity: 89%'}"
5459,"{'title': 'colon_IBD_1156', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
5460,"{'title': 'Proficiency_Site3_20', 'description': 'Performed by Operator 1 from Site3 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 8ug; cRNA yield (ug) = 58.93; Lot# = 035PO41658D'}"
5461,"{'title': 'monocytes_-LPS_1', 'description': '28h medium', 'type': 'RNA', 'source_name_ch1': 'blood, -LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 28h medium'}"
5462,"{'title': 'newly diagnosed multiple myeloma 319', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
5463,"{'title': 'Blood sample from patient 117 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 117;\tday: Day 28;\tage (years): 33;\tsex: Male'}"
5464,"{'title': 'AML sample #99', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
5465,"{'title': 'GBM, TMZ/radiotherapy (ge197)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: ge197;\tage: 46.2;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 52.7;\tmgmt status: M'}"
5466,"{'title': 'GA_840', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5467,"{'title': 'X533', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
5468,"{'title': 'C011143', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6718_Tumor;\tfab: M3;\tSex: F;\trace: AA;\tage on study: 60;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
5469,"{'title': 'N_CD4_3', 'description': 'NS3 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Negative Selection', 'characteristics_ch1': 'age: 47;\tgender: Female;\tt_cell_purity: 92%'}"
5470,"{'title': 'RTX8 T0', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: baseline;\tgender: F;\tage (y): 68;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
5471,"{'title': 'ALL without MLL - sample 88', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5472,"{'title': 'N30364', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30364;\tsample: normal'}"
5473,"{'title': 'newly diagnosed multiple myeloma 128', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: II'}"
5474,"{'title': 'AML sample #48', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
5475,"{'title': 'Cell line C5.2_DR_2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
5476,"{'title': 'UNTREATED_922', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5477,"{'title': 'Patient 3415 AML17', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 17;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5478,"{'title': 'MDS patient 79', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
5479,"{'title': 'Globin_S2', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
5480,"{'title': 'Septic Shock_biological rep69 10-0021A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 8.9;\toutcome: Survivor;\tgroup: B'}"
5481,"{'title': 'X34165', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
5482,"{'title': '1946 - mAdbID:69961', 'description': 'mAdb experiment ID: 69961', 'type': 'RNA', 'source_name_ch1': '1946', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1946;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: ABC DLBCL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 0.68;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
5483,"{'title': 'U937_naive_curcumin_4h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, 1uM curcumin treated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
5484,"{'title': 'COL2_011853', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 64;\tgender: F;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 1'}"
5485,"{'title': 'Endometrium-d2-3-not pregnant rep 4', 'description': ""Gene expression of morphological more advanced endometria, assessed buy Noyes' criteria, (n=3) was compared with matched less advanced endometria (n=4)."", 'type': 'RNA', 'source_name_ch1': ""Endometrium on day of oocyte retrieval, dated as d2 or d3 of the luteal phase by Noyes' criteria, not pregnant"", 'characteristics_ch1': 'Endometrial dating d2-3, non-pregnant'}"
5486,"{'title': 'Liver189T (mRNA expression)', 'description': 'liver cancer HBV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 189T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately differentiated;\tgender: M;\tage: 68;\tvirus: HBV'}"
5487,"{'title': 'CD19_selected_B-cells_after_RFC_rep10', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after RFC'}"
5488,"{'title': 'N11354D6: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5489,"{'title': 'HF0329_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
5490,"{'title': '11-0045A_SIRS_day1_176', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5491,"{'title': 'DB720b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1472;\tdisease state: Uninfected;\tgender: Female;\tage: 52;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 837;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
5492,"{'title': 'colon_adenoma_980', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
5493,"{'title': 'VAN_00667', 'description': '07-23804', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 77;\tgender: M;\tipi_stage: 2B;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.99;\tprogression-free_survival (years): 0.99'}"
5494,"{'title': 'Sputum from Stage II Moderate, biological replicate 57', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 69;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39315'}"
5495,"{'title': 'endothelial_rep13', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:19h'}"
5496,"{'title': 'Replicate 1 for MB231untreated72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 1 for MB231untreated72h breast cell line'}"
5497,"{'title': 'IFNβ_1723', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5498,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 5', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
5499,"{'title': 'class F, rep21', 'description': 'VAN_00336f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 24;\tsex: F;\tdisease stage: 2;\talbumin level: 47;\themoglobin level: 139;\tlymphocyte percentage: 19;\twhite blood count: 8.8;\tinternational prognostic score (ips): 1'}"
5500,"{'title': 'UNTREATED_818', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
5501,"{'title': 'Human Hepatocytes_Control, Donor 1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 67; reason for liver resection: Liver metastasis, stomach cancer'}"
5502,"{'title': 'Septic Shock_biological rep46 05-0006', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.3;\toutcome: Survivor;\tgroup: A'}"
5503,"{'title': 'newly diagnosed multiple myeloma 27', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
5504,"{'title': 'AML 2757', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 52 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5505,"{'title': 'Healthy control 12', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
5506,"{'title': 'AML with normal karyotype #234', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 47;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 98;\tdisease state: de novo AML'}"
5507,"{'title': 'Insulin resistant patient 7 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
5508,"{'title': 'HepG2 APRIL 0h', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HepG2 cells, untreated', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocyte derived cancer'}"
5509,"{'title': '2.2.AF.6', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 6 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: AF;\thours post infection: 6'}"
5510,"{'title': 'S046', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S046', 'characteristics_ch1': 'patient id: P046;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 2'}"
5511,"{'title': 'CD19_selected_B-cells_after_FC_rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
5512,"{'title': 'AML 1747', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 59 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5513,"{'title': 'Blood sample from patient 147 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 147;\tday: Day 1;\tage (years): 31;\tsex: Female'}"
5514,"{'title': 'Adenocarcinoma, bone marrow positive AC 22', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'female pulmonary adenocarcinoma;\tbone marrow positive'}"
5515,"{'title': 'Sputum from Stage III Severe, biological replicate 21', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 57;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
5516,"{'title': 'newly diagnosed multiple myeloma 183', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
5517,"{'title': 'Control Con_rep3', 'description': 'Control paired  24', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
5518,"{'title': 'Young sedentary subject, biological replicate (YS3)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
5519,"{'title': '04-0002_Sepsis_day3_67', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5520,"{'title': 'AML 2695', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 37 years;\tscore: FAB M1;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5521,"{'title': 'Clone A cells cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
5522,"{'title': 'AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 2', 'description': 'AP-2 gamma silenced', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: AP-2 gamma targetting siRNA 2;\tcell line: MCF7'}"
5523,"{'title': 'Cervical cancer-lymph node negative-04-13', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 34.7;\tfigo stage: 2a'}"
5524,"{'title': 'No17LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No17;\tcell type: lymphocytes;\ttime point: under therapy'}"
5525,"{'title': 'AML 3324', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 26 years;\tscore: FAB M5;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5526,"{'title': 'N51783', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51783;\tsample: normal'}"
5527,"{'title': 'NSCLC_SCC_188', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 188.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
5528,"{'title': 'N10964A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5529,"{'title': 'RTX6 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: M;\tage (y): 59;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
5530,"{'title': 'ALL with MLL - sample 128', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5531,"{'title': 'S009', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S009', 'characteristics_ch1': 'patient id: P098;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 50'}"
5532,"{'title': 'CD31+ rep2 (endothelial study)', 'description': 'endothelial cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD31+ MACS sorted cells'}"
5533,"{'title': 'newly diagnosed multiple myeloma 171', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
5534,"{'title': 'csc: m1: i1: d01', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 1; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 1;\tReplicate: 1;\tBatch: d01'}"
5535,"{'title': 'NSCLC EMC TB0050he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
5536,"{'title': 'human cultured bladder HB DM, subject 12', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 57;\tDisease status: HB (control (stress incontinence, no bladder pain));\tCulture medium: DM (differentiating medium)'}"
5537,"{'title': 'K_STA13', 'description': 'K_STA13', 'type': 'RNA', 'source_name_ch1': 'STA13 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
5538,"{'title': 'Patient 3436 AML24', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 24;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5539,"{'title': 'Patient_8711_relapse', 'description': '8711R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 7;\tconclusions ig/tcr: stable;\tselected: yes'}"
5540,"{'title': 'SK-N-SH_BDNF_1d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
5541,"{'title': 'mock-infected, normal S15 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, normal S15', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
5542,"{'title': 'Patient 4399 AML76', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 76;\tcohort: Validation;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5543,"{'title': 'No5inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No5 nonRVR;\ttime point: under therapy'}"
5544,"{'title': 'Patient 4746 AML164', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 164;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
5545,"{'title': 'AML 7274', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 37 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5546,"{'title': '06-14-05_Miller_U133Plus2_0_A2P2d07EPO', 'description': 'Pool of 3 samples:;\t26-37 age;\tM/F;\tDay 7: proerythroblast', 'type': 'RNA', 'source_name_ch1': 'CD34+ progenitor cells subjected to EPO and harvested at day 7', 'characteristics_ch1': 'cell type: CD34+ hematopoietic progenitor cells;\tdevelopmental stage: proerythroblast;\ttissue type: primary cells from donated blood'}"
5547,"{'title': 'HF0639_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
5548,"{'title': 'control participant P311', 'description': 'Gene expression data from control participant LF', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
5549,"{'title': 'MDS patient 122', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
5550,"{'title': 'HF1344_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
5551,"{'title': 'Patient 4530 AML115', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 115;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5552,"{'title': 'newly diagnosed multiple myeloma 143', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: III'}"
5553,"{'title': 'H416 DMSO 0.001', 'description': 'H416 DMSO 0.001.CEL', 'type': 'RNA', 'source_name_ch1': 'H416 DMSO 0.001', 'characteristics_ch1': 'primary hepatocytes'}"
5554,"{'title': 'Sc3_3', 'description': 'Human testis Score 3 Replicate 3', 'type': 'RNA', 'source_name_ch1': 'Spermatogonial presence in tubuli', 'characteristics_ch1': 'tissue type: testicular biopsy;\tspermatogenic stage (johnsen score): Score 3'}"
5555,"{'title': 'EPN_416, non-recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_416, non-recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
5556,"{'title': 'VA133', 'description': '00-12223', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 77;\tgender: M;\tipi_stage: 4B;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.37;\tprogression-free_survival (years): 5.37'}"
5557,"{'title': 'control participant P313', 'description': 'Gene expression data from control participant SH', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
5558,"{'title': 'newly diagnosed multiple myeloma 320', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
5559,"{'title': 'X60102', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 2'}"
5560,"{'title': 'X3498', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : NA;\tConsolidated.Grade : NA'}"
5561,"{'title': 'Patient 3451 AML35', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 35;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5562,"{'title': 'T8607A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5563,"{'title': 'newly diagnosed multiple myeloma 283', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: III'}"
5564,"{'title': 'Astrocytoma_4', 'description': 'bh20061208u133v2_A_17-Astro6_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: astrocytoma;\tage: 47;\tgender: male;\ttumor grade: AIII'}"
5565,"{'title': 'S151', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S151', 'characteristics_ch1': 'patient id: P012;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
5566,"{'title': 'X23098', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 2'}"
5567,"{'title': 'MDS patient 9', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q plus other'}"
5568,"{'title': 'PBMCs_EB_before exercise_07', 'description': 'EB_Pre_143-SA', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 11;\tbefore-exercise'}"
5569,"{'title': 'X41300', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
5570,"{'title': 'Control (dupl) sample 5a', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
5571,"{'title': 'lymphocytes_HD_F_43y_2', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 15/50'}"
5572,"{'title': '11-0051A_SIRS_day1_133', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5573,"{'title': 'S142', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S142', 'characteristics_ch1': 'patient id: P121;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
5574,"{'title': 'SH-SY5Y(ECACC)_BDNF_1d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
5575,"{'title': 'KT0736_0_L_training', 'description': 'KT0736_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, training set'}"
5576,"{'title': 'newly diagnosed multiple myeloma 295', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
5577,"{'title': 'Patient_33', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 33;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.501242416118718;\tproliferation index: -0.901371432054056'}"
5578,"{'title': 'Patient 5173 AML219', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 219;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
5579,"{'title': 'Patient 5179 AML224', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 224;\tcohort: Validation;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5580,"{'title': 'X60148', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
5581,"{'title': 'Patient 4445 AML97', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 97;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
5582,"{'title': 'Patient 3450 AML34', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 34;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5583,"{'title': 'AML sample #13', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
5584,"{'title': 'Gastric GIST 2', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 64;\tTumor size: 4;\tKIT mutation: Wild type'}"
5585,"{'title': 'PBMCs_LB_before exercise_20', 'description': 'LB_Pre_187-EB', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 27;\tbefore-exercise'}"
5586,"{'title': 'PGA-Hs_H-2', 'description': 'Human subjects with hypertrophic cardiomyopathy;\tKeywords = hypertrophic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
5587,"{'title': '546 - mAdbID:70400', 'description': 'mAdb experiment ID: 70400', 'type': 'RNA', 'source_name_ch1': '546', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 546;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 0.77;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
5588,"{'title': 'HF1286_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5589,"{'title': 'AML 6980', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 17 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5590,"{'title': 'Cell line C5.2_D_1', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
5591,"{'title': 'KOPT-K1_DMSO_01', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'KOPT-K1 cells treated with DMSO', 'characteristics_ch1': 'cell type: T-cell;\tcell line: KOPT-K1'}"
5592,"{'title': 'prostate normal 1', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal prostate stroma', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: normal'}"
5593,"{'title': 'AML with normal karyotype #181', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 80;\tdisease state: de novo AML'}"
5594,"{'title': 'newly diagnosed multiple myeloma 192', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: nd'}"
5595,"{'title': 'S098', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S098', 'characteristics_ch1': 'patient id: P022;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
5596,"{'title': 'AML with normal karyotype #167', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 98;\tdisease state: de novo AML'}"
5597,"{'title': 'Subcutaneous adipose tissue, SAT16', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
5598,"{'title': 'AML sample #45', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00174;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
5599,"{'title': 'homozygot FH P254', 'description': 'Gene expression data from the homozygous FH participant K2', 'type': 'RNA', 'source_name_ch1': 'homozygot FH P254 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: homozygote FH'}"
5600,"{'title': 'M-27', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
5601,"{'title': 'COL2_030625', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 76;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1114;\tsecond apc mutation: 0;\t5q loh: 0'}"
5602,"{'title': 'NY79', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: Proliferation;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
5603,"{'title': 'newly diagnosed multiple myeloma 83', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: II'}"
5604,"{'title': 'Patient 4567 AML128', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 128;\tcohort: Validation;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5605,"{'title': 'test experiment not for use [wf20061103u133v2_U_03-Lc1-Pat-1-GD]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
5606,"{'title': 'PGA-Hs_S-21', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
5607,"{'title': 'non-malignant FTEn_patient 7', 'description': 'Gene expression profile of non-malignant FTE from control patient during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 41;\tCycle: Follicular;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
5608,"{'title': 'Gingival tissue sample 4 from patient 32, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 32 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
5609,"{'title': '636-1', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 1.7'}"
5610,"{'title': 'Blood sample from patient 174 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 174;\tday: Day 1;\tage (years): 56;\tsex: Female'}"
5611,"{'title': 'AML with normal karyotype #15', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 48;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 63;\tdisease state: de novo AML'}"
5612,"{'title': 'GBM, TMZ/radiotherapy (528bis)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 528;\tage: 33.3;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 24.47;\tmgmt status: U'}"
5613,"{'title': 'Gingival tissue sample 1 from patient 55, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 55 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5614,"{'title': 'monocytes_Q10H2_2', 'description': '24h Q10H2 preincubation, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +Q10H2, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h Q10H2 preincubation, 4h LPS stimulation'}"
5615,"{'title': 'MLD AML sample #21', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
5616,"{'title': 'Peripheral T-Cell lymphoma, unspecified 40', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-140', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: not available;\tgender: not available'}"
5617,"{'title': 'AML 7413', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 59 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5618,"{'title': 'Control-25', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tLc3', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - control;\tSex: M;\tage: 65;\ttissue ph: 6.47;\tpmi (hrs): 20.5;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
5619,"{'title': 'Normal N2', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary lung', 'characteristics_ch1': 'female pulmonary adenocarcinoma;\tnormal tissue'}"
5620,"{'title': 'group-2-pt-t17593495', 'description': 'group-2-pt-t17593495', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 18;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
5621,"{'title': 'NSCLC_AC_137', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 137.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
5622,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_1d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
5623,"{'title': 'Gingival tissue sample 1 from patient 7, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 7 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5624,"{'title': 'Muscle PCOS control 3', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
5625,"{'title': 'AML with normal karyotype #212', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 36;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 65;\tdisease state: de novo AML'}"
5626,"{'title': 'TOL9', 'description': 'Gene expression data from Tolerant 9', 'type': 'RNA', 'source_name_ch1': 'Tolerant9', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Tolerant'}"
5627,"{'title': 'mRNA of GBM-HGG093, Glioblastoma, 11.25 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 11.25 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 11.25 years'}"
5628,"{'title': 'newly diagnosed multiple myeloma 204', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
5629,"{'title': 'carcinoma_45 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 80;\tlocalization: caecum'}"
5630,"{'title': 'cord blood 1', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.1', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.1;\t'}"
5631,"{'title': 'Patient_50', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 50;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.623075727418579;\tproliferation index: -1.38621784391443'}"
5632,"{'title': 'Endometrium control 0 hours TCM-13', 'description': 'Control endometrium  0 hours TCM-13', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control endometrium  0 hours TCM-13'}"
5633,"{'title': 'newly diagnosed multiple myeloma 220', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: II'}"
5634,"{'title': 'Seminal vesicle, biological replicate 1', 'description': 'Gene expression from adult Human seminal vesicle', 'type': 'RNA', 'source_name_ch1': 'Normal seminal vesicle from adult man', 'characteristics_ch1': 'tissue: Seminal vesicle;\tage: adult'}"
5635,"{'title': 'Lung Normal 109N', 'description': 'Gene expression data from 109N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 74;\tstage: n/a'}"
5636,"{'title': 'X34078', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5637,"{'title': 'IC_MT U133 Plus 2.0', 'description': 'Gene expression data from peripheral blood sample', 'type': 'RNA', 'source_name_ch1': 'Human peripheral blood sample', 'characteristics_ch1': 'tissue: blood;\tdisease state: Infective colitis'}"
5638,"{'title': 'AML sample #48', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00185;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
5639,"{'title': 'adipose_postTZD_IRd-_s11', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 11'}"
5640,"{'title': 'UNTREATED_2104', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5641,"{'title': 'DietResistant _3 weeks_subject6', 'description': 'DietResistant _3 weeks_subject6', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 3 weeks;\tsubject: 6;\tgender: Female'}"
5642,"{'title': 'Patient 5017 AML177', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 177;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5643,"{'title': 'AML 2514', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 34 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5644,"{'title': 'GBM_differentiation_4 days_3', 'description': 'G63_DF_4d.CEL', 'type': 'RNA', 'source_name_ch1': 'glioblastoma stem cells, differentiation, 4 days', 'characteristics_ch1': 'tissue: brain;\tdisease status: glioblastoma;\tcell type: stem cells G63'}"
5645,"{'title': 'newly diagnosed multiple myeloma 88', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: II'}"
5646,"{'title': 'X41203', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
5647,"{'title': 'N11478A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5648,"{'title': 'Patient 4531 AML116', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 116;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5649,"{'title': 'Septic Shock_biological rep30', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 9.3;\toutcome: Survivor'}"
5650,"{'title': 'newly diagnosed multiple myeloma 113', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: nd'}"
5651,"{'title': 'SS gland, advanced, patient 11, batch 1', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: advanced SS'}"
5652,"{'title': 'C143', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.7'}"
5653,"{'title': 'Patient 22, IDC', 'description': '17118-1P_exp', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 22'}"
5654,"{'title': 'AML sample #13', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00081;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
5655,"{'title': '04-147 Transcriptome map', 'description': 'Data accompanying the paper: ""The 3D structure of human interphase;\tchromosomes is related to the transcriptome map. Goetze et al.,;\t(submitted). ', 'type': 'RNA', 'source_name_ch1': '04-147 cells', 'characteristics_ch1': 'Human primary fibroblasts derived from female skin'}"
5656,"{'title': 'Patient_8549_diagnosis', 'description': '8549D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 9;\tconclusions ig/tcr: stable;\tselected: yes'}"
5657,"{'title': 'AML with normal karyotype #34', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 78.8;\tdisease state: de novo AML'}"
5658,"{'title': 'Ultrafine particle exposure 2 -24 hours post-exposure', 'description': 'Gene expression data from circulating mononuclear cells after ultrafine carbon particle exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells after exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: UFP;\ttime: 24 hours'}"
5659,"{'title': 'N40645', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40645;\tsample: normal'}"
5660,"{'title': 'UNTREATED_2123', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5661,"{'title': 'HeLa_NT siRNA_rep1', 'description': 'Affymetrix HG U133+2 data', 'type': 'RNA', 'source_name_ch1': 'HeLa cells,control', 'characteristics_ch1': 'cell line: HeLa cancer cell line;\ttissue origin of cancer cell: cervix;\tprotocol: control siRNA'}"
5662,"{'title': 'newly diagnosed multiple myeloma 296', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: I'}"
5663,"{'title': 'SH-SY5Y(ECACC)_RA_6h_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
5664,"{'title': 'Subcutaneous adipose tissue, SAT38', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
5665,"{'title': 'AML 2307', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 48 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5666,"{'title': 'PTCL_BO_001', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5667,"{'title': 'K_STA18', 'description': 'K_STA18', 'type': 'RNA', 'source_name_ch1': 'STA18 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
5668,"{'title': 'human macrophages treated with PG-fimbriae, biological rep1', 'description': 'Gene expression data from human macrophages treated with PG-fimbriae for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis-fimbriae', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: P. gingivalis fimbriae;\ttreatment time: 2 hours;\tday: 9'}"
5669,"{'title': 'C98354', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7207_Tumor;\tfab: M2;\tSex: M;\trace: C;\tage on study: 31;\tcytogenetic change: trisomy 10; del(9)(q13q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5670,"{'title': 'PBMCs_EB_after exercise_05', 'description': 'EB_Peak_120-MJ', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 11;\tafter-exercise'}"
5671,"{'title': 'newly diagnosed multiple myeloma 215', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
5672,"{'title': 'UNTREATED_1788', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5673,"{'title': 'T3-4 (HCC stage 3-4)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'Human Liver', 'characteristics_ch1': 'HCC stage 3'}"
5674,"{'title': 'SI24', 'description': 'Gene expression data from Standard Immunotherapy 24', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 24', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
5675,"{'title': 'WB55b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 23;\trace: African American;\tperipheral blood cd4+ t cells (cells/ml): 209;\tplasma hiv-1 rna levels (copies/ml): 19,400'}"
5676,"{'title': 'DLBCL biopsy, sample 2195', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
5677,"{'title': 'HIV+ Individual HIV-9a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-9a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
5678,"{'title': '10-0011_Sepsis_day3_119', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5679,"{'title': 'non-malignant FTEn_patient 4', 'description': 'Gene expression profile of non-malignant FTE from control patient during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 36;\tCycle: Luteal;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
5680,"{'title': 'U937_ROS_untreated_18h_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
5681,"{'title': 'newly diagnosed multiple myeloma 148', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
5682,"{'title': 'Control NP', 'description': '08SE371', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
5683,"{'title': 'breast tumor 4', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to breast invasive tumor', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: tumor'}"
5684,"{'title': 'ALL without MLL - sample 45', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5685,"{'title': 'VCX control 6', 'description': 'arrayconsortium.tgen.org::biosample.435264;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 6;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 83 years'}"
5686,"{'title': 'AML 6890', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tgender: female;\tage: 37 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5687,"{'title': 'platelet_Ctrl_12', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from control', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Healthy Control'}"
5688,"{'title': 'C018_Control_F_67', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 67;\tpost-mortem delay: 6h;\tph: 6.7'}"
5689,"{'title': 'AML with normal karyotype #171', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 76;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 82;\tdisease state: de novo AML'}"
5690,"{'title': 'CLL cells  PB  patient #18', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #18'}"
5691,"{'title': 'HF0790_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5692,"{'title': 'Sepsis gram-negative V11', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
5693,"{'title': 'GA_851', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5694,"{'title': 'Muscle septic k55', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:male, Age:77yrs'}"
5695,"{'title': 'Gingival tissue sample 3 from patient 49, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 49 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
5696,"{'title': 'PBMCs vehicle treated for 2 hours,replicate 5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 2 hours,replicate 5', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
5697,"{'title': 'HUVEC_TNFa_2h45m', 'description': '2h45m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 2h45m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
5698,"{'title': 'newly diagnosed multiple myeloma 24', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
5699,"{'title': 'Gingival tissue sample 3 from patient 58, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 58 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
5700,"{'title': 'C00784', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7391_Tumor;\tfab: M1;\tSex: M;\trace: Asian;\tage on study: 59;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
5701,"{'title': 'Sepsis gram-negative V14', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
5702,"{'title': 'class S, rep55', 'description': 'VAN_00440.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 36;\tsex: M;\tdisease stage: 2;\talbumin level: 40;\themoglobin level: 147;\tlymphocyte percentage: 17;\twhite blood count: 8.7;\tinternational prognostic score (ips): 2'}"
5703,"{'title': 'B16', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.0'}"
5704,"{'title': 'MDS patient 137', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: other'}"
5705,"{'title': 'Oligodendrioglioma_3', 'description': 'bh20061208u133v2_A_24-Oligo6_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: oligodendrioglioma;\tage: 45;\tgender: male;\ttumor grade: OGII'}"
5706,"{'title': 'BL41 60 min nt-RNA Rep.3', 'description': 'newly transcribed RNA (nt-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
5707,"{'title': 'HF1509_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5708,"{'title': 'Replicate 2 for MCF7siRNActr breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 siRNA against ESR1 control at 18h'}"
5709,"{'title': 'Sputum from Stage II Moderate, biological replicate 28', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 61;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: F;\thyb date: 39324'}"
5710,"{'title': 'AML with normal karyotype #55', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 53;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 69.5;\tdisease state: de novo AML'}"
5711,"{'title': 'AML 2199', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 54 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5712,"{'title': 'Replicate 1 for MCF7control72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 1 for MCF7control72h breast cell line'}"
5713,"{'title': 'S4-14', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 14; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 14; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 14;\tSmoking status: smoker;\tPack-years: 20;\tAge: 41;\tSex: M;\tEthnic group: black'}"
5714,"{'title': 'Sputum from Stage II Moderate, biological replicate 42', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 57;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
5715,"{'title': 'siTOP1 MCF7-repeat 1 - mAdbID:83286', 'description': 'mAdb experiment ID: 83286', 'type': 'RNA', 'source_name_ch1': 'siTOP1 MCF7', 'characteristics_ch1': 'Tissue: breast;\tCell line: Breast Cancer Cell Line MCF7;\tCell type: epithelial cells;\tDisease state: Adenocarcinoma;\tgenotype/variation gene knock out'}"
5716,"{'title': 'AML with normal karyotype #139', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 66;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 57;\tdisease state: de novo AML'}"
5717,"{'title': 'HOSE2237', 'description': 'Gene expression data from ovarian surface epithelial cells', 'type': 'RNA', 'source_name_ch1': 'Normal', 'characteristics_ch1': 'tissue: ovary;\tcell type: Normal ovarian surface epithelium'}"
5718,"{'title': 'mRNA of GBM-HGG056, Glioblastoma, 4.7 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 4.7 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 4.7 years'}"
5719,"{'title': 'S150', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S150', 'characteristics_ch1': 'patient id: P011;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
5720,"{'title': 'DC_Unstimulated_Rep3', 'description': 'Circulating monocyte derived DCs were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure. At day four 10 million immature DCs were either left unstimulated or stimulated using plate bound anti-DC-SIGN antibody for 2 hr. Three replicates of non-stimulated or stimulated cells were taken and used to extract total RNA.', 'type': 'RNA', 'source_name_ch1': 'primary dendritic cells (DCs)', 'characteristics_ch1': 'Buffy coats were obtained from the National Blood Centre. Circulating myeloid dendritic cells (DCs) were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.'}"
5721,"{'title': 'X60111', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : 2'}"
5722,"{'title': 'HBEC4 High dose treatment group (1000 nM)', 'description': 'HBEC4 High dose treatment group (1000 nM)', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
5723,"{'title': 'Endometrium control 0 hours TCM-3', 'description': 'Control endometrium  0 hours TCM-3', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control endometrium  0 hours TCM-3'}"
5724,"{'title': 'newly diagnosed multiple myeloma 240', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: II'}"
5725,"{'title': 'IFNβ_881', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5726,"{'title': 'Septic Shock_biological rep65 10-0005', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 7.8;\toutcome: Survivor;\tgroup: B'}"
5727,"{'title': 'Control 40', 'description': '07SE534', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
5728,"{'title': 'T11580C1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
5729,"{'title': 'muscle_preTZD_preClamp_IRd_s10', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 10'}"
5730,"{'title': '11-0054A_Day1_32', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Male;\tSurvivor;\torganism: Staph aureus'}"
5731,"{'title': 'human macrophages treated with P. gingivalis, biological rep1', 'description': 'Gene expression data from human macrophages treated with P. gingivalis for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis 381', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: live P. gingivalis 381;\ttreatment time: 2 hours;\tday: 9'}"
5732,"{'title': 'AML 2666', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 35 years;\tscore: FAB M5;\trisk: unknown;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
5733,"{'title': 'Sepsis mixed infection TM3', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
5734,"{'title': 'Blood - Axial Spondyloarthropathy - 096A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Female;\tage: 33;\tset: 2;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
5735,"{'title': 'MLD AML sample #2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-wild type;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
5736,"{'title': 'PGA_PA-D_317', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
5737,"{'title': 'group-2-pt-t18145446', 'description': 'group-2-pt-t18145446', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 27;\tgender: female;\tfinal disposition: 88: Other (specify)'}"
5738,"{'title': 'Normal_colon_12_12April05', 'description': 'Normal_colon_12_12April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, cecum', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
5739,"{'title': 'Normal_3', 'description': 'Normal mucosa', 'type': 'RNA', 'source_name_ch1': 'Normal tissue 3', 'characteristics_ch1': 'tissue: esophagus, normal;\tgender: male, Japanese;\tage: 54'}"
5740,"{'title': 'Sputum from Stage II Moderate, biological replicate 55', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 66;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
5741,"{'title': 'AML 7054', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 44 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5742,"{'title': 'CDcNR2_beforeT', 'description': 'Colonic mucosal gene expression data from CDc non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
5743,"{'title': 'AML 7058', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 54 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5744,"{'title': 'AML 3314', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 31 years;\tscore: FAB unknown;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5745,"{'title': 'group-1-pt-t31938349', 'description': 'group-1-pt-t31938349', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 19;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
5746,"{'title': 'Peripheral T-Cell lymphoma, unspecified 2_replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-30', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: not available;\tgender: not available'}"
5747,"{'title': 'MERLION_X02K04465', 'description': 'MERLION-X02K04465', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=47, state=1', 'characteristics_ch1': 'pT2N0, male, age=47, state=1'}"
5748,"{'title': 'Patient_16', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 16;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.355610433341315;\tproliferation index: 0.593521386497591'}"
5749,"{'title': '05-213_NP', 'description': 'Prostate whole tissue.', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'tissue: prostate'}"
5750,"{'title': 'T30308', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30308;\tsample: tumor'}"
5751,"{'title': 'AML sample #39', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
5752,"{'title': 'class S, rep90', 'description': 'VAN_00558.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 37;\tsex: F;\tdisease stage: 2;\talbumin level: 41;\themoglobin level: 135;\tlymphocyte percentage: 28;\twhite blood count: 5.3;\tinternational prognostic score (ips): 1'}"
5753,"{'title': 'Liver375N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HBV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 375N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: LC;\tgender: M;\tage: 68;\tvirus: HBV'}"
5754,"{'title': 'AML with normal karyotype #102', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 83;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 74;\tdisease state: de novo AML'}"
5755,"{'title': 'Blood sample from patient 113 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 113;\tday: Day 180;\tage (years): 28;\tsex: Male'}"
5756,"{'title': 'MDS patient 33', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: del5q plus other'}"
5757,"{'title': 'AP-2 gamma targetting siRNA 3: CCACACUGGAGUCGCCGAAUA Technical Replicate 3', 'description': 'AP-2 gamma silenced', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: AP-2 gamma targetting siRNA 3;\tcell line: MCF7'}"
5758,"{'title': 'MCF7 Control treatment group', 'description': 'MCF7 Control treatment group', 'type': 'RNA', 'source_name_ch1': 'Ductal Breast Carcinoma Cell Line', 'characteristics_ch1': 'See publication for details'}"
5759,"{'title': 'LMP834', 'description': 'low-malignant tumors of the ovary', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: low-malignant tumors of the ovary'}"
5760,"{'title': 'HeLa Transcriptome maps', 'description': 'Data accompanying the paper: ""The 3D structure of human interphase;\tchromosomes is related to the transcriptome map. Goetze et al.,;\t(submitted). ', 'type': 'RNA', 'source_name_ch1': 'HeLa cells', 'characteristics_ch1': 'cervix carcinoma cells'}"
5761,"{'title': 'HF1280_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5762,"{'title': 'NY70', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: CTNNB1;\ttp53 mutation: 0;\tctnnb1 mutation: 239G>GT | G34G/V;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
5763,"{'title': 'Gingival tissue sample 2 from patient 62, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 62 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5764,"{'title': 'Tumor Tum_Ph1_rep3', 'description': 'Tumor paired  23', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N1;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
5765,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 22', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
5766,"{'title': 'Sepsis mixed infection  V24', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
5767,"{'title': 'p63shRNA_B3, p63-depleted', 'description': 'None', 'type': 'RNA', 'source_name_ch1': 'Cervical carcinoma', 'characteristics_ch1': 'Age: 66 yrs Gender: Female  Ethnicity: Caucasian'}"
5768,"{'title': 'AML 2769', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 55 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5769,"{'title': 'Glioblastoma_5', 'description': 'bh20061208u133v2_A_05-GBM5_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 43;\tgender: female;\ttumor grade: IV'}"
5770,"{'title': 'AML with normal karyotype #84', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 66;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 22;\tdisease state: de novo AML'}"
5771,"{'title': 'prostate tumor 1', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to prostate invasive tumor', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: tumor'}"
5772,"{'title': 'AML sample #70', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00397;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
5773,"{'title': 'UCNR8_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
5774,"{'title': 'IFNβ_1153', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
5775,"{'title': 'Patient_47', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 47;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.375968591131707;\tproliferation index: 6.01201847444113'}"
5776,"{'title': 'HF1589_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
5777,"{'title': 'ALL without MLL - sample 39', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5778,"{'title': '426980', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9693_Tumor;\tfab: M2;\tSex: M;\trace: W;\tage on study: 68;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5779,"{'title': 'AML 2284', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 32 years;\tscore: FAB M6;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5780,"{'title': 'HF1235_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
5781,"{'title': '05-0007_Septic Shock_day3_227', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
5782,"{'title': 'T47D Tamoxifen resistant', 'description': 'T47DTR', 'type': 'RNA', 'source_name_ch1': 'Breast cancer cell line T47D grown in tamoxifen containing media.', 'characteristics_ch1': 'cell line: T47D;\tgrowth condition: grown in tamoxifen containing media;\tcell type: This is a hypotriploid human breast cell;\tbiomaterial provider: ATCC'}"
5783,"{'title': 'Endometrium-prog A (01B05313-1)', 'description': '01B05313-1.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group A', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2-3;\tpregnancy status: pregnant;\tprogesterone serum level: group A (<=0.9ng/ml)'}"
5784,"{'title': 'Pilocytic astrocytoma chip 7754', 'description': 'Pilocytic astrocytoma.  Chip ID 7754', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
5785,"{'title': 'Patient 4, biopsy; Collagen colitis (excluded)', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'Collagen colitis (excluded)'}"
5786,"{'title': 'U937_ROS_untreated_4h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
5787,"{'title': 'MERLION_X02K01203', 'description': 'MERLION_X02K01203', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=70, state=0', 'characteristics_ch1': 'pT2N0, male, age=70, state=0'}"
5788,"{'title': 'colonic_crypt_epithelial_cells_normal_colon_14 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: normal colon;\tsex: female'}"
5789,"{'title': 'GBM, radiotherapy (55)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 55;\tage: 49.9;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 9.7;\tmgmt status: M'}"
5790,"{'title': 'No7LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No7;\tcell type: lymphocytes;\ttime point: under therapy'}"
5791,"{'title': 'Lung Normal 165N', 'description': 'Gene expression data from 165N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 64;\tstage: n/a'}"
5792,"{'title': 'c_NY106', 'description': 'normal liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; normal liver tissue', 'characteristics_ch1': 'normal liver tissue'}"
5793,"{'title': '22096', 'description': '11858', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24329;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
5794,"{'title': 'VA44', 'description': '96-15389', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 80;\tgender: F;\tipi_stage: 3A;\ttxprimary: CHOP3-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 5.82;\tprogression-free_survival (years): 5.82'}"
5795,"{'title': 'dmso: m1: i1: d02', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 1; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 1;\tReplicate: 1;\tBatch: d02'}"
5796,"{'title': 'gd cell activation+6h,donor 4', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 6 hours after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 6 hrs;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 6 h;\tindividual: donor 4'}"
5797,"{'title': 'aa_NY74', 'description': 'very advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very advanced HCC', 'characteristics_ch1': 'very advanced HCC'}"
5798,"{'title': 'N10739D4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5799,"{'title': 'sample 12, brca1 mutation positive, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: luteal;\tsample identifier: 12'}"
5800,"{'title': 'IFNβ_728', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
5801,"{'title': 'Subcutaneous adipose tissue, SAT19', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
5802,"{'title': 'U937_ROS_curcumin_4h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 1uM curcumin treated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
5803,"{'title': 'newly diagnosed multiple myeloma 174', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
5804,"{'title': 'MERLION_X00K06478', 'description': 'MERLION_X00K06478', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age:54, state:0', 'characteristics_ch1': 'pT2N0, female, age:54, state:0'}"
5805,"{'title': 'muscle_preTZD_preClamp_IRd+_s28', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 28'}"
5806,"{'title': 'B33', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.1'}"
5807,"{'title': 'SH-SY5Y(ATCC)_RA_2d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
5808,"{'title': 'X60107', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIB;\tConsolidated.Grade : 3'}"
5809,"{'title': 'conventional renal cell cancer; cRCCb_HA344', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
5810,"{'title': 'CD19_selected_B-cells_before_R_rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before Rituximab (control)'}"
5811,"{'title': 'colon_adenoma_1187', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
5812,"{'title': 'vCRC4', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: colorectal cancer'}"
5813,"{'title': 'AML 2766', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 42 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5814,"{'title': 'AML 7301', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 35 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5815,"{'title': 'TBM4 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tmeningeal tuberculosis'}"
5816,"{'title': 'MCF-7_0.001%DMSO_rep3', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: DMSO treated'}"
5817,"{'title': 'MCF-7_Ferulic acid_1μM_rep3', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Ferulic acid treated'}"
5818,"{'title': 'RM08Na', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1408;\tdisease state: Asympt;\tgender: Male;\tage: 39;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 685;\tplasma hiv-1     rna level   (copies/ml): 20014;\ttissue: lymph node'}"
5819,"{'title': 'X41266', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IC;\tConsolidated.Grade : 1'}"
5820,"{'title': 'newly diagnosed multiple myeloma 133', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
5821,"{'title': 'Gastric GIST 23', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 71;\tTumor size: 11;\tKIT mutation: Exon 11'}"
5822,"{'title': 'Patient 4747 AML165', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 165;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
5823,"{'title': 'Insulin sensitive patient 14 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
5824,"{'title': 'Mature unstimulated biological replicate 1 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: none;\tcell line: BE(2)-C'}"
5825,"{'title': 'NSCLC EMC TB0033he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
5826,"{'title': 'Gingival tissue sample 2 from patient 31, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 31 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5827,"{'title': 'bladder_T2-4_pool-1', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, T2, T3 or T4 (high grade)', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 5 individual samples.'}"
5828,"{'title': 'HF0828_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
5829,"{'title': 'Patient 21, biopsy; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
5830,"{'title': 'cin_NY50', 'description': 'cirrhotic liver tissue from patients without HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue from patients without HCC', 'characteristics_ch1': 'cirrhotic liver tissue from patients without HCC'}"
5831,"{'title': 'S138', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S138', 'characteristics_ch1': 'patient id: P123;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
5832,"{'title': 'Gingival tissue sample 3 from patient 77, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 77 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
5833,"{'title': 'Thyroid_ unaffected_paired with PTC69T', 'description': 'sample name in manuscript: N-PTC6', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: normal thyroid; Gender:male; Age:56'}"
5834,"{'title': 'AML 2191', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 45 years;\tscore: FAB Mx;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Pos;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5835,"{'title': 'EntorhinalCortex_male_52yrs_indiv71', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 52 years', 'characteristics_ch1': 'individual: 71, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 52'}"
5836,"{'title': 'newly diagnosed multiple myeloma 284', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: II'}"
5837,"{'title': 've_M63B', 'description': 'very early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very early HCC', 'characteristics_ch1': 'very early HCC'}"
5838,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
5839,"{'title': 'cadmium_08hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'cadmium_08hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
5840,"{'title': 'Replicate 3 for MB231inhibitor72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 3 for MB231inhibitor72h breast cell line'}"
5841,"{'title': 'IPMA 6', 'description': 'Gene expression data from microdissected epithelial cells of IPMA', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMA 6', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous adenoma (IPMA)'}"
5842,"{'title': '3.1.NDV.6', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 6 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 6'}"
5843,"{'title': 'S027', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S027', 'characteristics_ch1': 'patient id: P097;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
5844,"{'title': 'GA_652', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5845,"{'title': 'CD19_selected_B-cells_before_FC_rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before FC (control)'}"
5846,"{'title': 'CLL_FISHnormal_rep7', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'male'}"
5847,"{'title': 'class S, rep53', 'description': 'VAN_00414.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 29;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: 143;\tlymphocyte percentage: 28;\twhite blood count: 6.4;\tinternational prognostic score (ips): 2.3'}"
5848,"{'title': 'CLL cells  PB  patient #13 replicate1', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #13'}"
5849,"{'title': 'ALL without MLL - sample 25', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5850,"{'title': 'X94084', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5851,"{'title': 'Subcutaneous adipose tissue, SAT22', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
5852,"{'title': 'No28LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No28;\tcell type: lymphocytes;\ttime point: under therapy'}"
5853,"{'title': 'blood-vehicle-control-3', 'description': 'Unstimulated control.;\t203-0-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, control', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: control'}"
5854,"{'title': 'N_CD8_5', 'description': 'NS5 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Negative Selection', 'characteristics_ch1': 'age: 44;\tgender: Male;\tt_cell_purity: 76%'}"
5855,"{'title': 'DM1_F55_D_04', 'description': 'DM1 patient, age 55, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM1 patient;\tbiopsy site: Deltoid'}"
5856,"{'title': 'N11196A5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5857,"{'title': 'class S, rep92', 'description': 'VAN_00561.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 22;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: 123;\tlymphocyte percentage: 10;\twhite blood count: 10.2;\tinternational prognostic score (ips): 2.3'}"
5858,"{'title': 'X523', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5859,"{'title': 'TK07Nb', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1407;\tdisease state: Asympt;\tgender: Male;\tage: 35;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 372;\tplasma hiv-1     rna level   (copies/ml): 31922;\ttissue: lymph node'}"
5860,"{'title': 'AML sample #76', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00457;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
5861,"{'title': 'No9pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No9 nonRVR;\ttime point: before therapy'}"
5862,"{'title': 'ALCL_AV_002', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5863,"{'title': 'AML with normal karyotype #186', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 30;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 75;\tdisease state: de novo AML'}"
5864,"{'title': 'B41', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.7'}"
5865,"{'title': 'Gingival tissue sample 2 from patient 94, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 94 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5866,"{'title': 'AML 2239', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 48 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
5867,"{'title': 'Lung Normal 91N', 'description': 'Gene expression data from 91N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 76;\tstage: n/a'}"
5868,"{'title': 'Sputum from Stage III Severe, biological replicate 24', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 69;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
5869,"{'title': 'newly diagnosed multiple myeloma 3', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
5870,"{'title': 'MDS patient 108', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
5871,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 12 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 12 hours'}"
5872,"{'title': 'NLPHL5', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'nodular lymphocte-predominant Hodgkin lymphoma case 5', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)'}"
5873,"{'title': 'B2-RR-Pat.4 [wf20070302u133v2_U_02_SC_B2_73]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
5874,"{'title': 'AML with MLL - sample 138', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5875,"{'title': 'Insulin sensitive patient 2 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
5876,"{'title': 'ALL without MLL - sample 2', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
5877,"{'title': 'MDS patient 65', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: other'}"
5878,"{'title': 'X60090', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5879,"{'title': 'DietResistant _1 day_subject7', 'description': 'DietResistant _1 day_subject7', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 7;\tgender: Male'}"
5880,"{'title': 'CD19_selected_B-cells_after_FC_rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
5881,"{'title': 'GA_2074', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
5882,"{'title': '10354', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 74;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 35;\tDonor Sex: F;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
5883,"{'title': '818119', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '10892_Tumor;\tfab: M4;\tSex: F;\trace: W;\tage on study: 40;\tcytogenetic change: ND;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
5884,"{'title': 'monocytes_Q10H2_1', 'description': '24h Q10H2 preincubation, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +Q10H2, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h Q10H2 preincubation, 4h LPS stimulation'}"
5885,"{'title': 'group-2-pt-t15111525', 'description': 'group-2-pt-t15111525', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 43;\tgender: male;\tfinal disposition: 06: Home'}"
5886,"{'title': 'AML with normal karyotype #82', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 77;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 40;\tdisease state: de novo AML'}"
5887,"{'title': 'X459', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5888,"{'title': 'MERLION_X02K02472', 'description': 'MERLION_X02K02472', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=63, state=0', 'characteristics_ch1': 'pT2N0, male, age=63, state=0'}"
5889,"{'title': 'Hyperplast03', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Hyperplastic polyp'}"
5890,"{'title': 'KT0322_6_L_test3', 'description': 'KT0322_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set3', 'characteristics_ch1': '6 months, living donor, test set3'}"
5891,"{'title': 'M11', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 77;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 9;\ttp53 mutation: 0;\tctnnb1 mutation: 236C>CG | S33S/C;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
5892,"{'title': 'MERLION_X02K00932', 'description': 'MERLION_X02K00932', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=54, state=1', 'characteristics_ch1': 'pT2N0, male, age=54, state=1'}"
5893,"{'title': 'Normal_colon_29_20April05', 'description': 'Normal_colon_29_20April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, transverse', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
5894,"{'title': 'PGA-Hs_V-1', 'description': 'Human subjects with viral cardiomyopathy;\tKeywords = viral cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
5895,"{'title': 'Septic Shock_biological rep78 12-0002A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.4;\toutcome: Survivor;\tgroup: A'}"
5896,"{'title': 'KT0703_24_L_test3', 'description': 'KT0703_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
5897,"{'title': 'Peripheral T-Cell lymphoma, unspecified 38', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-136', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 58;\tgender: female'}"
5898,"{'title': 'AML with normal karyotype #130', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 74;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 72.5;\tdisease state: de novo AML'}"
5899,"{'title': '09_0002_SepticShock_Day3_75', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '09_0002_Patient, Day3'}"
5900,"{'title': 'DLBCL biopsy, sample 2044', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
5901,"{'title': 'blood, Blood: control-1_e1_le1', 'description': 'no nicotine treatment;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
5902,"{'title': 'Gastric GIST 3', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 68;\tTumor size: 19;\tKIT mutation: Exon 11'}"
5903,"{'title': 'L2L3 mutant, repeat 1', 'description': 'HePG2 cells infected with adenovirus expressing the L2L3 mutant of PGC-1', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
5904,"{'title': 'Old sedentary subject, biological replicate (OS8)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old sedentary subject', 'characteristics_ch1': 'no additional information'}"
5905,"{'title': 'mucosa_adenoma_40 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: adenoma;\tsex: female'}"
5906,"{'title': 'Normal Control C-6a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Normal Control C-6a', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
5907,"{'title': 'COL2_715', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 69;\tgender: M;\tlocalisation: Left;\tmetastasis: LIVER;\tfirst apc mutation: 1309;\tsecond apc mutation: 0;\t5q loh: 0'}"
5908,"{'title': 'B-ALL-32-0h-rep2', 'description': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10).;\ttechnical replicate to sample B-ALL-32-0h-rep1', 'type': 'RNA', 'source_name_ch1': 'B-ALL patient 32, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10).;\ttechnical replicate to sample B-ALL-32-0h-rep1'}"
5909,"{'title': '5351', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 66 years, FAB M4, cytogenetic poor risk, CEBPA wild type'}"
5910,"{'title': 'AML 7408', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 55 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5911,"{'title': 'GBM, radiotherapy (242)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 242;\tage: 54.1;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 14.34;\tmgmt status: U'}"
5912,"{'title': 'Huh7 cells cultured for 12 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 12 hours'}"
5913,"{'title': 'conventional renal cell cancer; cRCCa_HD42', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
5914,"{'title': 'HF1185_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
5915,"{'title': '32009', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant ERBB2;\tGrade High;\tStage IA;\tMicropapillary feature Positive;\t(LMP) implants Negative;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
5916,"{'title': 'HIV+ Individual HIV-2a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-2a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
5917,"{'title': 'Tumor NP_2', 'description': '08SE388', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
5918,"{'title': 'Gingival tissue sample 1 from patient 8, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 8 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5919,"{'title': 'Monocyte High PBM 6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 6'}"
5920,"{'title': 'Lung Cancer 132T', 'description': 'Gene expression data from 132T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 47;\tstage: 1B'}"
5921,"{'title': 'csc: m2: i3: d03', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 2; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 2;\tReplicate: 3;\tBatch: d03'}"
5922,"{'title': 'PGA-Hs_H-3', 'description': 'Human subjects with hypertrophic cardiomyopathy;\tKeywords = hypertrophic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
5923,"{'title': 'ALCL_AV_005', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
5924,"{'title': 'wt PGC-1, repeat 3', 'description': 'HePG2 cells infected with adenovirus expressing wt PGC-1', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
5925,"{'title': 'adipose_preTZD_IRd_s5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 5'}"
5926,"{'title': 'EntorhinalCortex_male_69yrs_indiv8', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 69 years', 'characteristics_ch1': 'individual: 8, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 69'}"
5927,"{'title': 'X23170', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5928,"{'title': 'Sepsis gram-negative TN3', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
5929,"{'title': 'newly diagnosed multiple myeloma 229', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: II'}"
5930,"{'title': 'Gingival tissue sample 1 from patient 50, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 50 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5931,"{'title': 'T40656', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40656;\tsample: tumor'}"
5932,"{'title': 'CD19_selected_B-cells_after_FC_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
5933,"{'title': 'AML sample #7', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
5934,"{'title': 'Patient 4089 AML50', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 50;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
5935,"{'title': '269', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6320_Tumor;\tfab: M2;\tSex: M;\trace: W;\tage on study: 23;\tcytogenetic change: trisomy Y;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
5936,"{'title': 'MDS patient 31', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
5937,"{'title': 'No21inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No21 nonRVR;\ttime point: under therapy'}"
5938,"{'title': 'S063', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S063', 'characteristics_ch1': 'patient id: P041;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
5939,"{'title': 'AML sample #49', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
5940,"{'title': 'DM2_M68_D_05', 'description': 'DM2 patient, age 68, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Deltoid'}"
5941,"{'title': 'VCX control 5', 'description': 'arrayconsortium.tgen.org::biosample.435250;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 5;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 76 years'}"
5942,"{'title': 'Pt20 isolated pericardial adipocytes, biological rep1', 'description': 'Pt20_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 20', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 20'}"
5943,"{'title': 'Patient_13', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 13;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.513563386871329;\tproliferation index: -3.53748933998774'}"
5944,"{'title': 'IFNβ_890', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
5945,"{'title': 'Glioblastoma_9', 'description': 'bh20061208u133v2_A_09-GBM9_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 68;\tgender: male;\ttumor grade: IV'}"
5946,"{'title': 'Proficiency_Site11_33', 'description': 'Performed by Operator 3 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 46.88182; Lot# = 125PO54621A'}"
5947,"{'title': 'hES_BG03_rep2_090811_6', 'description': 'Gene expression data from hES line BG03', 'type': 'RNA', 'source_name_ch1': 'hES line BG03', 'characteristics_ch1': 'cell line: hES line BG03'}"
5948,"{'title': 'Sputum from Stage II Moderate, biological replicate 40', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 71;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
5949,"{'title': 'N8696B2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
5950,"{'title': 'S157', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S157', 'characteristics_ch1': 'patient id: P017;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
5951,"{'title': 'Tumor NP_1', 'description': '08SE380', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
5952,"{'title': '76-2', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 76 treated 786-O cells, replicate 2'}"
5953,"{'title': '92014', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade NA;\tStage IIIB;\tMicropapillary feature Negative;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
5954,"{'title': 'whole blood_100251', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism with regression, Male', 'characteristics_ch1': 'Autism with regression, Male'}"
5955,"{'title': 'adipose_postTZD_IRd_s37', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 37'}"
5956,"{'title': 'C99860', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6713_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 54;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
5957,"{'title': 'TK07b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 35;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 372;\tplasma hiv-1 rna levels (copies/ml): 31,922'}"
5958,"{'title': 'PNS001', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 6;\tdisease activity (das28_v3): NA;\tresponse to anti-tnf therapy: NA'}"
5959,"{'title': 'class F, rep32', 'description': 'VAN_00081f1.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 36;\tsex: M;\tdisease stage: 4;\talbumin level: _;\themoglobin level: 131;\tlymphocyte percentage: 11;\twhite blood count: 9.6;\tinternational prognostic score (ips): 3.5'}"
5960,"{'title': 'Human Hepatocytes_Control, Donor 3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 69; reason for liver resection: Colorectal liver metastasis'}"
5961,"{'title': 'Endometrium group B hCG not pregnant 1', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group B, not pregnant', 'characteristics_ch1': 'treatment: hCG;\ttissue: endometrium'}"
5962,"{'title': '3486', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 65 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type'}"
5963,"{'title': 'Cervical cancer-lymph node positive-30-26', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 37.4;\tfigo stage: 1b1'}"
5964,"{'title': 'Human lymphatic endothelial cells TNFalpha_Rep 3', 'description': 'Here we have addressed important question of inflammation-induced mechanism for leukocyte transmigration of lymphatic vessel endothelium by comparing global gene expression profile of normal dermal lymphatic endothelial cells with/without TNFa added to the culture.', 'type': 'RNA', 'source_name_ch1': 'Primary lymphatic endothelial cells, cultured in vitro with TNFalpha, derived from skin samples obtained from healthy human donors during elective surgery.', 'characteristics_ch1': 'Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).'}"
5965,"{'title': 'AML 7277', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 31 years;\tscore: FAB M4E;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5966,"{'title': 'Sputum from Stage III Severe, biological replicate 49', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 63;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
5967,"{'title': 'PBMCs_LB_after exercise_11', 'description': 'LB_Peak_012-GR', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 17;\tafter-exercise'}"
5968,"{'title': 'Angioimmunoblastic T-cell lymphoma 13', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-149', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 68;\tgender: female'}"
5969,"{'title': 'Healthy volunteer HV6', 'description': 'Healthy volunteer', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: Healthy volunteer;\ttherapy: none;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
5970,"{'title': 'Patient 4603 AML131', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 131;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5971,"{'title': 'Patient 4770 AML166', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 166;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
5972,"{'title': 'GBM, TMZ/radiotherapy (1430)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1430;\tage: 37.3;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 15.36;\tmgmt status: M'}"
5973,"{'title': 'MDS patient 183', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
5974,"{'title': 'MLP-B (Senescent)', 'description': 'Senescent cells expressing a vector control replicate 2', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing a vector control', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
5975,"{'title': 'newly diagnosed multiple myeloma 272', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: II'}"
5976,"{'title': 'X434', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
5977,"{'title': 'newly diagnosed multiple myeloma 288', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: II'}"
5978,"{'title': 'H439 Myclobutanil 100uM', 'description': 'H439 Myclobutanil 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H439 Myclobutanil 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
5979,"{'title': 'normal Post ECP, biological rep1', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Post ECP', 'characteristics_ch1': 'disease state: normal;\tdose: post ECP;\tperipheral blood: Leukapheresis'}"
5980,"{'title': 'Gingival tissue sample 1 from patient 45, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 45 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
5981,"{'title': '911-1', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 4.2'}"
5982,"{'title': 'Sample 14054', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: 14054;\ttissue: blood;\tage: 76;\tgender: Male;\trs7956957 genotype: CC'}"
5983,"{'title': 'Scz-19', 'description': 'ID# from Supplementary Table 3 of PMID 18778695: -', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: M;\tage: 41;\ttissue ph: 6.64;\tpmi (hrs): 52;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): NA'}"
5984,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_54_4)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 39;\tSex: M'}"
5985,"{'title': 'Normal Control C-8a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Normal Control C-8a', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
5986,"{'title': 'HRV-infected, asthmatic S18 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, asthmatic S18', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
5987,"{'title': 'CDcR7_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
5988,"{'title': '6456', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 77 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
5989,"{'title': 'EC control 9', 'description': 'arrayconsortium.tgen.org::biosample.433999;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 9;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 79 years'}"
5990,"{'title': 'group-2-pt-t31254381', 'description': 'group-2-pt-t31254381', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 29;\tgender: male;\tfinal disposition: 09: Death'}"
5991,"{'title': 'rhabdoid tumor of kidney; RhT_HD4', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
5992,"{'title': 'Activated CD4+ T-cells with anti-CD3, anti-CD28 and IL-12 and harvested after 8 hours incubation', 'description': 'Gene expression data from resting CD4+ T-cells.;\tCD4_T8', 'type': 'RNA', 'source_name_ch1': 'Normal CD4+ T-cell subset', 'characteristics_ch1': 'cell type: CD4+ T-cell'}"
5993,"{'title': 'not used-treatment interrupted [wf20071123u133v2_U_13_SZ13_Lc1_M_46yr_No_151]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
5994,"{'title': 'patient Post ECP, biological rep2', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'CTCL patient Post ECP', 'characteristics_ch1': 'disease state: cutaneous T cell lymphoma;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
5995,"{'title': 'AML 5283', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 35 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
5996,"{'title': 'X23172', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
5997,"{'title': 'muscle_preTZD_preClamp_IRd-_s39', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 39'}"
5998,"{'title': 'B1-RR-Pat.10 [wf20070130u133v2_U_09-B1-Pat.7-RS]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
5999,"{'title': 'PA224', 'description': 'PA224', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
6000,"{'title': 'AML sample #1', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
6001,"{'title': 'Tumor Tum_Ph2_rep8', 'description': 'Tumor paired  12', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N1;\thistology: cdi/cli;\tgrade: _;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
6002,"{'title': 'MDS patient 148', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: other'}"
6003,"{'title': 'Patient 26, biopsy; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
6004,"{'title': 'B70', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 3.1'}"
6005,"{'title': 'S067', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S067', 'characteristics_ch1': 'patient id: P043;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 35'}"
6006,"{'title': 'Cervical cancer-lymph node negative-13-43', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 71.0;\tfigo stage: 1b2'}"
6007,"{'title': 'AML sample #66', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
6008,"{'title': 'IFNβ_1014', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6009,"{'title': 'AML sample #36', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00131;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6010,"{'title': 'DLBCL biopsy, sample 2064', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
6011,"{'title': 'untreated: m1: i3: d08', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 1; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 1;\tReplicate: 3;\tBatch: d08'}"
6012,"{'title': '569053', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9845_Tumor;\tfab: M6;\tSex: M;\trace: W;\tage on study: 77;\tcytogenetic change: >3;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6013,"{'title': 'PCSC-1 parental biol repl 1', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-1 parental cultures in PCSCs medium', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-1;\tculture type: adherent'}"
6014,"{'title': 'Transfection Reagent Only Technical Replicate 1', 'description': 'transfection reagent only', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: Transfection Reagent;\tcell line: MCF7'}"
6015,"{'title': 'Peripheral T-Cell lymphoma, unspecified 1', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-15', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 77;\tgender: male'}"
6016,"{'title': 'MDS patient 179', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
6017,"{'title': 'SH-SY5Y(ATCC)_RA_6h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
6018,"{'title': 'cord blood 3_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.14', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.14;\t'}"
6019,"{'title': 'PGA_PA-S_386', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
6020,"{'title': 'AML 3481', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 46 years;\tscore: RAEB;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6021,"{'title': 'Septic Shock_biological rep10 01-0045A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 8.8;\toutcome: Survivor;\tgroup: B'}"
6022,"{'title': 'AML 2207', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 30 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: 11q23;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
6023,"{'title': 'newly diagnosed multiple myeloma 137', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: nd'}"
6024,"{'title': 'N8881D4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6025,"{'title': 'Patient 4710 AML141', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 141;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6026,"{'title': 'Patient_7170_relapse', 'description': '7170R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 18;\tconclusions ig/tcr: stable;\tselected: no'}"
6027,"{'title': 'mock-infected, normal S7 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, normal S7', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
6028,"{'title': 'FAKsiRNA, rep2', 'description': 'Gene expression data from FAKsiRNA', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7, FAKsiRNA', 'characteristics_ch1': 'FAKsiRNA#2'}"
6029,"{'title': '44196', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tmutant KRAS;\tGrade NA;\tStage IB;\tMicropapillary feature NA;\t(LMP) implants NA;\tAdjacent LMP;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6030,"{'title': 'UCNR2_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
6031,"{'title': 'U937_naive_curcumin_18h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, 1uM curcumin treated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
6032,"{'title': 'HUVEC_K13_ER_UT', 'description': '06_0396.CEL', 'type': 'RNA', 'source_name_ch1': 'Human Umbilical Vein Endothelial Cells', 'characteristics_ch1': 'cell type: Human Umbilical Vein Endothelial Cells;\tcell type: primary cells'}"
6033,"{'title': '22052', 'description': '11687', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24273;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
6034,"{'title': '60258', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6035,"{'title': 'platelet_sickle_6', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
6036,"{'title': 'Hippocampus_male_82yrs_indiv106', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 82 years', 'characteristics_ch1': 'individual: 106, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 82'}"
6037,"{'title': 'newly diagnosed multiple myeloma 253', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: II'}"
6038,"{'title': 'IFNβ_919', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6039,"{'title': 'IFNβ_884', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6040,"{'title': 'newly diagnosed multiple myeloma 89', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: nd'}"
6041,"{'title': 'Blood - Axial Spondyloarthropathy - 097A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Female;\tage: 51;\tset: 2;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
6042,"{'title': 'RTX8 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: F;\tage (y): 68;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
6043,"{'title': 'KT0812_0_D_training', 'description': 'KT0812_0_D_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, training', 'characteristics_ch1': 'baseline, deceased donor, training'}"
6044,"{'title': 'Septic Shock_biological rep41 02-0001', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 7.3;\toutcome: Survivor;\tgroup: B'}"
6045,"{'title': 'S039', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S039', 'characteristics_ch1': 'patient id: P110;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 22'}"
6046,"{'title': 'newly diagnosed multiple myeloma 146', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
6047,"{'title': '93C287', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7381_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 46;\tcytogenetic change: inv(16)(p13q22); +22;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6048,"{'title': 'H4_HC24h', 'description': 'gene expression data for H4 treated with HC for 24 h', 'type': 'RNA', 'source_name_ch1': 'human fetal small intestinal epithelial cell, HC 24h', 'characteristics_ch1': 'origin: fetal;\tcell line: H4;\ttreatment: hydrocortisone;\ttreatment: 24 h'}"
6049,"{'title': '2092 - mAdbID:66614', 'description': 'mAdb experiment ID: 66614', 'type': 'RNA', 'source_name_ch1': '2092', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 2092;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 1.27;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
6050,"{'title': 'adenocarcinoma_38 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 76;\tlocalization: transverse'}"
6051,"{'title': 'adipose_preTZD_IRd_s29', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 29'}"
6052,"{'title': 'UCNR13_afterT', 'description': 'Colonic mucosal gene expression data from UC non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
6053,"{'title': 'KT0738_0_L_test1', 'description': 'KT0738_0_L_test1', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, test set1', 'characteristics_ch1': 'baseline, living donor, testset1'}"
6054,"{'title': 'K_STA4', 'description': 'K_STA4', 'type': 'RNA', 'source_name_ch1': 'STA4 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
6055,"{'title': 'VT_Epidi_norm_50ans_corps', 'description': 'biological rep 2', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus,50 years-old, corpus segment', 'characteristics_ch1': 'Seminal vesicles'}"
6056,"{'title': 'PBMCs_EB_before exercise_03', 'description': 'EB_Pre_095-RB', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 10;\tbefore-exercise'}"
6057,"{'title': 'Patient 27, colonocytes; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'Control'}"
6058,"{'title': 'MERLION_X01K03697', 'description': 'MERLION_X01K03697', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=62, state=NA', 'characteristics_ch1': 'pT2N0, female, age=62, state=NA'}"
6059,"{'title': '156704', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7503_Tumor;\tfab: M4;\tSex: M;\trace: W;\tage on study: 49;\tcytogenetic change: inv(16)(p13q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6060,"{'title': 'class F, rep36', 'description': 'VAN_00258f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 71;\tsex: M;\tdisease stage: 4;\talbumin level: 16;\themoglobin level: 86;\tlymphocyte percentage: 2;\twhite blood count: 6.8;\tinternational prognostic score (ips): 7'}"
6061,"{'title': 'hES_WIBR3_rep2_090811_2', 'description': 'Gene expression data from hES line WIBR3', 'type': 'RNA', 'source_name_ch1': 'hES line WIBR3', 'characteristics_ch1': 'cell line: hES line WIBR3'}"
6062,"{'title': 'Cell line HB4a_R1', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
6063,"{'title': 'EntorhinalCortex_female_37yrs_indiv45', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 37 years', 'characteristics_ch1': 'individual: 45, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 37'}"
6064,"{'title': 'Cervical cancer-lymph node negative-01-01', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 56.4;\tfigo stage: 1b1'}"
6065,"{'title': 'S060', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S060', 'characteristics_ch1': 'patient id: P090;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
6066,"{'title': ""Wilms' FFPE D-1"", 'description': 'L746-A-HG-U133_Plus_2-01-1 (S07-1035N-FFPE)', 'type': 'RNA', 'source_name_ch1': 'Formalin-fixed paraffin-embedded tissue, kidney', 'characteristics_ch1': 'tissue: kidney;\tfixation: FFPE;\tblock age (at extraction in years): 0.5;\tbiological replicate: rep-1;\tdonor: C normal'}"
6067,"{'title': 'GBM, radiotherapy (345)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 345;\tage: 59.4;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 5.56;\tmgmt status: M'}"
6068,"{'title': 'NSG200', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 6.14;\tdisease activity (das28_v3): 2.15;\tresponse to anti-tnf therapy: RESPONSE'}"
6069,"{'title': 'normal Post ECP, biological rep5', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Post ECP', 'characteristics_ch1': 'disease state: normal;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
6070,"{'title': 'Patient 28, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
6071,"{'title': 'mucosa_distant_normal_colon_30 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: mucosa;\tmalignacy: distant normal colon;\tsex: female'}"
6072,"{'title': 'healthy breast 2, biological rep. 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'healthy', 'characteristics_ch1': 'tissue: breast;\tdisease state: healthy'}"
6073,"{'title': 'Thyroid_papillary carcinoma 26', 'description': 'sample name in manuscript: T-PTC3', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue:tumor; Gender: male; Age:43; Tumor stage:T2NxMx'}"
6074,"{'title': 'class F, rep3', 'description': 'NEB_9.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 34;\tsex: M;\tdisease stage: 1;\talbumin level: 44;\themoglobin level: 174;\tlymphocyte percentage: 34;\twhite blood count: 11.2;\tinternational prognostic score (ips): 2'}"
6075,"{'title': 'CD19_selected_B-cells_after_FC_rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after FC'}"
6076,"{'title': 'Donor3_6h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 3 treated with DMSO for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 3;\tagent: control;\ttime: 6h;\tgender: Female;\tage: 70 years old'}"
6077,"{'title': 'GBM, radiotherapy (566)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 566;\tage: 43.9;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 15.62;\tmgmt status: U'}"
6078,"{'title': 'N11209A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6079,"{'title': 'Cervical cancer-lymph node positive-36-50', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 42.3;\tfigo stage: 1b1'}"
6080,"{'title': 'KT1046_12_L_test2_test3', 'description': 'KT1046_12_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set2 and test set3', 'characteristics_ch1': '12 months, living donor, test set2 and test set3'}"
6081,"{'title': 'Control 31', 'description': '07SE522', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
6082,"{'title': 'B-ALL-32-0h-rep1', 'description': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10).', 'type': 'RNA', 'source_name_ch1': 'B-ALL patient 32, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10).'}"
6083,"{'title': 'HPB-ALL_DMSO_01', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'HPB-ALL cells treated with DMSO', 'characteristics_ch1': 'cell type: T-cell;\tcell line: HPB-ALL'}"
6084,"{'title': 'Bronchial epithelial cells, day 8, donor 2', 'description': 'Bronchial epithelial cells, day 8, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 8 of air-liquid interface culture'}"
6085,"{'title': '22095', 'description': '11857', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24328;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
6086,"{'title': 'non-malignant FTEb_patient 11', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 37;\tCycle: Follicular;\tBRCA1/2 mutation: BRCA1 185delAG;\tFamily History: Unknown'}"
6087,"{'title': 'class S, rep22', 'description': 'VAN_00160.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 21;\tsex: F;\tdisease stage: 2;\talbumin level: 40;\themoglobin level: 138;\tlymphocyte percentage: 23;\twhite blood count: 8.6;\tinternational prognostic score (ips): 1'}"
6088,"{'title': 'normal_colon_30 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 61;\tlocalization: sigmoid'}"
6089,"{'title': 'colon_IBD_1060', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
6090,"{'title': 'C023_Control_M_38', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 38;\tpost-mortem delay: 6h;\tph: 6.9'}"
6091,"{'title': 'AML with normal karyotype #159', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 61;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 76;\tdisease state: t-AML'}"
6092,"{'title': 'DLBCL biopsy, sample 2153', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
6093,"{'title': 'Liver_hyperglycima_no.3', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: type 2 diabetes'}"
6094,"{'title': 'MERLION_X03K05815', 'description': 'MERLION_X03K05815', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=75, state=0', 'characteristics_ch1': 'pT2N0, female, age=75, state=0'}"
6095,"{'title': 'Sputum from Stage II Moderate, biological replicate 2', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 57;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
6096,"{'title': 'NSCLC_AC_233', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 233.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
6097,"{'title': 'Muscle-FamilyHistoryPositive-18', 'description': 'Jos3728;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 60;\tfamily history: Family history positive - 2 parents;\tbody mass index (kg/m2): 32;\tfasting glucose (ogtt): 94.5;\t2 hour glucose (ogtt): 163;\themoglobin a1c: 5.7;\tfasting glucose (iv0gavg): 102;\tfasting insulin (iv0inavg): 16.7;\tsi: 0.91;\twaist hip ratio: 0.911'}"
6098,"{'title': 'C135', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.0'}"
6099,"{'title': 'DLBCL7', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 7', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
6100,"{'title': 'AML with normal karyotype #169', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 65;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 39;\tdisease state: de novo AML'}"
6101,"{'title': 'VT_Epidi_norm_47ans_corps', 'description': 'biological rep 2', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus,47 years-old, corpus segment', 'characteristics_ch1': 'Seminal vesicles'}"
6102,"{'title': '32117', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade Low;\tStage IIA;\tMicropapillary feature Negative;\t(LMP) implants Negative;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6103,"{'title': 'NB58 U133p2 (breast epithelial study)', 'description': 'RNA from bulk normal breast or normal breast organoid', 'type': 'RNA', 'source_name_ch1': 'NB58', 'characteristics_ch1': 'bulk normal breast or normal breast organoid'}"
6104,"{'title': 'B43', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.1'}"
6105,"{'title': 'MDS patient 182', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
6106,"{'title': 'control_B1, empty vector', 'description': 'None', 'type': 'RNA', 'source_name_ch1': 'Cervical carcinoma', 'characteristics_ch1': 'Age: 66 yrs Gender: Female  Ethnicity: Caucasian'}"
6107,"{'title': 'AML 3325', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 41 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6108,"{'title': 'N8615A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6109,"{'title': 'Tumor Tum_Ph3_rep2', 'description': 'Tumor paired  15', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T3;\tn: N0;\thistology: cli;\tgrade: _;\treceptor: NEG;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
6110,"{'title': 'c_NY103', 'description': 'normal liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; normal liver tissue', 'characteristics_ch1': 'normal liver tissue'}"
6111,"{'title': 'newly diagnosed multiple myeloma 285', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: II'}"
6112,"{'title': 'B96', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 73;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\tafp: 13;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
6113,"{'title': 'Patient_20', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 20;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.71937220865602;\tproliferation index: 10.2681090107626'}"
6114,"{'title': 'CDcR5_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
6115,"{'title': 'No20pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No20 nonRVR;\ttime point: before therapy'}"
6116,"{'title': 'Liver, biological replicate 1', 'description': 'Liver1', 'type': 'RNA', 'source_name_ch1': 'Liver', 'characteristics_ch1': 'tissue: liver;\tgender: female'}"
6117,"{'title': 'muscle_preTZD_preClamp_IRd+_s22', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 22'}"
6118,"{'title': 'CDcR6_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
6119,"{'title': 'N11792A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6120,"{'title': 'C140', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 3.0'}"
6121,"{'title': 'brain, unknown: R1C_e1_le1', 'description': 'rotenone 1 week C;\tTreatment, type=time_course, measurement=1.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
6122,"{'title': '40-1', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 40 treated 786-O cells, replicate 1'}"
6123,"{'title': 'carcinoma_97 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 56;\tlocalization: ascending'}"
6124,"{'title': 'N_M43_?_03', 'description': 'Normal Adult patient, age 43, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'Normal Adult patient;\tbiopsy site:  unknown'}"
6125,"{'title': 'Recurrent GBM, TMZ/radiotherapy (65R)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: recurrent GBM;\tpatient: 65;\tage: 46.5;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 13.22;\tmgmt status: M'}"
6126,"{'title': 'KS64a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 34;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 202;\tplasma hiv-1 rna levels (copies/ml): 122,000'}"
6127,"{'title': 'AML with normal karyotype #78', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 91;\tdisease state: S-AML'}"
6128,"{'title': 'Proficiency_Site11_27', 'description': 'Performed by Operator 2 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 61.25; Lot# = 125PO54621A'}"
6129,"{'title': 'PNS031', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.92;\tdisease activity (das28_v3): 4.54;\tresponse to anti-tnf therapy: MEDIUM'}"
6130,"{'title': 'S1-7', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 7; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 7; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 7;\tSmoking status: smoker;\tPack-years: 25;\tAge: 40;\tSex: F;\tEthnic group: black'}"
6131,"{'title': 'newly diagnosed multiple myeloma 64', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: III'}"
6132,"{'title': 'TNF II BEAS 2b_ML03', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - TNF-α', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
6133,"{'title': 'Sputum from Stage III Severe, biological replicate 25', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 68;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
6134,"{'title': 'Patient 4698 AML132', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 132;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6135,"{'title': 'Muscle control 7', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
6136,"{'title': 'HUVEC_Vector_UT', 'description': '06_0394.CEL', 'type': 'RNA', 'source_name_ch1': 'Human Umbilical Vein Endothelial Cells', 'characteristics_ch1': 'cell type: Human Umbilical Vein Endothelial Cells;\tcell type: primary cells'}"
6137,"{'title': 'AML with normal karyotype #151', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 41;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 85;\tdisease state: de novo AML'}"
6138,"{'title': 'B2', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 1.0'}"
6139,"{'title': 'Replicate 1 for MT3 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6140,"{'title': 'EPN_195, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_195, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
6141,"{'title': 'Pax_C5', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene;\tmolecule: total RNA'}"
6142,"{'title': 'FAKsiRNA, rep3', 'description': 'Gene expression data from FAKsiRNA', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7, FAKsiRNA', 'characteristics_ch1': 'FAKsiRNA#1'}"
6143,"{'title': 'Sputum from Stage II Moderate, biological replicate 46', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 69;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
6144,"{'title': 'UCR3_beforeT', 'description': 'Colonic mucosal gene expression data from UC responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
6145,"{'title': 'cHL6', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 6', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
6146,"{'title': 'Patient 5177 AML222', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 222;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
6147,"{'title': 'carcinoma_89 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 69;\tlocalization: transverse'}"
6148,"{'title': 'N11196A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6149,"{'title': 'ALL without MLL - sample 55', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
6150,"{'title': 'Clinically localized primary prostate cancer tissue pool PX1', 'description': 'clinically localized prostate cancer tissue pool extracted from sample P1, P2, P3, P4 and P5', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Primary, localized, pooled, prostate cancer'}"
6151,"{'title': 'MLD AML sample #26', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
6152,"{'title': 'MDA MB231 control cell pmig/pRS-IRES-GFP  rep1', 'description': 'gene expression data from MDA MB231 pmig/pRS-IRES-GFP', 'type': 'RNA', 'source_name_ch1': 'breast cancer cell line MDA MB231', 'characteristics_ch1': 'stable breast cancer cell line MDA MB231 with control vector'}"
6153,"{'title': 'COL2_200', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 70;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1309;\tsecond apc mutation: 0;\t5q loh: 1'}"
6154,"{'title': 'Lung Normal 6N', 'description': 'Gene expression data from 6N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 54;\tstage: n/a'}"
6155,"{'title': 'Sepsis gram-positive V4', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
6156,"{'title': 'PBMC_ectopic_validation_19', 'description': 'Blood collection: Samples collected by leukapheresis and stored in liquid nitrogen.;\tPBMC isolation:', 'type': 'RNA', 'source_name_ch1': 'PBMCs from patients with other cancer types (e.g., gastrointestinal and brain cancers)', 'characteristics_ch1': 'phenotype: Ectopic;\ttissue: peripheral blood leukocytes;\tdata set: validation'}"
6157,"{'title': '01-0044A_Septic Shock_day1_9', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6158,"{'title': '04-0008A_SIRS_day1_71', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6159,"{'title': 'Huh7 cells_JFH-1 Infected 18 hours_ rep3', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 18 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 18 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
6160,"{'title': 'Normal_colon_20_13April05', 'description': 'Normal_colon_20_13April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, sigmoid', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
6161,"{'title': 'Endometrium-prog B (01B03997)', 'description': '01B03997.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group B', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2-3;\tpregnancy status: non-pregnant;\tprogesterone serum level: group B (1-1.5 ng/ml)'}"
6162,"{'title': 'Patient_6309_relapse', 'description': '6309R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 32;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
6163,"{'title': 'KT0624_0_L_training', 'description': 'KT0624_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, trainingset'}"
6164,"{'title': 'mRNA of GBM-HGG014, Glioblastoma, 7 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 7 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 7 years'}"
6165,"{'title': 'Gingival tissue sample 1 from patient 68, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 68 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6166,"{'title': 'HF1186_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
6167,"{'title': 'AML without MLL - sample 94', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
6168,"{'title': 'papillary renal cell cancer; pRCCb_HA454b', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
6169,"{'title': 'adenocarcinoma_105 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 67;\tlocalization: rectum'}"
6170,"{'title': 'muscle_preTZD_preClamp_NRd_s14', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 14'}"
6171,"{'title': 'Lung Cancer 130T', 'description': 'Gene expression data from 130T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 51;\tstage: 2A'}"
6172,"{'title': 'Huh7 cells_Mock Infected 24 hours_ rep2', 'description': 'Gene expression data from Huh7 cells treated with mock media for 24 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 24 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
6173,"{'title': 'PGA-Hs_P-6', 'description': 'Human subjects with post-partum cardiomyopathy;\tKeywords = post-partum cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
6174,"{'title': 'EC control 4', 'description': 'arrayconsortium.tgen.org::biosample.433929;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 4;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 80 years'}"
6175,"{'title': 'neuron_rep4', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:39, gender:female, diagnostic group: control, PMI:58h'}"
6176,"{'title': 'Patient 4218 AML60', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 60;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6177,"{'title': 'AML with normal karyotype #188', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 48;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 88;\tdisease state: de novo AML'}"
6178,"{'title': 'Control 29', 'description': '07SE519', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
6179,"{'title': 'HUVEC_TNFa_1h30m', 'description': '1h30m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 1h30m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
6180,"{'title': 'colon_normal_1431', 'description': 'total RNA extracted from cells obtained using biopsy of the colon in a healthy control', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
6181,"{'title': 'Spleen_control_S4', 'description': 'Spleen control S4', 'type': 'RNA', 'source_name_ch1': 'normal spleen sample', 'characteristics_ch1': 'tissue: normal spleen'}"
6182,"{'title': 'AML 3310', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 55 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6183,"{'title': 'Fibroblast 3', 'description': 'Gene expression data obtained from fibroblasts', 'type': 'RNA', 'source_name_ch1': 'fibroblast', 'characteristics_ch1': 'cell line: Detroit 551 fetal skin fibroblast from ATCC'}"
6184,"{'title': 'Gingival tissue sample 4 from patient 35, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 35 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6185,"{'title': 'Huh7 cells_JFH-1 Infected 12 hours_ rep3', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 12 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 12 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
6186,"{'title': 'AML 2267', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 29 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6187,"{'title': 'control_04hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_04hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
6188,"{'title': 'mucosa_distant_normal_colon_39 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: mucosa;\tmalignacy: distant normal colon;\tsex: female'}"
6189,"{'title': 'newly diagnosed multiple myeloma 147', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
6190,"{'title': 'group-2-pt-t32937784', 'description': 'group-2-pt-t32937784', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 24;\tgender: female;\tfinal disposition: 06: Home'}"
6191,"{'title': 'mRNA of OT-HGG021, Anaplastic Oligodendroglioma, 22.7 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 22.7 years', 'characteristics_ch1': 'disease: Anaplastic Oligodendroglioma;\tage: 22.7 years'}"
6192,"{'title': 'N8689A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6193,"{'title': 'Glioblastoma_4', 'description': 'bh20061208u133v2_A_04-GBM4_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 44;\tgender: male;\ttumor grade: IV'}"
6194,"{'title': 'human BM MSC BMP2 stimulated day 3 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 3', 'type': 'RNA', 'source_name_ch1': 'donor 3, stimulated with BMP2 for 3 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 3 days'}"
6195,"{'title': 'NSCLC EMC 2381N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
6196,"{'title': 'mucosa_distant_normal_colon_28 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: mucosa;\tmalignacy: distant normal colon;\tsex: female'}"
6197,"{'title': 'KT1041_3_L_test3', 'description': 'KT1041_3_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set3', 'characteristics_ch1': '3 months, living donor, test set3'}"
6198,"{'title': 'AML 2210', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 37 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6199,"{'title': 'Patient 4431 AML94', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 94;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6200,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_3d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
6201,"{'title': 'AML 3320', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 51 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6202,"{'title': 'X20041', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 3'}"
6203,"{'title': 'HF0975_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
6204,"{'title': 'GPR54-suppressed Ishikawa treated with metastin-10, biological rep1', 'description': 'Gene expression data from Ishikawa cells that were introduced with GPR54 siRNA and treated with metastin-10.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells introduced with GPR54 siRNA and treated with metastin-10', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: GPR54-specific siRNA;\tpeptide treatment: metastin-10'}"
6205,"{'title': 'Muscle-FamilyHistoryPositive-19', 'description': 'Jos3730;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 25;\tfamily history: Family history positive - 2 parents;\tbody mass index (kg/m2): 22;\tfasting glucose (ogtt): 90;\t2 hour glucose (ogtt): 36;\themoglobin a1c: 4.6;\tfasting glucose (iv0gavg): 88;\tfasting insulin (iv0inavg): 8.6;\tsi: 4.02;\twaist hip ratio: 0.71'}"
6206,"{'title': 'monocytes_+LPS_1', 'description': '24h medium, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h medium, 4h LPS stimulation'}"
6207,"{'title': 'class S, rep42', 'description': 'VAN_00400.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 67;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: _;\tlymphocyte percentage: 100;\twhite blood count: _;\tinternational prognostic score (ips): 3.5'}"
6208,"{'title': 'BC12115', 'description': '200406.12.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 55;\tmolecular subtype: LuminalA;\thistology: MIX;\tpt: pT2;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: --;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: neg;\terbb2p ihc status: --;\tigf1r ihc status: pos;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: --;\tmfs: 0;\tmfsdel (month): 54.64'}"
6209,"{'title': 'N1-41', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
6210,"{'title': 'cadmium_04hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'cadmium_04hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
6211,"{'title': 'C181', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 7.0'}"
6212,"{'title': 'HepG2, biological replicate 1', 'description': 'HepG2_1', 'type': 'RNA', 'source_name_ch1': 'HepG2', 'characteristics_ch1': 'cell line: HepG2;\tgender: female'}"
6213,"{'title': 'C00391', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6701_Tumor;\tfab: M1;\tSex: F;\trace: C;\tage on study: 37;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
6214,"{'title': 'AML sample #69', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00395;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6215,"{'title': 'Control TC9', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
6216,"{'title': 'AML 2189', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 53 years;\tscore: FAB M4E;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6217,"{'title': 'EntorhinalCortex_male_80yrs_indiv15', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 80 years', 'characteristics_ch1': 'individual: 15, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 80'}"
6218,"{'title': 'Scz-24', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tL2', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - schizophrenia;\tSex: M;\tage: 65;\ttissue ph: 6.57;\tpmi (hrs): 41;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): 150 mg'}"
6219,"{'title': 'mesenchymal stem cells, lot#4F1127, 9th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F1127, passage number 9', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F1127, 9th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
6220,"{'title': 'KT0704_6_L_test3', 'description': 'KT0704_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set3', 'characteristics_ch1': '6 months, living donor, test set3'}"
6221,"{'title': 'MDS patient 34', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: other'}"
6222,"{'title': 'Peripheral T-Cell lymphoma, unspecified 22', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-78', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 56;\tgender: male'}"
6223,"{'title': 'No13LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No13;\tcell type: hepatocytes;\ttime point: before therapy'}"
6224,"{'title': 'Gingival tissue sample 1 from patient 20, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 20 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6225,"{'title': 'Patient 5151 AML204', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 204;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6226,"{'title': 'human macrophages treated with PG-fimbriae, biological rep2', 'description': 'Gene expression data from human macrophages treated with PG-fimbriae for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis-fimbriae', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: P. gingivalis fimbriae;\ttreatment time: 2 hours;\tday: 9'}"
6227,"{'title': 'Human Hepatocytes_Control, Donor_2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: female; age: 60; reason for liver resection: liver metastasis, mamma carcinoma'}"
6228,"{'title': 'Non-tolerant PBMCs_NoTOL_VHC_9', 'description': 'see M.Martinez-Llordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from non-tolerant liver transplant recipient with hepatitis C infection, under treatment with tacrolimus.'}"
6229,"{'title': 'T40875', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40875;\tsample: tumor'}"
6230,"{'title': 'Hippocampus_male_69yrs_indiv93', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 69 years', 'characteristics_ch1': 'individual: 93, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 69'}"
6231,"{'title': 'non-pCR breast biopsy, sample 1 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 1 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
6232,"{'title': 'NSG201', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 6.18;\tdisease activity (das28_v3): 6.06;\tresponse to anti-tnf therapy: NORESPONSE'}"
6233,"{'title': 'Sepsis gram-positive V5', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
6234,"{'title': 'B80', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 56;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\tafp: 7;\ttp53 mutation: 0;\tctnnb1 mutation: 271T>TG,p.S45S/A;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
6235,"{'title': 'D20_C', 'description': 'Gene expression data from cell line knocked-down for SDHB gene', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma cell line Hep3B cells, plasmid siSDHB, clone D20', 'characteristics_ch1': 'Hep3B cells stably transfected with short hairpin vectors containing an siRNA directed to SDHB;\tHep3B cells stably transfected with plasmid siSDHB, clone D20, replicate 3'}"
6236,"{'title': 'cord blood 22_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.7', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.7;\t'}"
6237,"{'title': 'Insulin resistant patient 8 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
6238,"{'title': 'MCF7 High dose treatment group', 'description': 'High dose treatment group', 'type': 'RNA', 'source_name_ch1': 'Ductal Breast Carcinoma Cell Line', 'characteristics_ch1': 'See publication for details'}"
6239,"{'title': 'Replicate 3 for MB231untreated breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 untreated cell line to compare to older profiled MB231 sample. See ATCC/DSMZ for cell line details.'}"
6240,"{'title': 'Clone A cells cultured for 24 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 24 hours'}"
6241,"{'title': 'Lean_1 day_subject11', 'description': 'Lean_1 day_subject11', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Lean;\ttime point: 1 day;\tsubject: 11;\tgender: Female'}"
6242,"{'title': 'NSCLC EMC SCC2321N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
6243,"{'title': 'CLL cells  PB  patient #14', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #14'}"
6244,"{'title': 'newly diagnosed multiple myeloma 4', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: nd'}"
6245,"{'title': 'MCF7', 'description': 'Gene expression data from MCF7', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7', 'characteristics_ch1': 'MCF7'}"
6246,"{'title': 'HF0377_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
6247,"{'title': 'LMP2082', 'description': 'low-malignant tumors of the ovary', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: low-malignant tumors of the ovary'}"
6248,"{'title': 'Patient_6892_relapse', 'description': '6892R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 34;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
6249,"{'title': 'class S, rep74', 'description': 'VAN_00494.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 80;\tsex: F;\tdisease stage: 1;\talbumin level: 43;\themoglobin level: 124;\tlymphocyte percentage: 18;\twhite blood count: 8.3;\tinternational prognostic score (ips): 2'}"
6250,"{'title': 'brain_endothelial_cells_rep2', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'endothelial cells from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 32'}"
6251,"{'title': 'IFNβ_2158', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6252,"{'title': '22062', 'description': '11697', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: N/A;\tGender: F;\tTSP_Patient# 24287;\tSmoking_Status: Not Available;\tPathology: Large cell Neuroendocrine carcinoma'}"
6253,"{'title': 'Pilocytic astrocytoma chip 7758', 'description': 'Pilocytic astrocytoma.  Chip ID 7758', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
6254,"{'title': 'Sepsis gram-positive TP3', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
6255,"{'title': 'AML without MLL - sample 102', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
6256,"{'title': 'group-2-pt-t20325754', 'description': 'group-2-pt-t20325754', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 21;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
6257,"{'title': 'cord blood 18', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.2', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.2;\t'}"
6258,"{'title': 'AML 6981', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 17 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: neg'}"
6259,"{'title': 'Donor1_24h_DMSO', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 1 treated with DMSO for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 1;\tagent: control;\ttime: 24h;\tgender: Male;\tage: 63 years old'}"
6260,"{'title': 'Patient 4728 AML150', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 150;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6261,"{'title': 'Blood sample from patient 121 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 121;\tday: Day 1;\tage (years): 62;\tsex: Male'}"
6262,"{'title': 'Clone A cells treated with 5uM CsA and cultured for 12 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 12 hours'}"
6263,"{'title': 'B51', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.2'}"
6264,"{'title': 'AML with normal karyotype #213', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 61;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 30;\tdisease state: S-AML'}"
6265,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R3', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 54.04;\t%cd3cd8: 40.46;\t%cd8+cd28-: 3.45;\t%cd8+cd28+: 20.71;\t%cd4cd25cd62l: 6.14;\t%cd3delta1: 0.8;\t%cd3delta2: 1.92;\tratio delta1/delta2: 0.42;\t%cd3gammadelta: 2.47;\t%cd3alphabeta: 96.76;\t%cd4cd8-ab+(dn): 4.15;\t%cd4 cd62l+cd45+: 37.23;\t%cd4 cd62l-cd45+: 0.10;\t%cd4 cd62l - cd45-: 10.68;\t%cd4cd62l+cd45-: 51.99;\t%cd4 ccr7+ cd45 -: 17.26;\t%cd4 ccr7+ cd45+: 34.52;\t%cd4 ccr7 - cd45+: 4.85;\t%cd4 ccr7 – cd45-: 43.37;\t%cd8 cd62l+ cd45-: 38.29;\t%cd8cd62l+ cd45+: 42.79;\t%cd8cd62l- cd45+: 2.05;\t%cd8cd62l- cd45 -: 16.13;\t%cd8ccr7+ cd45-: 2.56;\t%cd8ccr7+ cd45+: 36.78;\t%cd8ccr7-cd45+: 6.70;\t%cd8ccr7-cd45 -: 53.96;\t%cd3-cd56+cd16+: 29.99;\t%nkts: 15.25;\t%cd19: 8.62;\t%cd4foxp3+: 14.59'}"
6266,"{'title': 'class S, rep77', 'description': 'VAN_00502.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 46;\tsex: M;\tdisease stage: 1;\talbumin level: 41;\themoglobin level: 167;\tlymphocyte percentage: 18;\twhite blood count: 10.8;\tinternational prognostic score (ips): 3'}"
6267,"{'title': 'class S, rep26', 'description': 'VAN_00165.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 16;\tsex: F;\tdisease stage: 4;\talbumin level: 23;\themoglobin level: 77;\tlymphocyte percentage: 18;\twhite blood count: 9.7;\tinternational prognostic score (ips): 4'}"
6268,"{'title': 'shRB-A (Senescent)', 'description': 'Senescent cells expressing shRNA targeting RB replicate 1', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing shRNA targeting RB', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
6269,"{'title': '15_0007_SepticShock_Day3_14', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '15_0007_Patient, Day3'}"
6270,"{'title': 'newly diagnosed multiple myeloma 149', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
6271,"{'title': 'Human Hepatocytes_Control, Donor_3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: female; age: 43; reason for liver resection: liver adenoma'}"
6272,"{'title': 'Normal_reactive_lymph_node_pool', 'description': 'Reference sample, pool of 5 lymph nodes with follicular hyperplasia', 'type': 'RNA', 'source_name_ch1': 'Reference sample, pool of 5 lymph nodes with follicular hyperplasia', 'characteristics_ch1': 'Tissue: lymph node with follicular hyperplasia, nr of pooled samples: 5'}"
6273,"{'title': 'IFNβ_1116', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6274,"{'title': 'group-2-pt-t22528008', 'description': 'group-2-pt-t22528008', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 40;\tgender: female;\tfinal disposition: 06: Home'}"
6275,"{'title': 'N8380A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6276,"{'title': 'AML sample #2', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
6277,"{'title': 'IFNβ_829', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
6278,"{'title': 'Small intestinal GIST 2', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human small intestinal GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 68;\tTumor size: 4;\tKIT mutation: Exon 9'}"
6279,"{'title': 'Blood_TD51282_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
6280,"{'title': 'N51677', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51677;\tsample: normal'}"
6281,"{'title': 'Gingival tissue sample 2 from patient 65, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 65 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6282,"{'title': 'NSG412', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 6.2;\tdisease activity (das28_v3): 5.69;\tresponse to anti-tnf therapy: NORESPONSE'}"
6283,"{'title': 'Patient 4554 AML123', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 123;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6284,"{'title': 'newly diagnosed multiple myeloma 2', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
6285,"{'title': 'Gingival tissue sample 2 from patient 3, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 3 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6286,"{'title': 'Blood - Control - 090A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 49;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
6287,"{'title': 'Spleen_control_MIX', 'description': 'Spleen control (MIX)', 'type': 'RNA', 'source_name_ch1': 'mix of normal spleen samples', 'characteristics_ch1': 'tissue: multiple normal spleens'}"
6288,"{'title': 'S024_Scz_M_75', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 75;\tpost-mortem delay: 9h;\tph: 6.3'}"
6289,"{'title': 'AML with normal karyotype #203', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 52;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
6290,"{'title': 'PCB77 treated HepG2 cells at T24, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines after 24 hours of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 24 hours of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
6291,"{'title': 'AML 5284', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 41 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6292,"{'title': 'Gingival tissue sample 1 from patient 77, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 77 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6293,"{'title': 'T+S I BEAS2b_ML06C', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - mechanical stretch plus TNF-α', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
6294,"{'title': 'AML sample #82', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00576;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6295,"{'title': 'Treatment-3, cells cultured in DMEM plus 5 mM HisOH', 'description': 'none;\tnone', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
6296,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_60_4)', 'description': 'Gene expression data from whole blood 7 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 71;\tSex: M'}"
6297,"{'title': 'Subcutaneous adipose tissue, SAT3', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
6298,"{'title': 'THP-1 +SS2, biological rep2', 'description': 'Gene expression data from THP-1 cells after incubated with Streptcoccus suis 2 strain SC19 for 3 hours', 'type': 'RNA', 'source_name_ch1': 'THP-1 cells infected Streptcoccus suis 2 strain SC19,3 hours', 'characteristics_ch1': 'cell type: monocyte;\tcell line: THP-1;\tgrowth properties: suspension;\tinfected with bacterial strain: Streptcoccus suis 2 strain SC19'}"
6299,"{'title': 'MLD AML sample #5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
6300,"{'title': 'newly diagnosed multiple myeloma 51', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: None;\tiss: I'}"
6301,"{'title': 'Patient_5818_diagnosis', 'description': '5818D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 5;\tconclusions ig/tcr: stable;\tselected: yes'}"
6302,"{'title': 'AML 7063', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 48 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6303,"{'title': 'class F, rep13', 'description': 'NEB_20.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 23;\tsex: M;\tdisease stage: 2;\talbumin level: 34;\themoglobin level: 138;\tlymphocyte percentage: 12;\twhite blood count: 8.2;\tinternational prognostic score (ips): 3'}"
6304,"{'title': 'KS640c', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1464;\tdisease state: Asympt;\tgender: Male;\tage: 34;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 202;\tplasma hiv-1     rna level   (copies/ml): 122000;\ttissue: lymph node'}"
6305,"{'title': 'N8456B2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6306,"{'title': 'ALL without MLL - sample 13', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
6307,"{'title': 'MCF-7_Ferulic acid_1μM_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Ferulic acid treated'}"
6308,"{'title': 'AML 5364', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 60 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
6309,"{'title': 'Gingival tissue sample 1 from patient 3, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 3 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6310,"{'title': 'Stretch II BEAS 2b_ML04', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - mechanical stretch', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
6311,"{'title': 'Human Hepatocytes_Doxorubicin, Donor 4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 76; reason for liver resection: Hepatocellular carcinoma'}"
6312,"{'title': 'Huh7 cells cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
6313,"{'title': 'ST-treated_6h replicate 3', 'description': ""Performed by UTMB microarray core per manufacturer's instructions"", 'type': 'RNA', 'source_name_ch1': 'THP-1 cells', 'characteristics_ch1': 'cell type: Human myelogenous leukemia (macrophage-like) cells;\tcell line: THP-1'}"
6314,"{'title': 'Control-19', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc11', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 43;\ttissue ph: 6.25;\tpmi (hrs): 45;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
6315,"{'title': 'Germinal Center Centroblasts, sample 4', 'description': 'CD77-positive B-cells from human tonsil, purified by magnetic cell separation.;\tGene expression data from purified germinal center centroblasts', 'type': 'RNA', 'source_name_ch1': 'Germinal Center Centroblasts from human tonsil', 'characteristics_ch1': 'cell type: CD77-positive B-cells from human tonsil'}"
6316,"{'title': 'Normal breast (B64)', 'description': 'no additional info;\tnone', 'type': 'RNA', 'source_name_ch1': 'B64', 'characteristics_ch1': 'NB'}"
6317,"{'title': 'X440', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
6318,"{'title': '15_0005C_Day1_43', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Female'}"
6319,"{'title': 'Filtered air exposure 3 -baseline', 'description': 'Gene expression data from circulating mononuclear cells before exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells before exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: FA;\ttime: 0 hour'}"
6320,"{'title': 'Sepsis mixed infection V13', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
6321,"{'title': 'group-2-pt-t4508690', 'description': 'group-2-pt-t4508690', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 41;\tgender: female;\tfinal disposition: control'}"
6322,"{'title': 'AML 2291', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 49 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6323,"{'title': 'Muscle-FamilyHistoryPositive-5', 'description': 'Jos3700;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 26;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 26;\tfasting glucose (ogtt): 86.5;\t2 hour glucose (ogtt): 169;\themoglobin a1c: 5;\tfasting glucose (iv0gavg): 92;\tfasting insulin (iv0inavg): 2.1;\tsi: 4.5;\twaist hip ratio: 0.755'}"
6324,"{'title': 'high grade serous carcinoma_patient 5', 'description': 'Gene expression profile of high grade serous carcinoma of fallopian tube', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected high grade serous carcinoma', 'characteristics_ch1': 'Age: 57;\tCycle: NA;\tBRCA1/2 mutation: Unknown;\tFamily History: Yes'}"
6325,"{'title': 'AML with normal karyotype #127', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 67;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 61;\tdisease state: de novo AML'}"
6326,"{'title': 'Germinal Center Centrocytes, sample 5', 'description': 'CD10-positive CD77-negative B-cells purified by magnetic cell separation.;\tGene expression data from purified germinal center centrocytes', 'type': 'RNA', 'source_name_ch1': 'Germinal Center Centrocytes from human tonsil', 'characteristics_ch1': 'cell type: CD10-positive cell type: CD77-negative B-cells purified by magnetic cell separation.'}"
6327,"{'title': 'AML with normal karyotype #230', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 45;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 69;\tdisease state: de novo AML'}"
6328,"{'title': 'HF0966_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 3'}"
6329,"{'title': 'X22029', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
6330,"{'title': 'cord blood 28_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 4.11', 'characteristics_ch1': 'Cord blood arsenic exposure level 4.11;\t'}"
6331,"{'title': 'Proficiency_Site5_17', 'description': 'Performed by Operator 1 from Site5 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 48.99; Lot# = 035PO41658D'}"
6332,"{'title': 'non-malignant FTEn_patient 8', 'description': 'Gene expression profile of non-malignant FTE from control patient during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 42;\tCycle: Follicular;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
6333,"{'title': 'DM1_M21_?_10', 'description': 'DM1 patient, age 21, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM1 patient;\tbiopsy site:  unknown'}"
6334,"{'title': 'Subject 4, Family 2, Affected', 'description': 'microarray hybridization data 07/10/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Male;\tfamily: 2;\tage: 30;\tdisease status: Affected;\ttissue: Muscle: Deltoid'}"
6335,"{'title': 'Endometrium group A rFSH not pregnant 5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group A, not pregnant', 'characteristics_ch1': 'treatment: rFSH;\ttissue: endometrium'}"
6336,"{'title': 'AML with normal karyotype #60', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 58;\tdisease state: de novo AML'}"
6337,"{'title': 'MLD AML sample #37', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-wild type;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
6338,"{'title': 'NSCLC_AC_169', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 169.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
6339,"{'title': 'VCX control 3', 'description': 'arrayconsortium.tgen.org::biosample.435222;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 3;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 63 years'}"
6340,"{'title': 'mesenchymal stem cells, lot#4F0760, 9th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0760, passage number 9', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0760, 9th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
6341,"{'title': '933124', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7502_Tumor;\tfab: M1;\tSex: F;\trace: W;\tage on study: 57;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
6342,"{'title': 'MLD AML sample #48', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-wild type;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
6343,"{'title': 'Gingival tissue sample 3 from patient 14, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 14 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6344,"{'title': 'Angioimmunoblastic T-cell lymphoma 17', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-27', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 75;\tgender: female'}"
6345,"{'title': 'GA_901', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6346,"{'title': 'group-2-pt-t28856947', 'description': 'group-2-pt-t28856947', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 17;\tgender: male;\tfinal disposition: 05: Home with services'}"
6347,"{'title': 'HF1407_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
6348,"{'title': 'MLD AML sample #12', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
6349,"{'title': 'Pt14 whole subcutaneous adipose tissue, biological rep1', 'description': 'Pt14_SQAT', 'type': 'RNA', 'source_name_ch1': 'Whole subcutaneous adipose tissue, patient 14', 'characteristics_ch1': 'tissue: whole subcutaneous adipose tissue;\tpatient: 14'}"
6350,"{'title': 'AML 6720', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 38 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: neg'}"
6351,"{'title': 'Gingival tissue sample 2 from patient 11, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 11 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6352,"{'title': 'X20019', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 3'}"
6353,"{'title': 'KT0474_12_L_test2', 'description': 'KT0474_12_L_test2', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set2', 'characteristics_ch1': '12 months, living donor, test set2'}"
6354,"{'title': 'Insulin sensitive patient 12 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
6355,"{'title': 'T117 U133p2', 'description': 'bulk breast tumor RNA from patient T117', 'type': 'RNA', 'source_name_ch1': 'T117', 'characteristics_ch1': 'breast tumor'}"
6356,"{'title': 'PGA-Hs_V-5', 'description': 'Human subjects with viral cardiomyopathy;\tKeywords = viral cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
6357,"{'title': 'Tumor Tum_Ph3_rep3', 'description': 'Tumor paired  13', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T3;\tn: N3;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
6358,"{'title': 'Blood - Axial Spondyloarthropathy - 069A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 58;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
6359,"{'title': 'HC7', 'description': 'Gene expression data from Healthy Control 7', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 7', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
6360,"{'title': 'AML 2215', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 31 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6361,"{'title': 'E161K heart, technical replicate B Mas5', 'description': 'Gene expression data from left ventricle of human heart with E161K LMNA mutation', 'type': 'RNA', 'source_name_ch1': 'left ventricle patient with E161K LMNA mutation', 'characteristics_ch1': 'gender: male;\tdevelopmental stage: adult;\torgan: heart;\ttissue: left ventricle;\tgenotype: LMNA E161K;\tdata analysis algorithm: Mas5'}"
6362,"{'title': 'AML 2222', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
6363,"{'title': 'Liver365T (mRNA expression)', 'description': 'liver cancer HCV+', 'type': 'RNA', 'source_name_ch1': 'liver cancer tissue', 'characteristics_ch1': 'case number: 365T;\ttissue: liver cancer tissue;\tdisease state: cancer;\tpathology: moderately differentiated;\tgender: F;\tage: 71;\tvirus: HCV'}"
6364,"{'title': 'X23182', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 2'}"
6365,"{'title': 'CRCCD03', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CRC-CD'}"
6366,"{'title': 'PCSC-3 sphere biol repl 1', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-3 spheres 7 days in SCM-1% KO', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-3;\tculture type: sphere'}"
6367,"{'title': 'C99483', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6705_Tumor;\tfab: M2;\tSex: F;\trace: C;\tage on study: 28;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
6368,"{'title': '14-0002A_Septic Shock_day1_195', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6369,"{'title': 'newly diagnosed multiple myeloma 107', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
6370,"{'title': 'Patient 3442 AML27', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 27;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6371,"{'title': '44262', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade NA;\tStage IC;\tMicropapillary feature Positive;\t(LMP) implants NA;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6372,"{'title': 'GA_671', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
6373,"{'title': 'Septic Shock_biological rep4 01-0021', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.9;\toutcome: Survivor;\tgroup: B'}"
6374,"{'title': 'endothelial_rep9', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:19, gender:male, diagnostic group: schizophrenia, PMI:28h'}"
6375,"{'title': 'T11478C1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
6376,"{'title': 'PBMCs vehicle treated for 2 hours,replicate 1', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 2 hours,replicate 1', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
6377,"{'title': 'Sepsis V35', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis'}"
6378,"{'title': '412761', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9839_Tumor;\tfab: M5;\tSex: M;\trace: W;\tage on study: 48;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
6379,"{'title': 'KT1007_24_L_test3', 'description': 'KT1007_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
6380,"{'title': 'class S, rep6', 'description': 'NEB_1068.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 59;\tsex: F;\tdisease stage: 2;\talbumin level: 35;\themoglobin level: 110;\tlymphocyte percentage: 7;\twhite blood count: 6.5;\tinternational prognostic score (ips): 2'}"
6381,"{'title': 'Tumor 38', 'description': '07SE533', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
6382,"{'title': 'MH580b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1458;\tdisease state: Acute;\tgender: Male;\tage: 51;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 400;\tplasma hiv-1     rna level   (copies/ml): 439000;\ttissue: lymph node'}"
6383,"{'title': 'X558', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
6384,"{'title': 'NSCLC_AC_271', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 271.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
6385,"{'title': 'Lung-sarcoidosis-rep5', 'description': 'frozen sarcoidosis lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen sarcoidosis lung tissue', 'characteristics_ch1': 'disease state: sarcoidosis;\tbiopsy type: surgical;\ttissue: lung'}"
6386,"{'title': 'AML 2220', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 48 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6387,"{'title': 'newly diagnosed multiple myeloma 144', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
6388,"{'title': 'Lean_1 day_subject16', 'description': 'Lean_1 day_subject16', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Lean;\ttime point: 1 day;\tsubject: 16;\tgender: Female'}"
6389,"{'title': 'AML sample #106', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
6390,"{'title': 'AML with normal karyotype #179', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 39;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 67;\tdisease state: de novo AML'}"
6391,"{'title': 'UCNR14_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
6392,"{'title': ""HUVECs  treated with 4 µg/ml vWF in Hank's buffered salt solution for 4 hours rep 3"", 'description': 'HUVECs activated with vWF', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells  treated with vWF in HBSS', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
6393,"{'title': 'MDS patient 163', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
6394,"{'title': 'Angioimmunoblastic T-cell lymphoma 34', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-94', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 53;\tgender: male'}"
6395,"{'title': 'adenocarcinoma_72 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 48;\tlocalization: rectum'}"
6396,"{'title': 'DietResistant _1 day_subject5', 'description': 'DietResistant _1 day_subject5', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 5;\tgender: Female'}"
6397,"{'title': '26-260611_Septic Shock_day1_222', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6398,"{'title': 'Control-23', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tLc1', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - control;\tSex: M;\tage: 57;\ttissue ph: 6.43;\tpmi (hrs): 27;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
6399,"{'title': 'Blood sample from patient 179 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 179;\tday: Day 1;\tage (years): 58;\tsex: Female'}"
6400,"{'title': 'N2-49', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
6401,"{'title': 'Patient 3494 AML41', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 41;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6402,"{'title': 'patient Pre ECP, biological rep1', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'CTCL patient Pre ECP', 'characteristics_ch1': 'disease state: cutaneous T cell lymphoma;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
6403,"{'title': 'carcinoma_24 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 59;\tlocalization: rectum'}"
6404,"{'title': 'Replicate 1 for EFM192A breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6405,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_77_04)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 41;\tSex: M'}"
6406,"{'title': 'AML 7411', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6407,"{'title': 'Sputum from Stage IV Severe, biological replicate 5', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 64;\tgender: F;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
6408,"{'title': 'carcinoma_87 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 58;\tlocalization: transverse'}"
6409,"{'title': '01_0019_SepticShock_Day3_121', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0019_Patient, Day3'}"
6410,"{'title': 'T51677', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51677;\tsample: tumor'}"
6411,"{'title': 'Sputum from Stage II Moderate, biological replicate 15', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 61;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
6412,"{'title': 'PGA_PA-S_281', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
6413,"{'title': 'MLD AML sample #16', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
6414,"{'title': 'Muscle-FamilyHistoryNegative-6', 'description': 'Jos3670;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 23;\tfamily history: Family history negative;\tbody mass index (kg/m2): 25;\tfasting glucose (ogtt): 77;\t2 hour glucose (ogtt): 90;\themoglobin a1c: 4.3;\tfasting glucose (iv0gavg): 91;\tfasting insulin (iv0inavg): 8;\tsi: 6.53;\twaist hip ratio: 0.833'}"
6415,"{'title': 'PA102', 'description': 'PA102', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: extended;\tcell type: Synovial fluid mononuclear cells'}"
6416,"{'title': 'B2-Non-RR-16 [wf20070130u133v2_U_02-B2-Pat.5-CE]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
6417,"{'title': 'Sputum from Stage III Severe, biological replicate 18', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 55;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
6418,"{'title': 'Patient 5150 AML203', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 203;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6419,"{'title': 'Blood - Axial Spondyloarthropathy - 074A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 61;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
6420,"{'title': 'HIP control 5', 'description': 'arrayconsortium.tgen.org::biosample.434561;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 5;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 63 years'}"
6421,"{'title': 'PBMCs vehicle treated for 2 hours,replicate 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 2 hours,replicate 2', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
6422,"{'title': 'No16pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No16RVR;\ttime point: before therapy'}"
6423,"{'title': 'X44110', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : 2'}"
6424,"{'title': 'Pt12 isolated pericardial adipocytes, biological rep1', 'description': 'Pt12_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 12', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 12'}"
6425,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for48 hours rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
6426,"{'title': 'S153', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S153', 'characteristics_ch1': 'patient id: P018;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
6427,"{'title': 'NSCLC EMC SCC2299N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
6428,"{'title': 'a_NY36', 'description': 'advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; advanced HCC', 'characteristics_ch1': 'advanced HCC'}"
6429,"{'title': 'T cell donor 1, control', 'description': 'Cells treated with DMSO vehicle control', 'type': 'RNA', 'source_name_ch1': 'MACS purified T cells from healthy donor peripheral blood', 'characteristics_ch1': 'T cell donor 1, control'}"
6430,"{'title': 'Recurrent GBM, TMZ/radiotherapy (1795R)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: recurrent GBM;\tpatient: 1795;\tage: 43.4;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 72.04;\tmgmt status: M'}"
6431,"{'title': 'normal_colon_68 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: male;\tprotocol: surgery;\tage: 78;\tlocalization: rectum'}"
6432,"{'title': 'PBMC-1-RR-Pat.4 [wf20070302u133v2_U_03_SC_LC1_73]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
6433,"{'title': 'NB42 U133p2', 'description': 'RNA from bulk normal breast or normal bresat organoid', 'type': 'RNA', 'source_name_ch1': 'NB42', 'characteristics_ch1': 'bulk normal breast or normal bresat organoid'}"
6434,"{'title': 'S033', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S033', 'characteristics_ch1': 'patient id: P087;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 85'}"
6435,"{'title': 'HF0471_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
6436,"{'title': 'CDcR5_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
6437,"{'title': 'Patient 4875 AML169', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 169;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6438,"{'title': '11-0054A_Septic Shock_day1_182', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6439,"{'title': 'AML sample #6', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
6440,"{'title': 'MDS patient 173', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
6441,"{'title': 'N11580C4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6442,"{'title': 'AML 1316', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 19 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
6443,"{'title': 'AML with normal karyotype #148', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 74;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 85.5;\tdisease state: de novo AML'}"
6444,"{'title': '08SE858HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
6445,"{'title': '3.1.NDV.16', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 16 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 16'}"
6446,"{'title': '826984', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6337_Tumor;\tfab: M4;\tSex: F;\trace: W;\tage on study: 51;\tcytogenetic change: -Xt(5;21)(q31;q22); t(1;6)(q21;p23);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6447,"{'title': 'AML 6976', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 31 years;\tscore: FAB M0;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6448,"{'title': 'N2-39', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
6449,"{'title': 'newly diagnosed multiple myeloma 280', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
6450,"{'title': 'WU59a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 36;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 286;\tplasma hiv-1 rna levels (copies/ml): 100,000'}"
6451,"{'title': 'PA207', 'description': 'PA207', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: extended;\tcell type: Synovial fluid mononuclear cells'}"
6452,"{'title': 'Control TC5', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
6453,"{'title': 'newly diagnosed multiple myeloma 28', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: II'}"
6454,"{'title': 'Control TC2', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
6455,"{'title': 'Primary hepatocyte, biological replicate 3', 'description': 'PH_3', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocyte', 'characteristics_ch1': 'cell type: primary hepatocyte;\tgender: female'}"
6456,"{'title': 'Training_Site1_03', 'description': 'Performed by Operator 1 from Site1 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 11.46; Lot# = 035PO41658D'}"
6457,"{'title': 'S154', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S154', 'characteristics_ch1': 'patient id: P015;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
6458,"{'title': 'Sputum from Stage III Severe, biological replicate 52', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 69;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
6459,"{'title': 'Patient 4744 AML163', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 163;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6460,"{'title': 'Muscle-FamilyHistoryPositive-6', 'description': 'Jos3702;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 25;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 39;\tfasting glucose (ogtt): 100.5;\t2 hour glucose (ogtt): 149;\themoglobin a1c: 5.7;\tfasting glucose (iv0gavg): 93;\tfasting insulin (iv0inavg): 22;\tsi: 1.06;\twaist hip ratio: 0.957'}"
6461,"{'title': 'KT0555_24_D_test2_test3', 'description': 'KT0555_24_D_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, deceased donor, test set2 and test set3', 'characteristics_ch1': '24 months, deceased donor, test set2 and test set3'}"
6462,"{'title': 'Adenocarcinoma, bone marrow positive AC 27', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'female pulmonary adenocarcinoma;\tbone marrow positive'}"
6463,"{'title': 'Replicate 3 for MB231inhibitor breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 mir-221/222 inhibitor at 18h'}"
6464,"{'title': 'Blood_TD19901_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
6465,"{'title': 'MERLION_X01K02786', 'description': 'MERLION_X01K02786', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=81, state=0', 'characteristics_ch1': 'pT2N0, male, age=81, state=0'}"
6466,"{'title': 'Blood Sample of subject 36 after inhalation; Group B: inhalation with 0.7 ppm FA 24 h before sampling', 'description': 'Bl_Group_B_AI_subject_36', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 24 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 24 h;\tsubject: 36;\tgroup: B'}"
6467,"{'title': 'COL2_363', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 46;\tgender: M;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1355;\tsecond apc mutation: 1399;\t5q loh: 0'}"
6468,"{'title': 'endothelial_rep14', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human endothelial cells isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: endothelial, age:47, gender:male, diagnostic group: control, PMI:11h'}"
6469,"{'title': 'NSG405', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.33;\tdisease activity (das28_v3): 2.99;\tresponse to anti-tnf therapy: RESPONSE'}"
6470,"{'title': 'T40741', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40741;\tsample: tumor'}"
6471,"{'title': 'T+S II BEAS 2b_ML06', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - mechanical stretch plus TNF-α', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
6472,"{'title': 'Control_biological rep21 11-0052C', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 6;\toutcome: n/a;\tgroup: n/a'}"
6473,"{'title': 'neuron_rep14', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:47, gender:female, diagnostic group: schizophrenia, PMI:35h'}"
6474,"{'title': 'AML sample #28', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00069;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
6475,"{'title': 'C169', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Mixed;\ttumor size: 2.9'}"
6476,"{'title': 'Human lymphatic endothelial cells TNFalpha_Rep 1', 'description': 'Here we have addressed important question of inflammation-induced mechanism for leukocyte transmigration of lymphatic vessel endothelium by comparing global gene expression profile of normal dermal lymphatic endothelial cells with/without TNFa added to the culture.', 'type': 'RNA', 'source_name_ch1': 'Primary lymphatic endothelial cells cultured in vitro for 72h +/- TNFalpha derived from skin samples obtained from healthy human donors during elective surgery.', 'characteristics_ch1': 'Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).'}"
6477,"{'title': 'DietSensitive _3 weeks_subject9', 'description': 'DietSensitive _3 weeks_subject9', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 3 weeks;\tsubject: 9;\tgender: Male'}"
6478,"{'title': 'C00574', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7386_Tumor;\tfab: M3;\tSex: F;\trace: C;\tage on study: 22;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6479,"{'title': '40-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 40 treated 786-O cells, replicate 3'}"
6480,"{'title': 'DietResistant _3 weeks_subject5', 'description': 'DietResistant _3 weeks_subject5', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 3 weeks;\tsubject: 5;\tgender: Female'}"
6481,"{'title': 'DietResistant _3 weeks_subject7', 'description': 'DietResistant _3 weeks_subject7', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 3 weeks;\tsubject: 7;\tgender: Male'}"
6482,"{'title': 'NB83 U133p2 (breast epithelial study)', 'description': 'RNA from bulk normal breast or normal breast organoid', 'type': 'RNA', 'source_name_ch1': 'NB83', 'characteristics_ch1': 'bulk normal breast or normal breast organoid'}"
6483,"{'title': 'T-cell acute lymphoblastic leukemia, JURKAT', 'description': 'Gene expression data from T-ALL cell line.;\tJURKAT', 'type': 'RNA', 'source_name_ch1': 'T-ALL cell line', 'characteristics_ch1': 'cell type: T-ALL;\tage: 14;\tgender: male'}"
6484,"{'title': 'NSCLC_SCC_77', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 77.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
6485,"{'title': 'Gingival tissue sample 2 from patient 71, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 71 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6486,"{'title': 'NSCLC_AC_434', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 434.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
6487,"{'title': 'PTCL_AV_019', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
6488,"{'title': 'whole blood_101369', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
6489,"{'title': 'AML sample #10', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00073;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6490,"{'title': 'Gingival tissue sample 2 from patient 93, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 93 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6491,"{'title': 'BC9822', 'description': '080306.11.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 40;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: --;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: neg;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: neg;\terbb2p ihc status: --;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: neg;\tfoxa1 ihc status: --;\tmfs: 1;\tmfsdel (month): 12.29'}"
6492,"{'title': 'Monocyte High PBM 8', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 8'}"
6493,"{'title': 'N7397F3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6494,"{'title': 'C991646', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6708_Tumor;\tfab: M2;\tSex: M;\trace: C;\tage on study: 42;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6495,"{'title': 'Adipose tissue_426_control_rep3', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, normal weight, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: normal weight;\tgender: F;\tage: 8 year;\tz score bmi: 0.12'}"
6496,"{'title': 'control participant P351', 'description': 'Gene expression data from control participant RF', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
6497,"{'title': 'CDcR10_beforeT', 'description': 'Colonic mucosal gene expression data from CDc responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
6498,"{'title': 'Lung Normal 142N', 'description': 'Gene expression data from 142N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 51;\tstage: n/a'}"
6499,"{'title': 'Treatment-2, cells cultured in DMEM plus 5 mM HisOH', 'description': 'none;\tnone', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
6500,"{'title': '579', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tWild Type (BRAF/KRAS/ERBB2);\tGrade High;\tStage IC;\tMicropapillary feature Positive;\t(LMP) implants Negative;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6501,"{'title': 'HF0897_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
6502,"{'title': 'Pt5 whole pericardial adipose tissue, biological rep1', 'description': 'Pt5_PCAT', 'type': 'RNA', 'source_name_ch1': 'Whole pericardial adipose tissue, patient 5', 'characteristics_ch1': 'tissue: whole pericardial adipose tissue;\tpatient: 5'}"
6503,"{'title': 'Patient 18, biopsy; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
6504,"{'title': 'GBM, TMZ/radiotherapy (93)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 93;\tage: 70.3;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 10.43;\tmgmt status: U'}"
6505,"{'title': 'Patient 4557 AML125', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 125;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6506,"{'title': 'Tolerant PBMC_TOL_27', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtaiend from a tolerant liver transplant recipient, virus hepatitis C negative'}"
6507,"{'title': 'Insulin resistant patient 15 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
6508,"{'title': 'Training_Site6_05', 'description': 'Performed by Operator 1 from Site6 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
6509,"{'title': 'Hippocampus_male_20yrs_indiv83', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 20 years', 'characteristics_ch1': 'individual: 83, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 20'}"
6510,"{'title': 'Garp d3', 'description': 'Garp d3', 'type': 'RNA', 'source_name_ch1': 'Garp d3', 'characteristics_ch1': 'genetic modification:;\ttissue: T-cells'}"
6511,"{'title': 'Proficiency_Site4_22', 'description': 'Performed by Operator 1 from Site4 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 8ug; cRNA yield (ug) = 72.7; Lot# = 035PO41658D'}"
6512,"{'title': 'PBMCs_EB_before exercise_09', 'description': 'EB_Pre_175-AD', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 11;\tbefore-exercise'}"
6513,"{'title': 'non-malignant FTEb_patient 12', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 39;\tCycle: Follicular;\tBRCA1/2 mutation: BRCA1 185delAG;\tFamily History: Yes'}"
6514,"{'title': '93C275', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7377_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 38;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
6515,"{'title': 'DLBCL biopsy, sample 2085', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
6516,"{'title': 'Lung Normal 179N', 'description': 'Gene expression data from 179N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 55;\tstage: n/a'}"
6517,"{'title': 'human left atrial_control_5', 'description': 'K10_control', 'type': 'RNA', 'source_name_ch1': 'human left atrial appendage - control', 'characteristics_ch1': 'tissue: left atrial appendage'}"
6518,"{'title': '1948 - mAdbID:66612', 'description': 'mAdb experiment ID: 66612', 'type': 'RNA', 'source_name_ch1': '1948', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1948;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 7.95;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
6519,"{'title': 'colon_adenoma_1700', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
6520,"{'title': 'GA_701', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
6521,"{'title': 'AML 2287', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 16 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6522,"{'title': 'Bronchial epithelial cells, day 8, donor 3', 'description': 'Bronchial epithelial cells, day 8, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 8 of air-liquid interface culture'}"
6523,"{'title': 'Pt21 whole pericardial adipose tissue, biological rep1', 'description': 'Pt21_PCAT', 'type': 'RNA', 'source_name_ch1': 'Whole pericardial adipose tissue, patient 21', 'characteristics_ch1': 'tissue: whole pericardial adipose tissue;\tpatient: 21'}"
6524,"{'title': 'CDcNR7_afterT', 'description': 'Colonic mucosal gene expression data from CDc non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
6525,"{'title': 'Replicate 1 for MDAMB468 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6526,"{'title': 'N11478A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6527,"{'title': 'CD16- 1', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'human CD16- monocytes', 'characteristics_ch1': 'monocyte subsets: CD16- monocytes'}"
6528,"{'title': 'Replicate 1 for MDA231 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6529,"{'title': 'Replicate 1 for CAL851 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6530,"{'title': 'S081', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S081', 'characteristics_ch1': 'patient id: P053;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 40'}"
6531,"{'title': 'bladder_T1GH_pool-2', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, T1 high grade', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 4 individual samples.'}"
6532,"{'title': 'Patient 4499 AML104', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 104;\tcohort: Validation;\tkaryotype: t(15;17);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6533,"{'title': '11-0049B_SIRS resolved_day3_179', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6534,"{'title': 'AML with normal karyotype #196', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 43;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 97;\tdisease state: de novo AML'}"
6535,"{'title': 'Patient 5178 AML223', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 223;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6536,"{'title': 'Ishikawa treated with metastin-10, biological rep2', 'description': 'Gene expression data from Ishikawa cells treated with metastin-10.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells treated with metastin-10', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: negative control siRNA;\tpeptide treatment: metastin-10'}"
6537,"{'title': 'PC control 13', 'description': 'arrayconsortium.tgen.org::biosample.435024;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 13;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: male\xa0;\tgenetic variation: None\xa0;\tage: 78 years'}"
6538,"{'title': 'C99934', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6607_Tumor;\tfab: M1;\tSex: F;\trace: C;\tage on study: 37;\tcytogenetic change: Normal;\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 1'}"
6539,"{'title': 'NLPHL_lymph_node_case6', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: female, Age: 22, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, An Arbor Stage: IIB, follow-up: 10 years; status at last follow-up: alive without disease""}"
6540,"{'title': 'AML 7417', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 29 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: neg'}"
6541,"{'title': 'Growing cells, rep1', 'description': 'gene expression data from growing cells', 'type': 'RNA', 'source_name_ch1': 'Growing activated hepatic stellate cells', 'characteristics_ch1': 'fibrogenic cells of the liver'}"
6542,"{'title': 'Bronchial epithelial cells, day 21, donor 3', 'description': 'Bronchial epithelial cells, day 21, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 21 of air-liquid interface culture'}"
6543,"{'title': 'normal brain_1', 'description': 'bh20061208u133v2_A_35-Brain1_1', 'type': 'RNA', 'source_name_ch1': 'normal brain tissue', 'characteristics_ch1': 'tissue: brain'}"
6544,"{'title': 'K_AR9', 'description': 'K_AR9', 'type': 'RNA', 'source_name_ch1': 'AR9 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
6545,"{'title': 'Sputum from Stage III Severe, biological replicate 32', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 72;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
6546,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R24', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 31.77;\t%cd3cd8: 59.41;\t%cd8+cd28-: 10.44;\t%cd8+cd28+: 7.71;\t%cd4cd25cd62l: 1.65;\t%cd3delta1: 4.91;\t%cd3delta2: 3.38;\tratio delta1/delta2: 1.45;\t%cd3gammadelta: 7.82;\t%cd3alphabeta: 85.06;\t%cd4cd8-ab+(dn): 3.51;\t%cd4 cd62l+cd45+: 42.96;\t%cd4 cd62l-cd45+: 0.44;\t%cd4 cd62l - cd45-: 18.46;\t%cd4cd62l+cd45-: 38.14;\t%cd4 ccr7+ cd45 -: 29.05;\t%cd4 ccr7+ cd45+: 48.97;\t%cd4 ccr7 - cd45+: 2.97;\t%cd4 ccr7 – cd45-: 19.01;\t%cd8 cd62l+ cd45-: 10.99;\t%cd8cd62l+ cd45+: 49.23;\t%cd8cd62l- cd45+: 16.49;\t%cd8cd62l- cd45 -: 23.30;\t%cd8ccr7+ cd45-: 4.22;\t%cd8ccr7+ cd45+: 29.25;\t%cd8ccr7-cd45+: 37.78;\t%cd8ccr7-cd45 -: 28.75;\t%cd3-cd56+cd16+: 37.01;\t%nkts: 13.17;\t%cd19: 8.86;\t%cd4foxp3+: 1.65'}"
6547,"{'title': 'Epilepsy patient E4, 24 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 taken 24 hours after GC administration.;\t;\tE4-24h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E4, 24 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: dexamethasone;\ttreatment_time: 24 hrs;\tpatient: E4'}"
6548,"{'title': 'C149', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.2'}"
6549,"{'title': 'X51083', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
6550,"{'title': 'AML with normal karyotype #1', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Peripheral Blood;\tblast cell percentage: 2;\tdisease state: S-AML'}"
6551,"{'title': 'PH29a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 59;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 370;\tplasma hiv-1 rna levels (copies/ml): 484,694'}"
6552,"{'title': 'Gingival tissue sample 2 from patient 32, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 32 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6553,"{'title': 'Patient 1, colonocytes; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
6554,"{'title': 'Bronchial epithelial cells, day 21, donor 2', 'description': 'Bronchial epithelial cells, day 21, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 21 of air-liquid interface culture'}"
6555,"{'title': '7176', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 70 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
6556,"{'title': 'platelet_sickle_8', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
6557,"{'title': 'DietSensitive _3 weeks_subject4', 'description': 'DietSensitive _3 weeks_subject4', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 3 weeks;\tsubject: 4;\tgender: Female'}"
6558,"{'title': 'Cervical cancer-lymph node negative-14-44', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 35.9;\tfigo stage: 1b2'}"
6559,"{'title': 'AML 3483', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 45 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6560,"{'title': 'newly diagnosed multiple myeloma 108', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: nd'}"
6561,"{'title': '1375 (HIV+)', 'description': 'Gene expression data from frozen ARL tumor specimen', 'type': 'RNA', 'source_name_ch1': 'Frozen Tumor Biopsy_Colon', 'characteristics_ch1': 'specimen: frozen ARL tumor biopsy;\ttumor biopsy origin: Colon;\tage at diagnosis: 46;\tgender: Male;\tpathology diagnosis: DLBCL (PC);\tmolecular diagnosis: DLBCL_NC;\tebv status: positive'}"
6562,"{'title': 'adipose_preTZD_IRd+_s33', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 33'}"
6563,"{'title': 'normal_colon_29 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 61;\tlocalization: sigmoid'}"
6564,"{'title': 'X93075', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 3'}"
6565,"{'title': 'Replicative Senescent rep6', 'description': 'BJ fibroblasts passaged in culture till they reached senescence (population doubling >85) as assessed by SA-Bgal. 72h starved in serum-free media and incubated at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Late passage BJ fibroblasts'}"
6566,"{'title': 'Huh7 cells cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
6567,"{'title': 'KT0780_3_L_paired', 'description': 'KT0780_3_L_paired', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, paired set', 'characteristics_ch1': '3 months, living donor, paired set'}"
6568,"{'title': 'M96', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 67;\tSex: F;\tcode: resection;\tclass: CTNNB1;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
6569,"{'title': 'Angioimmunoblastic T-cell lymphoma 5', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-101', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 65;\tgender: male'}"
6570,"{'title': 'GBM_stem_4 days_2', 'description': 'G52_SC.CEL', 'type': 'RNA', 'source_name_ch1': 'glioblastoma stem cells, stem, 4 days', 'characteristics_ch1': 'tissue: brain;\tdisease status: glioblastoma;\tcell type: stem cells G52'}"
6571,"{'title': 'Sample R199', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: R199;\ttissue: blood;\tage: 50;\tgender: Female;\trs7956957 genotype: GG'}"
6572,"{'title': 'whole blood_101682', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism with regression, Male', 'characteristics_ch1': 'Autism with regression, Male'}"
6573,"{'title': 'Lung-normal-rep1', 'description': 'frozen normal lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen disease-free lung tissue', 'characteristics_ch1': 'disease state: normal;\tbiopsy type: surgical;\ttissue: lung'}"
6574,"{'title': 'Subcutaneous adipose tissue, SAT2', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
6575,"{'title': 'heterozygot FH P282', 'description': 'Gene expression data from the heterozygous FH participant M', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: heterozygote FH'}"
6576,"{'title': 'control cell donor 2', 'description': 'RNA from healthy donor', 'type': 'RNA', 'source_name_ch1': 'primary macrophages, control', 'characteristics_ch1': 'cell type: monocyte-derived macrophage;\tagent: control'}"
6577,"{'title': 'COL2_702', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 78;\tgender: F;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 1'}"
6578,"{'title': 'SU360b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1436;\tdisease state: Asympt;\tgender: Male;\tage: 63;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 248;\tplasma hiv-1     rna level   (copies/ml): 46400;\ttissue: lymph node'}"
6579,"{'title': 'Septic Shock_biological rep13', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.6;\toutcome: Nonsurvivor'}"
6580,"{'title': 'AML 2750', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 40 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6581,"{'title': 'AML sample #18', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00030;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
6582,"{'title': 'IFNβ_836', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6583,"{'title': 'NSCLC_AC_334', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 334.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
6584,"{'title': 'B89', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Mixed;\ttumor size: 1.5'}"
6585,"{'title': '01-0046A_Sepsis_day1_45', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6586,"{'title': 'HepG2 cells_GW7647_6h_rep2', 'description': 'A125_05_GW6', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells treated with PPARα agonist GW7647 at 100 nM for 6h', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatoma;\ttreatment: PPARα agonist GW7647;\ttreatment duration: 6 hr'}"
6587,"{'title': 'N8669A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6588,"{'title': 'colon_IBD_1533', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
6589,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R10', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 66.01;\t%cd3cd8: 25.02;\t%cd8+cd28-: 14.66;\t%cd8+cd28+: 4.59;\t%cd4cd25cd62l: 6.83;\t%cd3delta1: 4.75;\t%cd3delta2: 0.45;\tratio delta1/delta2: 10.5555555555556;\t%cd3gammadelta: 6.36;\t%cd3alphabeta: 95.36;\t%cd4cd8-ab+(dn): 3.13;\t%cd4 cd62l+cd45+: 39.09;\t%cd4 cd62l-cd45+: 0.54;\t%cd4 cd62l - cd45-: 15.87;\t%cd4cd62l+cd45-: 44.50;\t%cd4 ccr7+ cd45 -: 27.13;\t%cd4 ccr7+ cd45+: 37.11;\t%cd4 ccr7 - cd45+: 2.26;\t%cd4 ccr7 – cd45-: 33.49;\t%cd8 cd62l+ cd45-: 9.73;\t%cd8cd62l+ cd45+: 20.96;\t%cd8cd62l- cd45+: 56.78;\t%cd8cd62l- cd45 -: 13.533;\t%cd8ccr7+ cd45-: 2.6;\t%cd8ccr7+ cd45+: 5.84;\t%cd8ccr7-cd45+: 71.22;\t%cd8ccr7-cd45 -: 20.3;\t%cd3-cd56+cd16+: 11.13;\t%nkts: 6.62;\t%cd19: 17.90;\t%cd4foxp3+: 4.73'}"
6590,"{'title': 'class S, rep36', 'description': 'VAN_00363.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 24;\tsex: M;\tdisease stage: 2;\talbumin level: 47;\themoglobin level: 165;\tlymphocyte percentage: 17;\twhite blood count: 10.4;\tinternational prognostic score (ips): 2'}"
6591,"{'title': 'HUVECs  maintained in EGM2 media, the control rep 2', 'description': 'HUVECs in the basal state', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
6592,"{'title': 'AML with normal karyotype #184', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 44;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 100;\tdisease state: de novo AML'}"
6593,"{'title': 'DietResistant _3 weeks_subject4', 'description': 'DietResistant _3 weeks_subject4', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 3 weeks;\tsubject: 4;\tgender: Female'}"
6594,"{'title': 'MLD AML sample #28', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
6595,"{'title': 'Septic Shock_biological rep27 01-0034A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.7;\toutcome: Survivor;\tgroup: C'}"
6596,"{'title': 'NY34', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 75;\tSex: M;\tcode: resection;\tclass: Inflammation;\tafp: 98.3;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
6597,"{'title': 'GA_891', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6598,"{'title': 'PBMCs_AuNP_48hr_1', 'description': 'Gene expression data from PBMCs treated with AuNP EGFP oligonucleotide complex for 48 hours', 'type': 'RNA', 'source_name_ch1': 'PBMCs', 'characteristics_ch1': 'cell type: PBMCs;\ttreatment group: treated with AuNP EGFP oligonucleotide complex for 48 hours'}"
6599,"{'title': 'T cell donor 3, rolipram', 'description': 'Cells treated with 20 uM rolipram', 'type': 'RNA', 'source_name_ch1': 'MACS purified T cells from healthy donor peripheral blood', 'characteristics_ch1': 'T cell donor 3, rolipram'}"
6600,"{'title': 'normal Post ECP, biological rep2', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Post ECP', 'characteristics_ch1': 'disease state: normal;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
6601,"{'title': 'Gingival tissue sample 2 from patient 47, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 47 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6602,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_24_4)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 54;\tSex: M'}"
6603,"{'title': 'MDS patient 22', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q plus monosomy7/del7q plus other'}"
6604,"{'title': 'PGA-Hs_S-11', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
6605,"{'title': 'PA291', 'description': 'PA291', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: extended;\tcell type: Synovial fluid mononuclear cells'}"
6606,"{'title': 'CDcR7_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
6607,"{'title': 'Patient 3475 AML38', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 38;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6608,"{'title': 'newly diagnosed multiple myeloma 80', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
6609,"{'title': 'Training_Site2_04', 'description': 'Performed by Operator 1 from Site2 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 49.16112; Lot# = 035PO41658D'}"
6610,"{'title': 'CLL cells  LN patient #12', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #12'}"
6611,"{'title': 'UNTREATED_1685', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6612,"{'title': 'Simvastatin treated 24h, sample 1, Simvastatin is anti-inflammatory in macrophages', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'human peripheral blood monocyte-derived macrophages', 'characteristics_ch1': 'from unknown healthy blood-donor volunteers (Finnish Red Cross)'}"
6613,"{'title': 'conventional renal cell cancer; cRCCa_HA322', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
6614,"{'title': 'PCB153 treated HepG2 cells at T0.5, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines after 30 minutes of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
6615,"{'title': 'PC control 3', 'description': 'arrayconsortium.tgen.org::biosample.434884;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior Cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 3;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior Cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: female\xa0;\tgenetic variation: None\xa0;\tage: 102 years'}"
6616,"{'title': 'Subcutaneous adipose tissue, SAT49', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
6617,"{'title': 'B1-Non-RR-Pat.13 [wf20071123u133v2_U_11_BJ23_B1_M_49yr_No_151]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
6618,"{'title': 'hES_WIBR2_rep2_090811_12', 'description': 'Gene expression data from hES line WIBR2', 'type': 'RNA', 'source_name_ch1': 'hES line WIBR2', 'characteristics_ch1': 'cell line: hES line WIBR2'}"
6619,"{'title': 'group-1-pt-t5376310', 'description': 'group-1-pt-t5376310', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 55;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
6620,"{'title': 'Adrenocortical adenoma with wild-type CTNNB1-4', 'description': 'Gene expression profile of an adrenocortical adenoma  with wild-type CTNNB1 gene', 'type': 'RNA', 'source_name_ch1': 'WT AA 4', 'characteristics_ch1': 'tissue: Adrenocortical adenoma;\ttumor secretion profile: Aldosterone;\tgenotype: WT CTNNB1'}"
6621,"{'title': 'NSCLC EMC SCC2301N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
6622,"{'title': 'Pt21 isolated pericardial adipocytes, biological rep1', 'description': 'Pt21_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 21', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 21'}"
6623,"{'title': 'control_32hr_rep2', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_32hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
6624,"{'title': 'mRNA of GBM-HGG154, Glioblastoma, 3.8 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 3.8 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 3.8 years'}"
6625,"{'title': 'S066', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S066', 'characteristics_ch1': 'patient id: P039;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 1'}"
6626,"{'title': 'Patient 4216 AML59', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 59;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6627,"{'title': 'ci_NY17', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
6628,"{'title': 'AML 7149', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 37 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
6629,"{'title': 'Patient_6991_diagnosis', 'description': '6991D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pro-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 19;\tconclusions ig/tcr: stable;\tselected: no'}"
6630,"{'title': 'U937_ROS_curcumin_18h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 1uM curcumin treated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
6631,"{'title': 'newly diagnosed multiple myeloma 76', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
6632,"{'title': 'prostate normal 5', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal prostate stroma', 'characteristics_ch1': 'tissue: prostate;\tnormal/tumor: normal'}"
6633,"{'title': 'whole blood_101611', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Female', 'characteristics_ch1': 'Autism no regression, Female'}"
6634,"{'title': 'Blood Sample of subject 29 before inhalation; Group B', 'description': 'Bl_Group_B_BI_subject_29', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 29;\tgroup: B'}"
6635,"{'title': 'AML sample #74', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
6636,"{'title': 'Old trained subject, biological replicate (OT2)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old trained subject', 'characteristics_ch1': 'no additional information'}"
6637,"{'title': 'C991632', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6700_Tumor;\tfab: M1;\tSex: F;\trace: C;\tage on study: 50;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
6638,"{'title': 'HRV-infected, asthmatic S17 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, asthmatic S17', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
6639,"{'title': 'PMNs_normal_bone_marrow_4', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'PMNs (neutrophils) sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
6640,"{'title': 'cord blood 31_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 14.74', 'characteristics_ch1': 'Cord blood arsenic exposure level 14.74;\t'}"
6641,"{'title': 'Patient_5513_diagnosis', 'description': '5513D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 23;\tconclusions ig/tcr: stable;\tselected: yes'}"
6642,"{'title': 'HF1246_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 2'}"
6643,"{'title': 'Replicate 1 for HS578T breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6644,"{'title': 'Gingival tissue sample 1 from patient 21, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 21 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6645,"{'title': 'Young trained subject, biological replicate (YT2)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
6646,"{'title': 'X70054', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
6647,"{'title': 'group-1-pt-t25158203', 'description': 'group-1-pt-t25158203', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 54;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
6648,"{'title': 'HS+LPS_3', 'description': 'HS+LPS treatment 3', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells with heat shock and LPS', 'characteristics_ch1': 'heat shock/lipopolysaccharide treated cells'}"
6649,"{'title': 'HepG2 cells, control, rep1', 'description': 'Expression profiling from HepG2 cells', 'type': 'RNA', 'source_name_ch1': 'Cultured HepG2 cells,  ATCC# HB-8065', 'characteristics_ch1': 'cell line: HepG2;\tgenotype/variation: control'}"
6650,"{'title': 'AILD_006', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
6651,"{'title': 'Control 61', 'description': '08SE377', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
6652,"{'title': 'Replicate 1 for MB231inhibitor72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 1 for MB231inhibitor72h breast cell line'}"
6653,"{'title': 'newly diagnosed multiple myeloma 163', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: II'}"
6654,"{'title': 'newly diagnosed multiple myeloma 37', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: II'}"
6655,"{'title': 'muscle_preTZD_preClamp_IRd_s30', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 30'}"
6656,"{'title': 'PGA_PA-S_242', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
6657,"{'title': 'CD19_selected_B-cells_after_RFC_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after RFC'}"
6658,"{'title': 'AML 7075', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 55 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
6659,"{'title': 'Tonsil epithelium 1', 'description': 'Laser Capture Microdissected Epithelium of Tonsil from healthy donors.', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic Tonsil of Sleap Apnea Adult Patient', 'characteristics_ch1': 'Tonsil Epithelium'}"
6660,"{'title': 'Gingival tissue sample 1 from patient 5, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 5 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6661,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R31', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 74.57;\t%cd3cd8: 23.32;\t%cd8+cd28-: 7.84;\t%cd8+cd28+: 6.89;\t%cd4cd25cd62l: 8.97;\t%cd3delta1: 0.44;\t%cd3delta2: 1.55;\tratio delta1/delta2: 0.28;\t%cd3gammadelta: 0.9;\t%cd3alphabeta: 97.44;\t%cd4cd8-ab+(dn): 1.50;\t%cd4 cd62l+cd45+: 28.97;\t%cd4 cd62l-cd45+: 0.08;\t%cd4 cd62l - cd45-: 20.27;\t%cd4cd62l+cd45-: 50.68;\t%cd4 ccr7+ cd45 -: 40.76;\t%cd4 ccr7+ cd45+: 35.31;\t%cd4 ccr7 - cd45+: 0.54;\t%cd4 ccr7 – cd45-: 23.38;\t%cd8 cd62l+ cd45-: 14.90;\t%cd8cd62l+ cd45+: 27.47;\t%cd8cd62l- cd45+: 15.16;\t%cd8cd62l- cd45 -: 42.47;\t%cd8ccr7+ cd45-: 2.94;\t%cd8ccr7+ cd45+: 17.90;\t%cd8ccr7-cd45+: 35.37;\t%cd8ccr7-cd45 -: 43.79;\t%cd3-cd56+cd16+: 62.69;\t%nkts: 3.56;\t%cd19: 2.85;\t%cd4foxp3+: 9.81'}"
6662,"{'title': 'GBM, TMZ/radiotherapy (558)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 558;\tage: 55.7;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 5.72;\tmgmt status: U'}"
6663,"{'title': 'NHDF at passage 6, from neonatal donor, biological rep 3', 'description': 'Gene expression data from NHDF in culture', 'type': 'RNA', 'source_name_ch1': 'NHDF in culture', 'characteristics_ch1': 'Fibroblast cells'}"
6664,"{'title': '01-0036A_Septic Shock_day1_3', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6665,"{'title': 'AML 5286', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 57 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6666,"{'title': 'AML sample #62', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00314;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6667,"{'title': 'Patient 4733 AML154', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 154;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6668,"{'title': 'S042', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S042', 'characteristics_ch1': 'patient id: P035;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 66'}"
6669,"{'title': '15-0001_Control_day1_204', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Control_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6670,"{'title': 'COL2_197', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 70;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1318;\tsecond apc mutation: 0;\t5q loh: 1'}"
6671,"{'title': 'DM2_M69_Q_03', 'description': 'DM2 patient, age 69, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Quadriceps'}"
6672,"{'title': 'Training_Site9_11', 'description': 'Performed by Operator 2 from Site9 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 11.05; Lot# = 035PO41658D'}"
6673,"{'title': 'X51053', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
6674,"{'title': 'H438 DMSO 0.001', 'description': 'H438 DMSO 0.001.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 DMSO 0.001', 'characteristics_ch1': 'primary hepatocytes'}"
6675,"{'title': 'SI25', 'description': 'Gene expression data from Standard Immunotherapy 25', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 25', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
6676,"{'title': 'Proficiency_Site9_22', 'description': 'Performed by Operator 1 from Site9 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 78.315; Lot# = 035PO41658D'}"
6677,"{'title': 'mesenchymal stem cells, lot#4F0591, 9th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0591, passage number 9', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0591, 9th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
6678,"{'title': 'adipose_preTZD_IRd_s25', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 25'}"
6679,"{'title': 'Patient 20, colonocytes; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'Control'}"
6680,"{'title': 'PTCL_AV_029', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
6681,"{'title': 'newly diagnosed multiple myeloma 40', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
6682,"{'title': 'control_B2, empty vector', 'description': 'None', 'type': 'RNA', 'source_name_ch1': 'Cervical carcinoma', 'characteristics_ch1': 'Age: 66 yrs Gender: Female  Ethnicity: Caucasian'}"
6683,"{'title': 'Lung Cancer 92T', 'description': 'Gene expression data from 92T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 48;\tstage: 1B'}"
6684,"{'title': 'H439 Myclobutanil 30uM', 'description': 'H439 Myclobutanil 30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H439 Myclobutanil 30uM', 'characteristics_ch1': 'primary hepatocytes'}"
6685,"{'title': 'siWT-3', 'description': 'PLC/PRF/5 were transfected in triplicate with WT1 specific siRNAs (siWT) and siRNAs control (siGL)', 'type': 'RNA', 'source_name_ch1': 'PLC/PRF/5 cells transfected with 2 duplexes of specific siRNA targeting exons 7 and 10 of WT1', 'characteristics_ch1': 'Human hepatoma cell line'}"
6686,"{'title': 'AML sample #63', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00324;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6687,"{'title': 'UNTREATED_2071', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6688,"{'title': 'Septic Shock_biological rep56', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1.9;\toutcome: Survivor'}"
6689,"{'title': 'N11455B2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6690,"{'title': 'AML 2244', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 51 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Pos;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6691,"{'title': 'NSCLC_AC_136', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 136.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
6692,"{'title': 'Gingival tissue sample 1 from patient 15, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 15 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6693,"{'title': 'AML with normal karyotype #250', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 50;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
6694,"{'title': 'N2-51', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
6695,"{'title': 'N8514B5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6696,"{'title': 'GA_1778', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6697,"{'title': '05-0011_Septic Shock_day1_81', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6698,"{'title': 'NSCLC EMC LCC2334N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
6699,"{'title': 'AML 4335', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 44 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6700,"{'title': 'group-1-pt-t21452005', 'description': 'group-1-pt-t21452005', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 24;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
6701,"{'title': 'HUVEC_TNFa_0h30m', 'description': '0h30m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 0h30m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
6702,"{'title': 'N8608A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6703,"{'title': '15-0005_Control_day1_209', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Control_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6704,"{'title': 'Gastric GIST 11', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 51;\tTumor size: 12;\tKIT mutation: Exon 11'}"
6705,"{'title': 'normal Pre ECP, biological rep5', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Pre ECP', 'characteristics_ch1': 'disease state: normal;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
6706,"{'title': 'Training_Site1_07', 'description': 'Performed by Operator 1 from Site1 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
6707,"{'title': 'Sputum from Stage III Severe, biological replicate 1', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 68;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
6708,"{'title': '863018', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9678_Tumor;\tfab: M3;\tSex: M;\trace: W;\tage on study: 62;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
6709,"{'title': 'Foot siTUG1 Replicate 2', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siTUG1;\treplicate: 2'}"
6710,"{'title': 'S3L-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: smoker;\tPack-years: 30;\tAge: 44;\tSex: F;\tEthnic group: white'}"
6711,"{'title': 'AML without MLL - sample 113', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
6712,"{'title': 'Patient C06, control kidney from nephrectomy, without clamping', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C06, Sex: male, Age of patient: 44, Serum creatinine: 88 microMol/L, Control kidney from nephrectomy sample without clamping'}"
6713,"{'title': 'X70045', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : 3'}"
6714,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 2', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
6715,"{'title': 'GPR54-suppressed Ishikawa, biological rep3', 'description': 'Gene expression data from Ishikawa cells that were introduced with GPR54 siRNA.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells introduced with GPR54 siRNA', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: GPR54-specific siRNA;\tpeptide treatment: control peptide'}"
6716,"{'title': 'Patient 13, colonocytes; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'Control'}"
6717,"{'title': 'newly diagnosed multiple myeloma 5', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: I'}"
6718,"{'title': 'heterozygot FH P387neu', 'description': 'Gene expression data from the heterozygous FH participant LW', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: heterozygote FH'}"
6719,"{'title': 'Sputum from Stage II Moderate, biological replicate 58', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 56;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
6720,"{'title': 'EntorhinalCortex_male_20yrs_indiv78', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 20 years', 'characteristics_ch1': 'individual: 78, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 20'}"
6721,"{'title': 'No12inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No12 nonRVR;\ttime point: under therapy'}"
6722,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 6', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
6723,"{'title': 'UNTREATED_2518', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6724,"{'title': '10_0020_SepticShock_Day3_58', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '10_0020_Patient, Day3'}"
6725,"{'title': 'COL2_708', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 43;\tgender: F;\tlocalisation: Left;\tmetastasis: LIVER;\tfirst apc mutation: 0;\tsecond apc mutation: 0;\t5q loh: 0'}"
6726,"{'title': 'Blood_TD24111_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
6727,"{'title': 'non-malignant FTEb_patient 8', 'description': 'Gene expression profile of non-malignant FTE from BRCA1/2-mutation carrier during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier', 'characteristics_ch1': 'Age: 40;\tCycle: Follicular;\tBRCA1/2 mutation: BRCA1 185delAG;\tFamily History: Yes'}"
6728,"{'title': 'Normal Ovary, 2230', 'description': 'Gene expression data from normal ovary.;\tHOSE2230', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
6729,"{'title': 'AML 2233', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 59 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6730,"{'title': 'muscle_preTZD_preClamp_NRd_s19', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 19'}"
6731,"{'title': 'Pt5 isolated pericardial adipocytes, biological rep1', 'description': 'Pt5_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 5', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 5'}"
6732,"{'title': 'Lung Normal 157N', 'description': 'Gene expression data from 157N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 73;\tstage: n/a'}"
6733,"{'title': 'liver donor 60', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from liver donor 60', 'characteristics_ch1': 'tissue: liver;\torigin: liver donor'}"
6734,"{'title': 'S162', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S162', 'characteristics_ch1': 'patient id: P032;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
6735,"{'title': 'Cell line HB4a_R3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
6736,"{'title': 'PBMCs_EB_after exercise_10', 'description': 'EB_Peak_192-GC', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 9;\tafter-exercise'}"
6737,"{'title': 'Bronchial epithelial cells, day 17, donor 2', 'description': 'Bronchial epithelial cells, day 17, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 17 of air-liquid interface culture'}"
6738,"{'title': '147796', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '10570_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 78;\tcytogenetic change: >3;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6739,"{'title': 'GBM, radiotherapy (527)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 527;\tage: 52.6;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 0;\tsurvival time in months: 24.41;\tmgmt status: M'}"
6740,"{'title': 'AML sample #47', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00181;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6741,"{'title': 'sample 17, brca1 mutation negative, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation negative, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: no;\tovarian cycle status: luteal;\tsample identifier: 17'}"
6742,"{'title': 'AML 3316', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6743,"{'title': 'NZK19_Wied', 'description': 'non-metastatic primary clear-cell renal cell carcinoma, batch 1', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: male;\ttumor stage (uicc 2002): pT2;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G2;\tdfs/follow-up: Follow-up = 140 months;\tlocalisation of metastases: none'}"
6744,"{'title': 'B37', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Lobular;\ttumor size: 5.2'}"
6745,"{'title': 'Cell line HB4a_DRC_6', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
6746,"{'title': 'Septic Shock_biological rep28', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.3;\toutcome: Nonsurvivor'}"
6747,"{'title': 'Proficiency_Site9_32', 'description': 'Performed by Operator 2 from Site9 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 8ug; cRNA yield (ug) = 52.8; Lot# = 035PO41658D'}"
6748,"{'title': '93C184', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7393_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 45;\tcytogenetic change: inv(16)(p13q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6749,"{'title': 'AML 2658', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 33 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6750,"{'title': 'GC B cell_pSG5_rep3', 'description': 'Amplified total RNA from transfected and FACS sorted GC Bells', 'type': 'RNA', 'source_name_ch1': 'GC B cell transfected with empty vector (pSG5), rep3', 'characteristics_ch1': 'GC B cells sorted using CD10 MACS from reactive human tonsils'}"
6751,"{'title': 'Gingival tissue sample 2 from patient 44, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 44 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6752,"{'title': 'ALL without MLL - sample 59', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
6753,"{'title': 'Gingival tissue sample 3 from patient 76, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 76 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6754,"{'title': 'PBMCs_EB_after exercise_08', 'description': 'EB_Peak_148-NJ', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 12;\tafter-exercise'}"
6755,"{'title': 'normal Pre ECP, biological rep1', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Pre ECP', 'characteristics_ch1': 'disease state: normal;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
6756,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_27_4)', 'description': 'Gene expression data from whole blood 7 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 65;\tSex: M'}"
6757,"{'title': '93C44', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6702_Tumor;\tfab: M2;\tSex: F;\trace: C;\tage on study: 51;\tcytogenetic change: t(8;21)(q22;q22);\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6758,"{'title': 'UNTREATED_817', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6759,"{'title': '4 hours post-infection, biological rep1', 'description': 'Gene expression data from cells 4 hours after HCMV infection', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
6760,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 2', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
6761,"{'title': 'B15', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: II;\tnode status: neg;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 2.3'}"
6762,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 7', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
6763,"{'title': 'newly diagnosed multiple myeloma 162', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
6764,"{'title': 'human BM MSC BMP2 stimulated day 7 rep 1', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 7', 'type': 'RNA', 'source_name_ch1': 'donor 1, stimulated with BMP2 for 7 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 7 days'}"
6765,"{'title': 'Globin_C3', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
6766,"{'title': 'MDS patient 100', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
6767,"{'title': '1941 - mAdbID:66610', 'description': 'mAdb experiment ID: 66610', 'type': 'RNA', 'source_name_ch1': '1941', 'characteristics_ch1': 'Gender: female;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1941;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: ALIVE;\tClinical info: Follow up years: 0.70;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
6768,"{'title': 'Training_Site6_06', 'description': 'Performed by Operator 1 from Site6 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
6769,"{'title': 'brain, unknown: UTC_e1_le1', 'description': 'untreated C;\tTreatment, type=time_course, measurement=1.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
6770,"{'title': 'T47D_emetine_10h', 'description': 'Cells treated with emetine for 10 hours.', 'type': 'RNA', 'source_name_ch1': 'T47D', 'characteristics_ch1': 'cell line: T47D breast cancer cell line;\ttreatment: emetine;\ttime: 10h'}"
6771,"{'title': 'high grade serous carcinoma_patient 4', 'description': 'Gene expression profile of high grade serous carcinoma of fallopian tube', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected high grade serous carcinoma', 'characteristics_ch1': 'Age: 59;\tCycle: NA;\tBRCA1/2 mutation: Unknown;\tFamily History: No'}"
6772,"{'title': 'Sputum from Stage II Moderate, biological replicate 35', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 62;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
6773,"{'title': 'AML 7307', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 39 years;\tscore: FAB M1;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6774,"{'title': '6462', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 70 years, FAB unknown, cytogenetic intermediate risk, CEBPA single mutant'}"
6775,"{'title': '14-0002B_Sepsis_day3_196', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6776,"{'title': 'Huh7 cells cultured for 48 hours rep6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
6777,"{'title': 'MDS patient 59', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
6778,"{'title': 'HRV-infected, asthmatic S10 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, asthmatic S10', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
6779,"{'title': 'N2-32', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
6780,"{'title': 'T40728', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40728;\tsample: tumor'}"
6781,"{'title': 'blood-vehicle-DHA-4', 'description': 'Unstimulated cells, DHA supplementation.;\t418-91-V', 'type': 'RNA', 'source_name_ch1': 'blood, vehicle, DHA', 'characteristics_ch1': 'tissue: blood;\tdisease: hypertriglyceridemia;\tlps: vehicle;\tdha: DHA'}"
6782,"{'title': 'GA_1089', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6783,"{'title': 'Recurrent GBM, TMZ/radiotherapy (57R)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: recurrent GBM;\tpatient: 57;\tage: 52.8;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 36.45;\tmgmt status: M'}"
6784,"{'title': 'Patient 4412 AML83', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 83;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: MLL-PTD'}"
6785,"{'title': 'adenocarcinoma_41 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 46;\tlocalization: rectum'}"
6786,"{'title': '01-0036A_Day1_1', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Female;\tSurvivor;\torganism: None'}"
6787,"{'title': 'Tumor Tum_Ph2_rep15', 'description': 'Tumor paired  2', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N1;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
6788,"{'title': 'No25pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No25RVR;\ttime point: before therapy'}"
6789,"{'title': 'TonsilPool4-CD3-4', 'description': 'Project: Cell-Specific Gene Expression in Langerhans Cell Histiocytosis.', 'type': 'RNA', 'source_name_ch1': 'Sorted CD3+ Cells from 5 pooled tonsils (presumably normal).', 'characteristics_ch1': 'tissue: tonsils;\tcell type: CD3+'}"
6790,"{'title': 'Pilocytic astrocytoma chip 7760', 'description': 'Pilocytic astrocytoma.  Chip ID 7760', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
6791,"{'title': 'liver donor 8', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from liver donor 8', 'characteristics_ch1': 'tissue: liver;\torigin: liver donor'}"
6792,"{'title': 'Epilepsy patient E3, untreated sample', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E3 before administration of GC.;\t;\tE3-0h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E3, before administration of GC', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: untreated;\ttreatment_time: 0 hrs;\tpatient: E3'}"
6793,"{'title': 'PTCL_028', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
6794,"{'title': 'C002017', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7385_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 34;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
6795,"{'title': 'HF0512_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
6796,"{'title': 'HepG2_HNF4a&HNF4g_knockdown_control_rep2', 'description': 'HepG2_HNF4a&HNF4gknockdouwncontrol_try2', 'type': 'RNA', 'source_name_ch1': 'HNF4a&HNF4g_knockdown_control', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocellular carcinoma'}"
6797,"{'title': 'Peripheral T-Cell lymphoma, unspecified 13', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-154', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 18;\tgender: male'}"
6798,"{'title': '22086', 'description': '11780', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24318;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
6799,"{'title': 'Septic Shock_biological rep44', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 4.4;\toutcome: Survivor'}"
6800,"{'title': 'newly diagnosed multiple myeloma 313', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: II'}"
6801,"{'title': 'Proficiency_Site11_19', 'description': 'Performed by Operator 1 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 68.37; Lot# = 125PO54621A'}"
6802,"{'title': 'X532', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
6803,"{'title': 'Scarmbled control knockdown, replicate 1', 'description': 'Gene expression data from HeLa cells infected with control retrovirus', 'type': 'RNA', 'source_name_ch1': 'HeLa cells infected with control retrovirus', 'characteristics_ch1': 'cell line: HeLa cervical carcinoma'}"
6804,"{'title': 'Sputum from Stage IV Severe, biological replicate 10', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 61;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
6805,"{'title': 'BL2', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'Burkitt lymphoma case 2', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with Burkitt lymphoma (BL)'}"
6806,"{'title': 'adipose_preTZD_IRd+_s24', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 24'}"
6807,"{'title': 'non-malignant FTEn_patient 2', 'description': 'Gene expression profile of non-malignant FTE from control patient during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 46;\tCycle: Luteal;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
6808,"{'title': 'T146 U133p2', 'description': 'bulk breast tumor RNA from patient T146', 'type': 'RNA', 'source_name_ch1': 'T146', 'characteristics_ch1': 'breast tumor'}"
6809,"{'title': 'BC10172', 'description': '130505.3.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 52;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT2;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: --;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: --;\tmfs: 0;\tmfsdel (month): 80.49'}"
6810,"{'title': 'adipose_postTZD_IRd-_s32', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 32'}"
6811,"{'title': 'Cell line C5.2_DRC_1', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
6812,"{'title': 'control-2, cells cultured in regular DMEM', 'description': 'none;\tnone', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
6813,"{'title': 'GBM, radiotherapy (159)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 159;\tage: 60.9;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 14.47;\tmgmt status: U'}"
6814,"{'title': 'adipose_postTZD_NRd_s19', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 19'}"
6815,"{'title': 'adipose_preTZD_NRd_s18', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 18'}"
6816,"{'title': 'AML 2544', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 37 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6817,"{'title': 'group-1-pt-t34670758', 'description': 'group-1-pt-t34670758', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 44;\tgender: male;\tfinal disposition: 06: Home'}"
6818,"{'title': 'lymphocytes_HD_F_56y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: female; Age: 56; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/43'}"
6819,"{'title': '269542', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9843_Tumor;\tfab: M0;\tSex: M;\trace: AA;\tage on study: 76;\tcytogenetic change: >3;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6820,"{'title': 'PBMCs treated at the IC90 for 24 hours,replicate 4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 24 hours,replicate 4', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
6821,"{'title': 'Patient 4400 AML77', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 77;\tcohort: Validation;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
6822,"{'title': '484 - mAdbID:66604', 'description': 'mAdb experiment ID: 66604', 'type': 'RNA', 'source_name_ch1': '484', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 484;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 1.39;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
6823,"{'title': '22107', 'description': '11868', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24342;\tSmoking_Status: Never;\tPathology: Adenocarcinoma'}"
6824,"{'title': 'HF0218_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
6825,"{'title': 'T8542A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
6826,"{'title': 'blood_cd34pos_D1', 'description': '3 samples CD34+ and 2 samples CD34-', 'type': 'RNA', 'source_name_ch1': 'periphereal blood', 'characteristics_ch1': 'healty donors treated with GCSF isolated CD34+ cells and CD34+ after 10dd of differentiating medium.'}"
6827,"{'title': 'Proficiency_Site4_19', 'description': 'Performed by Operator 1 from Site4 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 27.3; Lot# = 035PO41658D'}"
6828,"{'title': '34111', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tmutant KRAS;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6829,"{'title': 'Proficiency_Site11_18', 'description': 'Performed by Operator 1 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 58.76; Lot# = 125PO54621A'}"
6830,"{'title': 'Tumor 48', 'description': '08SE360', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
6831,"{'title': '10267', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 38;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 46;\tDonor Sex: M;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
6832,"{'title': 'patient Pre ECP, biological rep2', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'CTCL patient Pre ECP', 'characteristics_ch1': 'disease state: cutaneous T cell lymphoma;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
6833,"{'title': 'whole blood_101592', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism with regression, Male', 'characteristics_ch1': 'Autism with regression, Male'}"
6834,"{'title': 'T30 U133p2', 'description': 'bulk breast tumor RNA from patient T30', 'type': 'RNA', 'source_name_ch1': 'T30', 'characteristics_ch1': 'breast tumor'}"
6835,"{'title': 'Proficiency_Site11_26', 'description': 'Performed by Operator 2 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 66.53; Lot# = 125PO54621A'}"
6836,"{'title': 'mRNA of GBM-HGG061, Glioblastoma, 14.08 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 14.08 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 14.08 years'}"
6837,"{'title': 'AML sample #1', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00001;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
6838,"{'title': 'NSCLC_AC_273', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 273.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
6839,"{'title': 'adipose_postTZD_NRd_s14', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 14'}"
6840,"{'title': 'Normal_colon_19_12April05', 'description': 'Normal_colon_19_12April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, rectum', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
6841,"{'title': 'MDS patient 147', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: other'}"
6842,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R7', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 71.81;\t%cd3cd8: 22.93;\t%cd8+cd28-: 4.27;\t%cd8+cd28+: 4.27;\t%cd4cd25cd62l: null;\t%cd3delta1: 1.07;\t%cd3delta2: 2.19;\tratio delta1/delta2: 0.49;\t%cd3gammadelta: 3.25;\t%cd3alphabeta: 95.04;\t%cd4cd8-ab+(dn): 2.94;\t%cd4 cd62l+cd45+: 30.89;\t%cd4 cd62l-cd45+: 0.22;\t%cd4 cd62l - cd45-: 25.39;\t%cd4cd62l+cd45-: 43.50;\t%cd4 ccr7+ cd45 -: 26.64;\t%cd4 ccr7+ cd45+: 31.44;\t%cd4 ccr7 - cd45+: 1.23;\t%cd4 ccr7 – cd45-: 40.69;\t%cd8 cd62l+ cd45-: 19.27;\t%cd8cd62l+ cd45+: 44.04;\t%cd8cd62l- cd45+: 4.38;\t%cd8cd62l- cd45 -: 30.74;\t%cd8ccr7+ cd45-: 8.99;\t%cd8ccr7+ cd45+: 34.49;\t%cd8ccr7-cd45+: 7.89;\t%cd8ccr7-cd45 -: 48.62;\t%cd3-cd56+cd16+: 3.58;\t%nkts: 4.44;\t%cd19: 3.58;\t%cd4foxp3+: 4.40'}"
6843,"{'title': 'cHL10', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 10', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
6844,"{'title': 'Muscle-FamilyHistoryNegative-12', 'description': 'Jos3686;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 32;\tfamily history: Family history negative;\tbody mass index (kg/m2): 25;\tfasting glucose (ogtt): 86.5;\t2 hour glucose (ogtt): 105;\themoglobin a1c: 5.3;\tfasting glucose (iv0gavg): 85;\tfasting insulin (iv0inavg): 5.3;\tsi: 6.95;\twaist hip ratio: 0.836'}"
6845,"{'title': '7328', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 68 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type'}"
6846,"{'title': 'NB64 U133p2', 'description': 'RNA from bulk normal breast or normal bresat organoid', 'type': 'RNA', 'source_name_ch1': 'NB64', 'characteristics_ch1': 'bulk normal breast or normal bresat organoid'}"
6847,"{'title': 'Replicate 1 for ZR751 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6848,"{'title': 'T40730', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40730;\tsample: tumor'}"
6849,"{'title': 'Bronchial epithelial cells, day 1, donor 2', 'description': 'title = Bronchial epithelial cells, day 1, donor 2 source_name_ch1 = Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 1 of air-liquid interface culture'}"
6850,"{'title': 'MDS patient 84', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: trisomy8'}"
6851,"{'title': 'C98925', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6711_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 40;\tcytogenetic change: inv(16)(p13q22); +Y;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
6852,"{'title': 'control participant P338', 'description': 'Gene expression data from control participant T6', 'type': 'RNA', 'source_name_ch1': 'control participant P338 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: control participant'}"
6853,"{'title': 'Patient_5361_diagnosis', 'description': '5361D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 39;\tconclusions ig/tcr: stable;\tselected: no'}"
6854,"{'title': '11_0001_SepticShock_Day3_55', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0001_Patient, Day3'}"
6855,"{'title': 'Hippocampus_female_74yrs_indiv18', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 74 years', 'characteristics_ch1': 'individual: 18, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 74'}"
6856,"{'title': 'CLL cells  LN patient #3', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #3'}"
6857,"{'title': 'Lung Cancer 159T', 'description': 'Gene expression data from 159T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 59;\tstage: 1B'}"
6858,"{'title': 'HF0996_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
6859,"{'title': 'MDS patient 135', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
6860,"{'title': '4342', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 62 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
6861,"{'title': 'S122', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S122', 'characteristics_ch1': 'patient id: P040;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
6862,"{'title': 'Proficiency_Site8_24', 'description': 'Performed by Operator 1 from Site8 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 8ug; cRNA yield (ug) = 73; Lot# = 035PO41658D'}"
6863,"{'title': 'AML with normal karyotype #197', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 56;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 78;\tdisease state: de novo AML'}"
6864,"{'title': 'KT0977_6_D_test3', 'description': 'KT0977_6_D_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, deceased donor, test set3', 'characteristics_ch1': '6 months, deceased donor, test set3'}"
6865,"{'title': 'Tumor 3', 'description': '07SE488', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
6866,"{'title': 'AML sample #67', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00353;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
6867,"{'title': 'X70107', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
6868,"{'title': 'VAN_00606', 'description': '06-30025', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 68;\tgender: F;\tipi_stage: 3B;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.43;\tprogression-free_survival (years): 0.43'}"
6869,"{'title': 'GA_1802', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6870,"{'title': 'NSG004', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.92;\tdisease activity (das28_v3): 5.8;\tresponse to anti-tnf therapy: NORESPONSE'}"
6871,"{'title': 'colonic_mucosa_non_inflamed_744', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the colon, no macroscopic signs of inflammation.'}"
6872,"{'title': 'mRNA of GBM-HGG145, Glioblastoma, 14 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 14 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 14 years'}"
6873,"{'title': 'Monocyte_patient45_time3', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:African-american,Age:32,VAP day:3'}"
6874,"{'title': 'Tumor Tum_Ph1_rep8', 'description': 'Tumor paired  10', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N1;\thistology: cdi/cli;\tgrade: _;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
6875,"{'title': 'Insulin resistant patient 14 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
6876,"{'title': 'Patient_7304_diagnosis', 'description': '7304D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 38;\tconclusions ig/tcr: unstable;\tselected: no'}"
6877,"{'title': 'GBM, TMZ/radiotherapy (12)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 12;\tage: 37.9;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 17.37;\tmgmt status: M'}"
6878,"{'title': 'AML 2212', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 60 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6879,"{'title': 'PTCL.BO.08', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
6880,"{'title': 'adenocarcinoma_53 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 55;\tlocalization: sigmoid'}"
6881,"{'title': 'cord blood 20', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.63', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.63;\t'}"
6882,"{'title': 'Tumor 53', 'description': '08SE366', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
6883,"{'title': 'Tumor 57', 'description': '08SE370', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
6884,"{'title': 'AML 7306', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 51 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: 11q23;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6885,"{'title': 'AML 5358', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 40 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: 11q23;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6886,"{'title': 'PGA-Hs_S-18', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
6887,"{'title': 'S125', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S125', 'characteristics_ch1': 'patient id: P066;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 5'}"
6888,"{'title': 'HF0151_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
6889,"{'title': 'Sputum from Stage II Moderate, biological replicate 25', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 67;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
6890,"{'title': 'human BM MSC unstimulated rep 4', 'description': 'gene expression data of unstimulated human bone marrow mesenchymal stem cells', 'type': 'RNA', 'source_name_ch1': 'donor 4, unstimulated', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3'}"
6891,"{'title': 'HIV+ Individual HIV-6a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'HIV+ Individual HIV-6a', 'characteristics_ch1': 'CD4+ T-cells from HIV+ donor'}"
6892,"{'title': '10269', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 39;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 47;\tDonor Sex: F;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
6893,"{'title': 'No20LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No20;\tcell type: lymphocytes;\ttime point: under therapy'}"
6894,"{'title': 'Training_Site7_03', 'description': 'Performed by Operator 1 from Site7 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 8; Lot# = 035PO41658D'}"
6895,"{'title': 'AML 2756', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 37 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
6896,"{'title': 'NLPHL2', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'nodular lymphocte-predominant Hodgkin lymphoma case 2', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)'}"
6897,"{'title': 'Sputum from Stage III Severe, biological replicate 37', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 66;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: B;\thyb date: 39321'}"
6898,"{'title': 'Septic Shock_biological rep14', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1.2;\toutcome: Survivor'}"
6899,"{'title': 'Non-tolerant PBMCs_NoTOL_VHC_19', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from non-tolerant liver transplant recipient, with hepatitis C infection and under treatment with cyclosporine A.'}"
6900,"{'title': 'PNS025', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.82;\tdisease activity (das28_v3): 3.87;\tresponse to anti-tnf therapy: MEDIUM'}"
6901,"{'title': 'X516', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
6902,"{'title': 'Gingival tissue sample 4 from patient 2, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 2 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6903,"{'title': 'S020', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S020', 'characteristics_ch1': 'patient id: P091;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 57.5'}"
6904,"{'title': 'mRNA of GBM-HGG144, Glioblastoma, 19 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 19 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 19 years'}"
6905,"{'title': 'Gingival tissue sample 3 from patient 87, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 87 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6906,"{'title': 'UNTREATED_1721', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6907,"{'title': '2.1.NDV.14', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 14 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 14'}"
6908,"{'title': 'DietResistant _1 day_subject6', 'description': 'DietResistant _1 day_subject6', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 6;\tgender: Female'}"
6909,"{'title': 'Pilocytic astrocytoma chip 8032', 'description': 'Pilocytic astrocytoma.  Chip ID 8032', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
6910,"{'title': 'DLBCL biopsy, sample 2078', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
6911,"{'title': 'Peripheral T-Cell lymphoma, unspecified 29', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-118', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 59;\tgender: male'}"
6912,"{'title': 'G144-NS_A', 'description': 'U133Plus2_122906L_DK18.CEL', 'type': 'RNA', 'source_name_ch1': 'Glioblastoma derived cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: malignant;\tcell type: cell line;\tcell type: glioblastoma'}"
6913,"{'title': 'Old sedentary subject, biological replicate (OS6)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old sedentary subject', 'characteristics_ch1': 'no additional information'}"
6914,"{'title': 'mock-infected, asthmatic S16 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, asthmatic S16', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
6915,"{'title': 'HepG2_HNF4a&HNF4g_knockdown2_rep2', 'description': 'HepG2_HNF4a&HNF4gknockdouwn2_try2', 'type': 'RNA', 'source_name_ch1': 'HNF4a&HNF4g_knockdown2', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocellular carcinoma'}"
6916,"{'title': 'HF1227_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
6917,"{'title': 'Control 64', 'description': '08SE381', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
6918,"{'title': 'AML 6947', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 21 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6919,"{'title': 'MDS patient 123', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
6920,"{'title': 'Replicate 1 for HDQP1 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
6921,"{'title': 'PBMCs treated at the IC90 for 24 hours,replicate 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 24 hours,replicate 3', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
6922,"{'title': 'breast tumor 6', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to breast invasive tumor', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: tumor'}"
6923,"{'title': 'group-2-pt-t12449908', 'description': 'group-2-pt-t12449908', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 36;\tgender: male;\tfinal disposition: 09: Death'}"
6924,"{'title': 'SG-94A_phenotype of EPC colony assay', 'description': 'EPC sampled from blood and cultured', 'type': 'RNA', 'source_name_ch1': 'cultured EPC, baseline', 'characteristics_ch1': 'baseline'}"
6925,"{'title': 'Gingival tissue sample 1 from patient 52, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 52 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6926,"{'title': 'Gingival tissue sample 1 from patient 16, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 16 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6927,"{'title': 'AML without MLL - sample 111', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
6928,"{'title': '11-0059B_SIRS resolved_day3_186', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
6929,"{'title': 'negative control transfection for 4 hours', 'description': 'negative control transfection for 4 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
6930,"{'title': 'Angioimmunoblastic T-cell lymphoma 2', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-137', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 87;\tgender: female'}"
6931,"{'title': 'Patient_42', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 42;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.0561251711147808;\tproliferation index: -4.36615433434291'}"
6932,"{'title': 'Subcutaneous adipose tissue, SAT25', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
6933,"{'title': 'class S, rep70', 'description': 'VAN_00484.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 47;\tsex: M;\tdisease stage: 2;\talbumin level: 45;\themoglobin level: 146;\tlymphocyte percentage: 23;\twhite blood count: 8.2;\tinternational prognostic score (ips): 3'}"
6934,"{'title': 'CLL cells  PB  patient #12', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #12'}"
6935,"{'title': 'BC9991', 'description': '080311.09.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 59;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT2;\tpn: neg;\tgrade sbr: 2;\terbb2 ihc status: --;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: pos;\tigf1r ihc status: neg;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: neg;\tmfs: 1;\tmfsdel (month): 40.44'}"
6936,"{'title': 'Gingival tissue sample 3 from patient 38, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 38 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
6937,"{'title': 'HF1568_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 2'}"
6938,"{'title': 'Primary 26-1004 cirr primary (b)', 'description': 'Gene expression data  for primary', 'type': 'RNA', 'source_name_ch1': 'PrimaryHepatocellular Carcinoma', 'characteristics_ch1': 'Tissue: liver'}"
6939,"{'title': '296361', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '11425_Tumor;\tfab: M5;\tSex: F;\trace: W;\tage on study: 31;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
6940,"{'title': 'PTCL.PG.15', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
6941,"{'title': 'HUVEC_TNFa_3h30m', 'description': '3h30m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 3h30m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
6942,"{'title': 'S100', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S100', 'characteristics_ch1': 'patient id: P024;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
6943,"{'title': 'NSCLC EMC TB0022he', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: F'}"
6944,"{'title': 'HBEC4-Rep2 High dose treatment group (1000 nM).', 'description': 'HBEC4-Rep2 High dose treatment group (1000 nM).', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
6945,"{'title': 'Gingival tissue sample 1 from patient 37, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 37 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6946,"{'title': 'EntorhinalCortex_male_86yrs_indiv73', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 86 years', 'characteristics_ch1': 'individual: 73, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 86'}"
6947,"{'title': 'MCF-7_0.001%DMSO_rep1', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: DMSO treated'}"
6948,"{'title': 'Gingival tissue sample 1 from patient 95, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 95 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6949,"{'title': 'H448 DMSO 0.001', 'description': 'H448 DMSO 0.001.CEL', 'type': 'RNA', 'source_name_ch1': 'H448 DMSO 0.001', 'characteristics_ch1': 'primary hepatocytes'}"
6950,"{'title': '60170', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant ERBB2;\tGrade Low;\tStage IIB;\tMicropapillary feature Negative;\t(LMP) implants micro-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6951,"{'title': 'Gingival tissue sample 2 from patient 38, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 38 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6952,"{'title': 'class S, rep28', 'description': 'VAN_00179.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 18;\tsex: F;\tdisease stage: 2;\talbumin level: 36;\themoglobin level: 114;\tlymphocyte percentage: 20;\twhite blood count: 10;\tinternational prognostic score (ips): 2'}"
6953,"{'title': 'LPS-treated_6h replicate 3', 'description': ""Performed by UTMB microarray core per manufacturer's instructions"", 'type': 'RNA', 'source_name_ch1': 'THP-1 cells', 'characteristics_ch1': 'cell type: Human myelogenous leukemia (macrophage-like) cells;\tcell line: THP-1'}"
6954,"{'title': 'DietSensitive _6 weeks_subject1', 'description': 'DietSensitive _6 weeks_subject1', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 1;\tgender: Female'}"
6955,"{'title': 'N10910A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
6956,"{'title': 'newly diagnosed multiple myeloma 291', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
6957,"{'title': 'adipose_postTZD_NRd_s15', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 15'}"
6958,"{'title': 'Septic Shock_biological rep52 06-0004', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0;\toutcome: Survivor;\tgroup: A'}"
6959,"{'title': 'gd cell activation+7day,donor 4', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 7 days after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 7 days;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 7 d;\tindividual: donor 4'}"
6960,"{'title': 'MLD AML sample #27', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
6961,"{'title': 'si Control MCF7-repeat 1 - mAdbID:83291', 'description': 'mAdb experiment ID: 83291', 'type': 'RNA', 'source_name_ch1': 'si Control MCF7', 'characteristics_ch1': 'Tissue: breast;\tCell line: Breast Cancer Cell Line MCF7;\tCell type: epithelial cells;\tDisease state: Adenocarcinoma'}"
6962,"{'title': 'whole blood_100409', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Male', 'characteristics_ch1': 'General population, Male'}"
6963,"{'title': 'Lung Cancer 144T', 'description': 'Gene expression data from 144T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 57;\tstage: 3A'}"
6964,"{'title': 'Control_biological rep11', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 9.6;\toutcome: Survivor'}"
6965,"{'title': 'X22012', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
6966,"{'title': 'GA_1106', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
6967,"{'title': 'gd cell activation+6h,donor 1', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 6 hours after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 6 hrs;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 6 h;\tindividual: donor 1'}"
6968,"{'title': 'shRB-B (Senescent)', 'description': 'Senescent cells expressing shRNA targeting RB replicate 2', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing shRNA targeting RB', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
6969,"{'title': 'DMSO-3', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': '786-O cells treated with DMSO, replicate 3'}"
6970,"{'title': 'sample 33, brca1 mutation negative, follicular phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation negative, follicular phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: no;\tovarian cycle status: follicular;\tsample identifier: 33'}"
6971,"{'title': 'neuron_rep10', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:51, gender:male, diagnostic group: bipolar disorder, PMI:23h'}"
6972,"{'title': 'Sample 13: normal ovarian surface epithelium', 'description': 'Gene expression data from ovarian surface kinome', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium', 'characteristics_ch1': 'cell type: Ovarian Epithelium;\trisk group: Normal'}"
6973,"{'title': 'Gingival tissue sample 1 from patient 66, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 66 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
6974,"{'title': 'Lung Cancer 142T', 'description': 'Gene expression data from 142T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 51;\tstage: 3A'}"
6975,"{'title': 'newly diagnosed multiple myeloma 117', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: III'}"
6976,"{'title': 'AML 7186', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 40 years;\tscore: FAB M2;\trisk: unknown;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6977,"{'title': 'IFNβ_1068', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
6978,"{'title': 'MDS patient 134', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
6979,"{'title': 'SH-SY5Y(ECACC)_RA_5d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 5day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
6980,"{'title': 'newly diagnosed multiple myeloma 297', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
6981,"{'title': 'newly diagnosed multiple myeloma 114', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: None;\tiss: I'}"
6982,"{'title': 'colonic_mucosa_non_inflamed_741', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Control subject, biopsy taken from the colon, no macroscopic signs of inflammation.'}"
6983,"{'title': 'TC.DR+-2A', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
6984,"{'title': 'Sample T12', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: T12;\ttissue: blood;\tage: 76;\tgender: Female;\trs7956957 genotype: GG'}"
6985,"{'title': 'T51572', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51572;\tsample: tumor'}"
6986,"{'title': 'AML 5282', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 56 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
6987,"{'title': 'adenocarcinoma_74 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 78;\tlocalization: sigmoid'}"
6988,"{'title': 'Clone A cells treated with 5uM CsA and cultured for 24 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
6989,"{'title': '60267', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant KRAS;\tGrade Low;\tStage IIIC;\tMicropapillary feature Negative;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
6990,"{'title': 'Blood Sample of subject 29 after inhalation; Group B: inhalation with 0.7 ppm FA 24 h before sampling', 'description': 'Bl_Group_B_AI_subject_29', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 24 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 24 h;\tsubject: 29;\tgroup: B'}"
6991,"{'title': 'PA47', 'description': 'PA47', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
6992,"{'title': 'Control TC7', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
6993,"{'title': 'Control 38', 'description': '07SE532', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
6994,"{'title': 'brain_neurons_rep2', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'neurons from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 45; this individual had a medical history of schizophrenia'}"
6995,"{'title': 'PGA_PA-D_225', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
6996,"{'title': 'Cell line HB4a_DR2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
6997,"{'title': 'CLL_FISHnormal_rep5', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'female'}"
6998,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
6999,"{'title': 'Blood Sample of subject 10after inhalation; Group A: inhalation with 0.7 ppm FA 72 h before sampling', 'description': 'Bl_Group_A_AI_subject_10', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 72 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 72 h;\tsubject: 10;\tgroup: A'}"
7000,"{'title': 'DLBCL2', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 2', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
7001,"{'title': 'THRBL_lymph_node_case9', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: male, Age: 45, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: III, follow-up: <2 years; status at last follow-up: death with disease'}"
7002,"{'title': 'Pt10 isolated pericardial adipocytes, biological rep1', 'description': 'Pt10_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 10', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 10'}"
7003,"{'title': 'RTX12 T0', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).', 'characteristics_ch1': 'treatment: baseline;\tgender: F;\tage (y): 59;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Poor-responder;\ttissue: synovium'}"
7004,"{'title': 'Lung Normal 125N', 'description': 'Gene expression data from 125N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 64;\tstage: n/a'}"
7005,"{'title': 'miR-124 transfection for 72 hours', 'description': 'miR-124 transfection for 72 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
7006,"{'title': 'Lung siScramble Replicate2', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 2'}"
7007,"{'title': 'AML sample #72', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00404;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
7008,"{'title': 'C184', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Mixed;\ttumor size: 4.5'}"
7009,"{'title': 'Cervical cancer-lymph node negative-06-20', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 38.5;\tfigo stage: 1b1'}"
7010,"{'title': 'Old trained subject, biological replicate (OT3)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old trained subject', 'characteristics_ch1': 'no additional information'}"
7011,"{'title': 'AML 2754', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 28 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7012,"{'title': 'S145', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S145', 'characteristics_ch1': 'patient id: P008;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
7013,"{'title': 'Lung Normal 131N', 'description': 'Gene expression data from 131N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 71;\tstage: n/a'}"
7014,"{'title': 'Muscle control 11', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
7015,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R32', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 70.69;\t%cd3cd8: 26.57;\t%cd8+cd28-: 8.41;\t%cd8+cd28+: 8.89;\t%cd4cd25cd62l: 1.89;\t%cd3delta1: 1.51;\t%cd3delta2: 0.19;\tratio delta1/delta2: 7.95;\t%cd3gammadelta: 2.38;\t%cd3alphabeta: 93.88;\t%cd4cd8-ab+(dn): 2.91;\t%cd4 cd62l+cd45+: 17.58;\t%cd4 cd62l-cd45+: 0.29;\t%cd4 cd62l - cd45-: 26.06;\t%cd4cd62l+cd45-: 56.07;\t%cd4 ccr7+ cd45 -: 37.61;\t%cd4 ccr7+ cd45+: 18.40;\t%cd4 ccr7 - cd45+: 1.26;\t%cd4 ccr7 – cd45-: 42.73;\t%cd8 cd62l+ cd45-: 25.17;\t%cd8cd62l+ cd45+: 15.89;\t%cd8cd62l- cd45+: 16.50;\t%cd8cd62l- cd45 -: 42.45;\t%cd8ccr7+ cd45-: 7.23;\t%cd8ccr7+ cd45+: 12.57;\t%cd8ccr7-cd45+: 22.44;\t%cd8ccr7-cd45 -: 57.76;\t%cd3-cd56+cd16+: 29.09;\t%nkts: 3.92;\t%cd19: 11.11;\t%cd4foxp3+: 4.42'}"
7016,"{'title': 'C97581', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7205_Tumor;\tfab: M1;\tSex: F;\trace: C;\tage on study: 54;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
7017,"{'title': 'mesenchymal stem cells, lot#5F0138, 24th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#5F0138, passage number 24', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#5F0138, 24th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
7018,"{'title': 'VA147', 'description': '05-24395', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: spleen;\tage: 56;\tgender: M;\tipi_stage: 4B;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 2.86;\tprogression-free_survival (years): 2.86'}"
7019,"{'title': 'carcinoma_91 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 76;\tlocalization: ascending'}"
7020,"{'title': '975684', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9692_Tumor;\tfab: M1;\tSex: F;\trace: W;\tage on study: 53;\tcytogenetic change: trisomy 8;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
7021,"{'title': 'DM2_M32_D_06', 'description': 'DM2 patient, age 32, gender Male', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site: Deltoid'}"
7022,"{'title': 'NB87 U133p2', 'description': 'RNA from bulk normal breast or normal bresat organoid', 'type': 'RNA', 'source_name_ch1': 'NB87', 'characteristics_ch1': 'bulk normal breast or normal bresat organoid'}"
7023,"{'title': 'Endometrium-prog A (01B04869)', 'description': '01B04869.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group A', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2-3;\tpregnancy status: pregnant;\tprogesterone serum level: group A (<=0.9ng/ml)'}"
7024,"{'title': '673778', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9614_Tumor;\tfab: M3;\tSex: M;\trace: W;\tage on study: 53;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7025,"{'title': 'GBM, TMZ/radiotherapy (80)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 80;\tage: 46.7;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 30.43;\tmgmt status: M'}"
7026,"{'title': 'Patient 5061 AML190', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 190;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
7027,"{'title': 'SH-SY5Y(ECACC)_BDNF_2d_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
7028,"{'title': 'AML 2283', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 57 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7029,"{'title': 'Cell line HB4a_D_3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line -DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
7030,"{'title': 'Normal Ovary, 2228', 'description': 'Gene expression data from normal ovary.;\tHOSE2228', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
7031,"{'title': 'T10739D1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
7032,"{'title': 'Blood Sample of subject 10 before inhalation; Group A', 'description': 'Bl_Group_A_BI_subject_10', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 10;\tgroup: A'}"
7033,"{'title': 'Blood - Control - 157A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 45;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
7034,"{'title': 'NSCLC EMC 2411N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
7035,"{'title': 'UNTREATED_718', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7036,"{'title': 'Gingival tissue sample 2 from patient 26, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 26 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7037,"{'title': 'LTB4 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tLatent'}"
7038,"{'title': 'Adult-B-ALL-6h', 'description': 'homo sapiens, childhood ALL patient (male, aged 72 years), peripheral blood taken 6h after GC-monotherapy initiation, leukocyte isolation CD10 targeted enrichment for malignant blasts', 'type': 'RNA', 'source_name_ch1': 'Adult B-ALL patient, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, childhood ALL patient (male, aged 72 years), peripheral blood taken 6h after GC-monotherapy initiation, leukocyte isolation CD10 targeted enrichment for malignant blasts '}"
7039,"{'title': 'HF0520_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
7040,"{'title': 'VM27a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Female;\tage: 40;\trace: African American;\tperipheral blood cd4+ t cells (cells/ml): 112;\tplasma hiv-1 rna levels (copies/ml): 12,046'}"
7041,"{'title': 'S044', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S044', 'characteristics_ch1': 'patient id: P042;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 18'}"
7042,"{'title': 'NSCLC_SCC_37', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 37.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
7043,"{'title': 'Patient_5449_diagnosis', 'description': '5449D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 24;\tconclusions ig/tcr: stable;\tselected: yes'}"
7044,"{'title': 'Scz-30', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tL8', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - schizophrenia;\tSex: M;\tage: 67;\ttissue ph: 6.46;\tpmi (hrs): 21;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): 75 mg'}"
7045,"{'title': 'H448 Triadimefon 10uM', 'description': 'H448 Triadimefon 10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H448 Triadimefon 10uM', 'characteristics_ch1': 'primary hepatocytes'}"
7046,"{'title': 'adenocarcinoma_7 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 64;\tlocalization: sigmoid'}"
7047,"{'title': 'Ultrafine particle exposure 1 -baseline', 'description': 'Gene expression data from circulating mononuclear cells before exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells before exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: UFP;\ttime: 0 hour'}"
7048,"{'title': 'Liver364N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HCV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 364N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: LC;\tgender: M;\tage: 74;\tvirus: HCV'}"
7049,"{'title': 'AML with normal karyotype #189', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 39;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 65;\tdisease state: de novo AML'}"
7050,"{'title': 'Myeloma tumor, sample 9', 'description': 'MM_TUMOR_09;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: male;\tdisease state: advanced multiple myeloma (MM)'}"
7051,"{'title': 'non-pCR breast biopsy, sample 9 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 9 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
7052,"{'title': 'DLBCL biopsy, sample 2104', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
7053,"{'title': 'BRCA1 carrier (dupl) sample 3a', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from BCRA1 mutation carrier', 'characteristics_ch1': 'Breast epithelial cells'}"
7054,"{'title': '08SE866HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
7055,"{'title': 'PGA-Hs_P-5', 'description': 'Human subjects with post-partum cardiomyopathy;\tKeywords = post-partum cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7056,"{'title': 'Blood sample from patient 163 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 163;\tday: Day 90;\tage (years): 64;\tsex: Female'}"
7057,"{'title': 'Control_biological rep17', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 2.9;\toutcome: Survivor'}"
7058,"{'title': 'AML with normal karyotype #120', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 39;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 91;\tdisease state: de novo AML'}"
7059,"{'title': 'IFNβ_709', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
7060,"{'title': 'AML with normal karyotype #155', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 23;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 91.5;\tdisease state: de novo AML'}"
7061,"{'title': 'CLL_del13q_rep6', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with del13q', 'characteristics_ch1': 'female'}"
7062,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Good Responder 1', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, good responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
7063,"{'title': '2.1.NDV.10', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 10 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 10'}"
7064,"{'title': ""Wilms' FF B-1"", 'description': 'L750-A-HG-U133_Plus_2-01-1 (S99-2051N-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney', 'characteristics_ch1': 'tissue: kidney;\tfixation: FF;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-1;\tdonor: A normal'}"
7065,"{'title': 'H133+_H448_Propi_30uM', 'description': 'H133+_H448_Propi_30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H448_Propi_30uM', 'characteristics_ch1': 'primary hepatocytes'}"
7066,"{'title': 'HepG2_HNF4a&HNF4g_knockdown2_rep1', 'description': 'HepG2_HNF4a&HNF4gknockdouwn2_try1', 'type': 'RNA', 'source_name_ch1': 'HNF4a&HNF4g_knockdown2', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocellular carcinoma'}"
7067,"{'title': 'GA_521', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
7068,"{'title': 'Endometrium-prog B (01B08073)', 'description': '01B08073.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group B', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2-3;\tpregnancy status: pregnant;\tprogesterone serum level: group B (1-1.5 ng/ml)'}"
7069,"{'title': 'Patient 4085 AML47', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 47;\tcohort: Validation;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7070,"{'title': 'EPN_393, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_393, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
7071,"{'title': 'PGA-Hs_S-19', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7072,"{'title': 'AML sample #105', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
7073,"{'title': 'group-1-pt-t27248819', 'description': 'group-1-pt-t27248819', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 21;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
7074,"{'title': 'breast tumor 1', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Stroma associated to breast invasive tumor', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: tumor'}"
7075,"{'title': 'Patient 8446 AML236', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 236;\tcohort: Validation;\tkaryotype: t(7;12);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7076,"{'title': 'H448 Triadimefon 100uM', 'description': 'H448 Triadimefon 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H448 Triadimefon 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
7077,"{'title': 'JS300a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1430;\tdisease state: Acute;\tgender: Male;\tage: 26;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 683;\tplasma hiv-1     rna level   (copies/ml): 3610;\ttissue: lymph node'}"
7078,"{'title': 'Gingival tissue sample 2 from patient 90, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 90 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7079,"{'title': 'human macrophages treated with saline, biological rep1', 'description': 'Gene expression data from human macrophages treated with saline (control) for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with saline', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: saline;\ttreatment time: 2 hours;\tday: 9'}"
7080,"{'title': 'colon_CRC_1499', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
7081,"{'title': 'No6pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No6 nonRVR;\ttime point: before therapy'}"
7082,"{'title': 'EntorhinalCortex_female_34yrs_indiv35', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 34 years', 'characteristics_ch1': 'individual: 35, AA;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 34'}"
7083,"{'title': 'B65', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.1'}"
7084,"{'title': 'CLL cells  PB  patient #1', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #1'}"
7085,"{'title': 'CD01', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CD'}"
7086,"{'title': 'Gingival tissue sample 2 from patient 34, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 34 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7087,"{'title': 'TBM2 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tmeningeal tuberculosis'}"
7088,"{'title': 'Patient 4905 AML170', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 170;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7089,"{'title': 'AML 2176', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 41 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7090,"{'title': 'Adrenocortical adenoma with wild-type CTNNB1-1', 'description': 'Gene expression profile of an adrenocortical adenoma  with wild-type CTNNB1 gene', 'type': 'RNA', 'source_name_ch1': 'WT AA 1', 'characteristics_ch1': 'tissue: Adrenocortical adenoma;\ttumor secretion profile: Cortisol;\tgenotype: WT CTNNB1'}"
7091,"{'title': 'NSG300', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.73;\tdisease activity (das28_v3): 4.21;\tresponse to anti-tnf therapy: NORESPONSE'}"
7092,"{'title': 'Lung Cancer 103T', 'description': 'Gene expression data from 103T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 55;\tstage: 4'}"
7093,"{'title': 'PMNs_normal_bone_marrow_1', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'PMNs (neutrophils) sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
7094,"{'title': 'hES_H9_rep1_081006_15', 'description': 'Gene expression data from hES line H9', 'type': 'RNA', 'source_name_ch1': 'hES line H9', 'characteristics_ch1': 'cell line: hES line H9'}"
7095,"{'title': 'Gingival tissue sample 4 from patient 17, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 17 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
7096,"{'title': 'Blood sample from patient 147 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 147;\tday: Day 180;\tage (years): 31;\tsex: Female'}"
7097,"{'title': 'Clone A cells treated with 5uM CsA and cultured for 48 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
7098,"{'title': 'Pt19 isolated pericardial adipocytes, biological rep1', 'description': 'Pt19_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 19', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 19'}"
7099,"{'title': 'PBMCs treated at the IC90 for 2 hours,replicate 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at the IC90 for 2 hours,replicate 2', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
7100,"{'title': 'T cell donor 2, control', 'description': 'Cells treated with DMSO vehicle control', 'type': 'RNA', 'source_name_ch1': 'MACS purified T cells from healthy donor peripheral blood', 'characteristics_ch1': 'T cell donor 2, control'}"
7101,"{'title': 'GA_1726', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7102,"{'title': '03-0001A_Sepsis_day1_64', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7103,"{'title': 'RTX5 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: F;\tage (y): 33;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
7104,"{'title': 'group-2-pt-t14841022', 'description': 'group-2-pt-t14841022', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 37;\tgender: female;\tfinal disposition: 88: Other (specify)'}"
7105,"{'title': 'EntorhinalCortex_female_91yrs_indiv94', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 91 years', 'characteristics_ch1': 'individual: 94, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 91'}"
7106,"{'title': '3.2.AF.6', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 6 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: AF;\thours post infection: 6'}"
7107,"{'title': 'newly diagnosed multiple myeloma 309', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
7108,"{'title': 'Adipose tissue_423_control_rep1', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, normal weight, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: normal weight;\tgender: M;\tage: 10 year;\tz score bmi: -1.45'}"
7109,"{'title': 'PGA-Hs_H-4', 'description': 'Human subjects with hypertrophic cardiomyopathy;\tKeywords = hypertrophic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7110,"{'title': 'mRNA of AA-HGG060, Anaplastic Astrocytoma, 2.75 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 2.75 years', 'characteristics_ch1': 'disease: Anaplastic Astrocytoma;\tage: 2.75 years'}"
7111,"{'title': 'Blood - Sarcoidosis - 003A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 45;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
7112,"{'title': 'IFNβ_844', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7113,"{'title': 'AML sample #29', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00071;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
7114,"{'title': 'AML 2192', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 45 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
7115,"{'title': 'MDS patient 12', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q'}"
7116,"{'title': '10-0027A_Sepsis_day1_107', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7117,"{'title': 'MDS patient 29', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: other'}"
7118,"{'title': '01_0030_SepticShock_Day3_109', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0030_Patient, Day3'}"
7119,"{'title': 'X32022', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
7120,"{'title': 'CLL cells  PB  patient #13 replicate2', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #13'}"
7121,"{'title': 'Gingival tissue sample 2 from patient 41, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 41 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7122,"{'title': 'C013_Control_M_61', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Male;\tage: 61;\tpost-mortem delay: 16.5h;\tph: 6.2'}"
7123,"{'title': 'MDS patient 91', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
7124,"{'title': 'Hippocampus_male_86yrs_indiv73', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 86 years', 'characteristics_ch1': 'individual: 73, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 86'}"
7125,"{'title': 'VA148', 'description': '05-24904', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: thyroid;\tage: 57;\tgender: F;\tipi_stage: 1AE;\ttxprimary: CHOP3-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 2.66;\tprogression-free_survival (years): 2.66'}"
7126,"{'title': 'Training_Site5_06', 'description': 'Performed by Operator 1 from Site5 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
7127,"{'title': 'Lung Normal 133N', 'description': 'Gene expression data from 133N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 70;\tstage: n/a'}"
7128,"{'title': 'DLBCL biopsy, sample 2023', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
7129,"{'title': 'AML with normal karyotype #9', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 28;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 52.5;\tdisease state: de novo AML'}"
7130,"{'title': '27_70603_SepticShock_Day1_6', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '27_70603_Patient, Day1'}"
7131,"{'title': 'HPB-ALL_DMSO_03', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'HPB-ALL cells treated with DMSO', 'characteristics_ch1': 'cell type: T-cell;\tcell line: HPB-ALL'}"
7132,"{'title': 'MERLION_X01K02059', 'description': 'MERLION_X01K02059', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=77, state=1', 'characteristics_ch1': 'pT2N0, male, age=77, state=1'}"
7133,"{'title': 'Pt10 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt10_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 10', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 10'}"
7134,"{'title': 'Cell line C5.2_R_4', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
7135,"{'title': 'Lung Cancer 122T', 'description': 'Gene expression data from 122T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 59;\tstage: 1B'}"
7136,"{'title': 'newly diagnosed multiple myeloma 41', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: nd'}"
7137,"{'title': '775109', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9844_Tumor;\tfab: M5;\tSex: M;\trace: W;\tage on study: 45;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7138,"{'title': 'Sputum from Stage II Moderate, biological replicate 48', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 65;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
7139,"{'title': 'Sputum from Stage II Moderate, biological replicate 1', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 69;\tgender: F;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
7140,"{'title': 'Patient 5026 AML179', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 179;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: MLL-PTD'}"
7141,"{'title': 'Endometrium in trophoblast conditioned medium for 3 hours TCM-8', 'description': 'Trophoblast conditioned medium endometrium  3 hours TCM-8', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Trophoblast conditioned medium endometrium  3 hours TCM-8'}"
7142,"{'title': 'AML with normal karyotype #241', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 58;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 75;\tdisease state: de novo AML'}"
7143,"{'title': 'Pax_C1', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene;\tmolecule: total RNA'}"
7144,"{'title': 'cord blood 27', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 3.24', 'characteristics_ch1': 'Cord blood arsenic exposure level 3.24;\t'}"
7145,"{'title': 'K_AR14', 'description': 'K_AR14', 'type': 'RNA', 'source_name_ch1': 'AR14 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1A'}"
7146,"{'title': 'Proficiency_Site2_20', 'description': 'Performed by Operator 1 from Site2 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 8ug; cRNA yield (ug) = 52.63; Lot# = 035PO41658D'}"
7147,"{'title': 'MCF-7 +ER siRNA + vehicle rep1 (MD37)', 'description': 'Gene expression data from MCF-7cells treated with vehicle and ER siRNA;\tMD37', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with vehicle and ER siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: ER siRNA;\tagent: control (vehicle);\tdose: n/a'}"
7148,"{'title': 'N8671B5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7149,"{'title': 'B70', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 64;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\tafp: 3;\ttp53 mutation: 0;\tctnnb1 mutation: 233A>AG,p.D32D/G;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
7150,"{'title': 'group-2-pt-t10999830', 'description': 'group-2-pt-t10999830', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 45;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
7151,"{'title': 'Control Con_rep26', 'description': 'Control paired  2', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
7152,"{'title': 'C130', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 4.0'}"
7153,"{'title': 'muscle_preTZD_preClamp_IRd_s9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 9'}"
7154,"{'title': 'B26', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 1.1'}"
7155,"{'title': '10273', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 70;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 59;\tDonor Sex: F;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
7156,"{'title': 'Sputum from Stage IV Severe, biological replicate 7', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 71;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
7157,"{'title': 'S020_Scz_F_82', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 82;\tpost-mortem delay: 8.5h;\tph: 5.9'}"
7158,"{'title': 'Monocyte_patient41_time3', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:Caucasian,Age:33,VAP day:5'}"
7159,"{'title': 'Scz-20', 'description': 'ID# from Supplementary Table 3 of PMID 18778695: -', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: M;\tage: 35;\ttissue ph: 6.27;\tpmi (hrs): 47;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): 300 mg'}"
7160,"{'title': 'PR890b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1389;\tdisease state: Acute;\tgender: Male;\tage: 32;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 824;\tplasma hiv-1     rna level   (copies/ml): 32173;\ttissue: lymph node'}"
7161,"{'title': 'Insulin sensitive patient 7 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: omental adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
7162,"{'title': 'COL2_707', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 78;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1211;\tsecond apc mutation: 1309;\t5q loh: 0'}"
7163,"{'title': 'Sputum from Stage III Severe, biological replicate 41', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 64;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
7164,"{'title': 'C97651', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7218_Tumor;\tfab: M1;\tSex: M;\trace: C;\tage on study: 26;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
7165,"{'title': 'normal_colon_18 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: colonoscopy;\tage: 62;\tlocalization: ascending'}"
7166,"{'title': 'S109', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S109', 'characteristics_ch1': 'patient id: P002;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
7167,"{'title': 'mRNA of AA-HGG082, Anaplastic Astrocytoma, 5 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 5 years', 'characteristics_ch1': 'disease: Anaplastic Astrocytoma;\tage: 5 years'}"
7168,"{'title': 'AML sample #89', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
7169,"{'title': 'PGA-Hs_S-15', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7170,"{'title': 'Gingival tissue sample 1 from patient 58, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 58 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7171,"{'title': 'muscle_preTZD_preClamp_IRd+_s48', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 48'}"
7172,"{'title': 'B2-RR-Pat.8 [wf20071123u133v2_U_10_CH22_B2_M_38yr_alpha_151]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
7173,"{'title': 'Endometrium-prog B (01B03931b)', 'description': '01B03931b.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group B', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d2-3;\tpregnancy status: non-pregnant;\tprogesterone serum level: group B (1-1.5 ng/ml)'}"
7174,"{'title': 'HIP control 9', 'description': 'arrayconsortium.tgen.org::biosample.434617;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 9;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 79 years'}"
7175,"{'title': 'Septic Shock_biological rep80 14-0002A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 5.9;\toutcome: Survivor;\tgroup: B'}"
7176,"{'title': 'Lung Cancer 121T', 'description': 'Gene expression data from 121T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 60;\tstage: 1B'}"
7177,"{'title': 'Liver_hyperglycima_no.10', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: type 2 diabetes'}"
7178,"{'title': 'AML 2175', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 57 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7179,"{'title': 'Replicate 2 for KPL1 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
7180,"{'title': 'centrocyte, tonsil#6', 'description': 'centrocyte, tonsil#6', 'type': 'RNA', 'source_name_ch1': 'Inflamed non tumoral human tonsil#6', 'characteristics_ch1': 'cell suspension: Flow sorted cells;\tcell type: centrocyte, tonsil'}"
7181,"{'title': 'M13', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: 0;\tage: 71;\tSex: M;\tcode: resection;\tclass: Unannotated;\tafp: 16;\tctnnb1 mutation: 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
7182,"{'title': 'AML 2289', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 50 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7183,"{'title': 'ALL with MLL - sample 131', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7184,"{'title': 'Lung Cancer 134T', 'description': 'Gene expression data from 134T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 52;\tstage: 2B'}"
7185,"{'title': 'T40836', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40836;\tsample: tumor'}"
7186,"{'title': 'AML 7150', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 20 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7187,"{'title': '09_0001_SepticShock_Day3_77', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '09_0001_Patient, Day3'}"
7188,"{'title': 'HPB-ALL_SAHM1_01', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'HPB-ALL cells treated with SAHM1', 'characteristics_ch1': 'cell type: T-cell;\tcell line: HPB-ALL'}"
7189,"{'title': 'Replicate 1 for MCF7untreated breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 untreated cell line to compare to older profiled MCF7 sample. See ATCC/DSMZ for cell line details.'}"
7190,"{'title': 'AML 7169', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 54 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7191,"{'title': 'Lung Normal 92N', 'description': 'Gene expression data from 92N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 48;\tstage: n/a'}"
7192,"{'title': 'Sepsis gram-positive TP9', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Positive'}"
7193,"{'title': 'AML 7406', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 25 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
7194,"{'title': 'Blood sample from patient 160 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 160;\tday: Day 90;\tage (years): 35;\tsex: Female'}"
7195,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R23', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 61.84;\t%cd3cd8: 31.65;\t%cd8+cd28-: 12.07;\t%cd8+cd28+: 8.87;\t%cd4cd25cd62l: 4.90;\t%cd3delta1: 1.89;\t%cd3delta2: 2.06;\tratio delta1/delta2: 0.92;\t%cd3gammadelta: 4.1;\t%cd3alphabeta: 94.76;\t%cd4cd8-ab+(dn): 4.83;\t%cd4 cd62l+cd45+: 11.90;\t%cd4 cd62l-cd45+: 9.68;\t%cd4 cd62l - cd45-: 38.52;\t%cd4cd62l+cd45-: 39.90;\t%cd4 ccr7+ cd45 -: 12.87;\t%cd4 ccr7+ cd45+: 1.17;\t%cd4 ccr7 - cd45+: 21.81;\t%cd4 ccr7 – cd45-: 64.15;\t%cd8 cd62l+ cd45-: 9.99;\t%cd8cd62l+ cd45+: 14.49;\t%cd8cd62l- cd45+: 41.56;\t%cd8cd62l- cd45 -: 33.96;\t%cd8ccr7+ cd45-: 0.94;\t%cd8ccr7+ cd45+: 1.66;\t%cd8ccr7-cd45+: 53.63;\t%cd8ccr7-cd45 -: 43.76;\t%cd3-cd56+cd16+: 3.15;\t%nkts: 33.01;\t%cd19: 6.80;\t%cd4foxp3+: 3.86'}"
7196,"{'title': 'NSCLC_AC_113', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 113.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
7197,"{'title': 'Patient 5174 AML220', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 220;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7198,"{'title': 'class F, rep25', 'description': 'VAN_00158f1.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 42;\tsex: M;\tdisease stage: 2;\talbumin level: 38;\themoglobin level: 130;\tlymphocyte percentage: 15;\twhite blood count: 9.2;\tinternational prognostic score (ips): 3'}"
7199,"{'title': 'AP760b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1476;\tdisease state: Uninfected;\tgender: Female;\tage: 28;\trace: Hispanic;\tblood cd4+ t  cell count (cells/ml): 704;\tplasma hiv-1     rna level   (copies/ml): Undetectable;\ttissue: lymph node'}"
7200,"{'title': 'whole blood_101669', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism with regression, Male', 'characteristics_ch1': 'Autism with regression, Male'}"
7201,"{'title': 'Patient 4529 AML114', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 114;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7202,"{'title': 'Astrocytoma_7', 'description': 'bh20061208u133v2_A_20-Astro10_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: astrocytoma;\tage: 44;\tgender: male;\ttumor grade: AIII/IV'}"
7203,"{'title': '77-1', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 77 treated 786-O cells, replicate 1'}"
7204,"{'title': 'Septic Shock_biological rep85 15-0017', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.3;\toutcome: Survivor;\tgroup: A'}"
7205,"{'title': 'MCF7 vector control', 'description': 'Gene expression data from MCF7 vector control', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7-Vector', 'characteristics_ch1': 'MCF-7-Vector'}"
7206,"{'title': '34113', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 2;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
7207,"{'title': 'K_STA8', 'description': 'K_STA8', 'type': 'RNA', 'source_name_ch1': 'STA8 kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
7208,"{'title': 'AML with normal karyotype #198', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 43;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 62;\tdisease state: de novo AML'}"
7209,"{'title': 'AML with normal karyotype #20', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 54;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 84;\tdisease state: de novo AML'}"
7210,"{'title': 'AML 2669', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 45 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7211,"{'title': 'Control_biological rep4 04-0010C', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0;\toutcome: n/a;\tgroup: n/a'}"
7212,"{'title': 'AML with normal karyotype #249', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 50;\tdisease state: de novo AML'}"
7213,"{'title': 'Gingival tissue sample 1 from patient 74, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 74 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7214,"{'title': 'IFNβ_1208', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
7215,"{'title': 'H1_ES_2', 'description': 'Gene expression data obtained from human ES', 'type': 'RNA', 'source_name_ch1': 'human ES', 'characteristics_ch1': 'cell type: ES;\tcell line: H1 Human embryonic stem cells'}"
7216,"{'title': 'T40726', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40726;\tsample: tumor'}"
7217,"{'title': 'Gingival tissue sample 3 from patient 27, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 27 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
7218,"{'title': 'Activated CD8+ T-cells with anti-CD3, anti-CD28 and IL-12 and harvested after 48 hours incubation', 'description': 'Gene expression data from resting CD8+ T-cells.;\tCD8-T48', 'type': 'RNA', 'source_name_ch1': 'Normal CD8+ T-cell subset', 'characteristics_ch1': 'cell type: CD8+ T-cell'}"
7219,"{'title': 'NSCLC EMC 2323N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
7220,"{'title': 'vad6', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: adenoma'}"
7221,"{'title': 'M-19', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
7222,"{'title': 'monocytes_Q10_2', 'description': '24h Q10 preincubation, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +Q10, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h Q10 preincubation, 4h LPS stimulation'}"
7223,"{'title': 'Control_biological rep31 15-0003', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 3.8;\toutcome: Survivor;\tgroup: n/a'}"
7224,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 12 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 12 hours'}"
7225,"{'title': '1448', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 47 years, FAB M3, cytogenetic intermediate risk, CEBPA wild type'}"
7226,"{'title': 'Control 68', 'description': '08SE389', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
7227,"{'title': 'c_NY102', 'description': 'normal liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; normal liver tissue', 'characteristics_ch1': 'normal liver tissue'}"
7228,"{'title': 'group-2-pt-t10899813', 'description': 'group-2-pt-t10899813', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 40;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
7229,"{'title': 'AML with normal karyotype #28', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 41;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 86;\tdisease state: de novo AML'}"
7230,"{'title': 'X22031', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
7231,"{'title': 'M-15', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
7232,"{'title': 'Lung Normal 143N', 'description': 'Gene expression data from 143N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 59;\tstage: n/a'}"
7233,"{'title': 'newly diagnosed multiple myeloma 63', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: nd'}"
7234,"{'title': 'newly diagnosed multiple myeloma 140', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
7235,"{'title': 'MCF10A cells cocultured with breast cancer associated fibroblasts that extracted from breast cancer sample No 15', 'description': 'gene expression data from MCF10A cells cocultured with breast fibroblasts', 'type': 'RNA', 'source_name_ch1': 'MCF10A cells', 'characteristics_ch1': 'cell line, normal mammary epithelium, immortalized'}"
7236,"{'title': 'colonic_mucosa_inflamation_76', 'description': 'The sample is a part of an analysis of colonic gene expression in patients with ulcerative colitis', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal endoscopic pinch biopsy', 'characteristics_ch1': 'Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible'}"
7237,"{'title': 'GBM, TMZ/radiotherapy (396)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 396;\tage: 49.8;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 15.53;\tmgmt status: M'}"
7238,"{'title': 'SI26', 'description': 'Gene expression data from Standard Immunotherapy 26', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 26', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
7239,"{'title': 'Patient 3443 AML28', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 28;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7240,"{'title': 'conventional renal cell cancer; cRCCb_HD2', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7241,"{'title': 'DLBCL biopsy, sample 2057', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
7242,"{'title': 'TNS1B', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siLincTNS1;\treplicate: 2'}"
7243,"{'title': 'RM08Nb', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1408;\tdisease state: Asympt;\tgender: Male;\tage: 39;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 685;\tplasma hiv-1     rna level   (copies/ml): 20014;\ttissue: lymph node'}"
7244,"{'title': 'sample 35, brca1 mutation negative, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation negative, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: no;\tovarian cycle status: luteal;\tsample identifier: 35'}"
7245,"{'title': 'Endometrium - not pregnant [08-9292-1]', 'description': '08-9292-1', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, not pregnant', 'characteristics_ch1': 'tissue: endometrium on day of oocyte retrieval;\tstate: non-pregnant'}"
7246,"{'title': 'GBM, radiotherapy (70)', 'description': 'MGMT status: ?', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 70;\tage: 52.7;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 0;\tsurvival time in months: 33.62;\tmgmt status: ?'}"
7247,"{'title': 'adipose_postTZD_IRd-_s13', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 13'}"
7248,"{'title': '852559', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9847_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 18;\tcytogenetic change: >3;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7249,"{'title': 'Blood Sample of subject 3 after inhalation; Group C: inhalation with 0.7 ppm FA 0h before sampling', 'description': 'Bl_Group_C_AI_subject_3', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 0 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 0 h;\tsubject: 3;\tgroup: C'}"
7250,"{'title': 'Lung Cancer 179T', 'description': 'Gene expression data from 179T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 55;\tstage: 1'}"
7251,"{'title': 'Clone A cells cultured for 48 hours rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
7252,"{'title': 'AML 7302', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: male;\tage: 50 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
7253,"{'title': 'Tumor Tum_Ph2_rep7', 'description': 'Tumor paired  20', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N0;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
7254,"{'title': 'Patient 5064 AML193', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 193;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7255,"{'title': 'M100', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: 0;\tage: 69;\tSex: F;\tcode: resection;\tclass: Unannotated;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
7256,"{'title': 'SH-SY5Y(ATCC)_RA_1d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
7257,"{'title': 'Endometrium-prog B (01b5848-1)', 'description': '01b5848-1.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group B', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d4;\tpregnancy status: non-pregnant;\tprogesterone serum level: group B (1-1.5 ng/ml)'}"
7258,"{'title': 'Pilocytic astrocytoma chip 7751', 'description': 'Pilocytic astrocytoma.  Chip ID 7751', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
7259,"{'title': 'Clone A cells treated with 1uM CsA and cultured for 24 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 1uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 1uM;\ttime: 24 hours'}"
7260,"{'title': 'S118', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S118', 'characteristics_ch1': 'patient id: P001;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
7261,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 12', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
7262,"{'title': 'CD31+ rep5 (endothelial study)', 'description': 'endothelial cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD31+ MACS sorted cells'}"
7263,"{'title': 'Quadriceps muscle at T0, control patient 1', 'description': 'Gene expression data from quadriceps muscle biopsy of control patient', 'type': 'RNA', 'source_name_ch1': 'Quadriceps muscle, control patient, T0', 'characteristics_ch1': 'tissue type: Quadriceps muscle;\tpatient group: total knee arthroplasty control patient;\ttime point: T0'}"
7264,"{'title': 'centroblast, tonsil#6', 'description': 'centroblast, tonsil#6', 'type': 'RNA', 'source_name_ch1': 'Inflamed non tumoral human tonsil#6', 'characteristics_ch1': 'cell suspension: Flow sorted cells;\tcell type: centroblast, tonsil'}"
7265,"{'title': 'Control, rep 3', 'description': 'Gene expression data from control HUVEC', 'type': 'RNA', 'source_name_ch1': 'HUVEC control', 'characteristics_ch1': 'cell type: Endothelial cell;\tagent: ethanol;\tdose: 0.1%'}"
7266,"{'title': 'newly diagnosed multiple myeloma 22', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
7267,"{'title': 'Proficiency_Site1_17', 'description': 'Performed by Operator 1 from Site1 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 16.66; Lot# = 035PO41658D'}"
7268,"{'title': 'class F, rep19', 'description': 'NEB_1060.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 84;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: _;\tlymphocyte percentage: _;\twhite blood count: _;\tinternational prognostic score (ips): 2.3'}"
7269,"{'title': 'D551, biological replicate 1', 'description': 'gene expression from D551, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'D551 cells from ATCC', 'characteristics_ch1': 'cell type: fibroblast;\tcell line: D551'}"
7270,"{'title': 'Muscle PCOS control 10', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
7271,"{'title': 'PBMC-2-RR-Pat.3 [wf20070130u133v2_U_20-Lc2-Pat.9-WV]', 'description': 'Post-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Post-interferon blood sample', 'characteristics_ch1': 'treatment status: Post-interferon'}"
7272,"{'title': 'Patient_07', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 7;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.51586790086378;\tproliferation index: 8.19473138862296'}"
7273,"{'title': 'AML 7114', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 54 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7274,"{'title': 'Blood_TD23461_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
7275,"{'title': 'VA58', 'description': '05-21634', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 81;\tgender: M;\tipi_stage: 3B;\ttxprimary: CHOP6-RITU-RAD;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 1.41;\tprogression-free_survival (years): 0.72'}"
7276,"{'title': 'EntorhinalCortex_male_85yrs_indiv46', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 85 years', 'characteristics_ch1': 'individual: 46, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 85'}"
7277,"{'title': '6455', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 72 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
7278,"{'title': 'AML with normal karyotype #248', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 27;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: >30;\tdisease state: de novo AML'}"
7279,"{'title': 'AML with normal karyotype #76', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 43;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 50;\tdisease state: de novo AML'}"
7280,"{'title': 'Huh7 cells treated with FH HDL, biological rep 1', 'description': 'Gene expression data from Huh7 cells treated with HDL from Normal or FH subjects in lipoprotein-depleted serum.', 'type': 'RNA', 'source_name_ch1': 'Human Huh7 cells, in culture', 'characteristics_ch1': 'cell line: Huh7;\ttreatment: familial hypercholesterolemia HDL'}"
7281,"{'title': 'newly diagnosed multiple myeloma 187', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
7282,"{'title': 'B52', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.5'}"
7283,"{'title': 'X23202', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
7284,"{'title': 'B86', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: pos;\ttumor type: Lobular;\ttumor size: 1.5'}"
7285,"{'title': 'Old sedentary subject, biological replicate (OS4)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old sedentary subject', 'characteristics_ch1': 'no additional information'}"
7286,"{'title': 'RTX9 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: F;\tage (y): 21;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Moderate-responder;\ttissue: synovium'}"
7287,"{'title': 'TC.DR-6', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
7288,"{'title': 'HIP control 1', 'description': 'arrayconsortium.tgen.org::biosample.434505;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 1;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 85 days'}"
7289,"{'title': 'C115', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.5'}"
7290,"{'title': 'newly diagnosed multiple myeloma 33', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: II'}"
7291,"{'title': 'X70135', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
7292,"{'title': 'Gingival tissue sample 1 from patient 65, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 65 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7293,"{'title': 'untreated-aza-3', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tDemethylation: aza;\tReplicate: 3'}"
7294,"{'title': 'UCR8_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
7295,"{'title': 'S001', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S001', 'characteristics_ch1': 'patient id: P089;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
7296,"{'title': 'brain_neurons_rep1', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'neurons from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 46'}"
7297,"{'title': 'CF630a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1463;\tdisease state: Asympt;\tgender: Male;\tage: 23;\trace: African American;\tblood cd4+ t  cell count (cells/ml): 259;\tplasma hiv-1     rna level   (copies/ml): 27200;\ttissue: lymph node'}"
7298,"{'title': 'VA57', 'description': '04-29264', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 19;\tgender: M;\tipi_stage: 1AE;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 2.61;\tprogression-free_survival (years): 2.61'}"
7299,"{'title': 'Gingival tissue sample 2 from patient 58, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 58 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7300,"{'title': 'Metastatic prostate cancer tissue pool WX2', 'description': 'hormone-refractory metastatic prostate cancer tissue pool from sample W1,W2,W3 and W4, replicates of WX1', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'metastatic, pooled, prostate cancer'}"
7301,"{'title': 'CC3', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'centrocytes donor 3', 'characteristics_ch1': 'centrocytes, isolated from tonsils by fluorescence-activated cell sorting'}"
7302,"{'title': 'Group B2-IVIG+IVMP-Post-4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, IVMP + IVIG post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: methylprednisolone (IVMP) + IVIG;\ttime: post-treatment'}"
7303,"{'title': 'Benign prostate tissue N3', 'description': 'benign prostate tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Benign, prostate tissue'}"
7304,"{'title': 'PCB153 treated HepG2 cells at T6, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines after 6 hours of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
7305,"{'title': 'GBM, TMZ/radiotherapy (106)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 106;\tage: 27.3;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 10.43;\tmgmt status: U'}"
7306,"{'title': 'breast normal 2', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal breast stroma', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: normal'}"
7307,"{'title': 'Septic Shock_biological rep44 04-0005', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.6;\toutcome: Nonsurvivor;\tgroup: B'}"
7308,"{'title': 'Huh7 cells_Mock Infected 48 hours_ rep3', 'description': 'Gene expression data from Huh7 cells treated with mock media for 48 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 48 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
7309,"{'title': 'Tumor 49', 'description': '08SE362', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
7310,"{'title': '10-0001_Sepsis_day3_189', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7311,"{'title': 'Gingival tissue sample 2 from patient 64, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 64 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7312,"{'title': 'newly diagnosed multiple myeloma 234', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: III'}"
7313,"{'title': 'ST-treated_6h replicate 1', 'description': ""Performed by UTMB microarray core per manufacturer's instructions"", 'type': 'RNA', 'source_name_ch1': 'THP-1 cells', 'characteristics_ch1': 'cell type: Human myelogenous leukemia (macrophage-like) cells;\tcell line: THP-1'}"
7314,"{'title': 'H416 Myclobutanil 10uM', 'description': 'H416 Myclobutanil 10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H416 Myclobutanil 10uM', 'characteristics_ch1': 'primary hepatocytes'}"
7315,"{'title': 'NSCLC EMC ADC2315N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
7316,"{'title': 'KT0755_0_L_training', 'description': 'KT0755_0_L_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, training set', 'characteristics_ch1': 'baseline, living donor, training set'}"
7317,"{'title': 'AML 2510', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 26 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7318,"{'title': 'X41010', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIC;\tConsolidated.Grade : 2'}"
7319,"{'title': 'AML 7191', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 45 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7320,"{'title': 'Replicate 1 for MDA175 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
7321,"{'title': 'GA_759', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7322,"{'title': 'AML with normal karyotype #96', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 39;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 61;\tdisease state: de novo AML'}"
7323,"{'title': 'monocytes_-LPS_2', 'description': '28h medium', 'type': 'RNA', 'source_name_ch1': 'blood, -LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 28h medium'}"
7324,"{'title': 'normal_colon_8 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: male;\tprotocol: surgery;\tage: 74;\tlocalization: ascending'}"
7325,"{'title': 'Blood - Control - 153A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 29;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
7326,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_26_4)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 41;\tSex: M'}"
7327,"{'title': '3.1.NDV.8', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 8 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: NDV;\thours post infection: 8'}"
7328,"{'title': 'C97286', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7225_Tumor;\tfab: M4;\tSex: F;\trace: H;\tage on study: 23;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7329,"{'title': 'Replicate 1 for UACC893 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
7330,"{'title': 'AML with normal karyotype #116', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 66;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 14;\tdisease state: de novo AML'}"
7331,"{'title': 'Control 70', 'description': '08SE391', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
7332,"{'title': 'Stretch I BEAS2b_ML02C', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - mechanical stretch', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
7333,"{'title': 'Huh7 cells cultured for 12 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 12 hours'}"
7334,"{'title': 'Endometrium-prog C (01b9515-2)', 'description': '01b9515-2.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group C', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d4;\tpregnancy status: non-pregnant;\tprogesterone serum level: group C (> 1.5ng/ml)'}"
7335,"{'title': '15-0004_Septic Shock_day1_207', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7336,"{'title': 'human macrophages treated with PG-LPS, biological rep1', 'description': 'Gene expression data from human macrophages treated with PG-LPS for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis-LPS', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: P. gingivalis lipopolysaccharide (LPS);\ttreatment time: 2 hours;\tday: 9'}"
7337,"{'title': 'C147', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.5'}"
7338,"{'title': 'AML 2293', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 57 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7339,"{'title': 'non-SS control gland, patient 16, batch 2', 'description': 'RNA from minor salivary gland', 'type': 'RNA', 'source_name_ch1': 'minor salivary gland', 'characteristics_ch1': 'tissue: minor salivary gland;\tdisease status: non-SS control'}"
7340,"{'title': 'Patient_6449_relapse', 'description': '6449R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 8;\tconclusions ig/tcr: some clonal evolution;\tselected: no'}"
7341,"{'title': '08SE860HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
7342,"{'title': 'whole blood_100812', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Female', 'characteristics_ch1': 'Autism no regression, Female'}"
7343,"{'title': 'Gingival tissue sample 1 from patient 18, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 18 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7344,"{'title': 'ALL without MLL - sample 50', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7345,"{'title': 'Stable-P9 (B737)', 'description': 'Stable-P9', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Stable'}"
7346,"{'title': 'CD34(+) hematopoietic progenitor cells for comparison', 'description': 'Gene expression data from CD34(+) hematopoietic progenitor cells', 'type': 'RNA', 'source_name_ch1': 'Human umbilical cord', 'characteristics_ch1': 'cell type: CD34+ hematopoietic progenitor cells;\ttreatment: none'}"
7347,"{'title': 'CD19_selected_B-cells_before_R_rep8', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before Rituximab (control)'}"
7348,"{'title': 'carcinoma_25 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 47;\tlocalization: caecum'}"
7349,"{'title': 'Patient 4385 AML71', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 71;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7350,"{'title': 'PGA-Hs_D-3', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7351,"{'title': 'Liver189N (mRNA expression)', 'description': 'surrounding noncancerous liver tissue, HBV+', 'type': 'RNA', 'source_name_ch1': 'surrounding noncancerous liver tissue', 'characteristics_ch1': 'case number: 189N;\ttissue: surrounding noncancerous liver tissue;\tdisease state: control;\tpathology: Chronic hepatitis;\tgender: M;\tage: 68;\tvirus: HBV'}"
7352,"{'title': 'AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 2', 'description': 'AP-2 gamma silenced', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: AP-2 gamma targetting siRNA 1;\tcell line: MCF7'}"
7353,"{'title': 'HBEC3-Rep2 Control treatment group (DMSO)', 'description': 'HBEC3-Rep2 Control treatment group (DMSO)', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
7354,"{'title': 'K_AR15', 'description': 'K_AR15', 'type': 'RNA', 'source_name_ch1': 'AR15 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1A'}"
7355,"{'title': 'Pt4 isolated pericardial adipocytes, biological rep1', 'description': 'Pt4_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 4', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 4'}"
7356,"{'title': 'GBM, TMZ/radiotherapy (90)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 90;\tage: 60.6;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 29.77;\tmgmt status: M'}"
7357,"{'title': 'Patient 5156 AML209', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 209;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7358,"{'title': 'Sputum from Stage III Severe, biological replicate 50', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 64;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
7359,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_70_05)', 'description': 'Gene expression data from whole blood 30 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 65;\tSex: F'}"
7360,"{'title': 'AML with normal karyotype #105', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 61;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 95.5;\tdisease state: de novo AML'}"
7361,"{'title': '11_0013C_Day1_25', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Female'}"
7362,"{'title': 'SCRC', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 1'}"
7363,"{'title': 'CLL_FISHnormal_rep9', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with no del13q', 'characteristics_ch1': 'female'}"
7364,"{'title': '2.1.NDV.6', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 6 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 6'}"
7365,"{'title': 'Gingival tissue sample 2 from patient 29, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 29 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7366,"{'title': 'No28LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No28;\tcell type: hepatocytes;\ttime point: before therapy'}"
7367,"{'title': 'No20LCMHpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No20;\tcell type: hepatocytes;\ttime point: before therapy'}"
7368,"{'title': 'class S, rep2', 'description': 'NEB_1061.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 25;\tsex: F;\tdisease stage: 2;\talbumin level: 41;\themoglobin level: 123;\tlymphocyte percentage: 10;\twhite blood count: 11;\tinternational prognostic score (ips): 1'}"
7369,"{'title': 'UNTREATED_1657', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
7370,"{'title': 'Patient_04', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 4;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.442330122421712;\tproliferation index: 8.90038334364493'}"
7371,"{'title': 'EntorhinalCortex_male_95yrs_indiv14', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 95 years', 'characteristics_ch1': 'individual: 14, C;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 95'}"
7372,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_27_5)', 'description': 'Gene expression data from whole blood 30 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 65;\tSex: M'}"
7373,"{'title': 'T116 U133p2', 'description': 'bulk breast tumor RNA from patient T116', 'type': 'RNA', 'source_name_ch1': 'T116', 'characteristics_ch1': 'breast tumor'}"
7374,"{'title': '692900', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7506_Tumor;\tfab: M0;\tSex: M;\trace: W;\tage on study: 39;\tcytogenetic change: del(5)(q22q33); t(10;11)(p13~p15;q22~q23) i(17)(q10);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
7375,"{'title': 'Insulin resistant patient 4 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
7376,"{'title': 'Gingival tissue sample 1 from patient 63, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 63 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7377,"{'title': 'CP_Str_08-028_CD90posi', 'description': 'Prostate tumor-associated stromal cells.', 'type': 'RNA', 'source_name_ch1': 'cancer prostate', 'characteristics_ch1': 'tissue: prostate;\tcell type: CD90+ MACS sorted cells;\tgleason: 3+4;\ttumor stage: T2c;\ttumor volume: 2.5 cc'}"
7378,"{'title': 'AML without MLL - sample 103', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7379,"{'title': 'group-1-pt-t33226222', 'description': 'group-1-pt-t33226222', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 18;\tgender: male;\tfinal disposition: 05: Home with services'}"
7380,"{'title': 'DLBCL biopsy, sample 2093', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
7381,"{'title': 'UNTREATED_616', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7382,"{'title': 'MCF7, biological rep2', 'description': 'Gene expression data from MCF7 breast cancer cell line expressing Estrogen receptor', 'type': 'RNA', 'source_name_ch1': 'MCF7 expressing Estrogen receptor alpha', 'characteristics_ch1': 'knockdown: control;\tcell line: MCF7'}"
7383,"{'title': 'CD19_selected_B-cells_after_RFC_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after RFC'}"
7384,"{'title': 'carcinoma_71 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 54;\tlocalization: descending'}"
7385,"{'title': 'Patient 8, biopsy; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
7386,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R20', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
7387,"{'title': 'TC.DR+-4', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
7388,"{'title': 'PBMCs vehicle treated for 24 hours,replicate 5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 24 hours,replicate 5', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
7389,"{'title': 'UCNR3_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
7390,"{'title': 'Subcutaneous adipose tissue, SAT43', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
7391,"{'title': 'NSCLC_AC_331', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 331.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
7392,"{'title': 'Control_biological rep15', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 2.9;\toutcome: Survivor'}"
7393,"{'title': 'KT0575_0_D_test1', 'description': 'KT0575_0_D_test1', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, test set1', 'characteristics_ch1': 'baseline, deceased donor, testset1'}"
7394,"{'title': 'AML with normal karyotype #39', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 44;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 58;\tdisease state: de novo AML'}"
7395,"{'title': 'Gingival tissue sample 2 from patient 18, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 18 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7396,"{'title': 'AML sample #19', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
7397,"{'title': 'AML with normal karyotype #222', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: positive;\tage: 39;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 45;\tdisease state: de novo AML'}"
7398,"{'title': 'Old trained subject, biological replicate (OT4)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old trained subject', 'characteristics_ch1': 'no additional information'}"
7399,"{'title': 'newly diagnosed multiple myeloma 260', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: III'}"
7400,"{'title': 'LTB1 stim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivio stimulation TB extract for 4 hrs', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tLatent'}"
7401,"{'title': 'Patient 5033 AML182', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 182;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7402,"{'title': 'DM2_F42_?_15', 'description': 'DM2 patient, age 42, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site:  unknown'}"
7403,"{'title': 'MDS patient 94', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
7404,"{'title': 'PGA_PA-D_229', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
7405,"{'title': '22074', 'description': '11725', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24299;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
7406,"{'title': 'AML 6363', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 23 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos?;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7407,"{'title': 'Muscle control 12', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
7408,"{'title': '150951', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6324_Tumor;\tfab: M0;\tSex: F;\trace: W;\tage on study: 39;\tcytogenetic change: del(5)(q22q33);\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7409,"{'title': 'lymphocytes_HD_M_55y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: male; Age: 55; Tissue: lymphocytes (blood); IT15 CAG repeats: 25/43'}"
7410,"{'title': 'Patient 3447 AML32', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 32;\tcohort: Discovery;\tkaryotype: t(7;12);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7411,"{'title': 'Lung Cancer 167T', 'description': 'Gene expression data from 167T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 53;\tstage: 2B'}"
7412,"{'title': 'Gingival tissue sample 4 from patient 65, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 65 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
7413,"{'title': 'Sputum from Stage II Moderate, biological replicate 12', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 71;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
7414,"{'title': 'N10176F3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7415,"{'title': 'CF63a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 23;\trace: African American;\tperipheral blood cd4+ t cells (cells/ml): 259;\tplasma hiv-1 rna levels (copies/ml): 27,200'}"
7416,"{'title': 'HeLa_SRA siRNA_rep2', 'description': 'Affymetrix HG U133+2 data', 'type': 'RNA', 'source_name_ch1': 'HeLa cells, SRA siRNA', 'characteristics_ch1': 'cell line: HeLa cancer cell line;\ttissue origin of cancer cell: cervix;\tprotocol: siRNA-mediated SRA depletion'}"
7417,"{'title': 'Replicate 3 for MCF7mimic72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 3 for MCF7mimic72h breast cell line'}"
7418,"{'title': 'ALL with MLL - sample 132', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7419,"{'title': 'muscle_preTZD_preClamp_IRd+_s49', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 49'}"
7420,"{'title': 'Blood sample from patient 173 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 173;\tday: Day 90;\tage (years): 56;\tsex: Female'}"
7421,"{'title': 'Old sedentary subject, biological replicate (OS9)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old sedentary subject', 'characteristics_ch1': 'no additional information'}"
7422,"{'title': 'Gingival tissue sample 1 from patient 30, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 30 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7423,"{'title': 'M104', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 72;\tSex: F;\tcode: resection;\tclass: Unannotated;\ttp53 mutation: 284G>GT | D259D/Y;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
7424,"{'title': 'X60169', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IC;\tConsolidated.Grade : 3'}"
7425,"{'title': 'group-1-pt-t34933880', 'description': 'group-1-pt-t34933880', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 47;\tgender: male;\tfinal disposition: 06: Home'}"
7426,"{'title': 'No24inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 2 No24RVR;\ttime point: under therapy'}"
7427,"{'title': 'MLD AML sample #43', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
7428,"{'title': 'Septic Shock_biological rep37', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1.2;\toutcome: Survivor'}"
7429,"{'title': 'MDS patient 62', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
7430,"{'title': 'Mature unstimulated biological replicate 2 (WEEV)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: none;\tcell line: BE(2)-C'}"
7431,"{'title': 'HF0990_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
7432,"{'title': '3.1.AF.0', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 0 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: AF;\thours post infection: 0'}"
7433,"{'title': 'Clinically localized primary prostate cancer P4', 'description': 'clinically localized prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Primary, localized, prostate cancer'}"
7434,"{'title': 'adenocarcinoma_14 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 80;\tlocalization: transverse'}"
7435,"{'title': 'C97464', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7227_Tumor;\tfab: M4;\tSex: F;\trace: H;\tage on study: 49;\tcytogenetic change: t(11;19)(q23;p13); del(20q);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7436,"{'title': 'Training_Site5_03', 'description': 'Performed by Operator 1 from Site5 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 28.29; Lot# = 035PO41658D'}"
7437,"{'title': 'Peripheral T-Cell lymphoma, unspecified 26', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-90', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 69;\tgender: female'}"
7438,"{'title': 'Replicate 1 for DU4475 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
7439,"{'title': 'AML with normal karyotype #65', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 26;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 63;\tdisease state: de novo AML'}"
7440,"{'title': 'Patient 4736 AML157', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 157;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7441,"{'title': 'AML 2511', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 35 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7442,"{'title': 'AML with normal karyotype #74', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 54;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 92;\tdisease state: de novo AML'}"
7443,"{'title': 'Patient_18', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 18;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.324453277931946;\tproliferation index: 6.94911260396531'}"
7444,"{'title': 'H438 Propiconazole 10uM', 'description': 'H438 Propiconazole 10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 Propiconazole 10uM', 'characteristics_ch1': 'primary hepatocytes'}"
7445,"{'title': 'ESCC_5', 'description': 'ESCC, TNM stage III, poorly differentiated', 'type': 'RNA', 'source_name_ch1': 'ESCC tumor tissue 5', 'characteristics_ch1': 'tissue: esophagus, tumor;\tgender: male, Japanese;\tage: 52'}"
7446,"{'title': 'PGA_PA-N_291', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
7447,"{'title': '296', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7497_Tumor;\tfab: M4;\tSex: M;\trace: W;\tage on study: 81;\tcytogenetic change: Normal;\tflt3 d835: 1;\tflt3 itd: 0;\tnpm1 ins: 1'}"
7448,"{'title': 'Normal_colon_14_12April05', 'description': 'Normal_colon_14_12April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, ascending', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
7449,"{'title': 'AML 2685', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 42 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: -9q;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7450,"{'title': 'Muscle PCOS control 7', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
7451,"{'title': 'CD31+ rep4 (endothelial study)', 'description': 'endothelial cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD31+ MACS sorted cells'}"
7452,"{'title': '509733', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6339_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 38;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7453,"{'title': 'NY44', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: NA;\tcode: transplant;\tclass: Inflammation;\ttp53 mutation: 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
7454,"{'title': 'THRBL_lymph_node_case4', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: male, Age: 52, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: IV, IPI prognostic score: high, follow-up: 3 years; status at last follow-up: alive with disease'}"
7455,"{'title': 'Cervical cancer-lymph node negative-11-35', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 51.6;\tfigo stage: 2a'}"
7456,"{'title': 'hg_NY15', 'description': 'high-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; high-grade dysplastic liver tissue', 'characteristics_ch1': 'high-grade dysplastic liver tissue'}"
7457,"{'title': 'mRNA of OT-HGG007, Anaplastic Oligodendroglioma, 16.7 years, Post-ALL', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 16.7 years', 'characteristics_ch1': 'disease: Anaplastic Oligodendroglioma;\tage: 16.7 years; Other: Post-ALL'}"
7458,"{'title': 'NSCLC EMC ADC2247N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
7459,"{'title': 'Sputum from Stage III Severe, biological replicate 42', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 63;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
7460,"{'title': 'N8627A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7461,"{'title': 'D28B', 'description': '05-24065', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 66;\tgender: M;\tipi_stage: 1A;\ttxprimary: CHOP4-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 2.48;\tprogression-free_survival (years): 2.48'}"
7462,"{'title': 'C991148', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7375_Tumor;\tfab: M4;\tSex: F;\trace: C;\tage on study: 30;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
7463,"{'title': ""Wilms' FFPE E-1"", 'description': 'L747-A-HG-U133_Plus_2-01-1 (S06-965W-FFPE)', 'type': 'RNA', 'source_name_ch1': 'Formalin-fixed paraffin-embedded tissue, kidney tumor', 'characteristics_ch1': ""tissue: Wilms' Tumor;\tfixation: FFPE;\tblock age (at extraction in years): 1.5;\tbiological replicate: rep-1;\tdonor: B tumor""}"
7464,"{'title': 'DC_Stimulated_Rep1', 'description': 'Circulating monocyte derived DCs were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure. At day four 10 million immature DCs were either left unstimulated or stimulated using plate bound anti-DC-SIGN antibody for 2 hr. Three replicates of non-stimulated or stimulated cells were taken and used to extract total RNA.', 'type': 'RNA', 'source_name_ch1': 'primary dendritic cells (DCs)', 'characteristics_ch1': 'Buffy coats were obtained from the National Blood Centre. Circulating myeloid dendritic cells (DCs) were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.'}"
7465,"{'title': 'Recurrent GBM, radiotherapy (212R)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: recurrent GBM;\tpatient: 212;\tage: 59.3;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 16.22;\tmgmt status: U'}"
7466,"{'title': 'MERLION_X02K02039', 'description': 'MERLION_X02K02039', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=62, state=NA', 'characteristics_ch1': 'pT2N0, male, age=62, state=NA'}"
7467,"{'title': 'G174-NS', 'description': 'U133Plus2_122906L_DK02.CEL', 'type': 'RNA', 'source_name_ch1': 'Giant cell glioblastoma derived cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: malignant;\tcell type: cell line;\tcell type: glioblastoma'}"
7468,"{'title': 'UNTREATED_1015', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7469,"{'title': '01-0038A_Sepsis_day1_4', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7470,"{'title': 'Muscle septic k60', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:female, Age:67yrs'}"
7471,"{'title': 'KT0516_24_L_test3', 'description': 'KT0516_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
7472,"{'title': 'AML with normal karyotype #251', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: >30;\tdisease state: de novo AML'}"
7473,"{'title': 'IFNβ_2070', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
7474,"{'title': 'Lung Normal 124N', 'description': 'Gene expression data from 124N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 62;\tstage: n/a'}"
7475,"{'title': 'CD34+cells_normal_bone_marrow_5', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'CD34+ cells sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
7476,"{'title': 'Growing cells, rep2', 'description': 'gene expression data from growing cells', 'type': 'RNA', 'source_name_ch1': 'Growing activated hepatic stellate cells', 'characteristics_ch1': 'fibrogenic cells of the liver'}"
7477,"{'title': 'No20LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No20;\tcell type: lymphocytes;\ttime point: before therapy'}"
7478,"{'title': 'human left atrial_control_3', 'description': 'K7_control', 'type': 'RNA', 'source_name_ch1': 'human left atrial appendage - control', 'characteristics_ch1': 'tissue: left atrial appendage'}"
7479,"{'title': 'conventional renal cell cancer; cRCCa_HD172B', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7480,"{'title': 'cord blood 14', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.12', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.12;\t'}"
7481,"{'title': 'Group B2-IVIG+IVMP-Post-5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, IVMP + IVIG post-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: methylprednisolone (IVMP) + IVIG;\ttime: post-treatment'}"
7482,"{'title': 'Control (dupl) sample 1b', 'description': 'The arrays included duplicates from four normal controls and from two BRCA1 mutation carriers and single arrays from another two BRCA1 mutation carriers', 'type': 'RNA', 'source_name_ch1': 'Breast epithelial cells from normal controls', 'characteristics_ch1': 'Breast epithelial cells'}"
7483,"{'title': 'MERLION_X01K05273', 'description': 'MERLION_X01K05273', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=57, state=0', 'characteristics_ch1': 'pT2N0, male, age=57, state=0'}"
7484,"{'title': 'AML with MLL - sample 133', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7485,"{'title': 'Muscle septic k56', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, septic patient', 'characteristics_ch1': 'Gender:female, Age:69yrs'}"
7486,"{'title': 'AML 6238', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 30 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: 11q23;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: neg'}"
7487,"{'title': 'GBM, TMZ/radiotherapy (288)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 288;\tage: 44.5;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 26.78;\tmgmt status: M'}"
7488,"{'title': 'Non-tumoral,  (1076)', 'description': 'patient: 1076; age: NA; gender: NA; treatment: NA; survival status: NA; survival time in months: NA', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: non-tumoral;\tpatient: 1076;\tage: NA;\tgender: NA;\ttreatment: NA;\tsurvival status: NA;\tsurvival time in months: NA'}"
7489,"{'title': 'NSCLC EMC SCC2305N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
7490,"{'title': 'dmso: m4: i1: d05', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Month: 4; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tMonth: 4;\tReplicate: 1;\tBatch: d05'}"
7491,"{'title': '51005', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IV;\tMicropapillary feature NA;\t(LMP) implants NA;\tAdjacent Brenner Tumor;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
7492,"{'title': '3.2.NDV.6', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 6 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 6'}"
7493,"{'title': 'Blood sample from patient 180 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 180;\tday: Day 180;\tage (years): 63;\tsex: Female'}"
7494,"{'title': 'bladder_T2-4_pool-3', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, T2, T3 or T4 (high grade)', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 5 individual samples.'}"
7495,"{'title': 'C97592', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7200_Tumor;\tfab: M4;\tSex: F;\trace: H;\tage on study: 30;\tcytogenetic change: inv(16)(p13q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7496,"{'title': 'Stable-P5', 'description': 'Stable-P5', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Stable'}"
7497,"{'title': 'M94', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 67;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\ttp53 mutation: 0;\tctnnb1 mutation: 236C>CT,p.S33S/F;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
7498,"{'title': 'muscle_preTZD_preClamp_IRd_s25', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 25'}"
7499,"{'title': 'Patient 5004 AML172', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 172;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7500,"{'title': 'Angioimmunoblastic T-cell lymphoma 31', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-84', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 62;\tgender: male'}"
7501,"{'title': 'CO3', 'description': 'Colonic mucosal gene expression data from control individual', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from control individual', 'characteristics_ch1': 'tissue: Colon;\tdisease: Control;\tresponse to infliximab: Not applicable;\tbefore or after first infliximab treatment: Not applicable'}"
7502,"{'title': 'Activated CD8+ T-cells with anti-CD3, anti-CD28 and IL-12 and harvested after 8 hours incubation', 'description': 'Gene expression data from resting CD8+ T-cells.;\tCD8-T8', 'type': 'RNA', 'source_name_ch1': 'Normal CD8+ T-cell subset', 'characteristics_ch1': 'cell type: CD8+ T-cell'}"
7503,"{'title': 'IPMC 4', 'description': 'Gene expression data from microdissected epithelial cells of IPMC', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMC 4', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous carcinoma (IPMC)'}"
7504,"{'title': 'T11147A3: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
7505,"{'title': 'human BM MSC TGFb3 stimulated day 3 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 3', 'type': 'RNA', 'source_name_ch1': 'donor 6, stimulated with TGFb3 for 3 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 3 days'}"
7506,"{'title': 'IFNβ_1148', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7507,"{'title': 'HF1613_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
7508,"{'title': 'GBM, TMZ/radiotherapy (360)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 360;\tage: 55.8;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 22.89;\tmgmt status: M'}"
7509,"{'title': 'DS350b', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1335;\tdisease state: Asympt;\tgender: Male;\tage: 32;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 400;\tplasma hiv-1     rna level   (copies/ml): 15284;\ttissue: lymph node'}"
7510,"{'title': 'Control_biological rep20 11-0036', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0.2;\toutcome: n/a;\tgroup: n/a'}"
7511,"{'title': 'Sputum from Stage III Severe, biological replicate 29', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 62;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
7512,"{'title': 'ALL without MLL - sample 52', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7513,"{'title': 'AML sample #89', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00621;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
7514,"{'title': 'Insulin sensitive patient 9 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin sensitive'}"
7515,"{'title': 'newly diagnosed multiple myeloma 12', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
7516,"{'title': 'newly diagnosed multiple myeloma 98', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
7517,"{'title': 'VCX control 7', 'description': 'arrayconsortium.tgen.org::biosample.435279;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Primary Visual Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: VCX control 7;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Primary Visual Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 79 years'}"
7518,"{'title': 'PGA-Hs_S-17', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7519,"{'title': 'Gingival tissue sample 2 from patient 63, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 63 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7520,"{'title': 'Gingival tissue sample 2 from patient 89, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 89 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7521,"{'title': 'Control Huh7_Vec#1', 'description': 'Replicates were done by using the same total RNA preparation', 'type': 'RNA', 'source_name_ch1': 'Huh7 Cells with PCI-Neo stable integration into genome', 'characteristics_ch1': 'Huh7 Cells with PCI-Neo stable integration into genome'}"
7522,"{'title': 'AML 2200', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 38 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7523,"{'title': 'Scz-8', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tS8', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness-schizophrenia;\tSex: F;\tage: 36;\ttissue ph: 6.28;\tpmi (hrs): 45;\ttype of drug: Haloperidol;\tdrug dose (chlorpromazine equivalents): 160 mg'}"
7524,"{'title': 'SH-SY5Y(ECACC)_BDNF_3d_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
7525,"{'title': 'heterozygot FH P273', 'description': 'Gene expression data from the heterozygous FH participant D', 'type': 'RNA', 'source_name_ch1': 'heterozygot FH P273 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: heterozygote FH'}"
7526,"{'title': '5353', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 74 years, FAB M4, cytogenetic good risk, CEBPA wild type'}"
7527,"{'title': 'Training_Site5_05', 'description': 'Performed by Operator 1 from Site5 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
7528,"{'title': 'neuron_rep8', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:46, gender:male, diagnostic group: control, PMI:31h'}"
7529,"{'title': 'S047', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S047', 'characteristics_ch1': 'patient id: P069;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 60'}"
7530,"{'title': 'T30617', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30617;\tsample: tumor'}"
7531,"{'title': 'Monocyte cell line, control 3', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: serum starved'}"
7532,"{'title': 'PBMCs vehicle treated for 2 hours,replicate 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 2 hours,replicate 3', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
7533,"{'title': 'Control_biological rep30 15-0002', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 1.8;\toutcome: Survivor;\tgroup: n/a'}"
7534,"{'title': 'Scarmbled control knockdown, replicate 2', 'description': 'Gene expression data from HeLa cells infected with control retrovirus', 'type': 'RNA', 'source_name_ch1': 'HeLa cells infected with control retrovirus', 'characteristics_ch1': 'cell line: HeLa cervical carcinoma'}"
7535,"{'title': 'lg_NY11', 'description': 'low-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; low-grade dysplastic liver tissue', 'characteristics_ch1': 'low-grade dysplastic liver tissue'}"
7536,"{'title': 'DietSensitive _1 day_subject5', 'description': 'DietSensitive _1 day_subject5', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 5;\tgender: Female'}"
7537,"{'title': 'newly diagnosed multiple myeloma 180', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: II'}"
7538,"{'title': 'colon_CRC_1146', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
7539,"{'title': 'S152', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S152', 'characteristics_ch1': 'patient id: P013;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
7540,"{'title': 'newly diagnosed multiple myeloma 110', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: II'}"
7541,"{'title': 'PCSC-2 sphere biol repl 2', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-2 spheres 7 days in SCM-1% KO', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-2;\tculture type: sphere'}"
7542,"{'title': 'Sputum from Stage IV Severe, biological replicate 9', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 73;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39315'}"
7543,"{'title': 'X23178', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
7544,"{'title': '01_0024_SepticShock_Day1_118', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0024_Patient, Day1'}"
7545,"{'title': 'Proficiency_Site10_23', 'description': 'Performed by Operator 1 from Site10 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 64.7; Lot# = 065PO36893A'}"
7546,"{'title': 'newly diagnosed multiple myeloma 289', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
7547,"{'title': 'human BM MSC TGFb3 stimulated day 1 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 1', 'type': 'RNA', 'source_name_ch1': 'donor 6, stimulated with TGFb3 for 1 day', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 1 day'}"
7548,"{'title': 'MDS patient 21', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
7549,"{'title': 'CLL cells  PB  patient #10', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #10'}"
7550,"{'title': 'No1pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No1RVR;\ttime point: before therapy'}"
7551,"{'title': 'KT0781_0_D_training', 'description': 'KT0781_0_D_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, training set', 'characteristics_ch1': 'baseline, deceased donor, training set'}"
7552,"{'title': 'AML with normal karyotype #158', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
7553,"{'title': 'group-1-pt-t24884150', 'description': 'group-1-pt-t24884150', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 45;\tgender: male;\tfinal disposition: 05: Home with services'}"
7554,"{'title': 'AML 7070', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 39 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7555,"{'title': 'NSG415', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): NA;\tdisease activity (das28_v3): NA;\tresponse to anti-tnf therapy: NA'}"
7556,"{'title': 'AML sample #81', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00510;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
7557,"{'title': 'platelet_sickle_10', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
7558,"{'title': '22064', 'description': '11699', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: African American;\tGender: M;\tTSP_Patient# 24289;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
7559,"{'title': 'humanMDM_Healthy_untreated', 'description': 'see Affymetrix standard protocol', 'type': 'RNA', 'source_name_ch1': 'humanMDM_Healthy_untreated', 'characteristics_ch1': 'monocyte-derived macrophages of 13 male healthy subjects'}"
7560,"{'title': 'hES_BG01_rep4_081006_14', 'description': 'Gene expression data from hES line BG01', 'type': 'RNA', 'source_name_ch1': 'hES line BG01', 'characteristics_ch1': 'cell line: hES line BG01'}"
7561,"{'title': 'test experiment not for use [wf20060926u133v2_U_02_B2-Pat.1-GD-alpha]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
7562,"{'title': 'ALL without MLL - sample 23', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7563,"{'title': 'csc: m1: i2: d01', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 1; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 1;\tReplicate: 2;\tBatch: d01'}"
7564,"{'title': 'Bronchial epithelial cells, day 28, donor 3', 'description': 'Bronchial epithelial cells, day 18, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 28 of air-liquid interface culture'}"
7565,"{'title': 'adenocarcinoma_19 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 60;\tlocalization: descending'}"
7566,"{'title': 'Cell line C5.2_D_3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
7567,"{'title': 'miR-124 transfection for 4 hours', 'description': 'miR-124 transfection for 4 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
7568,"{'title': 'Lung Cancer 154T', 'description': 'Gene expression data from 154T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 73;\tstage: 1B'}"
7569,"{'title': 'newly diagnosed multiple myeloma 71', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
7570,"{'title': 'Adult T-cell leukemia/lymphoma-2', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-12', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 47;\tgender: male'}"
7571,"{'title': '3493', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 66 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type'}"
7572,"{'title': 'mRNA of GBM-HGG001, Glioblastoma, 5.8 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 5.8 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 5.8 years'}"
7573,"{'title': 'homozygot FH P253', 'description': 'Gene expression data from the homozygous FH participant K2', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: homozygote FH'}"
7574,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 12 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 12 hours'}"
7575,"{'title': 'DS35b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 32;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 400;\tplasma hiv-1 rna levels (copies/ml): 15,284'}"
7576,"{'title': 'AML 2668', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 41 years;\tscore: FAB M0;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7577,"{'title': 'AML sample #3', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
7578,"{'title': 'HF0442-5_U133P2', 'description': 'Brain tissue from  patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from  patient', 'characteristics_ch1': 'Histopathological diagnostic:'}"
7579,"{'title': 'PCB77 treated HepG2 cells at T0, biological replicate 2', 'description': 'Gene expression data from HepG2 cell lines before PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation before PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
7580,"{'title': 'EC control 13', 'description': 'arrayconsortium.tgen.org::biosample.434055;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 13;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 78 years'}"
7581,"{'title': 'T143 U133p2', 'description': 'bulk breast tumor RNA from patient T143', 'type': 'RNA', 'source_name_ch1': 'T143', 'characteristics_ch1': 'breast tumor'}"
7582,"{'title': 'Patient 4721 AML149', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 149;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: MLL-PTD'}"
7583,"{'title': 'Blood sample from patient 173 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 173;\tday: Day 180;\tage (years): 56;\tsex: Female'}"
7584,"{'title': 'renal oncocytoma; RO_HD171A', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7585,"{'title': 'Muscle control 6', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
7586,"{'title': 'AML with normal karyotype #64', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 39;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 93;\tdisease state: de novo AML'}"
7587,"{'title': 'Monocyte cell line, control 4', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: serum starved'}"
7588,"{'title': 'PNS034', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.6;\tdisease activity (das28_v3): 3.05;\tresponse to anti-tnf therapy: RESPONSE'}"
7589,"{'title': 'SI14', 'description': 'Gene expression data from Standard Immunotherapy 14', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 14', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
7590,"{'title': 'control virus-infected replicate 1 (monocytes)', 'description': 'Adenovirus-infected monocytes', 'type': 'RNA', 'source_name_ch1': 'Primary human monocytes', 'characteristics_ch1': 'Monocytes from buffy coat preparation'}"
7591,"{'title': 'X70070', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IA;\tConsolidated.Grade : 1'}"
7592,"{'title': 'whole blood_100537', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
7593,"{'title': 'Subcutaneous adipose tissue, SAT45', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
7594,"{'title': 'Metastatic prostate cancer W4', 'description': 'hormone-refractory metastatic prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Metastatic, prostate cancer'}"
7595,"{'title': 'Bronchial epithelial cells, day 1, donor 1', 'description': 'Bronchial epithelial cells, day 1, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 1 of air-liquid interface culture'}"
7596,"{'title': 'CXCL4_B', 'description': 'CXCL4_B', 'type': 'RNA', 'source_name_ch1': 'primary human monocyte-derived macrophages', 'characteristics_ch1': 'cell type: primary human monocyte-derived macrophages;\tdifferentiation factor: CXCL4'}"
7597,"{'title': 'HF0189_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
7598,"{'title': 'newly diagnosed multiple myeloma 191', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
7599,"{'title': 'Control-9', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc1', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 53;\ttissue ph: 6.43;\tpmi (hrs): 12;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
7600,"{'title': 'Patient 5031 AML180', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 180;\tcohort: Validation;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7601,"{'title': 'Patient_6633_relapse', 'description': '6633R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pro-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 68;\tconclusions ig/tcr: stable;\tselected: yes'}"
7602,"{'title': 'N30582', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30582;\tsample: normal'}"
7603,"{'title': 'Cervical cancer-lymph node negative-08-32', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 47.4;\tfigo stage: 1b1'}"
7604,"{'title': 'group-1-pt-t26802595', 'description': 'group-1-pt-t26802595', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 27;\tgender: male;\tfinal disposition: 06: Home'}"
7605,"{'title': '02-0001_Septic Shock_day1_59', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7606,"{'title': 'Sputum from Stage II Moderate, biological replicate 33', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 67;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
7607,"{'title': 'NSG506', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.65;\tdisease activity (das28_v3): 3.51;\tresponse to anti-tnf therapy: MEDIUM'}"
7608,"{'title': 'colon_IBD_1118', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
7609,"{'title': '01_0026_SepticShock_Day1_114', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0026_Patient, Day1'}"
7610,"{'title': 'Monocyte_patient41_time11', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:Caucasian,Age:33,VAP day:5'}"
7611,"{'title': 'IFNβ_1523', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7612,"{'title': 'mesenchymal stem cells, lot#4F1127, 4th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F1127, passage number 4', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F1127, 4th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
7613,"{'title': 'GliNS2', 'description': 'U133Plus2_122906L_DK17.CEL', 'type': 'RNA', 'source_name_ch1': 'Glioblastoma derived cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: malignant;\tcell type: cell line;\tcell type: glioblastoma'}"
7614,"{'title': 'Sample 27 perihematomal area', 'description': 'Gene expression data from human brain samples 5h after intracerebral hemorrhage.', 'type': 'RNA', 'source_name_ch1': 'Human brain sample of intracerebral hemorrhage perihematomal area', 'characteristics_ch1': 'tissue: brain;\tage: 72;\tgender: female'}"
7615,"{'title': 'Septic Shock_biological rep57', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1;\toutcome: Survivor'}"
7616,"{'title': 'HF1587_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
7617,"{'title': 'AML 2225', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 47 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7618,"{'title': 'S012_Scz_M_63', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 63;\tpost-mortem delay: 30h;\tph: 6.5'}"
7619,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R14', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 62.38;\t%cd3cd8: 31.85;\t%cd8+cd28-: 10.90;\t%cd8+cd28+: 12.52;\t%cd4cd25cd62l: 4.45;\t%cd3delta1: 4.93;\t%cd3delta2: 1.63;\tratio delta1/delta2: 3.02;\t%cd3gammadelta: 4.73;\t%cd3alphabeta: 95.13;\t%cd4cd8-ab+(dn): 3.06;\t%cd4 cd62l+cd45+: 47.29;\t%cd4 cd62l-cd45+: 0.81;\t%cd4 cd62l - cd45-: 14.06;\t%cd4cd62l+cd45-: 37.84;\t%cd4 ccr7+ cd45 -: 20.56;\t%cd4 ccr7+ cd45+: 45.57;\t%cd4 ccr7 - cd45+: 6.92;\t%cd4 ccr7 – cd45-: 26.95;\t%cd8 cd62l+ cd45-: 10.64;\t%cd8cd62l+ cd45+: 32.10;\t%cd8cd62l- cd45+: 29.01;\t%cd8cd62l- cd45 -: 28.25;\t%cd8ccr7+ cd45-: 2.09;\t%cd8ccr7+ cd45+: 26.03;\t%cd8ccr7-cd45+: 38.04;\t%cd8ccr7-cd45 -: 33.84;\t%cd3-cd56+cd16+: 12.71;\t%nkts: 11.42;\t%cd19: 9.65;\t%cd4foxp3+: 3.37'}"
7620,"{'title': 'Bleomycin-treated rep4', 'description': 'BJ fibroblasts artificially-aged', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Human foreskin BJ fibroblasts;\t100ug/ml of bleomycin sulfate for 24hr, 72 serum-free incubation in 3% O2'}"
7621,"{'title': 'Bronchial epithelial cells, day 1, donor 3', 'description': 'Bronchial epithelial cells, day 1, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 1 of air-liquid interface culture'}"
7622,"{'title': 'N10608K3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7623,"{'title': 'VA136', 'description': '03-16394', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: NC;\tpathology: DLBC;\ttissue: spleen;\tage: 21;\tgender: M;\tipi_stage: 4B;\ttxprimary: CHOP2-RITU-SPLE;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 0.40;\tprogression-free_survival (years): 0.40'}"
7624,"{'title': 'MCF-7_Si-Wu-Tang_0.0256mg/ml_rep3', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
7625,"{'title': 'HF1606_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
7626,"{'title': 'Blood Sample of subject 28 after inhalation; Group B: inhalation with 0.7 ppm FA 24 h before sampling', 'description': 'Bl_Group_B_AI_subject_28', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 24 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 24 h;\tsubject: 28;\tgroup: B'}"
7627,"{'title': '05-0003_Septic Shock_day1_74', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7628,"{'title': 'Clone A  cells treated with 5uM CsA and cultured for 48 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
7629,"{'title': 'ci_NY43', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
7630,"{'title': 'ALL without MLL - sample 8', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7631,"{'title': '09_0001_SepticShock_Day1_78', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '09_0001_Patient, Day1'}"
7632,"{'title': 'AML 2203', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 37 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7633,"{'title': 'Replicate 3 for MCF7control breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 mir-221/222 mimic control at 18h'}"
7634,"{'title': 'AML sample #27', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00065;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
7635,"{'title': 'Patient 17, biopsy; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
7636,"{'title': 'C99618', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7211_Tumor;\tfab: M4;\tSex: F;\trace: C;\tage on study: 22;\tcytogenetic change: inv(16)(p13q22); add(20)(q13.3);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7637,"{'title': 'C99430', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6608_Tumor;\tfab: M2;\tSex: F;\trace: C;\tage on study: 35;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
7638,"{'title': 'normal Post ECP, biological rep3', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'normal Post ECP', 'characteristics_ch1': 'disease state: normal;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
7639,"{'title': 'X484', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
7640,"{'title': 'group-2-pt-t20628135', 'description': 'group-2-pt-t20628135', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 50;\tgender: female;\tfinal disposition: 06: Home'}"
7641,"{'title': 'MERLION_X00K06181', 'description': 'MERLION_X00K06181', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:50, state:1', 'characteristics_ch1': 'pT2N0, male, age:50, state:1'}"
7642,"{'title': '777 - mAdbID:66369', 'description': 'mAdb experiment ID: 66369', 'type': 'RNA', 'source_name_ch1': '777', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 777;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 4.27;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
7643,"{'title': 'newly diagnosed multiple myeloma 207', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: II'}"
7644,"{'title': 'newly diagnosed multiple myeloma 69', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
7645,"{'title': '245', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6319_Tumor;\tfab: M1;\tSex: F;\trace: W;\tage on study: 68;\tcytogenetic change: trisomy 21;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7646,"{'title': '22070', 'description': '11721', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24295;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
7647,"{'title': 'Peripheral T-Cell lymphoma, unspecified 32', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-124', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 82;\tgender: female'}"
7648,"{'title': 'Gastric GIST 16', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 41;\tTumor size: 4;\tKIT mutation: Exon 11'}"
7649,"{'title': 'CDcNR4_afterT', 'description': 'Colonic mucosal gene expression data from CDc non-responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
7650,"{'title': 'AML sample #15', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MLL_00088;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
7651,"{'title': 'class S, rep64', 'description': 'VAN_00475.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 31;\tsex: M;\tdisease stage: 2;\talbumin level: 42;\themoglobin level: 155;\tlymphocyte percentage: 19;\twhite blood count: 9.3;\tinternational prognostic score (ips): 2'}"
7652,"{'title': 'VM27b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Female;\tage: 40;\trace: African American;\tperipheral blood cd4+ t cells (cells/ml): 112;\tplasma hiv-1 rna levels (copies/ml): 12,046'}"
7653,"{'title': 'Patient 3, colonocytes; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'Control'}"
7654,"{'title': 'Patient 11, biopsy; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
7655,"{'title': 'PBMCs_LB_before exercise_12', 'description': 'LB_Pre_019-TP', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 18;\tbefore-exercise'}"
7656,"{'title': 'whole blood_100652', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
7657,"{'title': 'B54', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: II;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 1.3'}"
7658,"{'title': 'csc: m4: i1: d05', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 4; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 4;\tReplicate: 1;\tBatch: d05'}"
7659,"{'title': 'conventional renal cell cancer; cRCCb_HD110B', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7660,"{'title': 'S058', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S058', 'characteristics_ch1': 'patient id: P088;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
7661,"{'title': 'Cell line HB4a_DR6', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
7662,"{'title': 'breast normal 5', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal breast stroma', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: normal'}"
7663,"{'title': 'adipose_postTZD_IRd-_s4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 4'}"
7664,"{'title': 'Monocyte_patient41_time9', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:Caucasian,Age:33,VAP day:5'}"
7665,"{'title': 'AML with normal karyotype #27', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 37;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 56;\tdisease state: de novo AML'}"
7666,"{'title': 'Sample 31 perihematomal area', 'description': 'Gene expression data from human brain samples 5h after intracerebral hemorrhage.', 'type': 'RNA', 'source_name_ch1': 'Human brain sample of intracerebral hemorrhage perihematomal area', 'characteristics_ch1': 'tissue: brain;\tage: 86;\tgender: male'}"
7667,"{'title': 'p63shRNA_B1, p63-depleted', 'description': 'None', 'type': 'RNA', 'source_name_ch1': 'Cervical carcinoma', 'characteristics_ch1': 'Age: 66 yrs Gender: Female  Ethnicity: Caucasian'}"
7668,"{'title': 'DLBCL biopsy, sample 2024', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
7669,"{'title': 'control participant P307', 'description': 'Gene expression data from control participant KP', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
7670,"{'title': 'AML 7121', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 49 years;\tscore: FAB M2;\trisk: unknown;\tcebpa: wild type;\tkaryotype: failure;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7671,"{'title': 'sample 28, brca1 mutation positive, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: luteal;\tsample identifier: 28'}"
7672,"{'title': 'Replicate 2 for MB231untreated72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 2 for MB231untreated72h breast cell line'}"
7673,"{'title': 'AML with normal karyotype #54', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: n./a.;\tage: 59;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 78;\tdisease state: de novo AML'}"
7674,"{'title': 'Monocyte High PBM 3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Circulating monocytes in low-PBM phase', 'characteristics_ch1': 'Monocyte-High-PBM 3'}"
7675,"{'title': 'Human Hepatocytes_Doxorubicin, Donor 2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 72; reason for liver resection: Liver metastasis, gastrointestinal stromal tumor'}"
7676,"{'title': 'W12 cervical ectokeratinocytes, Series 1 passage 19 (p19) #1', 'description': 'W12 cervical ectokeratinocytes; a model that recapitulates features of neoplastic progression in vitro; originally described in Stanley et al 1989, PMID 2467886;\tW12 Series 1 passage 19 (p19) #1', 'type': 'RNA', 'source_name_ch1': 'W12 passage 19 replicate 1 of 3', 'characteristics_ch1': 'gender: Female;\tcell line: W12 cervical ectokeratinocytes;\tanatomical site: Cervix;\tpassage: 19 (p19)'}"
7677,"{'title': 'Patient 21, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
7678,"{'title': 'SH-SY5Y(ATCC)_RA_6h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
7679,"{'title': 'GBM, TMZ/radiotherapy (222)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 222;\tage: 61.6;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 11.84;\tmgmt status: U'}"
7680,"{'title': '11-0040A_SIRS_day1_129', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7681,"{'title': 'patient Pre ECP, biological rep3', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'CTCL patient Pre ECP', 'characteristics_ch1': 'disease state: cutaneous T cell lymphoma;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
7682,"{'title': 'X44196', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IB;\tConsolidated.Grade : 1'}"
7683,"{'title': 'newly diagnosed multiple myeloma 46', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
7684,"{'title': 'TNS1A', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siLincTNS1;\treplicate: 1'}"
7685,"{'title': '10-0021A_Day1_19', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Male;\tSurvivor;\torganism: None'}"
7686,"{'title': '17-0001A_Septic Shock_day1_216', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7687,"{'title': 'PNS044', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.92;\tdisease activity (das28_v3): 2.73;\tresponse to anti-tnf therapy: RESPONSE'}"
7688,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_1d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
7689,"{'title': 'Chlamydia pneumoniae infected (10)', 'description': 'Chlamydia pneumoniae infected (10)', 'type': 'RNA', 'source_name_ch1': 'Chlamydia pneumoniae infected', 'characteristics_ch1': 'infection: Chlamydia pneumoniae;\ttissue: Dendritic cells derived from human monocytes'}"
7690,"{'title': 'colonic_crypt_epithelial_cells_adenoma_13 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: adenoma;\tsex: female'}"
7691,"{'title': 'HepG2_HNF4a&HNF4g_knockdown1_rep3', 'description': 'HepG2_HNF4a&HNF4gknockdouwn1_try3', 'type': 'RNA', 'source_name_ch1': 'HNF4a&HNF4g_knockdown1', 'characteristics_ch1': 'cell line: HepG2;\tcell type: hepatocellular carcinoma'}"
7692,"{'title': 'PGA_PA-N_118', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
7693,"{'title': 'S015_Scz_M_56', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 56;\tpost-mortem delay: 16.5h;\tph: 6.4'}"
7694,"{'title': 'AML sample #67', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
7695,"{'title': 'AR-P14', 'description': 'AR-P14', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
7696,"{'title': 'neuron_rep9', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:35, gender:male, diagnostic group: bipolar disorder, PMI:35h'}"
7697,"{'title': 'DM2_F65_?_14', 'description': 'DM2 patient, age 65, gender Female', 'type': 'RNA', 'source_name_ch1': 'Skeletal Muscle', 'characteristics_ch1': 'DM2 patient;\tbiopsy site:  unknown'}"
7698,"{'title': 'AML sample #77', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
7699,"{'title': 'VA59', 'description': '04-14066', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: spleen;\tage: 65;\tgender: M;\tipi_stage: 4B;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after treatment for first relapse;\tcode_os: alive;\tcode_pfs: dead;\toverall_survival (years): 4.29;\tprogression-free_survival (years): 2.23'}"
7700,"{'title': 'Gastric GIST 18', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 72;\tTumor size: 25;\tKIT mutation: Exon 11'}"
7701,"{'title': 'Cell line C5.2_DR_4', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
7702,"{'title': 'PA174', 'description': 'PA174', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
7703,"{'title': 'Gingival tissue sample 1 from patient 59, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 59 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7704,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 16', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
7705,"{'title': 'Control II BEAS2b_ML01', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - control', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
7706,"{'title': 'conventional renal cell cancer; cRCCb_HA463', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7707,"{'title': 'X23036', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
7708,"{'title': 'conventional renal cell cancer; cRCCb_HD93', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7709,"{'title': 'Cervical cancer-lymph node negative-05-18', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 55.5;\tfigo stage: 1b1'}"
7710,"{'title': 'Group B1-IVIG-Pre-4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'IVIG-resistant patient, single-IVIG pre-treatment', 'characteristics_ch1': 'tissue: whole blood;\tpatient: IVIG-resistant patient;\ttreatment: IVIG;\ttime: pre-treatment'}"
7711,"{'title': 'MDS patient 113', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
7712,"{'title': 'AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 1', 'description': 'AP-2 gamma silenced', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: AP-2 gamma targetting siRNA 1;\tcell line: MCF7'}"
7713,"{'title': '77-2', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 77 treated 786-O cells, replicate 2'}"
7714,"{'title': 'Tumor Tum_Ph1_rep1', 'description': 'not paired', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N0;\thistology: cdi;\tgrade: III;\treceptor: NEG;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 2'}"
7715,"{'title': 'Huh7 cells_Mock Infected 18 hours_ rep2', 'description': 'Gene expression data from Huh7 cells treated with mock media for 18 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 18 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
7716,"{'title': '22065', 'description': '11716', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24290;\tSmoking_Status: Not Available;\tPathology: Sqaumous cell carcinoma'}"
7717,"{'title': 'newly diagnosed multiple myeloma 164', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: nd'}"
7718,"{'title': 'HF0523_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
7719,"{'title': 'AML 7183', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: male;\tage: 51 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7720,"{'title': 'AML 2182', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 20 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7721,"{'title': 'NSG411', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.32;\tdisease activity (das28_v3): 3.01;\tresponse to anti-tnf therapy: RESPONSE'}"
7722,"{'title': 'DietSensitive _1 day_subject9', 'description': 'DietSensitive _1 day_subject9', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 9;\tgender: Male'}"
7723,"{'title': 'class S, rep11', 'description': 'VAN_00067.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 69;\tsex: F;\tdisease stage: 2;\talbumin level: 47;\themoglobin level: 138;\tlymphocyte percentage: 9;\twhite blood count: 8.6;\tinternational prognostic score (ips): 2'}"
7724,"{'title': 'E161K heart, technical replicate B RMA', 'description': 'Gene expression data from left ventricle of human heart with E161K LMNA mutation', 'type': 'RNA', 'source_name_ch1': 'left ventricle patient with E161K LMNA mutation', 'characteristics_ch1': 'gender: male;\tdevelopmental stage: adult;\torgan: heart;\ttissue: left ventricle;\tgenotype: LMNA E161K;\tdata analysis algorithm: RMA'}"
7725,"{'title': 'C125', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.5'}"
7726,"{'title': '237', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6318_Tumor;\tfab: M1;\tSex: M;\trace: W;\tage on study: 46;\tcytogenetic change: der(7)t(7;8)(p15;q13)t(8;21)(q22;q22);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7727,"{'title': 'shRB-B (Senescent)  E2', 'description': 'Senescent cells expressing shRNA targeting RB replicate 2, experiment 2', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing shRNA targeting RB', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
7728,"{'title': 'Control 16', 'description': '08SE352', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
7729,"{'title': 'D47B', 'description': '04-36183', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: NC;\tpathology: COMPOSITE (>50% DLBCL, remaining FL);\ttissue: lymph node;\tage: 73;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP3-RITU-RAD;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 1.29;\tprogression-free_survival (years): 0.55'}"
7730,"{'title': 'Sputum from Stage III Severe, biological replicate 8', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 64;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
7731,"{'title': 'conventional renal cell cancer; cRCCa_HD212', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7732,"{'title': 'H133+_H416_Propi_30uM', 'description': 'H133+_H416_Propi_30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H416_Propi_30uM', 'characteristics_ch1': 'primary hepatocytes'}"
7733,"{'title': 'Normal Ovary, 2226', 'description': 'Gene expression data from normal ovary.;\tHOSE2226', 'type': 'RNA', 'source_name_ch1': 'normal ovarian surface epithelium (OSE)', 'characteristics_ch1': 'tissue: ovarian surface epithelium (OSE)'}"
7734,"{'title': 'PMNs_normal_bone_marrow_5', 'description': 'To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.', 'type': 'RNA', 'source_name_ch1': 'PMNs (neutrophils) sorted from normal human bone marrow', 'characteristics_ch1': 'Adult normal healthy volunteer'}"
7735,"{'title': 'renal oncocytoma; RO_HD1175', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7736,"{'title': 'brain_endothelial_cells_rep7', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'endothelial cells from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 34'}"
7737,"{'title': 'GBM, TMZ/radiotherapy (1437)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 1437;\tage: 48.3;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 15.66;\tmgmt status: U'}"
7738,"{'title': 'N11123D4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7739,"{'title': 'C95135', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7206_Tumor;\tfab: M2;\tSex: M;\trace: C;\tage on study: 43;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
7740,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_2d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
7741,"{'title': 'Muscle-FamilyHistoryPositive-21', 'description': 'Jos3734;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 46;\tfamily history: Family history positive - 2 parents;\tbody mass index (kg/m2): 31;\tfasting glucose (ogtt): 99.5;\t2 hour glucose (ogtt): 144;\themoglobin a1c: 4.8;\tfasting glucose (iv0gavg): 98;\tfasting insulin (iv0inavg): 10.5;\tsi: 2.02;\twaist hip ratio: 0.968'}"
7742,"{'title': 'PBMCs_EB_after exercise_09', 'description': 'EB_Peak_176-AD', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs after 30 min bout of exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 11;\tafter-exercise'}"
7743,"{'title': '44428', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
7744,"{'title': 'HOSE2061', 'description': 'Gene expression data from ovarian surface epithelial cells', 'type': 'RNA', 'source_name_ch1': 'Normal', 'characteristics_ch1': 'tissue: ovary;\tcell type: Normal ovarian surface epithelium'}"
7745,"{'title': 'PBMC from Kidney transplant under CsA monotherapy R35', 'description': 'PBMC from Kidney transplant under CsA monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: CsA monotherapy;\t%cd3cd4: 54.83;\t%cd3cd8: 37.24;\t%cd8+cd28-: 17.80;\t%cd8+cd28+: 10.47;\t%cd4cd25cd62l: 6.91;\t%cd3delta1: 1.81;\t%cd3delta2: 3.89;\tratio delta1/delta2: 0.47;\t%cd3gammadelta: 5.64;\t%cd3alphabeta: 89.07;\t%cd4cd8-ab+(dn): 1.45;\t%cd4 cd62l+cd45+: 40.58;\t%cd4 cd62l-cd45+: 17.84;\t%cd4 cd62l - cd45-: 17.10;\t%cd4cd62l+cd45-: 24.48;\t%cd4 ccr7+ cd45 -: 11.25;\t%cd4 ccr7+ cd45+: 34.67;\t%cd4 ccr7 - cd45+: 29.96;\t%cd4 ccr7 – cd45-: 24.12;\t%cd8 cd62l+ cd45-: 0.76;\t%cd8cd62l+ cd45+: 29.85;\t%cd8cd62l- cd45+: 67.69;\t%cd8cd62l- cd45 -: 1.69;\t%cd8ccr7+ cd45-: 0.32;\t%cd8ccr7+ cd45+: 12.43;\t%cd8ccr7-cd45+: 84.26;\t%cd8ccr7-cd45 -: 2.99;\t%cd3-cd56+cd16+: 39.22;\t%nkts: 6.82;\t%cd19: 1.01;\t%cd4foxp3+: 8.14'}"
7746,"{'title': 'Lung Cancer 119T', 'description': 'Gene expression data from 119T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 76;\tstage: 2B'}"
7747,"{'title': 'Patient 4702 AML136', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 136;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7748,"{'title': 'Foot siTUG1 Replicate 3', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siTUG1;\treplicate: 3'}"
7749,"{'title': 'HUVEC_TNFa_0h45m', 'description': '0h45m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 0h45m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
7750,"{'title': 'VA41-2', 'description': '05-12224', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 82;\tgender: F;\tipi_stage: 3A;\ttxprimary: FLUD1;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 0.28;\tprogression-free_survival (years): 0.16'}"
7751,"{'title': 'Control-17', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tIc9', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - control;\tSex: M;\tage: 42;\ttissue ph: 6.34;\tpmi (hrs): 63;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
7752,"{'title': 'neuron_rep15', 'description': 'amplified RNA', 'type': 'RNA', 'source_name_ch1': 'human neurons isolated from postmortem dorsolateral prefrontal cortex', 'characteristics_ch1': 'Cell type: neuronal, age:34, gender:male, diagnostic group: control, PMI:22h'}"
7753,"{'title': 'N8615A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7754,"{'title': 'M-05', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
7755,"{'title': 'AML with normal karyotype #107', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: n./a.;\tage: 46;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 96;\tdisease state: de novo AML'}"
7756,"{'title': '5288', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 64 years, FAB M2, cytogenetic poor risk, CEBPA wild type'}"
7757,"{'title': 'carcinoma_2 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 64;\tlocalization: sigmoid'}"
7758,"{'title': 'monocytes_+LPS_3', 'description': '24h medium, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h medium, 4h LPS stimulation'}"
7759,"{'title': 'H133+_H448_Tri_30uM', 'description': 'H133+_H448_Tri_30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H448_Tri_30uM', 'characteristics_ch1': 'primary hepatocytes'}"
7760,"{'title': 'carcinoma_36 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 82;\tlocalization: ascending'}"
7761,"{'title': 'UCNR15_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
7762,"{'title': 'Lung Cancer 106T', 'description': 'Gene expression data from 106T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 57;\tstage: 2B'}"
7763,"{'title': 'BL41 60 min p-RNA Rep.3', 'description': 'unbound, preexisting RNA (p-RNA)', 'type': 'RNA', 'source_name_ch1': 'B41 human B-cells', 'characteristics_ch1': 'Burkitt lymphoma cell line'}"
7764,"{'title': 'aa_NY218', 'description': 'very advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very advanced HCC', 'characteristics_ch1': 'very advanced HCC'}"
7765,"{'title': 'UNTREATED_1748', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7766,"{'title': 'PGA_PA-D_64', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
7767,"{'title': 'Sputum from Stage III Severe, biological replicate 43', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 57;\tgender: F;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
7768,"{'title': 'Muscle control k67', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:male, Age:76yrs'}"
7769,"{'title': 'newly diagnosed multiple myeloma 245', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
7770,"{'title': 'Subject 3, Family 1, Control', 'description': 'microarray hybridization data 07/10/2007', 'type': 'RNA', 'source_name_ch1': 'human skeletal muscle', 'characteristics_ch1': 'sex: Female;\tfamily: 1;\tage: 41;\tdisease status: Control;\ttissue: Muscle: Biceps'}"
7771,"{'title': 'S005', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S005', 'characteristics_ch1': 'patient id: P079;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 67.5'}"
7772,"{'title': 'NF-3', 'description': 'Gene expression data from non-failing control hearts', 'type': 'RNA', 'source_name_ch1': 'Non-Failing Sample 2', 'characteristics_ch1': 'sample pairs: none;\ttissue: Myocard;\tvad status: unsupported;\tdisease status: none;\tvad: none;\tage: 40;\tgender: m'}"
7773,"{'title': 'Hippocampus_female_26yrs_indiv76', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 26 years', 'characteristics_ch1': 'individual: 76, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 26'}"
7774,"{'title': 'AML sample #80', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00482;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
7775,"{'title': 'X70124', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIB;\tConsolidated.Grade : 1'}"
7776,"{'title': 'AML with normal karyotype #185', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 55;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 65;\tdisease state: t-AML'}"
7777,"{'title': 'T40975', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40975;\tsample: tumor'}"
7778,"{'title': 'mucosa_adenoma_11 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: adenoma;\tsex: female'}"
7779,"{'title': 'PBMCs_Oligo_GFP', 'description': 'Gene expression data from PBMCs treated with Oligofectamine with EGFP oligonucleotide', 'type': 'RNA', 'source_name_ch1': 'PBMCs', 'characteristics_ch1': 'cell type: PBMCs;\ttreatment group: treated with Oligofectamine with EGFP oligonucleotide'}"
7780,"{'title': 'TC.DR-2', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
7781,"{'title': 'Patient 4408 AML81', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 81;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
7782,"{'title': 'human cultured bladder IC DM, subject 1', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 29;\tDisease status: IC (interstitial cystitis);\tCulture medium: DM (differentiating medium)'}"
7783,"{'title': 'Gastric GIST 9', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 69;\tTumor size: 20;\tKIT mutation: Exon 11'}"
7784,"{'title': 'AML without MLL - sample 108', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7785,"{'title': 'IFNβ_832', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7786,"{'title': 'IPMC 5', 'description': 'Gene expression data from microdissected epithelial cells of IPMC', 'type': 'RNA', 'source_name_ch1': 'microdissected epithelial cells from IPMC 5', 'characteristics_ch1': 'tissue: pancreas;\tcell type: epithelial cells;\tdisease status: intraductal papillary-mucinous carcinoma (IPMC)'}"
7787,"{'title': '08SE862HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
7788,"{'title': 'CD49a+ rep4 (stromal cell study)', 'description': 'Prostate stromal fibromuscular cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD49a+ MACS sorted cells'}"
7789,"{'title': 'Lung Normal 123N', 'description': 'Gene expression data from 123N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 53;\tstage: n/a'}"
7790,"{'title': 'UCNR1_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
7791,"{'title': 'AML 6448', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 50 years;\tscore: RAEB-t;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7792,"{'title': 'heterozygot FH P265', 'description': 'Gene expression data from the heterozygous FH participant B', 'type': 'RNA', 'source_name_ch1': 'heterozygot FH P265 (human CD3 positive T cells)', 'characteristics_ch1': 'cell type: T cell;\tdisease state: heterozygote FH'}"
7793,"{'title': 'Cell line C5.2_D_2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
7794,"{'title': 'class S, rep23', 'description': 'VAN_00161.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 25;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: 129;\tlymphocyte percentage: 11;\twhite blood count: 10.5;\tinternational prognostic score (ips): 2.3'}"
7795,"{'title': 'MCF7 silenced Estrogen receptor, biological rep1', 'description': 'Gene expression data from MCF7 breast cancer cell line with silenced Estrogen receptor', 'type': 'RNA', 'source_name_ch1': 'MCF7 silenced Estrogen receptor alpha (PII)', 'characteristics_ch1': 'knockdown: estrogen receptor alpha KD;\tcell line: MCF7'}"
7796,"{'title': 'Blood sample from patient 114 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 114;\tday: Day 90;\tage (years): 39;\tsex: Male'}"
7797,"{'title': 'PBMC-1-RR-Pat.9 [wf20071123u133v2_U_15_HT20_Lc1_F_50yr_No_151]', 'description': 'Pre-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon blood sample', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
7798,"{'title': 'U937_naive_untreated_4h_rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, untreated, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
7799,"{'title': 'S041', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S041', 'characteristics_ch1': 'patient id: P116;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 25'}"
7800,"{'title': 'cMyb virus-infected replicate 1\t(monocytes)', 'description': 'Adenovirus-infected monocytes', 'type': 'RNA', 'source_name_ch1': 'Primary human monocytes', 'characteristics_ch1': 'Monocytes from buffy coat preparation'}"
7801,"{'title': 'HBEC2 Low dose treatment group (100 nM).', 'description': 'HBEC2 Low dose treatment group (100 nM).', 'type': 'RNA', 'source_name_ch1': 'Immortalized Bronchial Epithelial Cells (HBEC)', 'characteristics_ch1': 'See publication for details.'}"
7802,"{'title': '15-0007_Septic Shock_day1_210', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7803,"{'title': 'N7397F5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7804,"{'title': 'CD34+CD45RA+Lin- HPCs transduced with empty vector cultured onto 5 µg of Delta1ext-IgG', 'description': 'BCE_05;\tGene expression data from Notch-activated (5 µg) cells transduced with empty vector', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA-Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: hematopoietic progenitors;\tgenotype/variation: transduced with empty vector;\ttreatment group: Notch-activated (5 µg)'}"
7805,"{'title': 'AML 6247', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 60 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: single mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
7806,"{'title': 'adenocarcinoma_65 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 57;\tlocalization: sigmoid'}"
7807,"{'title': 'Oligodendrioglioma_4', 'description': 'bh20061208u133v2_A_25-Oligo7_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: oligodendrioglioma;\tage: 33;\tgender: male;\ttumor grade: OGII'}"
7808,"{'title': 'Control 57', 'description': '08SE369', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
7809,"{'title': 'group-1-pt-t4009237', 'description': 'group-1-pt-t4009237', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 47;\tgender: male;\tfinal disposition: 06: Home'}"
7810,"{'title': 'NSCLC EMC 2333N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
7811,"{'title': 'N40836', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40836;\tsample: normal'}"
7812,"{'title': 'adenocarcinoma_47 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 59;\tlocalization: sigmoid'}"
7813,"{'title': 'human BM MSC TGFb3 stimulated day 21 rep 2', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 21', 'type': 'RNA', 'source_name_ch1': 'donor 5, stimulated with TGFb3 for 21 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 21 days'}"
7814,"{'title': 'ALL without MLL - sample 31', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7815,"{'title': 'Gingival tissue sample 3 from patient 62, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 62 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
7816,"{'title': 'PHI-CTR-1UP-S2', 'description': 'We examined the effects of 48h of knee immobilization on alterations in mRNA and protein in human skeletal muscle.  Biopsies were taken from the vastus lateralis muscle of five men (20.4 + 0.5 years) before and after 48h immobilization.', 'type': 'RNA', 'source_name_ch1': 'Human skeletal muscle', 'characteristics_ch1': 'treatment:control;'}"
7817,"{'title': 'HUVEC_TNFa_0h15m', 'description': '0h15m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 0h15m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
7818,"{'title': 'Patient 5185 AML228', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 228;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7819,"{'title': 'Control 47', 'description': '08SE357', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
7820,"{'title': 'Tumor Tum_Ph1_rep9', 'description': 'Tumor paired  6', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N0;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
7821,"{'title': 'brain_neurons_rep4', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'neurons from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 47'}"
7822,"{'title': '05-220_CaP', 'description': 'Prostate cancer whole tissue.', 'type': 'RNA', 'source_name_ch1': 'cancer prostate', 'characteristics_ch1': 'tissue: prostate;\tgleason: 4+5;\ttumor stage: T3aN1;\ttumor volume: > 5 cc'}"
7823,"{'title': 'ALL without MLL - sample 22', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7824,"{'title': 'MDS patient 99', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
7825,"{'title': ""Wilms' tumor; WT_RK20"", 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7826,"{'title': 'Subcutaneous adipose tissue, SAT5', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
7827,"{'title': 'B66', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Mixed;\ttumor size: 2.0'}"
7828,"{'title': 'Cervical cancer-lymph node positive-33-38', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 37.4;\tfigo stage: 1b1'}"
7829,"{'title': 'AML 7062', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 53 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: nd'}"
7830,"{'title': '70103', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
7831,"{'title': 'class S, rep82', 'description': 'VAN_00514.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 32;\tsex: M;\tdisease stage: 2;\talbumin level: 38;\themoglobin level: 152;\tlymphocyte percentage: 12;\twhite blood count: 9.9;\tinternational prognostic score (ips): 3'}"
7832,"{'title': 'N11003A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7833,"{'title': '2.2.NDV.4', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 4 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: NDV;\thours post infection: 4'}"
7834,"{'title': 'monocytes_Q10H2_3', 'description': '24h Q10H2 preincubation, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +Q10H2, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h Q10H2 preincubation, 4h LPS stimulation'}"
7835,"{'title': 'e_M43B', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
7836,"{'title': 'newly diagnosed multiple myeloma 92', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
7837,"{'title': 'KT0296_12_L_test3', 'description': 'KT0296_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
7838,"{'title': 'SG-92B_phenotype of EPC colony assay', 'description': 'EPC sampled from blood and cultured', 'type': 'RNA', 'source_name_ch1': 'cultured EPC, after 3 months of exercise', 'characteristics_ch1': 'after 3 months of exercise'}"
7839,"{'title': 'conventional renal cell cancer; cRCCa_HD44', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
7840,"{'title': 'NSG413', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): NA;\tdisease activity (das28_v3): NA;\tresponse to anti-tnf therapy: NA'}"
7841,"{'title': 'T21 U133p2', 'description': 'bulk breast tumor RNA from patient T21', 'type': 'RNA', 'source_name_ch1': 'T21', 'characteristics_ch1': 'breast tumor'}"
7842,"{'title': 'H133+_H438_Tri_10uM', 'description': 'H133+_H438_Tri_10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H438_Tri_10uM', 'characteristics_ch1': 'primary hepatocytes'}"
7843,"{'title': 'A_2m25', 'description': 'advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; advanced HCC', 'characteristics_ch1': 'advanced HCC'}"
7844,"{'title': 'Replicate 1 for BT474.tb breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
7845,"{'title': 'Blood sample from patient 106 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 106;\tday: Day 1;\tage (years): 40;\tsex: Male'}"
7846,"{'title': 'U937_naive_untreated_18h_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, untreated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
7847,"{'title': 'VA53', 'description': '04-29995', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 73;\tgender: F;\tipi_stage: 2A;\ttxprimary: CHOP4-RITU;\tstatus: toxic death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 0.52;\tprogression-free_survival (years): 0.52'}"
7848,"{'title': 'MCF7 vector control, rep2', 'description': 'Gene expression data from MCF7 vector control', 'type': 'RNA', 'source_name_ch1': 'human breast cancer cell line, MCF-7, vector control', 'characteristics_ch1': 'MCF-7-Vector'}"
7849,"{'title': 'Patient C11, control kidney from nephrectomy, cortex + medulla', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C11, Sex: male, Age of patient: 82, Serum creatinine: 113 microMol/L, Control kidney sample (cortex+medulla)  from nephrectomy'}"
7850,"{'title': 'MDS patient 166', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: other'}"
7851,"{'title': 'IFNβ_1080', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7852,"{'title': 'newly diagnosed multiple myeloma 135', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: II'}"
7853,"{'title': 'vCRC1', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: colorectal cancer'}"
7854,"{'title': '11_0019C_Day1_28', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Male'}"
7855,"{'title': 'MDS patient 116', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
7856,"{'title': 'X379', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
7857,"{'title': 'P_CD8_7', 'description': 'PS7 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Positive Selection', 'characteristics_ch1': 'age: 37;\tgender: Male;\tt_cell_purity: 94.10%'}"
7858,"{'title': 'Insulin sensitive patient 12 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
7859,"{'title': 'newly diagnosed multiple myeloma 211', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: I'}"
7860,"{'title': 'Training_Site7_07', 'description': 'Performed by Operator 1 from Site7 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
7861,"{'title': 'MLD AML sample #15', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
7862,"{'title': 'B21', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 3.0'}"
7863,"{'title': 'Young rep4', 'description': 'Early passage BJ fibroblasts, grown in serum-free media for 72hrs at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Early passage human foreskin BJ fibroblasts'}"
7864,"{'title': 'centroblast, tonsil#11', 'description': 'centroblast, tonsil#11', 'type': 'RNA', 'source_name_ch1': 'Inflamed non tumoral human tonsil#11', 'characteristics_ch1': 'cell suspension: Flow sorted cells;\tcell type: centroblast, tonsil'}"
7865,"{'title': 'SK-N-SH_BDNF_6h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
7866,"{'title': 'Septic Shock_biological rep63 10-0020', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.9;\toutcome: Nonsurvivor;\tgroup: B'}"
7867,"{'title': 'Huh7 cells_Mock Infected 24 hours_ rep3', 'description': 'Gene expression data from Huh7 cells treated with mock media for 24 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 24 hours', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
7868,"{'title': 'VA141', 'description': '04-23426', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: NC;\tpathology: DLBC;\ttissue: spleen;\tage: 73;\tgender: M;\tipi_stage: 2BE;\ttxprimary: SPLE-CHOP-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 3.76;\tprogression-free_survival (years): 3.76'}"
7869,"{'title': 'PNS020', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 4.19;\tdisease activity (das28_v3): 2.34;\tresponse to anti-tnf therapy: RESPONSE'}"
7870,"{'title': 'S035', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S035', 'characteristics_ch1': 'patient id: P099;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 25'}"
7871,"{'title': 'AR-P2', 'description': 'AR-P2', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
7872,"{'title': 'X44087', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
7873,"{'title': 'HUVECs  maintained in EGM2 media, the control rep 3', 'description': 'HUVECs in the basal state', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
7874,"{'title': 'Septic Shock_biological rep10', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 8.3;\toutcome: Survivor'}"
7875,"{'title': 'healthy breast 4, biological rep. 4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'healthy', 'characteristics_ch1': 'tissue: breast;\tdisease state: healthy'}"
7876,"{'title': 'DLBCL biopsy, sample 2069', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
7877,"{'title': 'AML with normal karyotype #245', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 51;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
7878,"{'title': 'Sputum from Stage II Moderate, biological replicate 32', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 49;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
7879,"{'title': 'dH1F_Fibro_1', 'description': 'Gene expression data obtained from fibroblasts', 'type': 'RNA', 'source_name_ch1': 'human fibroblast', 'characteristics_ch1': 'cell type: fibroblast;\tcell line: GM04981 from Coriell'}"
7880,"{'title': 'KT0947_6_D_test2_test3', 'description': 'KT0947_6_D_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, deceased donor, test set2 and test set3', 'characteristics_ch1': '6 months, deceased donor, test set2 and test set3'}"
7881,"{'title': 'AML with normal karyotype #176', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 47;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 95;\tdisease state: de novo AML'}"
7882,"{'title': 'AML 6241', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 48 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
7883,"{'title': 'lymphocytes_HD_F_61y', 'description': 'Affymetrix U133 Human Genome 2.0 Plus arrays', 'type': 'RNA', 'source_name_ch1': 'lymphocytes (blood)', 'characteristics_ch1': 'Sample Group: HD patient; Gender: female; Age: 61; Tissue: lymphocytes (blood); IT15 CAG repeats: 19/44'}"
7884,"{'title': 'Septic Shock_biological rep67 10-0018', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.5;\toutcome: Survivor;\tgroup: B'}"
7885,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 6', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
7886,"{'title': 'Normal_colon_31_13April05', 'description': 'Normal_colon_31_13April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, transverse', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
7887,"{'title': 'HF1469_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
7888,"{'title': 'Muscle-FamilyHistoryPositive-9', 'description': 'Jos3710;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 44;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 31;\tfasting glucose (ogtt): 98.5;\t2 hour glucose (ogtt): 72;\themoglobin a1c: 5;\tfasting glucose (iv0gavg): 94;\tfasting insulin (iv0inavg): 14.3;\tsi: 4.45;\twaist hip ratio: 0.914'}"
7889,"{'title': 'MDS patient 35', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: del5q'}"
7890,"{'title': 'NSCLC_AC_276', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 276.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
7891,"{'title': 'HF1295_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
7892,"{'title': 'T10962A5: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
7893,"{'title': 'Patient 3399 AML11', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 11;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
7894,"{'title': 'IFNβ_2442', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
7895,"{'title': 'class F, rep23', 'description': 'VAN_00080f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 26;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: 145;\tlymphocyte percentage: 6;\twhite blood count: 21.4;\tinternational prognostic score (ips): 2.3'}"
7896,"{'title': 'Angioimmunoblastic T-cell lymphoma 28', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-75', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 43;\tgender: male'}"
7897,"{'title': 'Blood sample from patient 114 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 114;\tday: Day 1;\tage (years): 39;\tsex: Male'}"
7898,"{'title': 'MERLION_X03K05419', 'description': 'MERLION_X03K05419', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=67, state=0', 'characteristics_ch1': 'pT2N0, male, age=67, state=0'}"
7899,"{'title': 'U937_naive_curcumin_18h_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, 1uM curcumin treated, 18h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
7900,"{'title': '22094', 'description': '11856', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24327;\tSmoking_Status: Never;\tPathology: Adenocarcinoma'}"
7901,"{'title': 'wt PGC-1, repeat 2', 'description': 'HePG2 cells infected with adenovirus expressing wt PGC-1', 'type': 'RNA', 'source_name_ch1': 'HepG2 cells', 'characteristics_ch1': 'Human hepatocellular carcinoma cell line'}"
7902,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R6', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 56.36;\t%cd3cd8: 37.60;\t%cd8+cd28-: 5.04;\t%cd8+cd28+: 13.79;\t%cd4cd25cd62l: 6.34;\t%cd3delta1: 0.27;\t%cd3delta2: 6.7;\tratio delta1/delta2: 0.04;\t%cd3gammadelta: 6.78;\t%cd3alphabeta: 92.93;\t%cd4cd8-ab+(dn): 2.28;\t%cd4 cd62l+cd45+: 8.04;\t%cd4 cd62l-cd45+: 0.04;\t%cd4 cd62l - cd45-: 41.97;\t%cd4cd62l+cd45-: 49.95;\t%cd4 ccr7+ cd45 -: 30.43;\t%cd4 ccr7+ cd45+: 9.90;\t%cd4 ccr7 - cd45+: 0.68;\t%cd4 ccr7 – cd45-: 58.99;\t%cd8 cd62l+ cd45-: 28.01;\t%cd8cd62l+ cd45+: 9.10;\t%cd8cd62l- cd45+: 4.48;\t%cd8cd62l- cd45 -: 58.41;\t%cd8ccr7+ cd45-: 3.37;\t%cd8ccr7+ cd45+: 5.97;\t%cd8ccr7-cd45+: 6.51;\t%cd8ccr7-cd45 -: 84.16;\t%cd3-cd56+cd16+: 2.38;\t%nkts: 11.64;\t%cd19: 6.92;\t%cd4foxp3+: 9.90'}"
7903,"{'title': 'Germinal Center Centrocytes, sample 3', 'description': 'CD10-positive CD77-negative B-cells purified by magnetic cell separation.;\tGene expression data from purified germinal center centrocytes', 'type': 'RNA', 'source_name_ch1': 'Germinal Center Centrocytes from human tonsil', 'characteristics_ch1': 'cell type: CD10-positive cell type: CD77-negative B-cells purified by magnetic cell separation.'}"
7904,"{'title': 'IRX2', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincIRX5;\treplicate: 2'}"
7905,"{'title': 'SK-N-SH_RA_6h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 6hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
7906,"{'title': 'AML with normal karyotype #57', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 44;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 68;\tdisease state: de novo AML'}"
7907,"{'title': 'cord blood 6', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.38', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.38;\t'}"
7908,"{'title': 'group-2-pt-t12459034', 'description': 'group-2-pt-t12459034', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 21;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
7909,"{'title': 'Scz-5', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tS5', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness-schizophrenia;\tSex: M;\tage: 22;\ttissue ph: 6.07;\tpmi (hrs): 37;\ttype of drug: Trifluoperazine, Flupenthixol;\tdrug dose (chlorpromazine equivalents): 450 mg'}"
7910,"{'title': 'human cultured bladder IC KM, subject 10', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 39;\tDisease status: IC (interstitial cystitis);\tCulture medium: KM (proliferating medium)'}"
7911,"{'title': 'KT0430_3_D_test2_test3', 'description': 'KT0430_3_D_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, deceased donor, test set2 and test set3', 'characteristics_ch1': '3 months, deceased donor, test set2 and test set3'}"
7912,"{'title': 'B1-Non-RR-12 [wf20070302u133v2_U_11_HW_B1_73]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
7913,"{'title': 'Lung-normal-rep4', 'description': 'frozen normal lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen disease-free lung tissue', 'characteristics_ch1': 'disease state: normal;\tbiopsy type: surgical;\ttissue: lung'}"
7914,"{'title': 'NS2-7', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 7; Smoking status: non-smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 7; Smoking status: non-smoker', 'characteristics_ch1': 'Time: Day 7;\tSmoking status: non-smoker;\tPack-years: 0;\tAge: 36;\tSex: M;\tEthnic group: white'}"
7915,"{'title': 'No15LCMPinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No15;\tcell type: lymphocytes;\ttime point: under therapy'}"
7916,"{'title': 'gd cell control time 0,donor 3', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated prior to activation;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: control;\ttime: 0;\tindividual: donor 3'}"
7917,"{'title': 'Patient_5260_relapse', 'description': '5260R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 44;\tconclusions ig/tcr: some clonal evolution;\tselected: yes'}"
7918,"{'title': 'IFNβ_2057', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7919,"{'title': 'Subcutaneous adipose tissue, SAT7', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
7920,"{'title': 'Subcutaneous adipose tissue, SAT42', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
7921,"{'title': 'Germinal Center Centrocytes, sample 1', 'description': 'CD10-positive CD77-negative B-cells purified by magnetic cell separation.;\tGene expression data from purified germinal center centrocytes', 'type': 'RNA', 'source_name_ch1': 'Germinal Center Centrocytes from human tonsil', 'characteristics_ch1': 'cell type: CD10-positive cell type: CD77-negative B-cells purified by magnetic cell separation.'}"
7922,"{'title': 'MDS patient 46', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: del5q plus monosomy7/del7q plus other'}"
7923,"{'title': 'UNTREATED_2076', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7924,"{'title': '04-0003_Septic Shock_day3_69', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7925,"{'title': 'Patient 4405 AML80', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 80;\tcohort: Validation;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
7926,"{'title': 'Hippocampus_male_91yrs_indiv16-07', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 91 years', 'characteristics_ch1': 'individual: 16-07, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 91'}"
7927,"{'title': 'AML 1432', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 53 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7928,"{'title': 'BC11041', 'description': '160306.08.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: NIBC;\tage of diagnosis (year): 72;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT2;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: pos;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: pos;\tigf1r ihc status: --;\tegfr ihc status: pos;\ttop2a ihc status: neg;\tfoxa1 ihc status: pos;\tmfs: 1;\tmfsdel (month): 11.47'}"
7929,"{'title': 'Control Con_rep6', 'description': 'Control paired  9', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: S;\tn: 0;\thistology: 0;\tgrade: 0;\treceptor: 0;\tki-67: 0;\ttumor (t) vs healthy (s): S;\tphenotypes: S'}"
7930,"{'title': 'NSCLC_AC_97', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 97.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
7931,"{'title': 'NSCLC_SCC_22', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 22.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
7932,"{'title': 'TS350a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1435;\tdisease state: Acute;\tgender: Male;\tage: 42;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 410;\tplasma hiv-1     rna level   (copies/ml): > 100,000;\ttissue: lymph node'}"
7933,"{'title': 'THRBL_lymph_node_case3', 'description': 'T cell/histiocyte rich B cell lymphoma affecting a lymph node', 'type': 'RNA', 'source_name_ch1': 'lymph node affected by THRBL', 'characteristics_ch1': 'Gender: male, Age: 50, Tissue: lymph node taken at diagnosis affected by T cell/histiocyte rich B cell lymphoma, An Arbor Stage: IVA, IPI prognostic score: low intermediate, follow-up: 4 years; status at last follow-up: alive without disease'}"
7934,"{'title': 'MLD AML sample #47', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
7935,"{'title': 'HBEC2 Control treatment group (DMSO)', 'description': 'HBEC2 Control treatment group (DMSO)', 'type': 'RNA', 'source_name_ch1': 'Immortalized bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
7936,"{'title': 'Huh7 cells_Mock Infected 6 hours_ rep3', 'description': 'Gene expression data from Huh7 cells treated with mock media for 6 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 6 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
7937,"{'title': 'colon_normal_1440', 'description': 'total RNA extracted from cells obtained using biopsy of the colon in a healthy control', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
7938,"{'title': 'VA156', 'description': '06-19919', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 22;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP4-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.82;\tprogression-free_survival (years): 1.82'}"
7939,"{'title': 'AML sample #59', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
7940,"{'title': 'Capan-1 V1 siGNE', 'description': None, 'type': 'RNA', 'source_name_ch1': 'Capan-I cells siGNE-transfected', 'characteristics_ch1': 'cell line: Capan-1;\tcell type: pancreatic carcinoma cells;\tgne mrna: knock-down'}"
7941,"{'title': 'IFNβ_1781', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7942,"{'title': 'MDS patient 48', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: monosomy7/del(7q)'}"
7943,"{'title': 'MDS patient 54', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
7944,"{'title': 'M-28', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
7945,"{'title': 'PGA-Hs_P-7', 'description': 'Human subjects with post-partum cardiomyopathy;\tKeywords = post-partum cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7946,"{'title': 'CDcNR1_beforeT', 'description': 'Colonic mucosal gene expression data from CDc non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
7947,"{'title': 'AML 2467', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 44 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7948,"{'title': 'Blood sample from patient 159 at Day 14', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 159;\tday: Day 14;\tage (years): 23;\tsex: Female'}"
7949,"{'title': 'hES_WIBR7_rep2_090811_4', 'description': 'Gene expression data from hES line WIBR7', 'type': 'RNA', 'source_name_ch1': 'hES line WIBR7', 'characteristics_ch1': 'cell line: hES line WIBR7'}"
7950,"{'title': '11-0024_Sepsis_day1_166', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7951,"{'title': 'Patient 1, IDC', 'description': '12605-1P 10-17-07', 'type': 'RNA', 'source_name_ch1': 'Breast, IDC', 'characteristics_ch1': 'tissue: breast cancer;\ttissue type: infiltrating ductal carcinoma (IDC);\tpatient: 1'}"
7952,"{'title': 'Patient 4712 AML142', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 142;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
7953,"{'title': 'Adenocarcinoma, bone marrow positive AC 23', 'description': 'Gene expression profile of lung tumor', 'type': 'RNA', 'source_name_ch1': 'Human pulmonary adenocarcinoma', 'characteristics_ch1': 'male pulmonary adenocarcinoma;\tbone marrow positive'}"
7954,"{'title': 'C163', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 2.3'}"
7955,"{'title': 'PGA-Hs_D-2', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
7956,"{'title': 'Differentiated HepaRG, biological replicate 1', 'description': 'Diff1', 'type': 'RNA', 'source_name_ch1': 'Differentiated well-confluent HepaRG', 'characteristics_ch1': 'cell line: HepaRG;\tdifferentiation state: differentiated;\tgender: female'}"
7957,"{'title': 'colon_CRC_1494', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
7958,"{'title': 'Normal_colon_08_12April05', 'description': 'Normal_colon_08_12April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, rectum', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
7959,"{'title': 'DietSensitive _1 day_subject1', 'description': 'DietSensitive _1 day_subject1', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 1;\tgender: Female'}"
7960,"{'title': 'UNTREATED_1503', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7961,"{'title': 'X60267', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 1'}"
7962,"{'title': '11_0001_SepticShock_Day1_56', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0001_Patient, Day1'}"
7963,"{'title': 'Sample T61', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: T61;\ttissue: blood;\tage: 75;\tgender: Male;\trs7956957 genotype: GG'}"
7964,"{'title': 'KT0519_6_L_test3', 'description': 'KT0519_6_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months. living donor, test set3', 'characteristics_ch1': '6 months. living donor, test set3'}"
7965,"{'title': 'cord blood 29_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 9.66', 'characteristics_ch1': 'Cord blood arsenic exposure level 9.66;\t'}"
7966,"{'title': 'ALL without MLL - sample 51', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
7967,"{'title': 'mRNA of GBM-HGG059, Glioblastoma, 14.3 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 14.3 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 14.3 years'}"
7968,"{'title': 'Septic Shock_biological rep45 05-0003', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 7.3;\toutcome: Survivor;\tgroup: A'}"
7969,"{'title': 'cord blood 21', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.66', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.66;\t'}"
7970,"{'title': 'Gingival tissue sample 3 from patient 94, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 94 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
7971,"{'title': 'Lung Cancer 135T', 'description': 'Gene expression data from 135T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 39;\tstage: 1A'}"
7972,"{'title': 'GA_1660', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7973,"{'title': 'UNTREATED_2119', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7974,"{'title': 'group-2-pt-t12485562', 'description': 'group-2-pt-t12485562', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 35;\tgender: female;\tfinal disposition: 06: Home'}"
7975,"{'title': '09-0001_Sepsis_day3_101', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
7976,"{'title': 'Gingival tissue sample 2 from patient 86, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 86 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
7977,"{'title': 'AML 2171', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 40 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
7978,"{'title': ""Wilms' FF F-1"", 'description': 'L754-A-HG-U133_Plus_2-01-1 (S06-965N-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney', 'characteristics_ch1': 'tissue: kidney;\tfixation: FF;\tblock age (at extraction in years): 1.5;\tbiological replicate: rep-1;\tdonor: B normal'}"
7979,"{'title': 'AML with normal karyotype #119', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 77;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 67.5;\tdisease state: de novo AML'}"
7980,"{'title': 'Adipose tissue_429_control_rep6', 'description': 'Normal', 'type': 'RNA', 'source_name_ch1': 'Omental adipose tissue, normal weight, child', 'characteristics_ch1': 'tissue: omental adipose;\tgroup: normal weight;\tgender: M;\tage: 7 year;\tz score bmi: -0.36'}"
7981,"{'title': 'CB6', 'description': None, 'type': 'RNA', 'source_name_ch1': 'iPSC line 6 generated from human cord blood MNC', 'characteristics_ch1': 'cell type: transgene-free iPSC'}"
7982,"{'title': 'Patient_8148_diagnosis', 'description': '8148D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD7 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: T-ALL;\tall subtype: T-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: stable;\tselected: no'}"
7983,"{'title': 'NY208', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 63;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 3.1;\ttp53 mutation: 0;\tctnnb1 mutation: 235T>TC | S33S/P;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
7984,"{'title': 'AML sample #42', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
7985,"{'title': 'S016', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S016', 'characteristics_ch1': 'patient id: P067;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 60'}"
7986,"{'title': 'X512', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
7987,"{'title': 'Replicate 1 for MDAMB453 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
7988,"{'title': 'Myeloma tumor, sample 5', 'description': 'MM_TUMOR_05;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: female;\tdisease state: advanced multiple myeloma (MM)'}"
7989,"{'title': 'X60120', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : LMP;\tSubtype : Ser/PapSer;\tStageCode : IIC;\tConsolidated.Grade : 1'}"
7990,"{'title': 'Lung Cancer 115T', 'description': 'Gene expression data from 115T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 80;\tstage: 1B'}"
7991,"{'title': 'Glioblastoma_7', 'description': 'bh20061208u133v2_A_07-GBM7_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 35;\tgender: female;\ttumor grade: IV'}"
7992,"{'title': 'human macrophages treated with saline, biological rep3', 'description': 'Gene expression data from human macrophages treated with saline (control) for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with saline', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: saline;\ttreatment time: 2 hours;\tday: 9'}"
7993,"{'title': 'RJ560a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1456;\tdisease state: Asympt;\tgender: Male;\tage: 49;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 478;\tplasma hiv-1     rna level   (copies/ml): 174000;\ttissue: lymph node'}"
7994,"{'title': 'NSCLC EMC 2393N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
7995,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 12 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 12 hours'}"
7996,"{'title': 'NSCLC_SCC_95', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 95.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
7997,"{'title': 'T11770A1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
7998,"{'title': 'IFNβ_2065', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
7999,"{'title': 'S002_Scz_M_82', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 82;\tpost-mortem delay: 11h;\tph: 6'}"
8000,"{'title': '22037', 'description': '11704', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24252;\tSmoking_Status: Current;\tPathology: Adenocarcinoma'}"
8001,"{'title': 'AML 2542', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 20 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
8002,"{'title': 'B45', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.9'}"
8003,"{'title': 'conventional renal cell cancer; cRCCa_HD114', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8004,"{'title': 'N1-01', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with No RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
8005,"{'title': 'KT0663_3_L_test3', 'description': 'KT0663_3_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set3', 'characteristics_ch1': '3 months, living donor, test set3'}"
8006,"{'title': 'CLL cells  PB  patient #11', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #11'}"
8007,"{'title': 'M-38', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Long-term practitioner of daily RR practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
8008,"{'title': 'S077', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S077', 'characteristics_ch1': 'patient id: P057;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
8009,"{'title': 'Tolerant PBMC_TOL_VHC_2', 'description': 'see M.Martinez-Llordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from tolerant liver transplant recipient with hepatitis C virus infection.'}"
8010,"{'title': 'IFNβ_815', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8011,"{'title': 'class S, rep21', 'description': 'VAN_00131.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 17;\tsex: M;\tdisease stage: 2;\talbumin level: 48;\themoglobin level: 145;\tlymphocyte percentage: 18;\twhite blood count: 7;\tinternational prognostic score (ips): 2'}"
8012,"{'title': 'UNTREATED_2136', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8013,"{'title': 'AML sample #8', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
8014,"{'title': '10242', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 43;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 19;\tDonor Sex: F;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
8015,"{'title': '34079', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant KRAS;\tGrade NA;\tStage IA;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8016,"{'title': 'AML sample #45', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
8017,"{'title': 'Blood Sample of subject 44 after inhalation; Group A: inhalation with 0.7 ppm FA 72 h before sampling', 'description': 'Bl_Group_A_AI_subject_44', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 72 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 72 h;\tsubject: 44;\tgroup: A'}"
8018,"{'title': 'NZK 7', 'description': 'early metastatic primary clear-cell renal cell carcinoma, batch 4', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: male;\ttumor stage (uicc 2002): pT1a;\tlymph node status: N2;\tinitial distant metastases: M0;\ttumor grade: G3;\tdfs/follow-up: DFS = 0 months;\tlocalisation of metastases: lymph node'}"
8019,"{'title': 'Patient 10, colonocytes; UC non-inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Colonocytes from human colonic mucosa', 'characteristics_ch1': 'UC non-inflamed'}"
8020,"{'title': 'TBM4 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tmeningeal tuberculosis'}"
8021,"{'title': 'Human lymphatic endothelial cells TNFalpha_Rep 2', 'description': 'Here we have addressed important question of inflammation-induced mechanism for leukocyte transmigration of lymphatic vessel endothelium by comparing global gene expression profile of normal dermal lymphatic endothelial cells with/without TNFa added to the culture.', 'type': 'RNA', 'source_name_ch1': 'Primary lymphatic endothelial cells, cultured in vitro with TNFalpha, derived from skin samples obtained from healthy human donors during elective surgery.', 'characteristics_ch1': 'Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).'}"
8022,"{'title': 'Patient 3474 AML37', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 37;\tcohort: Discovery;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
8023,"{'title': 'GBM, radiotherapy (147)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 147;\tage: 49.4;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 15.07;\tmgmt status: M'}"
8024,"{'title': 'SH-SY5Y(ECACC)_RA_1d_rep3', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
8025,"{'title': '110', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7490_Tumor;\tfab: M3;\tSex: F;\trace: W;\tage on study: 61;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8026,"{'title': 'Gingival tissue sample 1 from patient 46, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 46 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8027,"{'title': 'mRNA of GBM-HGG006, Glioblastoma, 6.3 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 6.3 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 6.3 years'}"
8028,"{'title': 'Patient C16, control kidney from nephrectomy', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C16, Sex: male, Age of patient: 71, Serum creatinine: 114 microMol/L, Control kidney sample  from nephrectomy'}"
8029,"{'title': 'MDS patient 72', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
8030,"{'title': 'CD19_selected_B-cells_before_R_rep9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before Rituximab (control)'}"
8031,"{'title': 'MCF-7 +scrambled siRNA + vehicle rep2 (MD32)', 'description': 'Gene expression data from MCF-7cells treated with vehicle and scrambled siRNA;\tMD32', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with vehicle and scrambled siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: control (scrambled siRNA);\tagent: control (vehicle);\tdose: n/a'}"
8032,"{'title': 'Gastric GIST 7', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 58;\tTumor size: 13;\tKIT mutation: Exon 11'}"
8033,"{'title': 'Insulin resistant patient 10 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin resistant'}"
8034,"{'title': 'MDS patient 47', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: normal'}"
8035,"{'title': 'sample 41, brca1 mutation negative, follicular phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation negative, follicular phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: no;\tovarian cycle status: follicular;\tsample identifier: 41'}"
8036,"{'title': 'X94067', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8037,"{'title': 'adipose_preTZD_IRd_s41', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 41'}"
8038,"{'title': 'whole blood mRNA from patients presenting with UA (MM_UA_58_05)', 'description': 'Gene expression data from whole blood 30 days post UA', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post UA', 'characteristics_ch1': 'disease: UA;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 48;\tSex: M'}"
8039,"{'title': 'group-1-pt-t3396312', 'description': 'group-1-pt-t3396312', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 32;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
8040,"{'title': 'AML 2543', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 52 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8041,"{'title': 'MCF-7_Ferulic acid_0.1μM_rep3', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Ferulic acid treated'}"
8042,"{'title': 'Patient 4532 AML117', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 117;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8043,"{'title': 'TK62a', 'description': 'lymph node, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 43;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 81;\tplasma hiv-1 rna levels (copies/ml): 35,000'}"
8044,"{'title': 'B1-Non-RR-2 [wf20070130u133v2_U_05-B1-Pat.6-PS]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
8045,"{'title': 'PC control 11', 'description': 'arrayconsortium.tgen.org::biosample.434996;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Posterior cingulate', 'characteristics_ch1': 'sample amount: 10 ug;\tbio-source name: PC control 11;\torganism: Human\xa0;\torgan/tissue type: brain\xa0;\torgan region: Posterior cingulate\xa0;\tcell type: layer III neurons\xa0;\tethnicity: Caucasian\xa0;\tdevelopmental stage: Adult\xa0;\tdisease state: normal\xa0;\tsex: female\xa0;\tgenetic variation: None\xa0;\tage: 73 years'}"
8046,"{'title': 'AML 2507', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 48 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8047,"{'title': 'Patient 4511 AML110', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 110;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: NPM1;\tcebpa: wild type;\tmll-ptd: wild type'}"
8048,"{'title': 'Training_Site1_05', 'description': 'Performed by Operator 1 from Site1 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
8049,"{'title': 'mock-infected, asthmatic S17 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, asthmatic S17', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
8050,"{'title': 'S082', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S082', 'characteristics_ch1': 'patient id: P059;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 21'}"
8051,"{'title': 'Blood_TD51282_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
8052,"{'title': 'P_CD4_10', 'description': 'PS10 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Positive Selection', 'characteristics_ch1': 'age: 27;\tgender: Female;\tt_cell_purity: 92%'}"
8053,"{'title': 'Sputum from Stage III Severe, biological replicate 57', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 70;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39315'}"
8054,"{'title': 'AILD_AV_004', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
8055,"{'title': 'Clone A cells cultured for 48 hours rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
8056,"{'title': 'Patient 4700 AML134', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 134;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8057,"{'title': 'DietSensitive _6 weeks_subject3', 'description': 'DietSensitive _6 weeks_subject3', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 3;\tgender: Female'}"
8058,"{'title': 'newly diagnosed multiple myeloma 271', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: I'}"
8059,"{'title': 'colonic_crypt_epithelial_cells_normal_colon_31 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: normal colon;\tsex: female'}"
8060,"{'title': 'AML 6723', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 32 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8061,"{'title': 'N_CD8_2', 'description': 'NS2 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Negative Selection', 'characteristics_ch1': 'age: 33;\tgender: Male;\tt_cell_purity: 88%'}"
8062,"{'title': 'KT0799_0_D_test1', 'description': 'KT0799_0_D_test1', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, test set1', 'characteristics_ch1': 'baseline, deceased donor, testset1'}"
8063,"{'title': 'LMP1779', 'description': 'low-malignant tumors of the ovary', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: low-malignant tumors of the ovary'}"
8064,"{'title': 'Gingival tissue sample 2 from patient 92, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 92 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8065,"{'title': 'UCNR9_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
8066,"{'title': 'Gingival tissue sample 1 from patient 23, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 23 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8067,"{'title': 'untreated: m3: i2: d04', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 3; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 3;\tReplicate: 2;\tBatch: d04'}"
8068,"{'title': 'IFNβ_910', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8069,"{'title': 'newly diagnosed multiple myeloma 304', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: II'}"
8070,"{'title': 'Angioimmunoblastic T-cell lymphoma 22', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-58', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 72;\tgender: male'}"
8071,"{'title': 'normal_colon_79 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: colonoscopy;\tage: 50;\tlocalization: rectum'}"
8072,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 48 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
8073,"{'title': 'control-3, cells cultured in regular DMEM', 'description': 'none;\tnone', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
8074,"{'title': 'Muscle PCOS control 18', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
8075,"{'title': 'breast normal 3', 'description': 'Gene expression profiling of laser-microdissected stroma.', 'type': 'RNA', 'source_name_ch1': 'Normal breast stroma', 'characteristics_ch1': 'tissue: breast;\tnormal/tumor: normal'}"
8076,"{'title': 'Blood - Control - 088A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 34;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
8077,"{'title': 'PA203', 'description': 'PA203', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
8078,"{'title': 'Patient_5361_relapse', 'description': '5361R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 39;\tconclusions ig/tcr: stable;\tselected: no'}"
8079,"{'title': 'UNTREATED_892', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8080,"{'title': 'N2-40', 'description': 'Human Blood', 'type': 'RNA', 'source_name_ch1': 'Healthy Subject with 8 weeks of  RR Practice', 'characteristics_ch1': 'Effect of MIND and Body on Blood Transcriptome'}"
8081,"{'title': 'Young trained subject, biological replicate (YT8)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young trained subject', 'characteristics_ch1': 'no additional information'}"
8082,"{'title': 'ALL without MLL - sample 29', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8083,"{'title': 'T cell donor 3, control', 'description': 'Cells treated with DMSO vehicle control', 'type': 'RNA', 'source_name_ch1': 'MACS purified T cells from healthy donor peripheral blood', 'characteristics_ch1': 'T cell donor 3, control'}"
8084,"{'title': 'RTX10 T12', 'description': 'twenty patients with ra (17 women and 3 men, average age +/- sem: 52,6+/-3,8 years) were included in the study. All patients met the American College of Rheumatology classification criteria for the diagnosis of RA. All patients had active disease at the time of tissue sampling and were resistant to TNF blockade. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All of them had a swollen knee at inclusion. Rituximab therapy was administrated at a dose of 1,000 mg IV at baseline (T0) and at week 2, together with 125 mg IV Methylprednisolone. Clinical parameters at baseline (T0) and 12 weeks after the initiation of therapy (T12) was evaluated using DAS(28)-CRP scores and clinical responses were assessed using EULAR response criteria. Synovial biopsies were obtained by needle-arthroscopy of an affected knee from all patients at T0 and T12. For each procedure, 4 to 8 synovial samples were kept overnight at 4°C in a RNA stabilizing solution (RNALater, Ambion, Applied Biosystems, TX, USA) and then stored at –80°C for later RNA extraction. The same amount of tissue was snap-frozen in liquid nitrogen and kept at –80°C for immunostaining experiments on frozen sections. The remaining material was fixed in 10% formaldehyde and paraffin embedded for conventional optical evaluation and immunostaining of selected markers. All the experiments (RNA extraction, histology, immunohistochemistry) were performed on at least 4 biopsies harvested during every procedure in order to correct for variations related to the potential heterogeneous distribution of synovial inflammation. The study was approved by the ethics committee of the Université catholique de Louvain and informed consent was obtained from all patients.', 'type': 'RNA', 'source_name_ch1': 'Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).', 'characteristics_ch1': 'treatment: 12 weeks of RTX therapy;\tgender: M;\tage (y): 64;\tsample type: synovial knee biopsy;\tdisease state: rheumatoid arthritis;\tresponse: EULAR Poor-responder;\ttissue: synovium'}"
8085,"{'title': 'non-malignant FTEn_patient 5', 'description': 'Gene expression profile of non-malignant FTE from control patient during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 43;\tCycle: Luteal;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
8086,"{'title': 'PA80', 'description': 'PA80', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: extended;\tcell type: Synovial fluid mononuclear cells'}"
8087,"{'title': 'B14', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: II;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.5'}"
8088,"{'title': 'S037', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S037', 'characteristics_ch1': 'patient id: P104;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 50'}"
8089,"{'title': 'Blood - Axial Spondyloarthropathy - 089A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Female;\tage: 32;\tset: 2;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
8090,"{'title': 'UNTREATED_2084', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8091,"{'title': 'Septic Shock_biological rep58 09-0001', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.9;\toutcome: Survivor;\tgroup: B'}"
8092,"{'title': 'Young sedentary subject, biological replicate (YS8)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,young sedentary subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,young sedentary subject', 'characteristics_ch1': 'no additional information'}"
8093,"{'title': 'Lung Normal 146N', 'description': 'Gene expression data from 146N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 48;\tstage: n/a'}"
8094,"{'title': 'B94', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 1.0'}"
8095,"{'title': 'Hippocampus_female_34yrs_indiv35', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 34 years', 'characteristics_ch1': 'individual: 35, AA;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 34'}"
8096,"{'title': 'Globin_C2', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: Control;\trna prep: PAXgene Globin reduced;\tmolecule: Globin-depleted RNA'}"
8097,"{'title': 'Training_Site8_13', 'description': 'Performed by Operator 1 from Site8 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
8098,"{'title': 'AML 6244', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: pos;\tgender: female;\tage: 57 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8099,"{'title': 'Blood_TD19902_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
8100,"{'title': 'AML 7168', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: neg;\tgender: female;\tage: 33 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8101,"{'title': 'X70005', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8102,"{'title': 'Patient_8549_relapse', 'description': '8549R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 9;\tconclusions ig/tcr: stable;\tselected: yes'}"
8103,"{'title': 'N11451A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8104,"{'title': 'Oligodendrioglioma_5', 'description': 'bh20061208u133v2_A_26-Oligo8_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: oligodendrioglioma;\tage: 45;\tgender: male;\ttumor grade: OGIII'}"
8105,"{'title': 'Blood - Control - 022A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Male;\tage: 57;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
8106,"{'title': '22102', 'description': '11863', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24337;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
8107,"{'title': 'Endometrium - not pregnant [08-10333-3]', 'description': '08-10333-3', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, not pregnant', 'characteristics_ch1': 'tissue: endometrium on day of oocyte retrieval;\tstate: non-pregnant'}"
8108,"{'title': '10140', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 43;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: no information;\tDonor Sex: M;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
8109,"{'title': 'Patient C05, control kidney from nephrectomy', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C05, Sex: female, Age of patient: 37, Serum creatinine: 36 microMol/L, Control kidney sample  from nephrectomy'}"
8110,"{'title': 'Resting CD8+ T-cells (FACS sorted)', 'description': 'Gene expression data from resting CD8+ T-cells.;\tCD8-T0', 'type': 'RNA', 'source_name_ch1': 'Normal CD8+ T-cell subset', 'characteristics_ch1': 'cell type: CD8+ T-cell'}"
8111,"{'title': 'NSCLC_SCC_301', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 301.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
8112,"{'title': 'NORM#31', 'description': 'U133Plus2_122906L_DK07.CEL', 'type': 'RNA', 'source_name_ch1': 'Non-malignant human cortex sample', 'characteristics_ch1': 'tissue: brain;\tcondition: Primary biopsy;\tcell type: non-malignant;\tcell type: primary tissue;\tcell type: normal cortex'}"
8113,"{'title': 'B cell donor 1, rolipram', 'description': 'Cells treated with 20 uM rolipram', 'type': 'RNA', 'source_name_ch1': 'MACS purified resting B cells from healthy donor peripheral blood', 'characteristics_ch1': 'B cell donor 1, rolipram'}"
8114,"{'title': 'Monocyte_patient41_time1', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:Caucasian,Age:33,VAP day:5'}"
8115,"{'title': 'ALL without MLL - sample 64', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8116,"{'title': 'Gingival tissue sample 1 from patient 9, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 9 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8117,"{'title': 'NF-14', 'description': 'Gene expression data from non-failing control hearts', 'type': 'RNA', 'source_name_ch1': 'Non-Failing Sample 8', 'characteristics_ch1': 'sample pairs: none;\ttissue: Myocard;\tvad status: unsupported;\tdisease status: none;\tvad: none;\tage: 23;\tgender: f'}"
8118,"{'title': 'Replicate 1 for MDAMB415 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8119,"{'title': 'N8703A3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8120,"{'title': 'colon_CRC_1486', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
8121,"{'title': 'Normal_colon_36_13April05', 'description': 'Normal_colon_36_13April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, rectum', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
8122,"{'title': 'Replicate 2 for MCF7siRNActr72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 2 for MCF7siRNActr72h breast cell line'}"
8123,"{'title': 'Clone A cells treated with 5uM NIM811 and cultured for 24 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM NIM811, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: NIM811;\tconcentration: 5uM;\ttime: 24 hours'}"
8124,"{'title': 'newly diagnosed multiple myeloma 73', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: nd'}"
8125,"{'title': 'Patient 4090 AML51', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 51;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8126,"{'title': 'HF0615_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
8127,"{'title': 'Non-tolerant PBMCs_NoTOL_VHC_10', 'description': 'see M.Martinez-Llordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells from a non-tolerant human liver transplant recipient with hepatitis C virus infection and under treatment with cyclosporine A.'}"
8128,"{'title': 'Replicate 1 for HCC1395 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8129,"{'title': 'Angioimmunoblastic T-cell lymphoma 9', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-143', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 55;\tgender: female'}"
8130,"{'title': 'hyperplastic polyp_sporadic_distal', 'description': 'Gene expression data from samples of patients with HPPS.;\tA983PC', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic polyp located in distal colon from a sporadic HPPS patient', 'characteristics_ch1': 'tissue: colon;\thistology: hyperplastic polyp;\tcolon location: distal;\tdisease: hyperplastic polyposis syndrome (HPPS);\thereditary nature of hpps: sporadic'}"
8131,"{'title': 'group-1-pt-t23748670', 'description': 'group-1-pt-t23748670', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 43;\tgender: male;\tfinal disposition: 06: Home'}"
8132,"{'title': 'Blood Sample of subject 32 before inhalation; Group C', 'description': 'Bl_Group_C_BI_subject_32', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 32;\tgroup: C'}"
8133,"{'title': 'AML sample #71', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
8134,"{'title': 'CLL cells  LN patient #14', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #14'}"
8135,"{'title': 'ALL with MLL - sample 120', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8136,"{'title': 'Pt8 isolated pericardial adipocytes, biological rep1', 'description': 'Pt8_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 8', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 8'}"
8137,"{'title': 'Hepatosplenic T-cell lymphoma 1', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-139', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 46;\tgender: male'}"
8138,"{'title': 'mRNA of GBV-HGG160, Glioblastoma variant, 14.3 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 14.3 years', 'characteristics_ch1': 'disease: Glioblastoma variant;\tage: 14.3 years'}"
8139,"{'title': 'N11003A2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8140,"{'title': 'papillary renal cell cancer; pRCCa_HD108', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8141,"{'title': 'normal_colon_9 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: colonoscopy;\tage: 55;\tlocalization: caecum'}"
8142,"{'title': 'Septic Shock_biological rep43', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.1;\toutcome: Nonsurvivor'}"
8143,"{'title': 'MDS patient 32', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
8144,"{'title': 'B39', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 73;\tSex: M;\tcode: resection;\tclass: Inflammation;\tafp: 20;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
8145,"{'title': 'AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 1', 'description': 'AP-2 gamma silenced', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: AP-2 gamma targetting siRNA 2;\tcell line: MCF7'}"
8146,"{'title': 'Astrocytoma_1', 'description': 'bh20061208u133v2_A_14-Astro2_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: astrocytoma;\tage: 43;\tgender: male;\ttumor grade: AIII'}"
8147,"{'title': 'HF0137_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
8148,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 13', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
8149,"{'title': 'Recurrent GBM, TMZ/radiotherapy (155R)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: recurrent GBM;\tpatient: 155;\tage: 52.5;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 20.89;\tmgmt status: M'}"
8150,"{'title': 'Patient_48', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 48;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.213824090771352;\tproliferation index: 0.0312526727299704'}"
8151,"{'title': 'HD1-STS-6h', 'description': 'biological source:;\thomo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation', 'type': 'RNA', 'source_name_ch1': 'healthy donor HD1, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation'}"
8152,"{'title': 'IFNβ_1206', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8153,"{'title': 'AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 3', 'description': 'AP-2 gamma silenced', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: AP-2 gamma targetting siRNA 2;\tcell line: MCF7'}"
8154,"{'title': 'NSCLC_AC_210', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 210.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
8155,"{'title': 'Gingival tissue sample 3 from patient 93, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 93 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
8156,"{'title': '10409', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 50;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 56;\tDonor Sex: M;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
8157,"{'title': 'MERLION_X03K01466', 'description': 'MERLION_X03K01466', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=64, state=1', 'characteristics_ch1': 'pT2N0, male, age=64, state=1'}"
8158,"{'title': 'NY226', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: B;\tage: 73;\tSex: F;\tcode: resection;\tclass: CTNNB1;\tafp: 10.4;\ttp53 mutation: 0;\tctnnb1 mutation: 248C>CT | S37S/F;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8159,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 7', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
8160,"{'title': 'KT0614_12_L_test3', 'description': 'KT0614_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
8161,"{'title': 'adipose_postTZD_IRd_s44', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 44'}"
8162,"{'title': 'Young rep5', 'description': 'Early passage BJ fibroblasts, grown in serum-free media for 72hrs at 3% O2', 'type': 'RNA', 'source_name_ch1': 'Human Foreskin BJ fibroblasts', 'characteristics_ch1': 'Early passage human foreskin BJ fibroblasts'}"
8163,"{'title': 'Insulin sensitive patient 10 - subcutaneous adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese female', 'characteristics_ch1': 'tissue: subcutaneous adipose;\tgender: female;\tmetabolic status: insulin sensitive'}"
8164,"{'title': '10355', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 50;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 47;\tDonor Sex: F;\tCAN Banff Score =1;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
8165,"{'title': 'N8463I1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8166,"{'title': 'AML sample #36', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
8167,"{'title': 'newly diagnosed multiple myeloma 139', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: I'}"
8168,"{'title': 'Donor1_6h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 1 treated with Wy14643 for 6h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 1;\tagent: Wy14643;\ttime: 6h;\tgender: Male;\tage: 63 years old'}"
8169,"{'title': 'Blood - Control - 156A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 45;\tset: 2;\ttissue: Blood;\tdisease state: Control'}"
8170,"{'title': 'Gingival tissue sample 1 from patient 71, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 71 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8171,"{'title': 'B80', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.5'}"
8172,"{'title': 'Patient_51', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 51;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: -0.381646013610684;\tproliferation index: -2.43834473226913'}"
8173,"{'title': 'Patient 5157 AML210', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 210;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: C-KIT;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8174,"{'title': 'UCR1_beforeT', 'description': 'Colonic mucosal gene expression data from UC responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
8175,"{'title': 'CLL cells  LN patient #4', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'LN derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Lymph node;\tpatient: patient #4'}"
8176,"{'title': 'ALL with MLL - sample 127', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8177,"{'title': 'AML sample #66', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00351;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
8178,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R37', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 65.65;\t%cd3cd8: 30.31;\t%cd8+cd28-: 2.57;\t%cd8+cd28+: 17.52;\t%cd4cd25cd62l: 4.97;\t%cd3delta1: 1.28;\t%cd3delta2: 1.82;\tratio delta1/delta2: 0.7;\t%cd3gammadelta: 2.8;\t%cd3alphabeta: 94.37;\t%cd4cd8-ab+(dn): 2.59;\t%cd4 cd62l+cd45+: 44.42;\t%cd4 cd62l-cd45+: 0.20;\t%cd4 cd62l - cd45-: 10.76;\t%cd4cd62l+cd45-: 44.62;\t%cd4 ccr7+ cd45 -: 29.68;\t%cd4 ccr7+ cd45+: 44.32;\t%cd4 ccr7 - cd45+: 2.32;\t%cd4 ccr7 – cd45-: 23.69;\t%cd8 cd62l+ cd45-: 8.38;\t%cd8cd62l+ cd45+: 74.17;\t%cd8cd62l- cd45+: 4.21;\t%cd8cd62l- cd45 -: 13.23;\t%cd8ccr7+ cd45-: 3.82;\t%cd8ccr7+ cd45+: 62.89;\t%cd8ccr7-cd45+: 8.31;\t%cd8ccr7-cd45 -: 24.97;\t%cd3-cd56+cd16+: 10.66;\t%nkts: 5.21;\t%cd19: 9.70;\t%cd4foxp3+: 9.65'}"
8179,"{'title': 'Peripheral T-Cell lymphoma, unspecified 37', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-134', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 65;\tgender: male'}"
8180,"{'title': 'S075', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S075', 'characteristics_ch1': 'patient id: P071;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
8181,"{'title': 'AML 2272', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 35 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: +8;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8182,"{'title': 'UNTREATED_847', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8183,"{'title': 'AML 6884', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 19 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8184,"{'title': 'Recurrent GBM, TMZ/radiotherapy (1854R)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: recurrent GBM;\tpatient: 1854;\tage: 52;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 0;\tsurvival time in months: 63.49;\tmgmt status: M'}"
8185,"{'title': 'RA Synovial biopsy T12 post-adalimumab therapy, Poor Responder 1', 'description': 'Patient has rheumatoid arthritis (RA), according to the American College of rheumatology criteria for the diagnosis of RA. All patients included in this study had active disease at the time of initiation of adalimumab therapy and were resistant to conventional therapy. They all had erosive changes imaged on conventional x-rays of the hands and/or feet. All patients were treated with disease-modifying antirheumatic drugs (DMARD’s), 23 with methotrexate (median dose 15 mg/week, range 7.5 – 20 mg/week), and 2 with leflunomide (20 mg/day); 18 of them were treated with low-dose steroids (prednisolone ≤ 7.5 mg/day). Six patients had been included in double-blind clinical trials before inclusion in the present study (1 in a Golimumab versus placebo trial, 3 in a MapKinase inhibitor versus placebo trial and 2 in a TACE-inhibitor versus placebo trial). These trials were stopped at least 3 months prior to initiation of TNF-blocking therapy. All drug dosages were stable from at least 3 months prior to initiation of TNF blocking therapy until completion of the study. No steroid injections were allowed during the duration of the study.', 'type': 'RNA', 'source_name_ch1': 'Synovial biopsy, RA patient, 12 weeks after adalimumab therapy, poor responder', 'characteristics_ch1': 'tissue: synovial tissue from knee;\tdisease: rheumatoid arthritis'}"
8186,"{'title': 'Gingival tissue sample 1 from patient 93, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 93 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8187,"{'title': 'Peripheral T-Cell lymphoma, unspecified 6', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-105', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 54;\tgender: male'}"
8188,"{'title': 'Cord Blood 19, biological replicate 5', 'description': 'Gene expression data of reticulocytes from umbilical cord blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from umbilical cord blood', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: reticulocytes'}"
8189,"{'title': '2.2.AF.2', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 2 hours post infection, donor 1, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 2;\tinfection condition: AF;\thours post infection: 2'}"
8190,"{'title': 'Patient 5036 AML184', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 184;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8191,"{'title': 'newly diagnosed multiple myeloma 165', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
8192,"{'title': 'Control TC1', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
8193,"{'title': 'CD34+CD45RA+Lin- HPCs transduced with empty vector cultured onto 2 µg of Delta1ext-IgG', 'description': 'BCE_03;\tGene expression data from Notch-activated (2 µg) cells transduced with empty vector', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA-Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: hematopoietic progenitors;\tgenotype/variation: transduced with empty vector;\ttreatment group: Notch-activated (2 µg)'}"
8194,"{'title': '07-0005_Sepsis_day1_97', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8195,"{'title': 'AML with normal karyotype #70', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 45;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: n./a.;\tdisease state: de novo AML'}"
8196,"{'title': 'muscle_preTZD_preClamp_IRd-_s6', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: - (non responder);\tsubject: 6'}"
8197,"{'title': 'ZFP161B', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siLincZFP161;\treplicate: 1'}"
8198,"{'title': 'GA_1218', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
8199,"{'title': 'NY331', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 51;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 19;\ttp53 mutation: 0;\tctnnb1 mutation: 232G>GA | D32D/N;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8200,"{'title': 'ALL without MLL - sample 35', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8201,"{'title': 'Gingival tissue sample 3 from patient 68, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 68 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
8202,"{'title': 'no GvHD d90', 'description': 'no GvHD d90;\tMHH0889', 'type': 'RNA', 'source_name_ch1': 'blood from allogeneic stem cell transplantation (SCT) patient', 'characteristics_ch1': 'disease state: no GvHD;\tcell type: CD4+CD25highCD127low/- Tregs;\ttime: 90 days'}"
8203,"{'title': 'S064', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S064', 'characteristics_ch1': 'patient id: P106;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
8204,"{'title': '5291', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 67 years, RAEB-t, cytogenetic intermediate risk, CEBPA wild type'}"
8205,"{'title': 'C97529', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7204_Tumor;\tfab: M1;\tSex: M;\trace: C;\tage on study: 33;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8206,"{'title': 'X450', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 1'}"
8207,"{'title': 'AML sample #83', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
8208,"{'title': 'AML with normal karyotype #138', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 36;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 72;\tdisease state: de novo AML'}"
8209,"{'title': 'class S, rep85', 'description': 'VAN_00517.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 52;\tsex: M;\tdisease stage: 2;\talbumin level: 37;\themoglobin level: 142;\tlymphocyte percentage: 6;\twhite blood count: 9.4;\tinternational prognostic score (ips): 5'}"
8210,"{'title': 'HF0087_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
8211,"{'title': 'AML 2273', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 16 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
8212,"{'title': 'AML 2281', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 20 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8213,"{'title': 'Adult T-cell leukemia/lymphoma-6', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-64', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 80;\tgender: male'}"
8214,"{'title': 'Patient_8237_relapse', 'description': '8237R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: female;\trelapse type: isolated bone marrow;\tmonths to relapse: 13;\tconclusions ig/tcr: N/A;\tselected: no'}"
8215,"{'title': 'newly diagnosed multiple myeloma 131', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
8216,"{'title': 'Control-3', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tSc3', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness - control;\tSex: M;\tage: 21;\ttissue ph: 5.82;\tpmi (hrs): 40;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
8217,"{'title': '06-14-05_Miller_U133Plus2_0_A3P3d07EPO', 'description': 'Pool of 3 samples:;\t25-45 age;\tM/F;\tDay 7: proerythroblast', 'type': 'RNA', 'source_name_ch1': 'CD34+ progenitor cells subjected to EPO and harvested at day 7', 'characteristics_ch1': 'cell type: CD34+ hematopoietic progenitor cells;\tdevelopmental stage: proerythroblast;\ttissue type: primary cells from donated blood'}"
8218,"{'title': 'Proficiency_Site8_22', 'description': 'Performed by Operator 1 from Site8 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 57; Lot# = 035PO41658D'}"
8219,"{'title': 'class S, rep5', 'description': 'NEB_1065.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 38;\tsex: F;\tdisease stage: 4;\talbumin level: 38;\themoglobin level: 116;\tlymphocyte percentage: 20;\twhite blood count: 9.9;\tinternational prognostic score (ips): 2'}"
8220,"{'title': 'Gingival tissue sample 3 from patient 34, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 34 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
8221,"{'title': 'lg_NY56', 'description': 'low-grade dysplastic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; low-grade dysplastic liver tissue', 'characteristics_ch1': 'low-grade dysplastic liver tissue'}"
8222,"{'title': 'Simvastatin treated 12h, sample 1, Simvastatin is anti-inflammatory in macrophages', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'human peripheral blood monocyte-derived macrophages', 'characteristics_ch1': 'from unknown healthy blood-donor volunteers (Finnish Red Cross)'}"
8223,"{'title': 'B34', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: neg;\ttumor type: Lobular;\ttumor size: 2.5'}"
8224,"{'title': 'Peripheral T-Cell lymphoma, unspecified 27', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-91', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 80;\tgender: female'}"
8225,"{'title': 'Tumor 64', 'description': '08SE382', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
8226,"{'title': 'Oligodendrioglioma_6', 'description': 'bh20061208u133v2_A_27-Oligo9_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: oligodendrioglioma;\tage: 45;\tgender: male;\ttumor grade: OGIII'}"
8227,"{'title': 'Muscle-FamilyHistoryPositive-4', 'description': 'Jos3696;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 31;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 20;\tfasting glucose (ogtt): 93;\t2 hour glucose (ogtt): 128;\themoglobin a1c: 4.9;\tfasting glucose (iv0gavg): 96;\tfasting insulin (iv0inavg): 5.1;\tsi: 7.61;\twaist hip ratio: 0.745'}"
8228,"{'title': 'G166-NS_B', 'description': 'U133Plus2_122906L_DK01.CEL', 'type': 'RNA', 'source_name_ch1': 'Glioblastoma derived cell line', 'characteristics_ch1': 'tissue: brain;\tcondition: Proliferating cultures in EGF and FGF-2;\tcell type: malignant;\tcell type: cell line;\tcell type: glioblastoma'}"
8229,"{'title': 'Cervical cancer-lymph node positive-37-56', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 46.3;\tfigo stage: 1b1'}"
8230,"{'title': 'Proficiency_Site4_14', 'description': 'Performed by Operator 1 from Site4 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 56.4; Lot# = 035PO41658D'}"
8231,"{'title': 'Endometrium control 0 hours TCM-4', 'description': 'Control endometrium  0 hours TCM-4', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control endometrium  0 hours TCM-4'}"
8232,"{'title': 'Clone A cells cultured for 24 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 24 hours'}"
8233,"{'title': 'non-pCR breast biopsy, sample 8 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 8 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
8234,"{'title': 'carcinoma_56 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 78;\tlocalization: ascending'}"
8235,"{'title': 'Monocyte cell line, serum only 1', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: Added serum only'}"
8236,"{'title': 'class F, rep11', 'description': 'NEB_18.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 68;\tsex: F;\tdisease stage: 2;\talbumin level: 35;\themoglobin level: 126;\tlymphocyte percentage: 23;\twhite blood count: 3.9;\tinternational prognostic score (ips): 1'}"
8237,"{'title': 'human BM MSC BMP2 stimulated day 21 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by BMP2 for chondrogenic differentiation: day 21', 'type': 'RNA', 'source_name_ch1': 'donor 3, stimulated with BMP2 for 21 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 21 days'}"
8238,"{'title': 'class F, rep4', 'description': 'NEB_10.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: EARLY;\tage (years): 16;\tsex: M;\tdisease stage: 2;\talbumin level: 41;\themoglobin level: 113;\tlymphocyte percentage: 9;\twhite blood count: 9.5;\tinternational prognostic score (ips): 2'}"
8239,"{'title': 'Adult T-cell leukemia/lymphoma-11', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-71', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 72;\tgender: male'}"
8240,"{'title': '294154', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9851_Tumor;\tfab: M5;\tSex: M;\trace: W;\tage on study: 44;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 1'}"
8241,"{'title': 'Hippocampus_female_37yrs_indiv45', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 37 years', 'characteristics_ch1': 'individual: 45, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 37'}"
8242,"{'title': 'centroblast, tonsil#7', 'description': 'centroblast, tonsil#7', 'type': 'RNA', 'source_name_ch1': 'Inflamed non tumoral human tonsil#7', 'characteristics_ch1': 'cell suspension: Flow sorted cells;\tcell type: centroblast, tonsil'}"
8243,"{'title': 'No14pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No14 nonRVR;\ttime point: before therapy'}"
8244,"{'title': '24 hours post-infection, biological rep1', 'description': 'Gene expression data from cells 24 hours after HCMV infection', 'type': 'RNA', 'source_name_ch1': 'Human neural stem cell culture', 'characteristics_ch1': 'cell type: Post-mortem, fetal, human brain-derived neural stem cells;\tgenotype: Normal;\tage: no more than passage 15'}"
8245,"{'title': 'S3R-7', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 7; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 7; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 7;\tSmoking status: smoker;\tPack-years: 30;\tAge: 44;\tSex: F;\tEthnic group: white'}"
8246,"{'title': 'normal Post ECP, biological rep6', 'description': 'this sample involved data from two arrays', 'type': 'RNA', 'source_name_ch1': 'normal Post ECP', 'characteristics_ch1': 'disease state: normal;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
8247,"{'title': 'AML 3311', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8248,"{'title': 'MonoMac6 - leukotriene C4', 'description': 'Stimulation of MonoMac6 cells with leukotriene C4', 'type': 'RNA', 'source_name_ch1': 'human monocytic cell line MonoMac6 stimulated for 12 h with leukotriene C4', 'characteristics_ch1': 'cultured MonoMac6 cells, near confluent state, incubated for 12 h in the presence of 100 nM leukotriene C4 dissolved in DMSO'}"
8249,"{'title': 'Replicate 1 for HCC1569 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8250,"{'title': 'Patient C15, control kidney from nephrectomy', 'description': 'Gene expression data from human normal adult kidney (from nephrectomy).', 'type': 'RNA', 'source_name_ch1': 'Human control kidney from nephrectomy', 'characteristics_ch1': 'Patient identifier: C15, Sex: male, Age of patient: 60, Serum creatinine: 93 microMol/L, Control kidney sample  from nephrectomy'}"
8251,"{'title': 'Training_Site4_08', 'description': 'Performed by Operator 1 from Site4 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
8252,"{'title': 'Control-24', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tLc2', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - control;\tSex: M;\tage: 68;\ttissue ph: 6.06;\tpmi (hrs): 41;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
8253,"{'title': 'newly diagnosed multiple myeloma 310', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: I'}"
8254,"{'title': 'X34019', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8255,"{'title': 'Huh7 cells cultured for 24 hours rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 24 hours'}"
8256,"{'title': 'Donor 4 - LTD4 stimulated', 'description': 'Elutriated monocytes from donor 4 treated with LTD4 for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes stimulated with LTD4 (100nM) for 30 min.'}"
8257,"{'title': 'NB60 U133p2 (breast epithelial study)', 'description': 'RNA from bulk normal breast or normal breast organoid', 'type': 'RNA', 'source_name_ch1': 'NB60', 'characteristics_ch1': 'bulk normal breast or normal breast organoid'}"
8258,"{'title': 'AML with normal karyotype #244', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 56;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: >30;\tdisease state: de novo AML'}"
8259,"{'title': 'non-pCR breast biopsy, sample 6 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 6 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
8260,"{'title': 'KT0588_3_D_test2_test3', 'description': 'KT0588_3_D_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, deceased donor, test set2 and test set3', 'characteristics_ch1': '3 months, deceased donor, test set2 and test set3'}"
8261,"{'title': 'B cell donor 2, rolipram', 'description': 'Cells treated with 20 uM rolipram', 'type': 'RNA', 'source_name_ch1': 'MACS purified resting B cells from healthy donor peripheral blood', 'characteristics_ch1': 'B cell donor 2, rolipram'}"
8262,"{'title': 'CHM_FB_26', 'description': 'Strunnikova_26_111308', 'type': 'RNA', 'source_name_ch1': 'primary FB cultures from CHM patients', 'characteristics_ch1': 'cell type: primary fibroblasts cultures;\tdisease: choroideremia'}"
8263,"{'title': 'csc: m4: i2: d06', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: csc; Month: 4; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: csc;\tMonth: 4;\tReplicate: 2;\tBatch: d06'}"
8264,"{'title': 'AML sample #43', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
8265,"{'title': 'NSCLC EMC ADC2269N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
8266,"{'title': 'KT0422_24_L_test3', 'description': 'KT0422_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
8267,"{'title': '22085', 'description': '11779', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24317;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
8268,"{'title': 'MERLION_X02K03683', 'description': 'MERLION_X02K03683', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=78, state=0', 'characteristics_ch1': 'pT2N0, male, age=78, state=0'}"
8269,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_71_5)', 'description': 'Gene expression data from whole blood 30 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 30 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 30;\ttissue: blood;\tethinicity: caucasian;\tage: 69;\tSex: M'}"
8270,"{'title': 'CB5', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'centroblasts donor 5', 'characteristics_ch1': 'centroblasts, isolated from tonsils by fluorescence-activated cell sorting'}"
8271,"{'title': 'AML with normal karyotype #240', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 59;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 99;\tdisease state: de novo AML'}"
8272,"{'title': '01-0018_Sepsis_day3_25', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8273,"{'title': 'No17LCMHinf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 RVR No17;\tcell type: hepatocytes;\ttime point: under therapy'}"
8274,"{'title': 'C002_Control_F_87', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'gender: Female;\tage: 87;\tpost-mortem delay: 14.5h;\tph: 6.5'}"
8275,"{'title': 'HF0533_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
8276,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R5', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 68.21;\t%cd3cd8: 6.69;\t%cd8+cd28-: 34.83;\t%cd8+cd28+: 8.40;\t%cd4cd25cd62l: 4.27;\t%cd3delta1: 0.41;\t%cd3delta2: 2.22;\tratio delta1/delta2: 0.18;\t%cd3gammadelta: 0.81;\t%cd3alphabeta: 96.22;\t%cd4cd8-ab+(dn): 3.08;\t%cd4 cd62l+cd45+: 24.54;\t%cd4 cd62l-cd45+: 6.19;\t%cd4 cd62l - cd45-: 37.25;\t%cd4cd62l+cd45-: 32.02;\t%cd4 ccr7+ cd45 -: 12.81;\t%cd4 ccr7+ cd45+: 25.80;\t%cd4 ccr7 - cd45+: 14.13;\t%cd4 ccr7 – cd45-: 47.26;\t%cd8 cd62l+ cd45-: 31.71;\t%cd8cd62l+ cd45+: 31.98;\t%cd8cd62l- cd45+: 10.97;\t%cd8cd62l- cd45 -: 25.33;\t%cd8ccr7+ cd45-: 2.63;\t%cd8ccr7+ cd45+: 19.57;\t%cd8ccr7-cd45+: 20.85;\t%cd8ccr7-cd45 -: 56.95;\t%cd3-cd56+cd16+: 46.24;\t%nkts: 17.27;\t%cd19: 5.37;\t%cd4foxp3+: 3.53'}"
8277,"{'title': 'Septic Shock_biological rep55', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 4.2;\toutcome: Nonsurvivor'}"
8278,"{'title': 'Monocyte cell line, serum only 3', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: Added serum only'}"
8279,"{'title': 'control_16hr_rep2', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'control_16hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
8280,"{'title': '01-0061B_Septic Shock_day3_16', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8281,"{'title': 'S012', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S012', 'characteristics_ch1': 'patient id: P064;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 55'}"
8282,"{'title': 'S128', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S128', 'characteristics_ch1': 'patient id: P005;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: '}"
8283,"{'title': 'Bronchial epithelial cells, day 4, donor 1', 'description': 'Bronchial epithelial cells, day 4, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 4 of air-liquid interface culture'}"
8284,"{'title': 'Mature WEEV infected biological replicate 1 (WEEV)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: WEEV 6h;\tcell line: BE(2)-C'}"
8285,"{'title': 'S086', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S086', 'characteristics_ch1': 'patient id: P100;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 70'}"
8286,"{'title': 'CHM_FB_21', 'description': 'Strunnikova_21_111308', 'type': 'RNA', 'source_name_ch1': 'primary FB cultures from CHM patients', 'characteristics_ch1': 'cell type: primary fibroblasts cultures;\tdisease: choroideremia'}"
8287,"{'title': 'EC control 10', 'description': 'arrayconsortium.tgen.org::biosample.434013;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 10;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: female\xa0;\tGenetic Variation: None\xa0;\tAge: 88 years'}"
8288,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R13', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 42.26;\t%cd3cd8: 46.82;\t%cd8+cd28-: 10.58;\t%cd8+cd28+: 6.22;\t%cd4cd25cd62l: 4.24;\t%cd3delta1: 1.57;\t%cd3delta2: 1.5;\tratio delta1/delta2: 1.05;\t%cd3gammadelta: 7.71;\t%cd3alphabeta: 86.28;\t%cd4cd8-ab+(dn): 7.70;\t%cd4 cd62l+cd45+: 2.92;\t%cd4 cd62l-cd45+: 0.24;\t%cd4 cd62l - cd45-: 49.41;\t%cd4cd62l+cd45-: 47.43;\t%cd4 ccr7+ cd45 -: 17.78;\t%cd4 ccr7+ cd45+: 2.24;\t%cd4 ccr7 - cd45+: 1.17;\t%cd4 ccr7 – cd45-: 78.81;\t%cd8 cd62l+ cd45-: 9.57;\t%cd8cd62l+ cd45+: 11.60;\t%cd8cd62l- cd45+: 27.92;\t%cd8cd62l- cd45 -: 50.91;\t%cd8ccr7+ cd45-: 4.55;\t%cd8ccr7+ cd45+: 2.06;\t%cd8ccr7-cd45+: 28.37;\t%cd8ccr7-cd45 -: 65.02;\t%cd3-cd56+cd16+: 63.24;\t%nkts: 18.27;\t%cd19: 3.99;\t%cd4foxp3+: 7.38'}"
8289,"{'title': 'ISC Control heart, technical replicate A RMA', 'description': 'Gene expression data from left ventricle of human heart with no LMNA mutation', 'type': 'RNA', 'source_name_ch1': 'left ventricle patient with ischemic cardiomyopathy', 'characteristics_ch1': 'gender: male;\tdevelopmental stage: adult;\torgan: heart;\ttissue: left ventricle;\tgenotype: LMNA wt;\tdata analysis algorithm: RMA'}"
8290,"{'title': 'Replicate 2 for MDA435 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8291,"{'title': 'MDS patient 104', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: monosomy7/del(7q)'}"
8292,"{'title': 'Blood_TD51282_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
8293,"{'title': 'ci_NY8', 'description': 'cirrhotic liver tissue', 'type': 'RNA', 'source_name_ch1': 'human liver; cirrhotic liver tissue', 'characteristics_ch1': 'cirrhotic liver tissue'}"
8294,"{'title': 'AML with normal karyotype #16', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 52;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 81.5;\tdisease state: de novo AML'}"
8295,"{'title': 'Adult T-cell leukemia/lymphoma-8', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-66', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 78;\tgender: male'}"
8296,"{'title': 'UC03', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: UC'}"
8297,"{'title': 'sample 9, brca1 mutation negative, follicular phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation negative, follicular phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: no;\tovarian cycle status: follicular;\tsample identifier: 9'}"
8298,"{'title': 'X41064', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
8299,"{'title': 'AML with normal karyotype #19', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 52;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 68;\tdisease state: de novo AML'}"
8300,"{'title': 'N40728', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40728;\tsample: normal'}"
8301,"{'title': '01-0061A_Septic Shock_day1_15', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8302,"{'title': 'TOL16', 'description': 'Gene expression data from Tolerant 16', 'type': 'RNA', 'source_name_ch1': 'Tolerant16', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Tolerant'}"
8303,"{'title': 'AML 6371', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 43 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: ;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8304,"{'title': 'cHL12', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 12', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
8305,"{'title': 'Thyroid_ papillary carcinoma 50', 'description': 'sample name in manuscript: T-PTC4', 'type': 'RNA', 'source_name_ch1': 'frozen surgical tissue', 'characteristics_ch1': 'Tissue: tumor; Gender:male; Age:33  Tumor stage:T1N0MX'}"
8306,"{'title': 'vn4', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: normal'}"
8307,"{'title': 'colon_adenoma_995', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
8308,"{'title': 'IFNβ_643', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8309,"{'title': 'PTCL.BO-12', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
8310,"{'title': 'AML 6237', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 59 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8311,"{'title': 'AML 6952', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 52 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8312,"{'title': 'UNTREATED_850', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8313,"{'title': 'DLBCL biopsy, sample 2060', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8314,"{'title': 'Gingival tissue sample 2 from patient 7, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 7 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8315,"{'title': 'B74', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: C;\tage: 57;\tSex: M;\tcode: resection;\tclass: Proliferation;\tafp: 3;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8316,"{'title': 'cord blood 26_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 2.29', 'characteristics_ch1': 'Cord blood arsenic exposure level 2.29;\t'}"
8317,"{'title': 'B98', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 76;\tSex: F;\tcode: resection;\tclass: Proliferation;\tafp: 1291;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8318,"{'title': 'Control 37', 'description': '07SE530', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
8319,"{'title': 'AML with normal karyotype #67', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 68;\tdisease state: de novo AML'}"
8320,"{'title': 'sample 43, brca1 mutation negative, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation negative, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: no;\tovarian cycle status: luteal;\tsample identifier: 43'}"
8321,"{'title': 'adenocarcinoma_61 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 68;\tlocalization: sigmoid'}"
8322,"{'title': 'AML sample #27', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
8323,"{'title': 'Patient 5239 AML232', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 232;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8324,"{'title': 'N30308', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30308;\tsample: normal'}"
8325,"{'title': 'dmso-aza-1', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tDemethylation: aza;\tReplicate: 1'}"
8326,"{'title': 'muscle_preTZD_preClamp_IRd_s29', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 29'}"
8327,"{'title': 'WB910a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1391;\tdisease state: Acute;\tgender: Male;\tage: 37;\trace: African American;\tblood cd4+ t  cell count (cells/ml): 414;\tplasma hiv-1     rna level   (copies/ml): 24718;\ttissue: lymph node'}"
8328,"{'title': 'AML sample #56', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00245;\tanalysis i: not included;\tanalysis ii: AML-MRC'}"
8329,"{'title': 'KT0832_0_D_test1', 'description': 'KT0832_0_D_test1', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor,  test set1', 'characteristics_ch1': 'baseline, deceased donor,  test set1'}"
8330,"{'title': 'blood, Blood: 1mM nic - 2_e1_le1', 'description': '1mM nicotine treatment for 1 hour;\tTreatment, type=incubate', 'type': 'RNA', 'source_name_ch1': 'blood, Blood', 'characteristics_ch1': None}"
8331,"{'title': 'AML with normal karyotype #80', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 78;\tdisease state: de novo AML'}"
8332,"{'title': 'VA64', 'description': '03-34768', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 62;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP3-RITU-RAD;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 4.49;\tprogression-free_survival (years): 4.49'}"
8333,"{'title': 'Treatment-4, cells cultured in DMEM plus 5 mM HisOH', 'description': 'none;\tnone', 'type': 'RNA', 'source_name_ch1': 'Human Hepatoma Cells', 'characteristics_ch1': 'cell type: Human Hepatoma Cells'}"
8334,"{'title': 'No22inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No22RVR;\ttime point: under therapy'}"
8335,"{'title': 'AML 3319', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 49 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8336,"{'title': 'DLBCL biopsy, sample 2160', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8337,"{'title': 'AML with normal karyotype #123', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 61;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Peripheral Blood;\tblast cell percentage: 87;\tdisease state: de novo AML'}"
8338,"{'title': 'Control V9', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
8339,"{'title': 'X34801', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8340,"{'title': 'hyperplastic polyp_familial_distal', 'description': 'Gene expression data from samples of patients with HPPS.;\tA686P1A', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic polyp located in distal colon from a familial HPPS patient', 'characteristics_ch1': 'tissue: colon;\thistology: hyperplastic polyp;\tcolon location: distal;\tdisease: hyperplastic polyposis syndrome (HPPS);\thereditary nature of hpps: familial'}"
8341,"{'title': 'Septic Shock_biological rep26 01-0007A', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 3.7;\toutcome: Nonsurvivor;\tgroup: A'}"
8342,"{'title': '10168', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 60;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 60;\tDonor Sex: M;\tCAN Banff Score =3;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
8343,"{'title': 'X70123', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8344,"{'title': 'PA215', 'description': 'PA215', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: persistent;\tcell type: Synovial fluid mononuclear cells'}"
8345,"{'title': 'MERLION_X02K01279', 'description': 'MERLION_X02K01279', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=68, state=1', 'characteristics_ch1': 'pT2N0, male, age=68, state=1'}"
8346,"{'title': 'Monocyte_patient50_time9', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:Caucasian,Age:59,VAP day:7'}"
8347,"{'title': 'Gingival tissue sample 1 from patient 48, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 48 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8348,"{'title': 'Sepsis V31', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis'}"
8349,"{'title': 'No15LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No15;\tcell type: lymphocytes;\ttime point: before therapy'}"
8350,"{'title': 'newly diagnosed multiple myeloma 214', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: I'}"
8351,"{'title': 'X32103', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 3'}"
8352,"{'title': 'Gastric GIST 14', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 52;\tTumor size: 7;\tKIT mutation: Exon 11'}"
8353,"{'title': 'HC3', 'description': 'Gene expression data from Healthy Control 3', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 3', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
8354,"{'title': '01_0051A_Day1_13', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Female;\tSurvivor;\torganism: Strep pneumo'}"
8355,"{'title': 'Gingival tissue sample 2 from patient 50, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 50 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8356,"{'title': 'VAN_00697', 'description': '07-30628', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 58;\tgender: M;\tipi_stage: 2A;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.73;\tprogression-free_survival (years): 0.73'}"
8357,"{'title': 'adipose_preTZD_NRd_s15', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 15'}"
8358,"{'title': 'DLBCL biopsy, sample 2127', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8359,"{'title': '10-0012_Sepsis_day3_121', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8360,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_2d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
8361,"{'title': 'newly diagnosed multiple myeloma 53', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
8362,"{'title': '04-0004_Septic Shock_day1_219', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8363,"{'title': 'class S, rep91', 'description': 'VAN_00560.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 41;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: 156;\tlymphocyte percentage: 26;\twhite blood count: 9.5;\tinternational prognostic score (ips): 2.3'}"
8364,"{'title': 'Blood Sample of subject 25 before inhalation; Group B', 'description': 'Bl_Group_B_BI_subject_25', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 25;\tgroup: B'}"
8365,"{'title': 'Small intestinal GIST 7', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human small intestinal GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 82;\tTumor size: 4;\tKIT mutation: Exon 9'}"
8366,"{'title': 'muscle_preTZD_preClamp_IRd+_s35', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 35'}"
8367,"{'title': 'TC.CD8-1', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
8368,"{'title': 'newly diagnosed multiple myeloma 193', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: I'}"
8369,"{'title': '01-0059B_SIRS resolved_day3_13', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS resolved_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8370,"{'title': 'UNTREATED_746', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8371,"{'title': 'NSCLC_AC_282', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 282.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: adenocarcinoma'}"
8372,"{'title': 'Patient 103 AML1', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 1;\tcohort: Discovery;\tkaryotype: t(7;12);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: PTPN11;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8373,"{'title': 'colon_CRC_1479', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
8374,"{'title': 'Control_biological rep2 01-0105', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0.9;\toutcome: n/a;\tgroup: n/a'}"
8375,"{'title': 'GA_1061', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8376,"{'title': 'M71', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 72;\tSex: M;\tcode: resection;\tclass: Unannotated;\tafp: 6;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Not used'}"
8377,"{'title': 'VAN_00589', 'description': '06-23907', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 50;\tgender: M;\ttxprimary: CHOP6-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 1.78;\tprogression-free_survival (years): 1.78'}"
8378,"{'title': 'Peripheral T-Cell lymphoma, unspecified 44', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-03', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 76;\tgender: male'}"
8379,"{'title': 'blood_cd34neg_D2', 'description': '3 samples CD34+ and 2 samples CD34-', 'type': 'RNA', 'source_name_ch1': 'periphereal blood', 'characteristics_ch1': 'healty donor treated with GCSF isolated CD34+ cells and CD34+ after 10dd of differentiating medium.'}"
8380,"{'title': 'Septic Shock_biological rep53 06-0006', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 2.2;\toutcome: Survivor;\tgroup: A'}"
8381,"{'title': 'Gingival tissue sample 1 from patient 89, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 89 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8382,"{'title': 'HUVEC_TNFa_4h00m', 'description': '4h00m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 4h00m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
8383,"{'title': 'Old trained subject, biological replicate (OT20)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old trained subject', 'characteristics_ch1': 'no additional information'}"
8384,"{'title': 'T51176', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51176;\tsample: tumor'}"
8385,"{'title': 'GBM, TMZ/radiotherapy (563)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 563;\tage: 52.8;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 8.59;\tmgmt status: U'}"
8386,"{'title': 'Peripheral T-Cell lymphoma, unspecified 10', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-16', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 77;\tgender: male'}"
8387,"{'title': 'VAN_00596', 'description': '06-25470', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: GCB;\tpathology: DLBC;\ttissue: lymph node;\tage: 68;\tgender: F;\tipi_stage: 1A;\ttxprimary: CHOP4-RITU;\tstatus: free of disease after initial treatment;\tcode_os: alive;\tcode_pfs: alive;\toverall_survival (years): 0.93;\tprogression-free_survival (years): 0.93'}"
8388,"{'title': 'AML sample #60', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00260;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
8389,"{'title': 'HF0201_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
8390,"{'title': 'Gene expression: HCC38', 'description': 'Breast cancer cell line, ATCC# CRL-2314', 'type': 'RNA', 'source_name_ch1': 'RNA from cell line', 'characteristics_ch1': 'cell line: HCC38;\tcatalog number: ATCC# CRL-2314'}"
8391,"{'title': 'Sputum from Stage IV Severe, biological replicate 8', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 72;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
8392,"{'title': 'untreated: m1: i1: d02', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 1; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 1;\tReplicate: 1;\tBatch: d02'}"
8393,"{'title': 'Monocyte_patient45_time9', 'description': 'Gene expression data (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)', 'type': 'RNA', 'source_name_ch1': 'Monocyte', 'characteristics_ch1': 'Gender:Male,Ethnicity:African-american,Age:32,VAP day:3'}"
8394,"{'title': 'chromophobe renal cell cancer; chRCC_HA315', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8395,"{'title': 'AML sample #92', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00677;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
8396,"{'title': 'heterozygot FH P560', 'description': 'Gene expression data from the heterozygous FH participant DW', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: heterozygote FH'}"
8397,"{'title': 'PTB2 unstim', 'description': 'Gene expression of monocyte derived macrophages (MDMs) from subjects with three clinical forms of TB including LTB, PTB and TBM (n = 4 in each group) was examined by microarray. MDMs were stimulated either with a whole cell lysate of M. tuberculosis H37Rv or PBS for 4 hours.', 'type': 'RNA', 'source_name_ch1': 'macrophage, ex vivo stimulation with media (control)', 'characteristics_ch1': '5 day monocyte-derived macrophage;\tPulmonary'}"
8398,"{'title': 'Patient_37', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 37;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.0703811172271713;\tproliferation index: 1.33539882001009'}"
8399,"{'title': 'Replicate 1 for HCC1419 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8400,"{'title': 'C116', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: neg;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 3.5'}"
8401,"{'title': 'Glioblastoma_1', 'description': 'bh20061208u133v2_A_01-GBM1_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: glioblastoma;\tage: 46;\tgender: male;\ttumor grade: IV'}"
8402,"{'title': 'C99508', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7195_Tumor;\tfab: M2;\tSex: M;\trace: H;\tage on study: 55;\tcytogenetic change: t(8;10;21)(q22;q26;q22); -Y;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8403,"{'title': 'No4LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 1 nonRVR No4;\tcell type: lymphocytes;\ttime point: before therapy'}"
8404,"{'title': 'Replicate 1 for BT483 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8405,"{'title': 'KT0497_3_L_test3', 'description': 'KT0497_3_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set3', 'characteristics_ch1': '3 months, living donor, test set3'}"
8406,"{'title': 'Training_Site7_06', 'description': 'Performed by Operator 1 from Site7 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
8407,"{'title': 'Cadmium_00hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'Cadmium_00hr', 'characteristics_ch1': 'Gender: Male; Tissue: prostate.'}"
8408,"{'title': 'sample 42, brca1 mutation positive, follicular phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, follicular phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: follicular;\tsample identifier: 42'}"
8409,"{'title': 'Training_Site2_05', 'description': 'Performed by Operator 1 from Site2 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CML in blast crisis', 'characteristics_ch1': 'chronic myeloid leukemia [CML] patient lysates of mononuclear cells'}"
8410,"{'title': 'newly diagnosed multiple myeloma 264', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: II'}"
8411,"{'title': 'adenocarcinoma_48 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 60;\tlocalization: sigmoid'}"
8412,"{'title': 'S158', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S158', 'characteristics_ch1': 'patient id: P049;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 66.5'}"
8413,"{'title': 'AML with normal karyotype #190', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 52;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Peripheral Blood;\tblast cell percentage: 84;\tdisease state: de novo AML'}"
8414,"{'title': 'MERLION_X00K06057', 'description': 'MERLION_X00K06057', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age:77 , state:0', 'characteristics_ch1': 'pT2N0, male, age:77 , state:0'}"
8415,"{'title': 'cord blood 14_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.12', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.12;\t'}"
8416,"{'title': 'Patient_7170_diagnosis', 'description': '7170D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 18;\tconclusions ig/tcr: stable;\tselected: no'}"
8417,"{'title': 'PTCL_021', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
8418,"{'title': '22091', 'description': '11785', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24324;\tSmoking_Status: Never;\tPathology: Adenocarcinoma'}"
8419,"{'title': 'N9112A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8420,"{'title': 'Replicate 1 for CAL120 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8421,"{'title': 'Donor 1 - control', 'description': 'Elutriated monocytes from donor 1 treated with vehicle control for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes exposed to vehicle control (EtOH)'}"
8422,"{'title': 'AML 2193', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 50 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8423,"{'title': 'AML 2534', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 58 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8424,"{'title': 'Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 1', 'description': 'non silencing control', 'type': 'RNA', 'source_name_ch1': 'siRNA treated MCF-7 breast carcinoma cell line', 'characteristics_ch1': 'protocol: Non-silencing control siRNA;\tcell line: MCF7'}"
8425,"{'title': 'Huh7 cells_Mock Infected 12 hours_ rep3', 'description': 'Gene expression data from Huh7 cells treated with mock media for 12 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, Mock Infected, 12 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
8426,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, young, subject 1', 'description': 'Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, young', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: Y (21-43 y)'}"
8427,"{'title': 'brain, unknown: R1A_e1_le1', 'description': 'rotenone 1 week A;\tTreatment, type=time_course, measurement=1.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
8428,"{'title': 'Blood - Sarcoidosis - 005A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Female;\tage: 48;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
8429,"{'title': 'EntorhinalCortex_male_42yrs_indiv86', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 42 years', 'characteristics_ch1': 'individual: 86, AA;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 42'}"
8430,"{'title': 'AML 2253', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 43 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Pos'}"
8431,"{'title': 'DLBCL biopsy, sample 2109', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8432,"{'title': 'Blood sample from patient 179 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 179;\tday: Day 28;\tage (years): 58;\tsex: Female'}"
8433,"{'title': 'AML 2190', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 15 years;\tscore: FAB M5;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: -5/7(q);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
8434,"{'title': 'group-2-pt-t6243678', 'description': 'group-2-pt-t6243678', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 20;\tgender: male;\tfinal disposition: control'}"
8435,"{'title': 'COL2_206', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 71;\tgender: F;\tlocalisation: Right;\tmetastasis: 0;\tfirst apc mutation: 631;\tsecond apc mutation: 0;\t5q loh: 1'}"
8436,"{'title': 'adipose_preTZD_NRd_s20', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 20'}"
8437,"{'title': 'Patient_6475_diagnosis', 'description': '6475D.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Common ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 40;\tconclusions ig/tcr: stable;\tselected: no'}"
8438,"{'title': 'Training_Site5_07', 'description': 'Performed by Operator 1 from Site5 at Training stage', 'type': 'RNA', 'source_name_ch1': 'AML with t(8;21)', 'characteristics_ch1': 'acute myeloid leukemia [AML w/ translocation t(8;21) or FAB M2] patient lysates of mononuclear cells'}"
8439,"{'title': '3.1.AF.2', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 2 hours post infection, donor 2, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 1;\tinfection condition: AF;\thours post infection: 2'}"
8440,"{'title': 'MDS patient 25', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
8441,"{'title': 'untreated: m3: i1: d06', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 3; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 3;\tReplicate: 1;\tBatch: d06'}"
8442,"{'title': 'GBM, radiotherapy (63)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 63;\tage: 48.7;\tgender: MALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 16.28;\tmgmt status: M'}"
8443,"{'title': 'Patient 4420 AML89', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 89;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8444,"{'title': 'AML 2468', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 34 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8445,"{'title': 'Untreated PBMCs, replicate 1', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Untreated PBMCs, replicate 1', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
8446,"{'title': '964886', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9691_Tumor;\tfab: M3;\tSex: F;\trace: AA;\tage on study: 33;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
8447,"{'title': 'Scz-23', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tL1', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: long duration of illness - schizophrenia;\tSex: M;\tage: 57;\ttissue ph: 6.06;\tpmi (hrs): 24;\ttype of drug: Fluphenazine;\tdrug dose (chlorpromazine equivalents): 150 mg'}"
8448,"{'title': '6458', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 63 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
8449,"{'title': '11-0015_Sepsis_day3_154', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8450,"{'title': 'AML with normal karyotype #221', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: positive;\tage: 25;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 34;\tdisease state: de novo AML'}"
8451,"{'title': 'Filtered air exposure 1 -24 hours post-exposure', 'description': 'Gene expression data from circulating mononuclear cells after filtered air exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells after exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: FA;\ttime: 24 hours'}"
8452,"{'title': 'AML with normal karyotype #69', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 40;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 78.5;\tdisease state: de novo AML'}"
8453,"{'title': 'Replicate 2 for MCF7untreated72h breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'Replicate 2 for MCF7untreated72h breast cell line'}"
8454,"{'title': 'AML 2764', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 21 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8455,"{'title': '312340', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6330_Tumor;\tfab: M2;\tSex: M;\trace: W;\tage on study: 33;\tcytogenetic change: del(9)(q21q33); del(20)(q12);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8456,"{'title': '23055', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8457,"{'title': 'newly diagnosed multiple myeloma 132', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: I'}"
8458,"{'title': 'carcinoma_85 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: male;\tprotocol: surgery;\tage: 80;\tlocalization: sigmoid'}"
8459,"{'title': '41078', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant KRAS;\tGrade NA;\tStage IIB;\tMicropapillary feature NA;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8460,"{'title': 'NSG501', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): NA;\tdisease activity (das28_v3): 3.32;\tresponse to anti-tnf therapy: NA'}"
8461,"{'title': 'CD34+CD45RA+Lin- HPCs transduced with A2M cultured onto 2 µg of Delta1ext-IgG', 'description': 'BCE_04;\tGene expression data from Notch-activated (2 µg) cells transduced with A2M lentiviral vector', 'type': 'RNA', 'source_name_ch1': 'CD34+CD45RA-Lin- HPCs', 'characteristics_ch1': 'tissue: umbilical cord blood;\tcell type: hematopoietic progenitors;\tgenotype/variation: transduced with A2M;\ttreatment group: Notch-activated (2 µg)'}"
8462,"{'title': 'muscle_preTZD_preClamp_IRd_s5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 5'}"
8463,"{'title': 'NSCLC EMC SCC2273N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
8464,"{'title': 'MDS patient 15', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: del5q'}"
8465,"{'title': '432398', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9834_Tumor;\tfab: M2;\tSex: M;\trace: W;\tage on study: 67;\tcytogenetic change: >3;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
8466,"{'title': 'X22057', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
8467,"{'title': 'newly diagnosed multiple myeloma 17', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: nd'}"
8468,"{'title': 'CD16+ 1', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'human CD16+ monocytes', 'characteristics_ch1': 'monocyte subsets: CD16+ monocytes'}"
8469,"{'title': 'cord blood 25_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 1.76', 'characteristics_ch1': 'Cord blood arsenic exposure level 1.76;\t'}"
8470,"{'title': 'HIP control 12', 'description': 'arrayconsortium.tgen.org::biosample.434659;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: HIP control 12;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: hippocampus\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 69 years'}"
8471,"{'title': 'newly diagnosed multiple myeloma 156', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
8472,"{'title': 'Peripheral T-Cell lymphoma, unspecified 18', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-102', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 65;\tgender: male'}"
8473,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, young, subject 11', 'description': 'Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, young', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: Y (21-43 y)'}"
8474,"{'title': 'newly diagnosed multiple myeloma 14', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
8475,"{'title': 'AML with normal karyotype #219', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
8476,"{'title': 'AML 2238', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 21 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8477,"{'title': 'Pilocytic astrocytoma chip 8025', 'description': 'Pilocytic astrocytoma.  Chip ID 8025', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
8478,"{'title': 'Patient_15', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 15;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.289521225859907;\tproliferation index: 6.69559555744128'}"
8479,"{'title': 'S101', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S101', 'characteristics_ch1': 'patient id: P025;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Ctrl;\tpercentage of tumor: 0'}"
8480,"{'title': 'CD19_selected_B-cells_after_RFC_rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after RFC'}"
8481,"{'title': 'Pt7 whole subcutaneous adipose tissue, biological rep1', 'description': 'Pt7_SQAT', 'type': 'RNA', 'source_name_ch1': 'Whole subcutaneous adipose tissue, patient 7', 'characteristics_ch1': 'tissue: whole subcutaneous adipose tissue;\tpatient: 7'}"
8482,"{'title': 'C98650', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6612_Tumor;\tfab: M4;\tSex: M;\trace: C;\tage on study: 35;\tcytogenetic change: inv(16)(p13q22); + 22;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8483,"{'title': 'NLPHL_lymph_node_case8', 'description': ""Nodular lymphocyte predominant Hodgkin's lymphoma affecting a lymph node"", 'type': 'RNA', 'source_name_ch1': 'lymph node affected by NLPHL', 'characteristics_ch1': ""Gender: male, Age: 43, Tissue: lymph node taken at diagnosis affected by nodular lymphocyte predominant Hodgkin's lymphoma, follow-up: lost for follow-up""}"
8484,"{'title': 'PNS005', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): 5.52;\tdisease activity (das28_v3): 3.3;\tresponse to anti-tnf therapy: MEDIUM'}"
8485,"{'title': 'AML with normal karyotype #24', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 41;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 85;\tdisease state: de novo AML'}"
8486,"{'title': 'GA_704', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8487,"{'title': 'group-2-pt-t6861920', 'description': 'group-2-pt-t6861920', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 34;\tgender: female;\tfinal disposition: control'}"
8488,"{'title': 'Lung Cancer 137T', 'description': 'Gene expression data from 137T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 79;\tstage: 1A'}"
8489,"{'title': 'CLL cells  PB  patient #26', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #26'}"
8490,"{'title': 'Muscle control k72', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:male, Age:70yrs'}"
8491,"{'title': 'Sample 30 perihematomal area', 'description': 'Gene expression data from human brain samples 5h after intracerebral hemorrhage.', 'type': 'RNA', 'source_name_ch1': 'Human brain sample of intracerebral hemorrhage perihematomal area', 'characteristics_ch1': 'tissue: brain;\tage: 67;\tgender: male'}"
8492,"{'title': 'DLBCL biopsy, sample 2144', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8493,"{'title': 'B76', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 1.2'}"
8494,"{'title': 'group-1-pt-t21411022', 'description': 'group-1-pt-t21411022', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 27;\tgender: female;\tfinal disposition: 02: Skilled nursing facility'}"
8495,"{'title': 'Training_Site1_04', 'description': 'Performed by Operator 1 from Site1 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 37.56; Lot# = 035PO41658D'}"
8496,"{'title': 'ALL with MLL - sample 123', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8497,"{'title': '01-0039A_SIRS_day1_5', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8498,"{'title': 'TC.DR--3', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Control', 'characteristics_ch1': 'Lymph-node biopsy'}"
8499,"{'title': 'KT0567_3_L_test2_test3', 'description': 'KT0567_3_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 3 months, living donor, test set2 and test set3', 'characteristics_ch1': '3 months, living donor,test set2 and test set3'}"
8500,"{'title': 'T1-4 (HCC stage 1-4)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'Human Liver', 'characteristics_ch1': 'HCC stage 1'}"
8501,"{'title': 'FOXF1A', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siLincFoxf1;\treplicate: 1'}"
8502,"{'title': 'CLL cells  PB  patient #6', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #6'}"
8503,"{'title': 'AML sample #40', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
8504,"{'title': 'CD19_selected_B-cells_before_FC_rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before FC (control)'}"
8505,"{'title': 'MCF-7_Si-Wu-Tang_0.256mg/ml_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
8506,"{'title': 'B2-Non-RR-Pat.13 [wf20071123u133v2_U_12_BJ23_B2_M_49yr_alpha_151]', 'description': 'Post-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Post-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Post-interferon'}"
8507,"{'title': 'Myeloma tumor, sample 8', 'description': 'MM_TUMOR_08;\tNewly diagnosed patient.', 'type': 'RNA', 'source_name_ch1': 'Bone marrow, tumor cells, MM', 'characteristics_ch1': 'tissue: bone marrow;\tcell type: CD138+ tumor plasma cells;\tgender: male;\tdisease state: advanced multiple myeloma (MM)'}"
8508,"{'title': '5287', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 67 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
8509,"{'title': '01_0024_SepticShock_Day3_117', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0024_Patient, Day3'}"
8510,"{'title': 'Septic Shock_biological rep42', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 1;\toutcome: Survivor'}"
8511,"{'title': 'AML 2209', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 55 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8512,"{'title': 'Insulin resistant patient 13 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
8513,"{'title': 'Gingival tissue sample 3 from patient 7, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 7 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8514,"{'title': 'mRNA of GBM-HGG162, Glioblastoma, 13.5 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 13.5 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 13.5 years'}"
8515,"{'title': 'brain, unknown: UTB_e1_le1', 'description': 'untreated B;\tTreatment, type=time_course, measurement=1.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
8516,"{'title': 'C00205', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6616_Tumor;\tfab: M3;\tSex: M;\trace: C;\tage on study: 49;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8517,"{'title': 'AML 2204', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 50 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8518,"{'title': 'X94019', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
8519,"{'title': 'Benign prostate tissue N4', 'description': 'benign prostate tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Benign, Prostate tissue'}"
8520,"{'title': 'Donor6_24h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 6 treated with Wy14643 for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 6;\tagent: Wy14643;\ttime: 24h;\tgender: Male;\tage: 73 years old'}"
8521,"{'title': 'GA_814', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8522,"{'title': 'UNTREATED_2072', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8523,"{'title': 'VT_Epidi_norm_47ans_queue', 'description': 'biological rep 3', 'type': 'RNA', 'source_name_ch1': 'Normal epididimus,47 years-old, tail segment', 'characteristics_ch1': 'Seminal vesicles'}"
8524,"{'title': 'group-1-pt-t2684174', 'description': 'group-1-pt-t2684174', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 52;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
8525,"{'title': 'AML 6372', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 41 years;\tscore: FAB M1;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8526,"{'title': 'colonic_crypt_epithelial_cells_distant_normal_colon_25 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: distant normal colon;\tsex: female'}"
8527,"{'title': 'Gingival tissue sample 2 from patient 88, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 88 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8528,"{'title': 'Cell line C5.2_DR_1', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) + DOXORUBICIN (30nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
8529,"{'title': 'untreated: m4: i2: d05', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 4; Replicate: 2', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 4;\tReplicate: 2;\tBatch: d05'}"
8530,"{'title': 'H438 Propiconazole 30uM', 'description': 'H438 Propiconazole 30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 Propiconazole 30uM', 'characteristics_ch1': 'primary hepatocytes'}"
8531,"{'title': 'Gingival tissue sample 1 from patient 47, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 47 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8532,"{'title': 'Lung Normal 106N', 'description': 'Gene expression data from 106N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 57;\tstage: n/a'}"
8533,"{'title': 'Pax_S4', 'description': 'standard labeling and hybridization procedure', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'tissue: peripheral blood;\tsubject: sickle-cell patient;\trna prep: PAXgene;\tmolecule: total RNA'}"
8534,"{'title': 'N9100J3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8535,"{'title': 'SG-95B_phenotype of EPC colony assay', 'description': 'EPC sampled from blood and cultured', 'type': 'RNA', 'source_name_ch1': 'cultured EPC, after 3 months of exercise', 'characteristics_ch1': 'after 3 months of exercise'}"
8536,"{'title': 'Muscle-FamilyHistoryNegative-10', 'description': 'Jos3678;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 50;\tfamily history: Family history negative;\tbody mass index (kg/m2): 33;\tfasting glucose (ogtt): 105;\t2 hour glucose (ogtt): 146;\themoglobin a1c: 5.4;\tfasting glucose (iv0gavg): 109;\tfasting insulin (iv0inavg): 15.9;\tsi: 1.7;\twaist hip ratio: 1.018'}"
8537,"{'title': 'AML with normal karyotype #133', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 54;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 69;\tdisease state: de novo AML'}"
8538,"{'title': 'normal_colon_57 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: normal colon;\tSex: female;\tprotocol: surgery;\tage: 71;\tlocalization: rectum'}"
8539,"{'title': 'T10928M1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
8540,"{'title': 'non-malignant FTEn_patient 9', 'description': 'Gene expression profile of non-malignant FTE from control patient during the follicular phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 46;\tCycle: Follicular;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
8541,"{'title': 'X34111', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8542,"{'title': 'TOL18', 'description': 'Gene expression data from Tolerant 18', 'type': 'RNA', 'source_name_ch1': 'Tolerant18', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Tolerant'}"
8543,"{'title': 'N_CD8_1', 'description': 'NS1 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Negative Selection', 'characteristics_ch1': 'age: 35;\tgender: Male;\tt_cell_purity: 91%'}"
8544,"{'title': 'Cord blood CD21lo transitional B cells, rep2', 'description': 'Sample pooled from 3 cord blood donors.', 'type': 'RNA', 'source_name_ch1': 'Cord blood CD21lo transitional B cells', 'characteristics_ch1': 'tissue: cord blood;\tb-cell subset: CD20+CD10+CD27-CD21lo'}"
8545,"{'title': 'Hyperplast09', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Hyperplastic polyp'}"
8546,"{'title': 'EPN_507, recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_507, recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
8547,"{'title': 'NY323', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 70;\tSex: M;\tcode: resection;\tclass: Inflammation;\tafp: 19.2;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8548,"{'title': 'Lung-normal-rep6', 'description': 'frozen normal lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen disease-free lung tissue', 'characteristics_ch1': 'disease state: normal;\tbiopsy type: surgical;\ttissue: lung'}"
8549,"{'title': 'AML sample #85', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
8550,"{'title': 'Patient 3412 AML15', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 15;\tcohort: Validation;\tkaryotype: unknown cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
8551,"{'title': 'MERLION_X03K04513', 'description': 'MERLION_X03K04513', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=65, state=0', 'characteristics_ch1': 'pT2N0, female, age=65, state=0'}"
8552,"{'title': 'DietSensitive _1 day_subject6', 'description': 'DietSensitive _1 day_subject6', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 1 day;\tsubject: 6;\tgender: Female'}"
8553,"{'title': 'CO2', 'description': 'Colonic mucosal gene expression data from control individual', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from control individual', 'characteristics_ch1': 'tissue: Colon;\tdisease: Control;\tresponse to infliximab: Not applicable;\tbefore or after first infliximab treatment: Not applicable'}"
8554,"{'title': 'AML sample #71', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00398;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
8555,"{'title': '32066', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant ERBB2;\tGrade High;\tStage IIIA;\tMicropapillary feature Positive;\t(LMP) implants micro-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8556,"{'title': 'KT0818_0_D_training', 'description': 'KT0818_0_D_training', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, training set', 'characteristics_ch1': 'baseline, deceased, training set'}"
8557,"{'title': 'IFNβ_2054', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8558,"{'title': 'GBM, TMZ/radiotherapy (190)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 190;\tage: 60.5;\tgender: MALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 17.34;\tmgmt status: M'}"
8559,"{'title': 'adipose_preTZD_IRd_s30', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 30'}"
8560,"{'title': 'mock-infected, asthmatic S18 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from mock-infected PBE cells from asthmatic individual', 'type': 'RNA', 'source_name_ch1': 'mock-infected PBE cells, asthmatic S18', 'characteristics_ch1': 'Human primary bronchial epithelial cells from patients with mild asthma, cultured in monolayers, passage 3;\t16 hours p.i.'}"
8561,"{'title': 'newly diagnosed multiple myeloma 250', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
8562,"{'title': 'brain, unknown: R4C_e1_le1', 'description': 'rotenone 4 weeks C;\tTreatment, type=time_course, measurement=4.0 weeks', 'type': 'RNA', 'source_name_ch1': 'brain, unknown', 'characteristics_ch1': None}"
8563,"{'title': 'T10786D1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
8564,"{'title': 'Subcutaneous adipose tissue, SAT9', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
8565,"{'title': 'Liver biopsy-Control-B1 [wf20070302u133v2_U_09_TT_B1_73]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
8566,"{'title': 'normal Post ECP, biological rep4', 'description': 'this sample involved data from two arrays', 'type': 'RNA', 'source_name_ch1': 'normal Post ECP', 'characteristics_ch1': 'disease state: normal;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
8567,"{'title': 'Scz-16', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tInt8', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: intermediate duration of illness - schizophrenia;\tSex: M;\tage: 32;\ttissue ph: 6.05;\tpmi (hrs): 17;\ttype of drug: Haloperidol;\tdrug dose (chlorpromazine equivalents): 670 mg'}"
8568,"{'title': 'bladder_TaGL_pool-3', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, Ta low grade', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 5 individual samples.'}"
8569,"{'title': 'N11354D1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8570,"{'title': 'Normal breast (B87)', 'description': 'no additional info;\tnone', 'type': 'RNA', 'source_name_ch1': 'B87', 'characteristics_ch1': 'NB'}"
8571,"{'title': 'HF0488_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
8572,"{'title': 'Blood sample from patient 117 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 117;\tday: Day 1;\tage (years): 33;\tsex: Male'}"
8573,"{'title': 'Hippocampus_female_99yrs_indiv2', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 99 years', 'characteristics_ch1': 'individual: 2, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 99'}"
8574,"{'title': 'KT0596_12_L_test2_test3', 'description': 'KT0596_12_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set2 and test set3', 'characteristics_ch1': '12 months, living donor, test set2 and test set3'}"
8575,"{'title': 'Tolerant PBMC_TOL_VHC_7', 'description': 'see M.Martinez-Llordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells from tolerant liver transplant recipient with hepatitis C virus infection'}"
8576,"{'title': 'B74', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: pos;\ttumor type: Ductal;\ttumor size: 2.2'}"
8577,"{'title': 'Lung Cancer 6T', 'description': 'Gene expression data from 6T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 54;\tstage: 1A'}"
8578,"{'title': 'N9100J1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8579,"{'title': 'group-1-pt-t4539940', 'description': 'group-1-pt-t4539940', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 49;\tgender: male;\tfinal disposition: 01: Inpatient rehabilitation facility'}"
8580,"{'title': 'Lung Normal 119N', 'description': 'Gene expression data from 119N', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of adjacent normal', 'characteristics_ch1': 'tissue: paired normal adjacent;\tgender: female;\tage: 76;\tstage: n/a'}"
8581,"{'title': 'Human Hepatocytes_Doxorubicin, Donor 1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 67; reason for liver resection: Liver metastasis, stomach cancer'}"
8582,"{'title': '7146', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'male, 65 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
8583,"{'title': 'control cell donor 1', 'description': 'RNA from healthy donor', 'type': 'RNA', 'source_name_ch1': 'primary macrophages, control', 'characteristics_ch1': 'cell type: monocyte-derived macrophage;\tagent: control'}"
8584,"{'title': 'adipose_postTZD_IRd_s7', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 7'}"
8585,"{'title': 'Muscle-FamilyHistoryPositive-17', 'description': 'Jos3726;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 46;\tfamily history: Family history positive - 2 parents;\tbody mass index (kg/m2): 23;\tfasting glucose (ogtt): 90;\t2 hour glucose (ogtt): 105;\themoglobin a1c: 5.2;\tfasting glucose (iv0gavg): 91;\tfasting insulin (iv0inavg): 7.7;\tsi: 6.11;\twaist hip ratio: 0.953'}"
8586,"{'title': 'Angioimmunoblastic T-cell lymphoma 1', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-127', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 77;\tgender: female'}"
8587,"{'title': 'MERLION_X01K04005', 'description': 'MERLION_X01K04005', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=56, state=1', 'characteristics_ch1': 'pT2N0, male, age=56, state=1'}"
8588,"{'title': 'S087', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S087', 'characteristics_ch1': 'patient id: P101;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 80'}"
8589,"{'title': 'S013_Scz_F_65', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 65;\tpost-mortem delay: 3h;\tph: 6.1'}"
8590,"{'title': 'AML 2549', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 26 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8591,"{'title': 'Epilepsy patient E4, 6 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 taken 6 hours after GC administration.;\t;\tE4-6h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E4, 6 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: dexamethasone;\ttreatment_time: 6 hrs;\tpatient: E4'}"
8592,"{'title': 'AML without MLL - sample 114', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8593,"{'title': 'mRNA of GBM-HGG005, Glioblastoma, 16.5 years', 'description': 'Gene expression data from pediatric HGG patient.', 'type': 'RNA', 'source_name_ch1': 'brain of 16.5 years', 'characteristics_ch1': 'disease: Glioblastoma;\tage: 16.5 years'}"
8594,"{'title': 'Bronchial epithelial cells, day 8, donor 1', 'description': 'Bronchial epithelial cells, day 8, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 8 of air-liquid interface culture'}"
8595,"{'title': 'NSCLC_SCC_364', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 364.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
8596,"{'title': 'Gingival tissue sample 3 from patient 66, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 66 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
8597,"{'title': '05-0006_Septic Shock_day3_76', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8598,"{'title': 'BC13591', 'description': '160306.02.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 75;\tmolecular subtype: ERBB2;\thistology: DUC;\tpt: pT3;\tpn: pos;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: neg;\tpr ihc status: neg;\tp53 ihc status: --;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: pos;\ttop2a ihc status: pos;\tfoxa1 ihc status: --;\tmfs: 0;\tmfsdel (month): 16.69'}"
8599,"{'title': 'MCF-7_Si-Wu-Tang_2.56mg/ml_rep1', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: Si-Wu-Tang treated'}"
8600,"{'title': 'C001819', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6615_Tumor;\tfab: M3;\tSex: F;\trace: H;\tage on study: 33;\tcytogenetic change: t(15;17)(q22;q21);\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
8601,"{'title': '11-0016_SIRS_day1_155', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'SIRS_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8602,"{'title': 'CD19_selected_B-cells_after_R_rep7', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after Rituximab'}"
8603,"{'title': 'group-2-pt-t12149903', 'description': 'group-2-pt-t12149903', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 48;\tgender: male;\tfinal disposition: 05: Home with services'}"
8604,"{'title': 'NS3-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: non-smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: non-smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: non-smoker;\tPack-years: 0;\tAge: 40;\tSex: M;\tEthnic group: white'}"
8605,"{'title': 'Patient 4735 AML156', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 156;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8606,"{'title': 'conventional renal cell cancer; cRCCb_HD214', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8607,"{'title': 'No28LCMPpre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy LCM', 'characteristics_ch1': 'tissue: Liver biopsy LCM;\tgenotype: 2 RVR No28;\tcell type: lymphocytes;\ttime point: before therapy'}"
8608,"{'title': 'DLBCL biopsy, sample 2103', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8609,"{'title': '10516', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 54;\tRecipient Sex: F;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 49;\tDonor Sex: M;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
8610,"{'title': 'Blood_TD32681_Daytwo_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Male;\tage: 12;\ttissue: whole blood'}"
8611,"{'title': 'Tonsil epithelium 5-repeat- batch2', 'description': 'Laser Capture Microdissected Epithelium of Tonsil from healthy donors.', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic Tonsil of Sleap Apnea Adult Patient', 'characteristics_ch1': 'Tonsil Epithelium'}"
8612,"{'title': 'AML 2297', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 37 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8613,"{'title': 'S002', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S002', 'characteristics_ch1': 'patient id: P096;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0'}"
8614,"{'title': 'colon_adenoma_1138', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
8615,"{'title': 'N51721', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51721;\tsample: normal'}"
8616,"{'title': 'Peripheral T-Cell lymphoma, unspecified 17', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-22', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 87;\tgender: female'}"
8617,"{'title': 'S011_Scz_M_82', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 82;\tpost-mortem delay: 5h;\tph: 6.2'}"
8618,"{'title': 'AML with normal karyotype #132', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 78;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Peripheral Blood;\tblast cell percentage: 12;\tdisease state: de novo AML'}"
8619,"{'title': 'CCD-18Co TREATED (digested orange extract, 60 μM total flavanones)_24h_biological rep2', 'description': 'Gene expression data from normal colon CCD-18Co cells exposed for 24h to a pre-digested orange extract containing a mixture of flavanones.', 'type': 'RNA', 'source_name_ch1': 'CCD-18Co fibroblasts, pre-digested orange extract rich in flavanones', 'characteristics_ch1': 'cell line: CCD-18Co;\tcell type: Normal human colon fibroblasts cells;\tconfluency: ~90% confluent monolayer;\ttreatment: pre-digested orange extract containing a mixture of flavanones;\ttreatment time: 24h'}"
8620,"{'title': 'C9967', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6605_Tumor;\tfab: M1;\tSex: F;\trace: C;\tage on study: 35;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8621,"{'title': 'human cultured bladder IC KM, subject 1', 'description': 'Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.', 'type': 'RNA', 'source_name_ch1': 'human', 'characteristics_ch1': 'Female, age 29;\tDisease status: IC (interstitial cystitis);\tCulture medium: KM (proliferating medium)'}"
8622,"{'title': 'Subcutaneous adipose tissue, SAT48', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
8623,"{'title': 'Septic Shock_biological rep84 15-0008', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 9.4;\toutcome: Nonsurvivor;\tgroup: A'}"
8624,"{'title': 'Sputum from Stage IV Severe, biological replicate 4', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 74;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
8625,"{'title': 'X561', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIA;\tConsolidated.Grade : 2'}"
8626,"{'title': 'HF0108_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
8627,"{'title': 'IFNβ_2150', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8628,"{'title': 'P_CD4_8', 'description': 'PS8 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Positive Selection', 'characteristics_ch1': 'age: 33;\tgender: Female;\tt_cell_purity: 90%'}"
8629,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 15', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
8630,"{'title': 'Muscle-FamilyHistoryPositive-12', 'description': 'Jos3716;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 25;\tfamily history: Family history positive - 1 parent;\tbody mass index (kg/m2): 22;\tfasting glucose (ogtt): 90.5;\t2 hour glucose (ogtt): 127;\themoglobin a1c: 4.9;\tfasting glucose (iv0gavg): 81;\tfasting insulin (iv0inavg): 6.5;\tsi: 6.9;\twaist hip ratio: 0.885'}"
8631,"{'title': 'PGA-Hs_S-9', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
8632,"{'title': 'Control_biological rep3 01-0106', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 5.3;\toutcome: n/a;\tgroup: n/a'}"
8633,"{'title': 'cord blood 29', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 9.66', 'characteristics_ch1': 'Cord blood arsenic exposure level 9.66;\t'}"
8634,"{'title': 'EPN_306, non-recurrent', 'description': 'Gene expression data from surgical tumor sample of ependymoma', 'type': 'RNA', 'source_name_ch1': 'EPN_306, non-recurrent', 'characteristics_ch1': 'tissue: brain tumor (ependymoma);\tgenotype: brain tumor (ependymoma)'}"
8635,"{'title': 'NZK16', 'description': 'late metastatic primary clear-cell renal cell carcinoma, batch 1', 'type': 'RNA', 'source_name_ch1': 'primary clear-cell renal cell carcinoma', 'characteristics_ch1': 'tissue: primary clear-cell renal cell carcinoma;\tgender: male;\ttumor stage (uicc 2002): pT1b;\tlymph node status: N0;\tinitial distant metastases: M0;\ttumor grade: G2;\tdfs/follow-up: DFS = 60 months;\tlocalisation of metastases: adrenal gland, renal, pancreas, parotis'}"
8636,"{'title': 'MDS patient 5', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: del5q'}"
8637,"{'title': 'DLBCL4', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 4', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
8638,"{'title': 'HRV-infected, normal S14 (U133 Plus 2.0 Array)', 'description': 'Gene expression data from HRV-infected PBE cells from normal (control) individual', 'type': 'RNA', 'source_name_ch1': 'HRV-infected PBE cells, normal S14', 'characteristics_ch1': 'Human primary bronchial epithelial cells from normal (control) individuals, cultured in monolayers, passage 3;\t16 hours p.i.'}"
8639,"{'title': 'N7954C3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8640,"{'title': 'Sputum from Stage III Severe, biological replicate 2', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 60;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
8641,"{'title': 'Senescent cells, rep1', 'description': 'gene expression data from senescent cells', 'type': 'RNA', 'source_name_ch1': 'Senescent activated hepatic stellate cells', 'characteristics_ch1': 'fibrogenic cells of the liver'}"
8642,"{'title': '3489', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'female, 68 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type'}"
8643,"{'title': 'non-pCR breast biopsy, sample 13 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 13 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
8644,"{'title': 'H439 Propiconazole 30uM', 'description': 'H439 Propiconazole 30uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H439 Propiconazole 30uM', 'characteristics_ch1': 'primary hepatocytes'}"
8645,"{'title': '22039', 'description': '11706', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: F;\tTSP_Patient# 24256;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
8646,"{'title': 'Patient_6991_relapse', 'description': '6991R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pro-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 19;\tconclusions ig/tcr: stable;\tselected: no'}"
8647,"{'title': 'SH-SY5Y(ECACC)_RA_0h_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
8648,"{'title': 'AML 6376', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 36 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: -9q;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
8649,"{'title': 'T30162', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30162;\tsample: tumor'}"
8650,"{'title': 'class F, rep1', 'description': 'NEB_2.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 50;\tsex: M;\tdisease stage: 2;\talbumin level: 29;\themoglobin level: 148;\tlymphocyte percentage: 17;\twhite blood count: 6.2;\tinternational prognostic score (ips): 3'}"
8651,"{'title': 'X34103', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8652,"{'title': 'Patient_6417_relapse', 'description': '6417R.CEL', 'type': 'RNA', 'source_name_ch1': 'leukemic cells, purified using CD19 beads on autoMACS', 'characteristics_ch1': 'cell type: leukemic lymphoblasts;\tdisease status: Acute Lymphoblastic Leukemia (ALL);\tall type: Precursor-B-ALL;\tall subtype: Pre-B-ALL;\tgender: male;\trelapse type: isolated bone marrow;\tmonths to relapse: 63;\tconclusions ig/tcr: unstable;\tselected: yes'}"
8653,"{'title': 'untreated: m2: i3: d03', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 2; Replicate: 3', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 2;\tReplicate: 3;\tBatch: d03'}"
8654,"{'title': 'PGA-Hs_F-4', 'description': 'Human subjects with familial cardiomyopathy;\tKeywords = Familial Cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
8655,"{'title': 'Ctrl_2', 'description': 'Control 2', 'type': 'RNA', 'source_name_ch1': 'Cultured THP-1 mononuclear cells', 'characteristics_ch1': 'control cells'}"
8656,"{'title': 'newly diagnosed multiple myeloma 258', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-2;\tiss: III'}"
8657,"{'title': 'MCF10A cells cocultured with breast cancer associated fibroblasts that extracted from breast cancer sample No 12', 'description': 'gene expression data from MCF10A cells cocultured with breast fibroblasts', 'type': 'RNA', 'source_name_ch1': 'MCF10A cells', 'characteristics_ch1': 'cell line, normal mammary epithelium, immortalized'}"
8658,"{'title': 'SI6', 'description': 'Gene expression data from Standard Immunotherapy 6', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 6', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
8659,"{'title': 'AML with normal karyotype #99', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: negative;\tcebpa: negative;\tage: 88;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 76;\tdisease state: de novo AML'}"
8660,"{'title': 'Cervical cancer-lymph node positive-34-45', 'description': 'Gene expression data from cervical cancer tissue of patient with pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Positive;\tage at diagnosis: 45.5;\tfigo stage: 1b2'}"
8661,"{'title': 'S001_Scz_F_75', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 75;\tpost-mortem delay: 3h;\tph: 6'}"
8662,"{'title': 'Muscle-FamilyHistoryNegative-2', 'description': 'Jos3662;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: male;\tage (years): 23;\tfamily history: Family history negative;\tbody mass index (kg/m2): 23;\tfasting glucose (ogtt): 84.5;\t2 hour glucose (ogtt): 112;\themoglobin a1c: 5;\tfasting glucose (iv0gavg): 87;\tfasting insulin (iv0inavg): 4.4;\tsi: 8.31;\twaist hip ratio: 0.792'}"
8663,"{'title': 'Benign prostate tissue N2', 'description': 'benign prostate tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Benign, Prostate tissue'}"
8664,"{'title': 'clear cell sarcoma of the kidney; CCSK_HA302', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8665,"{'title': 'Blood sample from patient 114 at Day 180', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 114;\tday: Day 180;\tage (years): 39;\tsex: Male'}"
8666,"{'title': 'B3', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 1.7'}"
8667,"{'title': 'Gingival tissue sample 1 from patient 69, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 69 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8668,"{'title': 'AML with normal karyotype #129', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 67;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 68;\tdisease state: de novo AML'}"
8669,"{'title': 'CRCB03', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CRC-B'}"
8670,"{'title': 'KT0801_0_L_test1', 'description': 'KT0801_0_L_test1', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, test set1', 'characteristics_ch1': 'baseline, living donor, testset1'}"
8671,"{'title': 'Blood - Control - 023A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 83;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
8672,"{'title': 'AML 2647', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 22 years;\tscore: FAB M4E;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8673,"{'title': 'Pilocytic astrocytoma chip 7748', 'description': 'Pilocytic astrocytoma.  Chip ID 7748', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
8674,"{'title': 'newly diagnosed multiple myeloma 275', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
8675,"{'title': 'ESCC_3', 'description': 'ESCC, TNM stage III, moderately differentiated', 'type': 'RNA', 'source_name_ch1': 'ESCC tumor tissue 3', 'characteristics_ch1': 'tissue: esophagus, tumor;\tgender: male, Japanese;\tage: 54'}"
8676,"{'title': 'colonic_crypt_epithelial_cells_distant_normal_colon_23 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: distant normal colon;\tsex: female'}"
8677,"{'title': 'SH-SY5Y(ECACC)_RA_inhibiter_LY294002_1d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of LY294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 1day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
8678,"{'title': 'cadmium_32hr_rep1', 'description': 'Immortalized normal prostate epithelial cell line (NPrEC), which showed basal epithelial cell phenotype, was established in our lab (Mobley et al., 2003).', 'type': 'RNA', 'source_name_ch1': 'cadmium_32hr', 'characteristics_ch1': 'Gender: Male; Tissue: Prostate.'}"
8679,"{'title': 'FOXF1B', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siLincFoxf1;\treplicate: 2'}"
8680,"{'title': 'HF1232_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
8681,"{'title': 'Ishikawa treated with metastin-10, biological rep3', 'description': 'Gene expression data from Ishikawa cells treated with metastin-10.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells treated with metastin-10', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: negative control siRNA;\tpeptide treatment: metastin-10'}"
8682,"{'title': '11_0011_Control_Day1_49', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '11_0011_Normal, Day1'}"
8683,"{'title': 'newly diagnosed multiple myeloma 94', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
8684,"{'title': 'AML sample #23', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00056;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
8685,"{'title': 'P_CD8_10', 'description': 'PS10 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Positive Selection', 'characteristics_ch1': 'age: 31;\tgender: Male;\tt_cell_purity: 89%'}"
8686,"{'title': 'Insulin resistant patient 12 - omental adipose tissue', 'description': 'Gene expression data from human adipose tissue obtained during gastric bypass surgery.', 'type': 'RNA', 'source_name_ch1': 'Obese male', 'characteristics_ch1': 'tissue: omental adipose;\tgender: male;\tmetabolic status: insulin resistant'}"
8687,"{'title': 'Septic Shock_biological rep60', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 7.7;\toutcome: Survivor'}"
8688,"{'title': 'DLBCL biopsy, sample 2046', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8689,"{'title': 'B29', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: A;\tage: 76;\tSex: M;\tcode: resection;\tclass: Unannotated;\tafp: 27;\ttp53 mutation: 0;\tctnnb1 mutation: 239G>GA,p.G34G/E;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 1;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: no;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8690,"{'title': 'Blood_TD32681_Daytwo_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Male;\tage: 12;\ttissue: whole blood'}"
8691,"{'title': 'AML with MLL - sample 139', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8692,"{'title': 'AML sample #98', 'description': 'de novo AML, NPM1 mutated, other chromosomal aberrations', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 3-positive (mutated);\tkaryotype: other chromosomal aberrations'}"
8693,"{'title': 'Hippocampus_female_30yrs_indiv82', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 30 years', 'characteristics_ch1': 'individual: 82, AA;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 30'}"
8694,"{'title': 'Angioimmunoblastic T-cell lymphoma21', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-37', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 70;\tgender: female'}"
8695,"{'title': 'Cervical cancer-lymph node negative-16-51', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 47.4;\tfigo stage: 1b2'}"
8696,"{'title': 'Patient 4409 AML82', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 82;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8697,"{'title': 'Patient 5149 AML202', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 202;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: MLL-PTD'}"
8698,"{'title': 'non-malignant FTEn_patient 3', 'description': 'Gene expression profile of non-malignant FTE from control patient during the luteal phase', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected non-malignant FTE from normal control patient', 'characteristics_ch1': 'Age: 42;\tCycle: Luteal;\tBRCA1/2 mutation: NA;\tFamily History: No'}"
8699,"{'title': 'group-2-pt-t11200547', 'description': 'group-2-pt-t11200547', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 31;\tgender: female;\tfinal disposition: control'}"
8700,"{'title': 'AML with normal karyotype #49', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 42;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 77.5;\tdisease state: de novo AML'}"
8701,"{'title': 'Patient 4525 AML111', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 111;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8702,"{'title': 'AML 6975', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M4;\trisk: cytogenetic intermediate;\tcebpa: double mutant;\tkaryotype: -9q;\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: pos'}"
8703,"{'title': 'AML 6719', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 33 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8704,"{'title': 'SG-94B_phenotype of EPC colony assay', 'description': 'EPC sampled from blood and cultured', 'type': 'RNA', 'source_name_ch1': 'cultured EPC, after 3 months of exercise', 'characteristics_ch1': 'after 3 months of exercise'}"
8705,"{'title': 'THP-1 +SS2, biological rep1', 'description': 'Gene expression data from THP-1 cells after incubated with Streptcoccus suis 2 strain SC19 for 3 hours', 'type': 'RNA', 'source_name_ch1': 'THP-1 cells infected Streptcoccus suis 2 strain SC19,3 hours', 'characteristics_ch1': 'cell type: monocyte;\tcell line: THP-1;\tgrowth properties: suspension;\tinfected with bacterial strain: Streptcoccus suis 2 strain SC19'}"
8706,"{'title': 'papillary renal cell cancer; pRCCb_HA454a', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8707,"{'title': 'KT0387_24_L_test3', 'description': 'KT0387_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
8708,"{'title': 'NHDF at passage 4, from adult donor, biological rep 2', 'description': 'Gene expression data from NHDF in culture', 'type': 'RNA', 'source_name_ch1': 'NHDF in culture', 'characteristics_ch1': 'Fibroblast cells'}"
8709,"{'title': 'whole blood_101726', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Male', 'characteristics_ch1': 'General population, Male'}"
8710,"{'title': 'Normal_colon_23_13April05', 'description': 'Normal_colon_23_13April05.csv', 'type': 'RNA', 'source_name_ch1': 'colorectum, ascending', 'characteristics_ch1': ""Tissue: Colorectal mucosa;\tLocation: (as per 'SOURCE')""}"
8711,"{'title': 'Pt16 isolated pericardial adipocytes, biological rep1', 'description': 'Pt16_pcAds', 'type': 'RNA', 'source_name_ch1': 'Isolated pericardial adipocytes, patient 16', 'characteristics_ch1': 'tissue: isolated pericardial adipocytes;\tpatient: 16'}"
8712,"{'title': 'e_NY204', 'description': 'early HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; early HCC', 'characteristics_ch1': 'early HCC'}"
8713,"{'title': 'CD19_selected_B-cells_before_R_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before Rituximab (control)'}"
8714,"{'title': 'Proficiency_Site11_25', 'description': 'Performed by Operator 2 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1.5ug; cRNA yield (ug) = 55.85; Lot# = 125PO54621A'}"
8715,"{'title': 'Endometrium - pregnant [VE-3]', 'description': 'VE-3', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval,  pregnant', 'characteristics_ch1': 'tissue: endometrium on day of oocyte retrieval;\tstate: pregnant'}"
8716,"{'title': 'CD19_selected_B-cells_before_FC_rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before FC (control)'}"
8717,"{'title': 'SH-SY5Y(ATCC)_RA_0h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
8718,"{'title': 'adenocarcinoma_67 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: male;\tprotocol: colonoscopy;\tage: 59;\tlocalization: sigmoid'}"
8719,"{'title': 'SH-SY5Y(ECACC)_BDNF_2d_rep1', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, brain-derived neurotrophic factor (BDNF), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
8720,"{'title': 'H133+_H448_PB_1000uM', 'description': 'H133+_H448_PB_1000uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H133+_H448_PB_1000uM', 'characteristics_ch1': 'primary hepatocytes'}"
8721,"{'title': 'EntorhinalCortex_male_33yrs_indiv84', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, male, 33 years', 'characteristics_ch1': 'individual: 84, AA;\tbrain region: entorhinal cortex;\tgender: male;\tage (yrs): 33'}"
8722,"{'title': '1991 - mAdbID:74492', 'description': 'mAdb experiment ID: 74492', 'type': 'RNA', 'source_name_ch1': '1991', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 1991;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: GCB DLBCL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 1.00;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
8723,"{'title': '01-0038B_Sepsis_day3_42', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Sepsis_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
8724,"{'title': 'AML sample #86', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00597;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
8725,"{'title': 'Normal liver N11_E-AFMX-11-448274825', 'description': 'Gene expression data from a frozen liver biopsy obtained from a healthy adult subject who suffered sudden death', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from normal liver', 'characteristics_ch1': 'tissue: normal liver;\tarrayexpress repository sample id: data retrieved from arrayexpress database, E-AFMX-11-448274825;\tage: 29 years;\tgender: female'}"
8726,"{'title': 'Cell line C5.2_R_2', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
8727,"{'title': 'Patient 3420 AML19', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 19;\tcohort: Discovery;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8728,"{'title': 'Donor liver T0-08', 'description': 'Gene expression data from a frozen liver biopsy obtained from a brain dead donor during explantation', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from donor liver', 'characteristics_ch1': 'tissue: donor liver;\tdonor: brain dead donor;\tage: 48 years;\tgender: female'}"
8729,"{'title': 'Lung Cancer 177T', 'description': 'Gene expression data from 177T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 50;\tstage: 2'}"
8730,"{'title': 'Sputum from Stage II Moderate, biological replicate 27', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 70;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 1;\tbatch: A;\thyb date: 39322'}"
8731,"{'title': '10305', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 46;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 34;\tDonor Sex: M;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
8732,"{'title': 'AML sample #14', 'description': 'de novo AML, NPM1 wild type, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 1-negative (wild type);\tkaryotype: normal karyotype'}"
8733,"{'title': 'X487', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8734,"{'title': 'Patient 5644 AML235', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 235;\tcohort: Validation;\tkaryotype: t(7;12);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8735,"{'title': 'CD34+YFP', 'description': '-', 'type': 'RNA', 'source_name_ch1': 'Cord Blood', 'characteristics_ch1': 'transduction: control;\tcell type: CD34+/YFP+'}"
8736,"{'title': '638 - mAdbID:70401', 'description': 'mAdb experiment ID: 70401', 'type': 'RNA', 'source_name_ch1': '638', 'characteristics_ch1': 'Gender: male;\tAge: NA;\tTissue: lymph node;\tDisease state: Lymphoma;\tIndividual: 638;\tClinical info: Submitting diagnosis: DLBCL;\tClinical info: Final microarray diagnosis: PMBL;\tClinical info: Follow up status: DEAD;\tClinical info: Follow up years: 0.69;\tClinical info: Chemotherapy: NA;\tClinical info: ECOG performance status: NA;\tClinical info: Stage: NA;\tClinical info: LDH ratio: NA;\tClinical info: Number of extranodal sites: NA'}"
8737,"{'title': '2.1.NDV.8', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 8 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: NDV;\thours post infection: 8'}"
8738,"{'title': 'DLBCL biopsy, sample 2108', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8739,"{'title': 'Septic Shock_biological rep25 01-0080', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 3;\toutcome: Survivor;\tgroup: B'}"
8740,"{'title': '22083', 'description': '11777', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24314;\tSmoking_Status: Former;\tPathology: Adenocarcinoma'}"
8741,"{'title': 'cHL2', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'classical Hodgkin lymphoma case 2', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with classical Hodgkin lymphoma (cHL)'}"
8742,"{'title': 'Patient 5013 AML176', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 176;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: CEBPA;\tmll-ptd: wild type'}"
8743,"{'title': 'vad1', 'description': 'Gene expression data from laser microdissected colonic epithelial cells', 'type': 'RNA', 'source_name_ch1': 'laser microdissected human colonic epithelial cell sample', 'characteristics_ch1': 'isolation method: laser microdissected;\tcell type: colonic epithelial cells;\tdisease state: adenoma'}"
8744,"{'title': 'CLL_del13q_rep1', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with del13q', 'characteristics_ch1': 'female'}"
8745,"{'title': 'STXBP2', 'description': 'siRNAs targeting specific lincRNAs or non-targeting siRNAs used as controls', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: siLincSTXBP5;\treplicate: 1'}"
8746,"{'title': '23106', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8747,"{'title': 'Subcutaneous adipose tissue, SAT13', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
8748,"{'title': 'AML 2228', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 41 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
8749,"{'title': 'Oligodendrioglioma_2', 'description': 'bh20061208u133v2_A_23-Oligo5_1', 'type': 'RNA', 'source_name_ch1': 'brain tumor tissue', 'characteristics_ch1': 'tissue: primary brain tumor;\tcell type: oligodendrioglioma;\tage: 31;\tgender: male;\ttumor grade: OA'}"
8750,"{'title': 'KT0600_24_L_test3', 'description': 'KT0600_24_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 24 months, living donor, test set3', 'characteristics_ch1': '24 months, living donor, test set3'}"
8751,"{'title': 'ALL without MLL - sample 40', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8752,"{'title': 'N8703A4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8753,"{'title': 'Sample T48', 'description': 'Gene expression data from human blood samples', 'type': 'RNA', 'source_name_ch1': 'Human blood sample', 'characteristics_ch1': 'sample id: T48;\ttissue: blood;\tage: 73;\tgender: Male;\trs7956957 genotype: GG'}"
8754,"{'title': 'AML 6730', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 49 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8755,"{'title': 'bladder_TaGL_pool-1', 'description': 'Individual array of a bladder cancer expression experiment.', 'type': 'RNA', 'source_name_ch1': 'Tumoral bladder tissues, Ta low grade', 'characteristics_ch1': 'Tissues extracted using cold cup from transurethral resections.;\tImmediately frozen and stored at -80ºC until processed.;\tPool of 5 individual samples.'}"
8756,"{'title': 'Sputum from Stage II Moderate, biological replicate 62', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 63;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39316'}"
8757,"{'title': 'Patient 5R AML237', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 237;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8758,"{'title': 'AML with normal karyotype #117', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 45;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 64.5;\tdisease state: de novo AML'}"
8759,"{'title': 'sample 36, brca1 mutation positive, luteal phase fallopian tube', 'description': 'Gene expression data from histologically normal fallopian tube epithelium.', 'type': 'RNA', 'source_name_ch1': 'histological normal fallopian tubes, brca1 mutation positive, luteal phase', 'characteristics_ch1': 'tissue: fallopian tube epithelium;\thistology: normal;\tbrca1 mutation: yes;\tovarian cycle status: luteal;\tsample identifier: 36'}"
8760,"{'title': 'Epilepsy patient E4, untreated sample', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 before administration of GC.;\t;\tE4-0h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E4, before administration of GC', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: untreated;\ttreatment_time: 0 hrs;\tpatient: E4'}"
8761,"{'title': ""HUVECs  treated with Hank's buffered salt solution for 4 hours rep 3"", 'description': 'Serum-deprived HUVECs', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells  treated with HBSS', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
8762,"{'title': 'N8456B1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8763,"{'title': 'CD19_selected_B-cells_before_FC_rep7', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: before FC (control)'}"
8764,"{'title': 'non-pCR breast biopsy, sample 8 rep 2', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 8 rep 2', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
8765,"{'title': 'Training_Site11_03', 'description': 'Performed by Operator 1 from Site11 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 41.74569; Lot# = 035PO41658D'}"
8766,"{'title': 'No15inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No15 nonRVR;\ttime point: under therapy'}"
8767,"{'title': 'TOL7', 'description': 'Gene expression data from Tolerant 7', 'type': 'RNA', 'source_name_ch1': 'Tolerant7', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Tolerant'}"
8768,"{'title': 'X44080', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8769,"{'title': 'adipose_preTZD_IRd_s9', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 9'}"
8770,"{'title': 'Gingival tissue sample 1 from patient 39, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 39 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8771,"{'title': 'Subcutaneous adipose tissue, SAT15', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
8772,"{'title': 'Adult T-cell leukemia/lymphoma-12', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-73', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 47;\tgender: male'}"
8773,"{'title': 'Blood_TD23461_Dayone_10am', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Female;\tage: 12;\ttissue: whole blood'}"
8774,"{'title': 'NY321', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: C;\tage: 55;\tSex: F;\tcode: resection;\tclass: CTNNB1;\tafp: 21.5;\ttp53 mutation: 0;\tctnnb1 mutation: 234_245het_delCTCTGGAATCCA;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8775,"{'title': 'Tumor Tum_Ph4_rep1', 'description': 'Tumor paired  19', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T4;\tn: N0;\thistology: cli;\tgrade: _;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
8776,"{'title': 'Huh7 cells_JFH-1 Infected 24 hours_ rep3', 'description': 'Gene expression data from Huh7 cells Infected with JFH-1 for 24 hours', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, JFH-1 Infected, 24 hours.', 'characteristics_ch1': 'cell type: hepatoma cells;\tcell line: Huh7'}"
8777,"{'title': 'adenocarcinoma_12 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 77;\tlocalization: ascending'}"
8778,"{'title': 'PBMC_ectopic_validation_20', 'description': 'Blood collection: Samples collected by leukapheresis and stored in liquid nitrogen.;\tPBMC isolation:', 'type': 'RNA', 'source_name_ch1': 'PBMCs from patients with other cancer types (e.g., gastrointestinal and brain cancers)', 'characteristics_ch1': 'phenotype: Ectopic;\ttissue: peripheral blood leukocytes;\tdata set: validation'}"
8779,"{'title': 'AML 7077', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 53 years;\tscore: RAEB;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8780,"{'title': 'NSCLC EMC 2409N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
8781,"{'title': 'UNTREATED_1800', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 13;\tage: adult'}"
8782,"{'title': 'T40728_rep', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40728;\tsample: tumor'}"
8783,"{'title': 'UNTREATED_572', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC non treated at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
8784,"{'title': 'Huh7 cells cultured for 48 hours rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: control;\tconcentration: n/a;\ttime: 48 hours'}"
8785,"{'title': 'Quadriceps muscle at T0, control patient 4', 'description': 'Gene expression data from quadriceps muscle biopsy of control patient', 'type': 'RNA', 'source_name_ch1': 'Quadriceps muscle, control patient, T0', 'characteristics_ch1': 'tissue type: Quadriceps muscle;\tpatient group: total knee arthroplasty control patient;\ttime point: T0'}"
8786,"{'title': 'UCR2_afterT', 'description': 'Colonic mucosal gene expression data from UC responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
8787,"{'title': ""Wilms' FF B-2"", 'description': 'L750-A-HG-U133_Plus_2-02-1 (S99-2051N-Frozen)', 'type': 'RNA', 'source_name_ch1': 'Fresh-frozen tissue, kidney', 'characteristics_ch1': 'tissue: kidney;\tfixation: FF;\tblock age (at extraction in years): 7.5;\tbiological replicate: rep-2;\tdonor: A normal'}"
8788,"{'title': 'H438 Triadimefon 100uM', 'description': 'H438 Triadimefon 100uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 Triadimefon 100uM', 'characteristics_ch1': 'primary hepatocytes'}"
8789,"{'title': 'Pilocytic astrocytoma chip 7764', 'description': 'Pilocytic astrocytoma.  Chip ID 7764', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
8790,"{'title': 'N11123D2: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8791,"{'title': 'Control_biological rep13', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 1.2;\toutcome: Survivor'}"
8792,"{'title': 'EC control 1', 'description': 'arrayconsortium.tgen.org::biosample.433887;\tAD control', 'type': 'RNA', 'source_name_ch1': 'brain, Entorhinal Cortex', 'characteristics_ch1': 'Sample Amount: 10 ug;\tBio-Source Name: EC control 1;\tOrganism: Human\xa0;\tOrgan/Tissue Type: brain\xa0;\tOrgan Region: Entorhinal Cortex\xa0;\tCell Type: layer III neurons\xa0;\tEthnicity: Caucasian\xa0;\tDevelopmental Stage: Adult\xa0;\tDisease State: normal\xa0;\tSex: male\xa0;\tGenetic Variation: None\xa0;\tAge: 63 years'}"
8793,"{'title': 'Sepsis mixed infection TM6', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tMixed Infection'}"
8794,"{'title': 'Normal Control C-5a', 'description': 'Activated CD4+ T cells were similarly isolated by positive;\tselection from CD4+ T cells using CD25 microbeads (Miltenyi Biotec, Auburn, CA). In order to ensure isolation of CD25lo cells, the manufacturer’s protocol was altered such that 2 μL of CD25 microbeads and 8 μL of wash media (PBS pH 7.2-7.4, 2% newborn calf serum, 0.1% glucose, 1% pen/strep, 12mM HEPES pH 7.2) were used per million CD4+ T cells. Purity of isolated CD25+ cells was almost always greater than 95%.', 'type': 'RNA', 'source_name_ch1': 'Normal Control C-5a', 'characteristics_ch1': 'CD4+ T-cells from normal HIV- donor'}"
8795,"{'title': 'Septic Shock_biological rep76 11-0007', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 8;\toutcome: Survivor;\tgroup: B'}"
8796,"{'title': 'Sepsis gram-negative V8', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
8797,"{'title': 'Control_biological rep1 01-0104', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 3.3;\toutcome: n/a;\tgroup: n/a'}"
8798,"{'title': '01_0030_SepticShock_Day1_110', 'description': '1) Control day 1; 2) Septic shock day 1; 3) Septic shock day 3 (same patient cohort as Septic shock day 1).', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children and children with septic shock.', 'characteristics_ch1': '01_0030_Patient, Day1'}"
8799,"{'title': 'EntorhinalCortex_female_26yrs_indiv76', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, entorhinal cortex, female, 26 years', 'characteristics_ch1': 'individual: 76, C;\tbrain region: entorhinal cortex;\tgender: female;\tage (yrs): 26'}"
8800,"{'title': 'Replicate 2 for CAL51 breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'No treatment. See ATCC/DSMZ for cell line details.'}"
8801,"{'title': 'muscle_preTZD_preClamp_IRd_s34', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 34'}"
8802,"{'title': 'GA_1182', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 11;\tage: adult'}"
8803,"{'title': 'S117', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S117', 'characteristics_ch1': 'patient id: P004;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
8804,"{'title': 'Peripheral T-Cell lymphoma, unspecified 23', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-81', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 66;\tgender: male'}"
8805,"{'title': 'PBMCs_AuNP_24hr_1', 'description': 'Gene expression data from PBMCs treated with AuNP EGFP oligonucleotide complex for 24 hours', 'type': 'RNA', 'source_name_ch1': 'PBMCs', 'characteristics_ch1': 'cell type: PBMCs;\ttreatment group: treated with AuNP EGFP oligonucleotide complex for 24 hours'}"
8806,"{'title': 'Sputum from Stage II Moderate, biological replicate 72', 'description': 'Gene expression data from COPD Stage II Moderate', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage II Moderate', 'characteristics_ch1': 'age: 64;\tgender: M;\tgold stage: Stage II;\tgroup: Moderate;\tplateid: 2;\tbatch: B;\thyb date: 39321'}"
8807,"{'title': 'Patient 3492 AML40', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 40;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8808,"{'title': 'primary colorectal carcinoma 1', 'description': 'total RNA isolated from primary colorectal carcinoma of stage D colorectal carcinoma patient 1', 'type': 'RNA', 'source_name_ch1': 'primary colorectal carcinoma from stage D colorectal carcinoma patient 1', 'characteristics_ch1': 'tissue: colon;\ttumor stage of patient: stage D;\tprimary site: colon'}"
8809,"{'title': 'newly diagnosed multiple myeloma 230', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
8810,"{'title': 'newly diagnosed multiple myeloma 244', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: II'}"
8811,"{'title': '3.2.NDV.10', 'description': 'NDV infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, NDV, 10 hours post infection, donor 2, sample 2', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 2;\tsample: 2;\tinfection condition: NDV;\thours post infection: 10'}"
8812,"{'title': 'Hippocampus_female_91yrs_indiv40-04', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, female, 91 years', 'characteristics_ch1': 'individual: 40-04, C;\tbrain region: hippocampus;\tgender: female;\tage (yrs): 91'}"
8813,"{'title': 'S009_Scz_M_87', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Male;\tage: 87;\tpost-mortem delay: 3.5h;\tph: 6'}"
8814,"{'title': 'PBMC-2-Non-RR-Pat.14 [wf20070510u133v2_U_08_SK15_M_LC2_IFNa_107_1]', 'description': 'Post-interferon blood sample', 'type': 'RNA', 'source_name_ch1': 'Post-interferon blood sample', 'characteristics_ch1': 'treatment status: Post-interferon'}"
8815,"{'title': 'NSCLC_SCC_75', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 75.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
8816,"{'title': 'MERLION_X03K03389', 'description': 'MERLION_X03K03389', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, male, age=67, state=1', 'characteristics_ch1': 'pT2N0, male, age=67, state=1'}"
8817,"{'title': 'MCF-7 + RARalpha siRNA + vehicle rep1 (MD41)', 'description': 'Gene expression data from MCF-7cells treated with vehicle and RARalpha siRNA;\tMD41', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with vehicle and RARalpha siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: RARalpha siRNA;\tagent: control (vehicle);\tdose: n/a'}"
8818,"{'title': 'X44417', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Endo;\tStageCode : IA;\tConsolidated.Grade : 1'}"
8819,"{'title': 'CRCB01', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: CRC-B'}"
8820,"{'title': 'patient Pre ECP, biological rep4', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'GVHD patient Pre ECP', 'characteristics_ch1': 'disease state: graft-versus host disease;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
8821,"{'title': 'HC1', 'description': 'Gene expression data from Healthy Control 1', 'type': 'RNA', 'source_name_ch1': 'Healthy Control 1', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Healthy Control'}"
8822,"{'title': 'Pt17 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt17_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 17', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 17'}"
8823,"{'title': '01_0053A_Day1_15', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Female;\tSurvivor;\torganism: Staph aureus'}"
8824,"{'title': 'Pilocytic astrocytoma chip 7749', 'description': 'Pilocytic astrocytoma.  Chip ID 7749', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
8825,"{'title': 'newly diagnosed multiple myeloma 186', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
8826,"{'title': 'B1-Non-RR-Pat.14 [wf20070510u133v2_U_05_SK15_M_B1_None_107_1]', 'description': 'Pre-interferon liver biopsy', 'type': 'RNA', 'source_name_ch1': 'Pre-interferon liver biopsy', 'characteristics_ch1': 'treatment status: Pre-interferon'}"
8827,"{'title': 'GA_894', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8828,"{'title': 'Blood - Axial Spondyloarthropathy - 033A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 62;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
8829,"{'title': 'AML sample #26', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00062;\tanalysis i: AML-NOS;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
8830,"{'title': 'liver donor 62', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from liver donor 62', 'characteristics_ch1': 'tissue: liver;\torigin: liver donor'}"
8831,"{'title': '22080', 'description': '11774', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: African American;\tGender: M;\tTSP_Patient# 24311;\tSmoking_Status: Not Available;\tPathology: Large cell Neuroendocrine carcinoma'}"
8832,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 48 hours rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
8833,"{'title': 'AML without MLL - sample 112', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8834,"{'title': 'Training_Site4_06', 'description': 'Performed by Operator 1 from Site4 at Training stage', 'type': 'RNA', 'source_name_ch1': 'CLL', 'characteristics_ch1': 'chronic lymphocytic leukemia [CLL] patient lysates of mononuclear cells'}"
8835,"{'title': 'collecting duct carcinoma; CDC_HD91', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8836,"{'title': 'N41027', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 41027;\tsample: normal'}"
8837,"{'title': 'DLBCL5', 'description': 'Analysis of differential gene expression in primary human lymphoma cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in comparison with primary lymphoma cells of classical Hodgkin lymphoma cells and other B-non-Hodgkin lymphoma (B-NHL) samples and subsets of non-neoplastic B lymphocytes isolated from blood or tonsils.', 'type': 'RNA', 'source_name_ch1': 'diffuse large B-cell lymphoma case 5', 'characteristics_ch1': 'primary lymphoma cells laser-microdissected from a patient diagnosed with diffuse large B-cell lymphoma (DLBCL)'}"
8838,"{'title': 'Blood sample from patient 180 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 180;\tday: Day 1;\tage (years): 63;\tsex: Female'}"
8839,"{'title': 'SGBS control, biological rep3', 'description': None, 'type': 'RNA', 'source_name_ch1': 'human SGBS mature adipocytes, control', 'characteristics_ch1': 'tissue: adipose;\tcell type: mature adipocytes;\tdisease state: Simpson-Golabi-Behmel syndrome (SGBS);\tcondition: normoxia'}"
8840,"{'title': '93050', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8841,"{'title': 'UCNR5_beforeT', 'description': 'Colonic mucosal gene expression data from UC non-responder before first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from UC non-responder before first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: UC;\tresponse to infliximab: No;\tbefore or after first infliximab treatment: Before first infliximab treatment'}"
8842,"{'title': 'MCF-7 + RARalpha siRNA + vehicle rep1 (MD42)', 'description': 'Gene expression data from MCF-7cells treated with vehicle and RARalpha siRNA;\tMD42', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with vehicle and RARalpha siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: RARalpha siRNA;\tagent: control (vehicle);\tdose: n/a'}"
8843,"{'title': 'H9_ES_1', 'description': 'Gene expression data obtained from human ES', 'type': 'RNA', 'source_name_ch1': 'human ES', 'characteristics_ch1': 'cell type: ES;\tcell line: H9 Human embryonic stem cells'}"
8844,"{'title': 'Tonsil epithelium 3', 'description': 'Laser Capture Microdissected Epithelium of Tonsil from healthy donors.', 'type': 'RNA', 'source_name_ch1': 'Hyperplastic Tonsil of Sleap Apnea Adult Patient', 'characteristics_ch1': 'Tonsil Epithelium'}"
8845,"{'title': 'class F, rep38', 'description': 'VAN_00377f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: REFRACTORY;\tage (years): 78;\tsex: M;\tdisease stage: 3;\talbumin level: _;\themoglobin level: 95;\tlymphocyte percentage: 10;\twhite blood count: 11.7;\tinternational prognostic score (ips): 4.7'}"
8846,"{'title': 'Clone A cells treated with 5uM CsA and cultured for 24 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
8847,"{'title': 'PBMCs_LB_before exercise_15', 'description': 'LB_Pre_039-BT', 'type': 'RNA', 'source_name_ch1': 'Late Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 17;\tbefore-exercise'}"
8848,"{'title': 'Patient 4729 AML151', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 151;\tcohort: Discovery;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8849,"{'title': 'MDA-MB-468_emetine_10h', 'description': 'Cells treated with emetine for 10 hours.', 'type': 'RNA', 'source_name_ch1': 'MDA-MB-468', 'characteristics_ch1': 'cell line: MDA-MB-468 breast cancer cell line;\ttreatment: emetine;\ttime: 10h'}"
8850,"{'title': 'AML 5357', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 43 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8851,"{'title': 'Lung Cancer 118T', 'description': 'Gene expression data from 118T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 63;\tstage: 1A'}"
8852,"{'title': 'Endometrium group B hCG not pregnant 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group B, not pregnant', 'characteristics_ch1': 'treatment: hCG;\ttissue: endometrium'}"
8853,"{'title': 'AML 3293', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 36 years;\tscore: FAB M3;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Pos;\tcebpa mutation: Neg'}"
8854,"{'title': 'Pilocytic astrocytoma chip 8031', 'description': 'Pilocytic astrocytoma.  Chip ID 8031', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
8855,"{'title': 'Donor4_24h_Wy', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary hepatocytes isolated from Donor 4 treated with Wy14643 for 24h', 'characteristics_ch1': 'cell type: Primary hepatocytes;\tdonor: 4;\tagent: Wy14643;\ttime: 24h;\tgender: Female;\tage: 54 years old'}"
8856,"{'title': 'S129', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S129', 'characteristics_ch1': 'patient id: P006;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
8857,"{'title': 'whole blood_100760', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - mental retardation or developmental delay, Female', 'characteristics_ch1': 'mental retardation or developmental delay, Female'}"
8858,"{'title': 'GBM, radiotherapy (349)', 'description': 'MGMT status: M', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 349;\tage: 51.7;\tgender: FEMALE;\ttreatment: radiotherapy;\tsurvival status: 1;\tsurvival time in months: 14.14;\tmgmt status: M'}"
8859,"{'title': 'Normal liver N10_E-AFMX-11-448274747', 'description': 'Gene expression data from a frozen liver biopsy obtained from a healthy adult subject who suffered sudden death', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from normal liver', 'characteristics_ch1': 'tissue: normal liver;\tarrayexpress repository sample id: data retrieved from arrayexpress database, E-AFMX-11-448274747;\tage: 27 years;\tgender: female'}"
8860,"{'title': 'HF0467_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
8861,"{'title': 'class S, rep78', 'description': 'VAN_00506.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 25;\tsex: M;\tdisease stage: 2;\talbumin level: 34;\themoglobin level: 115;\tlymphocyte percentage: 10;\twhite blood count: 9.9;\tinternational prognostic score (ips): 3'}"
8862,"{'title': 'N51091', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 51091;\tsample: normal'}"
8863,"{'title': 'No23inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No23 nonRVR;\ttime point: under therapy'}"
8864,"{'title': 'PGA-Hs_S-14', 'description': 'Human subjects with ischemic cardiomyopathy;\tKeywords = ischemic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
8865,"{'title': 'AML with normal karyotype #229', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 49;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 61;\tdisease state: de novo AML'}"
8866,"{'title': 'newly diagnosed multiple myeloma 47', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: SOCS3/PRL3;\tiss: I'}"
8867,"{'title': 'WI38, biological replicate 1', 'description': 'gene expression from WI38, biological replicate 1', 'type': 'RNA', 'source_name_ch1': 'WI38 cells from ATCC', 'characteristics_ch1': 'cell type: fibroblast;\tcell line: WI38'}"
8868,"{'title': 'Lung Cancer 189T', 'description': 'Gene expression data from 189T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 59;\tstage: 1A'}"
8869,"{'title': 'NSCLC EMC SCC2313N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
8870,"{'title': 'human left atrial_patient_1', 'description': 'V1_patient', 'type': 'RNA', 'source_name_ch1': 'human left atrial appendage - atrial fibrillation patient', 'characteristics_ch1': 'tissue: left atrial appendage'}"
8871,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 14', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
8872,"{'title': 'X32013', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
8873,"{'title': 'Training_Site6_03', 'description': 'Performed by Operator 1 from Site6 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 1ug; cRNA yield (ug) = 9.23404; Lot# = 035PO41658D'}"
8874,"{'title': 'newly diagnosed multiple myeloma 176', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CD-1;\tiss: III'}"
8875,"{'title': 'Patient 4715 AML145', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 145;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8876,"{'title': 'Blood - Axial Spondyloarthropathy - 030A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 45;\tset: 1;\ttissue: Blood;\tdisease state: Axial Spondyloarthropathy'}"
8877,"{'title': 'Patient 3444 AML29', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 29;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8878,"{'title': 'NSCLC_SCC_25', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 25.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
8879,"{'title': 'HF0141_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
8880,"{'title': 'DLBCL biopsy, sample 2113', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
8881,"{'title': 'PBMCs_AuNP_48hr_2', 'description': 'Gene expression data from PBMCs treated with AuNP EGFP oligonucleotide complex for 48 hours', 'type': 'RNA', 'source_name_ch1': 'PBMCs', 'characteristics_ch1': 'cell type: PBMCs;\ttreatment group: treated with AuNP EGFP oligonucleotide complex for 48 hours'}"
8882,"{'title': 'N30162', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 30162;\tsample: normal'}"
8883,"{'title': 'AML 6243', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 18 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: idt(16);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8884,"{'title': 'Blood sample from patient 154 at Day 28', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 154;\tday: Day 28;\tage (years): 37;\tsex: Female'}"
8885,"{'title': '70055', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant ERBB2;\tGrade High;\tStage IA;\tMicropapillary feature Positive;\t(LMP) implants micro-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8886,"{'title': 'PCB153 treated HepG2 cells at T1.5, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines after 1.5 hours of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
8887,"{'title': 'Hippocampus_male_33yrs_indiv84', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 33 years', 'characteristics_ch1': 'individual: 84, AA;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 33'}"
8888,"{'title': 'ALL without MLL - sample 87', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
8889,"{'title': 'MDS patient 45', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 2 (RAEB2);\tgenome/variation: del5q'}"
8890,"{'title': 'M90', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 70;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\ttp53 mutation: 0;\tctnnb1 mutation: 233A>AG,p.D32D/G;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
8891,"{'title': 'AML 7272', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: pos;\tidh2: pos;\tgender: male;\tage: 48 years;\tscore: FAB M2;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
8892,"{'title': 'Subcutaneous adipose tissue, SAT36', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
8893,"{'title': 'conventional renal cell cancer; cRCCb_HD12', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8894,"{'title': 'X41023', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8895,"{'title': 'GA_956', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8896,"{'title': 'SH-SY5Y(ATCC)_RA_inhibiter_LY294002_3d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions in the presence of Ly294002.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), LY294002, 3day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
8897,"{'title': 'Patient_35', 'description': 'Gene expression data from CD138+ selected plasma cells', 'type': 'RNA', 'source_name_ch1': 'CD138 selected plasma cells', 'characteristics_ch1': 'patient: 35;\tdisease state: multiple myeloma;\tcell type: CD138+ selected plasma cells;\trisk score: 0.821645793753646;\tproliferation index: 8.76470082316777'}"
8898,"{'title': ""Wilms' tumor; WT_RK16"", 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8899,"{'title': 'PBMCs vehicle treated for 24 hours,replicate 3', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 24 hours,replicate 3', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
8900,"{'title': 'Muscle control 8', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
8901,"{'title': 'aa_NY226', 'description': 'very advanced HCC', 'type': 'RNA', 'source_name_ch1': 'human liver; very advanced HCC', 'characteristics_ch1': 'very advanced HCC'}"
8902,"{'title': 'control participant P309', 'description': 'Gene expression data from control participant DB', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
8903,"{'title': 'Septic Shock_biological rep29', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 0.8;\toutcome: Survivor'}"
8904,"{'title': 'C136', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 3.5'}"
8905,"{'title': '70070', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade Low;\tStage IA;\tMicropapillary feature Negative;\t(LMP) implants micro-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
8906,"{'title': 'N8642A2: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
8907,"{'title': 'S097', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S097', 'characteristics_ch1': 'patient id: P115;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 3'}"
8908,"{'title': 'S095', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S095', 'characteristics_ch1': 'patient id: P119;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 0.5'}"
8909,"{'title': 'dmso-none-1', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Demethylation: none', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tDemethylation: none;\tReplicate: 1'}"
8910,"{'title': 'newly diagnosed multiple myeloma 157', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MF;\tiss: III'}"
8911,"{'title': 'newly diagnosed multiple myeloma 318', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: II'}"
8912,"{'title': 'pTV', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'shRNA vector only control 786-O cells (pTV)'}"
8913,"{'title': 'Blood sample from patient 121 at Day 90', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 121;\tday: Day 90;\tage (years): 62;\tsex: Male'}"
8914,"{'title': 'untreated: m4: i1: d05', 'description': 'Effects of chronic exposure of human bronchial epithelial cells to low doses of cigarette smoke condensate', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Month: 4; Replicate: 1', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: untreated;\tMonth: 4;\tReplicate: 1;\tBatch: d05'}"
8915,"{'title': 'COL2_12', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 66;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 1328;\tsecond apc mutation: 0;\t5q loh: 0'}"
8916,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 48 hours rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 48 hours'}"
8917,"{'title': 'HF0171_U133P2', 'description': 'Brain tissue from epilepsy patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from epilepsy patient', 'characteristics_ch1': 'Histopathological diagnostic: non-tumor'}"
8918,"{'title': '380949', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '9853_Tumor;\tfab: M5;\tSex: F;\trace: W;\tage on study: 59;\tcytogenetic change: -X;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
8919,"{'title': 'T40645', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40645;\tsample: tumor'}"
8920,"{'title': 'MDS patient 172', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: normal'}"
8921,"{'title': 'explanted liver Patient 1 (HBV-associated acute liver failure) - 2', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from explanted liver Patient 1', 'characteristics_ch1': 'tissue: liver;\torigin: HBV-associated acute liver failure'}"
8922,"{'title': 'PCB153 treated HepG2 cells at T18, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines after 18 hours of PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
8923,"{'title': 'B93', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: I;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 0.8'}"
8924,"{'title': 'Pilocytic astrocytoma chip 8026', 'description': 'Pilocytic astrocytoma.  Chip ID 8026', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
8925,"{'title': 'Cell line HB4a_R6', 'description': None, 'type': 'RNA', 'source_name_ch1': 'HB4a cell line - RAPAMYCIN (20nM) treatment', 'characteristics_ch1': 'cell line: HB4a;\tcell line origin: Normal Breast Epithelial;\tcell type: Human Normal Breast Epithelial cell line'}"
8926,"{'title': 'adenocarcinoma_73 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 67;\tlocalization: sigmoid'}"
8927,"{'title': 'NSCLC EMC 2335N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: Not available'}"
8928,"{'title': 'K_AR1', 'description': 'K_AR1', 'type': 'RNA', 'source_name_ch1': 'AR1 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
8929,"{'title': 'PCB153 treated HepG2 cells at T0, biological replicate 1', 'description': 'Gene expression data from HepG2 cell lines before PCB153 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
8930,"{'title': 'N8456B4: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
8931,"{'title': 'Proficiency_Site3_19', 'description': 'Performed by Operator 1 from Site3 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 60.34; Lot# = 035PO41658D'}"
8932,"{'title': 'X44078', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIB;\tConsolidated.Grade : 2'}"
8933,"{'title': 'monocytes_+LPS_2', 'description': '24h medium, 4h LPS stimulation', 'type': 'RNA', 'source_name_ch1': 'blood, +LPS', 'characteristics_ch1': 'cell type: myeloid monocytic cells;\tprotocol: 24h medium, 4h LPS stimulation'}"
8934,"{'title': 'cord blood 22', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.7', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.7;\t'}"
8935,"{'title': 'Hippocampus_male_95yrs_indiv14', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 95 years', 'characteristics_ch1': 'individual: 14, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 95'}"
8936,"{'title': 'AML 2236', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 36 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8937,"{'title': 'C014_Control_M91', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem control', 'characteristics_ch1': 'age: 91;\tpost-mortem delay: 4.5h;\tph: 6.3'}"
8938,"{'title': 'GFP d3', 'description': 'GFP d3', 'type': 'RNA', 'source_name_ch1': 'GFP d3', 'characteristics_ch1': 'genetic modification:;\ttissue: T-cells'}"
8939,"{'title': 'PBMCs treated at 3xIC90 for 2 hours,replicate 2', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs treated at 3xIC90 for 2 hours,replicate 2', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
8940,"{'title': 'GBM_stem_4 days_1', 'description': 'G48_SC.CEL', 'type': 'RNA', 'source_name_ch1': 'glioblastoma stem cells, stem, 4 days', 'characteristics_ch1': 'tissue: brain;\tdisease status: glioblastoma;\tcell type: stem cells G48'}"
8941,"{'title': 'Replicate 1 for MCF7control breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MCF7 mir-221/222 mimic control at 18h'}"
8942,"{'title': 'S104', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S104', 'characteristics_ch1': 'patient id: P058;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 20'}"
8943,"{'title': 'DietSensitive _6 weeks_subject2', 'description': 'DietSensitive _6 weeks_subject2', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Sensitive;\ttime point: 6 weeks;\tsubject: 2;\tgender: Female'}"
8944,"{'title': 'Huh7 cells treated with 5uM CsA and cultured for 12 hours rep3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM CsA, cultured for 12 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: CsA;\tconcentration: 5uM;\ttime: 12 hours'}"
8945,"{'title': 'Muscle control k66', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, control subject', 'characteristics_ch1': 'Gender:male, Age:76yrs'}"
8946,"{'title': 'MDS patient 127', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
8947,"{'title': 'Control_biological rep7', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: normal control;\tage (years): 8.7;\toutcome: Survivor'}"
8948,"{'title': 'class F, rep29', 'description': 'VAN_00497f2.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 17;\tsex: M;\tdisease stage: 2;\talbumin level: _;\themoglobin level: 123;\tlymphocyte percentage: 9;\twhite blood count: 7.1;\tinternational prognostic score (ips): 2.3'}"
8949,"{'title': 'Adult Blood 20, biological replicate 6', 'description': 'Gene expression data of reticulocytes from adult periperal blood.', 'type': 'RNA', 'source_name_ch1': 'Reticulocytes from adult periperal blood', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: reticulocytes;\tdevelopmental stage: adult'}"
8950,"{'title': 'conventional renal cell cancer; cRCCb_HD115A', 'description': 'gene expression data for renal tumor', 'type': 'RNA', 'source_name_ch1': 'renal tissue', 'characteristics_ch1': 'renal tumor'}"
8951,"{'title': 'Septic Shock_biological rep63', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: Whole Blood;\tdisease state: septic shock patient;\tage (years): 3.6;\toutcome: Survivor'}"
8952,"{'title': 'carcinoma_15 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: carcinoma;\tSex: female;\tprotocol: surgery;\tage: 64;\tlocalization: rectum'}"
8953,"{'title': 'Blood sample from patient 160 at Day 1', 'description': 'Gene expression data from venous blood drawn in the morning from fasted subject.', 'type': 'RNA', 'source_name_ch1': 'Venous blood from healthy individual', 'characteristics_ch1': 'tissue: Blood;\tpatient identifier: 160;\tday: Day 1;\tage (years): 35;\tsex: Female'}"
8954,"{'title': 'Foot siScramble Replicate3', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Foot Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: foot;\tcell type: primary fibroblasts;\tsirna: Non-targetting siRNA Control;\treplicate: 3'}"
8955,"{'title': 'TK620a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1462;\tdisease state: AIDS;\tgender: Male;\tage: 43;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 81;\tplasma hiv-1     rna level   (copies/ml): 35000;\ttissue: lymph node'}"
8956,"{'title': 'C173', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: pos;\tHER2: neg;\tB-R grade: III;\tnode status: pos;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 2.3'}"
8957,"{'title': 'MDS patient 20', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: normal'}"
8958,"{'title': 'NF-1', 'description': 'Gene expression data from non-failing control hearts', 'type': 'RNA', 'source_name_ch1': 'Non-Failing Sample 1', 'characteristics_ch1': 'sample pairs: none;\ttissue: Myocard;\tvad status: unsupported;\tdisease status: none;\tvad: none;\tage: 18;\tgender: f'}"
8959,"{'title': 'Patient 3397 AML9', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 9;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8960,"{'title': 'Gingival tissue sample 2 from patient 20, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 20 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8961,"{'title': 'newly diagnosed multiple myeloma 299', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
8962,"{'title': 'Patient 4418 AML88', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 88;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
8963,"{'title': 'Patient 12, biopsy; Control', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'Control'}"
8964,"{'title': 'Proficiency_Site1_18', 'description': 'Performed by Operator 1 from Site1 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 3ug; cRNA yield (ug) = 30.6; Lot# = 035PO41658D'}"
8965,"{'title': 'CDcR8_afterT', 'description': 'Colonic mucosal gene expression data from CDc responder after first infliximab treatment', 'type': 'RNA', 'source_name_ch1': 'Colonic mucosal biopsy from CDc responder after first infliximab treatment', 'characteristics_ch1': 'tissue: Colon;\tdisease: CD;\tresponse to infliximab: Yes;\tbefore or after first infliximab treatment: After first infliximab treatment'}"
8966,"{'title': 'Mature unstimulated biological replicate 2 (IFN)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'RA-differentiated BE(2)-C cell line', 'characteristics_ch1': 'differentiation: mature;\ttreatment: none;\tcell line: BE(2)-C'}"
8967,"{'title': 'NSCLC EMC LCC2233N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
8968,"{'title': 'Angioimmunoblastic T-cell lymphoma 6', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-104', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 64;\tgender: male'}"
8969,"{'title': 'Muscle PCOS control 9', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
8970,"{'title': 'HBEC3 Low dose treatment group (100 nM).', 'description': 'HBEC3 Low dose treatment group (100 nM).', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells (HBEC)', 'characteristics_ch1': 'See publication for details.'}"
8971,"{'title': 'explanted liver Patient 1 (HBV-associated acute liver failure) - 4', 'description': 'Gene expression data from liver', 'type': 'RNA', 'source_name_ch1': 'specimen obtained from explanted liver Patient 1', 'characteristics_ch1': 'tissue: liver;\torigin: HBV-associated acute liver failure'}"
8972,"{'title': 'Muscle control 17', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
8973,"{'title': 'group-2-pt-t9308516', 'description': 'group-2-pt-t9308516', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 19;\tgender: male;\tfinal disposition: control'}"
8974,"{'title': 'AML 2752', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 16 years;\tscore: FAB M2;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(8;21);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8975,"{'title': 'Adult T-cell leukemia/lymphoma-1_replicate', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-08', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 48;\tgender: male'}"
8976,"{'title': 'dmso-none-2', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Demethylation: none', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tDemethylation: none;\tReplicate: 2'}"
8977,"{'title': 'HF0960_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
8978,"{'title': 'GA_889', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
8979,"{'title': 'Gingival tissue sample 2 from patient 84, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 84 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
8980,"{'title': 'X20027', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 3'}"
8981,"{'title': 'Cervical cancer-lymph node negative-10-34', 'description': 'Gene expression data from cervical cancer tissue of patient with no pelvic lymph node metastasis', 'type': 'RNA', 'source_name_ch1': 'Early stage cervical cancer', 'characteristics_ch1': 'pelvic lymph nodes: Negative;\tage at diagnosis: 35.8;\tfigo stage: 1b2'}"
8982,"{'title': 'whole blood_101832', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
8983,"{'title': 'MERLION_X02K04518', 'description': 'MERLION_X02K04518', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=61, sate=0', 'characteristics_ch1': 'pT2N0, female, age=61, sate=0'}"
8984,"{'title': 'TNF I BEAS2b_ML05C', 'description': 'Gene expression data from cells', 'type': 'RNA', 'source_name_ch1': 'BEAS-2B - TNF-α', 'characteristics_ch1': 'cell line: Human Bronchial Epithelial Cells Beas-B2;\tcell type: Transformed Pulmonary distal (small) airway cell'}"
8985,"{'title': 'AML 2271', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Pos;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8986,"{'title': 'Filtered air exposure 3 -24 hours post-exposure', 'description': 'Gene expression data from circulating mononuclear cells after filtered air exposure', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells after exposure', 'characteristics_ch1': 'cell type: mononuclear cells;\tagent: FA;\ttime: 24 hours'}"
8987,"{'title': 'brain_neurons_rep3', 'description': 'individual suffered sudden death, without brain injury', 'type': 'RNA', 'source_name_ch1': 'neurons from dorsolateral prefrontal cortex', 'characteristics_ch1': 'sex: m; age (years): 37'}"
8988,"{'title': 'class S, rep41', 'description': 'VAN_00399.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 26;\tsex: M;\tdisease stage: 2;\talbumin level: 43;\themoglobin level: 151;\tlymphocyte percentage: 31;\twhite blood count: 4.4;\tinternational prognostic score (ips): 2'}"
8989,"{'title': 'muscle_preTZD_preClamp_IRd_s42', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tsubject: 42'}"
8990,"{'title': 'Huh7 cells treated with 5uM NIM811 and cultured for 48 hours rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells, treated with 5uM NIM811, cultured for 48 hours', 'characteristics_ch1': 'hcv genotype: n/a;\tagent: NIM811;\tconcentration: 5uM;\ttime: 48 hours'}"
8991,"{'title': 'NSCLC_SCC_165', 'description': 'Gene expression data from human non-small cell lung cancer tumor tissue 165.', 'type': 'RNA', 'source_name_ch1': 'human non-small cell lung cancer tumor tissue', 'characteristics_ch1': 'disease state: squamous cell carcinoma'}"
8992,"{'title': 'Blood - Sarcoidosis - 049A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 63;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
8993,"{'title': 'class S, rep63', 'description': 'VAN_00474.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 62;\tsex: M;\tdisease stage: 3;\talbumin level: 43;\themoglobin level: 150;\tlymphocyte percentage: 23;\twhite blood count: 12.2;\tinternational prognostic score (ips): 3'}"
8994,"{'title': 'Clinically localized primary prostate cancer P1', 'description': 'clinically localized prostate cancer tissue', 'type': 'RNA', 'source_name_ch1': 'Prostate', 'characteristics_ch1': 'Primary, Prostate cancer, localized'}"
8995,"{'title': 'HF0453_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
8996,"{'title': '08SE861HGU133Plus2.0', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Human entorhinal cortex', 'characteristics_ch1': 'tissue: brain'}"
8997,"{'title': 'AML 2259', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 18 years;\tscore: FAB M4;\trisk: cytogenetic poor;\tcebpa: wild type;\tkaryotype: Complex;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
8998,"{'title': 'T40892', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40892;\tsample: tumor'}"
8999,"{'title': 'Healthy control 4', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: healthy control'}"
9000,"{'title': 'HF0702_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
9001,"{'title': 'HUVEC_TNFa_3h15m', 'description': '3h15m after TNFa stimulation', 'type': 'RNA', 'source_name_ch1': 'TNFa 3h15m', 'characteristics_ch1': 'Hman umbilical vein cells'}"
9002,"{'title': 'P_CD4_7', 'description': 'PS7 CD4', 'type': 'RNA', 'source_name_ch1': 'CD4 T cells, Positive Selection', 'characteristics_ch1': 'age: 47;\tgender: Female;\tt_cell_purity: 97.50%'}"
9003,"{'title': 'BC14972', 'description': '260406.01.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 71;\tmolecular subtype: LuminalA;\thistology: DUC;\tpt: --;\tpn: neg;\tgrade sbr: 2;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: neg;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: --;\tmfs: 0;\tmfsdel (month): 9.33'}"
9004,"{'title': 'mesenchymal stem cells, lot#4F0760, 4th passage', 'description': 'GCOS1.4;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#4F0760, passage number 4', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#4F0760, 4th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
9005,"{'title': 'Gingival tissue sample 3 from patient 92, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 92 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
9006,"{'title': 'PGA-Hs_V-6', 'description': 'Human subjects with viral cardiomyopathy;\tKeywords = viral cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
9007,"{'title': 'AML sample #41', 'description': 'AML samples investigated according to WHO 2008 classification', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'sample id: MUC_00163;\tanalysis i: AML-MLD-sole;\tanalysis ii: AML-NOS plus AML-MLD-sole'}"
9008,"{'title': 'class S, rep48', 'description': 'VAN_00407.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 39;\tsex: M;\tdisease stage: 2;\talbumin level: 45;\themoglobin level: 129;\tlymphocyte percentage: 7;\twhite blood count: 13.9;\tinternational prognostic score (ips): 3'}"
9009,"{'title': 'MDA MB231 YAP knock down cell pmig-YAP/pRS-IRES-GFP-YAP rep1', 'description': 'gene expression data from MDA MB231 pmig-YAP/pRS-IRES-GFP-YAP', 'type': 'RNA', 'source_name_ch1': 'breast cancer cell line MDA MB231', 'characteristics_ch1': 'stable breast cancer cell line MDA MB231with YAP gene knock down'}"
9010,"{'title': '02-0002A_Day1_16', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Female;\tSurvivor;\torganism: Group A Strep'}"
9011,"{'title': 'mucosa_adenoma_3 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: adenoma;\tsex: female'}"
9012,"{'title': 'control participant P329', 'description': 'Gene expression data from control participant T2', 'type': 'RNA', 'source_name_ch1': 'human CD14 positive monopcytes', 'characteristics_ch1': 'cell type: monocyte;\tdisease state: control participant'}"
9013,"{'title': 'Proficiency_Site11_28', 'description': 'Performed by Operator 2 from Site11 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 8ug; cRNA yield (ug) = 73.27; Lot# = 125PO54621A'}"
9014,"{'title': 'S4-0', 'description': 'airway epithelial cells obtained by bronchoscopy and brushing;\tTime: Day 0; Smoking status: smoker', 'type': 'RNA', 'source_name_ch1': 'Time: Day 0; Smoking status: smoker', 'characteristics_ch1': 'Time: Day 0;\tSmoking status: smoker;\tPack-years: 20;\tAge: 41;\tSex: M;\tEthnic group: black'}"
9015,"{'title': 'GL38b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 49;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 147;\tplasma hiv-1 rna levels (copies/ml): 4,960'}"
9016,"{'title': 'CLL cells  PB  patient #9', 'description': 'primary CLL cells', 'type': 'RNA', 'source_name_ch1': 'PB derived CLL cells', 'characteristics_ch1': 'cell type: CLL;\torigin: Peripheral blood;\tpatient: patient #9'}"
9017,"{'title': 'Patient 5240 AML233', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 233;\tcohort: Discovery;\tkaryotype: CN-AML;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
9018,"{'title': 'Donor 3 - LTD4 stimulated', 'description': 'Elutriated monocytes from donor 3 treated with LTD4 for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes stimulated with LTD4 (100nM) for 30 min.'}"
9019,"{'title': 'Blood Sample of subject 4 before inhalation; Group C', 'description': 'Bl_Group_C_BI_subject_4', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 4;\tgroup: C'}"
9020,"{'title': '23053', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9021,"{'title': 'dmso-aza-3', 'description': 'Response of human bronchial epithelial cells to chronicly applied low doses of cigarette smoke condensate and subsequent demethylation agent', 'type': 'RNA', 'source_name_ch1': 'normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Demethylation: aza', 'characteristics_ch1': 'normal human bronchial epithelial cells (BEAS-2B);\tTreatment: dmso;\tDemethylation: aza;\tReplicate: 3'}"
9022,"{'title': '23170', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9023,"{'title': 'SI7', 'description': 'Gene expression data from Standard Immunotherapy 7', 'type': 'RNA', 'source_name_ch1': 'Standard Immunotherapy 7', 'characteristics_ch1': 'tissue: Blood;\tphenotype: Standard Immunotherapy'}"
9024,"{'title': 'Monocyte cell line, serum and inhibitor 3', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: Added serum and Erk-1/2 inhibitor U0126'}"
9025,"{'title': 'Human Hepatocytes_Doxorubicin, Donor 3', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Primary human hepatocytes', 'characteristics_ch1': 'Human hepatocytes isolated from specimens obtained from patients undergoing hepatic resections;\tsex: male; age: 69; reason for liver resection: Colorectal liver metastasis'}"
9026,"{'title': 'newly diagnosed multiple myeloma 196', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: III'}"
9027,"{'title': 'PBMC from Kidney transplant under SRL monotherapy R12', 'description': 'PBMC from Kidney transplant under SRL monotherapy', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: kidney transplant recipient;\ttherapy: SRL monotherapy;\t%cd3cd4: 59.52;\t%cd3cd8: 34.10;\t%cd8+cd28-: 7.92;\t%cd8+cd28+: 6.63;\t%cd4cd25cd62l: 4.00;\t%cd3delta1: 0.3;\t%cd3delta2: 2.1;\tratio delta1/delta2: 0.14;\t%cd3gammadelta: 2.9;\t%cd3alphabeta: 91.42;\t%cd4cd8-ab+(dn): 11.72;\t%cd4 cd62l+cd45+: 10.27;\t%cd4 cd62l-cd45+: 0.33;\t%cd4 cd62l - cd45-: 47.38;\t%cd4cd62l+cd45-: 42.02;\t%cd4 ccr7+ cd45 -: 81.43;\t%cd4 ccr7+ cd45+: 14.87;\t%cd4 ccr7 - cd45+: 0.07;\t%cd4 ccr7 – cd45-: 3.63;\t%cd8 cd62l+ cd45-: 21.47;\t%cd8cd62l+ cd45+: 33.79;\t%cd8cd62l- cd45+: 15.62;\t%cd8cd62l- cd45 -: 29.12;\t%cd8ccr7+ cd45-: 3.50;\t%cd8ccr7+ cd45+: 6.44;\t%cd8ccr7-cd45+: 39.14;\t%cd8ccr7-cd45 -: 50.90;\t%cd3-cd56+cd16+: 34.95;\t%nkts: 8.94;\t%cd19: 5.01;\t%cd4foxp3+: 5.72'}"
9028,"{'title': 'newly diagnosed multiple myeloma 223', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: II'}"
9029,"{'title': 'GBM, TMZ/radiotherapy (274)', 'description': 'MGMT status: U', 'type': 'RNA', 'source_name_ch1': 'brain (resected material)', 'characteristics_ch1': 'tissue: brain (resected material);\tdisease status: GBM;\tpatient: 274;\tage: 48.8;\tgender: FEMALE;\ttreatment: TMZ/radiotherapy;\tsurvival status: 1;\tsurvival time in months: 9.18;\tmgmt status: U'}"
9030,"{'title': 'K_AR5', 'description': 'K_AR5', 'type': 'RNA', 'source_name_ch1': 'AR5 kidney allograft biopsy, acute rejection', 'characteristics_ch1': 'acute rejection;\tbanff classification: Grade 1B'}"
9031,"{'title': 'H438 PB 1000uM', 'description': 'H438 PB 1000uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H438 PB 1000uM', 'characteristics_ch1': 'primary hepatocytes'}"
9032,"{'title': 'Control_biological rep10 11-0009', 'description': 'Gene expression data from normal control', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: normal control;\tage (years): 0.7;\toutcome: Survivor;\tgroup: n/a'}"
9033,"{'title': 'LMP1868', 'description': 'low-malignant tumors of the ovary', 'type': 'RNA', 'source_name_ch1': 'Laser-capture microdissected tumor cells', 'characteristics_ch1': 'tissue: low-malignant tumors of the ovary'}"
9034,"{'title': 'miR-124 transfection for 16 hours', 'description': 'miR-124 transfection for 16 hours', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line', 'characteristics_ch1': 'Originated from human liver'}"
9035,"{'title': 'Gingival tissue sample 3 from patient 42, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 42 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
9036,"{'title': 'MERLION_X01K03555', 'description': 'MERLION_X01K03555', 'type': 'RNA', 'source_name_ch1': 'Lung cancer, pT2N0, female, age=65, state=0', 'characteristics_ch1': 'pT2N0, female, age=65, state=0'}"
9037,"{'title': 'Tumor 6', 'description': '07SE490', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
9038,"{'title': 'Epilepsy patient E3, 24 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E3 taken 24 hours after GC administration.;\t;\tE3-24h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E3, 24 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: dexamethasone;\ttreatment_time: 24 hrs;\tpatient: E3'}"
9039,"{'title': 'HBE_t0_code2', 'description': 'Gene expression data from human airway epithelium treated as described.', 'type': 'RNA', 'source_name_ch1': 'well-differentiated primary airway bronchial culture', 'characteristics_ch1': 'Genotype:normal'}"
9040,"{'title': 'Donor 4 - control', 'description': 'Elutriated monocytes from donor 4 treated with vehicle control for 30 min.', 'type': 'RNA', 'source_name_ch1': 'Human elutriated monocytes', 'characteristics_ch1': 'Monocytes exposed to vehicle control (EtOH)'}"
9041,"{'title': 'T-cell acute lymphoblastic leukemia, JURKAT_B', 'description': 'Gene expression data from T-ALL cell line.;\tJURKAT_B', 'type': 'RNA', 'source_name_ch1': 'T-ALL cell line', 'characteristics_ch1': 'cell type: T-ALL;\tage: 14;\tgender: male'}"
9042,"{'title': 'K_STA9', 'description': 'K_STA9', 'type': 'RNA', 'source_name_ch1': 'STA9_ kidney allograft biopsy, stable', 'characteristics_ch1': 'stable'}"
9043,"{'title': 'Endometrium group B hCG not pregnant 5', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group B, not pregnant', 'characteristics_ch1': 'treatment: hCG;\ttissue: endometrium'}"
9044,"{'title': 'Blood_TD32681_Dayone_2pm', 'description': 'Venous blood samples were collected using a standard phlebotomy protocol in conjunction with the PAXgene Blood RNA System (Becton & Dickinson, Oxford), which allows the collection, stabilization and transportation of a whole blood cellular RNA sample in a closed evacuated system.', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'gender: Male;\tage: 12;\ttissue: whole blood'}"
9045,"{'title': 'SK-N-SH_RA_0h_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 0hour', 'characteristics_ch1': 'Cell line: SH-SY5Y (HTB-11, obtained from ATCC (American Type Culture Collection Cultures))'}"
9046,"{'title': 'Lung-normal-rep3', 'description': 'frozen normal lung tissue', 'type': 'RNA', 'source_name_ch1': 'Frozen disease-free lung tissue', 'characteristics_ch1': 'disease state: normal;\tbiopsy type: surgical;\ttissue: lung'}"
9047,"{'title': 'DLBCL biopsy, sample 2015', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
9048,"{'title': 'MCF-7_0.001%DMSO_rep2', 'description': 'Gene expression profiling data from human breast cancer cell line MCF-7', 'type': 'RNA', 'source_name_ch1': 'Human breast cancer cell line MCF-7', 'characteristics_ch1': 'cell line: breast cancer cell line MCF-7;\ttreatment: DMSO treated'}"
9049,"{'title': 'vastus lateralis, protein intake: 1.00 g/kg, old, subject 19', 'description': 'Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 1.00 g/kg, old', 'characteristics_ch1': 'Protein intake: 1.00 g/kg;\tTrial: P125;\tSex: Male;\tAge: O (63-79 y)'}"
9050,"{'title': 'KT0955_12_L_test3', 'description': 'KT0955_12_L_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 12 months, living donor, test set3', 'characteristics_ch1': '12 months, living donor, test set3'}"
9051,"{'title': 'Sputum from Stage III Severe, biological replicate 22', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 66;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39323'}"
9052,"{'title': 'MDS patient 136', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with ringed sideroblasts (RARS);\tgenome/variation: other'}"
9053,"{'title': '06-0009A_Day1_17', 'description': 'Septic shock', 'type': 'RNA', 'source_name_ch1': 'Whole blood from children with septic shock.', 'characteristics_ch1': 'Septic shock;\tgender: Female;\tSurvivor;\torganism: None'}"
9054,"{'title': 'Cell line C5.2_DRC_4', 'description': None, 'type': 'RNA', 'source_name_ch1': 'C5.2a cell line - vehicle (DMSO)', 'characteristics_ch1': 'cell line: C5.2a;\tcell line origin: C5.2 cell was derived by the transfection of HB4a with the cDNA full-lenght corresponding to the HER-2;\tcell type: Human Breast Epithelial cell line -tranfected with HER2 cDNA'}"
9055,"{'title': 'N10964A1: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
9056,"{'title': 'newly diagnosed multiple myeloma 216', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: NFκB;\tiss: I'}"
9057,"{'title': 'Muscle control 10', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
9058,"{'title': 'AML 7055', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 43 years;\tscore: FAB M2;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
9059,"{'title': 'TonsilPool-CD3-2', 'description': 'Project: Cell-Specific Gene Expression in Langerhans Cell Histiocytosis.', 'type': 'RNA', 'source_name_ch1': 'Sorted CD3+ Cells from 5 pooled tonsils (presumably normal).', 'characteristics_ch1': 'tissue: tonsils;\tcell type: CD3+'}"
9060,"{'title': 'Sputum from Stage IV Severe, biological replicate 13', 'description': 'Gene expression data from COPD Stage IV Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage IV Severe', 'characteristics_ch1': 'age: 75;\tgender: M;\tgold stage: Stage IV;\tgroup: Severe;\tplateid: 2;\tbatch: C;\thyb date: 39322'}"
9061,"{'title': 'adenocarcinoma_54 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 43;\tlocalization: sigmoid'}"
9062,"{'title': 'cord blood 32', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 68.63', 'characteristics_ch1': 'Cord blood arsenic exposure level 68.63;\t'}"
9063,"{'title': 'gd cell activation+7day,donor 3', 'description': 'Gene expression data from purified TCRVgamma9 positive cells', 'type': 'RNA', 'source_name_ch1': 'human blood sample, freshly isolated and purified, 7 days after in vitro activation', 'characteristics_ch1': 'sample type: peripheral blood lymphocytes isolated and activated in vitro for 7 days;\tcell type: TCRVgamma9+ gamma delta T cells;\ttreatment: BrHPP/IL2;\ttime: 7 d;\tindividual: donor 3'}"
9064,"{'title': 'Angioimmunoblastic T-cell lymphoma 7', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-112', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 48;\tgender: female'}"
9065,"{'title': 'newly diagnosed multiple myeloma 287', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
9066,"{'title': 'NSG305', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'whole blood from rheumatoid arthritis patient treated with anti_TNF therapy', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: rheumatoid arthritis;\tprotocol: anti_TNF therapy;\tdisease activity (das28_v1): NA;\tdisease activity (das28_v3): NA;\tresponse to anti-tnf therapy: NA'}"
9067,"{'title': 'PA55', 'description': 'PA55', 'type': 'RNA', 'source_name_ch1': 'Synovial fluid mononuclear cells', 'characteristics_ch1': 'outcome at one year: extended;\tcell type: Synovial fluid mononuclear cells'}"
9068,"{'title': 'non-pCR breast biopsy, sample 2 rep 1', 'description': 'Gene expression data from pretreatment breast needle biopsies', 'type': 'RNA', 'source_name_ch1': 'breast needle biopsy, pretreatment, sample 2 rep 1', 'characteristics_ch1': 'pathological complete response: no;\ttissue: Breast tumor biopsy'}"
9069,"{'title': 'MDS patient 170', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia (RA);\tgenome/variation: other'}"
9070,"{'title': 'Blood Sample of subject 9 after inhalation; Group A: inhalation with 0.7 ppm FA 72 h before sampling', 'description': 'Bl_Group_A_AI_subject_9', 'type': 'RNA', 'source_name_ch1': 'Blood sample after inhalation, 0.7 ppm FA 72 hr before sampling', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: formaldehyde vapors;\ttreatment dosage: 0.7 ppm;\ttime before sampling: 72 h;\tsubject: 9;\tgroup: A'}"
9071,"{'title': 'Gingival tissue sample 2 from patient 9, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 9 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
9072,"{'title': 'newly diagnosed multiple myeloma 261', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: Myeloid;\tiss: I'}"
9073,"{'title': 'DLBCL biopsy, sample 2087', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
9074,"{'title': 'adipose_preTZD_IRd_s42', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: preTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 42'}"
9075,"{'title': 'No21pre', 'description': 'Before therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No21 nonRVR;\ttime point: before therapy'}"
9076,"{'title': 'MLD AML sample #34', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: with MLD;\tflt3-itd mutation: FLT3-mutated;\tcell type: mononuclear cell'}"
9077,"{'title': 'DietResistant _1 day_subject1', 'description': 'DietResistant _1 day_subject1', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'diet: Resistant;\ttime point: 1 day;\tsubject: 1;\tgender: Female'}"
9078,"{'title': 'GA_1071', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
9079,"{'title': 'class F, rep18', 'description': 'NEB_27.CEL', 'type': 'RNA', 'source_name_ch1': 'Nebraska sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: LATE;\tage (years): 65;\tsex: F;\tdisease stage: 2;\talbumin level: 41;\themoglobin level: 156;\tlymphocyte percentage: 27;\twhite blood count: 7;\tinternational prognostic score (ips): 1'}"
9080,"{'title': 'ALL without MLL - sample 6', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
9081,"{'title': 'AML sample #76', 'description': 'de novo AML, NPM1 mutated, normal karyotype', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1: 2-positive (mutated);\tkaryotype: normal karyotype'}"
9082,"{'title': 'mesenchymal stem cells, lot#5F0138, 9th passage', 'description': 'GCOS1.2;\tGene expression data from mesenchymal stem cells cultured in MSCGM (mesenchymal stem cell growth medium), lot#5F0138, passage number 9', 'type': 'RNA', 'source_name_ch1': 'mesenchymal stem cells, lot#5F0138, 9th passage', 'characteristics_ch1': 'bone marrow mesenchymal stem cells'}"
9083,"{'title': 'Blood Sample of subject 28 before inhalation; Group B', 'description': 'Bl_Group_B_BI_subject_28', 'type': 'RNA', 'source_name_ch1': 'Blood sample before inhalation', 'characteristics_ch1': 'tissue: blood;\tgender: male;\tsmoking status: non-smoker;\ttreatment: none;\tsubject: 28;\tgroup: B'}"
9084,"{'title': '10485', 'description': 'RNA from Whole Blood of patients with Chronic Allograft Nephropathy or Well Functioning Kidney Transplants', 'type': 'RNA', 'source_name_ch1': 'Whole Blood', 'characteristics_ch1': 'Recipient Age: 76;\tRecipient Sex: M;\tDrug Regime: FK506 [Tacrolimus];\tDonor Age: 65;\tDonor Sex: M;\tCAN Banff Score =0;\tCAN scores are representative of the severity of can (0-mild CAN; 1-moderate CAN, 2&3- severe CAN)'}"
9085,"{'title': 'HBEC2-Rep2 Control treatment group (DMSO).', 'description': 'HBEC2-Rep2 Control treatment group (DMSO).', 'type': 'RNA', 'source_name_ch1': 'Immortalized human bronchial epithelial cells', 'characteristics_ch1': 'See publication for details.'}"
9086,"{'title': 'whole blood mRNA from patients presenting with MI (MM_MI_57_04)', 'description': 'Gene expression data from whole blood7 days post MI', 'type': 'RNA', 'source_name_ch1': 'whole blood mRNA 7 days post MI', 'characteristics_ch1': 'disease: MI;\ttime point: day 7;\ttissue: blood;\tethinicity: caucasian;\tage: 64;\tSex: M'}"
9087,"{'title': 'No6inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No6 nonRVR;\ttime point: under therapy'}"
9088,"{'title': 'MCF7_emetine_10h', 'description': 'Cells treated with emetine for 10 hours.', 'type': 'RNA', 'source_name_ch1': 'MCF7', 'characteristics_ch1': 'cell line: MCF7 breast cancer cell line;\ttreatment: emetine;\ttime: 10h'}"
9089,"{'title': 'GL380a', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'lymph node', 'characteristics_ch1': 'patient id: 1438;\tdisease state: AIDS;\tgender: Male;\tage: 49;\trace: Caucasian;\tblood cd4+ t  cell count (cells/ml): 147;\tplasma hiv-1     rna level   (copies/ml): 4960;\ttissue: lymph node'}"
9090,"{'title': 'adenocarcinoma_66 (macro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: adenocarcinoma;\tSex: female;\tprotocol: colonoscopy;\tage: 75;\tlocalization: caecum'}"
9091,"{'title': 'CLL_del13q_rep9', 'description': '50 ng total RNA amplified with Ovation RNA Amplification system (NuGen, Inc.)', 'type': 'RNA', 'source_name_ch1': 'chronic lymphocytic leukemia (CLL) with del13q', 'characteristics_ch1': 'male'}"
9092,"{'title': '41-1', 'description': 'Gene expression values less than a minimum threshold of 20 or a maximum threshold of 16000 were set to 20 and 16000, respectively. Genes with minimal variation across the dataset were discarded (maximum/minimum < 3 or maximum – minimum < 100).', 'type': 'RNA', 'source_name_ch1': 'Human Clear Cell Renal Carcinoma cell line', 'characteristics_ch1': 'Compound 41 treated 786-O cells, replicate 1'}"
9093,"{'title': 'AML with normal karyotype #174', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: negative;\tage: 80;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 95;\tdisease state: de novo AML'}"
9094,"{'title': 'colon_CRC_1651', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colorectal cancer', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
9095,"{'title': 'Muscle control 2', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
9096,"{'title': 'KT0819_0_D_test1', 'description': 'KT0819_0_D_test1', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, deceased donor, test set1', 'characteristics_ch1': 'baseline, deceased donor, testset1'}"
9097,"{'title': 'PBMCs_HIV', 'description': 'Gene expression data from PBMCs infected with HIV', 'type': 'RNA', 'source_name_ch1': 'PBMCs', 'characteristics_ch1': 'cell type: PBMCs;\ttreatment group: infected with HIV'}"
9098,"{'title': '70056', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant KRAS;\tGrade NA;\tStage IV;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9099,"{'title': 'Patient 5145 AML198', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 198;\tcohort: Discovery;\tkaryotype: t(15;17);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
9100,"{'title': 'Training_Site6_04', 'description': 'Performed by Operator 1 from Site6 at Training stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 18.9313; Lot# = 035PO41658D'}"
9101,"{'title': 'Adult-B-ALL-0h', 'description': 'biological source:;\thomo sapiens, ALL patient (male, aged 72 years), peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts.', 'type': 'RNA', 'source_name_ch1': 'Adult B-ALL patient, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, ALL patient (male, aged 72 years), peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts.'}"
9102,"{'title': 'AML 2172', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 18 years;\tscore: FAB M4;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
9103,"{'title': '525', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 2;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9104,"{'title': 'newly diagnosed multiple myeloma 265', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: HY;\tiss: III'}"
9105,"{'title': '311636', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6329_Tumor;\tfab: M4;\tSex: F;\trace: W;\tage on study: 64;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 1'}"
9106,"{'title': 'Endometrium in control conditioned medium for 12 hours TCM-11', 'description': 'Control conditioned medium endometrium  12 hours TCM-11', 'type': 'RNA', 'source_name_ch1': 'uterus', 'characteristics_ch1': 'Control conditioned medium endometrium  12 hours TCM-11'}"
9107,"{'title': 'Sputum from Stage III Severe, biological replicate 31', 'description': 'Gene expression data from COPD Stage III Severe', 'type': 'RNA', 'source_name_ch1': 'Sputum from COPD Stage III Severe', 'characteristics_ch1': 'age: 67;\tgender: M;\tgold stage: Stage III;\tgroup: Severe;\tplateid: 1;\tbatch: A;\thyb date: 39321'}"
9108,"{'title': 'PGA_PA-S_297', 'description': 'To establish changes in cardiac transcription profiles brought about by heart failure we collected myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from ""normal"" organ donors whose hearts cannot be used for transplants. The transcriptional profile of the mRNA in these samples will be measured with gene array technology. Changes in transcriptional profiles can be correlated with the physiologic profile of heart-failure hearts acquired at the time of transplantation.http://cardiogenomics.med.harvard.edu/project-detail?project_id=229;\tKeywords = human, idiopathic, ischemic, cardiac, hypertrophy', 'type': 'RNA', 'source_name_ch1': 'Left Ventricle Biopsy', 'characteristics_ch1': None}"
9109,"{'title': 'AML with normal karyotype #175', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 57;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 90;\tdisease state: de novo AML'}"
9110,"{'title': 'PCB77 treated HepG2 cells at T0, biological replicate 3', 'description': 'Gene expression data from HepG2 cell lines before PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation before PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
9111,"{'title': 'Endometrium-prog C (01b7079-3)', 'description': '01b7079-3.CEL', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, prog group C', 'characteristics_ch1': 'tissue: Endometrial biopsy tissue;\tdevelopmental stage: Endometrial dating d4;\tpregnancy status: non-pregnant;\tprogesterone serum level: group C (> 1.5ng/ml)'}"
9112,"{'title': 'cord blood 4_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.17', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.17;\t'}"
9113,"{'title': 'Hippocampus_male_80yrs_indiv15', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 80 years', 'characteristics_ch1': 'individual: 15, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 80'}"
9114,"{'title': 'Patient 5005 AML173', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 173;\tcohort: Validation;\tkaryotype: remaining cytogenetics;\tflt3-itd: FLT3-ITD;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
9115,"{'title': 'Pilocytic astrocytoma chip 8029', 'description': 'Pilocytic astrocytoma.  Chip ID 8029', 'type': 'RNA', 'source_name_ch1': 'Pilocytic astrocytoma', 'characteristics_ch1': 'Brain tumor, WHO grade I, Pilocytic astrocytoma'}"
9116,"{'title': 'ADHGD02', 'description': 'Gene expression data from colonic biopsy sample', 'type': 'RNA', 'source_name_ch1': 'human colonic biopsy sample', 'characteristics_ch1': 'Biopsy: Adenoma with high-grade dysplasia'}"
9117,"{'title': 'Patient 14, biopsy; UC inflamed', 'description': 'Gene expression data from human colonic mucosa', 'type': 'RNA', 'source_name_ch1': 'Biopsy from human colonic mucosa', 'characteristics_ch1': 'UC inflamed'}"
9118,"{'title': 'X27098', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
9119,"{'title': 'Clone A  cells treated with 5uM CsA and cultured for 24 hours rep4', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, treated with 5uM CsA, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: CsA;\tconcentration: 5uM;\ttime: 24 hours'}"
9120,"{'title': 'NB83 U133p2', 'description': 'RNA from bulk normal breast or normal bresat organoid', 'type': 'RNA', 'source_name_ch1': 'NB83', 'characteristics_ch1': 'bulk normal breast or normal bresat organoid'}"
9121,"{'title': 'mucosa_distant_normal_colon_27 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: mucosa;\tmalignacy: distant normal colon;\tsex: female'}"
9122,"{'title': 'B19', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: Yes;\tbclc_staging: B;\tage: 60;\tSex: M;\tcode: resection;\tclass: Polysomy chr7;\tafp: 188;\ttp53 mutation: 0;\tctnnb1 mutation: 0;\timmunohistochemistry: pRPS6 : 1;\timmunohistochemistry: pIGFR1 : 1;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 0;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
9123,"{'title': 'HF0894_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
9124,"{'title': 'PGA-Hs_P-4', 'description': 'Human subjects with post-partum cardiomyopathy;\tKeywords = post-partum cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
9125,"{'title': 'adipose_postTZD_IRd_s34', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 34'}"
9126,"{'title': 'CD49a+ rep3 (stromal cell study)', 'description': 'Prostate stromal fibromuscular cells', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'CD49a+ MACS sorted cells'}"
9127,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, old, subject 20', 'description': 'Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, old', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: O (63-79 y)'}"
9128,"{'title': 'Septic Shock_biological rep77 11-0035', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 1.7;\toutcome: Survivor;\tgroup: B'}"
9129,"{'title': 'whole blood_100247', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - Autism no regression, Male', 'characteristics_ch1': 'Autism no regression, Male'}"
9130,"{'title': 'BC12652', 'description': '080306.16.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: IPC;\ttype: IBC;\tage of diagnosis (year): 43;\tmolecular subtype: Normal;\thistology: DUC;\tpt: --;\tpn: neg;\tgrade sbr: 3;\terbb2 ihc status: pos;\ter ihc status: pos;\tpr ihc status: pos;\tp53 ihc status: neg;\tki67 ihc status: pos;\terbb2.ht ihc status: pos;\terbb2.tab ihc status: pos;\terbb2p ihc status: neg;\tigf1r ihc status: pos;\tegfr ihc status: neg;\ttop2a ihc status: pos;\tfoxa1 ihc status: pos;\tmfs: 0;\tmfsdel (month): 41.79'}"
9131,"{'title': 'vastus lateralis, protein intake:0.50 g/kg, old, subject 15', 'description': 'Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake:0.50 g/kg, old', 'characteristics_ch1': 'Protein intake:0.50 g/kg;\tTrial:P63;\tSex: Male;\tAge: O (63-79 y)'}"
9132,"{'title': 'N40741', 'description': 'Gene expression data from surgical samples', 'type': 'RNA', 'source_name_ch1': 'pancreas', 'characteristics_ch1': 'patient: 40741;\tsample: normal'}"
9133,"{'title': 'Germinal Center Centroblasts, sample 5', 'description': 'CD77-positive B-cells from human tonsil, purified by magnetic cell separation.;\tGene expression data from purified germinal center centroblasts', 'type': 'RNA', 'source_name_ch1': 'Germinal Center Centroblasts from human tonsil', 'characteristics_ch1': 'cell type: CD77-positive B-cells from human tonsil'}"
9134,"{'title': 'PGA-Hs_D-5', 'description': 'Human subjects with idiopathic cardiomyopathy;\tKeywords = idiopathic cardiomyopathy', 'type': 'RNA', 'source_name_ch1': 'left ventricle biopsy', 'characteristics_ch1': None}"
9135,"{'title': 'Gastric GIST 15', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human gastric GIST.', 'characteristics_ch1': 'Gender: male;\tAge: 81;\tTumor size: 6;\tKIT mutation: Exon 11'}"
9136,"{'title': 'MLP-A (Senescent)', 'description': 'Senescent cells expressing a vector control replicate 1', 'type': 'RNA', 'source_name_ch1': 'Senescent cells expressing a vector control', 'characteristics_ch1': 'cell line: IMR90;\tgrowth state: ras-induced senescence'}"
9137,"{'title': 'Patient 5165 AML214', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 214;\tcohort: Discovery;\tkaryotype: MLL-rearrangement;\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
9138,"{'title': 'Muscle PCOS control 6', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
9139,"{'title': 'Small intestinal GIST 1', 'description': 'Frozen tumour specimens from untreated GIST of the stomach or small intestine.', 'type': 'RNA', 'source_name_ch1': 'Total RNA from human small intestinal GIST.', 'characteristics_ch1': 'Gender: female;\tAge: 61;\tTumor size: 3;\tKIT mutation: Exon 9'}"
9140,"{'title': 'colonic_crypt_epithelial_cells_distant_normal_colon_26 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: norma colon;\ttissue morphology: colonic crypt epithelial cells;\tmalignacy: distant normal colon;\tsex: female'}"
9141,"{'title': '2.1.AF.6', 'description': 'Control (allantoic fluid only)  infected monocyte-derived conventional DCs', 'type': 'RNA', 'source_name_ch1': 'dendritic cell, control, 6 hours post infection, donor 1, sample 1', 'characteristics_ch1': 'cell type: Monocyte-derived conventional dendritic cells;\tdonor: 1;\tsample: 1;\tinfection condition: AF;\thours post infection: 6'}"
9142,"{'title': 'Control 66', 'description': '08SE798', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
9143,"{'title': 'Hippocampus_male_75yrs_indiv96', 'description': 'Brain from cognitively intact individual.', 'type': 'RNA', 'source_name_ch1': 'brain, hippocampus, male, 75 years', 'characteristics_ch1': 'individual: 96, C;\tbrain region: hippocampus;\tgender: male;\tage (yrs): 75'}"
9144,"{'title': 'newly diagnosed multiple myeloma 52', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
9145,"{'title': 'Muscle-FamilyHistoryPositive-15', 'description': 'Jos3722;\tGene expression of skeletal muscle from subject without diabetes', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle', 'characteristics_ch1': 'tissue: skeletal muscle;\tgender: female;\tage (years): 25;\tfamily history: Family history positive - 2 parents;\tbody mass index (kg/m2): 42;\tfasting glucose (ogtt): 99.5;\t2 hour glucose (ogtt): 170;\themoglobin a1c: 5.6;\tfasting glucose (iv0gavg): 112;\tfasting insulin (iv0inavg): 15.6;\tsi: 1.62;\twaist hip ratio: 0.808'}"
9146,"{'title': 'muscle_preTZD_preClamp_IRd+_s40', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: IRd (insulin resistant);\tresponse to tzd treatment: + (responder);\tsubject: 40'}"
9147,"{'title': 'Lung siTUG1 Replicate2', 'description': 'lincRNA knock downs', 'type': 'RNA', 'source_name_ch1': 'Primary Lung Fibroblasts, siRNA-transfected', 'characteristics_ch1': 'tissue: lung;\tcell type: primary fibroblasts;\tsirna: siTUG1;\treplicate: 2'}"
9148,"{'title': 'Tumor Tum_Ph2_rep13', 'description': 'Tumor paired  5', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T2;\tn: N1;\thistology: cli;\tgrade: _;\treceptor: POS;\tki-67: >25;\ttumor (t) vs healthy (s): T;\tphenotypes: 3'}"
9149,"{'title': 'AML with normal karyotype #111', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 54;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 74;\tdisease state: de novo AML'}"
9150,"{'title': 'AML with normal karyotype #56', 'description': 'DRE', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: positive;\tcebpa: negative;\tage: 36;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 93;\tdisease state: de novo AML'}"
9151,"{'title': 'DLBCL biopsy, sample 2063', 'description': 'frozen biopsy of lymph node tumor;\tGene expression data from primary DLBCL biopsy', 'type': 'RNA', 'source_name_ch1': 'DLBCL frozen biopsy', 'characteristics_ch1': 'tissue: lymph node tumor'}"
9152,"{'title': 'AML with normal karyotype #214', 'description': 'ULM', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: negative;\tflt3-itd: positive;\tcebpa: n./a.;\tage: 22;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 95;\tdisease state: de novo AML'}"
9153,"{'title': '22029', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IV;\tMicropapillary feature NA;\t(LMP) implants NA;\tno co-exhistant histology noted;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9154,"{'title': 'Patient 4704 AML138', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 138;\tcohort: Validation;\tkaryotype: t(8;21);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
9155,"{'title': 'human macrophages treated with P. gingivalis, biological rep3', 'description': 'Gene expression data from human macrophages treated with P. gingivalis for 2 hours.', 'type': 'RNA', 'source_name_ch1': 'human macrophages, 2hr treatment with P. gingivalis 381', 'characteristics_ch1': 'tissue: blood;\tcell type: macrophages;\ttreatment: live P. gingivalis 381;\ttreatment time: 2 hours;\tday: 9'}"
9156,"{'title': 'HF0986_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
9157,"{'title': 'Patient 4533 AML118', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 118;\tcohort: Discovery;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: N/K-RAS;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
9158,"{'title': 'Tumor Tum_Ph1_rep6', 'description': 'Tumor paired  21', 'type': 'RNA', 'source_name_ch1': 'Human Breast', 'characteristics_ch1': 't: T1;\tn: N0;\thistology: cdi;\tgrade: II;\treceptor: POS;\tki-67: <25;\ttumor (t) vs healthy (s): T;\tphenotypes: 1'}"
9159,"{'title': '70088', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\twild type (BRAF/KRAS);\tGrade 3;\tStage IIIC;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9160,"{'title': 'Epilepsy patient E5, untreated sample', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E5 before administration of GC.;\t;\tE5-0h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E5, before administration of GC', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: untreated;\ttreatment_time: 0 hrs;\tpatient: E5'}"
9161,"{'title': 'N11464B3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
9162,"{'title': 'Old trained subject, biological replicate (OT5)', 'description': 'Expression of mRNA in Vastus Lateralis muscle,old trained subject', 'type': 'RNA', 'source_name_ch1': 'Vastus Lateralis muscle,old trained subject', 'characteristics_ch1': 'no additional information'}"
9163,"{'title': 'colon_adenoma_1141', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having colon adenoma', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
9164,"{'title': 'SH-SY5Y(ECACC)_RA_2d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions and at five different time points (0h, 6h, 1d, 2d and 3d, respectively) after the cells were transferred to serum-free medium containing BDNF.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (EC94030304, obtained from ECACC (European Collection of Cell Cultures))'}"
9165,"{'title': '05-220_NP', 'description': 'Prostate whole tissue.', 'type': 'RNA', 'source_name_ch1': 'normal prostate', 'characteristics_ch1': 'tissue: prostate'}"
9166,"{'title': 'PBMCs_EB_before exercise_08', 'description': 'EB_Pre_147-NJ', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 12;\tbefore-exercise'}"
9167,"{'title': '11_0020C_Day1_29', 'description': 'Controls', 'type': 'RNA', 'source_name_ch1': 'Whole blood from normal children.', 'characteristics_ch1': 'Control;\tSurvivor;\tgender: Male'}"
9168,"{'title': 'Sepsis gram-negative TN8', 'description': 'Training set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Sepsis;\tGram-Negative'}"
9169,"{'title': 'Liver_hyperglycima_no.7', 'description': 'Gene expression data from human liver.', 'type': 'RNA', 'source_name_ch1': 'Liver, fasting', 'characteristics_ch1': 'tissue: liver;\tgender: male;\tdisease status: type 2 diabetes'}"
9170,"{'title': 'Pt14 isolated subcutaneous adipocytes, biological rep1', 'description': 'Pt14_sqAds', 'type': 'RNA', 'source_name_ch1': 'Isolated subcutaneous adipocytes, patient 14', 'characteristics_ch1': 'tissue: isolated subcutaneous adipocytes;\tpatient: 14'}"
9171,"{'title': 'AML with normal karyotype #152', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 63;\tdiagnosis: AML with normal karyotype;\tgender: female;\tspecimen type: Bone Marrow;\tblast cell percentage: 90.5;\tdisease state: de novo AML'}"
9172,"{'title': 'N10650C3: Unremarkable breast ducts (Normal)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Unremarkable breast ducts (Normal)'}"
9173,"{'title': 'D551, biological replicate 2', 'description': 'gene expression from D551, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'D551 cells from ATCC', 'characteristics_ch1': 'cell type: fibroblast;\tcell line: D551'}"
9174,"{'title': 'HF1269_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: astrocytoma, grade 3'}"
9175,"{'title': 'AML 6882', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 37 years;\tscore: FAB M5;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: NN;\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Neg;\tn-ras mutation: Pos;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
9176,"{'title': 'colon_IBD_1175', 'description': 'total RNA extracted from cells obtained using biopsy in a patient having inflammatory bowel disease', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
9177,"{'title': 'Septic Shock_biological rep49 05-0011', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0;\toutcome: Survivor;\tgroup: A'}"
9178,"{'title': 'Pt3 whole pericardial adipose tissue, biological rep1', 'description': 'Pt3_PCAT', 'type': 'RNA', 'source_name_ch1': 'Whole pericardial adipose tissue, patient 3', 'characteristics_ch1': 'tissue: whole pericardial adipose tissue;\tpatient: 3'}"
9179,"{'title': '93C40', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '6710_Tumor;\tfab: M4;\tSex: F;\trace: C;\tage on study: 40;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 0;\tnpm1 ins: 0'}"
9180,"{'title': 'Bronchial epithelial cells, day 14, donor 1', 'description': 'Bronchial epithelial cells, day 14, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 14 of air-liquid interface culture'}"
9181,"{'title': 'S028_Scz_F_28', 'description': 'none', 'type': 'RNA', 'source_name_ch1': 'Brain BA10 post-mortem schizophrenic', 'characteristics_ch1': 'gender: Female;\tage: 28;\tpost-mortem delay: 11h;\tph: 6.3'}"
9182,"{'title': 'Non-tolerant PBMCs_NoTOL_16', 'description': 'see M.Martinez-LLordella et al. Am J Transplant', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'Peripheral blood mononuclear cells obtained from non-tolerant liver transplant recipient, hepatitis C virus negative, under treatment with tacrolimus.'}"
9183,"{'title': 'muscle_preTZD_preClamp_NRd_s20', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'skeletal muscle (vastus lateralis)', 'characteristics_ch1': 'tissue: muscle;\ttzd treatment: preTZD;\tclamp status: preClamp;\tinsulin resistance: NRd (insulin sensitive);\tsubject: 20'}"
9184,"{'title': 'Gingival tissue sample 3 from patient 37, Unaffected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 37 gingival tissue sample collected as Unaffected', 'characteristics_ch1': 'Gingival tissue phenotype: Healthy (no BoP + PPD of<5 mm + CAL of<3 2 mm;\tTissue: Gingival'}"
9185,"{'title': 'P_CD8_8', 'description': 'PS8 CD8', 'type': 'RNA', 'source_name_ch1': 'CD8 T cells, Positive Selection', 'characteristics_ch1': 'age: 44;\tgender: Male;\tt_cell_purity: 89.50%'}"
9186,"{'title': '261', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Carcinoma, Serous', 'characteristics_ch1': 'Malignant;\tnot mutation tested;\tGrade 2;\tStage IV;\tMicropapillary feature NA;\t(LMP) implants NA;\tCo-exhistant histology NA;\tINV Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9187,"{'title': 'platelet_sickle_7', 'description': 'two-round amplification', 'type': 'RNA', 'source_name_ch1': 'platelet from sickle cell patient', 'characteristics_ch1': 'Tissue: peripheral blood, Subject:Sickle cell patient'}"
9188,"{'title': 'vastus lateralis, protein intake: 0.75 g/kg, young, subject 12', 'description': 'Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg', 'type': 'RNA', 'source_name_ch1': 'vastus lateralis, protein intake: 0.75 g/kg, young', 'characteristics_ch1': 'Protein intake: 0.75 g/kg;\tTrial: P94;\tSex: Male;\tAge: Y (21-43 y)'}"
9189,"{'title': 'ALL without MLL - sample 36', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
9190,"{'title': 'HNL-2 (normal human liver)', 'description': 'Tissue', 'type': 'RNA', 'source_name_ch1': 'human liver', 'characteristics_ch1': 'human'}"
9191,"{'title': 'Ishikawa non-treated, biological rep1', 'description': 'Gene expression data from Ishikawa cells that were not treated with metastin-10 and not introduced with GPR54 siRNA.', 'type': 'RNA', 'source_name_ch1': 'Ishikawa cells not introduced with GPR54 siRNA and not treated with metastin-10', 'characteristics_ch1': 'cell line: Ishikawa;\tcell type: endometrial cancer cells;\tsirna transfection: negative control siRNA;\tpeptide treatment: control peptide'}"
9192,"{'title': 'HF1097_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
9193,"{'title': 'Gingival tissue sample 1 from patient 24, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 24 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
9194,"{'title': 'PCB77 treated HepG2 cells at T6, biological replicate 3', 'description': 'Gene expression data from HepG2 cell lines after 6 hours of PCB77 treatment.', 'type': 'RNA', 'source_name_ch1': 'HepG2 cell line from ATCC at 8th generation after 6 hours of PCB77 treatment.', 'characteristics_ch1': 'genotype: Male;\tage: 15 years adolescent male'}"
9195,"{'title': 'human BM MSC TGFb3 stimulated day 21 rep 3', 'description': 'gene expression data of human bone marrow mesenchymal stem cells induced by TGFb3 for chondrogenic differentiation: day 21', 'type': 'RNA', 'source_name_ch1': 'donor 6, stimulated with TGFb3 for 21 days', 'characteristics_ch1': 'human BM-MSC cultured in α-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100μg/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 µl DMEM supplemented with 0.1 μM dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 21 days'}"
9196,"{'title': 'Patient 29, normal', 'description': '13108 3br 1-11-08', 'type': 'RNA', 'source_name_ch1': 'Breast, normal', 'characteristics_ch1': 'tissue: breast;\ttissue type: normal;\tpatient: 29'}"
9197,"{'title': 'TK62b', 'description': 'lymph node, biological replicate 2', 'type': 'RNA', 'source_name_ch1': 'Inguinal lymph node from HIV-1-infected individual', 'characteristics_ch1': 'tissue: Inguinal lymph node;\tgender: Male;\tage: 43;\trace: Caucasian;\tperipheral blood cd4+ t cells (cells/ml): 81;\tplasma hiv-1 rna levels (copies/ml): 35,000'}"
9198,"{'title': 'AR-P1 (B145)', 'description': 'AR-P1', 'type': 'RNA', 'source_name_ch1': 'Whole blood', 'characteristics_ch1': 'transplant state: Acute Rejection'}"
9199,"{'title': '04-0003_Septic Shock_day1_68', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
9200,"{'title': 'Blood - Control - 065A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: No uveitis;\tgender: Female;\tage: 25;\tset: 1;\ttissue: Blood;\tdisease state: Control'}"
9201,"{'title': 'PCSC-1 sphere biol repl 1', 'description': 'Gene expression data from parental-adherent considered as cells commited to differentiation', 'type': 'RNA', 'source_name_ch1': 'PCSC-1 spheres 7 days in SCM-1% KO', 'characteristics_ch1': 'cell type: prostate cancer stem cell primary lines;\tcell line: PCSC-1;\tculture type: sphere'}"
9202,"{'title': 'M17', 'description': '91 hepatocellular carcinomas were obtained at the time of surgical resection or orthotopic transplantation.', 'type': 'RNA', 'source_name_ch1': 'hepatocellular carcinoma', 'characteristics_ch1': 'vascular invasion: No;\tbclc_staging: A;\tage: 62;\tSex: M;\tcode: resection;\tclass: CTNNB1;\tafp: 13;\ttp53 mutation: 0;\tctnnb1 mutation: 247T>TG | S37S/A;\timmunohistochemistry: pRPS6 : 0;\timmunohistochemistry: pIGFR1 : 0;\timmunohistochemistry: pAkt : 0;\timmunohistochemistry: CTNNB1 : 1;\tused for prognostic prediction: yes;\tused for microrna profiling: Yes;\tuhrf1 study: Used in UHRF1 study (Mudbhary, et al., 2013)'}"
9203,"{'title': 'Gingival tissue sample 1 from patient 70, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 70 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
9204,"{'title': 'Tumor 26', 'description': '07SE514', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
9205,"{'title': 'newly diagnosed multiple myeloma 281', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: PR;\tiss: III'}"
9206,"{'title': 'Transplanted-reperfused liver T2-17', 'description': 'Gene expression data from a frozen liver biopsy obtained during transplantation procedure, 2 hours after reperfusion', 'type': 'RNA', 'source_name_ch1': 'Frozen biopsy from transplanted liver, 2 hours after reperfusion', 'characteristics_ch1': 'tissue: transplanted liver, 2 hours after reperfusion;\tgender: female;\tage: 47 years;\tprotocol: cold ischemia_6h 50min; Warm ischemia_50min'}"
9207,"{'title': 'Clone A cells cultured for 24 hours rep2', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'Huh7 cells with HCV replicon, cultured for 24 hours', 'characteristics_ch1': 'hcv genotype: genotype 1B;\tagent: control;\tconcentration: n/a;\ttime: 24 hours'}"
9208,"{'title': 'C98183', 'description': 'A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).', 'type': 'RNA', 'source_name_ch1': 'Bone marrow specimen from Tumor cells', 'characteristics_ch1': '7219_Tumor;\tfab: M2;\tSex: M;\trace: C;\tage on study: 41;\tcytogenetic change: Normal;\tflt3 d835: 0;\tflt3 itd: 1;\tnpm1 ins: 0'}"
9209,"{'title': 'S130', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S130', 'characteristics_ch1': 'patient id: P006;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): Biopsy;\tpercentage of tumor: 0'}"
9210,"{'title': 'Replicate 2 for MB231inhibitor breast cell line', 'description': 'Cell line, RPMI1640, 10 %FBS, 2mM L-glutamine, 10mM HEPES', 'type': 'RNA', 'source_name_ch1': 'Human cell line', 'characteristics_ch1': 'MB231 mir-221/222 inhibitor at 18h'}"
9211,"{'title': 'Muscle control 9', 'description': 'Vastus lateralis muscle', 'type': 'RNA', 'source_name_ch1': 'Vastus lateralis muscle', 'characteristics_ch1': 'Vastus lateralis muscle'}"
9212,"{'title': 'AML without MLL - sample 104', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
9213,"{'title': 'ALL without MLL - sample 9', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
9214,"{'title': 'Septic Shock_biological rep50 06-0001', 'description': 'Gene expression data from septic shock patient', 'type': 'RNA', 'source_name_ch1': 'Children ≤ 10 years old', 'characteristics_ch1': 'tissue: whole blood;\tdisease state: septic shock patient;\tage (years): 0.3;\toutcome: Survivor;\tgroup: A'}"
9215,"{'title': 'No20inf', 'description': 'Under therapy', 'type': 'RNA', 'source_name_ch1': 'Liver biopsy', 'characteristics_ch1': 'tissue: Liver biopsy;\tgenotype: 1 No20 nonRVR;\ttime point: under therapy'}"
9216,"{'title': 'group-2-pt-t28175962', 'description': 'group-2-pt-t28175962', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 44;\tgender: female;\tfinal disposition: 05: Home with services'}"
9217,"{'title': 'Monocyte cell line, serum and inhibitor 4', 'description': 'Gene expression data from serum stimulation of a human monocyte cell line', 'type': 'RNA', 'source_name_ch1': 'Monocyte cell line (CRL-9853)', 'characteristics_ch1': 'cell line: CRL-9853;\tcell type: monocyte;\tcondition: Added serum and Erk-1/2 inhibitor U0126'}"
9218,"{'title': 'cord blood 19_2', 'description': 'Gene expression data from newborn cord blood', 'type': 'RNA', 'source_name_ch1': 'cord blood arsenic exposure level 0.5', 'characteristics_ch1': 'Cord blood arsenic exposure level 0.5;\t'}"
9219,"{'title': 'KT0525_6_L_test2_test3', 'description': 'KT0525_6_L_test2_test3', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, 6 months, living donor, test set2 and test set3', 'characteristics_ch1': '6 months, living donor, test set2 and test set3'}"
9220,"{'title': 'CD19_selected_B-cells_after_R_rep5', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'CD19 selected B-cells', 'characteristics_ch1': 'treatment: after Rituximab'}"
9221,"{'title': 'Subcutaneous adipose tissue, SAT33', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
9222,"{'title': 'Epilepsy patient E4, 2 hours GC treatment', 'description': 'Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 taken 2 hours after GC administration.;\t;\tE4-2h', 'type': 'RNA', 'source_name_ch1': 'Mononuclear cells, epilepsy patient E4, 2 hours after GC administration', 'characteristics_ch1': 'tissue: peripheral blood;\tcell type: mononuclear cells;\tdisease state: epilepsy, non-leukemic;\ttreatment: dexamethasone;\ttreatment_time: 2 hrs;\tpatient: E4'}"
9223,"{'title': 'T10496H1: Invasive ductal carcinoma (IDC)', 'description': 'frozen breast tissue', 'type': 'RNA', 'source_name_ch1': 'frozen breast tissue', 'characteristics_ch1': 'Invasive ductal carcinoma (IDC)'}"
9224,"{'title': 'MDS patient 131', 'description': 'Gene expression data from bone marrow CD34+ cells', 'type': 'RNA', 'source_name_ch1': 'Bone marrow CD34+ cells', 'characteristics_ch1': 'tissue type: bone marrow;\tcell type: CD34+ hematopoietic stem cells (HSC);\tdisease status: myelodysplastic syndromes (MDS);\tdisease subtype: refractory anemia with excess blasts 1 (RAEB1);\tgenome/variation: normal'}"
9225,"{'title': 'H416 Propiconazole 10uM', 'description': 'H416 Propiconazole 10uM.CEL', 'type': 'RNA', 'source_name_ch1': 'H416 Propiconazole 10uM', 'characteristics_ch1': 'primary hepatocytes'}"
9226,"{'title': 'adipose_postTZD_IRd_s10', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'adipose tissue (abdominal subcutaneous)', 'characteristics_ch1': 'tissue: adipose;\ttzd treatment: postTZD;\tinsulin resistance: IRd (insulin resistant);\tsubject: 10'}"
9227,"{'title': 'PBMCs_EB_before exercise_10', 'description': 'EB_Pre_191-GC', 'type': 'RNA', 'source_name_ch1': 'Early Boys PBMCs before exercise', 'characteristics_ch1': 'PBMCs, healthy male, age 9;\tbefore-exercise'}"
9228,"{'title': 'Lung Cancer 2T', 'description': 'Gene expression data from 2T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 55;\tstage: 1A'}"
9229,"{'title': 'patient Pre ECP, biological rep6', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'GVHD patient Pre ECP', 'characteristics_ch1': 'disease state: graft-versus host disease;\tdose: pre ECP;\tperipheral blood: Leukapheresis'}"
9230,"{'title': 'GA_1012', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  GA at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
9231,"{'title': 'SH-SY5Y(ATCC)_RA_2d_rep2', 'description': 'Sampling of RNA was performed at six different time points (0h, 6h, 1d, 2d, 3d, and 5d, respectively) under RA inducible conditions.', 'type': 'RNA', 'source_name_ch1': 'neuroblastoma cell, retinoic acid (RA), 2day', 'characteristics_ch1': 'Cell line: SH-SY5Y (CRL-2266, obtained from ATCC (American Type Culture Collection Cultures))'}"
9232,"{'title': 'U937_ROS_untreated_4h_rep1', 'description': 'no additional information', 'type': 'RNA', 'source_name_ch1': 'differentiated U937 cells, ROS exposed, 4h', 'characteristics_ch1': 'Immortilised monocyte cell line'}"
9233,"{'title': 'FHC - control 1', 'description': 'A study in patients with familial hypercholesterolemia', 'type': 'RNA', 'source_name_ch1': 'Control 1', 'characteristics_ch1': 'Gender: male;\tAge: 45 years ;\tDisease: none;\tDrugs: none;\tTissue: blood'}"
9234,"{'title': '22061', 'description': '11696', 'type': 'RNA', 'source_name_ch1': 'Lung', 'characteristics_ch1': 'Race: White;\tGender: M;\tTSP_Patient# 24286;\tSmoking_Status: Not Available;\tPathology: Adenocarcinoma'}"
9235,"{'title': 'Tumor 22', 'description': '07SE508', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
9236,"{'title': 'AML 6465', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: female;\tage: 54 years;\tscore: FAB M1;\trisk: cytogenetic intermediate;\tcebpa: wild type;\tkaryotype: Other;\tnpm1: Pos;\tflt3 itd mutation: Pos;\tflt3 tkd mutation: Neg;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: neg'}"
9237,"{'title': 'HF0285_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
9238,"{'title': 'group-1-pt-t24532226', 'description': 'group-1-pt-t24532226', 'type': 'RNA', 'source_name_ch1': 'blood', 'characteristics_ch1': 'age: 26;\tgender: male;\tfinal disposition: 02: Skilled nursing facility'}"
9239,"{'title': 'AML 2170', 'description': 'Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.', 'type': 'RNA', 'source_name_ch1': 'Blasts and mononuclear cells, AML patient', 'characteristics_ch1': 'disease state: Acute myeloid leukemia;\tcell type: blasts and mononuclear cells;\tidh1: neg;\tidh2: neg;\tgender: male;\tage: 54 years;\tscore: FAB M3;\trisk: cytogenetic good;\tcebpa: wild type;\tkaryotype: t(15;17);\tnpm1: Neg;\tflt3 itd mutation: Neg;\tflt3 tkd mutation: Pos;\tn-ras mutation: Neg;\tk-ras mutation: Neg;\tevi1 expression: Neg;\tcebpa mutation: Neg'}"
9240,"{'title': 'Angioimmunoblastic T-cell lymphoma 33', 'description': 'Gene expression data from PTCL pre-treated biopsy.;\tCLN-92', 'type': 'RNA', 'source_name_ch1': 'Pre-treated fresh frozen biopsy, PTCL', 'characteristics_ch1': 'cell type: PTCL;\tage: 70;\tgender: female'}"
9241,"{'title': 'MCF-7 +scrambled siRNA + 100 nM 4-hydroxytamoxifen rep2 (MD34)', 'description': 'Gene expression data from MCF-7cells treated with 100 nM 4-hydroxytamoxifen and scrambled siRNA;\tMD34', 'type': 'RNA', 'source_name_ch1': 'MCF-7cells treated with 100 nM 4-hydroxytamoxifen and scrambled siRNA', 'characteristics_ch1': 'cell line: MCF-7 breast cancer cell line;\tsirna: control (scrambled siRNA);\tagent: 4-hydroxytamoxifen;\tdose: 100 nM'}"
9242,"{'title': 'whole blood_100981', 'description': 'Gene expression in blood of children with autism spectrum disorder (ASD) was studied. Transcriptional profiles were compared with age and gender matched, typically developing children from the general population (GP) or IQ matched children with mental retardation or developmental delay (MR/DD).', 'type': 'RNA', 'source_name_ch1': 'Whole blood - General population, Male', 'characteristics_ch1': 'General population, Male'}"
9243,"{'title': 'class S, rep57', 'description': 'VAN_00442.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 59;\tsex: F;\tdisease stage: 3;\talbumin level: 40;\themoglobin level: 126;\tlymphocyte percentage: 33;\twhite blood count: 7.1;\tinternational prognostic score (ips): 2'}"
9244,"{'title': 'X51005', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IV;\tConsolidated.Grade : 3'}"
9245,"{'title': 'Gingival tissue sample 1 from patient 1, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 1 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
9246,"{'title': 'IFNβ_1136', 'description': 'Gene expression data from total PBMC fraction after Ficoll isolation', 'type': 'RNA', 'source_name_ch1': 'human PBMC treated with  IFNβ at sampling', 'characteristics_ch1': 'tissue: PBMC;\tgenotype icsbp1: 33;\tage: adult'}"
9247,"{'title': 'COL2_112', 'description': 'gene expression data from stage II primary colon adenocarcinoma after surgery only', 'type': 'RNA', 'source_name_ch1': 'colon adenocarcinoma stage II', 'characteristics_ch1': 'tissue: colon adenocarcinoma stage II;\tage at diagnosis: 75;\tgender: F;\tlocalisation: Left;\tmetastasis: 0;\tfirst apc mutation: 499;\tsecond apc mutation: 0;\t5q loh: 1'}"
9248,"{'title': 'NB69 U133p2', 'description': 'RNA from bulk normal breast or normal bresat organoid', 'type': 'RNA', 'source_name_ch1': 'NB69', 'characteristics_ch1': 'bulk normal breast or normal bresat organoid'}"
9249,"{'title': 'Control V3', 'description': 'Validation set', 'type': 'RNA', 'source_name_ch1': 'Circulating mononuclear cells', 'characteristics_ch1': 'Control'}"
9250,"{'title': 'MLD AML sample #31', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells after Ficoll purification', 'characteristics_ch1': 'npm1 mutation: NPM1-mutated;\tdisease state: without MLD;\tflt3-itd mutation: FLT3-wild type;\tcell type: mononuclear cell'}"
9251,"{'title': 'Control 44', 'description': '07SE543', 'type': 'RNA', 'source_name_ch1': 'Human Lung Control', 'characteristics_ch1': 'tissue: lung;\tsample type: control'}"
9252,"{'title': 'Subcutaneous adipose tissue, SAT10', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
9253,"{'title': 'ALL without MLL - sample 17', 'description': 'Gene expression data from pediatric acute leukemia samples at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human white blood cells', 'characteristics_ch1': 'Leukemia samples;\tBone Marrow'}"
9254,"{'title': 'T151 U133p2', 'description': 'bulk breast tumor RNA from patient T151', 'type': 'RNA', 'source_name_ch1': 'T151', 'characteristics_ch1': 'breast tumor'}"
9255,"{'title': 'ALCL_AV_003', 'description': 'Gene expression data from PTCL/U patient at diagnosis', 'type': 'RNA', 'source_name_ch1': 'Human subject, Patient', 'characteristics_ch1': 'Lymph-node biopsy'}"
9256,"{'title': 'newly diagnosed multiple myeloma 242', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: CTA;\tiss: II'}"
9257,"{'title': 'patient Post ECP, biological rep6', 'description': 'Gene expression data', 'type': 'RNA', 'source_name_ch1': 'GVHD patient Post ECP', 'characteristics_ch1': 'disease state: graft-versus host disease;\tdose: post ECP;\tperipheral blood: Treated with ECP and Incubated overnight'}"
9258,"{'title': 'S051', 'description': 'prostate', 'type': 'RNA', 'source_name_ch1': 'prostate, S051', 'characteristics_ch1': 'patient id: P114;\tsample type (t/tumor; biopsy; ctrl/autopsy sample): T;\tpercentage of tumor: 40'}"
9259,"{'title': 'VA135', 'description': '97-14402', 'type': 'RNA', 'source_name_ch1': 'DLBCL', 'characteristics_ch1': 'molecular_subtype_by_gene_expression: ABC;\tpathology: DLBC;\ttissue: lymph node;\tage: 67;\tgender: M;\tipi_stage: 4A;\ttxprimary: CHOP-RITU;\tstatus: lymphoma death;\tcode_os: dead;\tcode_pfs: dead;\toverall_survival (years): 0.94;\tprogression-free_survival (years): 0.59'}"
9260,"{'title': 'HF0445_U133P2', 'description': 'Brain tissue from GBM patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from GBM patient', 'characteristics_ch1': 'GBMs'}"
9261,"{'title': 'BC13742', 'description': '040706-03.CEL', 'type': 'RNA', 'source_name_ch1': 'Breast cancer', 'characteristics_ch1': 'center: Tunis;\ttype: NIBC;\tage of diagnosis (year): 57;\tmolecular subtype: ERBB2;\thistology: --;\tpt: --;\tpn: --;\tgrade sbr: --;\terbb2 ihc status: --;\ter ihc status: --;\tpr ihc status: --;\tp53 ihc status: --;\tki67 ihc status: --;\terbb2.ht ihc status: --;\terbb2.tab ihc status: --;\terbb2p ihc status: --;\tigf1r ihc status: --;\tegfr ihc status: --;\ttop2a ihc status: --;\tfoxa1 ihc status: --;\tmfs: --;\tmfsdel (month): --'}"
9262,"{'title': 'Control-6', 'description': 'ID# from Supplementary Table 3 of PMID 18778695:;\tSc6', 'type': 'RNA', 'source_name_ch1': 'prefrontal cortex', 'characteristics_ch1': 'brain region: BA46;\tstage of illness [short doi=<5 yrs; intermediate doi=7-18yrs; long doi=>28 yrs]: short duration of illness - control;\tSex: M;\tage: 25;\ttissue ph: 6.15;\tpmi (hrs): 35;\ttype of drug: NA;\tdrug dose (chlorpromazine equivalents): NA'}"
9263,"{'title': 'colon_normal_1024', 'description': 'total RNA extracted from cells obtained using biopsy of the colon in a healthy control', 'type': 'RNA', 'source_name_ch1': 'colon biopsy', 'characteristics_ch1': 'biopsy specimen'}"
9264,"{'title': 'PB34_iPS2_1', 'description': 'Gene expression data obtained from PB CD34+ blood iPS', 'type': 'RNA', 'source_name_ch1': 'iPS', 'characteristics_ch1': 'cell type: iPS cells;\tiPS derived from: PB CD34+ blood'}"
9265,"{'title': 'PBMCs vehicle treated for 24 hours,replicate 4', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'PBMCs vehicle treated for 24 hours,replicate 4', 'characteristics_ch1': 'cell type: peripheral blood mononuclear cells'}"
9266,"{'title': 'X23165', 'description': 'Gene expression data from human ovarian carcinoma', 'type': 'RNA', 'source_name_ch1': 'Carcinoma of ovary, fallopian tube or peritonem', 'characteristics_ch1': 'Primary.Site : Ovary;\tType : Malignant;\tSubtype : Ser/PapSer;\tStageCode : IIIC;\tConsolidated.Grade : 2'}"
9267,"{'title': 'HF0670_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: oligodendroglioma, grade 2'}"
9268,"{'title': '22002', 'description': 'Gene expression data from human ovarian tumours', 'type': 'RNA', 'source_name_ch1': 'Ovarian Tumour, Serous LMP', 'characteristics_ch1': 'LMP;\tmutant BRAF;\tGrade High;\tStage IIIB;\tMicropapillary feature Positive;\t(LMP) implants Non-invasive;\tCo-exhistant histology NA;\tLMP Cluster;\tPRIMARY;\tarrayed site Ovary;\tRNA taken from whole tumour sections'}"
9269,"{'title': 'HD2-RPK-0h', 'description': 'biological source:;\thomo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation.', 'type': 'RNA', 'source_name_ch1': 'healthy donor HD2, peripheral blood', 'characteristics_ch1': 'biological source:;\thomo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation.'}"
9270,"{'title': 'AML with normal karyotype #125', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: n./a.;\tage: 56;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 78;\tdisease state: de novo AML'}"
9271,"{'title': 'Healthy volunteer HV9', 'description': 'Healthy volunteer', 'type': 'RNA', 'source_name_ch1': 'Peripheral blood mononuclear cells', 'characteristics_ch1': 'cell type: Peripheral blood mononuclear cells;\tdisease status: Healthy volunteer;\ttherapy: none;\t%cd3cd4: null;\t%cd3cd8: null;\t%cd8+cd28-: null;\t%cd8+cd28+: null;\t%cd4cd25cd62l: null;\t%cd3delta1: null;\t%cd3delta2: null;\tratio delta1/delta2: null;\t%cd3gammadelta: null;\t%cd3alphabeta: null;\t%cd4cd8-ab+(dn): null;\t%cd4 cd62l+cd45+: null;\t%cd4 cd62l-cd45+: null;\t%cd4 cd62l - cd45-: null;\t%cd4cd62l+cd45-: null;\t%cd4 ccr7+ cd45 -: null;\t%cd4 ccr7+ cd45+: null;\t%cd4 ccr7 - cd45+: null;\t%cd4 ccr7 – cd45-: null;\t%cd8 cd62l+ cd45-: null;\t%cd8cd62l+ cd45+: null;\t%cd8cd62l- cd45+: null;\t%cd8cd62l- cd45 -: null;\t%cd8ccr7+ cd45-: null;\t%cd8ccr7+ cd45+: null;\t%cd8ccr7-cd45+: null;\t%cd8ccr7-cd45 -: null;\t%cd3-cd56+cd16+: null;\t%nkts: null;\t%cd19: null;\t%cd4foxp3+: null'}"
9272,"{'title': 'Blood - Sarcoidosis - 050A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 28;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
9273,"{'title': 'Tumor 21', 'description': '07SE506', 'type': 'RNA', 'source_name_ch1': 'Human Lung Tumor', 'characteristics_ch1': 'tissue: lung;\tsample type: tumor'}"
9274,"{'title': 'Gingival tissue sample 2 from patient 39, Affected site', 'description': ""A total of 90 subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among the patients referred for periodontal therapy to the Clinic for Post-doctoral Periodontics, Columbia University College of Dental Medicine. Eligible patients were (i) at least 13 yr old; (ii) had a minimum of 24 teeth present; (iii) had no past history of systematic periodontal therapy other than occasional prophylaxis provided by the referring general dentist, (iv) had received no systemic antibiotics or anti-inflammatory drugs for at least 6 months, (v) harbored a minimum of 4 teeth with radiographic bone loss, (vi) did not suffer from diabetes mellitus, (vii) did not suffer from any of the systemic conditions or genetic disorders that entail a diagnosis of 'Periodontitis as a manifestation of systemic diseases', (viii) were not pregnant, and (ix) were not current users of tobacco products or of nicotine replacement medication. Signed informed consent was obtained prior to enrollment. All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth, using a manual probe. The examination included assessments of presence/absence of dental plaque and bleeding on probing (BoP), and linear measurements of probing pocket depth (PPD) and clinical attachment level (CAL).  'Diseased' sites showed BoP, had an interproximal PPD of>3 mm, and a concomitant CAL of>2 mm. 'Healthy' sites showed no BoP, had PPD of<5 mm and CAL of<3 mm. A software program identified (i) maxillary 'diseased' and 'healthy' interdental papillae, based on the above criteria and (ii) pairs of diseased interdental papillae with similar clinical presentation, i.e., with PPD and CAL within 2 mm of each other. A posterior maxillary sextant encompassing a pair of qualifying 'diseased' interdental papillae was identified.  Periodontal surgery was performed at the identified sextant without any prior supra- or subgingival instrumentation. After infiltration with an appropriate local anesthetic, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and a portion of the underlying connective tissue."", 'type': 'RNA', 'source_name_ch1': 'Patient 39 gingival tissue sample collected as Affected', 'characteristics_ch1': 'Gingival tissue phenotype: Diseased (BoP + interproximal PPD of>3 mm + concomitant CAL of>2 mm);\tTissue: Gingival'}"
9275,"{'title': 'mucosa_carcinoma_9 (micro)', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'colon', 'characteristics_ch1': 'tissue: colon tumor;\ttissue morphology: mucosa;\tmalignacy: carcinoma;\tsex: female'}"
9276,"{'title': 'B63', 'description': 'Gene expression data from breast cancer tumor tissue.', 'type': 'RNA', 'source_name_ch1': 'breast cancer tumor tissue', 'characteristics_ch1': 'ER: neg;\tHER2: pos;\tB-R grade: III;\tnode status: neg;\tLVI: neg;\ttumor type: Ductal;\ttumor size: 3.0'}"
9277,"{'title': 'class S, rep47', 'description': 'VAN_00405.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 40;\tsex: F;\tdisease stage: 3;\talbumin level: _;\themoglobin level: _;\tlymphocyte percentage: 100;\twhite blood count: _;\tinternational prognostic score (ips): 0'}"
9278,"{'title': 'Blood - Sarcoidosis - 001A', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'peripheral blood', 'characteristics_ch1': 'uveitis status: Uveitis;\tgender: Male;\tage: 49;\tset: 1;\ttissue: Blood;\tdisease state: Sarcoidosis'}"
9279,"{'title': 'newly diagnosed multiple myeloma 72', 'description': 'Gene expression data from CD138 purified myeloma plasma cells at diagnosis included in HOVON65/GMMG-HD4', 'type': 'RNA', 'source_name_ch1': 'CD138 purified myeloma plasma cells', 'characteristics_ch1': 'cell type: CD138 purified myeloma plasma cells;\tcluster: MS;\tiss: III'}"
9280,"{'title': 'Bronchial epithelial cells, day 12, donor 2', 'description': 'Bronchial epithelial cells, day 12, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 12 of air-liquid interface culture'}"
9281,"{'title': 'Proficiency_Site4_21', 'description': 'Performed by Operator 1 from Site4 at Proficiency stage', 'type': 'RNA', 'source_name_ch1': 'HEPG2', 'characteristics_ch1': 'HepG2 (liver carcinoma) cell line;\tinput total RNA (ug) = 5ug; cRNA yield (ug) = 65.4; Lot# = 035PO41658D'}"
9282,"{'title': 'class S, rep39', 'description': 'VAN_00367.CEL', 'type': 'RNA', 'source_name_ch1': 'Vancouver sample', 'characteristics_ch1': 'tissue type: lymphoma;\tdisease status: chronic Hodgkin lymphoma;\trelapse type: _;\tage (years): 27;\tsex: F;\tdisease stage: 2;\talbumin level: 38;\themoglobin level: 129;\tlymphocyte percentage: 21;\twhite blood count: 11.2;\tinternational prognostic score (ips): 2'}"
9283,"{'title': 'KT0616_0_L_test1', 'description': 'KT0616_0_L_test1', 'type': 'RNA', 'source_name_ch1': 'kidney allograft biopsy, baseline, living donor, test set1', 'characteristics_ch1': 'baseline, living donor, testset1'}"
9284,"{'title': 'Lung Cancer 94T', 'description': 'Gene expression data from 94T', 'type': 'RNA', 'source_name_ch1': 'frozen tissue of primary tumor', 'characteristics_ch1': 'tissue: lung cancer;\tgender: female;\tage: 56;\tstage: 1A'}"
9285,"{'title': 'Subcutaneous adipose tissue, SAT35', 'description': 'Subcutaneous adipose tissue from 49 unrelated individuals.', 'type': 'RNA', 'source_name_ch1': 'Subcutaneous adipose tissue', 'characteristics_ch1': 'Subcutaneous adipose tissue'}"
9286,"{'title': '01-0022_Septic Shock_day3_218', 'description': '1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved', 'type': 'RNA', 'source_name_ch1': 'Septic Shock_day3', 'characteristics_ch1': 'Whole blood from normal children and children with SIRS, sepsis, or septic shock.'}"
9287,"{'title': 'Bronchial epithelial cells, day 28, donor 1', 'description': 'Bronchial epithelial cells, day 28, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'type': 'RNA', 'source_name_ch1': 'Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy', 'characteristics_ch1': 'Cells were harvested at day 28 of air-liquid interface culture'}"
9288,"{'title': 'Endometrium group A rFSH not pregnant 1', 'description': 'n/a', 'type': 'RNA', 'source_name_ch1': 'Endometrium on day of oocyte retrieval, group A, not pregnant', 'characteristics_ch1': 'treatment: rFSH;\ttissue: endometrium'}"
9289,"{'title': 'AML with normal karyotype #121', 'description': 'MUC', 'type': 'RNA', 'source_name_ch1': 'mononuclear cells from bone marrow', 'characteristics_ch1': 'npm1: positive;\tflt3-itd: negative;\tcebpa: negative;\tage: 73;\tdiagnosis: AML with normal karyotype;\tgender: male;\tspecimen type: Bone Marrow;\tblast cell percentage: 66;\tdisease state: de novo AML'}"
9290,"{'title': ""HUVECs  treated with 4 µg/ml vWF in Hank's buffered salt solution for 4 hours rep 2"", 'description': 'HUVECs activated with vWF', 'type': 'RNA', 'source_name_ch1': 'Human umbilical  vein endothelial cells  treated with vWF in HBSS', 'characteristics_ch1': 'cell type: human umbilical vein endothelial cell'}"
9291,"{'title': 'Patient 5147 AML200', 'description': 'Sample collected at diagnosis.', 'type': 'RNA', 'source_name_ch1': 'bone marrow or peripheral blood sample from child with acute myeloid leukemia', 'characteristics_ch1': 'tissue: bone marrow or peripheral blood;\tpatient id: 200;\tcohort: Validation;\tkaryotype: inv(16);\tflt3-itd: wild type;\tc-kit: wild type;\tn/k-ras: wild type;\tptpn11: wild type;\tnpm1: wild type;\tcebpa: wild type;\tmll-ptd: wild type'}"
9292,"{'title': 'NSCLC EMC LCC2281N', 'description': 'Gene expression data from normal lung', 'type': 'RNA', 'source_name_ch1': 'frozen tissue', 'characteristics_ch1': 'tissue type: healthy;\tcell type: healthy;\toverall survival: Not available;\tstatus: Not available;\tgender: M'}"
9293,"{'title': 'HF1671_U133P2', 'description': 'Brain tissue from glioma patient', 'type': 'RNA', 'source_name_ch1': 'Brain tissue from glioma patient', 'characteristics_ch1': 'Histopathological diagnostic: glioblastoma, grade 4'}"
